ID   NOTC2_MOUSE             Reviewed;        2470 AA.
AC   O35516; Q06008; Q60941;
DT   27-MAR-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   20-DEC-2017, entry version 186.
DE   RecName: Full=Neurogenic locus notch homolog protein 2;
DE            Short=Notch 2;
DE   AltName: Full=Motch B;
DE   Contains:
DE     RecName: Full=Notch 2 extracellular truncation;
DE   Contains:
DE     RecName: Full=Notch 2 intracellular domain;
DE   Flags: Precursor;
GN   Name=Notch2;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Thymus;
RA   Hamada Y., Higuchi M., Tsujimoto Y.;
RT   "Complete amino acid sequence and mutliform transcripts encoded by a
RT   single copy of mouse Notch2 gene.";
RL   Submitted (JUL-1994) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 316-1518.
RC   STRAIN=C57BL/6 X CBA; TISSUE=Embryo;
RX   PubMed=8440332; DOI=10.1006/excr.1993.1044;
RA   Lardelli M., Lendahl U.;
RT   "Motch A and Motch B-two mouse Notch homologues coexpressed in a wide
RT   variety of tissues.";
RL   Exp. Cell Res. 204:364-372(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1765-2153.
RX   PubMed=8917536; DOI=10.1073/pnas.93.23.13014;
RA   Milner L.A., Bigas A., Kopan R., Brashem-Stein C., Bernstein I.D.,
RA   Martin D.I.;
RT   "Inhibition of granulocytic differentiation by mNotch1.";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:13014-13019(1996).
RN   [4]
RP   FUNCTION.
RX   PubMed=10393120;
RA   Hamada Y., Kadokawa Y., Okabe M., Ikawa M., Coleman J.R.,
RA   Tsujimoto Y.;
RT   "Mutation in ankyrin repeats of the mouse Notch2 gene induces early
RT   embryonic lethality.";
RL   Development 126:3415-3424(1999).
RN   [5]
RP   DEVELOPMENTAL STAGE, AND ALTERNATIVE SPLICING.
RX   PubMed=7609614; DOI=10.1016/0169-328X(94)00257-F;
RA   Higuchi M., Kiyama H., Hayakawa T., Hamada Y., Tsujimoto Y.;
RT   "Differential expression of Notch1 and Notch2 in developing and adult
RT   mouse brain.";
RL   Brain Res. Mol. Brain Res. 29:263-272(1995).
RN   [6]
RP   PROTEOLYTIC PROCESSING, AND MUTAGENESIS OF MET-1699.
RX   PubMed=11518718; DOI=10.1074/jbc.M107234200;
RA   Saxena M.T., Schroeter E.H., Mumm J.S., Kopan R.;
RT   "Murine notch homologs (N1-4) undergo presenilin-dependent
RT   proteolysis.";
RL   J. Biol. Chem. 276:40268-40273(2001).
RN   [7]
RP   PROTEOLYTIC PROCESSING, AND MUTAGENESIS OF MET-1699.
RX   PubMed=11459941; DOI=10.1073/pnas.161269998;
RA   Mizutani T., Taniguchi Y., Aoki T., Hashimoto N., Honjo T.;
RT   "Conservation of the biochemical mechanisms of signal transduction
RT   among mammalian Notch family members.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:9026-9031(2001).
RN   [8]
RP   INTERACTION WITH MAML1.
RX   PubMed=15019995; DOI=10.1016/j.gene.2003.12.007;
RA   Wu L., Kobayashi K., Sun T., Gao P., Liu J., Nakamura M., Weisberg E.,
RA   Mukhopadhyay N.K., Griffin J.D.;
RT   "Cloning and functional characterization of the murine mastermind-like
RT   1 (Maml1) gene.";
RL   Gene 328:153-165(2004).
RN   [9]
RP   INTERACTION WITH HIF1AN.
RX   PubMed=17573339; DOI=10.1074/jbc.M704102200;
RA   Coleman M.L., McDonough M.A., Hewitson K.S., Coles C., Mecinovic J.,
RA   Edelmann M., Cook K.M., Cockman M.E., Lancaster D.E., Kessler B.M.,
RA   Oldham N.J., Ratcliffe P.J., Schofield C.J.;
RT   "Asparaginyl hydroxylation of the Notch ankyrin repeat domain by
RT   factor inhibiting hypoxia-inducible factor.";
RL   J. Biol. Chem. 282:24027-24038(2007).
RN   [10]
RP   FUNCTION AS POSITIVE REGULATOR OF OSTEOCLASTOGENESIS, AND INTERACTION
RP   WITH RELA.
RX   PubMed=18710934; DOI=10.1128/MCB.00299-08;
RA   Fukushima H., Nakao A., Okamoto F., Shin M., Kajiya H., Sakano S.,
RA   Bigas A., Jimi E., Okabe K.;
RT   "The association of Notch2 and NF-kappaB accelerates RANKL-induced
RT   osteoclastogenesis.";
RL   Mol. Cell. Biol. 28:6402-6412(2008).
RN   [11]
RP   HYDROXYLATION BY HIF1AN.
RX   PubMed=18299578; DOI=10.1073/pnas.0711591105;
RA   Zheng X., Linke S., Dias J.M., Zheng X., Gradin K., Wallis T.P.,
RA   Hamilton B.R., Gustafsson M., Ruas J.L., Wilkins S., Bilton R.L.,
RA   Brismar K., Whitelaw M.L., Pereira T., Gorman J.J., Ericson J.,
RA   Peet D.J., Lendahl U., Poellinger L.;
RT   "Interaction with factor inhibiting HIF-1 defines an additional mode
RT   of cross-coupling between the Notch and hypoxia signaling pathways.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:3368-3373(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1777; SER-1840 AND
RP   SER-1843, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=19144319; DOI=10.1016/j.immuni.2008.11.006;
RA   Trost M., English L., Lemieux S., Courcelles M., Desjardins M.,
RA   Thibault P.;
RT   "The phagosomal proteome in interferon-gamma-activated macrophages.";
RL   Immunity 30:143-154(2009).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Kidney, and Liver;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and
RT   expression.";
RL   Cell 143:1174-1189(2010).
RN   [14]
RP   GLYCOSYLATION AT SER-611, AND MUTAGENESIS OF SER-612.
RX   PubMed=21949356; DOI=10.1073/pnas.1109696108;
RA   Takeuchi H., Fernandez-Valdivia R.C., Caswell D.S., Nita-Lazar A.,
RA   Rana N.A., Garner T.P., Weldeghiorghis T.K., Macnaughtan M.A.,
RA   Jafar-Nejad H., Haltiwanger R.S.;
RT   "Rumi functions as both a protein O-glucosyltransferase and a protein
RT   O-xylosyltransferase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 108:16600-16605(2011).
CC   -!- FUNCTION: Functions as a receptor for membrane-bound ligands
CC       Jagged1, Jagged2 and Delta1 to regulate cell-fate determination.
CC       Upon ligand activation through the released notch intracellular
CC       domain (NICD) it forms a transcriptional activator complex with
CC       RBPJ/RBPSUH and activates genes of the enhancer of split locus.
CC       Affects the implementation of differentiation, proliferation and
CC       apoptotic programs (By similarity). May play an essential role in
CC       postimplantation development, probably in some aspect of cell
CC       specification and/or differentiation. In collaboration with
CC       RELA/p65 enhances NFATc1 promoter activity and positively
CC       regulates RANKL-induced osteoclast differentiation. Positively
CC       regulates self-renewal of liver cancer cells (By similarity).
CC       {ECO:0000250|UniProtKB:Q04721, ECO:0000269|PubMed:10393120,
CC       ECO:0000269|PubMed:18710934}.
CC   -!- SUBUNIT: Heterodimer of a C-terminal fragment N(TM) and an N-
CC       terminal fragment N(EC) which are probably linked by disulfide
CC       bonds. Interacts with MAML1, MAML2 and MAML3 which act as
CC       transcriptional coactivators for NOTCH2. Interacts with RELA/p65.
CC       Interacts with HIF1AN. Interacts (via ANK repeats) with TCIM, the
CC       interaction inhibits the nuclear translocation of NOTCH2 N2ICD (By
CC       similarity). {ECO:0000250, ECO:0000250|UniProtKB:Q04721,
CC       ECO:0000269|PubMed:15019995, ECO:0000269|PubMed:17573339,
CC       ECO:0000269|PubMed:18710934}.
CC   -!- SUBCELLULAR LOCATION: Notch 2 extracellular truncation: Cell
CC       membrane {ECO:0000250|UniProtKB:Q04721}; Single-pass type I
CC       membrane protein {ECO:0000250|UniProtKB:Q04721}.
CC   -!- SUBCELLULAR LOCATION: Notch 2 intracellular domain: Nucleus
CC       {ECO:0000250|UniProtKB:Q04721}. Cytoplasm
CC       {ECO:0000250|UniProtKB:Q04721}. Note=Following proteolytical
CC       processing NICD is translocated to the nucleus. Retained at the
CC       cytoplasm by TCIM. {ECO:0000250|UniProtKB:Q04721}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O35516-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O35516-2; Sequence=VSP_001405;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in the brain, liver, kidney,
CC       neuroepithelia, somites, optic vesicles and branchial arches, but
CC       not heart.
CC   -!- DEVELOPMENTAL STAGE: Expressed in the embryonic ventricular zone,
CC       the postnatal ependymal cells, and the choroid plexus throughout
CC       embryonic and postnatal development. {ECO:0000269|PubMed:7609614}.
CC   -!- PTM: Synthesized in the endoplasmic reticulum as an inactive form
CC       which is proteolytically cleaved by a furin-like convertase in the
CC       trans-Golgi network before it reaches the plasma membrane to yield
CC       an active, ligand-accessible form. Cleavage results in a C-
CC       terminal fragment N(TM) and a N-terminal fragment N(EC). Following
CC       ligand binding, it is cleaved by TNF-alpha converting enzyme
CC       (TACE) to yield a membrane-associated intermediate fragment called
CC       notch extracellular truncation (NEXT). This fragment is then
CC       cleaved by presenilin dependent gamma-secretase to release a
CC       notch-derived peptide containing the intracellular domain (NICD)
CC       from the membrane. {ECO:0000269|PubMed:11459941,
CC       ECO:0000269|PubMed:11518718}.
CC   -!- PTM: Hydroxylated by HIF1AN. {ECO:0000269|PubMed:18299578}.
CC   -!- PTM: Can be either O-glucosylated or O-xylosylated at Ser-611 by
CC       POGLUT1.
CC   -!- SIMILARITY: Belongs to the NOTCH family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D32210; BAA22094.1; -; mRNA.
DR   EMBL; X68279; CAA48340.1; -; mRNA.
DR   EMBL; U31881; AAC52924.1; -; mRNA.
DR   PIR; A49175; A49175.
DR   RefSeq; NP_035058.2; NM_010928.2.
DR   UniGene; Mm.485843; -.
DR   ProteinModelPortal; O35516; -.
DR   SMR; O35516; -.
DR   BioGrid; 201809; 6.
DR   CORUM; O35516; -.
DR   DIP; DIP-6008N; -.
DR   IntAct; O35516; 2.
DR   STRING; 10090.ENSMUSP00000078741; -.
DR   iPTMnet; O35516; -.
DR   PhosphoSitePlus; O35516; -.
DR   MaxQB; O35516; -.
DR   PaxDb; O35516; -.
DR   PeptideAtlas; O35516; -.
DR   PRIDE; O35516; -.
DR   GeneID; 18129; -.
DR   KEGG; mmu:18129; -.
DR   CTD; 4853; -.
DR   MGI; MGI:97364; Notch2.
DR   eggNOG; ENOG410IR7G; Eukaryota.
DR   eggNOG; COG0666; LUCA.
DR   HOGENOM; HOG000234369; -.
DR   HOVERGEN; HBG052650; -.
DR   InParanoid; O35516; -.
DR   KO; K20994; -.
DR   PhylomeDB; O35516; -.
DR   ChiTaRS; Notch2; mouse.
DR   PRO; PR:O35516; -.
DR   Proteomes; UP000000589; Unplaced.
DR   CleanEx; MM_NOTCH2; -.
DR   GO; GO:0009986; C:cell surface; ISS:UniProtKB.
DR   GO; GO:0005929; C:cilium; IDA:MGI.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISO:MGI.
DR   GO; GO:0016020; C:membrane; ISO:MGI.
DR   GO; GO:0005654; C:nucleoplasm; ISO:MGI.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISO:MGI.
DR   GO; GO:0043235; C:receptor complex; ISO:MGI.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0051059; F:NF-kappaB binding; IPI:UniProtKB.
DR   GO; GO:0004872; F:receptor activity; IEA:InterPro.
DR   GO; GO:0009887; P:animal organ morphogenesis; TAS:UniProtKB.
DR   GO; GO:0060413; P:atrial septum morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0046849; P:bone remodeling; ISO:MGI.
DR   GO; GO:0007050; P:cell cycle arrest; ISS:UniProtKB.
DR   GO; GO:0001709; P:cell fate determination; TAS:UniProtKB.
DR   GO; GO:0016049; P:cell growth; ISO:MGI.
DR   GO; GO:1990705; P:cholangiocyte proliferation; IMP:MGI.
DR   GO; GO:0061073; P:ciliary body morphogenesis; IMP:MGI.
DR   GO; GO:0042742; P:defense response to bacterium; IMP:MGI.
DR   GO; GO:0007368; P:determination of left/right symmetry; IMP:MGI.
DR   GO; GO:0030326; P:embryonic limb morphogenesis; IGI:MGI.
DR   GO; GO:0072104; P:glomerular capillary formation; IEP:UniProtKB.
DR   GO; GO:0072015; P:glomerular visceral epithelial cell development; IEP:UniProtKB.
DR   GO; GO:0001947; P:heart looping; IGI:BHF-UCL.
DR   GO; GO:0072574; P:hepatocyte proliferation; IMP:MGI.
DR   GO; GO:0006959; P:humoral immune response; IGI:MGI.
DR   GO; GO:0001701; P:in utero embryonic development; IMP:MGI.
DR   GO; GO:0002437; P:inflammatory response to antigenic stimulus; IGI:MGI.
DR   GO; GO:0072602; P:interleukin-4 secretion; IGI:MGI.
DR   GO; GO:0035622; P:intrahepatic bile duct development; IMP:MGI.
DR   GO; GO:0070986; P:left/right axis specification; IGI:BHF-UCL.
DR   GO; GO:0001889; P:liver development; IMP:MGI.
DR   GO; GO:0072576; P:liver morphogenesis; IMP:MGI.
DR   GO; GO:0002315; P:marginal zone B cell differentiation; IMP:UniProtKB.
DR   GO; GO:0002011; P:morphogenesis of an epithelial sheet; IMP:MGI.
DR   GO; GO:0035264; P:multicellular organism growth; IMP:MGI.
DR   GO; GO:0043011; P:myeloid dendritic cell differentiation; IMP:MGI.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; ISO:MGI.
DR   GO; GO:0045967; P:negative regulation of growth rate; ISS:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:MGI.
DR   GO; GO:0007219; P:Notch signaling pathway; ISS:UniProtKB.
DR   GO; GO:0060674; P:placenta blood vessel development; IMP:MGI.
DR   GO; GO:0001890; P:placenta development; IMP:MGI.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IGI:MGI.
DR   GO; GO:0030513; P:positive regulation of BMP signaling pathway; IMP:MGI.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IMP:MGI.
DR   GO; GO:0045672; P:positive regulation of osteoclast differentiation; IDA:UniProtKB.
DR   GO; GO:0046579; P:positive regulation of Ras protein signal transduction; ISS:UniProtKB.
DR   GO; GO:0072014; P:proximal tubule development; IEP:UniProtKB.
DR   GO; GO:0003184; P:pulmonary valve morphogenesis; ISO:MGI.
DR   GO; GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IMP:MGI.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0042060; P:wound healing; IDA:UniProtKB.
DR   CDD; cd00204; ANK; 2.
DR   Gene3D; 1.25.40.20; -; 3.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR024600; DUF3454_notch.
DR   InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR000152; EGF-type_Asp/Asn_hydroxyl_site.
DR   InterPro; IPR018097; EGF_Ca-bd_CS.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   InterPro; IPR008297; Notch.
DR   InterPro; IPR035993; Notch-like_dom_sf.
DR   InterPro; IPR022336; Notch_2.
DR   InterPro; IPR000800; Notch_dom.
DR   InterPro; IPR010660; Notch_NOD_dom.
DR   InterPro; IPR011656; Notch_NODP_dom.
DR   Pfam; PF12796; Ank_2; 2.
DR   Pfam; PF11936; DUF3454; 1.
DR   Pfam; PF00008; EGF; 24.
DR   Pfam; PF07645; EGF_CA; 5.
DR   Pfam; PF12661; hEGF; 3.
DR   Pfam; PF06816; NOD; 1.
DR   Pfam; PF07684; NODP; 1.
DR   Pfam; PF00066; Notch; 3.
DR   PIRSF; PIRSF002279; Notch; 1.
DR   PRINTS; PR01452; LNOTCHREPEAT.
DR   PRINTS; PR01985; NOTCH2.
DR   SMART; SM00248; ANK; 6.
DR   SMART; SM01334; DUF3454; 1.
DR   SMART; SM00181; EGF; 35.
DR   SMART; SM00179; EGF_CA; 33.
DR   SMART; SM00004; NL; 3.
DR   SMART; SM01338; NOD; 1.
DR   SMART; SM01339; NODP; 1.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   SUPFAM; SSF57184; SSF57184; 5.
DR   SUPFAM; SSF90193; SSF90193; 2.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 4.
DR   PROSITE; PS00010; ASX_HYDROXYL; 22.
DR   PROSITE; PS00022; EGF_1; 33.
DR   PROSITE; PS01186; EGF_2; 27.
DR   PROSITE; PS50026; EGF_3; 35.
DR   PROSITE; PS01187; EGF_CA; 22.
DR   PROSITE; PS50258; LNR; 3.
PE   1: Evidence at protein level;
KW   Activator; Alternative splicing; ANK repeat; Cell membrane;
KW   Complete proteome; Cytoplasm; Developmental protein; Differentiation;
KW   Disulfide bond; EGF-like domain; Glycoprotein; Membrane;
KW   Notch signaling pathway; Nucleus; Phosphoprotein; Receptor;
KW   Reference proteome; Repeat; Signal; Transcription;
KW   Transcription regulation; Transmembrane; Transmembrane helix.
FT   SIGNAL        1     25       {ECO:0000255}.
FT   CHAIN        26   2470       Neurogenic locus notch homolog protein 2.
FT                                /FTId=PRO_0000007686.
FT   CHAIN      1666   2470       Notch 2 extracellular truncation.
FT                                /FTId=PRO_0000007687.
FT   CHAIN      1697   2470       Notch 2 intracellular domain.
FT                                /FTId=PRO_0000007688.
FT   TOPO_DOM     26   1677       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1678   1698       Helical. {ECO:0000255}.
FT   TOPO_DOM   1699   2470       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       26     63       EGF-like 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN       64    102       EGF-like 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      105    143       EGF-like 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      144    180       EGF-like 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      182    219       EGF-like 5; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      221    256       EGF-like 6; incomplete.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      258    294       EGF-like 7; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      296    334       EGF-like 8; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      336    372       EGF-like 9; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      373    411       EGF-like 10. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      413    452       EGF-like 11; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      454    490       EGF-like 12; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      492    528       EGF-like 13; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      530    566       EGF-like 14; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      568    603       EGF-like 15; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      605    641       EGF-like 16; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      643    678       EGF-like 17; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      680    716       EGF-like 18; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      718    753       EGF-like 19. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      755    791       EGF-like 20; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      793    829       EGF-like 21; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      831    869       EGF-like 22. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      871    907       EGF-like 23; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      909    945       EGF-like 24; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      947    983       EGF-like 25; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      985   1021       EGF-like 26; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN     1023   1059       EGF-like 27; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN     1061   1097       EGF-like 28. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN     1099   1145       EGF-like 29. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN     1147   1183       EGF-like 30; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN     1185   1221       EGF-like 31; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN     1223   1260       EGF-like 32; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN     1262   1300       EGF-like 33. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN     1302   1345       EGF-like 34. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN     1372   1410       EGF-like 35. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   REPEAT     1423   1463       LNR 1.
FT   REPEAT     1464   1500       LNR 2.
FT   REPEAT     1501   1542       LNR 3.
FT   REPEAT     1825   1869       ANK 1.
FT   REPEAT     1874   1903       ANK 2.
FT   REPEAT     1907   1937       ANK 3.
FT   REPEAT     1941   1970       ANK 4.
FT   REPEAT     1974   2003       ANK 5.
FT   REPEAT     2007   2036       ANK 6.
FT   REGION     1423   1677       Negative regulatory region (NRR).
FT                                {ECO:0000250}.
FT   COMPBIAS   1645   1648       Poly-Ala.
FT   COMPBIAS   1992   1995       Poly-Leu.
FT   COMPBIAS   2183   2189       Poly-Ala.
FT   COMPBIAS   2425   2428       Poly-Ser.
FT   COMPBIAS   2445   2450       Poly-Gly.
FT   SITE        612    612       Essential for O-xylosylation.
FT   MOD_RES    1715   1715       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q04721}.
FT   MOD_RES    1777   1777       Phosphoserine.
FT                                {ECO:0000244|PubMed:19144319}.
FT   MOD_RES    1800   1800       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q04721}.
FT   MOD_RES    1802   1802       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q04721}.
FT   MOD_RES    1806   1806       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q04721}.
FT   MOD_RES    1840   1840       Phosphoserine.
FT                                {ECO:0000244|PubMed:19144319}.
FT   MOD_RES    1843   1843       Phosphoserine.
FT                                {ECO:0000244|PubMed:19144319}.
FT   MOD_RES    2068   2068       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q04721}.
FT   MOD_RES    2076   2076       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9QW30}.
FT   MOD_RES    2079   2079       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q04721}.
FT   MOD_RES    2095   2095       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q04721}.
FT   CARBOHYD     46     46       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    155    155       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    611    611       O-linked (Glc...) serine; alternate.
FT                                {ECO:0000269|PubMed:21949356}.
FT   CARBOHYD    611    611       O-linked (Xyl...) serine; alternate.
FT                                {ECO:0000269|PubMed:21949356}.
FT   CARBOHYD    731    731       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1100   1100       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1463   1463       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     28     41       {ECO:0000250}.
FT   DISULFID     35     51       {ECO:0000250}.
FT   DISULFID     53     62       {ECO:0000250}.
FT   DISULFID     68     79       {ECO:0000250}.
FT   DISULFID     73     90       {ECO:0000250}.
FT   DISULFID     92    101       {ECO:0000250}.
FT   DISULFID    109    121       {ECO:0000250}.
FT   DISULFID    115    131       {ECO:0000250}.
FT   DISULFID    133    142       {ECO:0000250}.
FT   DISULFID    148    159       {ECO:0000250}.
FT   DISULFID    153    168       {ECO:0000250}.
FT   DISULFID    170    179       {ECO:0000250}.
FT   DISULFID    186    198       {ECO:0000250}.
FT   DISULFID    192    207       {ECO:0000250}.
FT   DISULFID    209    218       {ECO:0000250}.
FT   DISULFID    228    244       {ECO:0000250}.
FT   DISULFID    246    255       {ECO:0000250}.
FT   DISULFID    262    273       {ECO:0000250}.
FT   DISULFID    267    282       {ECO:0000250}.
FT   DISULFID    284    293       {ECO:0000250}.
FT   DISULFID    300    313       {ECO:0000250}.
FT   DISULFID    307    322       {ECO:0000250}.
FT   DISULFID    324    333       {ECO:0000250}.
FT   DISULFID    340    351       {ECO:0000250}.
FT   DISULFID    345    360       {ECO:0000250}.
FT   DISULFID    362    371       {ECO:0000250}.
FT   DISULFID    377    388       {ECO:0000250}.
FT   DISULFID    382    399       {ECO:0000250}.
FT   DISULFID    401    410       {ECO:0000250}.
FT   DISULFID    417    431       {ECO:0000250}.
FT   DISULFID    425    440       {ECO:0000250}.
FT   DISULFID    442    451       {ECO:0000250}.
FT   DISULFID    458    469       {ECO:0000250}.
FT   DISULFID    463    478       {ECO:0000250}.
FT   DISULFID    480    489       {ECO:0000250}.
FT   DISULFID    496    507       {ECO:0000250}.
FT   DISULFID    501    516       {ECO:0000250}.
FT   DISULFID    518    527       {ECO:0000250}.
FT   DISULFID    534    545       {ECO:0000250}.
FT   DISULFID    539    554       {ECO:0000250}.
FT   DISULFID    556    565       {ECO:0000250}.
FT   DISULFID    572    582       {ECO:0000250}.
FT   DISULFID    577    591       {ECO:0000250}.
FT   DISULFID    593    602       {ECO:0000250}.
FT   DISULFID    609    620       {ECO:0000250}.
FT   DISULFID    614    629       {ECO:0000250}.
FT   DISULFID    631    640       {ECO:0000250}.
FT   DISULFID    647    657       {ECO:0000250}.
FT   DISULFID    652    666       {ECO:0000250}.
FT   DISULFID    668    677       {ECO:0000250}.
FT   DISULFID    684    695       {ECO:0000250}.
FT   DISULFID    689    704       {ECO:0000250}.
FT   DISULFID    706    715       {ECO:0000250}.
FT   DISULFID    722    732       {ECO:0000250}.
FT   DISULFID    727    741       {ECO:0000250}.
FT   DISULFID    743    752       {ECO:0000250}.
FT   DISULFID    759    770       {ECO:0000250}.
FT   DISULFID    764    779       {ECO:0000250}.
FT   DISULFID    781    790       {ECO:0000250}.
FT   DISULFID    797    808       {ECO:0000250}.
FT   DISULFID    802    817       {ECO:0000250}.
FT   DISULFID    819    828       {ECO:0000250}.
FT   DISULFID    835    846       {ECO:0000250}.
FT   DISULFID    840    857       {ECO:0000250}.
FT   DISULFID    859    868       {ECO:0000250}.
FT   DISULFID    875    886       {ECO:0000250}.
FT   DISULFID    880    895       {ECO:0000250}.
FT   DISULFID    897    906       {ECO:0000250}.
FT   DISULFID    913    924       {ECO:0000250}.
FT   DISULFID    918    933       {ECO:0000250}.
FT   DISULFID    935    944       {ECO:0000250}.
FT   DISULFID    951    962       {ECO:0000250}.
FT   DISULFID    956    971       {ECO:0000250}.
FT   DISULFID    973    982       {ECO:0000250}.
FT   DISULFID    989   1000       {ECO:0000250}.
FT   DISULFID    994   1009       {ECO:0000250}.
FT   DISULFID   1011   1020       {ECO:0000250}.
FT   DISULFID   1027   1038       {ECO:0000250}.
FT   DISULFID   1032   1047       {ECO:0000250}.
FT   DISULFID   1049   1058       {ECO:0000250}.
FT   DISULFID   1065   1076       {ECO:0000250}.
FT   DISULFID   1070   1085       {ECO:0000250}.
FT   DISULFID   1087   1096       {ECO:0000250}.
FT   DISULFID   1103   1124       {ECO:0000250}.
FT   DISULFID   1118   1133       {ECO:0000250}.
FT   DISULFID   1135   1144       {ECO:0000250}.
FT   DISULFID   1151   1162       {ECO:0000250}.
FT   DISULFID   1156   1171       {ECO:0000250}.
FT   DISULFID   1173   1182       {ECO:0000250}.
FT   DISULFID   1189   1200       {ECO:0000250}.
FT   DISULFID   1194   1209       {ECO:0000250}.
FT   DISULFID   1211   1220       {ECO:0000250}.
FT   DISULFID   1227   1239       {ECO:0000250}.
FT   DISULFID   1233   1248       {ECO:0000250}.
FT   DISULFID   1250   1259       {ECO:0000250}.
FT   DISULFID   1266   1279       {ECO:0000250}.
FT   DISULFID   1271   1288       {ECO:0000250}.
FT   DISULFID   1290   1299       {ECO:0000250}.
FT   DISULFID   1306   1317       {ECO:0000250}.
FT   DISULFID   1311   1329       {ECO:0000250}.
FT   DISULFID   1331   1344       {ECO:0000250}.
FT   DISULFID   1376   1387       {ECO:0000250}.
FT   DISULFID   1381   1398       {ECO:0000250}.
FT   DISULFID   1400   1409       {ECO:0000250}.
FT   DISULFID   1423   1446       {ECO:0000250}.
FT   DISULFID   1428   1441       {ECO:0000250}.
FT   DISULFID   1437   1453       {ECO:0000250}.
FT   DISULFID   1464   1487       {ECO:0000250}.
FT   DISULFID   1470   1482       {ECO:0000250}.
FT   DISULFID   1478   1494       {ECO:0000250}.
FT   DISULFID   1501   1525       {ECO:0000250}.
FT   DISULFID   1507   1520       {ECO:0000250}.
FT   DISULFID   1516   1532       {ECO:0000250}.
FT   DISULFID   1632   1639       {ECO:0000250}.
FT   VAR_SEQ    1302   1508       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_001405.
FT   MUTAGEN     612    612       S->A: No effect on O-glycosylation by
FT                                POGLUT1. Loss of O-xylosylation.
FT                                {ECO:0000269|PubMed:21949356}.
FT   MUTAGEN    1699   1699       M->L: No effect on NICD processing.
FT                                {ECO:0000269|PubMed:11459941,
FT                                ECO:0000269|PubMed:11518718}.
FT   MUTAGEN    1699   1699       M->V: Decreased NICD processing.
FT                                {ECO:0000269|PubMed:11459941,
FT                                ECO:0000269|PubMed:11518718}.
FT   CONFLICT   1340   1340       L -> C (in Ref. 2; CAA48340).
FT                                {ECO:0000305}.
FT   CONFLICT   1798   1798       S -> R (in Ref. 3; AAC52924).
FT                                {ECO:0000305}.
FT   CONFLICT   1901   1901       R -> A (in Ref. 3; AAC52924).
FT                                {ECO:0000305}.
FT   CONFLICT   1918   1918       G -> A (in Ref. 3; AAC52924).
FT                                {ECO:0000305}.
SQ   SEQUENCE   2470 AA;  265327 MW;  B55A31B35242716D CRC64;
     MPDLRPAALR ALLWLWLCGA GPAHALQCRG GQEPCVNEGT CVTYHNGTGF CRCPEGFLGE
     YCQHRDPCEK NRCQNGGTCV PQGMLGKATC RCAPGFTGED CQYSTSHPCF VSRPCQNGGT
     CHMLSRDTYE CTCQVGFTGK QCQWTDACLS HPCENGSTCT SVASQFSCKC PAGLTGQKCE
     ADINECDIPG RCQHGGTCLN LPGSYRCQCG QGFTGQHCDS PYVRGLPCVN GGTCRQTGDF
     TLECNCLPGF EGSTCERNID DCPNHKCQNG GVCVDGVNTY NCRCPPQWTG QFCTEDVDEC
     LLQPNACQNG GTCTNRNGGY GCVCVNGWSG DDCSENIDDC AYASCTPGST CIDRVASFSC
     LCPEGKAGLL CHLDDACISN PCHKGALCDT NPLNGQYICT CPQGYKGADC TEDVDECAMA
     NSNPCEHAGK CVNTDGAFHC ECLKGYAGPR CEMDINECHS DPCQNDATCL DKIGGFTCLC
     MPGFKGVHCE LEVNECQSNP CVNNGQCVDK VNRFQCLCPP GFTGPVCQID IDDCSSTPCL
     NGAKCIDHPN GYECQCATGF TGILCDENID NCDPDPCHHG QCQDGIDSYT CICNPGYMGA
     ICSDQIDECY SSPCLNDGRC IDLVNGYQCN CQPGTSGLNC EINFDDCASN PCMHGVCVDG
     INRYSCVCSP GFTGQRCNID IDECASNPCR KGATCINDVN GFRCICPEGP HHPSCYSQVN
     ECLSNPCIHG NCTGGLSGYK CLCDAGWVGV NCEVDKNECL SNPCQNGGTC NNLVNGYRCT
     CKKGFKGYNC QVNIDECASN PCLNQGTCFD DVSGYTCHCM LPYTGKNCQT VLAPCSPNPC
     ENAAVCKEAP NFESFSCLCA PGWQGKRCTV DVDECISKPC MNNGVCHNTQ GSYVCECPPG
     FSGMDCEEDI NDCLANPCQN GGSCVDHVNT FSCQCHPGFI GDKCQTDMNE CLSEPCKNGG
     TCSDYVNSYT CTCPAGFHGV HCENNIDECT ESSCFNGGTC VDGINSFSCL CPVGFTGPFC
     LHDINECSSN PCLNAGTCVD GLGTYRCICP LGYTGKNCQT LVNLCSRSPC KNKGTCVQEK
     ARPHCLCPPG WDGAYCDVLN VSCKAAALQK GVPVEHLCQH SGICINAGNT HHCQCPLGYT
     GSYCEEQLDE CASNPCQHGA TCNDFIGGYR CECVPGYQGV NCEYEVDECQ NQPCQNGGTC
     IDLVNHFKCS CPPGTRGLLC EENIDECAGG PHCLNGGQCV DRIGGYTCRC LPGFAGERCE
     GDINECLSNP CSSEGSLDCV QLKNNYNCIC RSAFTGRHCE TFLDVCPQKP CLNGGTCAVA
     SNMPDGFICR CPPGFSGARL QSSCGQVKCR RGEQCIHTDS GPRCFCLNPK DCESGCASNP
     CQHGGTCYPQ RQPPHYSCRC PPSFGGSHCE LYTAPTSTPP ATCQSQYCAD KARDGICDEA
     CNSHACQWDG GDCSLTMEDP WANCTSTLRC WEYINNQCDE QCNTAECLFD NFECQRNSKT
     CKYDKYCADH FKDNHCDQGC NSEECGWDGL DCASDQPENL AEGTLIIVVL LPPEQLLQDS
     RSFLRALGTL LHTNLRIKQD SQGALMVYPY FGEKSAAMKK QKMTRRSLPE EQEQEQEVIG
     SKIFLEIDNR QCVQDSDQCF KNTDAAAALL ASHAIQGTLS YPLVSVFSEL ESPRNAQLLY
     LLAVAVVIIL FFILLGVIMA KRKQAWLPLA AGRFTLRRDS SNHKRREPVG QDAVGLKNLS
     VQVSEANLIG SGTSEHWVDD EGPQPKKAKA EDEALLSEDD PIDRRPWTQQ HLEAADISHT
     PSLALTPPQA EQEVDVLDVN VRGPDGCTPL MLASLRGGSS DLSDEDEDAE DSSANIITDL
     VYQGASLQAQ TDRTGEMALH LAARYSRADA AKRLLDAGAD RNAQDNMGRC PLHAAVAGDA
     QGVFQILIRN RVTDLDARMN DGTTPLILAA RLAVEGMVAE LINCQADVNA VDDHGKSALH
     WAAAVNNVEA TLLLLKNGAN RDMQDNKEET PLFLAAREGS YEAAKILLDH FANRDITDHM
     DRLPRDVARD RMHHDIVRLL DEYNVTPSPP GTVLTSALSP VLCGPNRSFL SLKHTPMGKK
     ARRPNTKSTM PTSLPNLAKE AKDAKGSRRK KCLNEKVQLS ESSVTLSPVD SLESPHTYVS
     DATSSPMITS PGILQASPTP LLAAAAPAAP VHTQHALSFS NLHDMQPLAP GASTVLPSVS
     QLLSHHHIAP PGSSSAGSLG RLHPVPVPAD WMNRVEMNET QYSEMFGMVL APAEGAHPGI
     AAPQSRPPEG KHMSTQREPL PPIVTFQLIP KRSIAQAAGA PQTQSSCPPA VAGPLPSMYQ
     IPEMPRLPSV AFPPTMMPQQ EGQVAQTIVP TYHPFPASVG KYPTPPSQHS YASSNAAERT
     PSHGGHLQGE HPYLTPSPES PDQWSSSSPH SASDWSDVTT SPTPGGGGGG QRGPGTHMSE
     PPHSNMQVYA
//
ID   SE1L1_MOUSE             Reviewed;         790 AA.
AC   Q9Z2G6; Q9DBD8;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   27-APR-2001, sequence version 2.
DT   22-NOV-2017, entry version 145.
DE   RecName: Full=Protein sel-1 homolog 1;
DE   AltName: Full=Suppressor of lin-12-like protein 1;
DE            Short=Sel-1L;
DE   Flags: Precursor;
GN   Name=Sel1l; Synonyms=Sel1h;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND TISSUE SPECIFICITY.
RX   PubMed=9858735; DOI=10.1016/S0925-4773(98)00146-4;
RA   Donoviel D.B., Donoviel M.S., Fan E., Hadjantonakis A.-K.,
RA   Bernstein A.;
RT   "Cloning and characterization of Sel-1l, a murine homolog of the C.
RT   elegans sel-1 gene.";
RL   Mech. Dev. 78:203-207(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   STRAIN=C57BL/6J; TISSUE=Liver;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   FUNCTION, DEVELOPMENTAL STAGE, AND MISCELLANEOUS.
RX   PubMed=20170518; DOI=10.1186/1471-213X-10-19;
RA   Li S., Francisco A.B., Munroe R.J., Schimenti J.C., Long Q.;
RT   "SEL1L deficiency impairs growth and differentiation of pancreatic
RT   epithelial cells.";
RL   BMC Dev. Biol. 10:19-19(2010).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Brown adipose tissue, Heart, Kidney, Liver, Lung,
RC   Pancreas, Spleen, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and
RT   expression.";
RL   Cell 143:1174-1189(2010).
RN   [5]
RP   DISRUPTION PHENOTYPE, FUNCTION, TISSUE SPECIFICITY, GLYCOSYLATION, AND
RP   INTERACTION WITH SYVN1; LPL AND LMF1.
RX   PubMed=25066055; DOI=10.1016/j.cmet.2014.06.015;
RA   Sha H., Sun S., Francisco A.B., Ehrhardt N., Xue Z., Liu L.,
RA   Lawrence P., Mattijssen F., Guber R.D., Panhwar M.S., Brenna J.T.,
RA   Shi H., Xue B., Kersten S., Bensadoun A., Peterfy M., Long Q., Qi L.;
RT   "The ER-associated degradation adaptor protein Sel1L regulates LPL
RT   secretion and lipid metabolism.";
RL   Cell Metab. 20:458-470(2014).
RN   [6]
RP   DISRUPTION PHENOTYPE, FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=24453213; DOI=10.1073/pnas.1318114111;
RA   Sun S., Shi G., Han X., Francisco A.B., Ji Y., Mendonca N., Liu X.,
RA   Locasale J.W., Simpson K.W., Duhamel G.E., Kersten S., Yates J.R. III,
RA   Long Q., Qi L.;
RT   "Sel1L is indispensable for mammalian endoplasmic reticulum-associated
RT   degradation, endoplasmic reticulum homeostasis, and survival.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:E582-E591(2014).
RN   [7] {ECO:0000244|PDB:5B26}
RP   X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) OF 348-533, SUBUNIT,
RP   INTERACTION WITH SYVN1, REGION, AND MUTAGENESIS OF 512-GLY-GLY-513;
RP   515-ILE-LEU-516; TYR-519 AND LEU-521.
RX   PubMed=27064360; DOI=10.1038/srep20261;
RA   Jeong H., Sim H.J., Song E.K., Lee H., Ha S.C., Jun Y., Park T.J.,
RA   Lee C.;
RT   "Crystal structure of SEL1L: Insight into the roles of SLR motifs in
RT   ERAD pathway.";
RL   Sci. Rep. 6:20261-20261(2016).
CC   -!- FUNCTION: Plays a role in the endoplasmic reticulum quality
CC       control (ERQC) system also called ER-associated degradation (ERAD)
CC       involved in ubiquitin-dependent degradation of misfolded
CC       endoplasmic reticulum proteins (PubMed:25066055, PubMed:24453213).
CC       Enhances SYVN1 stability (PubMed:24453213). Plays a role in LPL
CC       maturation and secretion (PubMed:25066055). Required for normal
CC       differentiation of the pancreas epithelium, and for normal
CC       exocrine function and survival of pancreatic cells
CC       (PubMed:20170518, PubMed:24453213). May play a role in Notch
CC       signaling (PubMed:20170518). {ECO:0000269|PubMed:20170518,
CC       ECO:0000269|PubMed:24453213, ECO:0000269|PubMed:25066055}.
CC   -!- SUBUNIT: Homodimer and homooligomer (PubMed:27064360). Interacts
CC       with SYVN1; the interaction is direct (PubMed:25066055,
CC       PubMed:27064360). Part of a complex containing SEL1L, SYVN1 and
CC       DERL2. May form a complex with ERLEC1, HSPA5, OS9, and SYVN1.
CC       Interacts with FOXRED2 and EDEM1 (By similarity). Interacts with
CC       LPL and LMF1; may stabilize the complex formed by LPL and LMF1 and
CC       thereby promote the export of LPL dimers (PubMed:25066055).
CC       {ECO:0000250|UniProtKB:Q9UBV2, ECO:0000269|PubMed:25066055,
CC       ECO:0000269|PubMed:27064360}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:Q9UBV2}; Single-pass type I membrane
CC       protein {ECO:0000250|UniProtKB:Q9UBV2}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9Z2G6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9Z2G6-2; Sequence=VSP_004384;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Highly expressed in pancreas, white adipose
CC       tissue, liver and spleen (at protein level) (PubMed:25066055,
CC       PubMed:24453213). Detected in heart, brain, spleen, lung, liver,
CC       kidney and testis (PubMed:9858735). {ECO:0000269|PubMed:24453213,
CC       ECO:0000269|PubMed:25066055, ECO:0000269|PubMed:9858735}.
CC   -!- DEVELOPMENTAL STAGE: First detected at 12.5 dpc in a small number
CC       of pancreas epithelial cells. Highly expressed in embryonic
CC       pancreas epithelium at later stages of embryonic development.
CC       {ECO:0000269|PubMed:20170518}.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:25066055}.
CC   -!- DISRUPTION PHENOTYPE: Taxomifen-inducible gene disruption in adult
CC       mice leads to premature death within 3 weeks after the onset of
CC       taxomifen treatment. Mice progressively loose weight and become
CC       moribund despite increased food intake and normal blood glucose
CC       levels, suggesting nutrient maladsorption. After eight days of
CC       treatment, the pancreas was diffusely dark red and soft,
CC       suggesting severe pancreas atrophy. Still, the endocrine parts of
CC       the pancreas were not affected. Pancreas weight was about half of
CC       that of wild-type, the size of secretory zymogen granules was
CC       reduced and pancreatic lipase and alpha-amylase levels were
CC       strongly reduced. Besides, the morphology of the endoplasmic
CC       reticulum in pancreas acinar cells was abnormal, with swollen and
CC       fragmented cisternae. Likewise, SYVN1 protein levels are
CC       decreased, while those of other ERAD markers are increased
CC       (PubMed:24453213). Adipocyte-specific gene disruption does not
CC       give rise to any obvious phenotype when mice are kept on a low-fat
CC       diet. Mutant mice are resistant to diet-induced obesity when kept
CC       on a high-fat diet, in spite of normal food intake and physical
CC       activity. Mutant mice show dramatically reduced accumulation of
CC       fat mass relative to wild-type, while lean mass is not affected.
CC       Intriguingly, mutant mice display enlarged livers that develop
CC       steatosis and increased triglyceride levels. Mutant mice display
CC       increased fasting serum triglyceride and insulin levels. Likewise,
CC       mutant mice display hypertriglyceridemia after feeding, especially
CC       on a high-fat diet. In spite of increased cellular LPL levels, LPL
CC       secretion is reduced by 80 to 90% (PubMed:25066055).
CC       {ECO:0000269|PubMed:24453213, ECO:0000269|PubMed:25066055}.
CC   -!- MISCELLANEOUS: Gene disruption after residue 465 and replacement
CC       of the C-terminus with a beta-galactosidase-neomycin reporter gene
CC       construct leads to complete embryonic lethality; most die before
CC       13.5 dpc. Only 5% of the embryos are viable at 15.5 dpc. Mutant
CC       embryos display defects in the differentiation of the pancreas
CC       epithelium. The defects in pancreas differentiation can be
CC       alleviated by pharmacological inhibition of Notch signaling (in
CC       vitro). {ECO:0000269|PubMed:20170518}.
CC   -!- SIMILARITY: Belongs to the sel-1 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF063095; AAD05210.1; -; mRNA.
DR   EMBL; AK005023; BAB23750.1; -; mRNA.
DR   CCDS; CCDS26091.1; -. [Q9Z2G6-1]
DR   CCDS; CCDS49137.1; -. [Q9Z2G6-2]
DR   RefSeq; NP_001034178.1; NM_001039089.1. [Q9Z2G6-1]
DR   RefSeq; NP_035474.1; NM_011344.2. [Q9Z2G6-2]
DR   UniGene; Mm.250605; -.
DR   PDB; 5B26; X-ray; 2.60 A; A/B/C/D=348-533.
DR   PDBsum; 5B26; -.
DR   ProteinModelPortal; Q9Z2G6; -.
DR   SMR; Q9Z2G6; -.
DR   BioGrid; 203153; 5.
DR   DIP; DIP-61846N; -.
DR   IntAct; Q9Z2G6; 8.
DR   MINT; MINT-4134046; -.
DR   STRING; 10090.ENSMUSP00000021347; -.
DR   iPTMnet; Q9Z2G6; -.
DR   PhosphoSitePlus; Q9Z2G6; -.
DR   PaxDb; Q9Z2G6; -.
DR   PRIDE; Q9Z2G6; -.
DR   Ensembl; ENSMUST00000021347; ENSMUSP00000021347; ENSMUSG00000020964. [Q9Z2G6-1]
DR   Ensembl; ENSMUST00000167466; ENSMUSP00000129384; ENSMUSG00000020964. [Q9Z2G6-2]
DR   GeneID; 20338; -.
DR   KEGG; mmu:20338; -.
DR   UCSC; uc007oky.1; mouse. [Q9Z2G6-1]
DR   CTD; 6400; -.
DR   MGI; MGI:1329016; Sel1l.
DR   eggNOG; KOG1550; Eukaryota.
DR   eggNOG; COG0790; LUCA.
DR   GeneTree; ENSGT00530000063170; -.
DR   HOVERGEN; HBG057766; -.
DR   InParanoid; Q9Z2G6; -.
DR   KO; K14026; -.
DR   OMA; LAQMAMG; -.
DR   OrthoDB; EOG091G0315; -.
DR   TreeFam; TF315257; -.
DR   Reactome; R-MMU-382556; ABC-family proteins mediated transport.
DR   Reactome; R-MMU-5358346; Hedgehog ligand biogenesis.
DR   Reactome; R-MMU-901032; ER Quality Control Compartment (ERQC).
DR   ChiTaRS; Sel1l; mouse.
DR   PRO; PR:Q9Z2G6; -.
DR   Proteomes; UP000000589; Chromosome 12.
DR   Bgee; ENSMUSG00000020964; -.
DR   CleanEx; MM_SEL1L; -.
DR   ExpressionAtlas; Q9Z2G6; baseline and differential.
DR   Genevisible; Q9Z2G6; MM.
DR   GO; GO:0036513; C:Derlin-1 retrotranslocation complex; ISO:MGI.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0000839; C:Hrd1p ubiquitin ligase ERAD-L complex; ISS:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0036503; P:ERAD pathway; IMP:UniProtKB.
DR   GO; GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0009306; P:protein secretion; IMP:UniProtKB.
DR   GO; GO:0034976; P:response to endoplasmic reticulum stress; IMP:MGI.
DR   GO; GO:0030970; P:retrograde protein transport, ER to cytosol; ISO:MGI.
DR   GO; GO:0006641; P:triglyceride metabolic process; IMP:UniProtKB.
DR   CDD; cd00062; FN2; 1.
DR   Gene3D; 2.10.10.10; -; 1.
DR   InterPro; IPR000562; FN_type2_dom.
DR   InterPro; IPR036943; FN_type2_sf.
DR   InterPro; IPR013806; Kringle-like.
DR   InterPro; IPR006597; Sel1-like.
DR   Pfam; PF00040; fn2; 1.
DR   Pfam; PF08238; Sel1; 12.
DR   SMART; SM00059; FN2; 1.
DR   SMART; SM00671; SEL1; 11.
DR   SUPFAM; SSF57440; SSF57440; 1.
DR   PROSITE; PS00023; FN2_1; 1.
DR   PROSITE; PS51092; FN2_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Disulfide bond;
KW   Endoplasmic reticulum; Glycoprotein; Membrane;
KW   Notch signaling pathway; Phosphoprotein; Reference proteome; Repeat;
KW   Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL        1     21       {ECO:0000255}.
FT   CHAIN        22    790       Protein sel-1 homolog 1.
FT                                /FTId=PRO_0000022296.
FT   TOPO_DOM     22    734       Lumenal. {ECO:0000255}.
FT   TRANSMEM    735    755       Helical. {ECO:0000255}.
FT   TOPO_DOM    756    790       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      118    166       Fibronectin type-II.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00479}.
FT   REPEAT      179    214       Sel1-like 1.
FT   REPEAT      215    250       Sel1-like 2.
FT   REPEAT      251    286       Sel1-like 3.
FT   REPEAT      287    322       Sel1-like 4.
FT   REPEAT      369    405       Sel1-like 5.
FT   REPEAT      406    442       Sel1-like 6.
FT   REPEAT      443    478       Sel1-like 7.
FT   REPEAT      479    514       Sel1-like 8.
FT   REPEAT      515    550       Sel1-like 9.
FT   REPEAT      623    658       Sel1-like 10.
FT   REPEAT      660    695       Sel1-like 11.
FT   REGION       23    733       Interaction with ERLEC1, OS9 and SYVN1.
FT                                {ECO:0000250}.
FT   REGION      348    533       Important for homodimerization and
FT                                oligomerization.
FT                                {ECO:0000269|PubMed:27064360}.
FT   REGION      639    719       Interaction with SYVN1.
FT                                {ECO:0000269|PubMed:27064360}.
FT   REGION      734    790       Mediates retention in the endoplasmic
FT                                reticulum. {ECO:0000250}.
FT   COMPBIAS    766    789       Pro-rich.
FT   MOD_RES      64     64       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9UBV2}.
FT   CARBOHYD    191    191       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    213    213       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    268    268       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    427    427       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    604    604       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    123    149       {ECO:0000255|PROSITE-ProRule:PRU00479}.
FT   DISULFID    137    164       {ECO:0000255|PROSITE-ProRule:PRU00479}.
FT   VAR_SEQ     116    166       GTAHGEPCHFPFLFLDKEYDECTSDGREDGRLWCATTYDYK
FT                                TDEKWGFCET -> A (in isoform 2).
FT                                {ECO:0000303|PubMed:9858735}.
FT                                /FTId=VSP_004384.
FT   MUTAGEN     512    513       GG->KK: Abolishes homodimerization.
FT                                {ECO:0000269|PubMed:27064360}.
FT   MUTAGEN     515    516       IL->AA: Abolishes homodimerization; when
FT                                associated with A-519.
FT                                {ECO:0000269|PubMed:27064360}.
FT   MUTAGEN     519    519       Y->A: Abolishes homodimerization; when
FT                                associated with 515-A-A-516.
FT                                {ECO:0000269|PubMed:27064360}.
FT   MUTAGEN     521    521       L->A: Abolishes homodimerization.
FT                                {ECO:0000269|PubMed:27064360}.
FT   HELIX       354    365       {ECO:0000244|PDB:5B26}.
FT   HELIX       369    381       {ECO:0000244|PDB:5B26}.
FT   HELIX       390    402       {ECO:0000244|PDB:5B26}.
FT   HELIX       406    417       {ECO:0000244|PDB:5B26}.
FT   STRAND      421    423       {ECO:0000244|PDB:5B26}.
FT   HELIX       427    439       {ECO:0000244|PDB:5B26}.
FT   HELIX       443    454       {ECO:0000244|PDB:5B26}.
FT   STRAND      457    459       {ECO:0000244|PDB:5B26}.
FT   HELIX       463    475       {ECO:0000244|PDB:5B26}.
FT   HELIX       479    490       {ECO:0000244|PDB:5B26}.
FT   STRAND      493    496       {ECO:0000244|PDB:5B26}.
FT   HELIX       499    510       {ECO:0000244|PDB:5B26}.
FT   HELIX       517    521       {ECO:0000244|PDB:5B26}.
SQ   SEQUENCE   790 AA;  88340 MW;  47869F2AFB59B936 CRC64;
     MQVRVRLSLL LLCAVLLGSA AATSDDKTNQ DDSLDSKSSL PTDESVKDHT TTGKVVAGQI
     FVDSEEAEVE SLLQDEEDSS KTQEEEISFL ESPNPSSKTY EELKRVRKPV LTAIEGTAHG
     EPCHFPFLFL DKEYDECTSD GREDGRLWCA TTYDYKTDEK WGFCETEEDA AKRRQMQEAE
     MIYQAGMKIL NGSNRKSQKR EAYRYLQKAA GMNHTKALER VSYALLFGDY LTQNIQAAKE
     MFEKLTEEGS PKGQTGLGFL YASGLGVNSS QAKALVYYTF GALGGNLIAH MILGYRYWAG
     IGVLQSCESA LTHYRLVANH VASDISLTGG SVVQRIRLPD EVENPGMNSG MLEEDLIQYY
     QFLAEKGDVQ AQVGLGQLHL HGGRGVEQNH QRAFDYFNLA ANAGNSHAMA FLGKMYSEGS
     DIVPQSNETA LHYFKKAADM GNPVGQSGLG MAYLYGRGVQ VNYDLALKYF QKAAEQGWVD
     GQLQLGSMYY NGIGVKRDYK QALKYFNLAS QGGHILAFYN LAQMHASGTG VMRSCHTAVE
     LFKNVCERGR WSERLMTAYN SYKDEDYNAA VVQYLLLAEQ GYEVAQSNAA FILDQREATI
     VGENETYPRA LLHWNRAASQ GYTVARIKLG DYHFYGFGTD VDYETAFIHY RLASEQQHSA
     QAMFNLGYMH EKGLGIKQDI HLAKRFYDMA AEASPDAQVP VFLALCKLGV VYFLQYIREA
     NIRDLFTQLD MDQLLGPEWD LYLMTIIALL LGTVIAYRQR QHQDIPVPRP PGPRPAPPQQ
     EGPPEQQPPQ
//
ID   NICA_DROME              Reviewed;         695 AA.
AC   Q9VC27;
DT   11-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   27-APR-2001, sequence version 3.
DT   25-OCT-2017, entry version 135.
DE   RecName: Full=Nicastrin {ECO:0000303|PubMed:10993067};
DE   Flags: Precursor;
GN   Name=Nct {ECO:0000312|FlyBase:FBgn0039234}; Synonyms=NCSTN;
GN   ORFNames=CG7012 {ECO:0000312|FlyBase:FBgn0039234};
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha;
OC   Ephydroidea; Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=10993067; DOI=10.1038/35024009;
RA   Yu G., Nishimura M., Arawaka S., Levitan D., Zhang L., Tandon A.,
RA   Song Y.-Q., Rogaeva E., Chen F., Kawarai T., Supala A., Levesque L.,
RA   Yu H., Yang D.-S., Holmes E., Milman P., Liang Y., Zhang D.M.,
RA   Xu D.H., Sato C., Rogaev E., Smith M., Janus C., Zhang Y.,
RA   Aebersold R., Farrer L.S., Sorbi S., Bruni A., Fraser P.E.,
RA   St George-Hyslop P.H.;
RT   "Nicastrin modulates presenilin-mediated notch/glp-1 signal
RT   transduction and betaAPP processing.";
RL   Nature 407:48-54(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley;
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X.,
RA   Brandon R.C., Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D.,
RA   Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G.,
RA   Abril J.F., Agbayani A., An H.-J., Andrews-Pfannkoch C., Baldwin D.,
RA   Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M.,
RA   Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S.,
RA   Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P.,
RA   Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I.,
RA   Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P.,
RA   de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M.,
RA   Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P.,
RA   Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W.,
RA   Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K.,
RA   Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J.,
RA   Hostin D., Houston K.A., Howland T.J., Wei M.-H., Ibegwam C.,
RA   Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A.,
RA   Kimmel B.E., Kodira C.D., Kraft C.L., Kravitz S., Kulp D., Lai Z.,
RA   Lasko P., Lei Y., Levitsky A.A., Li J.H., Li Z., Liang Y., Lin X.,
RA   Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D.,
RA   Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A.,
RA   Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L.,
RA   Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M.,
RA   Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G.,
RA   Reinert K., Remington K., Saunders R.D.C., Scheeler F., Shen H.,
RA   Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E.,
RA   Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X.,
RA   Wang Z.-Y., Wassarman D.A., Weinstock G.M., Weissenbach J.,
RA   Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A.,
RA   Ye J., Yeh R.-F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L.,
RA   Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S.C., Zhu X.,
RA   Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q.,
RA   Stapleton M., Yamada C., Ashburner M., Gelbart W.M., Rubin G.M.,
RA   Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a
RT   systematic review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=Berkeley; TISSUE=Embryo;
RA   Stapleton M., Brokstein P., Hong L., Agbayani A., Carlson J.W.,
RA   Champe M., Chavez C., Dorsett V., Dresnek D., Farfan D., Frise E.,
RA   George R.A., Gonzalez M., Guarin H., Kronmiller B., Li P.W., Liao G.,
RA   Miranda A., Mungall C.J., Nunoo J., Pacleb J.M., Paragas V., Park S.,
RA   Patel S., Phouanenavong S., Wan K.H., Yu C., Lewis S.E., Rubin G.M.,
RA   Celniker S.E.;
RL   Submitted (JAN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   FUNCTION IN NOTCH SIGNALING.
RX   PubMed=11781576; DOI=10.1038/ncb1201-1129;
RA   Chung H.-M., Struhl G.;
RT   "Nicastrin is required for Presenilin-mediated transmembrane cleavage
RT   in Drosophila.";
RL   Nat. Cell Biol. 3:1129-1132(2001).
RN   [6]
RP   FUNCTION IN THE GAMMA-SECRETASE COMPLEX.
RX   PubMed=11782315; DOI=10.1016/S1534-5807(01)00105-8;
RA   Hu Y., Ye Y., Fortini M.E.;
RT   "Nicastrin is required for gamma-secretase cleavage of the Drosophila
RT   Notch receptor.";
RL   Dev. Cell 2:69-78(2002).
RN   [7]
RP   FUNCTION IN NOTCH SIGNALING.
RX   PubMed=11782316; DOI=10.1016/S1534-5807(01)00109-5;
RA   Lopez-Schier H., St Johnston D.;
RT   "Drosophila nicastrin is essential for the intramembranous cleavage of
RT   notch.";
RL   Dev. Cell 2:79-89(2002).
RN   [8]
RP   FUNCTION IN THE GAMMA-SECRETASE COMPLEX, AND INTERACTION WITH PSN;
RP   PEN-2 AND APH-1.
RX   PubMed=12660785; DOI=10.1038/nature01506;
RA   Takasugi N., Tomita T., Hayashi I., Tsuruoka M., Niimura M.,
RA   Takahashi Y., Thinakaran G., Iwatsubo T.;
RT   "The role of presenilin cofactors in the gamma-secretase complex.";
RL   Nature 422:438-441(2003).
CC   -!- FUNCTION: Essential subunit of the gamma-secretase complex, an
CC       endoprotease complex that catalyzes the intramembrane cleavage of
CC       integral membrane proteins such as Notch. It probably represents a
CC       stabilizing cofactor required for the assembly of the gamma-
CC       secretase complex. {ECO:0000269|PubMed:11781576,
CC       ECO:0000269|PubMed:11782315, ECO:0000269|PubMed:11782316,
CC       ECO:0000269|PubMed:12660785}.
CC   -!- SUBUNIT: Component of the gamma-secretase complex, a complex
CC       composed of a presenilin (Psn) homodimer, nicastrin (Nct), Aph-1
CC       and Pen-2.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250}; Single-pass type I
CC       membrane protein {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the nicastrin family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAO25002.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF240470; AAG11414.1; -; mRNA.
DR   EMBL; AE014297; AAF56349.2; -; Genomic_DNA.
DR   EMBL; BT003245; AAO25002.1; ALT_INIT; mRNA.
DR   RefSeq; NP_001163713.1; NM_001170242.2.
DR   RefSeq; NP_651297.2; NM_143040.5.
DR   UniGene; Dm.3407; -.
DR   ProteinModelPortal; Q9VC27; -.
DR   BioGrid; 67889; 9.
DR   DIP; DIP-23689N; -.
DR   MINT; MINT-997254; -.
DR   STRING; 7227.FBpp0291079; -.
DR   PaxDb; Q9VC27; -.
DR   PRIDE; Q9VC27; -.
DR   EnsemblMetazoa; FBtr0084705; FBpp0084083; FBgn0039234.
DR   EnsemblMetazoa; FBtr0301865; FBpp0291079; FBgn0039234.
DR   GeneID; 42964; -.
DR   KEGG; dme:Dmel_CG7012; -.
DR   UCSC; CG7012-RA; d. melanogaster.
DR   CTD; 42964; -.
DR   FlyBase; FBgn0039234; Nct.
DR   eggNOG; KOG2657; Eukaryota.
DR   eggNOG; ENOG410XT6X; LUCA.
DR   GeneTree; ENSGT00390000014633; -.
DR   InParanoid; Q9VC27; -.
DR   KO; K06171; -.
DR   OrthoDB; EOG091G03DV; -.
DR   PhylomeDB; Q9VC27; -.
DR   Reactome; R-DME-1251985; Nuclear signaling by ERBB4.
DR   Reactome; R-DME-1980148; Signaling by NOTCH3.
DR   Reactome; R-DME-1980150; Signaling by NOTCH4.
DR   Reactome; R-DME-3928665; EPH-ephrin mediated repulsion of cells.
DR   Reactome; R-DME-6798695; Neutrophil degranulation.
DR   GenomeRNAi; 42964; -.
DR   PRO; PR:Q9VC27; -.
DR   Proteomes; UP000000803; Chromosome 3R.
DR   Bgee; FBgn0039234; -.
DR   Genevisible; Q9VC27; DM.
DR   GO; GO:0070765; C:gamma-secretase complex; IPI:FlyBase.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005770; C:late endosome; IDA:FlyBase.
DR   GO; GO:0005886; C:plasma membrane; IDA:FlyBase.
DR   GO; GO:0055037; C:recycling endosome; IDA:FlyBase.
DR   GO; GO:0004175; F:endopeptidase activity; IBA:GO_Central.
DR   GO; GO:0007010; P:cytoskeleton organization; IMP:FlyBase.
DR   GO; GO:0046331; P:lateral inhibition; IMP:FlyBase.
DR   GO; GO:0006509; P:membrane protein ectodomain proteolysis; IMP:FlyBase.
DR   GO; GO:0007220; P:Notch receptor processing; IMP:FlyBase.
DR   GO; GO:0007219; P:Notch signaling pathway; IMP:FlyBase.
DR   GO; GO:0008594; P:photoreceptor cell morphogenesis; IMP:FlyBase.
DR   GO; GO:0016485; P:protein processing; IBA:GO_Central.
DR   GO; GO:0045463; P:R8 cell development; IMP:FlyBase.
DR   GO; GO:0045314; P:regulation of compound eye photoreceptor development; IMP:FlyBase.
DR   InterPro; IPR008710; Nicastrin.
DR   PANTHER; PTHR21092; PTHR21092; 1.
DR   Pfam; PF05450; Nicastrin; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Glycoprotein; Membrane; Notch signaling pathway;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL        1     22       {ECO:0000255}.
FT   CHAIN        23    695       Nicastrin.
FT                                /FTId=PRO_0000019685.
FT   TOPO_DOM     23    654       Extracellular. {ECO:0000255}.
FT   TRANSMEM    655    675       Helical. {ECO:0000255}.
FT   TOPO_DOM    676    695       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD     45     45       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    108    108       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    116    116       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    138    138       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    381    381       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    461    461       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    489    489       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    585    585       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    609    609       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CONFLICT    244    257       YATLYPRKPAIENN -> SPPCTPESQQSETT (in Ref.
FT                                1; AAG11414). {ECO:0000305}.
FT   CONFLICT    448    448       I -> T (in Ref. 1; AAG11414).
FT                                {ECO:0000305}.
SQ   SEQUENCE   695 AA;  77993 MW;  C9D9D0C05CDC772B CRC64;
     MEMRLNAASI WLLILSYGAT IAQGERTRDK MYEPIGGASC FRRLNGTHQT GCSSTYSGSV
     GVLHLINVEA DLEFLLSSPP SPPYAPMIPP HLFTRNNLMR LKEAGPKNIS VVLLINRTNQ
     MKQFSHELNC PNQYSGLNST SETCDASNPA KNWNPWGTGL LHEDFPFPIY YIADLDQVTK
     LEKCFQDFNN HNYETHALRS LCAVEVKSFM SAAVNTEVCM RRTNFINNLG GSKYCDPLEG
     RNVYATLYPR KPAIENNLET VHTNEKFILV TCRLDTTTMF DGVGLGAMDS LMGFAVFTHV
     AYLLKQLLPP QSKDLHNVLF VTFNGESYDY IGSQRFVYDM EKLQFPTEST GTPPIAFDNI
     DFMLDIGTLD DISNIKLHAL NGTTLAQQIL ERLNNYAKSP RYGFNLNIQS EMSAHLPPTS
     AQSFLRRDPN FNALILNARP TNKYYHSIYD DADNVDFTYA NTSKDFTQLT EVNDFKSLNP
     DSLQMKVRNV SSIVAMALYQ TITGKEYTGT KVANPLMADE FLYCFLQSAD CPLFKAASYP
     GSQLTNLPPM RYISVLGGSQ ESSGYTYRLL GYLLSQLQPD IHRDNCTDLP LHYFAGFNNI
     GECRLTTQNY SHALSPAFLI DGYDWSSGMY STWTESTWSQ FSARIFLRPS NVHQVTTLSV
     GIVVLIISFC LVYIISSRSE VLFEDLPASN AALFG
//
ID   DLLC_DANRE              Reviewed;         664 AA.
AC   Q9IAT6;
DT   05-JUL-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   22-NOV-2017, entry version 109.
DE   RecName: Full=Delta-like protein C;
DE            Short=DeltaC;
DE            Short=delC;
DE   Flags: Precursor;
GN   Name=dlc;
OS   Danio rerio (Zebrafish) (Brachydanio rerio).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Actinopterygii; Neopterygii; Teleostei; Ostariophysi; Cypriniformes;
OC   Cyprinidae; Danio.
OX   NCBI_TaxID=7955;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RX   PubMed=10585570; DOI=10.1016/S0925-4773(99)00231-2;
RA   Smithers L.E., Haddon C., Jiang Y.-J., Lewis J.;
RT   "Sequence and embryonic expression of deltaC in the zebrafish.";
RL   Mech. Dev. 90:119-123(2000).
RN   [2]
RP   FUNCTION.
RX   PubMed=11100729; DOI=10.1038/35044091;
RA   Jiang Y.-J., Aerne B.L., Smithers L., Haddon C., Ish-Horowicz D.,
RA   Lewis J.;
RT   "Notch signalling and the synchronization of the somite segmentation
RT   clock.";
RL   Nature 408:475-479(2000).
CC   -!- FUNCTION: Acts as a ligand for Notch receptors and is involved in
CC       somitogenesis. Can activate Notch receptors. Required in somite
CC       segmentation to keep the oscillations of neighboring presomitic
CC       mesoderm cells synchronized. {ECO:0000269|PubMed:11100729}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250}; Single-pass type I
CC       membrane protein {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Strongly expressed in the early retina, where
CC       it precedes other delta proteins. Also expressed in cranial
CC       ganglia, in sensory epithelia including ear and lateral line and
CC       in scattered epidermal cells. In the mesoderm, expression is
CC       visible by 50% epiboly; it is expressed subsequently in the tail
CC       bud, in stripes in the presomitic mesoderm and in the posterior
CC       half of each somite. Also expressed in notochord, blood vessels
CC       and pronephros. In contrast to other delta proteins, it is not
CC       expressed in the majority of nascent primary neurons. In somites,
CC       it marks the posterior part of each formed somite, while deltaD
CC       (dld) marks the anterior part. {ECO:0000269|PubMed:10585570}.
CC   -!- PTM: Ubiquitinated by mib, leading to its endocytosis and
CC       subsequent degradation. {ECO:0000250}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF146429; AAF27299.1; -; mRNA.
DR   RefSeq; NP_571019.1; NM_130944.1.
DR   UniGene; Dr.81314; -.
DR   ProteinModelPortal; Q9IAT6; -.
DR   SMR; Q9IAT6; -.
DR   BioGrid; 78356; 3.
DR   STRING; 7955.ENSDARP00000018643; -.
DR   PaxDb; Q9IAT6; -.
DR   GeneID; 30120; -.
DR   KEGG; dre:30120; -.
DR   CTD; 30120; -.
DR   ZFIN; ZDB-GENE-000125-4; dlc.
DR   eggNOG; ENOG410IR66; Eukaryota.
DR   eggNOG; ENOG410YWUI; LUCA.
DR   HOGENOM; HOG000267024; -.
DR   HOVERGEN; HBG007139; -.
DR   InParanoid; Q9IAT6; -.
DR   KO; K06051; -.
DR   PhylomeDB; Q9IAT6; -.
DR   PRO; PR:Q9IAT6; -.
DR   Proteomes; UP000000437; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; IDA:ZFIN.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IGI:ZFIN.
DR   GO; GO:0005886; C:plasma membrane; IDA:ZFIN.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0042802; F:identical protein binding; IDA:ZFIN.
DR   GO; GO:0030165; F:PDZ domain binding; IDA:ZFIN.
DR   GO; GO:0060842; P:arterial endothelial cell differentiation; IMP:ZFIN.
DR   GO; GO:0048514; P:blood vessel morphogenesis; IMP:ZFIN.
DR   GO; GO:0035907; P:dorsal aorta development; IGI:ZFIN.
DR   GO; GO:0002244; P:hematopoietic progenitor cell differentiation; IGI:ZFIN.
DR   GO; GO:0060218; P:hematopoietic stem cell differentiation; IMP:ZFIN.
DR   GO; GO:0048666; P:neuron development; IMP:ZFIN.
DR   GO; GO:0007219; P:Notch signaling pathway; IMP:ZFIN.
DR   GO; GO:0061056; P:sclerotome development; IGI:ZFIN.
DR   GO; GO:0001757; P:somite specification; IGI:ZFIN.
DR   GO; GO:0001756; P:somitogenesis; IMP:ZFIN.
DR   GO; GO:0021514; P:ventral spinal cord interneuron differentiation; IGI:ZFIN.
DR   InterPro; IPR001774; DSL.
DR   InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR000152; EGF-type_Asp/Asn_hydroxyl_site.
DR   InterPro; IPR018097; EGF_Ca-bd_CS.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   Pfam; PF01414; DSL; 1.
DR   Pfam; PF00008; EGF; 5.
DR   Pfam; PF12661; hEGF; 1.
DR   SMART; SM00051; DSL; 1.
DR   SMART; SM00181; EGF; 8.
DR   SMART; SM00179; EGF_CA; 6.
DR   SUPFAM; SSF57184; SSF57184; 1.
DR   PROSITE; PS00010; ASX_HYDROXYL; 2.
DR   PROSITE; PS51051; DSL; 1.
DR   PROSITE; PS00022; EGF_1; 8.
DR   PROSITE; PS01186; EGF_2; 8.
DR   PROSITE; PS50026; EGF_3; 7.
DR   PROSITE; PS01187; EGF_CA; 2.
PE   2: Evidence at transcript level;
KW   Calcium; Complete proteome; Developmental protein; Differentiation;
KW   Disulfide bond; EGF-like domain; Glycoprotein; Membrane;
KW   Notch signaling pathway; Reference proteome; Repeat; Signal;
KW   Transmembrane; Transmembrane helix; Ubl conjugation.
FT   SIGNAL        1     20       {ECO:0000255}.
FT   CHAIN        21    664       Delta-like protein C.
FT                                /FTId=PRO_0000007516.
FT   TOPO_DOM     21    511       Extracellular. {ECO:0000255}.
FT   TRANSMEM    512    532       Helical. {ECO:0000255}.
FT   TOPO_DOM    533    664       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      154    198       DSL. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00377}.
FT   DOMAIN      199    232       EGF-like 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      233    263       EGF-like 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      265    303       EGF-like 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      305    341       EGF-like 4; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      343    380       EGF-like 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      382    418       EGF-like 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      420    456       EGF-like 7; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      458    494       EGF-like 8. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   CARBOHYD    173    173       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    156    165       {ECO:0000250}.
FT   DISULFID    169    181       {ECO:0000250}.
FT   DISULFID    189    198       {ECO:0000250}.
FT   DISULFID    203    214       {ECO:0000250}.
FT   DISULFID    207    220       {ECO:0000250}.
FT   DISULFID    222    231       {ECO:0000250}.
FT   DISULFID    234    245       {ECO:0000250}.
FT   DISULFID    240    251       {ECO:0000250}.
FT   DISULFID    253    262       {ECO:0000250}.
FT   DISULFID    269    281       {ECO:0000250}.
FT   DISULFID    275    291       {ECO:0000250}.
FT   DISULFID    293    302       {ECO:0000250}.
FT   DISULFID    309    320       {ECO:0000250}.
FT   DISULFID    314    329       {ECO:0000250}.
FT   DISULFID    331    340       {ECO:0000250}.
FT   DISULFID    347    358       {ECO:0000250}.
FT   DISULFID    352    368       {ECO:0000250}.
FT   DISULFID    370    379       {ECO:0000250}.
FT   DISULFID    386    397       {ECO:0000250}.
FT   DISULFID    391    406       {ECO:0000250}.
FT   DISULFID    408    417       {ECO:0000250}.
FT   DISULFID    424    435       {ECO:0000250}.
FT   DISULFID    429    444       {ECO:0000250}.
FT   DISULFID    446    455       {ECO:0000250}.
FT   DISULFID    462    473       {ECO:0000250}.
FT   DISULFID    467    482       {ECO:0000250}.
FT   DISULFID    484    493       {ECO:0000250}.
SQ   SEQUENCE   664 AA;  72548 MW;  0AD6C34C8579116B CRC64;
     MARVLLTCFF ILISSHLGKS SGVFELKVLS FTSTSSVCKG SSDCQIFFRV CLKHSQALIL
     PEPPCTYGTG MSEILSADSI SSSAYISVPF NFKWPGIVSL IIETWNAETS DQSTENNNNM
     ISRLATKRRL AISEDWSQDV HLGRQSQLRF SYRVVCDEFY HGEECSDFCR PRNDTFGHFN
     CDAAGNRICL PGWKGDYCTE PICLSGCSEE NGYCEAPGEC KCRIGWEGPL CDECTRHPGC
     LHGTCNQPFQ CTCKEGWGGL FCNEDLNFCT NHKPCRNDAT CTNTGQGSYT CICKPGFSGK
     NCEIETNECD SNPCKNGGSC NDQENDYTCT CPQGFYGKNC EVSAMTCADG PCFNGGTCME
     KGSGSYSCRC PPGYMGSNCE KKIDRCSSDP CANGGQCLDL GNKATCRCRP GFTGSRCETN
     IDDCSSNPCQ NAGTCVDGIN GYTCTCTLGF SGKDCRVRSD ACSFMPCQNG GTCYTHFSGP
     VCQCPAGFMG TQCEYKQKPT PVNSPALPAA LIVSFTLGLI TLTLVICAAI VVLRQMRQNH
     KASSTTVRNN LDSVNNRISL SPTSPLGREK EAFLIPGGPF KVSNKDMALR STSVDTHSSD
     KSNYKQKMVD YNLSIDEKHT NNKLEKNSES TLLVPPLNYP KEGVYHPVYI IPEHIEQRVF
     ATEV
//
ID   GLT11_XENTR             Reviewed;         601 AA.
AC   Q6DJR8;
DT   22-JAN-2014, integrated into UniProtKB/Swiss-Prot.
DT   22-JAN-2014, sequence version 2.
DT   25-OCT-2017, entry version 77.
DE   RecName: Full=Polypeptide N-acetylgalactosaminyltransferase 11;
DE            EC=2.4.1.41;
DE   AltName: Full=Polypeptide GalNAc transferase 11;
DE            Short=GalNAc-T11;
DE            Short=pp-GaNTase 11;
DE   AltName: Full=Protein-UDP acetylgalactosaminyltransferase 11;
DE   AltName: Full=UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 11;
GN   Name=galnt11;
OS   Xenopus tropicalis (Western clawed frog) (Silurana tropicalis).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Amphibia; Batrachia; Anura; Pipoidea; Pipidae; Xenopodinae; Xenopus;
OC   Silurana.
OX   NCBI_TaxID=8364;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Embryo;
RG   NIH - Xenopus Gene Collection (XGC) project;
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   FUNCTION, DISRUPTION PHENOTYPE, AND INTERACTION WITH NOTCH1.
RX   PubMed=24226769; DOI=10.1038/nature12723;
RA   Boskovski M.T., Yuan S., Pedersen N.B., Goth C.K., Makova S.,
RA   Clausen H., Brueckner M., Khokha M.K.;
RT   "The heterotaxy gene GALNT11 glycosylates Notch to orchestrate cilia
RT   type and laterality.";
RL   Nature 504:456-459(2013).
CC   -!- FUNCTION: Polypeptide N-acetylgalactosaminyltransferase that
CC       catalyzes the initiation of protein O-linked glycosylation and is
CC       involved in left/right asymmetry by mediating O-glycosylation of
CC       NOTCH1. O-glycosylation of NOTCH1 promotes activation of NOTCH1,
CC       modulating the balance between motile and immotile (sensory) cilia
CC       at the left-right organiser (LRO). Polypeptide N-
CC       acetylgalactosaminyltransferases catalyze the transfer of an N-
CC       acetyl-D-galactosamine residue to a serine or threonine residue on
CC       the protein receptor. {ECO:0000269|PubMed:24226769}.
CC   -!- CATALYTIC ACTIVITY: UDP-N-acetyl-alpha-D-galactosamine +
CC       polypeptide = UDP + N-acetyl-alpha-D-galactosaminyl-polypeptide.
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250};
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108; Evidence={ECO:0000250};
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC   -!- SUBUNIT: Interacts with notch1. {ECO:0000269|PubMed:24226769}.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000250};
CC       Single-pass type II membrane protein {ECO:0000250}.
CC   -!- DOMAIN: There are two conserved domains in the glycosyltransferase
CC       region: the N-terminal domain (domain A, also called GT1 motif),
CC       which is probably involved in manganese coordination and substrate
CC       binding and the C-terminal domain (domain B, also called
CC       Gal/GalNAc-T motif), which is probably involved in catalytic
CC       reaction and UDP-Gal binding. {ECO:0000250}.
CC   -!- DOMAIN: The ricin B-type lectin domain binds to GalNAc and
CC       contributes to the glycopeptide specificity. {ECO:0000250}.
CC   -!- DISRUPTION PHENOTYPE: Aberrant left-right patterning resulting in
CC       abnormal cardiac loops, including leftward and symmetric/midline
CC       loops. {ECO:0000269|PubMed:24226769}.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 2 family. GalNAc-T
CC       subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH75106.1; Type=Frameshift; Positions=39; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC075106; AAH75106.1; ALT_FRAME; mRNA.
DR   RefSeq; NP_001006904.1; NM_001006903.1.
DR   UniGene; Str.1760; -.
DR   SMR; Q6DJR8; -.
DR   CAZy; CBM13; Carbohydrate-Binding Module Family 13.
DR   CAZy; GT27; Glycosyltransferase Family 27.
DR   GeneID; 448751; -.
DR   KEGG; xtr:448751; -.
DR   CTD; 63917; -.
DR   Xenbase; XB-GENE-981830; galnt11.
DR   HOVERGEN; HBG051699; -.
DR   KO; K00710; -.
DR   UniPathway; UPA00378; -.
DR   Proteomes; UP000008143; Unassembled WGS sequence.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   GO; GO:0005112; F:Notch binding; IDA:UniProtKB.
DR   GO; GO:0004653; F:polypeptide N-acetylgalactosaminyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0060271; P:cilium assembly; IMP:UniProtKB.
DR   GO; GO:0007368; P:determination of left/right symmetry; IMP:UniProtKB.
DR   GO; GO:0007220; P:Notch receptor processing; IMP:UniProtKB.
DR   GO; GO:0061314; P:Notch signaling involved in heart development; IMP:UniProtKB.
DR   GO; GO:0018243; P:protein O-linked glycosylation via threonine; IDA:UniProtKB.
DR   GO; GO:0008593; P:regulation of Notch signaling pathway; IMP:UniProtKB.
DR   CDD; cd00161; RICIN; 1.
DR   Gene3D; 3.90.550.10; -; 1.
DR   InterPro; IPR001173; Glyco_trans_2-like.
DR   InterPro; IPR029044; Nucleotide-diphossugar_trans.
DR   InterPro; IPR035992; Ricin_B-like_lectins.
DR   InterPro; IPR000772; Ricin_B_lectin.
DR   Pfam; PF00535; Glycos_transf_2; 1.
DR   Pfam; PF00652; Ricin_B_lectin; 1.
DR   SMART; SM00458; RICIN; 1.
DR   SUPFAM; SSF50370; SSF50370; 1.
DR   SUPFAM; SSF53448; SSF53448; 1.
DR   PROSITE; PS50231; RICIN_B_LECTIN; 1.
PE   1: Evidence at protein level;
KW   Calcium; Complete proteome; Disulfide bond; Glycoprotein;
KW   Glycosyltransferase; Golgi apparatus; Lectin; Manganese; Membrane;
KW   Notch signaling pathway; Reference proteome; Signal-anchor;
KW   Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN         1    601       Polypeptide N-
FT                                acetylgalactosaminyltransferase 11.
FT                                /FTId=PRO_0000425208.
FT   TOPO_DOM      1      7       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM      8     28       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     29    601       Lumenal. {ECO:0000255}.
FT   DOMAIN      469    600       Ricin B-type lectin.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00174}.
FT   REGION      143    254       Catalytic subdomain A. {ECO:0000250}.
FT   REGION      312    374       Catalytic subdomain B. {ECO:0000250}.
FT   CARBOHYD     29     29       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    202    202       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    508    508       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    486    505       {ECO:0000255|PROSITE-ProRule:PRU00174}.
FT   DISULFID    529    546       {ECO:0000255|PROSITE-ProRule:PRU00174}.
FT   DISULFID    571    589       {ECO:0000255|PROSITE-ProRule:PRU00174}.
SQ   SEQUENCE   601 AA;  68383 MW;  1FA0294A3CEEA236 CRC64;
     MGSAALRCFC YGCLFTSVTW TLLLFIYFNF SEESQGFRHV PVKGLEPYKP LPKKIYPRFS
     RDSMGQHSDP RKGHNGNQLE TEANADLSPE LGMIFNEQDQ DVRDVGYQKH AFNLLISNRL
     GYHRDVPDTR DSKCAKKTYP PDLPMASIVI CFYNEAFSAL LRTVHSVLDR TPAQLLHEII
     LVDDNSELDD LKKDLDGYMQ ENLSKKVKLV RNKQREGLIR GRMVGASHAT GDVLVFLDSH
     CEVNEMWLQP LLAPIKENPR TVVCPVIDII SADTLIYSSS PVVRGGFNWG LHFKWDPVPL
     AELGGPEGFS APFRSPTMAG GLFAMDREYF NMLGQYDSGM DIWGGENLEI SFRIWMCGGS
     LLIVPCSRVG HIFRKRRPYG SPGGHDTMAH NSLRLAHVWM DEYKDQYFAL RPELRNRDFG
     DIRERLALRR RLNCKSFKWY LDNIYPEMQV SGPNAKPQPP VFMNKGQKRP KILQRGRLIN
     MQTNRCLVAQ GHPSQKGGLV VAKECDYNDS EQVWSYNEEH ELILSNLLCL DMSETRSSDP
     PRLMKCHGSG GSQQWVFGKS NRLYQVSVGQ CLKLVDPMSR KGYVSMAICD GSPSQQWHLE
     N
//
ID   NICA_CAEEL              Reviewed;         723 AA.
AC   Q23316;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   26-SEP-2003, sequence version 3.
DT   22-NOV-2017, entry version 120.
DE   RecName: Full=Nicastrin;
DE   AltName: Full=Anterior-pharynx-defective protein 2;
DE   Flags: Precursor;
GN   Name=aph-2; ORFNames=ZC434.6;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
RN   [2]
RP   FUNCTION, AND GENE NAME.
RX   PubMed=10993067; DOI=10.1038/35024009;
RA   Yu G., Nishimura M., Arawaka S., Levitan D., Zhang L., Tandon A.,
RA   Song Y.-Q., Rogaeva E., Chen F., Kawarai T., Supala A., Levesque L.,
RA   Yu H., Yang D.-S., Holmes E., Milman P., Liang Y., Zhang D.M.,
RA   Xu D.H., Sato C., Rogaev E., Smith M., Janus C., Zhang Y.,
RA   Aebersold R., Farrer L.S., Sorbi S., Bruni A., Fraser P.E.,
RA   St George-Hyslop P.H.;
RT   "Nicastrin modulates presenilin-mediated notch/glp-1 signal
RT   transduction and betaAPP processing.";
RL   Nature 407:48-54(2000).
RN   [3]
RP   FUNCTION.
RX   PubMed=10804188;
RA   Goutte C., Hepler W., Mickey K.M., Priess J.R.;
RT   "aph-2 encodes a novel extracellular protein required for GLP-1-
RT   mediated signaling.";
RL   Development 127:2481-2492(2000).
RN   [4]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-181, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RC   STRAIN=Bristol N2;
RX   PubMed=17761667; DOI=10.1074/mcp.M600392-MCP200;
RA   Kaji H., Kamiie J., Kawakami H., Kido K., Yamauchi Y., Shinkawa T.,
RA   Taoka M., Takahashi N., Isobe T.;
RT   "Proteomics reveals N-linked glycoprotein diversity in Caenorhabditis
RT   elegans and suggests an atypical translocation mechanism for integral
RT   membrane proteins.";
RL   Mol. Cell. Proteomics 6:2100-2109(2007).
CC   -!- FUNCTION: Essential subunit of the gamma-secretase complex, an
CC       endoprotease complex that catalyzes the intramembrane cleavage of
CC       integral membrane proteins such as Notch (glp-1 or lin-12). It may
CC       represents a stabilizing cofactor required for the assembly of the
CC       gamma-secretase complex. {ECO:0000269|PubMed:10804188,
CC       ECO:0000269|PubMed:10993067}.
CC   -!- SUBUNIT: Component of the gamma-secretase complex, a complex
CC       probably composed of the presenilin homodimer (sel-12, hop-1 or
CC       spe-4), nicastrin (aph-2), aph-1 and pen-2. {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I
CC       membrane protein {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the nicastrin family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z75714; CAB00063.2; -; Genomic_DNA.
DR   PIR; T27570; T27570.
DR   RefSeq; NP_492712.2; NM_060311.3.
DR   UniGene; Cel.5001; -.
DR   ProteinModelPortal; Q23316; -.
DR   BioGrid; 38322; 1.
DR   STRING; 6239.ZC434.6b; -.
DR   iPTMnet; Q23316; -.
DR   EPD; Q23316; -.
DR   PaxDb; Q23316; -.
DR   PRIDE; Q23316; -.
DR   EnsemblMetazoa; ZC434.6b; ZC434.6b; WBGene00000148.
DR   GeneID; 172905; -.
DR   KEGG; cel:CELE_ZC434.6; -.
DR   UCSC; ZC434.6b; c. elegans.
DR   CTD; 172905; -.
DR   WormBase; ZC434.6b; CE34446; WBGene00000148; aph-2.
DR   eggNOG; KOG2657; Eukaryota.
DR   eggNOG; ENOG410XT6X; LUCA.
DR   GeneTree; ENSGT00390000014633; -.
DR   HOGENOM; HOG000290224; -.
DR   InParanoid; Q23316; -.
DR   KO; K06171; -.
DR   OMA; DNIFAFP; -.
DR   OrthoDB; EOG091G03DV; -.
DR   PhylomeDB; Q23316; -.
DR   Reactome; R-CEL-3928665; EPH-ephrin mediated repulsion of cells.
DR   Reactome; R-CEL-6798695; Neutrophil degranulation.
DR   SignaLink; Q23316; -.
DR   PRO; PR:Q23316; -.
DR   Proteomes; UP000001940; Chromosome I.
DR   Bgee; WBGene00000148; -.
DR   ExpressionAtlas; Q23316; baseline.
DR   GO; GO:0070765; C:gamma-secretase complex; ISS:WormBase.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IDA:WormBase.
DR   GO; GO:0004175; F:endopeptidase activity; IBA:GO_Central.
DR   GO; GO:0060581; P:cell fate commitment involved in pattern specification; IMP:WormBase.
DR   GO; GO:0048598; P:embryonic morphogenesis; IMP:WormBase.
DR   GO; GO:0007220; P:Notch receptor processing; IBA:GO_Central.
DR   GO; GO:0007219; P:Notch signaling pathway; IMP:WormBase.
DR   GO; GO:0018991; P:oviposition; IMP:WormBase.
DR   GO; GO:0060465; P:pharynx development; IMP:WormBase.
DR   GO; GO:0016485; P:protein processing; IBA:GO_Central.
DR   InterPro; IPR008710; Nicastrin.
DR   PANTHER; PTHR21092; PTHR21092; 1.
DR   Pfam; PF05450; Nicastrin; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Glycoprotein; Membrane; Notch signaling pathway;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL        1     16       {ECO:0000255}.
FT   CHAIN        17    723       Nicastrin.
FT                                /FTId=PRO_0000019684.
FT   TOPO_DOM     17    678       Extracellular. {ECO:0000255}.
FT   TRANSMEM    679    699       Helical. {ECO:0000255}.
FT   TOPO_DOM    700    723       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD     40     40       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    181    181       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:17761667}.
FT   CARBOHYD    271    271       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    328    328       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    409    409       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    627    627       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   723 AA;  81659 MW;  C7DF2D12ADBF8D9D CRC64;
     MKKWLVIVLI IAGIRCDGFS DQVFRTLFIG EGNACYRTFN KTHEFGCQAN RENENGLIVR
     IDKQEDFKNL DSCWNSFYPK YSGKYWALLP VNLIRRDTIS QLKSSKCLSG IVLYNSGESI
     HPGDESTAAS HDAECPNAAS DYYLQDKNEE YCERKINSRG AITRDGLMKI DWRIQMVFID
     NSTDLEIIEK CYSMFNKPKE DGSSGYPYCG MSFRLANMAA GNSEICYRRG KNDAKLFQMN
     IDSGDAPQLC GAMHSDNIFA FPTPIPTSPT NETIITSKYM MVTARMDSFG MIPEISVGEV
     SVLTSIISVL AAARSMGTQI EKWQKASNTS NRNVFFAFFN GESLDYIGSG AAAYQMENGK
     FPQMIRSDRT HIHPIRPNEL DYILEVQQIG VAKGRKYYVH VDGERYQQNK TQTDRVIDRI
     ERGLRSHAFD LEKPSGSGDR VPPASWHSFA KADAHVQSVL LAPYGKEYEY QRVNSILDKN
     EWTEDEREKA IQEIEAVSTA ILAAAADYVG VETDEVVAKV DKKLITTIFD CLITSNFWFD
     CDFMQKLDGG RYHKLFNSYG FNQKSTYISM ESHTAFPTVL HWLTIFALGS DKETLNVKSE
     KSCSHLGQFQ AFQMYTYTWQ PNPYTGNFSC LKSAIVKKVM VSPAVDSQTP EEEMNTRYST
     WMESVYIIES VNLYLMEDAS FEYTMILIAV ISALLSIFAV GRCSETTFIV DEGEPAAEGG
     EPL
//
ID   DLL3_MOUSE              Reviewed;         592 AA.
AC   O88516; O35675; Q80W06; Q9QWL9; Q9QWZ7;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1998, sequence version 1.
DT   22-NOV-2017, entry version 156.
DE   RecName: Full=Delta-like protein 3;
DE   AltName: Full=Drosophila Delta homolog 3;
DE            Short=Delta3;
DE            Short=M-Delta-3;
DE   Flags: Precursor;
GN   Name=Dll3;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   STRAIN=C57BL/6 X DBA; TISSUE=Embryo;
RX   PubMed=9272948;
RA   Dunwoodie S.L., Henrique D.M.P., Harrison S.M., Beddington R.S.P.;
RT   "Mouse Dll3: a novel divergent Delta gene which may complement the
RT   function of other Delta homologues during early pattern formation in
RT   the mouse embryo.";
RL   Development 124:3065-3076(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], ALTERNATIVE SPLICING, AND
RP   INVOLVEMENT IN PU.
RC   STRAIN=129/SvJ;
RX   PubMed=9662403; DOI=10.1038/961;
RA   Kusumi K., Sun E.S., Kerrebrock A.W., Bronson R.T., Chi D.-C.,
RA   Bulotsky M.S., Spencer J.B., Birren B.W., Frankel W.N., Lander E.S.;
RT   "The mouse pudgy mutation disrupts Delta homologue Dll3 and initiation
RT   of early somite boundaries.";
RL   Nat. Genet. 19:274-278(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Neural tube;
RA   Nakayama K., Nakayama N., Tomooka Y., Hayashi Y., Takahashi M.;
RT   "Specific expression of a divergent type of Delta in a set of earliest
RT   generated neurons including the prospective subplate neurons.";
RL   Submitted (APR-1998) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   STRAIN=C57BL/6J; TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Inhibits primary neurogenesis. May be required to divert
CC       neurons along a specific differentiation pathway. Plays a role in
CC       the formation of somite boundaries during segmentation of the
CC       paraxial mesoderm.
CC   -!- SUBUNIT: Can bind and activate Notch-1 or another Notch receptor.
CC       {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I
CC       membrane protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=2;
CC         IsoId=O88516-1; Sequence=Displayed;
CC       Name=1;
CC         IsoId=O88516-2; Sequence=VSP_001376;
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in the neuroectoderm
CC       and paraxial mesoderm during embryogenesis.
CC   -!- DOMAIN: The DSL domain is required for binding to the Notch
CC       receptor.
CC   -!- PTM: Ubiquitinated by MIB (MIB1 or MIB2), leading to its
CC       endocytosis and subsequent degradation. {ECO:0000250}.
CC   -!- DISEASE: Note=A truncating mutation in Dll3 is the cause of the
CC       pudgy (pu) phenotype. Pudgy mice exhibit patterning defects at the
CC       earliest stages of somitogenesis. Adult pudgy mice present severe
CC       vertebral and rib deformities. {ECO:0000269|PubMed:9662403}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF068865; AAC40170.1; -; Genomic_DNA.
DR   EMBL; AF068865; AAC40169.1; -; Genomic_DNA.
DR   EMBL; Y11895; CAA72637.1; -; mRNA.
DR   EMBL; AB013440; BAA33716.1; -; mRNA.
DR   EMBL; BC052002; AAH52002.1; -; mRNA.
DR   CCDS; CCDS39856.1; -. [O88516-2]
DR   RefSeq; NP_031892.2; NM_007866.2. [O88516-2]
DR   UniGene; Mm.12896; -.
DR   ProteinModelPortal; O88516; -.
DR   SMR; O88516; -.
DR   BioGrid; 199233; 1.
DR   STRING; 10090.ENSMUSP00000103951; -.
DR   PhosphoSitePlus; O88516; -.
DR   MaxQB; O88516; -.
DR   PaxDb; O88516; -.
DR   PRIDE; O88516; -.
DR   Ensembl; ENSMUST00000108315; ENSMUSP00000103951; ENSMUSG00000003436. [O88516-2]
DR   GeneID; 13389; -.
DR   KEGG; mmu:13389; -.
DR   CTD; 10683; -.
DR   MGI; MGI:1096877; Dll3.
DR   eggNOG; KOG1217; Eukaryota.
DR   eggNOG; ENOG410XP6K; LUCA.
DR   GeneTree; ENSGT00890000139375; -.
DR   HOGENOM; HOG000267024; -.
DR   HOVERGEN; HBG007139; -.
DR   InParanoid; O88516; -.
DR   KO; K06051; -.
DR   OMA; DECEAPP; -.
DR   PhylomeDB; O88516; -.
DR   TreeFam; TF351835; -.
DR   PRO; PR:O88516; -.
DR   Proteomes; UP000000589; Chromosome 7.
DR   Bgee; ENSMUSG00000003436; -.
DR   CleanEx; MM_DLL3; -.
DR   ExpressionAtlas; O88516; baseline and differential.
DR   Genevisible; O88516; MM.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0005112; F:Notch binding; NAS:UniProtKB.
DR   GO; GO:0001709; P:cell fate determination; NAS:UniProtKB.
DR   GO; GO:0007386; P:compartment pattern specification; IMP:MGI.
DR   GO; GO:0001701; P:in utero embryonic development; NAS:UniProtKB.
DR   GO; GO:0050768; P:negative regulation of neurogenesis; IDA:MGI.
DR   GO; GO:0007399; P:nervous system development; NAS:UniProtKB.
DR   GO; GO:0007219; P:Notch signaling pathway; NAS:UniProtKB.
DR   GO; GO:0048339; P:paraxial mesoderm development; IMP:MGI.
DR   GO; GO:0001501; P:skeletal system development; IMP:UniProtKB.
DR   GO; GO:0001756; P:somitogenesis; IDA:MGI.
DR   GO; GO:0009888; P:tissue development; IDA:MGI.
DR   InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   Pfam; PF00008; EGF; 3.
DR   Pfam; PF12661; hEGF; 2.
DR   SMART; SM00181; EGF; 6.
DR   SMART; SM00179; EGF_CA; 5.
DR   SUPFAM; SSF57184; SSF57184; 1.
DR   PROSITE; PS00022; EGF_1; 6.
DR   PROSITE; PS01186; EGF_2; 6.
DR   PROSITE; PS50026; EGF_3; 6.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Complete proteome; Developmental protein;
KW   Differentiation; Disulfide bond; EGF-like domain; Membrane;
KW   Notch signaling pathway; Reference proteome; Repeat; Signal;
KW   Transmembrane; Transmembrane helix; Ubl conjugation.
FT   SIGNAL        1     32       {ECO:0000255}.
FT   CHAIN        33    592       Delta-like protein 3.
FT                                /FTId=PRO_0000007510.
FT   TOPO_DOM     33    490       Extracellular. {ECO:0000255}.
FT   TRANSMEM    491    511       Helical. {ECO:0000255}.
FT   TOPO_DOM    512    592       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      174    213       DSL.
FT   DOMAIN      214    247       EGF-like 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      272    308       EGF-like 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      310    349       EGF-like 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      351    387       EGF-like 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      389    425       EGF-like 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      427    463       EGF-like 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DISULFID    218    229       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    222    235       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    237    246       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    276    287       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    281    296       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    298    307       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    314    325       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    319    337       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    339    348       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    355    366       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    360    375       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    377    386       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    393    404       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    398    413       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    415    424       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    431    442       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    436    451       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    453    462       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   VAR_SEQ     585    592       DWLIQVLF -> A (in isoform 1).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9272948,
FT                                ECO:0000303|Ref.3}.
FT                                /FTId=VSP_001376.
FT   CONFLICT     94     94       E -> K (in Ref. 3; BAA33716).
FT                                {ECO:0000305}.
FT   CONFLICT    401    401       G -> A (in Ref. 1; CAA72637).
FT                                {ECO:0000305}.
SQ   SEQUENCE   592 AA;  62069 MW;  1A84F8022E7E7DCC CRC64;
     MVSLQVSPLS QTLILAFLLP QALPAGVFEL QIHSFGPGPG LGTPRSPCNA RGPCRLFFRV
     CLKPGVSQEA TESLCALGAA LSTSVPVYTE HPGESAAALP LPDGLVRVPF RDAWPGTFSL
     VIETWREQLG EHAGGPAWNL LARVVGRRRL AAGGPWARDV QRTGTWELHF SYRARCEPPA
     VGAACARLCR SRSAPSRCGP GLRPCTPFPD ECEAPSVCRP GCSPEHGYCE EPDECRCLEG
     WTGPLCTVPV STSSCLNSRV PGPASTGCLL PGPGPCDGNP CANGGSCSET SGSFECACPR
     GFYGLRCEVS GVTCADGPCF NGGLCVGGED PDSAYVCHCP PGFQGSNCEK RVDRCSLQPC
     QNGGLCLDLG HALRCRCRAG FAGPRCEHDL DDCAGRACAN GGTCVEGGGS RRCSCALGFG
     GRDCRERADP CASRPCAHGG RCYAHFSGLV CACAPGYMGV RCEFAVRPDG ADAVPAAPRG
     LRQADPQRFL LPPALGLLVA AGLAGAALLV IHVRRRGPGQ DTGTRLLSGT REPSVHTLPD
     ALNNLRLQDG AGDGPSSSAD WNHPEDGDSR SIYVIPAPSI YAREDWLIQV LF
//
ID   GLT11_MOUSE             Reviewed;         608 AA.
AC   Q921L8; Q3TT83; Q8BU26; Q8K032;
DT   16-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   25-OCT-2017, entry version 131.
DE   RecName: Full=Polypeptide N-acetylgalactosaminyltransferase 11;
DE            EC=2.4.1.41;
DE   AltName: Full=Polypeptide GalNAc transferase 11;
DE            Short=GalNAc-T11;
DE            Short=pp-GaNTase 11;
DE   AltName: Full=Protein-UDP acetylgalactosaminyltransferase 11;
DE   AltName: Full=UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 11;
GN   Name=Galnt11;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RX   PubMed=11925450; DOI=10.1074/jbc.M202684200;
RA   Schwientek T., Bennett E.P., Flores C., Thacker J., Hollmann M.,
RA   Reis C.A., Behrens J., Mandel U., Keck B., Schaefer M.A.,
RA   Haselmann K., Zubarev R., Roepstorff P., Burchell J.M.,
RA   Taylor-Papadimitriou J., Hollingsworth M.A., Clausen H.;
RT   "Functional conservation of subfamilies of putative UDP-N-
RT   acetylgalactosamine:polypeptide N-acetylgalactosaminyltransferases in
RT   Drosophila, Caenorhabditis elegans, and mammals. One subfamily
RT   composed of l(2)35Aa is essential in Drosophila.";
RL   J. Biol. Chem. 277:22623-22638(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=C57BL/6J;
RA   Shimoji S., Reynolds P.R., Ten Hagen K.G., Tabak L.A.;
RT   "Characterization of a novel mouse UDP-GalNAc:polypeptide N-
RT   acetylgalactosaminyltransferase.";
RL   Submitted (MAR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J, and NOD; TISSUE=Ovary, and Thymus;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=FVB/N; TISSUE=Kidney, and Mammary tumor;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-95, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Kidney;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and
RT   expression.";
RL   Cell 143:1174-1189(2010).
RN   [6]
RP   DEVELOPMENTAL STAGE.
RX   PubMed=24226769; DOI=10.1038/nature12723;
RA   Boskovski M.T., Yuan S., Pedersen N.B., Goth C.K., Makova S.,
RA   Clausen H., Brueckner M., Khokha M.K.;
RT   "The heterotaxy gene GALNT11 glycosylates Notch to orchestrate cilia
RT   type and laterality.";
RL   Nature 504:456-459(2013).
CC   -!- FUNCTION: Polypeptide N-acetylgalactosaminyltransferase that
CC       catalyzes the initiation of protein O-linked glycosylation and is
CC       involved in left/right asymmetry by mediating O-glycosylation of
CC       NOTCH1. O-glycosylation of NOTCH1 promotes activation of NOTCH1,
CC       modulating the balance between motile and immotile (sensory) cilia
CC       at the left-right organiser (LRO). Polypeptide N-
CC       acetylgalactosaminyltransferases catalyze the transfer of an N-
CC       acetyl-D-galactosamine residue to a serine or threonine residue on
CC       the protein receptor. Displays the same enzyme activity toward
CC       MUC1, MUC4, and EA2 than GALNT1. Not involved in glycosylation of
CC       erythropoietin (EPO) (By similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: UDP-N-acetyl-alpha-D-galactosamine +
CC       polypeptide = UDP + N-acetyl-alpha-D-galactosaminyl-polypeptide.
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250};
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC   -!- SUBUNIT: Interacts with NOTCH1. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000250};
CC       Single-pass type II membrane protein {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Mainly expressed in kidney. Weakly expressed
CC       in other tissues. {ECO:0000269|PubMed:11925450}.
CC   -!- DEVELOPMENTAL STAGE: At E8.0, present in the left-right organiser
CC       (LRO) node, with enrichment in crown cells compared to pit cells
CC       (at protein level). {ECO:0000269|PubMed:24226769}.
CC   -!- DOMAIN: There are two conserved domains in the glycosyltransferase
CC       region: the N-terminal domain (domain A, also called GT1 motif),
CC       which is probably involved in manganese coordination and substrate
CC       binding and the C-terminal domain (domain B, also called
CC       Gal/GalNAc-T motif), which is probably involved in catalytic
CC       reaction and UDP-Gal binding. {ECO:0000250}.
CC   -!- DOMAIN: The ricin B-type lectin domain binds to GalNAc and
CC       contributes to the glycopeptide specificity. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 2 family. GalNAc-T
CC       subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH34184.1; Type=Erroneous termination; Positions=412; Note=Translated as Glu.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - GTase;
CC       Note=Polypeptide N-acetylgalactosaminyltransferase 11;
CC       URL="http://www.functionalglycomics.org/glycomics/molecule/jsp/glycoEnzyme/viewGlycoEnzyme.jsp?gbpId=gt_mou_519";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y12435; CAC79626.1; -; mRNA.
DR   EMBL; AF495528; AAQ06668.1; -; mRNA.
DR   EMBL; AK088014; BAC40096.1; -; mRNA.
DR   EMBL; AK161524; BAE36442.1; -; mRNA.
DR   EMBL; BC011428; AAH11428.1; -; mRNA.
DR   EMBL; BC021504; AAH21504.1; -; mRNA.
DR   EMBL; BC034184; AAH34184.1; ALT_SEQ; mRNA.
DR   EMBL; BC034185; AAH34185.1; -; mRNA.
DR   EMBL; BC036143; AAH36143.1; -; mRNA.
DR   EMBL; BC036145; AAH36145.1; -; mRNA.
DR   CCDS; CCDS19133.1; -.
DR   RefSeq; NP_659157.1; NM_144908.3.
DR   RefSeq; XP_006535744.1; XM_006535681.3.
DR   RefSeq; XP_011248066.1; XM_011249764.2.
DR   UniGene; Mm.21814; -.
DR   UniGene; Mm.246718; -.
DR   ProteinModelPortal; Q921L8; -.
DR   IntAct; Q921L8; 2.
DR   MINT; MINT-4096164; -.
DR   STRING; 10090.ENSMUSP00000036240; -.
DR   CAZy; CBM13; Carbohydrate-Binding Module Family 13.
DR   CAZy; GT27; Glycosyltransferase Family 27.
DR   iPTMnet; Q921L8; -.
DR   PhosphoSitePlus; Q921L8; -.
DR   MaxQB; Q921L8; -.
DR   PaxDb; Q921L8; -.
DR   PRIDE; Q921L8; -.
DR   Ensembl; ENSMUST00000045737; ENSMUSP00000036240; ENSMUSG00000038072.
DR   Ensembl; ENSMUST00000114950; ENSMUSP00000110600; ENSMUSG00000038072.
DR   Ensembl; ENSMUST00000114952; ENSMUSP00000110602; ENSMUSG00000038072.
DR   GeneID; 231050; -.
DR   KEGG; mmu:231050; -.
DR   UCSC; uc008wss.1; mouse.
DR   CTD; 63917; -.
DR   MGI; MGI:2444392; Galnt11.
DR   eggNOG; KOG3736; Eukaryota.
DR   eggNOG; ENOG410XPMK; LUCA.
DR   GeneTree; ENSGT00760000118828; -.
DR   HOGENOM; HOG000038227; -.
DR   HOVERGEN; HBG051699; -.
DR   InParanoid; Q921L8; -.
DR   KO; K00710; -.
DR   OMA; GPFRSPT; -.
DR   OrthoDB; EOG091G085O; -.
DR   PhylomeDB; Q921L8; -.
DR   TreeFam; TF313267; -.
DR   Reactome; R-MMU-913709; O-linked glycosylation of mucins.
DR   UniPathway; UPA00378; -.
DR   ChiTaRS; Galnt11; mouse.
DR   PRO; PR:Q921L8; -.
DR   Proteomes; UP000000589; Chromosome 5.
DR   Bgee; ENSMUSG00000038072; -.
DR   ExpressionAtlas; Q921L8; baseline and differential.
DR   Genevisible; Q921L8; MM.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005112; F:Notch binding; ISS:UniProtKB.
DR   GO; GO:0004653; F:polypeptide N-acetylgalactosaminyltransferase activity; ISS:UniProtKB.
DR   GO; GO:0060271; P:cilium assembly; ISS:UniProtKB.
DR   GO; GO:0007368; P:determination of left/right symmetry; ISS:UniProtKB.
DR   GO; GO:0007220; P:Notch receptor processing; ISS:UniProtKB.
DR   GO; GO:0061314; P:Notch signaling involved in heart development; ISS:UniProtKB.
DR   GO; GO:0018243; P:protein O-linked glycosylation via threonine; ISS:UniProtKB.
DR   GO; GO:0008593; P:regulation of Notch signaling pathway; ISS:UniProtKB.
DR   CDD; cd00161; RICIN; 1.
DR   Gene3D; 3.90.550.10; -; 1.
DR   InterPro; IPR001173; Glyco_trans_2-like.
DR   InterPro; IPR029044; Nucleotide-diphossugar_trans.
DR   InterPro; IPR035992; Ricin_B-like_lectins.
DR   InterPro; IPR000772; Ricin_B_lectin.
DR   Pfam; PF00535; Glycos_transf_2; 1.
DR   Pfam; PF00652; Ricin_B_lectin; 1.
DR   SMART; SM00458; RICIN; 1.
DR   SUPFAM; SSF50370; SSF50370; 2.
DR   SUPFAM; SSF53448; SSF53448; 1.
DR   PROSITE; PS50231; RICIN_B_LECTIN; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Disulfide bond; Glycoprotein; Glycosyltransferase;
KW   Golgi apparatus; Lectin; Manganese; Membrane; Metal-binding;
KW   Notch signaling pathway; Phosphoprotein; Reference proteome;
KW   Signal-anchor; Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN         1    608       Polypeptide N-
FT                                acetylgalactosaminyltransferase 11.
FT                                /FTId=PRO_0000059126.
FT   TOPO_DOM      1      6       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM      7     29       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     30    608       Lumenal. {ECO:0000255}.
FT   DOMAIN      476    607       Ricin B-type lectin.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00174}.
FT   REGION      150    261       Catalytic subdomain A.
FT   REGION      319    381       Catalytic subdomain B.
FT   METAL       245    245       Manganese. {ECO:0000250}.
FT   METAL       247    247       Manganese. {ECO:0000250}.
FT   METAL       378    378       Manganese. {ECO:0000250}.
FT   BINDING     191    191       Substrate. {ECO:0000250}.
FT   BINDING     222    222       Substrate. {ECO:0000250}.
FT   BINDING     246    246       Substrate. {ECO:0000250}.
FT   BINDING     350    350       Substrate. {ECO:0000250}.
FT   BINDING     381    381       Substrate. {ECO:0000250}.
FT   BINDING     386    386       Substrate. {ECO:0000250}.
FT   MOD_RES      95     95       Phosphoserine.
FT                                {ECO:0000244|PubMed:21183079}.
FT   CARBOHYD    423    423       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    428    428       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    141    373       {ECO:0000255|PROSITE-ProRule:PRU00174}.
FT   DISULFID    364    441       {ECO:0000255|PROSITE-ProRule:PRU00174}.
FT   DISULFID    493    512       {ECO:0000255|PROSITE-ProRule:PRU00174}.
FT   DISULFID    536    553       {ECO:0000255|PROSITE-ProRule:PRU00174}.
FT   DISULFID    578    596       {ECO:0000255|PROSITE-ProRule:PRU00174}.
FT   CONFLICT    545    545       S -> L (in Ref. 3; BAC40096).
FT                                {ECO:0000305}.
SQ   SEQUENCE   608 AA;  69201 MW;  0E452FDA1CA5668B CRC64;
     MGSITVRYFC YGCLFTSATW TVLLFIYFNF SEVTQPLRNV PIKGSGPHGP FPKKFYPRFT
     RGPGRVLDPQ FKANRIDRLM NNHIEDPDKG LSKSSSELGM IFNERDQELR DLGYQKHAFN
     MLISNRLGYH RDVPDTRNAE CRRKSYPTDL PTASIVICFY NEAFSALLRT VHSVVDRTPA
     HLLHEIILVD DSSDFDDLKG ELDEYIQRYL PAKVKVIRNM KREGLIRGRM IGAAHATGEV
     LVFLDSHCEV NVMWLQPLLA IILEDPHTVV CPVIDIISAD TLAYSSSPVV RGGFNWGLHF
     KWDLVPVSEL GGPDGATAPI RSPTMAGGLF AMNRQYFNDL GQYDSGMDIW GGENLEISFR
     IWMCGGKLFI LPCSRVGHIF RKRRPYGSPE GQDTMTHNSL RLAHVWLDEY KEQYFSLRPD
     LKNKSFGNIS ERVELRKKLG CQSFKWYLDN IYPEMQIPGP NAKPQQPVLI NRGPKRPRVL
     QRGRLYHLQT NKCLVAQGRS SQKGGLVLLK TCDYGDPTQV WIYNEDHELI LNNLLCLDMS
     ETRSSDPPRL MKCHGSGGSQ QWTFGKNNRL YQVSVGQCLR VMDLMDQKGY VGMAICDGSS
     SQQWRLEG
//
ID   DLLB_DANRE              Reviewed;         615 AA.
AC   O57409;
DT   05-JUL-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1998, sequence version 1.
DT   22-NOV-2017, entry version 121.
DE   RecName: Full=Delta-like protein B;
DE            Short=DeltaB;
DE   Flags: Precursor;
GN   Name=dlb;
OS   Danio rerio (Zebrafish) (Brachydanio rerio).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Actinopterygii; Neopterygii; Teleostei; Ostariophysi; Cypriniformes;
OC   Cyprinidae; Danio.
OX   NCBI_TaxID=7955;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY, AND
RP   DEVELOPMENTAL STAGE.
RX   PubMed=9425132;
RA   Haddon C., Smithers L., Schneider-Maunoury S., Coche T., Henrique D.,
RA   Lewis J.;
RT   "Multiple delta genes and lateral inhibition in zebrafish primary
RT   neurogenesis.";
RL   Development 125:359-370(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Embryo;
RG   NIH - Zebrafish Gene Collection (ZGC) project;
RL   Submitted (JUL-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   UBIQUITINATION.
RX   PubMed=12530964; DOI=10.1016/S1534-5807(02)00409-4;
RA   Itoh M., Kim C.-H., Palardy G., Oda T., Jiang Y.-J., Maust D.,
RA   Yeo S.-Y., Lorick K., Wright G.J., Ariza-McNaughton L., Weissman A.M.,
RA   Lewis J., Chandrasekharappa S.C., Chitnis A.B.;
RT   "Mind bomb is a ubiquitin ligase that is essential for efficient
RT   activation of Notch signaling by Delta.";
RL   Dev. Cell 4:67-82(2003).
CC   -!- FUNCTION: Acts as a ligand for Notch receptors and is involved in
CC       primary neurogenesis. Can activate Notch receptors, thereby
CC       playing a key role in lateral inhibition, a process that prevents
CC       the immediate neighbors of each nascent neural cell from
CC       simultaneously embarking on neural differentiation.
CC       {ECO:0000269|PubMed:9425132}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250}; Single-pass type I
CC       membrane protein {ECO:0000250}.
CC   -!- DEVELOPMENTAL STAGE: Expressed in the epiblast (the future
CC       neurectoderm) and in neuroblasts. Expressed in overlapping regions
CC       with deltaA (dla) and deltaD (dld), but differs in the neural
CC       plate: it is apparently confined to the scattered cells within
CC       those patches that differentiate as neurons, while dla and dld are
CC       expressed in patches of contiguous cells.
CC       {ECO:0000269|PubMed:9425132}.
CC   -!- PTM: Ubiquitinated by mib, leading to its endocytosis and
CC       subsequent degradation. {ECO:0000269|PubMed:12530964}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF006488; AAC41241.1; -; mRNA.
DR   EMBL; BC076414; AAH76414.1; -; mRNA.
DR   RefSeq; NP_571033.1; NM_130958.1.
DR   UniGene; Dr.574; -.
DR   ProteinModelPortal; O57409; -.
DR   SMR; O57409; -.
DR   STRING; 7955.ENSDARP00000021660; -.
DR   PaxDb; O57409; -.
DR   Ensembl; ENSDART00000019259; ENSDARP00000021660; ENSDARG00000004232.
DR   GeneID; 30141; -.
DR   KEGG; dre:30141; -.
DR   CTD; 30141; -.
DR   ZFIN; ZDB-GENE-980526-114; dlb.
DR   eggNOG; KOG1217; Eukaryota.
DR   eggNOG; ENOG410XP6K; LUCA.
DR   GeneTree; ENSGT00810000125346; -.
DR   HOGENOM; HOG000267024; -.
DR   HOVERGEN; HBG007139; -.
DR   InParanoid; O57409; -.
DR   KO; K06051; -.
DR   PhylomeDB; O57409; -.
DR   TreeFam; TF351835; -.
DR   PRO; PR:O57409; -.
DR   Proteomes; UP000000437; Chromosome 5.
DR   Bgee; ENSDARG00000004232; -.
DR   ExpressionAtlas; O57409; baseline.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0021536; P:diencephalon development; IMP:ZFIN.
DR   GO; GO:0030901; P:midbrain development; IGI:ZFIN.
DR   GO; GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW.
DR   InterPro; IPR001774; DSL.
DR   InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR000152; EGF-type_Asp/Asn_hydroxyl_site.
DR   InterPro; IPR018097; EGF_Ca-bd_CS.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   Pfam; PF01414; DSL; 1.
DR   Pfam; PF00008; EGF; 6.
DR   SMART; SM00051; DSL; 1.
DR   SMART; SM00181; EGF; 8.
DR   SMART; SM00179; EGF_CA; 6.
DR   SUPFAM; SSF57184; SSF57184; 1.
DR   PROSITE; PS00010; ASX_HYDROXYL; 2.
DR   PROSITE; PS51051; DSL; 1.
DR   PROSITE; PS00022; EGF_1; 9.
DR   PROSITE; PS01186; EGF_2; 7.
DR   PROSITE; PS50026; EGF_3; 8.
DR   PROSITE; PS01187; EGF_CA; 2.
PE   1: Evidence at protein level;
KW   Calcium; Complete proteome; Developmental protein; Differentiation;
KW   Disulfide bond; EGF-like domain; Glycoprotein; Membrane; Neurogenesis;
KW   Notch signaling pathway; Reference proteome; Repeat; Signal;
KW   Transmembrane; Transmembrane helix; Ubl conjugation.
FT   SIGNAL        1     20       {ECO:0000255}.
FT   CHAIN        21    615       Delta-like protein B.
FT                                /FTId=PRO_0000007515.
FT   TOPO_DOM     21    522       Extracellular. {ECO:0000255}.
FT   TRANSMEM    523    543       Helical. {ECO:0000255}.
FT   TOPO_DOM    544    615       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      159    203       DSL. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00377}.
FT   DOMAIN      204    237       EGF-like 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      241    268       EGF-like 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      270    308       EGF-like 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      310    346       EGF-like 4; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      348    385       EGF-like 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      387    423       EGF-like 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      425    461       EGF-like 7; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      463    499       EGF-like 8. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   COMPBIAS    544    552       Poly-Arg.
FT   CARBOHYD    459    459       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    161    170       {ECO:0000250}.
FT   DISULFID    174    186       {ECO:0000250}.
FT   DISULFID    194    203       {ECO:0000250}.
FT   DISULFID    208    219       {ECO:0000250}.
FT   DISULFID    212    225       {ECO:0000250}.
FT   DISULFID    227    236       {ECO:0000250}.
FT   DISULFID    245    250       {ECO:0000250}.
FT   DISULFID    258    267       {ECO:0000250}.
FT   DISULFID    274    286       {ECO:0000250}.
FT   DISULFID    280    296       {ECO:0000250}.
FT   DISULFID    298    307       {ECO:0000250}.
FT   DISULFID    314    325       {ECO:0000250}.
FT   DISULFID    319    334       {ECO:0000250}.
FT   DISULFID    336    345       {ECO:0000250}.
FT   DISULFID    352    363       {ECO:0000250}.
FT   DISULFID    357    373       {ECO:0000250}.
FT   DISULFID    375    384       {ECO:0000250}.
FT   DISULFID    391    402       {ECO:0000250}.
FT   DISULFID    396    411       {ECO:0000250}.
FT   DISULFID    413    422       {ECO:0000250}.
FT   DISULFID    429    440       {ECO:0000250}.
FT   DISULFID    434    449       {ECO:0000250}.
FT   DISULFID    451    460       {ECO:0000250}.
FT   DISULFID    467    478       {ECO:0000250}.
FT   DISULFID    472    487       {ECO:0000250}.
FT   DISULFID    489    498       {ECO:0000250}.
SQ   SEQUENCE   615 AA;  67593 MW;  CA18004428F5603C CRC64;
     MAHLSLYCLL SVSLLQLVAS SGVFELKVHS FSTTRRFCRR TRDCNIFFRI CLKHSEDVIS
     AEPPCTFGTG QTSVLRADQS SIASSAAIRV PFHFKWPGTF SLIIEAWNAE SPKEHHDYTE
     NQNNLISRLA TRRRLAVGED WSQDVHFGDQ SELRYSYHVF CDEFYFGEAC SDYCRPRDDT
     LGHYTCDENG NKECLVGWQG DYCSDPICSS DCSERHGYCE SPGECKCRLG WQGPSCSECV
     HYPGCLHGTC SQPWQCVCKE GWGGLFCNQD LNYCTNHKPC ANGATCTNTG QGSYTCTCRP
     GFGGTNCELE INECDCNPCK NGGSCNDLEN DYSCTCPQGF YGKNCEIIAM TCADDPCFNG
     GTCEEKFTGG YVCRCPPTFT GSNCEKRLDR CSHKPCANGG ECVDLGASAL CRCRPGFSGS
     RCETNIDDCA RYPCQNAGTC QDGINDYTCT CTLGFTGKNC SLRADACLTN PCLHGGTCFT
     HFSGPVCQCV PGFMGSTCEF PVQASLEKMA PRVGQTSPSA VAVSCVLGVL AVFLGVCVGL
     VVLRRRRHRL RRQQLCDSVF NDLETVNNLD RQHYPYDRDF SQVKPCNTEG RISLAASHTL
     PAGQEFLWSA GGGLR
//
ID   FOJO_DROME              Reviewed;         583 AA.
AC   P54360; Q24176; Q8SZ37; Q9V8E3;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   24-MAY-2005, sequence version 2.
DT   25-OCT-2017, entry version 130.
DE   RecName: Full=Extracellular serine/threonine protein kinase four-jointed {ECO:0000305};
DE            EC=2.7.11.1 {ECO:0000305};
DE   Contains:
DE     RecName: Full=Protein four-jointed, secreted isoform;
GN   Name=fj {ECO:0000312|FlyBase:FBgn0000658}; ORFNames=CG10917;
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha;
OC   Ephydroidea; Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY, AND
RP   DISRUPTION PHENOTYPE.
RC   TISSUE=Eye imaginal disk;
RX   PubMed=7555705;
RA   Villano J.L., Katz F.N.;
RT   "four-jointed is required for intermediate growth in the proximal-
RT   distal axis in Drosophila.";
RL   Development 121:2767-2777(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND TISSUE SPECIFICITY.
RC   STRAIN=Canton-S;
RX   PubMed=8606003; DOI=10.1006/dbio.1996.0038;
RA   Brodsky M.H., Steller H.;
RT   "Positional information along the dorsal-ventral axis of the
RT   Drosophila eye: graded expression of the four-jointed gene.";
RL   Dev. Biol. 173:428-446(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley;
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X.,
RA   Brandon R.C., Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D.,
RA   Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G.,
RA   Abril J.F., Agbayani A., An H.-J., Andrews-Pfannkoch C., Baldwin D.,
RA   Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M.,
RA   Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S.,
RA   Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P.,
RA   Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I.,
RA   Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P.,
RA   de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M.,
RA   Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P.,
RA   Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W.,
RA   Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K.,
RA   Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J.,
RA   Hostin D., Houston K.A., Howland T.J., Wei M.-H., Ibegwam C.,
RA   Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A.,
RA   Kimmel B.E., Kodira C.D., Kraft C.L., Kravitz S., Kulp D., Lai Z.,
RA   Lasko P., Lei Y., Levitsky A.A., Li J.H., Li Z., Liang Y., Lin X.,
RA   Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D.,
RA   Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A.,
RA   Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L.,
RA   Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M.,
RA   Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G.,
RA   Reinert K., Remington K., Saunders R.D.C., Scheeler F., Shen H.,
RA   Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E.,
RA   Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X.,
RA   Wang Z.-Y., Wassarman D.A., Weinstock G.M., Weissenbach J.,
RA   Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A.,
RA   Ye J., Yeh R.-F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L.,
RA   Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S.C., Zhu X.,
RA   Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [4]
RP   GENOME REANNOTATION.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q.,
RA   Stapleton M., Yamada C., Ashburner M., Gelbart W.M., Rubin G.M.,
RA   Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a
RT   systematic review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=Berkeley; TISSUE=Embryo;
RX   PubMed=12537569; DOI=10.1186/gb-2002-3-12-research0080;
RA   Stapleton M., Carlson J.W., Brokstein P., Yu C., Champe M.,
RA   George R.A., Guarin H., Kronmiller B., Pacleb J.M., Park S., Wan K.H.,
RA   Rubin G.M., Celniker S.E.;
RT   "A Drosophila full-length cDNA resource.";
RL   Genome Biol. 3:RESEARCH0080.1-RESEARCH0080.8(2002).
RN   [6]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=10607560; DOI=10.1016/S0960-9822(00)80081-0;
RA   Zeidler M.P., Perrimon N., Strutt D.I.;
RT   "The four-jointed gene is required in the Drosophila eye for
RT   ommatidial polarity specification.";
RL   Curr. Biol. 9:1363-1372(1999).
RN   [7]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=11566858;
RA   Buckles G.R., Rauskolb C., Villano J.L., Katz F.N.;
RT   "Four-jointed interacts with dachs, abelson and enabled and feeds back
RT   onto the Notch pathway to affect growth and segmentation in the
RT   Drosophila leg.";
RL   Development 128:3533-3542(2001).
RN   [8]
RP   FUNCTION, PROTEOLYTIC CLEAVAGE, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=14757640; DOI=10.1242/dev.00996;
RA   Strutt H., Mundy J., Hofstra K., Strutt D.;
RT   "Cleavage and secretion is not required for four-jointed function in
RT   Drosophila patterning.";
RL   Development 131:881-890(2004).
RN   [9]
RP   FUNCTION, AND MUTAGENESIS OF 490-ASP--GLU-492.
RX   PubMed=18635802; DOI=10.1126/science.1158159;
RA   Ishikawa H.O., Takeuchi H., Haltiwanger R.S., Irvine K.D.;
RT   "Four-jointed is a Golgi kinase that phosphorylates a subset of
RT   cadherin domains.";
RL   Science 321:401-404(2008).
CC   -!- FUNCTION: Golgi serine/threonine protein kinase required for
CC       intermediate growth in the proximal-distal axis. Phosphorylates
CC       specific residues within extracellular cadherin domains of Fat
CC       (ft) and Dachsous (ds) as they transit through the Golgi
CC       (PubMed:18635802). Acts in ommatidial polarity determination as a
CC       secondary signal downstream of Notch, JAK/STAT and wingless. Also
CC       necessary for the initiation, up-regulation or maintenance of
CC       Notch ligand, Serrate (Ser) expression in legs, thereby
CC       participating in a feedback loop with N signaling. Sufficient for
CC       joint formation and growth in the leg (PubMed:10607560,
CC       PubMed:11566858, PubMed:14757640, PubMed:7555705, PubMed:8606003).
CC       {ECO:0000269|PubMed:10607560, ECO:0000269|PubMed:11566858,
CC       ECO:0000269|PubMed:14757640, ECO:0000269|PubMed:18635802,
CC       ECO:0000269|PubMed:7555705, ECO:0000269|PubMed:8606003}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC       {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus membrane
CC       {ECO:0000269|PubMed:11566858, ECO:0000269|PubMed:14757640};
CC       Single-pass type II membrane protein {ECO:0000269|PubMed:11566858,
CC       ECO:0000269|PubMed:14757640}. Note=Golgi apparatus, in the wing
CC       pouch.
CC   -!- SUBCELLULAR LOCATION: Protein four-jointed, secreted isoform:
CC       Secreted {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: In the eye disk, expressed in a gradient ahead
CC       of the morphogenetic furrow, high at the equator and low at the
CC       poles of the eye. In the leg disk, expressed in concentric rings,
CC       possibly corresponding to segmental boundaries. In the wing disk,
CC       expression is localized in the wing pouch; low in peripheral
CC       regions and high towards the center. {ECO:0000269|PubMed:10607560,
CC       ECO:0000269|PubMed:11566858, ECO:0000269|PubMed:14757640,
CC       ECO:0000269|PubMed:7555705, ECO:0000269|PubMed:8606003}.
CC   -!- PTM: Proteolytically cleaved to yield a secreted protein.
CC       {ECO:0000269|PubMed:14757640}.
CC   -!- DISRUPTION PHENOTYPE: Mutants show reduced growth and altered
CC       differentiation only within restricted sectors of the proximal-
CC       distal (PD) axis in the leg and wing.
CC       {ECO:0000269|PubMed:7555705}.
CC   -!- SIMILARITY: Belongs to the FJX1/FJ family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U28837; AAA69524.1; -; mRNA.
DR   EMBL; U44904; AAB01809.1; -; mRNA.
DR   EMBL; AE013599; AAF57724.2; -; Genomic_DNA.
DR   EMBL; AY071147; AAL48769.1; -; mRNA.
DR   RefSeq; NP_477483.1; NM_058135.4.
DR   UniGene; Dm.4763; -.
DR   ProteinModelPortal; P54360; -.
DR   BioGrid; 62770; 23.
DR   MINT; MINT-917812; -.
DR   STRING; 7227.FBpp0085933; -.
DR   PaxDb; P54360; -.
DR   PRIDE; P54360; -.
DR   EnsemblMetazoa; FBtr0086754; FBpp0085933; FBgn0000658.
DR   GeneID; 37089; -.
DR   KEGG; dme:Dmel_CG10917; -.
DR   UCSC; CG10917-RA; d. melanogaster.
DR   CTD; 37089; -.
DR   FlyBase; FBgn0000658; fj.
DR   eggNOG; ENOG410IHNI; Eukaryota.
DR   eggNOG; ENOG410XSE2; LUCA.
DR   GeneTree; ENSGT00390000016768; -.
DR   InParanoid; P54360; -.
DR   KO; K16674; -.
DR   OMA; YRKGPER; -.
DR   OrthoDB; EOG091G0L1D; -.
DR   PhylomeDB; P54360; -.
DR   GenomeRNAi; 37089; -.
DR   PRO; PR:P54360; -.
DR   Proteomes; UP000000803; Chromosome 2R.
DR   Bgee; FBgn0000658; -.
DR   Genevisible; P54360; DM.
DR   GO; GO:0005615; C:extracellular space; IBA:GO_Central.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IDA:FlyBase.
DR   GO; GO:0004672; F:protein kinase activity; IDA:FlyBase.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0017147; F:Wnt-protein binding; IPI:FlyBase.
DR   GO; GO:0007267; P:cell-cell signaling; IDA:FlyBase.
DR   GO; GO:0045198; P:establishment of epithelial cell apical/basal polarity; IMP:FlyBase.
DR   GO; GO:0001737; P:establishment of imaginal disc-derived wing hair orientation; IMP:FlyBase.
DR   GO; GO:0042067; P:establishment of ommatidial planar polarity; IMP:UniProtKB.
DR   GO; GO:0001736; P:establishment of planar polarity; IMP:FlyBase.
DR   GO; GO:0007446; P:imaginal disc growth; IMP:FlyBase.
DR   GO; GO:0016348; P:imaginal disc-derived leg joint morphogenesis; IMP:FlyBase.
DR   GO; GO:0007474; P:imaginal disc-derived wing vein specification; IMP:FlyBase.
DR   GO; GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0044719; P:regulation of imaginal disc-derived wing size; IMP:FlyBase.
DR   GO; GO:0043393; P:regulation of protein binding; IDA:UniProtKB.
DR   GO; GO:0035159; P:regulation of tube length, open tracheal system; IMP:FlyBase.
DR   GO; GO:0060071; P:Wnt signaling pathway, planar cell polarity pathway; IGI:FlyBase.
DR   InterPro; IPR024868; FJX1/FJ.
DR   PANTHER; PTHR13147; PTHR13147; 1.
DR   PRINTS; PR02072; 4JOINTEDBOX1.
PE   1: Evidence at protein level;
KW   Complete proteome; Glycoprotein; Golgi apparatus; Kinase; Membrane;
KW   Notch signaling pathway; Reference proteome; Secreted;
KW   Serine/threonine-protein kinase; Signal-anchor; Transferase;
KW   Transmembrane; Transmembrane helix; Wnt signaling pathway.
FT   CHAIN         1    583       Extracellular serine/threonine protein
FT                                kinase four-jointed.
FT                                /FTId=PRO_0000087324.
FT   CHAIN         ?    583       Protein four-jointed, secreted isoform.
FT                                /FTId=PRO_0000292347.
FT   TOPO_DOM      1     78       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     79     99       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM    100    583       Extracellular. {ECO:0000255}.
FT   CARBOHYD    310    310       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    379    379       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    491    491       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   MUTAGEN     490    492       DNE->GGG: Abolishes the protein kinase
FT                                activity. {ECO:0000269|PubMed:18635802}.
FT   CONFLICT     48     48       P -> S (in Ref. 1; AAA69524 and 2;
FT                                AAB01809). {ECO:0000305}.
FT   CONFLICT    126    126       S -> T (in Ref. 1; AAA69524).
FT                                {ECO:0000305}.
FT   CONFLICT    193    193       L -> M (in Ref. 1; AAA69524).
FT                                {ECO:0000305}.
FT   CONFLICT    225    225       F -> L (in Ref. 1; AAA69524 and 2;
FT                                AAB01809). {ECO:0000305}.
FT   CONFLICT    288    288       R -> P (in Ref. 1; AAA69524).
FT                                {ECO:0000305}.
FT   CONFLICT    330    330       A -> R (in Ref. 1; AAA69524).
FT                                {ECO:0000305}.
SQ   SEQUENCE   583 AA;  65490 MW;  8AADC85FC85D09A4 CRC64;
     MYDIKRLEAG QQKLQQAQQP LGLDLSGQQQ QLTCSVITAP EHRANPNPSS ISQSNPSEAT
     HMTLLTLRRR RSLQRRACLL SILAAFVFGM ALGVVVPMFG LPRHQDSPPD LPEEQIQMVA
     VEPLSSYRVE FIKETDELSA EQVFRNAFHL EQDKDAPDSM VVKKLDTNDG SIKEFHVQRT
     ASGRYRKGPE RRLSKKMPER VQPQETSRSP TTSPTNPTSE HQAGFIEEDV YWGPTVEQAL
     PKGFAAKDQV SWERFVGEQG RVVRLEQGCG RMQNRMVVFA DGTRACARYR QNTDQIQGEI
     FSYYLGQLLN ISNLAPSAAT VVDTSTPNWA AALGDITQAQ WKERRPVVLT RWLSDLEPAG
     IPQPFQPLER HLNKHDVWNL TRHMQSERQA QSQPHGLLKR LGAASSPGSA HQSNAIEETG
     TGTETANGAL VQRLIELAQW SDLIVFDYLI ANLDRVVNNL YNFQWNADIM AAPAHNLARQ
     SASQLLVFLD NESGLLHGYR LLKKYEAYHS LLLDNLCVFR RPTIDALRRL RAAGAGRRLR
     DLFERTTSAG VRDVLPSLPD KSVKILVERI DRVLGQVQKC QGS
//
ID   NICA_DICDI              Reviewed;         659 AA.
AC   Q54JT7;
DT   29-APR-2008, integrated into UniProtKB/Swiss-Prot.
DT   18-MAR-2008, sequence version 2.
DT   27-SEP-2017, entry version 65.
DE   RecName: Full=Nicastrin;
DE   Flags: Precursor;
GN   Name=ncstn; ORFNames=DDB_G0287801;
OS   Dictyostelium discoideum (Slime mold).
OC   Eukaryota; Amoebozoa; Mycetozoa; Dictyosteliida; Dictyostelium.
OX   NCBI_TaxID=44689;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=AX4;
RX   PubMed=15875012; DOI=10.1038/nature03481;
RA   Eichinger L., Pachebat J.A., Gloeckner G., Rajandream M.A.,
RA   Sucgang R., Berriman M., Song J., Olsen R., Szafranski K., Xu Q.,
RA   Tunggal B., Kummerfeld S., Madera M., Konfortov B.A., Rivero F.,
RA   Bankier A.T., Lehmann R., Hamlin N., Davies R., Gaudet P., Fey P.,
RA   Pilcher K., Chen G., Saunders D., Sodergren E.J., Davis P.,
RA   Kerhornou A., Nie X., Hall N., Anjard C., Hemphill L., Bason N.,
RA   Farbrother P., Desany B., Just E., Morio T., Rost R., Churcher C.M.,
RA   Cooper J., Haydock S., van Driessche N., Cronin A., Goodhead I.,
RA   Muzny D.M., Mourier T., Pain A., Lu M., Harper D., Lindsay R.,
RA   Hauser H., James K.D., Quiles M., Madan Babu M., Saito T.,
RA   Buchrieser C., Wardroper A., Felder M., Thangavelu M., Johnson D.,
RA   Knights A., Loulseged H., Mungall K.L., Oliver K., Price C.,
RA   Quail M.A., Urushihara H., Hernandez J., Rabbinowitsch E., Steffen D.,
RA   Sanders M., Ma J., Kohara Y., Sharp S., Simmonds M.N., Spiegler S.,
RA   Tivey A., Sugano S., White B., Walker D., Woodward J.R., Winckler T.,
RA   Tanaka Y., Shaulsky G., Schleicher M., Weinstock G.M., Rosenthal A.,
RA   Cox E.C., Chisholm R.L., Gibbs R.A., Loomis W.F., Platzer M.,
RA   Kay R.R., Williams J.G., Dear P.H., Noegel A.A., Barrell B.G.,
RA   Kuspa A.;
RT   "The genome of the social amoeba Dictyostelium discoideum.";
RL   Nature 435:43-57(2005).
CC   -!- FUNCTION: Essential subunit of the gamma-secretase complex, an
CC       endoprotease complex that catalyzes the intramembrane cleavage of
CC       integral membrane proteins such as Notch receptors and APP
CC       (amyloid-beta precursor protein). It probably represents a
CC       stabilizing cofactor required for the assembly of the gamma-
CC       secretase complex (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Homodimer. Component of the gamma-secretase complex, a
CC       complex composed of a presenilin homodimer, nicastrin, aph1 and
CC       pen2 (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I
CC       membrane protein {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the nicastrin family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AAFI02000104; EAL63547.2; -; Genomic_DNA.
DR   RefSeq; XP_637065.2; XM_631973.2.
DR   SMR; Q54JT7; -.
DR   STRING; 44689.DDB0237950; -.
DR   PaxDb; Q54JT7; -.
DR   EnsemblProtists; EAL63547; EAL63547; DDB_G0287801.
DR   GeneID; 8626320; -.
DR   KEGG; ddi:DDB_G0287801; -.
DR   dictyBase; DDB_G0287801; ncstn.
DR   eggNOG; KOG2657; Eukaryota.
DR   eggNOG; ENOG410XT6X; LUCA.
DR   InParanoid; Q54JT7; -.
DR   KO; K06171; -.
DR   OMA; TWTESTW; -.
DR   PhylomeDB; Q54JT7; -.
DR   Reactome; R-DDI-6798695; Neutrophil degranulation.
DR   PRO; PR:Q54JT7; -.
DR   Proteomes; UP000002195; Chromosome 5.
DR   Proteomes; UP000002195; Unassembled WGS sequence.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0004175; F:endopeptidase activity; IBA:GO_Central.
DR   GO; GO:0006509; P:membrane protein ectodomain proteolysis; ISS:dictyBase.
DR   GO; GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0006909; P:phagocytosis; IGI:dictyBase.
DR   GO; GO:0016485; P:protein processing; IBA:GO_Central.
DR   GO; GO:0006508; P:proteolysis; IMP:dictyBase.
DR   GO; GO:0044671; P:sorocarp spore cell differentiation; IMP:dictyBase.
DR   InterPro; IPR008710; Nicastrin.
DR   PANTHER; PTHR21092; PTHR21092; 1.
DR   Pfam; PF05450; Nicastrin; 1.
PE   3: Inferred from homology;
KW   Complete proteome; Glycoprotein; Membrane; Notch signaling pathway;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL        1     22       {ECO:0000255}.
FT   CHAIN        23    659       Nicastrin.
FT                                /FTId=PRO_0000331269.
FT   TOPO_DOM     23    627       Extracellular. {ECO:0000255}.
FT   TRANSMEM    628    648       Helical. {ECO:0000255}.
FT   TOPO_DOM    649    659       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD     94     94       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    172    172       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    305    305       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    389    389       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    451    451       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    475    475       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    550    550       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    553    553       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    600    600       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   659 AA;  74480 MW;  69F53E95D4E82F40 CRC64;
     MKIKNYFIIV FIIIVLSTDV ISSQSSIEDK MYTSLNSYPC TRIMTLNGQI GCSSSHGGDS
     GILYLIDSDE SYHNYFSYNQ QKDIIVVFDS NYFNKTLVLE MYSKKKMNGA LVLTDIGKTY
     PYSPEDQYPI KQFGLYPDSN LNWNPNGDGF TYMNFPFPMF ALELKTSIII RNLSTINRDG
     KYPAYGAELD SFMQGAINAE TCLRRGFCEP VGGQSIWSSF SEVIDQSKPI ILVMLPIDAT
     AFFRDLATGT DQSGYALTVL LSMLNTLQGV DKTKWDKEVI FAMWNSERWG YVGSTNFVND
     LLNFNCTSLD SNNQNSCSSP PMLDLTFEQI KFENIYAIIE FNQIGRPVNS GKKTPNKLDI
     YNLVFHPNGG AGANQLMDVF SQSTQSYENS TIQFQKTTQN ELPPCSSMSF IKEINKKSAP
     NFIGTLVITD HDYQYNNPYF GDEQDNSGNI NTTTSTLFDM VQVFSKSIDL LAGGNGTVKV
     DDLFIREINV CLTQSITCNW VTKLMSTFPY NPIPNFYSGV YGVSPVNHIT PIETRFIFRM
     ATYLTQHRTN ATNCTSDNDC DTSSSICVNK VCLYSNTHYH NAISLAFSFD NSKSSWTIVN
     TSYPVFVESN WDYTTVRLFQ VGSYANEIWF LVSGLIELLL SVGIIFYIKK YLSKRYKLL
//
ID   PSNA_DICDI              Reviewed;         622 AA.
AC   Q54ET2;
DT   29-APR-2008, integrated into UniProtKB/Swiss-Prot.
DT   24-MAY-2005, sequence version 1.
DT   22-NOV-2017, entry version 78.
DE   RecName: Full=Presenilin-A;
DE            Short=PS-A;
DE            EC=3.4.23.-;
GN   Name=psenA; ORFNames=DDB_G0291352;
OS   Dictyostelium discoideum (Slime mold).
OC   Eukaryota; Amoebozoa; Mycetozoa; Dictyosteliida; Dictyostelium.
OX   NCBI_TaxID=44689;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=AX4;
RX   PubMed=15875012; DOI=10.1038/nature03481;
RA   Eichinger L., Pachebat J.A., Gloeckner G., Rajandream M.A.,
RA   Sucgang R., Berriman M., Song J., Olsen R., Szafranski K., Xu Q.,
RA   Tunggal B., Kummerfeld S., Madera M., Konfortov B.A., Rivero F.,
RA   Bankier A.T., Lehmann R., Hamlin N., Davies R., Gaudet P., Fey P.,
RA   Pilcher K., Chen G., Saunders D., Sodergren E.J., Davis P.,
RA   Kerhornou A., Nie X., Hall N., Anjard C., Hemphill L., Bason N.,
RA   Farbrother P., Desany B., Just E., Morio T., Rost R., Churcher C.M.,
RA   Cooper J., Haydock S., van Driessche N., Cronin A., Goodhead I.,
RA   Muzny D.M., Mourier T., Pain A., Lu M., Harper D., Lindsay R.,
RA   Hauser H., James K.D., Quiles M., Madan Babu M., Saito T.,
RA   Buchrieser C., Wardroper A., Felder M., Thangavelu M., Johnson D.,
RA   Knights A., Loulseged H., Mungall K.L., Oliver K., Price C.,
RA   Quail M.A., Urushihara H., Hernandez J., Rabbinowitsch E., Steffen D.,
RA   Sanders M., Ma J., Kohara Y., Sharp S., Simmonds M.N., Spiegler S.,
RA   Tivey A., Sugano S., White B., Walker D., Woodward J.R., Winckler T.,
RA   Tanaka Y., Shaulsky G., Schleicher M., Weinstock G.M., Rosenthal A.,
RA   Cox E.C., Chisholm R.L., Gibbs R.A., Loomis W.F., Platzer M.,
RA   Kay R.R., Williams J.G., Dear P.H., Noegel A.A., Barrell B.G.,
RA   Kuspa A.;
RT   "The genome of the social amoeba Dictyostelium discoideum.";
RL   Nature 435:43-57(2005).
CC   -!- FUNCTION: Probable catalytic subunit of the gamma-secretase
CC       complex, an endoprotease complex that catalyzes the intramembrane
CC       cleavage of integral membrane proteins such as Notch receptors.
CC       Requires the other members of the gamma-secretase complex to have
CC       a protease activity (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Homodimer. Component of the gamma-secretase complex, a
CC       complex composed of a presenilin homodimer, nicastrin, aph1 and
CC       pen2 (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}. Golgi
CC       apparatus membrane {ECO:0000250}; Multi-pass membrane protein
CC       {ECO:0000250}.
CC   -!- DOMAIN: The PAL motif is required for normal active site
CC       conformation. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the peptidase A22A family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AAFI02000177; EAL61660.1; -; Genomic_DNA.
DR   RefSeq; XP_635158.1; XM_630066.1.
DR   STRING; 44689.DDB0231427; -.
DR   MEROPS; A22.A09; -.
DR   PaxDb; Q54ET2; -.
DR   EnsemblProtists; EAL61660; EAL61660; DDB_G0291352.
DR   GeneID; 8628104; -.
DR   KEGG; ddi:DDB_G0291352; -.
DR   dictyBase; DDB_G0291352; psenA.
DR   eggNOG; KOG2736; Eukaryota.
DR   eggNOG; ENOG410XPZD; LUCA.
DR   InParanoid; Q54ET2; -.
DR   KO; K04505; -.
DR   PhylomeDB; Q54ET2; -.
DR   Reactome; R-DDI-6798695; Neutrophil degranulation.
DR   PRO; PR:Q54ET2; -.
DR   Proteomes; UP000002195; Chromosome 6.
DR   Proteomes; UP000002195; Unassembled WGS sequence.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0004190; F:aspartic-type endopeptidase activity; IEA:InterPro.
DR   GO; GO:0004175; F:endopeptidase activity; IBA:GO_Central.
DR   GO; GO:0055074; P:calcium ion homeostasis; IMP:dictyBase.
DR   GO; GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0016485; P:protein processing; IEA:InterPro.
DR   GO; GO:0043949; P:regulation of cAMP-mediated signaling; IGI:dictyBase.
DR   GO; GO:0030587; P:sorocarp development; IGI:dictyBase.
DR   GO; GO:0044671; P:sorocarp spore cell differentiation; IMP:dictyBase.
DR   GO; GO:0031149; P:sorocarp stalk cell differentiation; IGI:dictyBase.
DR   Gene3D; 2.130.10.10; -; 1.
DR   InterPro; IPR001108; Peptidase_A22A.
DR   InterPro; IPR006639; Preselin/SPP.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom_sf.
DR   PANTHER; PTHR10202; PTHR10202; 2.
DR   Pfam; PF01080; Presenilin; 1.
DR   PRINTS; PR01072; PRESENILIN.
DR   SMART; SM00730; PSN; 1.
PE   3: Inferred from homology;
KW   Complete proteome; Endoplasmic reticulum; Golgi apparatus; Hydrolase;
KW   Membrane; Notch signaling pathway; Protease; Reference proteome;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN         1    622       Presenilin-A.
FT                                /FTId=PRO_0000331267.
FT   TOPO_DOM      1    168       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    169    189       Helical. {ECO:0000255}.
FT   TOPO_DOM    190    227       Lumenal. {ECO:0000255}.
FT   TRANSMEM    228    248       Helical. {ECO:0000255}.
FT   TOPO_DOM    249    265       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    266    286       Helical. {ECO:0000255}.
FT   TOPO_DOM    287    289       Lumenal. {ECO:0000255}.
FT   TRANSMEM    290    310       Helical. {ECO:0000255}.
FT   TOPO_DOM    311    311       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    312    332       Helical. {ECO:0000255}.
FT   TOPO_DOM    333    341       Lumenal. {ECO:0000255}.
FT   TRANSMEM    342    362       Helical. {ECO:0000255}.
FT   TOPO_DOM    363    538       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    539    559       Helical. {ECO:0000255}.
FT   TOPO_DOM    560    562       Lumenal. {ECO:0000255}.
FT   TRANSMEM    563    583       Helical. {ECO:0000255}.
FT   TOPO_DOM    584    588       Cytoplasmic. {ECO:0000255}.
FT   INTRAMEM    589    609       Helical. {ECO:0000255}.
FT   TOPO_DOM    610    622       Cytoplasmic. {ECO:0000255}.
FT   MOTIF       588    590       PAL.
FT   COMPBIAS     22     62       Poly-Asn.
FT   COMPBIAS    145    157       Poly-Asp.
FT   COMPBIAS    398    407       Poly-Asn.
FT   COMPBIAS    419    423       Poly-Asn.
FT   COMPBIAS    435    450       Poly-Asn.
FT   ACT_SITE    351    351       {ECO:0000250}.
FT   ACT_SITE    543    543       {ECO:0000250}.
SQ   SEQUENCE   622 AA;  69503 MW;  CEBA16E5212967E6 CRC64;
     MKENEDEINK TDEKYKIKNP SNNGNNKNKN NNNNNNNNNN NNNNNNNNNN NNNNNNNNGN
     SNLENIEGLN KYNIYKKKKG KNESNTSLNN IYISSPNLSE RSDNSIGSYC TNKTMKSENS
     IINIETLFRD SVSEQNSDEC GSKVDKDLDE DDDDDDDETE VPELVDYSEM IVSILYPVCI
     TMVIVVLAIR AISSSTSKNS QIVEISNDNS GGNGDSSSGA DKMVFDSVVN SLIFLAVIIL
     STTIMVVLYK FKLMKALYAW LMGTSILLLG VFGGFLFLIL LAYLNLGLDY VTFVIVVWNF
     SVGGIVCIFW YSPKLLNQGY LISISVLMAL FFSRLPDWTT WGILSIVSIY DIFAVLCPGG
     PLRILIETAQ KRNENIPAMI YNASIYIGMI YNEDNLENNN NNNNNNNIEL NINEVDIENN
     NNNEDENKNN TEDGNNNNNK NKNNNNNNNN RIENENGAEN SSENGSITPP PTIPNFIKDE
     KEINRSSGSN GFPNFKKCAN DNILIGDAET NDEIVSNAES SIDSTISESY VKPKQSIRLG
     LGDFVFYSVL IGKAASYQIT TVFTVFIAII TGLFLTLILL AVFRRALPAL PMSIIFGIIV
     FFLTFKILIQ YIYFLGENQI FV
//
ID   PSN1_BOVIN              Reviewed;         478 AA.
AC   Q9XT97;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   22-NOV-2017, entry version 134.
DE   RecName: Full=Presenilin-1;
DE            Short=PS-1;
DE            EC=3.4.23.-;
DE   Contains:
DE     RecName: Full=Presenilin-1 NTF subunit;
DE   Contains:
DE     RecName: Full=Presenilin-1 CTF subunit;
DE   Contains:
DE     RecName: Full=Presenilin-1 CTF12;
DE              Short=PS1-CTF12;
GN   Name=PSEN1;
OS   Bos taurus (Bovine).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Ruminantia;
OC   Pecora; Bovidae; Bovinae; Bos.
OX   NCBI_TaxID=9913;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RA   Sahara N., Shirasawa T., Mori H.;
RT   "Molecular cloning of bovine presenilin 1 gene.";
RL   Submitted (DEC-1997) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Catalytic subunit of the gamma-secretase complex, an
CC       endoprotease complex that catalyzes the intramembrane cleavage of
CC       integral membrane proteins such as Notch receptors and APP
CC       (amyloid-beta precursor protein). Requires the presence of the
CC       other members of the gamma-secretase complex for protease
CC       activity. Plays a role in Notch and Wnt signaling cascades and
CC       regulation of downstream processes via its role in processing key
CC       regulatory proteins, and by regulating cytosolic CTNNB1 levels.
CC       Stimulates cell-cell adhesion via its interaction with CDH1; this
CC       stabilizes the complexes between CDH1 (E-cadherin) and its
CC       interaction partners CTNNB1 (beta-catenin), CTNND1 and JUP (gamma-
CC       catenin). Under conditions of apoptosis or calcium influx, cleaves
CC       CDH1. This promotes the disassembly of the complexes between CDH1
CC       and CTNND1, JUP and CTNNB1, increases the pool of cytoplasmic
CC       CTNNB1, and thereby negatively regulates Wnt signaling (By
CC       similarity). Required for normal embryonic brain and skeleton
CC       development, and for normal angiogenesis (By similarity).
CC       {ECO:0000250|UniProtKB:P49768, ECO:0000250|UniProtKB:P49769}.
CC   -!- SUBUNIT: Homodimer. The functional gamma-secretase complex is
CC       composed of at least four polypeptides: a presenilin homodimer
CC       (PSEN1 or PSEN2), nicastrin (NCSTN), APH1 (APH1A or APH1B) and
CC       PEN2. Such minimal complex is sufficient for secretase activity.
CC       Other components which are associated with the complex include
CC       SLC25A64, SLC5A7, PHB and PSEN1 isoform 3. Predominantly
CC       heterodimer of a N-terminal (NTF) and a C-terminal (CTF)
CC       endoproteolytical fragment. Associates with proteolytic processed
CC       C-terminal fragments C83 and C99 of the amyloid precursor protein
CC       (APP). Associates with NOTCH1. Associates with cadherin/catenin
CC       adhesion complexes through direct binding to CDH1 or CDH2.
CC       Interaction with CDH1 stabilizes the complex and stimulates cell-
CC       cell aggregation. Interaction with CDH2 is essential for
CC       trafficking of CDH2 from the endoplasmic reticulum to the plasma
CC       membrane. Interacts with CTNND2, CTNNB1, CTNND1, JUP, HERPUD1,
CC       FLNA, FLNB, MTCH1, PKP4 and PARL. Interacts through its N-terminus
CC       with isoform 3 of GFAP (By similarity). Interacts with DOCK3 (By
CC       similarity). Interacts with isoform 1 and isoform 3 of UBQLN1 (By
CC       similarity). {ECO:0000250|UniProtKB:P49768,
CC       ECO:0000250|UniProtKB:P49769}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:P49768}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:P49768}. Golgi apparatus membrane
CC       {ECO:0000250|UniProtKB:P49768}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:P49768}. Cytoplasmic granule
CC       {ECO:0000250|UniProtKB:P49768}. Cell membrane
CC       {ECO:0000250|UniProtKB:P49768}. Note=Translocates with bound
CC       NOTCH1 from the endoplasmic reticulum and/or Golgi to the cell
CC       surface. Colocalizes with CDH1/2 at sites of cell-cell contact.
CC       Colocalizes with CTNNB1 in the endoplasmic reticulum and the
CC       proximity of the plasma membrane. Also present in azurophil
CC       granules of neutrophils. Colocalizes with UBQLN1 in the cell
CC       membrane and in cytoplasmic juxtanuclear structures called
CC       aggresomes. {ECO:0000250|UniProtKB:P49768}.
CC   -!- DOMAIN: The PAL motif is required for normal active site
CC       conformation. {ECO:0000250|UniProtKB:P49768}.
CC   -!- PTM: Heterogeneous proteolytic processing generates N-terminal
CC       (NTF) and C-terminal (CTF) fragments of approximately 35 and 20
CC       kDa, respectively. During apoptosis, the C-terminal fragment (CTF)
CC       is further cleaved by caspase-3 to produce the fragment, PS1-
CC       CTF12. {ECO:0000250|UniProtKB:P49768}.
CC   -!- PTM: After endoproteolysis, the C-terminal fragment (CTF) is
CC       phosphorylated on serine residues by PKA and/or PKC.
CC       Phosphorylation on Ser-357 inhibits endoproteolysis.
CC       {ECO:0000250|UniProtKB:P49768}.
CC   -!- SIMILARITY: Belongs to the peptidase A22A family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF038936; AAD39023.1; -; mRNA.
DR   RefSeq; NP_777146.1; NM_174721.2.
DR   RefSeq; XP_005211988.1; XM_005211931.3.
DR   RefSeq; XP_005211989.1; XM_005211932.3.
DR   RefSeq; XP_015328709.1; XM_015473223.1.
DR   UniGene; Bt.51581; -.
DR   STRING; 9913.ENSBTAP00000040765; -.
DR   MEROPS; A22.001; -.
DR   PaxDb; Q9XT97; -.
DR   PRIDE; Q9XT97; -.
DR   Ensembl; ENSBTAT00000043175; ENSBTAP00000040765; ENSBTAG00000011757.
DR   GeneID; 282705; -.
DR   KEGG; bta:282705; -.
DR   CTD; 5663; -.
DR   eggNOG; KOG2736; Eukaryota.
DR   eggNOG; ENOG410XPZD; LUCA.
DR   GeneTree; ENSGT00390000016593; -.
DR   HOGENOM; HOG000240228; -.
DR   HOVERGEN; HBG011375; -.
DR   InParanoid; Q9XT97; -.
DR   KO; K04505; -.
DR   OMA; IAIHWKG; -.
DR   OrthoDB; EOG091G0C72; -.
DR   TreeFam; TF315040; -.
DR   Reactome; R-BTA-1251985; Nuclear signaling by ERBB4.
DR   Reactome; R-BTA-193692; Regulated proteolysis of p75NTR.
DR   Reactome; R-BTA-1980148; Signaling by NOTCH3.
DR   Reactome; R-BTA-1980150; Signaling by NOTCH4.
DR   Reactome; R-BTA-205043; NRIF signals cell death from the nucleus.
DR   Reactome; R-BTA-3928665; EPH-ephrin mediated repulsion of cells.
DR   Reactome; R-BTA-6798695; Neutrophil degranulation.
DR   Proteomes; UP000009136; Chromosome 10.
DR   Bgee; ENSBTAG00000011757; -.
DR   ExpressionAtlas; Q9XT97; baseline.
DR   GO; GO:0016235; C:aggresome; ISS:UniProtKB.
DR   GO; GO:0030424; C:axon; IBA:GO_Central.
DR   GO; GO:0005938; C:cell cortex; IBA:GO_Central.
DR   GO; GO:0030054; C:cell junction; IEA:Ensembl.
DR   GO; GO:0009986; C:cell surface; IBA:GO_Central.
DR   GO; GO:0005813; C:centrosome; IEA:Ensembl.
DR   GO; GO:0035253; C:ciliary rootlet; IBA:GO_Central.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IEA:Ensembl.
DR   GO; GO:0043198; C:dendritic shaft; IBA:GO_Central.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0070765; C:gamma-secretase complex; ISS:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; ISS:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0030426; C:growth cone; IBA:GO_Central.
DR   GO; GO:0016021; C:integral component of membrane; ISS:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISS:UniProtKB.
DR   GO; GO:0000776; C:kinetochore; IEA:Ensembl.
DR   GO; GO:0005765; C:lysosomal membrane; IBA:GO_Central.
DR   GO; GO:0045121; C:membrane raft; IBA:GO_Central.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IBA:GO_Central.
DR   GO; GO:0005739; C:mitochondrion; ISS:UniProtKB.
DR   GO; GO:0031594; C:neuromuscular junction; IBA:GO_Central.
DR   GO; GO:0043025; C:neuronal cell body; IBA:GO_Central.
DR   GO; GO:0005640; C:nuclear outer membrane; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0098793; C:presynapse; IEA:GOC.
DR   GO; GO:0005791; C:rough endoplasmic reticulum; IEA:Ensembl.
DR   GO; GO:0005790; C:smooth endoplasmic reticulum; IEA:Ensembl.
DR   GO; GO:0030018; C:Z disc; IBA:GO_Central.
DR   GO; GO:0042500; F:aspartic endopeptidase activity, intramembrane cleaving; ISS:UniProtKB.
DR   GO; GO:0008013; F:beta-catenin binding; IBA:GO_Central.
DR   GO; GO:0045296; F:cadherin binding; IBA:GO_Central.
DR   GO; GO:0005262; F:calcium channel activity; IEA:Ensembl.
DR   GO; GO:0004175; F:endopeptidase activity; IBA:GO_Central.
DR   GO; GO:0030165; F:PDZ domain binding; IEA:Ensembl.
DR   GO; GO:0000186; P:activation of MAPKK activity; IEA:Ensembl.
DR   GO; GO:0042987; P:amyloid precursor protein catabolic process; IBA:GO_Central.
DR   GO; GO:0042982; P:amyloid precursor protein metabolic process; ISS:UniProtKB.
DR   GO; GO:0034205; P:amyloid-beta formation; ISS:UniProtKB.
DR   GO; GO:0050435; P:amyloid-beta metabolic process; IBA:GO_Central.
DR   GO; GO:0002265; P:astrocyte activation involved in immune response; IEA:Ensembl.
DR   GO; GO:0000045; P:autophagosome assembly; IEA:Ensembl.
DR   GO; GO:0001568; P:blood vessel development; IEA:Ensembl.
DR   GO; GO:0048854; P:brain morphogenesis; IEA:Ensembl.
DR   GO; GO:0021870; P:Cajal-Retzius cell differentiation; IEA:Ensembl.
DR   GO; GO:0006816; P:calcium ion transport; IBA:GO_Central.
DR   GO; GO:0060070; P:canonical Wnt signaling pathway; IBA:GO_Central.
DR   GO; GO:0001708; P:cell fate specification; IEA:Ensembl.
DR   GO; GO:0098609; P:cell-cell adhesion; IEA:Ensembl.
DR   GO; GO:1904646; P:cellular response to amyloid-beta; IEA:Ensembl.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; IEA:Ensembl.
DR   GO; GO:0021795; P:cerebral cortex cell migration; IEA:Ensembl.
DR   GO; GO:0015871; P:choline transport; IEA:Ensembl.
DR   GO; GO:0021904; P:dorsal/ventral neural tube patterning; IEA:Ensembl.
DR   GO; GO:0030326; P:embryonic limb morphogenesis; IEA:Ensembl.
DR   GO; GO:0050673; P:epithelial cell proliferation; IEA:Ensembl.
DR   GO; GO:0001947; P:heart looping; IEA:Ensembl.
DR   GO; GO:0002244; P:hematopoietic progenitor cell differentiation; IEA:Ensembl.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:InterPro.
DR   GO; GO:0015813; P:L-glutamate transport; IEA:Ensembl.
DR   GO; GO:0006509; P:membrane protein ectodomain proteolysis; ISS:UniProtKB.
DR   GO; GO:0007613; P:memory; IEA:Ensembl.
DR   GO; GO:0006839; P:mitochondrial transport; IEA:Ensembl.
DR   GO; GO:0090647; P:modulation of age-related behavioral decline; IEA:Ensembl.
DR   GO; GO:0043011; P:myeloid dendritic cell differentiation; IEA:Ensembl.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IBA:GO_Central.
DR   GO; GO:2001234; P:negative regulation of apoptotic signaling pathway; IEA:Ensembl.
DR   GO; GO:0050771; P:negative regulation of axonogenesis; IEA:Ensembl.
DR   GO; GO:1904797; P:negative regulation of core promoter binding; IEA:Ensembl.
DR   GO; GO:0007175; P:negative regulation of epidermal growth factor-activated receptor activity; IEA:Ensembl.
DR   GO; GO:2000059; P:negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IEA:Ensembl.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   GO; GO:0051444; P:negative regulation of ubiquitin-protein transferase activity; IEA:Ensembl.
DR   GO; GO:0051402; P:neuron apoptotic process; IEA:Ensembl.
DR   GO; GO:0048666; P:neuron development; IEA:Ensembl.
DR   GO; GO:0001764; P:neuron migration; IEA:Ensembl.
DR   GO; GO:1990535; P:neuron projection maintenance; IEA:Ensembl.
DR   GO; GO:0007220; P:Notch receptor processing; IBA:GO_Central.
DR   GO; GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:1905908; P:positive regulation of amyloid fibril formation; IEA:Ensembl.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0043085; P:positive regulation of catalytic activity; ISS:UniProtKB.
DR   GO; GO:0050820; P:positive regulation of coagulation; IEA:Ensembl.
DR   GO; GO:0060999; P:positive regulation of dendritic spine development; IEA:Ensembl.
DR   GO; GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; IEA:Ensembl.
DR   GO; GO:0032092; P:positive regulation of protein binding; IEA:Ensembl.
DR   GO; GO:0033160; P:positive regulation of protein import into nucleus, translocation; IEA:Ensembl.
DR   GO; GO:0001921; P:positive regulation of receptor recycling; IEA:Ensembl.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl.
DR   GO; GO:0009791; P:post-embryonic development; IEA:Ensembl.
DR   GO; GO:0006486; P:protein glycosylation; IEA:Ensembl.
DR   GO; GO:0016485; P:protein processing; ISS:UniProtKB.
DR   GO; GO:0015031; P:protein transport; IEA:Ensembl.
DR   GO; GO:0060828; P:regulation of canonical Wnt signaling pathway; ISS:UniProtKB.
DR   GO; GO:0060075; P:regulation of resting membrane potential; IEA:Ensembl.
DR   GO; GO:0048167; P:regulation of synaptic plasticity; IEA:Ensembl.
DR   GO; GO:0051966; P:regulation of synaptic transmission, glutamatergic; IEA:Ensembl.
DR   GO; GO:0006979; P:response to oxidative stress; IEA:Ensembl.
DR   GO; GO:0048705; P:skeletal system morphogenesis; IEA:Ensembl.
DR   GO; GO:0043589; P:skin morphogenesis; IEA:Ensembl.
DR   GO; GO:0051563; P:smooth endoplasmic reticulum calcium ion homeostasis; IBA:GO_Central.
DR   GO; GO:0001756; P:somitogenesis; IEA:Ensembl.
DR   GO; GO:0050808; P:synapse organization; IEA:Ensembl.
DR   GO; GO:0016080; P:synaptic vesicle targeting; IEA:Ensembl.
DR   GO; GO:0002286; P:T cell activation involved in immune response; IEA:Ensembl.
DR   GO; GO:0050852; P:T cell receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0048538; P:thymus development; IEA:Ensembl.
DR   InterPro; IPR002031; Pept_A22A_PS1.
DR   InterPro; IPR001108; Peptidase_A22A.
DR   InterPro; IPR006639; Preselin/SPP.
DR   PANTHER; PTHR10202; PTHR10202; 1.
DR   Pfam; PF01080; Presenilin; 1.
DR   PRINTS; PR01072; PRESENILIN.
DR   PRINTS; PR01073; PRESENILIN1.
DR   SMART; SM00730; PSN; 1.
PE   2: Evidence at transcript level;
KW   Apoptosis; Cell adhesion; Cell membrane; Complete proteome;
KW   Endoplasmic reticulum; Golgi apparatus; Hydrolase; Membrane;
KW   Notch signaling pathway; Phosphoprotein; Protease; Reference proteome;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN         1    299       Presenilin-1 NTF subunit. {ECO:0000250}.
FT                                /FTId=PRO_0000025589.
FT   CHAIN       300    478       Presenilin-1 CTF subunit. {ECO:0000250}.
FT                                /FTId=PRO_0000025590.
FT   CHAIN       357    478       Presenilin-1 CTF12. {ECO:0000250}.
FT                                /FTId=PRO_0000236051.
FT   TOPO_DOM      1     83       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P49768}.
FT   TRANSMEM     84    104       Helical. {ECO:0000250|UniProtKB:P49768}.
FT   TOPO_DOM    105    133       Lumenal. {ECO:0000250|UniProtKB:P49768}.
FT   TRANSMEM    134    154       Helical. {ECO:0000250|UniProtKB:P49768}.
FT   TOPO_DOM    155    167       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P49768}.
FT   TRANSMEM    168    190       Helical. {ECO:0000250|UniProtKB:P49768}.
FT   TOPO_DOM    191    195       Lumenal. {ECO:0000250|UniProtKB:P49768}.
FT   TRANSMEM    196    217       Helical. {ECO:0000250|UniProtKB:P49768}.
FT   TOPO_DOM    218    221       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P49768}.
FT   TRANSMEM    222    242       Helical. {ECO:0000250|UniProtKB:P49768}.
FT   TOPO_DOM    243    249       Lumenal. {ECO:0000250|UniProtKB:P49768}.
FT   TRANSMEM    250    273       Helical. {ECO:0000250|UniProtKB:P49768}.
FT   TOPO_DOM    274    391       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P49768}.
FT   TRANSMEM    392    412       Helical. {ECO:0000250|UniProtKB:P49768}.
FT   TOPO_DOM    413    418       Lumenal. {ECO:0000250|UniProtKB:P49768}.
FT   TRANSMEM    419    439       Helical. {ECO:0000250|UniProtKB:P49768}.
FT   TOPO_DOM    440    443       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P49768}.
FT   TRANSMEM    444    464       Helical. {ECO:0000250|UniProtKB:P49768}.
FT   TOPO_DOM    465    478       Lumenal. {ECO:0000250|UniProtKB:P49768}.
FT   REGION      333    461       Required for interaction with CTNNB1.
FT                                {ECO:0000250|UniProtKB:P49768}.
FT   REGION      383    410       Required for interaction with CTNND2.
FT                                {ECO:0000250|UniProtKB:P49768}.
FT   REGION      475    478       Interaction with MTCH1.
FT                                {ECO:0000250|UniProtKB:P49768}.
FT   MOTIF       444    446       PAL. {ECO:0000305}.
FT   COMPBIAS     42     45       Poly-Arg.
FT   COMPBIAS     65     73       Poly-Glu.
FT   COMPBIAS     95     98       Poly-Val.
FT   ACT_SITE    258    258       {ECO:0000250|UniProtKB:P49768}.
FT   ACT_SITE    396    396       {ECO:0000250|UniProtKB:P49768}.
FT   SITE        292    293       Cleavage; alternate.
FT                                {ECO:0000250|UniProtKB:P49768}.
FT   SITE        293    294       Cleavage; alternate.
FT                                {ECO:0000250|UniProtKB:P49768}.
FT   SITE        299    300       Cleavage. {ECO:0000250|UniProtKB:P49768}.
FT   SITE        356    357       Cleavage; by caspase.
FT                                {ECO:0000250|UniProtKB:P49768}.
FT   MOD_RES      52     52       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P97887}.
FT   MOD_RES     311    311       Phosphoserine; by PKA.
FT                                {ECO:0000250|UniProtKB:P49768}.
FT   MOD_RES     340    340       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P97887}.
FT   MOD_RES     342    342       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P97887}.
FT   MOD_RES     357    357       Phosphoserine; by PKC.
FT                                {ECO:0000250|UniProtKB:P49768}.
FT   MOD_RES     378    378       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P49768}.
FT   MOD_RES     382    382       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P49769}.
SQ   SEQUENCE   478 AA;  53654 MW;  59E3FC0A1010D906 CRC64;
     MTELPAPLSY FQNAQMSEDN HLSNTVRSQN DSRERHEHGN ERRRRGNTES VSNGRAPSSS
     QQVVEQEEEE DEELTLKYGA KHVIMLFVPV TLCMVVVVAT IKSVSFYTRK DGQLIYTPFT
     EDTETVAQRA LHSILNAVIM ISVIVIMTIL LVVLYKYRCY KVIHAWLIVS SLLLLFFFSF
     IYLGEVFKTY NVAMDYISVA LLIWNFGVVG MIAIHWKGPL RLQQAYLIMI SALMALVFIK
     YLPEWTAWLI LAVISVYDLV AVLCPKGPLR MLVETAQERN ETLFPALIYS STMVWLVNMA
     EGDPEAQRKV SKNSNYNAQR PANSPVTTTG TESESQDPVT ESDDGGFSEE WEAQRDSRLG
     PHHSTAESRS AVQDLSSSIL ASEDPEERGV KLGLGDFIFY SVLVGKASAT ASGDWNTTIA
     CFVAILIGLC LTLLLLAIFK KALPALPVSI TFGLIFYFAT DYLVQPFMDQ LAFHQFYI
//
ID   LFNG_MOUSE              Reviewed;         378 AA.
AC   O09010; Q3U659; Q8K3F1; Q9DC10;
DT   10-JAN-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1997, sequence version 1.
DT   22-NOV-2017, entry version 139.
DE   RecName: Full=Beta-1,3-N-acetylglucosaminyltransferase lunatic fringe;
DE            EC=2.4.1.222;
DE   AltName: Full=O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase;
GN   Name=Lfng;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9187150;
RA   Johnston S.H., Rauskolb C., Wilson R., Prabhakaran B., Irvine K.D.,
RA   Vogt T.F.;
RT   "A family of mammalian Fringe genes implicated in boundary
RT   determination and the Notch pathway.";
RL   Development 124:2245-2254(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9207795; DOI=10.1038/ng0797-283;
RA   Cohen B., Bashirullah A., Dagnino L., Campbell C., Fisher W.W.,
RA   Leow C.C., Whiting E., Ryan D., Zinyk D., Boulianne G., Hui C.-C.,
RA   Gallie B., Phillips R.A., Lipshitz H.D., Egan S.E.;
RT   "Fringe boundaries coincide with Notch-dependent patterning centres in
RT   mammals and alter Notch-dependent development in Drosophila.";
RL   Nat. Genet. 16:283-288(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE OF 1-143, AND DEVELOPMENTAL STAGE.
RC   STRAIN=129S6/SvEvTac;
RX   PubMed=12110169; DOI=10.1016/S1534-5807(02)00212-5;
RA   Cole S.E., Levorse J.M., Tilghman S.M., Vogt T.F.;
RT   "Clock regulatory elements control cyclic expression of Lunatic fringe
RT   during somitogenesis.";
RL   Dev. Cell 3:75-84(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Bone marrow, and Lung;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [5]
RP   FUNCTION.
RX   PubMed=10330372; DOI=10.1016/S0960-9822(99)80212-7;
RA   del Barco Barrantes I., Elia A.J., Wuensch K., De Angelis M.H.,
RA   Mak T.W., Rossant J., Conlon R.A., Gossler A., de la Pompa J.L.;
RT   "Interaction between Notch signalling and Lunatic fringe during somite
RT   boundary formation in the mouse.";
RL   Curr. Biol. 9:470-480(1999).
RN   [6]
RP   FUNCTION.
RX   PubMed=12167404; DOI=10.1006/dbio.2002.0734;
RA   Mustonen T., Tuemmers M., Mikami T., Itoh N., Zhang N., Gridley T.,
RA   Thesleff I.;
RT   "Lunatic fringe, FGF, and BMP regulate the Notch pathway during
RT   epithelial morphogenesis of teeth.";
RL   Dev. Biol. 248:281-293(2002).
RN   [7]
RP   DEVELOPMENTAL STAGE.
RX   PubMed=9690473; DOI=10.1038/28632;
RA   Evrard Y.A., Lun Y., Aulehla A., Gan L., Johnson R.L.;
RT   "Lunatic fringe is an essential mediator of somite segmentation and
RT   patterning.";
RL   Nature 394:377-381(1998).
RN   [8]
RP   DEVELOPMENTAL STAGE.
RX   PubMed=10341080; DOI=10.1007/s003359901039;
RA   Moran J.L., Johnston S.H., Rauskolb C., Bhalerao J., Bowcock A.M.,
RA   Vogt T.F.;
RT   "Genomic structure, mapping, and expression analysis of the mammalian
RT   Lunatic, Manic, and Radical fringe genes.";
RL   Mamm. Genome 10:535-541(1999).
RN   [9]
RP   FUNCTION.
RX   PubMed=11520458; DOI=10.1016/S1074-7613(01)00189-3;
RA   Koch U., Lacombe T.A., Holland D., Bowman J.L., Cohen B.L., Egan S.E.,
RA   Guidos C.J.;
RT   "Subversion of the T/B lineage decision in the thymus by lunatic
RT   fringe-mediated inhibition of Notch-1.";
RL   Immunity 15:225-236(2001).
RN   [10]
RP   DEVELOPMENTAL STAGE.
RX   PubMed=12110168; DOI=10.1016/S1534-5807(02)00211-3;
RA   Morales A.V., Yasuda Y., Ish-Horowicz D.;
RT   "Periodic Lunatic fringe expression is controlled during segmentation
RT   by a cyclic transcriptional enhancer responsive to notch signaling.";
RL   Dev. Cell 3:63-74(2002).
RN   [11]
RP   FUNCTION, AND INTERACTION WITH NOTCH1.
RX   PubMed=28089369; DOI=10.1016/j.devcel.2016.12.013;
RA   Kakuda S., Haltiwanger R.S.;
RT   "Deciphering the fringe-mediated notch code: identification of
RT   activating and inhibiting sites allowing discrimination between
RT   ligands.";
RL   Dev. Cell 40:193-201(2017).
CC   -!- FUNCTION: Glycosyltransferase that initiates the elongation of O-
CC       linked fucose residues attached to EGF-like repeats in the
CC       extracellular domain of Notch molecules. Modulates NOTCH1 activity
CC       by modifying O-fucose residues at specific EGF-like domains
CC       resulting in inhibition of NOTCH1 activation by JAG1 and
CC       enhancement of NOTCH1 activation by DLL1 via an increase in its
CC       binding to DLL1 (PubMed:28089369). Decreases the binding of JAG1
CC       to NOTCH2 but not that of DLL1 (By similarity). Essential mediator
CC       of somite segmentation and patterning. During somite boundary
CC       formation, it restricts Notch activity in the presomitic mesoderm
CC       to a boundary-forming territory in the posterior half of the
CC       prospective somite. In this region, Notch function activates a set
CC       of genes that are involved in boundary formation and in anterior-
CC       posterior somite identity (PubMed:10330372). Ectopically expressed
CC       in the thymus, Lfgn inhibits Notch signaling which results in
CC       inhibition of T-cell commitment and promotes B-cell development in
CC       lymphoid progenitors (PubMed:11520458). May play a role in
CC       boundary formation of the enamel knot (PubMed:12167404).
CC       {ECO:0000250|UniProtKB:Q8NES3, ECO:0000269|PubMed:10330372,
CC       ECO:0000269|PubMed:11520458, ECO:0000269|PubMed:12167404,
CC       ECO:0000269|PubMed:28089369}.
CC   -!- CATALYTIC ACTIVITY: Transfers a beta-D-GlcNAc residue from UDP-D-
CC       GlcNAc to the fucose residue of a fucosylated protein acceptor.
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250};
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000250};
CC       Single-pass type II membrane protein {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Detected at 12.5 dpc in all tissues examined
CC       with the highest level observed in adult brain and spleen.
CC       Detected in the dental epithelium.
CC   -!- DEVELOPMENTAL STAGE: Developmental protein. During segmentation it
CC       shows a cyclic transcription pattern which is under the control of
CC       Notch. Expressed in the caudal region of the presomitic mesoderm
CC       with each cycle corresponding to the formation time of one somite.
CC       In the dental epithelium it is detected at stage E13.5. The
CC       pattern of expression corresponds exactly to the formation of the
CC       enamel knot between late bud and early cap stages.
CC       {ECO:0000269|PubMed:10341080, ECO:0000269|PubMed:12110168,
CC       ECO:0000269|PubMed:12110169, ECO:0000269|PubMed:9690473}.
CC   -!- PTM: A soluble form may be derived from the membrane form by
CC       proteolytic processing.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 31 family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - GTase;
CC       Note=lunatic fringe gene homolog (lfng);
CC       URL="http://www.functionalglycomics.org/glycomics/molecule/jsp/glycoEnzyme/viewGlycoEnzyme.jsp?gbpId=gt_mou_590";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U94351; AAC53262.1; -; mRNA.
DR   EMBL; AF015768; AAB71668.1; -; mRNA.
DR   EMBL; AY124581; AAM93541.1; -; Genomic_DNA.
DR   EMBL; AK004642; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AK153283; BAE31866.1; -; mRNA.
DR   CCDS; CCDS19821.1; -.
DR   RefSeq; NP_032520.1; NM_008494.3.
DR   UniGene; Mm.12834; -.
DR   ProteinModelPortal; O09010; -.
DR   SMR; O09010; -.
DR   STRING; 10090.ENSMUSP00000031555; -.
DR   CAZy; GT31; Glycosyltransferase Family 31.
DR   iPTMnet; O09010; -.
DR   PhosphoSitePlus; O09010; -.
DR   MaxQB; O09010; -.
DR   PaxDb; O09010; -.
DR   PRIDE; O09010; -.
DR   Ensembl; ENSMUST00000031555; ENSMUSP00000031555; ENSMUSG00000029570.
DR   GeneID; 16848; -.
DR   KEGG; mmu:16848; -.
DR   UCSC; uc009ahu.1; mouse.
DR   CTD; 3955; -.
DR   MGI; MGI:1095413; Lfng.
DR   eggNOG; ENOG410II9W; Eukaryota.
DR   eggNOG; ENOG410XS8Y; LUCA.
DR   GeneTree; ENSGT00390000009913; -.
DR   HOGENOM; HOG000046678; -.
DR   HOVERGEN; HBG007986; -.
DR   InParanoid; O09010; -.
DR   KO; K05948; -.
DR   OMA; PHTQDVY; -.
DR   OrthoDB; EOG091G08XO; -.
DR   PhylomeDB; O09010; -.
DR   TreeFam; TF324207; -.
DR   BRENDA; 2.4.1.222; 3474.
DR   PRO; PR:O09010; -.
DR   Proteomes; UP000000589; Chromosome 5.
DR   Bgee; ENSMUSG00000029570; -.
DR   ExpressionAtlas; O09010; baseline and differential.
DR   Genevisible; O09010; MM.
DR   GO; GO:1903561; C:extracellular vesicle; ISO:MGI.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0030173; C:integral component of Golgi membrane; IEA:InterPro.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0033829; F:O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0007386; P:compartment pattern specification; IMP:MGI.
DR   GO; GO:0002315; P:marginal zone B cell differentiation; IMP:UniProtKB.
DR   GO; GO:1902367; P:negative regulation of Notch signaling pathway involved in somitogenesis; IMP:UniProtKB.
DR   GO; GO:0001541; P:ovarian follicle development; IMP:MGI.
DR   GO; GO:0051446; P:positive regulation of meiotic cell cycle; IMP:MGI.
DR   GO; GO:0045747; P:positive regulation of Notch signaling pathway; IDA:MGI.
DR   GO; GO:0032092; P:positive regulation of protein binding; IDA:MGI.
DR   GO; GO:0036066; P:protein O-linked fucosylation; IMP:UniProtKB.
DR   GO; GO:0008593; P:regulation of Notch signaling pathway; IDA:UniProtKB.
DR   GO; GO:0014807; P:regulation of somitogenesis; IMP:MGI.
DR   GO; GO:0001756; P:somitogenesis; IMP:UniProtKB.
DR   GO; GO:0030217; P:T cell differentiation; IMP:UniProtKB.
DR   InterPro; IPR017374; Fringe.
DR   InterPro; IPR003378; Fringe-like.
DR   Pfam; PF02434; Fringe; 1.
DR   PIRSF; PIRSF038073; B-acetylgalactosaminyltfrase; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Developmental protein; Disulfide bond;
KW   Glycoprotein; Glycosyltransferase; Golgi apparatus; Manganese;
KW   Membrane; Metal-binding; Reference proteome; Signal-anchor;
KW   Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN         1    378       Beta-1,3-N-acetylglucosaminyltransferase
FT                                lunatic fringe.
FT                                /FTId=PRO_0000219177.
FT   TOPO_DOM      1      8       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM      9     29       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     30    378       Lumenal. {ECO:0000255}.
FT   ACT_SITE    289    289       {ECO:0000250}.
FT   METAL       201    201       Manganese. {ECO:0000250}.
FT   METAL       313    313       Manganese. {ECO:0000250}.
FT   BINDING     128    128       Substrate. {ECO:0000250}.
FT   BINDING     200    200       Substrate. {ECO:0000250}.
FT   SITE         85     86       Cleavage; by furin-like protease.
FT                                {ECO:0000255}.
FT   CARBOHYD    166    166       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    167    178       {ECO:0000250}.
FT   DISULFID    196    259       {ECO:0000250}.
FT   DISULFID    363    372       {ECO:0000250}.
FT   CONFLICT    343    343       V -> M (in Ref. 4; AK004642).
FT                                {ECO:0000305}.
FT   CONFLICT    361    361       V -> I (in Ref. 4; AK004642).
FT                                {ECO:0000305}.
SQ   SEQUENCE   378 AA;  41952 MW;  FD0A02597BF9AFED CRC64;
     MLQRCGRRLL LALVGALLAC LLVLTADPPP TPMPAERGRR ALRSLAGSSG GAPASGSRAA
     VDPGVLTREV HSLSEYFSLL TRARRDADPP PGVASRQGDG HPRPPAEVLS PRDVFIAVKT
     TRKFHRARLD LLFETWISRH KEMTFIFTDG EDEALAKLTG NVVLTNCSSA HSRQALSCKM
     AVEYDRFIES GKKWFCHVDD DNYVNLRALL RLLASYPHTQ DVYIGKPSLD RPIQATERIS
     EHKVRPVHFW FATGGAGFCI SRGLALKMGP WASGGHFMST AERIRLPDDC TIGYIVEALL
     GVPLIRSGLF HSHLENLQQV PTTELHEQVT LSYGMFENKR NAVHIKGPFS VEADPSRFRS
     VHCHLYPDTP WCPRSAIF
//
ID   NOTC1_MOUSE             Reviewed;        2531 AA.
AC   Q01705; Q06007; Q3TZW2; Q3U3Y2; Q61905; Q7TQ50; Q7TQ51; Q7TQ52;
AC   Q8K428; Q99JC2; Q9QW58; Q9R0X7;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   18-APR-2012, sequence version 3.
DT   20-DEC-2017, entry version 201.
DE   RecName: Full=Neurogenic locus notch homolog protein 1;
DE            Short=Notch 1;
DE   AltName: Full=Motch A;
DE   AltName: Full=mT14;
DE   AltName: Full=p300;
DE   Contains:
DE     RecName: Full=Notch 1 extracellular truncation;
DE              Short=NEXT;
DE   Contains:
DE     RecName: Full=Notch 1 intracellular domain;
DE              Short=NICD;
DE   Flags: Precursor;
GN   Name=Notch1; Synonyms=Motch;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Embryo;
RX   PubMed=8449489; DOI=10.1006/geno.1993.1055;
RA   Franco del Amo F., Gendron-Maguire M., Swiatek P.J., Jenkins N.A.,
RA   Copeland N.G., Gridley T.;
RT   "Cloning, analysis, and chromosomal localization of Notch-1, a mouse
RT   homolog of Drosophila Notch.";
RL   Genomics 15:259-264(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   STRAIN=BALB/cJ; TISSUE=Thymus;
RX   PubMed=7956822;
RA   Nye J.S., Kopan R., Axel R.;
RT   "An activated Notch suppresses neurogenesis and myogenesis but not
RT   gliogenesis in mammalian cells.";
RL   Development 120:2421-2430(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   STRAIN=BALB/cJ; TISSUE=Thymus;
RX   PubMed=12123574; DOI=10.1016/S0960-9822(02)00888-6;
RA   Foltz D.R., Santiago M.C., Berechid B.E., Nye J.S.;
RT   "Glycogen synthase kinase-3beta modulates notch signaling and
RT   stability.";
RL   Curr. Biol. 12:1006-1011(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=CB-17/SCID; TISSUE=Thymus;
RX   PubMed=12807718; DOI=10.1093/carcin/bgg071;
RA   Tsuji H., Ishii-Ohba H., Ukai H., Katsube T., Ogiu T.;
RT   "Radiation-induced deletions in the 5' end region of Notch1 lead to
RT   the formation of truncated proteins and are involved in the
RT   development of mouse thymic lymphomas.";
RL   Carcinogenesis 24:1257-1268(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S.,
RA   She X., Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W.,
RA   Kapustin Y., Meric P., Maglott D., Birtle Z., Marques A.C., Graves T.,
RA   Zhou S., Teague B., Potamousis K., Churas C., Place M., Herschleb J.,
RA   Runnheim R., Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z.,
RA   Lindblad-Toh K., Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of
RT   the mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 731-1899 (ISOFORM 2), AND DEVELOPMENTAL
RP   STAGE.
RC   STRAIN=CD-1; TISSUE=Embryo;
RX   PubMed=1426644; DOI=10.1016/0012-1606(92)90076-S;
RA   Reaume A.G., Conlon R.A., Zirngibl R., Yamaguchi T.P., Rossant J.;
RT   "Expression analysis of a Notch homologue in the mouse embryo.";
RL   Dev. Biol. 154:377-387(1992).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1161-1547.
RC   STRAIN=C57BL/6 X CBA; TISSUE=Embryo;
RX   PubMed=8440332; DOI=10.1006/excr.1993.1044;
RA   Lardelli M., Lendahl U.;
RT   "Motch A and Motch B-two mouse Notch homologues coexpressed in a wide
RT   variety of tissues.";
RL   Exp. Cell Res. 204:364-372(1993).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1373-2531.
RC   STRAIN=NOD;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1551-1647 (ISOFORM 1), AND DEVELOPMENTAL
RP   STAGE.
RC   TISSUE=Embryo;
RX   PubMed=1425352;
RA   Franco del Amo F., Smith D.E., Swiatek P.J., Gendron-Maguire M.,
RA   Greenspan R.J., McMahon A.P., Gridley T.;
RT   "Expression pattern of Motch, a mouse homolog of Drosophila Notch,
RT   suggests an important role in early postimplantation mouse
RT   development.";
RL   Development 115:737-744(1992).
RN   [12]
RP   PROTEIN SEQUENCE OF 1655-1659, CLEAVAGE BY FURIN-LIKE CONVERTASE, AND
RP   MUTAGENESIS OF 1651-ARG--ARG-1654.
RX   PubMed=9653148; DOI=10.1073/pnas.95.14.8108;
RA   Logeat F., Bessia C., Brou C., LeBail O., Jarriault S., Seidah N.G.,
RA   Israel A.;
RT   "The Notch1 receptor is cleaved constitutively by a furin-like
RT   convertase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:8108-8112(1998).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1659-1673.
RX   PubMed=10437788; DOI=10.1016/S0014-5793(99)00901-1;
RA   Lee J.S., Ishimoto A., Yanagawa S.;
RT   "Murine leukemia provirus-mediated activation of the Notch1 gene leads
RT   to induction of HES-1 in a mouse T lymphoma cell line, DL-3.";
RL   FEBS Lett. 455:276-280(1999).
RN   [14]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1865-2076, AND DEVELOPMENTAL STAGE IN
RP   HAIR FOLLICLES.
RX   PubMed=8486742; DOI=10.1083/jcb.121.3.631;
RA   Kopan R., Weintraub H.;
RT   "Mouse notch: expression in hair follicles correlates with cell fate
RT   determination.";
RL   J. Cell Biol. 121:631-641(1993).
RN   [15]
RP   PROTEIN SEQUENCE OF 1937-1952 AND 1995-2019, FUNCTION, INTERACTION
RP   WITH HIF1AN, HYDROXYLATION AT ASN-1945 AND ASN-2012 BY HIF1AN,
RP   MUTAGENESIS OF ASN-1945 AND ASN-2012, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=18299578; DOI=10.1073/pnas.0711591105;
RA   Zheng X., Linke S., Dias J.M., Zheng X., Gradin K., Wallis T.P.,
RA   Hamilton B.R., Gustafsson M., Ruas J.L., Wilkins S., Bilton R.L.,
RA   Brismar K., Whitelaw M.L., Pereira T., Gorman J.J., Ericson J.,
RA   Peet D.J., Lendahl U., Poellinger L.;
RT   "Interaction with factor inhibiting HIF-1 defines an additional mode
RT   of cross-coupling between the Notch and hypoxia signaling pathways.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:3368-3373(2008).
RN   [16]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1951-2201.
RX   PubMed=9384671;
RA   Messerle M., Follo M., Nehls M., Eggert H., Boehm T.;
RT   "Dynamic changes in gene expression during in vitro differentiation of
RT   mouse embryonic stem cells.";
RL   Cytokines Cell. Mol. Ther. 1:139-143(1995).
RN   [17]
RP   PARTIAL PROTEIN SEQUENCE, AND PROTEOLYTIC PROCESSING.
RX   PubMed=11518718; DOI=10.1074/jbc.M107234200;
RA   Saxena M.T., Schroeter E.H., Mumm J.S., Kopan R.;
RT   "Murine notch homologs (N1-4) undergo presenilin-dependent
RT   proteolysis.";
RL   J. Biol. Chem. 276:40268-40273(2001).
RN   [18]
RP   PROTEOLYTIC PROCESSING.
RX   PubMed=11459941; DOI=10.1073/pnas.161269998;
RA   Mizutani T., Taniguchi Y., Aoki T., Hashimoto N., Honjo T.;
RT   "Conservation of the biochemical mechanisms of signal transduction
RT   among mammalian Notch family members.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:9026-9031(2001).
RN   [19]
RP   INTERACTION WITH DTX1 AND DTX2.
RX   PubMed=11226752; DOI=10.1016/S0736-5748(00)00071-X;
RA   Kishi N., Tang Z., Maeda Y., Hirai A., Mo R., Ito M., Suzuki S.,
RA   Nakao K., Kinoshita T., Kadesch T., Hui C.-C., Artavanis-Tsakonas S.,
RA   Okano H., Matsuno K.;
RT   "Murine homologs of deltex define a novel gene family involved in
RT   vertebrate Notch signaling and neurogenesis.";
RL   Int. J. Dev. Neurosci. 19:21-35(2001).
RN   [20]
RP   INTERACTION WITH NOV.
RX   PubMed=12050162; DOI=10.1074/jbc.M203727200;
RA   Sakamoto K., Yamaguchi S., Ando R., Miyawaki A., Kabasawa Y.,
RA   Takagi M., Li C.L., Perbal B., Katsube K.;
RT   "The nephroblastoma overexpressed gene (NOV/ccn3) protein associates
RT   with Notch1 extracellular domain and inhibits myoblast differentiation
RT   via Notch signaling pathway.";
RL   J. Biol. Chem. 277:29399-29405(2002).
RN   [21]
RP   INTERACTION WITH MAML1.
RX   PubMed=15019995; DOI=10.1016/j.gene.2003.12.007;
RA   Wu L., Kobayashi K., Sun T., Gao P., Liu J., Nakamura M., Weisberg E.,
RA   Mukhopadhyay N.K., Griffin J.D.;
RT   "Cloning and functional characterization of the murine mastermind-like
RT   1 (Maml1) gene.";
RL   Gene 328:153-165(2004).
RN   [22]
RP   UBIQUITINATION AT LYS-1749, AND ENDOCYTOSIS.
RX   PubMed=15240571; DOI=10.1083/jcb.200310098;
RA   Gupta-Rossi N., Six E., LeBail O., Logeat F., Chastagner P., Olry A.,
RA   Israel A., Brou C.;
RT   "Monoubiquitination and endocytosis direct gamma-secretase cleavage of
RT   activated Notch receptor.";
RL   J. Cell Biol. 166:73-83(2004).
RN   [23]
RP   INTERACTION WITH DNER, FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=15965470; DOI=10.1038/nn1492;
RA   Eiraku M., Tohgo A., Ono K., Kaneko M., Fujishima K., Hirano T.,
RA   Kengaku M.;
RT   "DNER acts as a neuron-specific Notch ligand during Bergmann glial
RT   development.";
RL   Nat. Neurosci. 8:873-880(2005).
RN   [24]
RP   UBIQUITINATION BY ITCH.
RX   PubMed=18628966; DOI=10.1371/journal.pone.0002735;
RA   Chastagner P., Israel A., Brou C.;
RT   "AIP4/Itch regulates Notch receptor degradation in the absence of
RT   ligand.";
RL   PLoS ONE 3:E2735-E2735(2008).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-1851, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Pancreas;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and
RT   expression.";
RL   Cell 143:1174-1189(2010).
RN   [26]
RP   INTERACTION WITH AAK1.
RX   PubMed=21464124; DOI=10.1074/jbc.M110.190769;
RA   Gupta-Rossi N., Ortica S., Meas-Yedid V., Heuss S., Moretti J.,
RA   Olivo-Marin J.C., Israel A.;
RT   "The adaptor-associated kinase 1, AAK1, is a positive regulator of the
RT   Notch pathway.";
RL   J. Biol. Chem. 286:18720-18730(2011).
RN   [27]
RP   GLYCOSYLATION AT SER-65; THR-73; THR-116; SER-146; THR-194; SER-341;
RP   SER-378; SER-458; THR-466; SER-496; SER-534; SER-609; SER-647;
RP   SER-722; SER-759; THR-767; SER-797; THR-805; SER-951; SER-1027;
RP   THR-1035; SER-1065; SER-1189; THR-1197; SER-1273 AND THR-1362, AND
RP   MUTAGENESIS OF SER-65; SER-146; SER-341; SER-378; SER-458; SER-496;
RP   SER-534; SER-609; SER-647; SER-722; SER-759; SER-797; SER-951;
RP   SER-1027; SER-1065; SER-1189 AND SER-1273.
RX   PubMed=21757702; DOI=10.1074/jbc.M111.268243;
RA   Rana N.A., Nita-Lazar A., Takeuchi H., Kakuda S., Luther K.B.,
RA   Haltiwanger R.S.;
RT   "O-glucose trisaccharide is present at high but variable stoichiometry
RT   at multiple sites on mouse Notch1.";
RL   J. Biol. Chem. 286:31623-31637(2011).
RN   [28]
RP   FUNCTION AS NEUROGENESIS REPRESSOR, AND INTERACTION WITH BCL6.
RX   PubMed=23160044; DOI=10.1038/nn.3264;
RA   Tiberi L., van den Ameele J., Dimidschstein J., Piccirilli J.,
RA   Gall D., Herpoel A., Bilheu A., Bonnefont J., Iacovino M., Kyba M.,
RA   Bouschet T., Vanderhaeghen P.;
RT   "BCL6 controls neurogenesis through Sirt1-dependent epigenetic
RT   repression of selective Notch targets.";
RL   Nat. Neurosci. 15:1627-1635(2012).
RN   [29]
RP   UBIQUITINATION BY ITCH.
RX   PubMed=23886940; DOI=10.1242/jcs.130500;
RA   Puca L., Chastagner P., Meas-Yedid V., Israel A., Brou C.;
RT   "Alpha-arrestin 1 (ARRDC1) and beta-arrestins cooperate to mediate
RT   Notch degradation in mammals.";
RL   J. Cell Sci. 126:4457-4468(2013).
RN   [30]
RP   FUNCTION, AND INTERACTION WITH THBS4.
RX   PubMed=23615612; DOI=10.1038/nature12069;
RA   Benner E.J., Luciano D., Jo R., Abdi K., Paez-Gonzalez P., Sheng H.,
RA   Warner D.S., Liu C., Eroglu C., Kuo C.T.;
RT   "Protective astrogenesis from the SVZ niche after injury is controlled
RT   by Notch modulator Thbs4.";
RL   Nature 497:369-373(2013).
RN   [31]
RP   GLYCOSYLATION AT THR-73; THR-116; THR-194; THR-232; THR-311; THR-349;
RP   SER-458; THR-466; THR-617; THR-692; SER-759; THR-767; SER-784;
RP   SER-797; THR-805; THR-900; SER-921; THR-997; THR-1035; THR-1159;
RP   THR-1197; THR-1362; THR-1379 AND THR-1402, MUTAGENESIS OF THR-232;
RP   THR-311; THR-349; THR-466; THR-997; THR-1035; THR-1159; THR-1362 AND
RP   THR-1402, AND INTERACTION WITH DLL1 AND JAG1.
RX   PubMed=28089369; DOI=10.1016/j.devcel.2016.12.013;
RA   Kakuda S., Haltiwanger R.S.;
RT   "Deciphering the fringe-mediated notch code: identification of
RT   activating and inhibiting sites allowing discrimination between
RT   ligands.";
RL   Dev. Cell 40:193-201(2017).
RN   [32]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH MEGF10.
RX   PubMed=28498977; DOI=10.1093/hmg/ddx189;
RA   Saha M., Mitsuhashi S., Jones M.D., Manko K., Reddy H.M., Bruels C.,
RA   Cho K.A., Pacak C.A., Draper I., Kang P.B.;
RT   "Consequences of MEGF10 deficiency on myoblast function and Notch1
RT   interactions.";
RL   Hum. Mol. Genet. 26:2984-3000(2017).
RN   [33]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 1971-2104.
RX   PubMed=15802643; DOI=10.1110/ps.041184105;
RA   Lubman O.Y., Kopan R., Waksman G., Korolev S.;
RT   "The crystal structure of a partial mouse Notch-1 ankyrin domain:
RT   repeats 4 through 7 preserve an ankyrin fold.";
RL   Protein Sci. 14:1274-1281(2005).
RN   [34]
RP   X-RAY CRYSTALLOGRAPHY (2.35 ANGSTROMS) OF 1899-2106 IN COMPLEX WITH
RP   HIF1AN; IRON AND 2-OXOGLUTARATE, HYDROXYLATION AT ASN-1945 AND
RP   ASN-2012, MUTAGENESIS OF ASN-1945 AND ASN-2012, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RX   PubMed=17573339; DOI=10.1074/jbc.M704102200;
RA   Coleman M.L., McDonough M.A., Hewitson K.S., Coles C., Mecinovic J.,
RA   Edelmann M., Cook K.M., Cockman M.E., Lancaster D.E., Kessler B.M.,
RA   Oldham N.J., Ratcliffe P.J., Schofield C.J.;
RT   "Asparaginyl hydroxylation of the Notch ankyrin repeat domain by
RT   factor inhibiting hypoxia-inducible factor.";
RL   J. Biol. Chem. 282:24027-24038(2007).
CC   -!- FUNCTION: Functions as a receptor for membrane-bound ligands
CC       Jagged1, Jagged2 and Delta1 to regulate cell-fate determination.
CC       Upon ligand activation through the released notch intracellular
CC       domain (NICD) it forms a transcriptional activator complex with
CC       RBPJ/RBPSUH and activates genes of the enhancer of split locus.
CC       Affects the implementation of differentiation, proliferation and
CC       apoptotic programs. Involved in angiogenesis; negatively regulates
CC       endothelial cell proliferation and migration and angiogenic
CC       sprouting. Involved in the maturation of both CD4+ and CD8+ cells
CC       in the thymus. Important for follicular differentiation and
CC       possibly cell fate selection within the follicle. During
CC       cerebellar development, functions as a receptor for neuronal DNER
CC       and is involved in the differentiation of Bergmann glia. Represses
CC       neuronal and myogenic differentiation. May play an essential role
CC       in postimplantation development, probably in some aspect of cell
CC       specification and/or differentiation. May be involved in mesoderm
CC       development, somite formation and neurogenesis. May enhance HIF1A
CC       function by sequestering HIF1AN away from HIF1A. Required for the
CC       THBS4 function in regulating protective astrogenesis from the
CC       subventricular zone (SVZ) niche after injury. Involved in
CC       determination of left/right symmetry by modulating the balance
CC       between motile and immotile (sensory) cilia at the left-right
CC       organiser (LRO). {ECO:0000269|PubMed:15965470,
CC       ECO:0000269|PubMed:18299578, ECO:0000269|PubMed:23160044,
CC       ECO:0000269|PubMed:23615612}.
CC   -!- SUBUNIT: Heterodimer of a C-terminal fragment N(TM) and an N-
CC       terminal fragment N(EC) which are probably linked by disulfide
CC       bonds. Interacts with DNER, DTX1, DTX2 and RBPJ/RBPSUH. Also
CC       interacts with MAML1, MAML2 and MAML3 which act as transcriptional
CC       coactivators for NOTCH1. Notch 1 intracellular domain interacts
CC       with SNW1; the interaction involves multimerized NOTCH1 NICD and
CC       is implicated in a formation of an intermediate preactivation
CC       complex which associates with DNA-bound CBF-1/RBPJ. The activated
CC       membrane-bound form interacts with AAK1 which promotes NOTCH1
CC       stabilization. Forms a trimeric complex with FBXW7 and SGK1.
CC       Interacts with HIF1AN. HIF1AN negatively regulates the function of
CC       notch intracellular domain (NICD), accelerating myogenic
CC       differentiation. Interacts (via NICD) with SNAI1 (via zinc
CC       fingers); the interaction induces SNAI1 degradation via MDM2-
CC       mediated ubiquitination and inhibits SNAI1-induced cell invasion.
CC       Interacts (via NICD) with MDM2A. Interacts (via NICD) with BCL6;
CC       the interaction decreases MAML1 recruitment by NOTCH1 NICD on
CC       target genes DNA and inhibits NOTCH1 transcractivation activity.
CC       Interacts with THBS4. Interacts (via the EGF-like repeat region)
CC       with NOV (via CTCK domain) (PubMed:12050162). Interacts (via EGF-
CC       like domains) with DLL4 (via N-terminal DSL and MNNL domains) (By
CC       similarity). Interacts with ZMIZ1. Interacts (via NICD domain)
CC       with MEGF10 (via the cytoplasmic domain) (PubMed:28498977).
CC       Interacts with DLL1 and JAG1 (PubMed:28089369).
CC       {ECO:0000250|UniProtKB:Q07008, ECO:0000269|PubMed:11226752,
CC       ECO:0000269|PubMed:12050162, ECO:0000269|PubMed:15019995,
CC       ECO:0000269|PubMed:15965470, ECO:0000269|PubMed:17573339,
CC       ECO:0000269|PubMed:18299578, ECO:0000269|PubMed:21464124,
CC       ECO:0000269|PubMed:23160044, ECO:0000269|PubMed:23615612,
CC       ECO:0000269|PubMed:28089369, ECO:0000269|PubMed:28498977}.
CC   -!- INTERACTION:
CC       Q77CA8:LRORF2 (xeno); NbExp=3; IntAct=EBI-11292892, EBI-11292862;
CC       Q06330:RBPJ (xeno); NbExp=3; IntAct=EBI-1392707, EBI-632552;
CC       P31266:Rbpj; NbExp=8; IntAct=EBI-1392707, EBI-1392666;
CC       Q3TKT4:Smarca4; NbExp=2; IntAct=EBI-1392707, EBI-1210244;
CC       Q6P9Z1:Smarcd3; NbExp=2; IntAct=EBI-1392707, EBI-7525857;
CC       P28159:Su(H) (xeno); NbExp=3; IntAct=EBI-1392707, EBI-92180;
CC       P62991:Ubc; NbExp=3; IntAct=EBI-1392707, EBI-413074;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:28498977};
CC       Single-pass type I membrane protein.
CC   -!- SUBCELLULAR LOCATION: Notch 1 intracellular domain: Nucleus
CC       {ECO:0000269|PubMed:28498977}. Note=Following proteolytical
CC       processing NICD is translocated to the nucleus. Nuclear location
CC       may require MEGF10. {ECO:0000269|PubMed:28498977}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q01705-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q01705-2; Sequence=VSP_001402, VSP_001403, VSP_001404;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q01705-3; Sequence=VSP_043064;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=Q01705-4; Sequence=VSP_043065;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Highly expressed in the brain, lung and
CC       thymus. Expressed at lower levels in the spleen, bone-marrow,
CC       spinal cord, eyes, mammary gland, liver, intestine, skeletal
CC       muscle, kidney and heart. In the hair follicle, highly expressed
CC       exclusively in the epithelial compartment.
CC       {ECO:0000269|PubMed:15965470}.
CC   -!- DEVELOPMENTAL STAGE: First detected in the mesoderm at 7.5 dpc By
CC       8.5 dpc highly expressed in presomitic mesoderm, mesenchyme and
CC       endothelial cells, while much lower levels are seen in the
CC       neuroepithelium. Between 9.5-10.5 dpc expressed at high levels in
CC       the neuroepithelium. At 13.5 dpc expressed in the surface
CC       ectoderm, eye and developing whisker follicles. Hair follicle
CC       matrix cells expression starts as different cell types become
CC       distinguishable in the developing follicle. Expression persists
CC       throughout the growth phase of the follicle and maintains the same
CC       expression profile in the second hair cycle. The cells in the
CC       follicle that undergo a phase of high level expression are in
CC       transition from mitotic precursors to several discrete,
CC       differentiating cell types. Specifically expressed in cerebellar
CC       Bergmann glial cells during postnatal development.
CC       {ECO:0000269|PubMed:1425352, ECO:0000269|PubMed:1426644,
CC       ECO:0000269|PubMed:8486742}.
CC   -!- PTM: Synthesized in the endoplasmic reticulum as an inactive form
CC       which is proteolytically cleaved by a furin-like convertase in the
CC       trans-Golgi network before it reaches the plasma membrane to yield
CC       an active, ligand-accessible form. Cleavage results in a C-
CC       terminal fragment N(TM) and a N-terminal fragment N(EC). Following
CC       ligand binding, it is cleaved by ADAM17 to yield a membrane-
CC       associated intermediate fragment called notch extracellular
CC       truncation (NEXT). Following endocytosis, this fragment is then
CC       cleaved by presenilin dependent gamma-secretase to release a
CC       notch-derived peptide containing the intracellular domain (NICD)
CC       from the membrane.
CC   -!- PTM: Phosphorylated.
CC   -!- PTM: O-linked glycosylation by GALNT11 is involved in
CC       determination of left/right symmetry: glycosylation promotes
CC       activation of NOTCH1, possibly by promoting cleavage by ADAM17,
CC       modulating the balance between motile and immotile (sensory) cilia
CC       at the left-right organiser (LRO) (By similarity). O-glycosylated
CC       on the EGF-like domains (PubMed:21757702). Contains both O-linked
CC       fucose and O-linked glucose in the EGF-like domains 11, 12 and 13,
CC       which are interacting with the residues on DLL4 (By similarity).
CC       O-glycosylation at Ser-1027 is only partial (PubMed:21757702).
CC       MFNG-, RFNG- and LFNG-mediated modification of O-fucose residues
CC       at specific EGF-like domains results in inhibition of its
CC       activation by JAG1 and enhancement of its activation by DLL1 via
CC       an increased binding to DLL1 (PubMed:28089369).
CC       {ECO:0000250|UniProtKB:P46531, ECO:0000250|UniProtKB:Q07008,
CC       ECO:0000269|PubMed:21757702, ECO:0000269|PubMed:28089369}.
CC   -!- PTM: Ubiquitinated. Undergoes 'Lys-29'-linked polyubiquitination
CC       by ITCH; promotes the lysosomal degradation of non-activated
CC       internalized NOTCH1 (PubMed:18628966, PubMed:23886940).
CC       Monoubiquitination at Lys-1749 is required for activation by
CC       gamma-secretase cleavage, it promotes interaction with AAK1, which
CC       stabilizes it. Deubiquitination by EIF3F is necessary for nuclear
CC       import of activated Notch (PubMed:15240571).
CC       {ECO:0000269|PubMed:15240571, ECO:0000269|PubMed:18628966,
CC       ECO:0000269|PubMed:23886940}.
CC   -!- PTM: Hydroxylated at Asn-1945 and Asn-2012 by HIF1AN.
CC       Hydroxylation reduces affinity for HI1AN and may thus indirectly
CC       modulate negative regulation of NICD.
CC       {ECO:0000269|PubMed:17573339, ECO:0000269|PubMed:18299578}.
CC   -!- SIMILARITY: Belongs to the NOTCH family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z11886; CAA77941.1; -; mRNA.
DR   EMBL; AF508809; AAM28905.1; -; mRNA.
DR   EMBL; AB100603; BAC77038.1; -; Genomic_DNA.
DR   EMBL; AB100603; BAC77039.1; -; Genomic_DNA.
DR   EMBL; AB100603; BAC77040.1; -; Genomic_DNA.
DR   EMBL; AL732541; CAM20304.1; -; Genomic_DNA.
DR   EMBL; CH466542; EDL08321.1; -; Genomic_DNA.
DR   EMBL; BC138441; AAI38442.1; -; mRNA.
DR   EMBL; BC138442; AAI38443.1; -; mRNA.
DR   EMBL; L02613; AAK14898.1; -; mRNA.
DR   EMBL; X68278; CAA48339.1; -; mRNA.
DR   EMBL; AK154528; BAE32653.1; -; mRNA.
DR   EMBL; AK157475; BAE34095.1; -; mRNA.
DR   EMBL; AJ238029; CAB40733.1; -; mRNA.
DR   EMBL; X82562; CAA57909.1; -; mRNA.
DR   CCDS; CCDS15806.1; -. [Q01705-1]
DR   PIR; A46438; A46438.
DR   PIR; B49175; B49175.
DR   RefSeq; NP_032740.3; NM_008714.3. [Q01705-1]
DR   UniGene; Mm.290610; -.
DR   PDB; 1YMP; X-ray; 2.20 A; A/B=1971-2105.
DR   PDB; 2QC9; X-ray; 2.35 A; A/B=1899-2106.
DR   PDB; 2RQZ; NMR; -; A=452-489.
DR   PDB; 2RR0; NMR; -; A=452-489.
DR   PDB; 2RR2; NMR; -; A=452-489.
DR   PDB; 3P3N; X-ray; 2.40 A; B=1930-1949.
DR   PDB; 3P3P; X-ray; 2.60 A; B=1999-2016.
DR   PDB; 5KY0; X-ray; 1.53 A; B=452-491.
DR   PDB; 5KY4; X-ray; 1.47 A; B=983-1022.
DR   PDB; 5KY8; X-ray; 1.65 A; B=452-491.
DR   PDB; 5KY9; X-ray; 1.83 A; B=452-491.
DR   PDBsum; 1YMP; -.
DR   PDBsum; 2QC9; -.
DR   PDBsum; 2RQZ; -.
DR   PDBsum; 2RR0; -.
DR   PDBsum; 2RR2; -.
DR   PDBsum; 3P3N; -.
DR   PDBsum; 3P3P; -.
DR   PDBsum; 5KY0; -.
DR   PDBsum; 5KY4; -.
DR   PDBsum; 5KY8; -.
DR   PDBsum; 5KY9; -.
DR   ProteinModelPortal; Q01705; -.
DR   SMR; Q01705; -.
DR   BioGrid; 201808; 21.
DR   CORUM; Q01705; -.
DR   DIP; DIP-214N; -.
DR   IntAct; Q01705; 11.
DR   MINT; MINT-142586; -.
DR   STRING; 10090.ENSMUSP00000028288; -.
DR   iPTMnet; Q01705; -.
DR   PhosphoSitePlus; Q01705; -.
DR   PaxDb; Q01705; -.
DR   PeptideAtlas; Q01705; -.
DR   PRIDE; Q01705; -.
DR   Ensembl; ENSMUST00000028288; ENSMUSP00000028288; ENSMUSG00000026923. [Q01705-1]
DR   GeneID; 18128; -.
DR   KEGG; mmu:18128; -.
DR   UCSC; uc008ivl.2; mouse. [Q01705-1]
DR   CTD; 4851; -.
DR   MGI; MGI:97363; Notch1.
DR   eggNOG; ENOG410IR7G; Eukaryota.
DR   eggNOG; COG0666; LUCA.
DR   GeneTree; ENSGT00810000125346; -.
DR   HOGENOM; HOG000234369; -.
DR   HOVERGEN; HBG052650; -.
DR   InParanoid; Q01705; -.
DR   KO; K02599; -.
DR   OMA; QYVNSYT; -.
DR   OrthoDB; EOG091G01NU; -.
DR   TreeFam; TF351641; -.
DR   Reactome; R-MMU-1912420; Pre-NOTCH Processing in Golgi.
DR   Reactome; R-MMU-2122947; NOTCH1 Intracellular Domain Regulates Transcription.
DR   Reactome; R-MMU-2122948; Activated NOTCH1 Transmits Signal to the Nucleus.
DR   Reactome; R-MMU-350054; Notch-HLH transcription pathway.
DR   Reactome; R-MMU-8941856; RUNX3 regulates NOTCH signaling.
DR   EvolutionaryTrace; Q01705; -.
DR   PRO; PR:Q01705; -.
DR   Proteomes; UP000000589; Chromosome 2.
DR   Bgee; ENSMUSG00000026923; -.
DR   CleanEx; MM_NOTCH1; -.
DR   ExpressionAtlas; Q01705; baseline and differential.
DR   Genevisible; Q01705; MM.
DR   GO; GO:0001669; C:acrosomal vesicle; IEA:Ensembl.
DR   GO; GO:0005912; C:adherens junction; IDA:UniProtKB.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:UniProtKB.
DR   GO; GO:0071944; C:cell periphery; IDA:MGI.
DR   GO; GO:0009986; C:cell surface; IDA:MGI.
DR   GO; GO:0005737; C:cytoplasm; IDA:MGI.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IDA:MGI.
DR   GO; GO:0005856; C:cytoskeleton; ISS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:MGI.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0005887; C:integral component of plasma membrane; IC:UniProtKB.
DR   GO; GO:0030027; C:lamellipodium; ISS:UniProtKB.
DR   GO; GO:0002193; C:MAML1-RBP-Jkappa- ICN1 complex; ISO:MGI.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:AgBase.
DR   GO; GO:0005886; C:plasma membrane; IDA:MGI.
DR   GO; GO:0043235; C:receptor complex; ISO:MGI.
DR   GO; GO:0001726; C:ruffle; ISS:UniProtKB.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0003682; F:chromatin binding; IDA:MGI.
DR   GO; GO:0031490; F:chromatin DNA binding; IDA:MGI.
DR   GO; GO:0001047; F:core promoter binding; IDA:UniProtKB.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0004857; F:enzyme inhibitor activity; IDA:UniProtKB.
DR   GO; GO:0005112; F:Notch binding; IPI:MGI.
DR   GO; GO:0046982; F:protein heterodimerization activity; IDA:MGI.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:MGI.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; IDA:MGI.
DR   GO; GO:0001190; F:transcriptional activator activity, RNA polymerase II transcription factor binding; IDA:BHF-UCL.
DR   GO; GO:0004888; F:transmembrane signaling receptor activity; IEA:Ensembl.
DR   GO; GO:0031100; P:animal organ regeneration; IEA:Ensembl.
DR   GO; GO:0003180; P:aortic valve morphogenesis; ISS:BHF-UCL.
DR   GO; GO:1902263; P:apoptotic process involved in embryonic digit morphogenesis; IMP:MGI.
DR   GO; GO:0060842; P:arterial endothelial cell differentiation; IMP:BHF-UCL.
DR   GO; GO:0048708; P:astrocyte differentiation; IEA:Ensembl.
DR   GO; GO:0003162; P:atrioventricular node development; IMP:BHF-UCL.
DR   GO; GO:0003181; P:atrioventricular valve morphogenesis; IMP:BHF-UCL.
DR   GO; GO:0009912; P:auditory receptor cell fate commitment; IMP:MGI.
DR   GO; GO:0007409; P:axonogenesis; IDA:MGI.
DR   GO; GO:0048754; P:branching morphogenesis of an epithelial tube; IMP:MGI.
DR   GO; GO:0003209; P:cardiac atrium morphogenesis; IMP:BHF-UCL.
DR   GO; GO:0003207; P:cardiac chamber formation; IMP:BHF-UCL.
DR   GO; GO:0060317; P:cardiac epithelial to mesenchymal transition; IMP:BHF-UCL.
DR   GO; GO:0003214; P:cardiac left ventricle morphogenesis; IMP:BHF-UCL.
DR   GO; GO:0060038; P:cardiac muscle cell proliferation; IMP:BHF-UCL.
DR   GO; GO:0055008; P:cardiac muscle tissue morphogenesis; IMP:BHF-UCL.
DR   GO; GO:0003213; P:cardiac right atrium morphogenesis; IMP:BHF-UCL.
DR   GO; GO:0003219; P:cardiac right ventricle formation; IMP:MGI.
DR   GO; GO:0060411; P:cardiac septum morphogenesis; IMP:BHF-UCL.
DR   GO; GO:0060948; P:cardiac vascular smooth muscle cell development; IMP:BHF-UCL.
DR   GO; GO:0003208; P:cardiac ventricle morphogenesis; IMP:BHF-UCL.
DR   GO; GO:0007050; P:cell cycle arrest; IEA:Ensembl.
DR   GO; GO:0030154; P:cell differentiation; IMP:MGI.
DR   GO; GO:0021515; P:cell differentiation in spinal cord; IEA:Ensembl.
DR   GO; GO:0045165; P:cell fate commitment; IMP:MGI.
DR   GO; GO:0001708; P:cell fate specification; IMP:MGI.
DR   GO; GO:0003273; P:cell migration involved in endocardial cushion formation; IMP:BHF-UCL.
DR   GO; GO:0071372; P:cellular response to follicle-stimulating hormone stimulus; ISO:MGI.
DR   GO; GO:0035924; P:cellular response to vascular endothelial growth factor stimulus; ISS:UniProtKB.
DR   GO; GO:0060271; P:cilium assembly; ISS:UniProtKB.
DR   GO; GO:0072044; P:collecting duct development; IEP:UniProtKB.
DR   GO; GO:0007386; P:compartment pattern specification; IMP:MGI.
DR   GO; GO:0060982; P:coronary artery morphogenesis; IMP:BHF-UCL.
DR   GO; GO:0003169; P:coronary vein morphogenesis; IMP:BHF-UCL.
DR   GO; GO:0007368; P:determination of left/right symmetry; IMP:MGI.
DR   GO; GO:0072017; P:distal tubule development; IEP:UniProtKB.
DR   GO; GO:0035116; P:embryonic hindlimb morphogenesis; IMP:MGI.
DR   GO; GO:0030326; P:embryonic limb morphogenesis; IGI:MGI.
DR   GO; GO:0060956; P:endocardial cell differentiation; IMP:BHF-UCL.
DR   GO; GO:0003197; P:endocardial cushion development; IMP:MGI.
DR   GO; GO:0003203; P:endocardial cushion morphogenesis; IMP:BHF-UCL.
DR   GO; GO:0003157; P:endocardium development; IMP:BHF-UCL.
DR   GO; GO:0003160; P:endocardium morphogenesis; IMP:BHF-UCL.
DR   GO; GO:0007492; P:endoderm development; IMP:MGI.
DR   GO; GO:0008544; P:epidermis development; IGI:MGI.
DR   GO; GO:0001837; P:epithelial to mesenchymal transition; IMP:MGI.
DR   GO; GO:0003198; P:epithelial to mesenchymal transition involved in endocardial cushion formation; IMP:BHF-UCL.
DR   GO; GO:0030900; P:forebrain development; IMP:MGI.
DR   GO; GO:0007440; P:foregut morphogenesis; IMP:MGI.
DR   GO; GO:0010001; P:glial cell differentiation; IMP:MGI.
DR   GO; GO:0072144; P:glomerular mesangial cell development; IEP:UniProtKB.
DR   GO; GO:0003241; P:growth involved in heart morphogenesis; IMP:BHF-UCL.
DR   GO; GO:0031069; P:hair follicle morphogenesis; IMP:MGI.
DR   GO; GO:0007507; P:heart development; ISO:MGI.
DR   GO; GO:0001947; P:heart looping; IGI:BHF-UCL.
DR   GO; GO:0061384; P:heart trabecula morphogenesis; IMP:BHF-UCL.
DR   GO; GO:0006959; P:humoral immune response; IGI:MGI.
DR   GO; GO:0001701; P:in utero embryonic development; IMP:MGI.
DR   GO; GO:0002437; P:inflammatory response to antigenic stimulus; IGI:MGI.
DR   GO; GO:0072602; P:interleukin-4 secretion; IGI:MGI.
DR   GO; GO:0030216; P:keratinocyte differentiation; IMP:MGI.
DR   GO; GO:0070986; P:left/right axis specification; IGI:BHF-UCL.
DR   GO; GO:0001889; P:liver development; IMP:MGI.
DR   GO; GO:0030324; P:lung development; IMP:MGI.
DR   GO; GO:0014031; P:mesenchymal cell development; IMP:BHF-UCL.
DR   GO; GO:0003192; P:mitral valve formation; ISO:MGI.
DR   GO; GO:2000811; P:negative regulation of anoikis; ISO:MGI.
DR   GO; GO:0045608; P:negative regulation of auditory receptor cell differentiation; IMP:MGI.
DR   GO; GO:0030514; P:negative regulation of BMP signaling pathway; IMP:BHF-UCL.
DR   GO; GO:0045955; P:negative regulation of calcium ion-dependent exocytosis; IMP:MGI.
DR   GO; GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IMP:MGI.
DR   GO; GO:0043086; P:negative regulation of catalytic activity; IDA:UniProtKB.
DR   GO; GO:0060548; P:negative regulation of cell death; IMP:MGI.
DR   GO; GO:0045596; P:negative regulation of cell differentiation; IMP:MGI.
DR   GO; GO:0090051; P:negative regulation of cell migration involved in sprouting angiogenesis; ISS:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IMP:MGI.
DR   GO; GO:0010812; P:negative regulation of cell-substrate adhesion; ISO:MGI.
DR   GO; GO:2001027; P:negative regulation of endothelial cell chemotaxis; ISS:UniProtKB.
DR   GO; GO:0060253; P:negative regulation of glial cell proliferation; IDA:UniProtKB.
DR   GO; GO:0045967; P:negative regulation of growth rate; IEA:Ensembl.
DR   GO; GO:0045662; P:negative regulation of myoblast differentiation; ISO:MGI.
DR   GO; GO:0010832; P:negative regulation of myotube differentiation; IDA:UniProtKB.
DR   GO; GO:0050768; P:negative regulation of neurogenesis; IDA:UniProtKB.
DR   GO; GO:0045665; P:negative regulation of neuron differentiation; IMP:MGI.
DR   GO; GO:0048715; P:negative regulation of oligodendrocyte differentiation; IDA:UniProtKB.
DR   GO; GO:0030279; P:negative regulation of ossification; IMP:BHF-UCL.
DR   GO; GO:0045668; P:negative regulation of osteoblast differentiation; IMP:BHF-UCL.
DR   GO; GO:0046533; P:negative regulation of photoreceptor cell differentiation; IMP:MGI.
DR   GO; GO:2000974; P:negative regulation of pro-B cell differentiation; IMP:UniProtKB.
DR   GO; GO:2000737; P:negative regulation of stem cell differentiation; ISO:MGI.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:BHF-UCL.
DR   GO; GO:0021915; P:neural tube development; IMP:MGI.
DR   GO; GO:0030182; P:neuron differentiation; IMP:MGI.
DR   GO; GO:0048663; P:neuron fate commitment; IGI:MGI.
DR   GO; GO:0097150; P:neuronal stem cell population maintenance; IEA:Ensembl.
DR   GO; GO:0061314; P:Notch signaling involved in heart development; IMP:BHF-UCL.
DR   GO; GO:0007219; P:Notch signaling pathway; IDA:MGI.
DR   GO; GO:0003270; P:Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation; IMP:MGI.
DR   GO; GO:0048709; P:oligodendrocyte differentiation; IEA:Ensembl.
DR   GO; GO:0002051; P:osteoblast fate commitment; NAS:BHF-UCL.
DR   GO; GO:0003344; P:pericardium morphogenesis; IMP:BHF-UCL.
DR   GO; GO:1903849; P:positive regulation of aorta morphogenesis; IMP:MGI.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IDA:MGI.
DR   GO; GO:0048711; P:positive regulation of astrocyte differentiation; IDA:UniProtKB.
DR   GO; GO:0030513; P:positive regulation of BMP signaling pathway; IDA:UniProtKB.
DR   GO; GO:0060045; P:positive regulation of cardiac muscle cell proliferation; IMP:BHF-UCL.
DR   GO; GO:0030335; P:positive regulation of cell migration; IMP:BHF-UCL.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IGI:MGI.
DR   GO; GO:0045603; P:positive regulation of endothelial cell differentiation; IEA:Ensembl.
DR   GO; GO:1901189; P:positive regulation of ephrin receptor signaling pathway; IC:BHF-UCL.
DR   GO; GO:0050679; P:positive regulation of epithelial cell proliferation; IGI:MGI.
DR   GO; GO:0010718; P:positive regulation of epithelial to mesenchymal transition; IMP:BHF-UCL.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IEA:Ensembl.
DR   GO; GO:0046427; P:positive regulation of JAK-STAT cascade; IDA:UniProtKB.
DR   GO; GO:0045618; P:positive regulation of keratinocyte differentiation; IDA:MGI.
DR   GO; GO:0002052; P:positive regulation of neuroblast proliferation; IEA:Ensembl.
DR   GO; GO:0045747; P:positive regulation of Notch signaling pathway; IDA:MGI.
DR   GO; GO:0046579; P:positive regulation of Ras protein signal transduction; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB.
DR   GO; GO:0061419; P:positive regulation of transcription from RNA polymerase II promoter in response to hypoxia; IDA:UniProtKB.
DR   GO; GO:0007221; P:positive regulation of transcription of Notch receptor target; IGI:MGI.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0045070; P:positive regulation of viral genome replication; IMP:AgBase.
DR   GO; GO:0050434; P:positive regulation of viral transcription; IMP:AgBase.
DR   GO; GO:0060740; P:prostate gland epithelium morphogenesis; IMP:MGI.
DR   GO; GO:0003184; P:pulmonary valve morphogenesis; ISO:MGI.
DR   GO; GO:0045607; P:regulation of auditory receptor cell differentiation; IMP:MGI.
DR   GO; GO:0061344; P:regulation of cell adhesion involved in heart morphogenesis; IC:BHF-UCL.
DR   GO; GO:0030334; P:regulation of cell migration; IMP:BHF-UCL.
DR   GO; GO:0042127; P:regulation of cell proliferation; IGI:MGI.
DR   GO; GO:0050678; P:regulation of epithelial cell proliferation; IMP:MGI.
DR   GO; GO:0060768; P:regulation of epithelial cell proliferation involved in prostate gland development; IMP:MGI.
DR   GO; GO:1901201; P:regulation of extracellular matrix assembly; IMP:BHF-UCL.
DR   GO; GO:0010468; P:regulation of gene expression; IMP:MGI.
DR   GO; GO:0050767; P:regulation of neurogenesis; IMP:MGI.
DR   GO; GO:0008593; P:regulation of Notch signaling pathway; IGI:MGI.
DR   GO; GO:0014807; P:regulation of somitogenesis; IMP:MGI.
DR   GO; GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IMP:MGI.
DR   GO; GO:0003256; P:regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation; IMP:BHF-UCL.
DR   GO; GO:0031960; P:response to corticosteroid; IEA:Ensembl.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl.
DR   GO; GO:0032495; P:response to muramyl dipeptide; IDA:BHF-UCL.
DR   GO; GO:0060528; P:secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development; IMP:MGI.
DR   GO; GO:0035914; P:skeletal muscle cell differentiation; IMP:MGI.
DR   GO; GO:0048103; P:somatic stem cell division; IDA:MGI.
DR   GO; GO:0007283; P:spermatogenesis; IEA:Ensembl.
DR   GO; GO:0002040; P:sprouting angiogenesis; IMP:MGI.
DR   GO; GO:0042246; P:tissue regeneration; IEA:Ensembl.
DR   GO; GO:0035148; P:tube formation; ISS:UniProtKB.
DR   GO; GO:0060979; P:vasculogenesis involved in coronary vascular morphogenesis; IMP:BHF-UCL.
DR   GO; GO:0048845; P:venous blood vessel morphogenesis; IMP:MGI.
DR   GO; GO:0060843; P:venous endothelial cell differentiation; IMP:BHF-UCL.
DR   GO; GO:0060412; P:ventricular septum morphogenesis; ISO:MGI.
DR   GO; GO:0003222; P:ventricular trabecula myocardium morphogenesis; IMP:BHF-UCL.
DR   CDD; cd00204; ANK; 2.
DR   Gene3D; 1.25.40.20; -; 3.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR024600; DUF3454_notch.
DR   InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR000152; EGF-type_Asp/Asn_hydroxyl_site.
DR   InterPro; IPR018097; EGF_Ca-bd_CS.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   InterPro; IPR008297; Notch.
DR   InterPro; IPR035993; Notch-like_dom_sf.
DR   InterPro; IPR022362; Notch_1.
DR   InterPro; IPR000800; Notch_dom.
DR   InterPro; IPR010660; Notch_NOD_dom.
DR   InterPro; IPR011656; Notch_NODP_dom.
DR   Pfam; PF12796; Ank_2; 2.
DR   Pfam; PF11936; DUF3454; 1.
DR   Pfam; PF00008; EGF; 21.
DR   Pfam; PF07645; EGF_CA; 5.
DR   Pfam; PF12661; hEGF; 3.
DR   Pfam; PF06816; NOD; 1.
DR   Pfam; PF07684; NODP; 1.
DR   Pfam; PF00066; Notch; 3.
DR   PIRSF; PIRSF002279; Notch; 1.
DR   PRINTS; PR01452; LNOTCHREPEAT.
DR   PRINTS; PR01984; NOTCH1.
DR   SMART; SM00248; ANK; 6.
DR   SMART; SM01334; DUF3454; 1.
DR   SMART; SM00181; EGF; 36.
DR   SMART; SM00179; EGF_CA; 33.
DR   SMART; SM00004; NL; 3.
DR   SMART; SM01338; NOD; 1.
DR   SMART; SM01339; NODP; 1.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   SUPFAM; SSF57184; SSF57184; 6.
DR   SUPFAM; SSF90193; SSF90193; 3.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 4.
DR   PROSITE; PS00010; ASX_HYDROXYL; 22.
DR   PROSITE; PS00022; EGF_1; 35.
DR   PROSITE; PS01186; EGF_2; 27.
DR   PROSITE; PS50026; EGF_3; 36.
DR   PROSITE; PS01187; EGF_CA; 21.
DR   PROSITE; PS50258; LNR; 3.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Alternative splicing; Angiogenesis;
KW   ANK repeat; Calcium; Cell membrane; Complete proteome;
KW   Developmental protein; Differentiation; Direct protein sequencing;
KW   Disulfide bond; EGF-like domain; Glycoprotein; Hydroxylation;
KW   Isopeptide bond; Membrane; Metal-binding; Notch signaling pathway;
KW   Nucleus; Phosphoprotein; Receptor; Reference proteome; Repeat; Signal;
KW   Transcription; Transcription regulation; Transmembrane;
KW   Transmembrane helix; Ubl conjugation.
FT   SIGNAL        1     18       {ECO:0000255}.
FT   CHAIN        19   2531       Neurogenic locus notch homolog protein 1.
FT                                /FTId=PRO_0000007677.
FT   CHAIN      1711   2531       Notch 1 extracellular truncation.
FT                                /FTId=PRO_0000007678.
FT   CHAIN      1744   2531       Notch 1 intracellular domain.
FT                                /FTId=PRO_0000007679.
FT   TOPO_DOM     19   1725       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1726   1746       Helical. {ECO:0000255}.
FT   TOPO_DOM   1747   2531       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       20     58       EGF-like 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN       59     99       EGF-like 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      102    139       EGF-like 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      140    176       EGF-like 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      178    216       EGF-like 5; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      218    255       EGF-like 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      257    293       EGF-like 7; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      295    333       EGF-like 8; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      335    371       EGF-like 9; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      372    410       EGF-like 10; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      412    450       EGF-like 11; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      452    488       EGF-like 12; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      490    526       EGF-like 13; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      528    564       EGF-like 14; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      566    601       EGF-like 15; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      603    639       EGF-like 16; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      641    676       EGF-like 17; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      678    714       EGF-like 18; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      716    751       EGF-like 19; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      753    789       EGF-like 20; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      791    827       EGF-like 21; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      829    867       EGF-like 22. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      869    905       EGF-like 23; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      907    943       EGF-like 24. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      945    981       EGF-like 25; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      983   1019       EGF-like 26. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN     1021   1057       EGF-like 27; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN     1059   1095       EGF-like 28. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN     1097   1143       EGF-like 29. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN     1145   1181       EGF-like 30; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN     1183   1219       EGF-like 31; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN     1221   1265       EGF-like 32; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN     1267   1305       EGF-like 33. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN     1307   1346       EGF-like 34. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN     1348   1384       EGF-like 35. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN     1387   1426       EGF-like 36. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   REPEAT     1449   1489       LNR 1.
FT   REPEAT     1490   1531       LNR 2.
FT   REPEAT     1532   1571       LNR 3.
FT   REPEAT     1917   1946       ANK 1.
FT   REPEAT     1950   1980       ANK 2.
FT   REPEAT     1984   2013       ANK 3.
FT   REPEAT     2017   2046       ANK 4.
FT   REPEAT     2050   2079       ANK 5.
FT   REGION      420    421       Interaction with DLL4.
FT                                {ECO:0000250|UniProtKB:Q07008}.
FT   REGION      448    452       Interaction with DLL4.
FT                                {ECO:0000250|UniProtKB:Q07008}.
FT   REGION     1937   1945       HIF1AN-binding.
FT   REGION     2004   2012       HIF1AN-binding.
FT   METAL       432    432       Calcium 1; via carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:Q07008}.
FT   METAL       435    435       Calcium 1; via amide nitrogen.
FT                                {ECO:0000250|UniProtKB:Q07008}.
FT   METAL       452    452       Calcium 2.
FT                                {ECO:0000250|UniProtKB:Q07008}.
FT   METAL       453    453       Calcium 2; via carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:Q07008}.
FT   METAL       455    455       Calcium 2.
FT                                {ECO:0000250|UniProtKB:Q07008}.
FT   METAL       469    469       Calcium 2.
FT                                {ECO:0000250|UniProtKB:Q07008}.
FT   METAL       470    470       Calcium 2; via carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:Q07008}.
FT   METAL       490    490       Calcium 3.
FT                                {ECO:0000250|UniProtKB:Q07008}.
FT   METAL       491    491       Calcium 3; via carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:Q07008}.
FT   METAL       493    493       Calcium 3.
FT                                {ECO:0000250|UniProtKB:Q07008}.
FT   METAL       507    507       Calcium 3.
FT                                {ECO:0000250|UniProtKB:Q07008}.
FT   METAL       508    508       Calcium 3; via carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:Q07008}.
FT   METAL      1457   1457       Calcium 4; via carbonyl oxygen.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00525}.
FT   METAL      1460   1460       Calcium 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00525}.
FT   METAL      1475   1475       Calcium 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00525}.
FT   METAL      1478   1478       Calcium 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00525}.
FT   SITE        469    469       Interaction with DLL4.
FT                                {ECO:0000250|UniProtKB:Q07008}.
FT   SITE       1654   1655       Cleavage; by furin-like protease.
FT   SITE       1710   1711       Cleavage; by ADAM17. {ECO:0000250}.
FT   MOD_RES    1851   1851       Phosphothreonine.
FT                                {ECO:0000244|PubMed:21183079}.
FT   MOD_RES    1945   1945       (3S)-3-hydroxyasparagine; by HIF1AN;
FT                                partial. {ECO:0000269|PubMed:17573339,
FT                                ECO:0000269|PubMed:18299578}.
FT   MOD_RES    2012   2012       (3S)-3-hydroxyasparagine; by HIF1AN;
FT                                partial. {ECO:0000269|PubMed:17573339,
FT                                ECO:0000269|PubMed:18299578}.
FT   CARBOHYD     65     65       O-linked (Glc...) serine.
FT                                {ECO:0000269|PubMed:21757702}.
FT   CARBOHYD     73     73       O-linked (Fuc...) threonine.
FT                                {ECO:0000269|PubMed:21757702,
FT                                ECO:0000269|PubMed:28089369}.
FT   CARBOHYD    116    116       O-linked (Fuc...) threonine.
FT                                {ECO:0000269|PubMed:21757702,
FT                                ECO:0000269|PubMed:28089369}.
FT   CARBOHYD    146    146       O-linked (Glc...) serine.
FT                                {ECO:0000269|PubMed:21757702}.
FT   CARBOHYD    194    194       O-linked (Fuc...) threonine.
FT                                {ECO:0000269|PubMed:21757702,
FT                                ECO:0000269|PubMed:28089369}.
FT   CARBOHYD    232    232       O-linked (Fuc...) threonine; alternate.
FT                                {ECO:0000269|PubMed:28089369}.
FT   CARBOHYD    232    232       O-linked (GalNAc...) threonine;
FT                                alternate.
FT                                {ECO:0000250|UniProtKB:P46531}.
FT   CARBOHYD    311    311       O-linked (Fuc...) threonine.
FT                                {ECO:0000269|PubMed:28089369}.
FT   CARBOHYD    341    341       O-linked (Glc...) serine.
FT                                {ECO:0000269|PubMed:21757702}.
FT   CARBOHYD    349    349       O-linked (Fuc...) threonine.
FT                                {ECO:0000269|PubMed:28089369}.
FT   CARBOHYD    378    378       O-linked (Glc...) serine.
FT                                {ECO:0000269|PubMed:21757702}.
FT   CARBOHYD    435    435       O-linked (Glc...) serine.
FT                                {ECO:0000250|UniProtKB:Q07008}.
FT   CARBOHYD    458    458       O-linked (Glc...) serine.
FT                                {ECO:0000269|PubMed:21757702,
FT                                ECO:0000269|PubMed:28089369}.
FT   CARBOHYD    466    466       O-linked (Fuc...) threonine.
FT                                {ECO:0000269|PubMed:21757702,
FT                                ECO:0000269|PubMed:28089369}.
FT   CARBOHYD    496    496       O-linked (Glc...) serine.
FT                                {ECO:0000269|PubMed:21757702}.
FT   CARBOHYD    534    534       O-linked (Glc...) serine.
FT                                {ECO:0000269|PubMed:21757702}.
FT   CARBOHYD    609    609       O-linked (Glc...) serine.
FT                                {ECO:0000269|PubMed:21757702}.
FT   CARBOHYD    617    617       O-linked (Fuc...) threonine.
FT                                {ECO:0000269|PubMed:28089369}.
FT   CARBOHYD    647    647       O-linked (Glc...) serine.
FT                                {ECO:0000269|PubMed:21757702}.
FT   CARBOHYD    692    692       O-linked (Fuc...) threonine.
FT                                {ECO:0000269|PubMed:28089369}.
FT   CARBOHYD    722    722       O-linked (Glc...) serine.
FT                                {ECO:0000269|PubMed:21757702}.
FT   CARBOHYD    759    759       O-linked (Glc...) serine.
FT                                {ECO:0000269|PubMed:21757702,
FT                                ECO:0000269|PubMed:28089369}.
FT   CARBOHYD    767    767       O-linked (Fuc...) threonine.
FT                                {ECO:0000269|PubMed:21757702,
FT                                ECO:0000269|PubMed:28089369}.
FT   CARBOHYD    784    784       O-linked (GlcNAc) serine.
FT                                {ECO:0000269|PubMed:28089369}.
FT   CARBOHYD    797    797       O-linked (Glc...) serine.
FT                                {ECO:0000269|PubMed:21757702,
FT                                ECO:0000269|PubMed:28089369}.
FT   CARBOHYD    805    805       O-linked (Fuc...) threonine.
FT                                {ECO:0000269|PubMed:21757702,
FT                                ECO:0000269|PubMed:28089369}.
FT   CARBOHYD    888    888       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    900    900       O-linked (GlcNAc) threonine.
FT                                {ECO:0000269|PubMed:28089369}.
FT   CARBOHYD    921    921       O-linked (Fuc) serine.
FT                                {ECO:0000269|PubMed:28089369}.
FT   CARBOHYD    951    951       O-linked (Glc...) serine.
FT                                {ECO:0000269|PubMed:21757702}.
FT   CARBOHYD    959    959       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    997    997       O-linked (Fuc...) threonine.
FT                                {ECO:0000269|PubMed:28089369}.
FT   CARBOHYD   1027   1027       O-linked (Glc...) serine.
FT                                {ECO:0000269|PubMed:21757702}.
FT   CARBOHYD   1035   1035       O-linked (Fuc...) threonine.
FT                                {ECO:0000269|PubMed:21757702,
FT                                ECO:0000269|PubMed:28089369}.
FT   CARBOHYD   1065   1065       O-linked (Glc...) serine.
FT                                {ECO:0000269|PubMed:21757702}.
FT   CARBOHYD   1159   1159       O-linked (Fuc...) threonine.
FT                                {ECO:0000269|PubMed:28089369}.
FT   CARBOHYD   1179   1179       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1189   1189       O-linked (Glc...) serine.
FT                                {ECO:0000269|PubMed:21757702}.
FT   CARBOHYD   1197   1197       O-linked (Fuc...) threonine.
FT                                {ECO:0000269|PubMed:21757702,
FT                                ECO:0000269|PubMed:28089369}.
FT   CARBOHYD   1241   1241       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1273   1273       O-linked (Glc...) serine.
FT                                {ECO:0000269|PubMed:21757702}.
FT   CARBOHYD   1362   1362       O-linked (Fuc...) threonine.
FT                                {ECO:0000269|PubMed:21757702,
FT                                ECO:0000269|PubMed:28089369}.
FT   CARBOHYD   1379   1379       O-linked (GlcNAc...) threonine.
FT                                {ECO:0000269|PubMed:28089369}.
FT   CARBOHYD   1402   1402       O-linked (Fuc...) threonine; alternate.
FT                                {ECO:0000269|PubMed:28089369}.
FT   CARBOHYD   1402   1402       O-linked (GalNAc...) threonine;
FT                                alternate. {ECO:0000269|PubMed:28089369}.
FT   CARBOHYD   1489   1489       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1587   1587       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     24     37       {ECO:0000250}.
FT   DISULFID     31     46       {ECO:0000250}.
FT   DISULFID     63     74       {ECO:0000250}.
FT   DISULFID     68     87       {ECO:0000250}.
FT   DISULFID     89     98       {ECO:0000250}.
FT   DISULFID    106    117       {ECO:0000250}.
FT   DISULFID    111    127       {ECO:0000250}.
FT   DISULFID    129    138       {ECO:0000250}.
FT   DISULFID    144    155       {ECO:0000250}.
FT   DISULFID    149    164       {ECO:0000250}.
FT   DISULFID    166    175       {ECO:0000250}.
FT   DISULFID    182    195       {ECO:0000250}.
FT   DISULFID    189    204       {ECO:0000250}.
FT   DISULFID    206    215       {ECO:0000250}.
FT   DISULFID    222    233       {ECO:0000250}.
FT   DISULFID    227    243       {ECO:0000250}.
FT   DISULFID    245    254       {ECO:0000250}.
FT   DISULFID    261    272       {ECO:0000250}.
FT   DISULFID    266    281       {ECO:0000250}.
FT   DISULFID    283    292       {ECO:0000250}.
FT   DISULFID    299    312       {ECO:0000250}.
FT   DISULFID    306    321       {ECO:0000250}.
FT   DISULFID    323    332       {ECO:0000250}.
FT   DISULFID    339    350       {ECO:0000250}.
FT   DISULFID    344    359       {ECO:0000250}.
FT   DISULFID    361    370       {ECO:0000250}.
FT   DISULFID    376    387       {ECO:0000250}.
FT   DISULFID    381    398       {ECO:0000250}.
FT   DISULFID    400    409       {ECO:0000250}.
FT   DISULFID    416    429       {ECO:0000250|UniProtKB:Q07008}.
FT   DISULFID    423    438       {ECO:0000250|UniProtKB:Q07008}.
FT   DISULFID    440    449       {ECO:0000250|UniProtKB:Q07008}.
FT   DISULFID    456    467       {ECO:0000250|UniProtKB:Q07008}.
FT   DISULFID    461    476       {ECO:0000250|UniProtKB:Q07008}.
FT   DISULFID    478    487       {ECO:0000250|UniProtKB:Q07008}.
FT   DISULFID    494    505       {ECO:0000250|UniProtKB:Q07008}.
FT   DISULFID    499    514       {ECO:0000250|UniProtKB:Q07008}.
FT   DISULFID    516    525       {ECO:0000250|UniProtKB:Q07008}.
FT   DISULFID    532    543       {ECO:0000250}.
FT   DISULFID    537    552       {ECO:0000250}.
FT   DISULFID    554    563       {ECO:0000250}.
FT   DISULFID    570    580       {ECO:0000250}.
FT   DISULFID    575    589       {ECO:0000250}.
FT   DISULFID    591    600       {ECO:0000250}.
FT   DISULFID    607    618       {ECO:0000250}.
FT   DISULFID    612    627       {ECO:0000250}.
FT   DISULFID    629    638       {ECO:0000250}.
FT   DISULFID    645    655       {ECO:0000250}.
FT   DISULFID    650    664       {ECO:0000250}.
FT   DISULFID    666    675       {ECO:0000250}.
FT   DISULFID    682    693       {ECO:0000250}.
FT   DISULFID    687    702       {ECO:0000250}.
FT   DISULFID    704    713       {ECO:0000250}.
FT   DISULFID    720    730       {ECO:0000250}.
FT   DISULFID    725    739       {ECO:0000250}.
FT   DISULFID    741    750       {ECO:0000250}.
FT   DISULFID    757    768       {ECO:0000250}.
FT   DISULFID    762    777       {ECO:0000250}.
FT   DISULFID    779    788       {ECO:0000250}.
FT   DISULFID    795    806       {ECO:0000250}.
FT   DISULFID    800    815       {ECO:0000250}.
FT   DISULFID    817    826       {ECO:0000250}.
FT   DISULFID    833    844       {ECO:0000250}.
FT   DISULFID    838    855       {ECO:0000250}.
FT   DISULFID    857    866       {ECO:0000250}.
FT   DISULFID    873    884       {ECO:0000250}.
FT   DISULFID    878    893       {ECO:0000250}.
FT   DISULFID    895    904       {ECO:0000250}.
FT   DISULFID    911    922       {ECO:0000250}.
FT   DISULFID    916    931       {ECO:0000250}.
FT   DISULFID    933    942       {ECO:0000250}.
FT   DISULFID    949    960       {ECO:0000250}.
FT   DISULFID    954    969       {ECO:0000250}.
FT   DISULFID    971    980       {ECO:0000250}.
FT   DISULFID    987    998       {ECO:0000250}.
FT   DISULFID    992   1007       {ECO:0000250}.
FT   DISULFID   1009   1018       {ECO:0000250}.
FT   DISULFID   1025   1036       {ECO:0000250}.
FT   DISULFID   1030   1045       {ECO:0000250}.
FT   DISULFID   1047   1056       {ECO:0000250}.
FT   DISULFID   1063   1074       {ECO:0000250}.
FT   DISULFID   1068   1083       {ECO:0000250}.
FT   DISULFID   1085   1094       {ECO:0000250}.
FT   DISULFID   1101   1122       {ECO:0000250}.
FT   DISULFID   1116   1131       {ECO:0000250}.
FT   DISULFID   1133   1142       {ECO:0000250}.
FT   DISULFID   1149   1160       {ECO:0000250}.
FT   DISULFID   1154   1169       {ECO:0000250}.
FT   DISULFID   1171   1180       {ECO:0000250}.
FT   DISULFID   1187   1198       {ECO:0000250}.
FT   DISULFID   1192   1207       {ECO:0000250}.
FT   DISULFID   1209   1218       {ECO:0000250}.
FT   DISULFID   1225   1244       {ECO:0000250}.
FT   DISULFID   1238   1253       {ECO:0000250}.
FT   DISULFID   1255   1264       {ECO:0000250}.
FT   DISULFID   1271   1284       {ECO:0000250}.
FT   DISULFID   1276   1293       {ECO:0000250}.
FT   DISULFID   1295   1304       {ECO:0000250}.
FT   DISULFID   1311   1322       {ECO:0000250}.
FT   DISULFID   1316   1334       {ECO:0000250}.
FT   DISULFID   1336   1345       {ECO:0000250}.
FT   DISULFID   1352   1363       {ECO:0000250}.
FT   DISULFID   1357   1372       {ECO:0000250}.
FT   DISULFID   1374   1383       {ECO:0000250}.
FT   DISULFID   1391   1403       {ECO:0000250}.
FT   DISULFID   1397   1414       {ECO:0000250}.
FT   DISULFID   1416   1425       {ECO:0000250}.
FT   DISULFID   1449   1472       {ECO:0000250}.
FT   DISULFID   1454   1467       {ECO:0000250}.
FT   DISULFID   1463   1479       {ECO:0000250}.
FT   DISULFID   1490   1514       {ECO:0000250}.
FT   DISULFID   1496   1509       {ECO:0000250}.
FT   DISULFID   1505   1521       {ECO:0000250}.
FT   DISULFID   1536   1549       {ECO:0000250}.
FT   DISULFID   1545   1561       {ECO:0000250}.
FT   CROSSLNK   1749   1749       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:15240571}.
FT   VAR_SEQ       1     47       MPRLLTPLLCLTLLPALAARGLRCSQPSGTCLNGGRCEVAN
FT                                GTEACV -> MQTPLLSLAGATTELCFLPASVLASSLPGPS
FT                                L (in isoform 4). {ECO:0000305}.
FT                                /FTId=VSP_043065.
FT   VAR_SEQ       1     21       MPRLLTPLLCLTLLPALAARG -> MKNSNTLTNKWRMEQC
FT                                (in isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_043064.
FT   VAR_SEQ     857    914       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:1426644}.
FT                                /FTId=VSP_001402.
FT   VAR_SEQ    1329   1355       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:1426644}.
FT                                /FTId=VSP_001403.
FT   VAR_SEQ    1636   1854       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:1426644}.
FT                                /FTId=VSP_001404.
FT   MUTAGEN      65     65       S->A: No effect.
FT                                {ECO:0000269|PubMed:21757702}.
FT   MUTAGEN     146    146       S->A: No effect.
FT                                {ECO:0000269|PubMed:21757702}.
FT   MUTAGEN     232    232       T->V: No significant effect on its
FT                                binding and activation by DLL1 or JAG1.
FT                                No significant effect on RFNG-, LFNG- and
FT                                MFNG-mediated enhancement of its
FT                                activation by DLL1. Decrease in LFNG- and
FT                                MFNG-mediated inhibition of its
FT                                activation by JAG1. Significant decrease
FT                                in LFNG- and MFNG-mediated inhibition of
FT                                its activation by JAG1; when associated
FT                                with V-1402.
FT                                {ECO:0000269|PubMed:28089369}.
FT   MUTAGEN     311    311       T->V: Significant loss of binding and
FT                                activation by DLL1 or JAG1. Decrease in
FT                                RFNG-, LFNG- and MFNG-mediated
FT                                enhancement of its activation by DLL1.
FT                                Decrease in LFNG-mediated inhibition of
FT                                its activation by JAG1. Significant loss
FT                                of binding and activation by DLL1 or JAG1
FT                                and complete loss of RFNG- and LFNG-
FT                                mediated enhancement of its activation by
FT                                DLL1; when associated with V-466.
FT                                {ECO:0000269|PubMed:28089369}.
FT   MUTAGEN     341    341       S->A: No effect.
FT                                {ECO:0000269|PubMed:21757702}.
FT   MUTAGEN     349    349       T->V: Reduced binding and activation by
FT                                JAG1 but not DLL1. Decrease in MFNG-
FT                                mediated enhancement of its activation by
FT                                DLL1. {ECO:0000269|PubMed:28089369}.
FT   MUTAGEN     378    378       S->A: No effect.
FT                                {ECO:0000269|PubMed:21757702}.
FT   MUTAGEN     458    458       S->A: No effect.
FT                                {ECO:0000269|PubMed:21757702}.
FT   MUTAGEN     466    466       T->V: Reduced binding and activation by
FT                                DLL1 but not JAG1. Decrease in RFNG- and
FT                                LFNG-mediated enhancement of its
FT                                activation by DLL1. Loss of RFNG-mediated
FT                                enhancement of its activation by JAG1.
FT                                Significant loss of binding and
FT                                activation by DLL1 or JAG1 and complete
FT                                loss of RFNG- and LFNG-mediated
FT                                enhancement of its activation by DLL1;
FT                                when associated with V-311.
FT                                {ECO:0000269|PubMed:28089369}.
FT   MUTAGEN     496    496       S->A: No effect.
FT                                {ECO:0000269|PubMed:21757702}.
FT   MUTAGEN     534    534       S->A: No effect.
FT                                {ECO:0000269|PubMed:21757702}.
FT   MUTAGEN     609    609       S->A: No effect.
FT                                {ECO:0000269|PubMed:21757702}.
FT   MUTAGEN     647    647       S->A: No effect.
FT                                {ECO:0000269|PubMed:21757702}.
FT   MUTAGEN     722    722       S->A: No effect.
FT                                {ECO:0000269|PubMed:21757702}.
FT   MUTAGEN     759    759       S->A: No effect.
FT                                {ECO:0000269|PubMed:21757702}.
FT   MUTAGEN     797    797       S->A: No effect.
FT                                {ECO:0000269|PubMed:21757702}.
FT   MUTAGEN     951    951       S->A: No effect.
FT                                {ECO:0000269|PubMed:21757702}.
FT   MUTAGEN     997    997       T->V: Reduced binding and activation by
FT                                DLL1 but not JAG1. No effect on RFNG-,
FT                                LFNG- and MFNG-mediated enhancement of
FT                                its activation by DLL1. No effect on
FT                                LFNG- and MFNG-mediated inhibition of its
FT                                activation by JAG1.
FT                                {ECO:0000269|PubMed:28089369}.
FT   MUTAGEN    1027   1027       S->A: No effect.
FT                                {ECO:0000269|PubMed:21757702}.
FT   MUTAGEN    1035   1035       T->V: Reduced binding and activation by
FT                                JAG1 but not DLL1. No effect on RFNG-,
FT                                LFNG- and MFNG-mediated enhancement of
FT                                its activation by DLL1. No effect on
FT                                LFNG- and MFNG-mediated inhibition of its
FT                                activation by JAG1.
FT                                {ECO:0000269|PubMed:28089369}.
FT   MUTAGEN    1065   1065       S->A: Reduced activity.
FT                                {ECO:0000269|PubMed:21757702}.
FT   MUTAGEN    1159   1159       T->V: No significant effect on its
FT                                binding and activation by DLL1 or JAG1.
FT                                No effect on RFNG-, LFNG- and MFNG-
FT                                mediated enhancement of its activation by
FT                                DLL1. No effect on LFNG- and MFNG-
FT                                mediated inhibition of its activation by
FT                                JAG1. {ECO:0000269|PubMed:28089369}.
FT   MUTAGEN    1189   1189       S->A: No effect.
FT                                {ECO:0000269|PubMed:21757702}.
FT   MUTAGEN    1273   1273       S->A: No effect.
FT                                {ECO:0000269|PubMed:21757702}.
FT   MUTAGEN    1362   1362       T->V: No significant effect on its
FT                                binding and activation by DLL1 or JAG1.
FT                                No effect on RFNG-, LFNG- and MFNG-
FT                                mediated enhancement of its activation by
FT                                DLL1. No effect on LFNG- and MFNG-
FT                                mediated inhibition of its activation by
FT                                JAG1. {ECO:0000269|PubMed:28089369}.
FT   MUTAGEN    1402   1402       T->V: No significant effect on its
FT                                binding and activation by DLL1 or JAG1.
FT                                No effect on RFNG-, LFNG- and MFNG-
FT                                mediated enhancement of its activation by
FT                                DLL1. Decrease in LFNG- and MFNG-mediated
FT                                inhibition of its activation by JAG1.
FT                                Significant decrease in LFNG- and MFNG-
FT                                mediated inhibition of its activation by
FT                                JAG1; when associated with V-232.
FT                                {ECO:0000269|PubMed:28089369}.
FT   MUTAGEN    1651   1654       RQRR->AAAA: Processing by furin-like
FT                                convertase abolished.
FT                                {ECO:0000269|PubMed:9653148}.
FT   MUTAGEN    1744   1744       V->L: NICD processing severely reduced.
FT   MUTAGEN    1945   1945       N->A: Reduced ability to promote HIF1AN-
FT                                dependent 2-oxoglutarate decarboxylation
FT                                and greatly reduced transactivation
FT                                capacity. Abolished ability to promote
FT                                HIF1AN-dependent 2-oxoglutarate
FT                                decarboxylation; when associated with G-
FT                                2012. Almost abolished transactivation
FT                                capacity; when associated with A-2012.
FT                                {ECO:0000269|PubMed:17573339,
FT                                ECO:0000269|PubMed:18299578}.
FT   MUTAGEN    2012   2012       N->A: Slightly reduced ability to promote
FT                                HIF1AN-dependent 2-oxoglutarate
FT                                decarboxylation. Abolished ability to
FT                                promote HIF1AN-dependent 2-oxoglutarate
FT                                decarboxylation and almost abolished
FT                                transactivation capacity; when associated
FT                                with A-1945.
FT                                {ECO:0000269|PubMed:17573339,
FT                                ECO:0000269|PubMed:18299578}.
FT   MUTAGEN    2012   2012       N->G: Reduced ability to promote HIF1AN-
FT                                dependent 2-oxoglutarate decarboxylation.
FT                                Abolished ability to promote HIF1AN-
FT                                dependent 2-oxoglutarate decarboxylation;
FT                                when associated with A-1945.
FT                                {ECO:0000269|PubMed:17573339,
FT                                ECO:0000269|PubMed:18299578}.
FT   CONFLICT     17     17       L -> R (in Ref. 1; CAA77941).
FT                                {ECO:0000305}.
FT   CONFLICT     41     41       N -> S (in Ref. 1; CAA77941 and 3;
FT                                AAM28905). {ECO:0000305}.
FT   CONFLICT     48     48       C -> A (in Ref. 1; CAA77941).
FT                                {ECO:0000305}.
FT   CONFLICT     51     51       A -> S (in Ref. 1; CAA77941).
FT                                {ECO:0000305}.
FT   CONFLICT     60     60       S -> P (in Ref. 1; CAA77941).
FT                                {ECO:0000305}.
FT   CONFLICT     67     67       P -> R (in Ref. 1; CAA77941).
FT                                {ECO:0000305}.
FT   CONFLICT     75     75       H -> Y (in Ref. 1; CAA77941).
FT                                {ECO:0000305}.
FT   CONFLICT     82     82       T -> I (in Ref. 1; CAA77941).
FT                                {ECO:0000305}.
FT   CONFLICT    104    105       NA -> KP (in Ref. 1; CAA77941).
FT                                {ECO:0000305}.
FT   CONFLICT    130    130       P -> S (in Ref. 1; CAA77941).
FT                                {ECO:0000305}.
FT   CONFLICT    194    194       T -> H (in Ref. 1; CAA77941).
FT                                {ECO:0000305}.
FT   CONFLICT    207    207       R -> C (in Ref. 1; CAA77941).
FT                                {ECO:0000305}.
FT   CONFLICT    231    231       G -> A (in Ref. 1; CAA77941).
FT                                {ECO:0000305}.
FT   CONFLICT    287    287       W -> V (in Ref. 1; CAA77941).
FT                                {ECO:0000305}.
FT   CONFLICT    309    309       G -> A (in Ref. 1; CAA77941).
FT                                {ECO:0000305}.
FT   CONFLICT    373    374       ND -> KH (in Ref. 1; CAA77941).
FT                                {ECO:0000305}.
FT   CONFLICT    396    396       A -> R (in Ref. 1; CAA77941).
FT                                {ECO:0000305}.
FT   CONFLICT    417    417       A -> D (in Ref. 1; CAA77941).
FT                                {ECO:0000305}.
FT   CONFLICT    422    422       P -> R (in Ref. 1; CAA77941).
FT                                {ECO:0000305}.
FT   CONFLICT    448    448       R -> G (in Ref. 1; CAA77941).
FT                                {ECO:0000305}.
FT   CONFLICT    510    510       N -> H (in Ref. 1; CAA77941).
FT                                {ECO:0000305}.
FT   CONFLICT    835    835       T -> I (in Ref. 8; AAK14898).
FT                                {ECO:0000305}.
FT   CONFLICT    933    934       CL -> SV (in Ref. 8; AAK14898).
FT                                {ECO:0000305}.
FT   CONFLICT   1050   1050       G -> R (in Ref. 8; AAK14898).
FT                                {ECO:0000305}.
FT   CONFLICT   1104   1106       Missing (in Ref. 8; AAK14898).
FT                                {ECO:0000305}.
FT   CONFLICT   1155   1155       Q -> L (in Ref. 8; AAK14898).
FT                                {ECO:0000305}.
FT   CONFLICT   1209   1209       C -> W (in Ref. 8; AAK14898).
FT                                {ECO:0000305}.
FT   CONFLICT   1438   1438       R -> P (in Ref. 1; CAA77941).
FT                                {ECO:0000305}.
FT   CONFLICT   1545   1545       C -> S (in Ref. 8; AAK14898).
FT                                {ECO:0000305}.
FT   CONFLICT   1556   1556       W -> R (in Ref. 8; AAK14898).
FT                                {ECO:0000305}.
FT   CONFLICT   1572   1572       G -> R (in Ref. 8; AAK14898).
FT                                {ECO:0000305}.
FT   CONFLICT   1576   1576       L -> V (in Ref. 8; AAK14898).
FT                                {ECO:0000305}.
FT   CONFLICT   1609   1609       D -> H (in Ref. 8; AAK14898).
FT                                {ECO:0000305}.
FT   CONFLICT   1661   1661       I -> T (in Ref. 10; BAE32653).
FT                                {ECO:0000305}.
FT   CONFLICT   1864   1864       V -> D (in Ref. 8; AAK14898).
FT                                {ECO:0000305}.
FT   CONFLICT   1890   1890       S -> R (in Ref. 8; AAK14898).
FT                                {ECO:0000305}.
FT   CONFLICT   1896   1898       APA -> RPG (in Ref. 8; AAK14898).
FT                                {ECO:0000305}.
FT   CONFLICT   1933   1934       AA -> RR (in Ref. 1; CAA77941).
FT                                {ECO:0000305}.
FT   CONFLICT   1938   1938       Missing (in Ref. 1; CAA77941).
FT                                {ECO:0000305}.
FT   CONFLICT   1997   1997       V -> L (in Ref. 3; AAM28905).
FT                                {ECO:0000305}.
FT   CONFLICT   2046   2047       MQ -> IE (in Ref. 1; CAA77941).
FT                                {ECO:0000305}.
FT   CONFLICT   2054   2054       P -> S (in Ref. 1; CAA77941).
FT                                {ECO:0000305}.
FT   CONFLICT   2058   2062       AAREG -> SIRRE (in Ref. 1; CAA77941).
FT                                {ECO:0000305}.
FT   CONFLICT   2075   2075       A -> G (in Ref. 16; CAA57909).
FT                                {ECO:0000305}.
FT   CONFLICT   2086   2086       L -> M (in Ref. 10; BAE34095).
FT                                {ECO:0000305}.
FT   CONFLICT   2136   2136       L -> P (in Ref. 1; CAA77941).
FT                                {ECO:0000305}.
FT   CONFLICT   2172   2172       K -> S (in Ref. 1; CAA77941).
FT                                {ECO:0000305}.
FT   CONFLICT   2179   2179       C -> W (in Ref. 1; CAA77941).
FT                                {ECO:0000305}.
FT   CONFLICT   2185   2185       S -> SS (in Ref. 1; CAA77941).
FT                                {ECO:0000305}.
FT   CONFLICT   2206   2206       P -> H (in Ref. 1; CAA77941).
FT                                {ECO:0000305}.
FT   CONFLICT   2258   2258       P -> H (in Ref. 1; CAA77941).
FT                                {ECO:0000305}.
FT   CONFLICT   2273   2273       S -> C (in Ref. 1; CAA77941).
FT                                {ECO:0000305}.
FT   CONFLICT   2347   2347       N -> S (in Ref. 10; BAE34095).
FT                                {ECO:0000305}.
FT   CONFLICT   2380   2380       Q -> P (in Ref. 1; CAA77941).
FT                                {ECO:0000305}.
FT   CONFLICT   2483   2484       HP -> PT (in Ref. 1; CAA77941).
FT                                {ECO:0000305}.
FT   HELIX       456    458       {ECO:0000244|PDB:5KY0}.
FT   STRAND      462    464       {ECO:0000244|PDB:2RQZ}.
FT   STRAND      466    469       {ECO:0000244|PDB:5KY0}.
FT   STRAND      470    472       {ECO:0000244|PDB:2RR0}.
FT   STRAND      474    477       {ECO:0000244|PDB:5KY0}.
FT   STRAND      482    484       {ECO:0000244|PDB:5KY0}.
FT   STRAND      997   1000       {ECO:0000244|PDB:5KY4}.
FT   STRAND     1005   1008       {ECO:0000244|PDB:5KY4}.
FT   STRAND     1013   1015       {ECO:0000244|PDB:5KY4}.
FT   HELIX      1921   1927       {ECO:0000244|PDB:2QC9}.
FT   HELIX      1931   1939       {ECO:0000244|PDB:2QC9}.
FT   HELIX      1954   1961       {ECO:0000244|PDB:2QC9}.
FT   HELIX      1964   1972       {ECO:0000244|PDB:2QC9}.
FT   HELIX      1975   1977       {ECO:0000244|PDB:1YMP}.
FT   HELIX      1988   1995       {ECO:0000244|PDB:1YMP}.
FT   HELIX      2000   2006       {ECO:0000244|PDB:1YMP}.
FT   HELIX      2021   2027       {ECO:0000244|PDB:1YMP}.
FT   HELIX      2031   2039       {ECO:0000244|PDB:1YMP}.
FT   HELIX      2054   2061       {ECO:0000244|PDB:1YMP}.
FT   HELIX      2064   2072       {ECO:0000244|PDB:1YMP}.
FT   HELIX      2087   2093       {ECO:0000244|PDB:1YMP}.
FT   HELIX      2097   2103       {ECO:0000244|PDB:1YMP}.
SQ   SEQUENCE   2531 AA;  270835 MW;  97C91F69BABF02BF CRC64;
     MPRLLTPLLC LTLLPALAAR GLRCSQPSGT CLNGGRCEVA NGTEACVCSG AFVGQRCQDS
     NPCLSTPCKN AGTCHVVDHG GTVDYACSCP LGFSGPLCLT PLDNACLANP CRNGGTCDLL
     TLTEYKCRCP PGWSGKSCQQ ADPCASNPCA NGGQCLPFES SYICRCPPGF HGPTCRQDVN
     ECSQNPGLCR HGGTCHNEIG SYRCACRATH TGPHCELPYV PCSPSPCQNG GTCRPTGDTT
     HECACLPGFA GQNCEENVDD CPGNNCKNGG ACVDGVNTYN CRCPPEWTGQ YCTEDVDECQ
     LMPNACQNGG TCHNTHGGYN CVCVNGWTGE DCSENIDDCA SAACFQGATC HDRVASFYCE
     CPHGRTGLLC HLNDACISNP CNEGSNCDTN PVNGKAICTC PSGYTGPACS QDVDECALGA
     NPCEHAGKCL NTLGSFECQC LQGYTGPRCE IDVNECISNP CQNDATCLDQ IGEFQCICMP
     GYEGVYCEIN TDECASSPCL HNGHCMDKIN EFQCQCPKGF NGHLCQYDVD ECASTPCKNG
     AKCLDGPNTY TCVCTEGYTG THCEVDIDEC DPDPCHYGSC KDGVATFTCL CQPGYTGHHC
     ETNINECHSQ PCRHGGTCQD RDNSYLCLCL KGTTGPNCEI NLDDCASNPC DSGTCLDKID
     GYECACEPGY TGSMCNVNID ECAGSPCHNG GTCEDGIAGF TCRCPEGYHD PTCLSEVNEC
     NSNPCIHGAC RDGLNGYKCD CAPGWSGTNC DINNNECESN PCVNGGTCKD MTSGYVCTCR
     EGFSGPNCQT NINECASNPC LNQGTCIDDV AGYKCNCPLP YTGATCEVVL APCATSPCKN
     SGVCKESEDY ESFSCVCPTG WQGQTCEVDI NECVKSPCRH GASCQNTNGS YRCLCQAGYT
     GRNCESDIDD CRPNPCHNGG SCTDGINTAF CDCLPGFQGA FCEEDINECA SNPCQNGANC
     TDCVDSYTCT CPVGFNGIHC ENNTPDCTES SCFNGGTCVD GINSFTCLCP PGFTGSYCQY
     DVNECDSRPC LHGGTCQDSY GTYKCTCPQG YTGLNCQNLV RWCDSAPCKN GGRCWQTNTQ
     YHCECRSGWT GVNCDVLSVS CEVAAQKRGI DVTLLCQHGG LCVDEGDKHY CHCQAGYTGS
     YCEDEVDECS PNPCQNGATC TDYLGGFSCK CVAGYHGSNC SEEINECLSQ PCQNGGTCID
     LTNSYKCSCP RGTQGVHCEI NVDDCHPPLD PASRSPKCFN NGTCVDQVGG YTCTCPPGFV
     GERCEGDVNE CLSNPCDPRG TQNCVQRVND FHCECRAGHT GRRCESVING CRGKPCKNGG
     VCAVASNTAR GFICRCPAGF EGATCENDAR TCGSLRCLNG GTCISGPRSP TCLCLGSFTG
     PECQFPASSP CVGSNPCYNQ GTCEPTSENP FYRCLCPAKF NGLLCHILDY SFTGGAGRDI
     PPPQIEEACE LPECQVDAGN KVCNLQCNNH ACGWDGGDCS LNFNDPWKNC TQSLQCWKYF
     SDGHCDSQCN SAGCLFDGFD CQLTEGQCNP LYDQYCKDHF SDGHCDQGCN SAECEWDGLD
     CAEHVPERLA AGTLVLVVLL PPDQLRNNSF HFLRELSHVL HTNVVFKRDA QGQQMIFPYY
     GHEEELRKHP IKRSTVGWAT SSLLPGTSGG RQRRELDPMD IRGSIVYLEI DNRQCVQSSS
     QCFQSATDVA AFLGALASLG SLNIPYKIEA VKSEPVEPPL PSQLHLMYVA AAAFVLLFFV
     GCGVLLSRKR RRQHGQLWFP EGFKVSEASK KKRREPLGED SVGLKPLKNA SDGALMDDNQ
     NEWGDEDLET KKFRFEEPVV LPDLSDQTDH RQWTQQHLDA ADLRMSAMAP TPPQGEVDAD
     CMDVNVRGPD GFTPLMIASC SGGGLETGNS EEEEDAPAVI SDFIYQGASL HNQTDRTGET
     ALHLAARYSR SDAAKRLLEA SADANIQDNM GRTPLHAAVS ADAQGVFQIL LRNRATDLDA
     RMHDGTTPLI LAARLAVEGM LEDLINSHAD VNAVDDLGKS ALHWAAAVNN VDAAVVLLKN
     GANKDMQNNK EETPLFLAAR EGSYETAKVL LDHFANRDIT DHMDRLPRDI AQERMHHDIV
     RLLDEYNLVR SPQLHGTALG GTPTLSPTLC SPNGYLGNLK SATQGKKARK PSTKGLACGS
     KEAKDLKARR KKSQDGKGCL LDSSSMLSPV DSLESPHGYL SDVASPPLLP SPFQQSPSMP
     LSHLPGMPDT HLGISHLNVA AKPEMAALAG GSRLAFEPPP PRLSHLPVAS SASTVLSTNG
     TGAMNFTVGA PASLNGQCEW LPRLQNGMVP SQYNPLRPGV TPGTLSTQAA GLQHSMMGPL
     HSSLSTNTLS PIIYQGLPNT RLATQPHLVQ TQQVQPQNLQ LQPQNLQPPS QPHLSVSSAA
     NGHLGRSFLS GEPSQADVQP LGPSSLPVHT ILPQESQALP TSLPSSMVPP MTTTQFLTPP
     SQHSYSSSPV DNTPSHQLQV PEHPFLTPSP ESPDQWSSSS PHSNISDWSE GISSPPTTMP
     SQITHIPEAF K
//
ID   NOTCH_DROME             Reviewed;        2703 AA.
AC   P07207; O97458; P04154; Q9W4T8;
DT   01-NOV-1986, integrated into UniProtKB/Swiss-Prot.
DT   02-NOV-2001, sequence version 3.
DT   20-DEC-2017, entry version 222.
DE   RecName: Full=Neurogenic locus Notch protein;
DE   Contains:
DE     RecName: Full=Processed neurogenic locus Notch protein;
DE   Flags: Precursor;
GN   Name=N; ORFNames=CG3936;
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha;
OC   Ephydroidea; Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=Oregon-R; TISSUE=Embryo;
RX   PubMed=3935325; DOI=10.1016/0092-8674(85)90229-6;
RA   Wharton K.A., Johansen K.M., Xu T., Artavanis-Tsakonas S.;
RT   "Nucleotide sequence from the neurogenic locus notch implies a gene
RT   product that shares homology with proteins containing EGF-like
RT   repeats.";
RL   Cell 43:567-581(1985).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=Canton-S, and Oregon-R; TISSUE=Embryo;
RX   PubMed=3097517; DOI=10.1128/MCB.6.9.3094;
RA   Kidd S., Kelley M.R., Young M.W.;
RT   "Sequence of the notch locus of Drosophila melanogaster: relationship
RT   of the encoded protein to mammalian clotting and growth factors.";
RL   Mol. Cell. Biol. 6:3094-3108(1986).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley;
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X.,
RA   Brandon R.C., Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D.,
RA   Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G.,
RA   Abril J.F., Agbayani A., An H.-J., Andrews-Pfannkoch C., Baldwin D.,
RA   Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M.,
RA   Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S.,
RA   Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P.,
RA   Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I.,
RA   Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P.,
RA   de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M.,
RA   Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P.,
RA   Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W.,
RA   Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K.,
RA   Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J.,
RA   Hostin D., Houston K.A., Howland T.J., Wei M.-H., Ibegwam C.,
RA   Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A.,
RA   Kimmel B.E., Kodira C.D., Kraft C.L., Kravitz S., Kulp D., Lai Z.,
RA   Lasko P., Lei Y., Levitsky A.A., Li J.H., Li Z., Liang Y., Lin X.,
RA   Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D.,
RA   Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A.,
RA   Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L.,
RA   Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M.,
RA   Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G.,
RA   Reinert K., Remington K., Saunders R.D.C., Scheeler F., Shen H.,
RA   Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E.,
RA   Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X.,
RA   Wang Z.-Y., Wassarman D.A., Weinstock G.M., Weissenbach J.,
RA   Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A.,
RA   Ye J., Yeh R.-F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L.,
RA   Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S.C., Zhu X.,
RA   Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [4]
RP   GENOME REANNOTATION.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q.,
RA   Stapleton M., Yamada C., Ashburner M., Gelbart W.M., Rubin G.M.,
RA   Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a
RT   systematic review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Oregon-R;
RX   PubMed=10731137; DOI=10.1126/science.287.5461.2220;
RA   Benos P.V., Gatt M.K., Ashburner M., Murphy L., Harris D.,
RA   Barrell B.G., Ferraz C., Vidal S., Brun C., Demailles J., Cadieu E.,
RA   Dreano S., Gloux S., Lelaure V., Mottier S., Galibert F., Borkova D.,
RA   Minana B., Kafatos F.C., Louis C., Siden-Kiamos I., Bolshakov S.,
RA   Papagiannakis G., Spanos L., Cox S., Madueno E., de Pablos B.,
RA   Modolell J., Peter A., Schoettler P., Werner M., Mourkioti F.,
RA   Beinert N., Dowe G., Schaefer U., Jaeckle H., Bucheton A.,
RA   Callister D.M., Campbell L.A., Darlamitsou A., Henderson N.S.,
RA   McMillan P.J., Salles C., Tait E.A., Valenti P., Saunders R.D.C.,
RA   Glover D.M.;
RT   "From sequence to chromosome: the tip of the X chromosome of D.
RT   melanogaster.";
RL   Science 287:2220-2222(2000).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-8.
RX   PubMed=3037327; DOI=10.1128/MCB.7.4.1545;
RA   Kelley M.R., Kidd S., Berg R.L., Young M.W.;
RT   "Restriction of P-element insertions at the Notch locus of Drosophila
RT   melanogaster.";
RL   Mol. Cell. Biol. 7:1545-1548(1987).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 2505-2611.
RC   STRAIN=Oregon-R; TISSUE=Embryo;
RX   PubMed=2981631; DOI=10.1016/0092-8674(85)90308-3;
RA   Wharton K.A., Yedvobnick B., Finnerty V.G., Artavanis-Tsakonas S.;
RT   "opa: a novel family of transcribed repeats shared by the Notch locus
RT   and other developmentally regulated loci in D. melanogaster.";
RL   Cell 40:55-62(1985).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 2505-2604.
RX   PubMed=2780284; DOI=10.1093/nar/17.16.6463;
RA   Tautz D.;
RT   "Hypervariability of simple sequences as a general source for
RT   polymorphic DNA markers.";
RL   Nucleic Acids Res. 17:6463-6471(1989).
RN   [9]
RP   INTERACTION WITH DX, AND MUTANT SU42C.
RX   PubMed=8162848;
RA   Diederich R.J., Matsuno K., Hing H., Artavanis-Tsakonas S.;
RT   "Cytosolic interaction between deltex and Notch ankyrin repeats
RT   implicates deltex in the Notch signaling pathway.";
RL   Development 120:473-481(1994).
RN   [10]
RP   INTERACTION WITH DX.
RX   PubMed=7671825;
RA   Matsuno K., Diederich R.J., Go M.J., Blaumueller C.M.,
RA   Artavanis-Tsakonas S.;
RT   "Deltex acts as a positive regulator of Notch signaling through
RT   interactions with the Notch ankyrin repeats.";
RL   Development 121:2633-2644(1995).
RN   [11]
RP   S3 CLEAVAGE BY PSN.
RX   PubMed=10206646; DOI=10.1038/19091;
RA   Struhl G., Greenwald I.;
RT   "Presenilin is required for activity and nuclear access of Notch in
RT   Drosophila.";
RL   Nature 398:522-525(1999).
RN   [12]
RP   S3 CLEAVAGE BY PSN.
RX   PubMed=10206647; DOI=10.1038/19096;
RA   Ye Y., Lukinova N., Fortini M.E.;
RT   "Neurogenic phenotypes and altered Notch processing in Drosophila
RT   Presenilin mutants.";
RL   Nature 398:525-529(1999).
RN   [13]
RP   FUNCTION, AND INTERACTION WITH DL.
RX   PubMed=10935637; DOI=10.1038/35019075;
RA   Bruckner K., Perez L., Clausen H., Cohen S.;
RT   "Glycosyltransferase activity of Fringe modulates Notch-Delta
RT   interactions.";
RL   Nature 406:411-415(2000).
RN   [14]
RP   MUTANT MCD5.
RX   PubMed=11719214; DOI=10.1016/S0960-9822(01)00562-0;
RA   Ramain P., Khechumian K., Seugnet L., Arbogast N., Ackermann C.,
RA   Heitzler P.;
RT   "Novel Notch alleles reveal a Deltex-dependent pathway repressing
RT   neural fate.";
RL   Curr. Biol. 11:1729-1738(2001).
RN   [15]
RP   S2 CLEAVAGE BY KUZ.
RX   PubMed=11799064; DOI=10.1101/gad.942302;
RA   Lieber T., Kidd S., Young M.W.;
RT   "Kuzbanian-mediated cleavage of Drosophila Notch.";
RL   Genes Dev. 16:209-221(2002).
RN   [16]
RP   REVIEW.
RX   PubMed=12369105; DOI=10.1034/j.1601-5223.2002.1360201.x;
RA   Portin P.;
RT   "General outlines of the molecular genetics of the Notch signalling
RT   pathway in Drosophila melanogaster: a review.";
RL   Hereditas 136:89-96(2002).
RN   [17]
RP   GLYCOSYLATION, AND LIGAND-BINDING.
RX   PubMed=12909620; DOI=10.1074/jbc.M308687200;
RA   Okajima T., Xu A., Irvine K.D.;
RT   "Modulation of notch-ligand binding by protein O-fucosyltransferase 1
RT   and fringe.";
RL   J. Biol. Chem. 278:42340-42345(2003).
RN   [18]
RP   INTERACTION WITH NEDD4, UBIQUITINATION, AND MUTAGENESIS OF TYR-2328.
RX   PubMed=15620649; DOI=10.1016/j.cub.2004.12.028;
RA   Sakata T., Sakaguchi H., Tsuda L., Higashitani A., Aigaki T.,
RA   Matsuno K., Hayashi S.;
RT   "Drosophila Nedd4 regulates endocytosis of notch and suppresses its
RT   ligand-independent activation.";
RL   Curr. Biol. 14:2228-2236(2004).
RN   [19]
RP   INTERACTION WITH SU(DX).
RX   PubMed=15620650; DOI=10.1016/j.cub.2004.11.030;
RA   Wilkin M.B., Carbery A.-M., Fostier M., Aslam H., Mazaleyrat S.L.,
RA   Higgs J., Myat A., Evans D.A.P., Cornell M., Baron M.;
RT   "Regulation of notch endosomal sorting and signaling by Drosophila
RT   Nedd4 family proteins.";
RL   Curr. Biol. 14:2237-2244(2004).
RN   [20]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH O-FUT1.
RX   PubMed=17329366; DOI=10.1242/dev.02811;
RA   Sasamura T., Ishikawa H.O., Sasaki N., Higashi S., Kanai M., Nakao S.,
RA   Ayukawa T., Aigaki T., Noda K., Miyoshi E., Taniguchi N., Matsuno K.;
RT   "The O-fucosyltransferase O-fut1 is an extracellular component that is
RT   essential for the constitutive endocytic trafficking of Notch in
RT   Drosophila.";
RL   Development 134:1347-1356(2007).
RN   [21]
RP   FUNCTION.
RX   PubMed=18243100; DOI=10.1016/j.cell.2007.12.016;
RA   Acar M., Jafar-Nejad H., Takeuchi H., Rajan A., Ibrani D., Rana N.A.,
RA   Pan H., Haltiwanger R.S., Bellen H.J.;
RT   "Rumi is a CAP10 domain glycosyltransferase that modifies Notch and is
RT   required for Notch signaling.";
RL   Cell 132:247-258(2008).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2447, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY.
RC   TISSUE=Embryo;
RX   PubMed=18327897; DOI=10.1021/pr700696a;
RA   Zhai B., Villen J., Beausoleil S.A., Mintseris J., Gygi S.P.;
RT   "Phosphoproteome analysis of Drosophila melanogaster embryos.";
RL   J. Proteome Res. 7:1675-1682(2008).
RN   [23]
RP   GLYCOSYLATION AT THR-72; THR-110; THR-153; SER-183; THR-191; THR-210;
RP   SER-223; THR-231; THR-307; THR-348; THR-386; SER-427; THR-481;
RP   SER-494; SER-502; THR-519; SER-532; SER-570; THR-595; SER-608;
RP   SER-645; SER-683; THR-691; SER-721; SER-759; SER-797; THR-805;
RP   THR-822; THR-843; SER-922; SER-952; THR-960; SER-990; THR-998;
RP   SER-1036; SER-1066; THR-1074; THR-1112; SER-1189; THR-1197; THR-1235;
RP   SER-1273; SER-1303 AND SER-1381.
RX   PubMed=27268051; DOI=10.1074/jbc.M116.732537;
RA   Harvey B.M., Rana N.A., Moss H., Leonardi J., Jafar-Nejad H.,
RA   Haltiwanger R.S.;
RT   "Mapping sites of O-glycosylation and fringe elongation on Drosophila
RT   Notch.";
RL   J. Biol. Chem. 291:16348-16360(2016).
RN   [24]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 1901-2139, DOMAIN ANK
RP   REPEATS, AND SUBUNIT.
RX   PubMed=14573873; DOI=10.1110/ps.03279003;
RA   Zweifel M.E., Leahy D.J., Hughson F.M., Barrick D.;
RT   "Structure and stability of the ankyrin domain of the Drosophila Notch
RT   receptor.";
RL   Protein Sci. 12:2622-2632(2003).
CC   -!- FUNCTION: Signaling protein, which regulates, with both positive
CC       and negative signals, the differentiation of at least central and
CC       peripheral nervous system and eye, wing disk, oogenesis, segmental
CC       appendages such as antennae and legs, and muscles, through lateral
CC       inhibition or induction. Functions as a receptor for membrane-
CC       bound ligands Delta and Serrate to regulate cell-fate
CC       determination. Upon ligand activation, and releasing from the cell
CC       membrane, the Notch intracellular domain (NICD) forms a
CC       transcriptional activator complex with Su(H) (Suppressor of
CC       hairless) and activates genes of the E(spl) complex. Essential for
CC       proper differentiation of ectoderm. Fringe (fng) acts in the Golgi
CC       to determine the type of O-linked fucose on the EGF modules in N,
CC       altering the ability of N to bind with Delta (Dl). O-fut1 also has
CC       a role in modulating the interaction. Rumi acts in the endoplasmic
CC       reticulum to glucosylate the EGF modules in N, this is required
CC       for correct folding and cleavage of N.
CC       {ECO:0000269|PubMed:10935637, ECO:0000269|PubMed:18243100}.
CC   -!- SUBUNIT: Homomer. Interacts with Su(H) when activated. Interacts
CC       with Dx via its ANK repeats. Interacts with Dl via the EGF repeats
CC       and the Dl EGF repeats. Interacts with Nedd4 and Su(dx). Interacts
CC       with O-fut1; the interaction glycosylates N and transports N to
CC       early endosomes. {ECO:0000269|PubMed:10935637,
CC       ECO:0000269|PubMed:14573873, ECO:0000269|PubMed:15620649,
CC       ECO:0000269|PubMed:15620650, ECO:0000269|PubMed:17329366,
CC       ECO:0000269|PubMed:7671825, ECO:0000269|PubMed:8162848}.
CC   -!- INTERACTION:
CC       Q24279:cno; NbExp=3; IntAct=EBI-103438, EBI-868783;
CC       P10041:Dl; NbExp=2; IntAct=EBI-103438, EBI-115346;
CC       Q23985:dx; NbExp=4; IntAct=EBI-103438, EBI-190618;
CC       P28159:Su(H); NbExp=7; IntAct=EBI-103438, EBI-92180;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:17329366};
CC       Single-pass type I membrane protein {ECO:0000269|PubMed:17329366}.
CC       Endosome {ECO:0000269|PubMed:17329366}. Note=Transported to early
CC       endosomes by O-fut1 (PubMed:17329366).
CC   -!- SUBCELLULAR LOCATION: Processed neurogenic locus Notch protein:
CC       Nucleus. Note=Upon activation and S3 cleavage, it is released from
CC       the cell membrane and enters into the nucleus in conjunction with
CC       Su(H).
CC   -!- DOMAIN: Crystal structure of the ANK repeat domain shows that
CC       there are 7 repeats and the stabilizing C-terminal repeat enhances
CC       the protein stability by extending the ankyrin domain.
CC       {ECO:0000269|PubMed:14573873}.
CC   -!- PTM: Upon binding its ligands such as Delta or Serrate, it is
CC       cleaved (S2 cleavage) in its extracellular domain, close to the
CC       transmembrane domain. S2 cleavage is probably mediated by Kuz. It
CC       is then cleaved (S3 cleavage) downstream of its transmembrane
CC       domain, releasing it from the cell membrane. S3 cleavage requires
CC       Psn.
CC   -!- PTM: O-glycosylated (PubMed:12909620, PubMed:27268051). Three
CC       forms of O-glycosylation, O-fucosylation, O-glucosylation and O-
CC       GlcNAcylation, are detected (PubMed:27268051). O-fucosylated by O-
CC       fut1 in the EGF repeat domain which inhibits both Serrate/Ser- and
CC       Delta/Dl-binding (PubMed:12909620). {ECO:0000269|PubMed:12909620,
CC       ECO:0000269|PubMed:27268051}.
CC   -!- PTM: Ubiquitinated by Nedd4; which promotes ligand-independent
CC       endocytosis and proteasomal degradation. May also be ubiquitinated
CC       by Su(dx). {ECO:0000269|PubMed:15620649}.
CC   -!- SIMILARITY: Belongs to the NOTCH family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M16152; AAB59220.1; -; Genomic_DNA.
DR   EMBL; M16153; AAB59220.1; JOINED; Genomic_DNA.
DR   EMBL; M16149; AAB59220.1; JOINED; Genomic_DNA.
DR   EMBL; M16150; AAB59220.1; JOINED; Genomic_DNA.
DR   EMBL; M16151; AAB59220.1; JOINED; Genomic_DNA.
DR   EMBL; K03508; AAA28725.1; -; Genomic_DNA.
DR   EMBL; M13689; AAA28725.1; JOINED; Genomic_DNA.
DR   EMBL; K03507; AAA28725.1; JOINED; Genomic_DNA.
DR   EMBL; AE014298; AAF45848.2; -; Genomic_DNA.
DR   EMBL; AL035436; CAB37610.1; -; Genomic_DNA.
DR   EMBL; AL035395; CAB37610.1; JOINED; Genomic_DNA.
DR   EMBL; M16025; AAA28726.1; -; Genomic_DNA.
DR   EMBL; M12175; AAA74496.1; -; Genomic_DNA.
DR   PIR; A24420; A24420.
DR   RefSeq; NP_001245510.1; NM_001258581.2.
DR   RefSeq; NP_476859.2; NM_057511.4.
DR   PDB; 1OT8; X-ray; 2.00 A; A/B/C=1902-2139.
DR   PDB; 2JMF; NMR; -; B=2318-2333.
DR   PDBsum; 1OT8; -.
DR   PDBsum; 2JMF; -.
DR   ProteinModelPortal; P07207; -.
DR   SMR; P07207; -.
DR   BioGrid; 57823; 284.
DR   DIP; DIP-5N; -.
DR   IntAct; P07207; 231.
DR   MINT; MINT-133064; -.
DR   STRING; 7227.FBpp0070483; -.
DR   iPTMnet; P07207; -.
DR   PaxDb; P07207; -.
DR   PRIDE; P07207; -.
DR   EnsemblMetazoa; FBtr0070507; FBpp0070483; FBgn0004647.
DR   EnsemblMetazoa; FBtr0304659; FBpp0293201; FBgn0004647.
DR   GeneID; 31293; -.
DR   KEGG; dme:Dmel_CG3936; -.
DR   CTD; 109544; -.
DR   FlyBase; FBgn0004647; N.
DR   eggNOG; ENOG410IR7G; Eukaryota.
DR   eggNOG; COG0666; LUCA.
DR   GeneTree; ENSGT00810000125346; -.
DR   InParanoid; P07207; -.
DR   KO; K02599; -.
DR   OMA; QYVNSYT; -.
DR   OrthoDB; EOG091G01NU; -.
DR   PhylomeDB; P07207; -.
DR   Reactome; R-DME-1912420; Pre-NOTCH Processing in Golgi.
DR   Reactome; R-DME-1980148; Signaling by NOTCH3.
DR   Reactome; R-DME-1980150; Signaling by NOTCH4.
DR   Reactome; R-DME-2122948; Activated NOTCH1 Transmits Signal to the Nucleus.
DR   Reactome; R-DME-2979096; NOTCH2 Activation and Transmission of Signal to the Nucleus.
DR   Reactome; R-DME-8941856; RUNX3 regulates NOTCH signaling.
DR   SignaLink; P07207; -.
DR   ChiTaRS; N; fly.
DR   EvolutionaryTrace; P07207; -.
DR   GenomeRNAi; 31293; -.
DR   PRO; PR:P07207; -.
DR   Proteomes; UP000000803; Chromosome X.
DR   Bgee; FBgn0004647; -.
DR   ExpressionAtlas; P07207; differential.
DR   Genevisible; P07207; DM.
DR   GO; GO:0005912; C:adherens junction; IDA:FlyBase.
DR   GO; GO:0009986; C:cell surface; IDA:FlyBase.
DR   GO; GO:0005737; C:cytoplasm; IDA:FlyBase.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0030139; C:endocytic vesicle; IDA:FlyBase.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome.
DR   GO; GO:0005768; C:endosome; IDA:FlyBase.
DR   GO; GO:0005796; C:Golgi lumen; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; TAS:FlyBase.
DR   GO; GO:0005622; C:intracellular; IDA:FlyBase.
DR   GO; GO:0005770; C:late endosome; IDA:FlyBase.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:FlyBase.
DR   GO; GO:0005886; C:plasma membrane; IDA:FlyBase.
DR   GO; GO:0043234; C:protein complex; IPI:FlyBase.
DR   GO; GO:0035003; C:subapical complex; IDA:FlyBase.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0003682; F:chromatin binding; IDA:FlyBase.
DR   GO; GO:0004872; F:receptor activity; TAS:FlyBase.
DR   GO; GO:0004888; F:transmembrane signaling receptor activity; TAS:FlyBase.
DR   GO; GO:0007015; P:actin filament organization; IMP:FlyBase.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; TAS:FlyBase.
DR   GO; GO:0008356; P:asymmetric cell division; TAS:FlyBase.
DR   GO; GO:0007411; P:axon guidance; IMP:FlyBase.
DR   GO; GO:0007298; P:border follicle cell migration; IMP:FlyBase.
DR   GO; GO:0007155; P:cell adhesion; TAS:FlyBase.
DR   GO; GO:0043697; P:cell dedifferentiation; IGI:UniProtKB.
DR   GO; GO:0001708; P:cell fate specification; TAS:FlyBase.
DR   GO; GO:0022416; P:chaeta development; IMP:FlyBase.
DR   GO; GO:0008407; P:chaeta morphogenesis; IMP:FlyBase.
DR   GO; GO:0042676; P:compound eye cone cell fate commitment; TAS:FlyBase.
DR   GO; GO:0048749; P:compound eye development; IMP:FlyBase.
DR   GO; GO:0001745; P:compound eye morphogenesis; IMP:FlyBase.
DR   GO; GO:0046667; P:compound eye retinal cell programmed cell death; TAS:FlyBase.
DR   GO; GO:0042688; P:crystal cell differentiation; IMP:FlyBase.
DR   GO; GO:0002213; P:defense response to insect; IDA:FlyBase.
DR   GO; GO:0008340; P:determination of adult lifespan; IMP:FlyBase.
DR   GO; GO:0046843; P:dorsal appendage formation; IMP:FlyBase.
DR   GO; GO:0007391; P:dorsal closure; TAS:FlyBase.
DR   GO; GO:0009950; P:dorsal/ventral axis specification; IMP:FlyBase.
DR   GO; GO:0007451; P:dorsal/ventral lineage restriction, imaginal disc; TAS:FlyBase.
DR   GO; GO:0007450; P:dorsal/ventral pattern formation, imaginal disc; TAS:FlyBase.
DR   GO; GO:0007398; P:ectoderm development; TAS:FlyBase.
DR   GO; GO:0035165; P:embryonic crystal cell differentiation; TAS:FlyBase.
DR   GO; GO:0035162; P:embryonic hemopoiesis; IMP:FlyBase.
DR   GO; GO:0061331; P:epithelial cell proliferation involved in Malpighian tubule morphogenesis; IMP:FlyBase.
DR   GO; GO:0035153; P:epithelial cell type specification, open tracheal system; IMP:FlyBase.
DR   GO; GO:0060429; P:epithelium development; IMP:FlyBase.
DR   GO; GO:0042067; P:establishment of ommatidial planar polarity; TAS:FlyBase.
DR   GO; GO:0035214; P:eye-antennal disc development; IMP:FlyBase.
DR   GO; GO:0036099; P:female germ-line stem cell population maintenance; IMP:FlyBase.
DR   GO; GO:0007440; P:foregut morphogenesis; IMP:FlyBase.
DR   GO; GO:0060288; P:formation of a compartment boundary; IMP:FlyBase.
DR   GO; GO:0030718; P:germ-line stem cell population maintenance; IMP:FlyBase.
DR   GO; GO:0060250; P:germ-line stem-cell niche homeostasis; IMP:FlyBase.
DR   GO; GO:0007293; P:germarium-derived egg chamber formation; IMP:FlyBase.
DR   GO; GO:0030708; P:germarium-derived female germ-line cyst encapsulation; TAS:FlyBase.
DR   GO; GO:0010001; P:glial cell differentiation; IMP:FlyBase.
DR   GO; GO:0007403; P:glial cell fate determination; IMP:FlyBase.
DR   GO; GO:0008347; P:glial cell migration; IMP:FlyBase.
DR   GO; GO:0035172; P:hemocyte proliferation; IMP:FlyBase.
DR   GO; GO:0007157; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; IDA:FlyBase.
DR   GO; GO:0007446; P:imaginal disc growth; TAS:FlyBase.
DR   GO; GO:0007447; P:imaginal disc pattern formation; TAS:FlyBase.
DR   GO; GO:0016348; P:imaginal disc-derived leg joint morphogenesis; IMP:FlyBase.
DR   GO; GO:0036011; P:imaginal disc-derived leg segmentation; IMP:FlyBase.
DR   GO; GO:0048803; P:imaginal disc-derived male genitalia morphogenesis; IMP:FlyBase.
DR   GO; GO:0008587; P:imaginal disc-derived wing margin morphogenesis; IMP:FlyBase.
DR   GO; GO:0007476; P:imaginal disc-derived wing morphogenesis; IMP:FlyBase.
DR   GO; GO:0007474; P:imaginal disc-derived wing vein specification; IMP:FlyBase.
DR   GO; GO:0036335; P:intestinal stem cell homeostasis; IMP:FlyBase.
DR   GO; GO:0035171; P:lamellocyte differentiation; IMP:FlyBase.
DR   GO; GO:0035167; P:larval lymph gland hemopoiesis; IMP:FlyBase.
DR   GO; GO:0046331; P:lateral inhibition; IMP:FlyBase.
DR   GO; GO:0007478; P:leg disc morphogenesis; TAS:FlyBase.
DR   GO; GO:0007616; P:long-term memory; IMP:FlyBase.
DR   GO; GO:0035170; P:lymph gland crystal cell differentiation; TAS:FlyBase.
DR   GO; GO:0048542; P:lymph gland development; IMP:FlyBase.
DR   GO; GO:0061382; P:Malpighian tubule tip cell differentiation; IMP:FlyBase.
DR   GO; GO:0007498; P:mesoderm development; IMP:FlyBase.
DR   GO; GO:0016333; P:morphogenesis of follicular epithelium; NAS:FlyBase.
DR   GO; GO:0008045; P:motor neuron axon guidance; IMP:FlyBase.
DR   GO; GO:0007521; P:muscle cell fate determination; IMP:FlyBase.
DR   GO; GO:2000048; P:negative regulation of cell-cell adhesion mediated by cadherin; IMP:FlyBase.
DR   GO; GO:0045316; P:negative regulation of compound eye photoreceptor development; IMP:FlyBase.
DR   GO; GO:0035157; P:negative regulation of fusion cell fate specification; TAS:FlyBase.
DR   GO; GO:0010629; P:negative regulation of gene expression; IMP:UniProtKB.
DR   GO; GO:0046329; P:negative regulation of JNK cascade; NAS:FlyBase.
DR   GO; GO:0035204; P:negative regulation of lamellocyte differentiation; IMP:FlyBase.
DR   GO; GO:0050768; P:negative regulation of neurogenesis; IMP:FlyBase.
DR   GO; GO:0035155; P:negative regulation of terminal cell fate specification, open tracheal system; TAS:FlyBase.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:FlyBase.
DR   GO; GO:0050877; P:nervous system process; IMP:FlyBase.
DR   GO; GO:0014019; P:neuroblast development; IMP:UniProtKB.
DR   GO; GO:0007400; P:neuroblast fate determination; IDA:FlyBase.
DR   GO; GO:0007405; P:neuroblast proliferation; IMP:UniProtKB.
DR   GO; GO:0048666; P:neuron development; IMP:FlyBase.
DR   GO; GO:0097150; P:neuronal stem cell population maintenance; IMP:FlyBase.
DR   GO; GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0007314; P:oocyte anterior/posterior axis specification; TAS:FlyBase.
DR   GO; GO:0030720; P:oocyte localization involved in germarium-derived egg chamber formation; IMP:FlyBase.
DR   GO; GO:0048477; P:oogenesis; IMP:FlyBase.
DR   GO; GO:0007424; P:open tracheal system development; TAS:FlyBase.
DR   GO; GO:0030707; P:ovarian follicle cell development; IMP:FlyBase.
DR   GO; GO:0007297; P:ovarian follicle cell migration; IMP:FlyBase.
DR   GO; GO:0030713; P:ovarian follicle cell stalk formation; IMP:FlyBase.
DR   GO; GO:0007422; P:peripheral nervous system development; IMP:FlyBase.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IMP:FlyBase.
DR   GO; GO:0042691; P:positive regulation of crystal cell differentiation; IMP:FlyBase.
DR   GO; GO:1900087; P:positive regulation of G1/S transition of mitotic cell cycle; IMP:FlyBase.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:UniProtKB.
DR   GO; GO:0002052; P:positive regulation of neuroblast proliferation; IMP:UniProtKB.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; IMP:FlyBase.
DR   GO; GO:0045747; P:positive regulation of Notch signaling pathway; IMP:FlyBase.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:FlyBase.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:FlyBase.
DR   GO; GO:0048052; P:R1/R6 cell differentiation; IMP:FlyBase.
DR   GO; GO:0007464; P:R3/R4 cell fate commitment; NAS:FlyBase.
DR   GO; GO:0045466; P:R7 cell differentiation; IMP:FlyBase.
DR   GO; GO:0045463; P:R8 cell development; TAS:FlyBase.
DR   GO; GO:0045465; P:R8 cell differentiation; NAS:FlyBase.
DR   GO; GO:0007460; P:R8 cell fate commitment; TAS:FlyBase.
DR   GO; GO:0042686; P:regulation of cardioblast cell fate specification; IMP:FlyBase.
DR   GO; GO:0045595; P:regulation of cell differentiation; IMP:FlyBase.
DR   GO; GO:0042689; P:regulation of crystal cell differentiation; TAS:FlyBase.
DR   GO; GO:0051489; P:regulation of filopodium assembly; IMP:FlyBase.
DR   GO; GO:0010906; P:regulation of glucose metabolic process; IMP:FlyBase.
DR   GO; GO:0006110; P:regulation of glycolytic process; IMP:FlyBase.
DR   GO; GO:0040008; P:regulation of growth; IMP:FlyBase.
DR   GO; GO:0007346; P:regulation of mitotic cell cycle; TAS:FlyBase.
DR   GO; GO:1902692; P:regulation of neuroblast proliferation; IMP:UniProtKB.
DR   GO; GO:0050767; P:regulation of neurogenesis; IMP:FlyBase.
DR   GO; GO:0045468; P:regulation of R8 cell spacing in compound eye; NAS:FlyBase.
DR   GO; GO:0009608; P:response to symbiont; IMP:FlyBase.
DR   GO; GO:0046666; P:retinal cell programmed cell death; TAS:FlyBase.
DR   GO; GO:0016330; P:second mitotic wave involved in compound eye morphogenesis; IMP:FlyBase.
DR   GO; GO:0007423; P:sensory organ development; IMP:FlyBase.
DR   GO; GO:0016360; P:sensory organ precursor cell fate determination; IMP:FlyBase.
DR   GO; GO:0007519; P:skeletal muscle tissue development; IMP:FlyBase.
DR   GO; GO:0048863; P:stem cell differentiation; IMP:FlyBase.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0007419; P:ventral cord development; NAS:FlyBase.
DR   GO; GO:0048190; P:wing disc dorsal/ventral pattern formation; IMP:FlyBase.
DR   GO; GO:0035222; P:wing disc pattern formation; IMP:FlyBase.
DR   GO; GO:0007473; P:wing disc proximal/distal pattern formation; TAS:FlyBase.
DR   CDD; cd00204; ANK; 2.
DR   Gene3D; 1.25.40.20; -; 3.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR024600; DUF3454_notch.
DR   InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR000152; EGF-type_Asp/Asn_hydroxyl_site.
DR   InterPro; IPR018097; EGF_Ca-bd_CS.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   InterPro; IPR008297; Notch.
DR   InterPro; IPR035993; Notch-like_dom_sf.
DR   InterPro; IPR000800; Notch_dom.
DR   InterPro; IPR010660; Notch_NOD_dom.
DR   InterPro; IPR011656; Notch_NODP_dom.
DR   Pfam; PF12796; Ank_2; 2.
DR   Pfam; PF11936; DUF3454; 1.
DR   Pfam; PF00008; EGF; 24.
DR   Pfam; PF07645; EGF_CA; 4.
DR   Pfam; PF12661; hEGF; 2.
DR   Pfam; PF06816; NOD; 1.
DR   Pfam; PF07684; NODP; 1.
DR   Pfam; PF00066; Notch; 3.
DR   PIRSF; PIRSF002279; Notch; 1.
DR   PRINTS; PR01452; LNOTCHREPEAT.
DR   SMART; SM00248; ANK; 7.
DR   SMART; SM01334; DUF3454; 1.
DR   SMART; SM00181; EGF; 36.
DR   SMART; SM00179; EGF_CA; 33.
DR   SMART; SM00004; NL; 3.
DR   SMART; SM01338; NOD; 1.
DR   SMART; SM01339; NODP; 1.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   SUPFAM; SSF57184; SSF57184; 5.
DR   SUPFAM; SSF90193; SSF90193; 3.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 5.
DR   PROSITE; PS00010; ASX_HYDROXYL; 22.
DR   PROSITE; PS00022; EGF_1; 34.
DR   PROSITE; PS01186; EGF_2; 28.
DR   PROSITE; PS50026; EGF_3; 36.
DR   PROSITE; PS01187; EGF_CA; 21.
DR   PROSITE; PS50258; LNR; 3.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; ANK repeat; Cell membrane; Complete proteome;
KW   Developmental protein; Differentiation; Disulfide bond;
KW   EGF-like domain; Endosome; Glycoprotein; Membrane; Neurogenesis;
KW   Notch signaling pathway; Nucleus; Oogenesis; Phosphoprotein;
KW   Polymorphism; Receptor; Reference proteome; Repeat; Signal;
KW   Transcription; Transcription regulation; Transmembrane;
KW   Transmembrane helix; Ubl conjugation.
FT   SIGNAL        1     52       {ECO:0000255}.
FT   CHAIN        53   2703       Neurogenic locus Notch protein.
FT                                /FTId=PRO_0000007673.
FT   CHAIN         ?   2703       Processed neurogenic locus Notch protein.
FT                                /FTId=PRO_0000296234.
FT   TOPO_DOM     53   1745       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1746   1766       Helical. {ECO:0000255}.
FT   TOPO_DOM   1767   2703       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       58     95       EGF-like 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN       96    136       EGF-like 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      139    176       EGF-like 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      177    215       EGF-like 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      217    253       EGF-like 5; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      255    291       EGF-like 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      293    329       EGF-like 7; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      331    370       EGF-like 8; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      372    408       EGF-like 9; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      409    447       EGF-like 10. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      449    486       EGF-like 11; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      488    524       EGF-like 12; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      526    562       EGF-like 13; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      564    600       EGF-like 14; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      602    637       EGF-like 15; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      639    675       EGF-like 16; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      677    713       EGF-like 17; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      715    751       EGF-like 18; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      753    789       EGF-like 19; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      791    827       EGF-like 20; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      829    865       EGF-like 21; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      867    905       EGF-like 22. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      907    944       EGF-like 23; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      946    982       EGF-like 24; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      984   1020       EGF-like 25. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN     1022   1058       EGF-like 26; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN     1060   1096       EGF-like 27. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN     1098   1134       EGF-like 28. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN     1136   1181       EGF-like 29. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN     1183   1219       EGF-like 30; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN     1221   1257       EGF-like 31; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN     1259   1295       EGF-like 32; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN     1297   1335       EGF-like 33. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN     1337   1373       EGF-like 34. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN     1375   1412       EGF-like 35. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN     1415   1451       EGF-like 36. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   REPEAT     1482   1521       LNR 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00525}.
FT   REPEAT     1522   1557       LNR 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00525}.
FT   REPEAT     1559   1599       LNR 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00525}.
FT   REPEAT     1901   1945       ANK 1. {ECO:0000255}.
FT   REPEAT     1950   1979       ANK 2. {ECO:0000255}.
FT   REPEAT     1983   2013       ANK 3. {ECO:0000255}.
FT   REPEAT     2017   2046       ANK 4. {ECO:0000255}.
FT   REPEAT     2050   2079       ANK 5. {ECO:0000255}.
FT   REPEAT     2083   2112       ANK 6. {ECO:0000255}.
FT   REPEAT     2116   2139       ANK 7. {ECO:0000255}.
FT   REGION     2325   2328       Interaction with Nedd4.
FT   COMPBIAS   2264   2277       Ala-rich. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00001}.
FT   COMPBIAS   2369   2498       Gly-rich. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00008}.
FT   COMPBIAS   2533   2568       Gln-rich. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00006}.
FT   COMPBIAS   2587   2675       Ser-rich. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00016}.
FT   MOD_RES    2447   2447       Phosphoserine.
FT                                {ECO:0000269|PubMed:18327897}.
FT   CARBOHYD     72     72       O-linked (Fuc...) threonine.
FT                                {ECO:0000269|PubMed:27268051}.
FT   CARBOHYD    110    110       O-linked (Fuc...) threonine.
FT                                {ECO:0000269|PubMed:27268051}.
FT   CARBOHYD    153    153       O-linked (Fuc...) threonine.
FT                                {ECO:0000269|PubMed:27268051}.
FT   CARBOHYD    183    183       O-linked (Glc...) serine.
FT                                {ECO:0000269|PubMed:27268051}.
FT   CARBOHYD    191    191       O-linked (Fuc...) threonine.
FT                                {ECO:0000269|PubMed:27268051}.
FT   CARBOHYD    210    210       O-linked (GlcNAc...) threonine.
FT                                {ECO:0000269|PubMed:27268051}.
FT   CARBOHYD    223    223       O-linked (Glc...) serine.
FT                                {ECO:0000269|PubMed:27268051}.
FT   CARBOHYD    231    231       O-linked (Fuc...) threonine.
FT                                {ECO:0000269|PubMed:27268051}.
FT   CARBOHYD    307    307       O-linked (Fuc...) threonine.
FT                                {ECO:0000269|PubMed:27268051}.
FT   CARBOHYD    322    322       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    348    348       O-linked (Fuc...) threonine.
FT                                {ECO:0000269|PubMed:27268051}.
FT   CARBOHYD    371    371       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    386    386       O-linked (Fuc...) threonine.
FT                                {ECO:0000269|PubMed:27268051}.
FT   CARBOHYD    427    427       O-linked (Glc...) serine.
FT                                {ECO:0000269|PubMed:27268051}.
FT   CARBOHYD    430    430       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    475    475       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    481    481       O-linked (GlcNAc...) threonine.
FT                                {ECO:0000269|PubMed:27268051}.
FT   CARBOHYD    494    494       O-linked (Glc...) serine.
FT                                {ECO:0000269|PubMed:27268051}.
FT   CARBOHYD    502    502       O-linked (Fuc...) serine.
FT                                {ECO:0000269|PubMed:27268051}.
FT   CARBOHYD    519    519       O-linked (GlcNAc...) threonine.
FT                                {ECO:0000269|PubMed:27268051}.
FT   CARBOHYD    532    532       O-linked (Glc...) serine.
FT                                {ECO:0000269|PubMed:27268051}.
FT   CARBOHYD    570    570       O-linked (Glc...) serine.
FT                                {ECO:0000269|PubMed:27268051}.
FT   CARBOHYD    595    595       O-linked (GlcNAc...) threonine.
FT                                {ECO:0000269|PubMed:27268051}.
FT   CARBOHYD    608    608       O-linked (Glc...) serine.
FT                                {ECO:0000269|PubMed:27268051}.
FT   CARBOHYD    645    645       O-linked (Glc...) serine.
FT                                {ECO:0000269|PubMed:27268051}.
FT   CARBOHYD    683    683       O-linked (Glc...) serine.
FT                                {ECO:0000269|PubMed:27268051}.
FT   CARBOHYD    691    691       O-linked (Fuc...) threonine.
FT                                {ECO:0000269|PubMed:27268051}.
FT   CARBOHYD    721    721       O-linked (Glc...) serine.
FT                                {ECO:0000269|PubMed:27268051}.
FT   CARBOHYD    759    759       O-linked (Glc...) serine.
FT                                {ECO:0000269|PubMed:27268051}.
FT   CARBOHYD    797    797       O-linked (Glc...) serine.
FT                                {ECO:0000269|PubMed:27268051}.
FT   CARBOHYD    805    805       O-linked (Fuc...) threonine.
FT                                {ECO:0000269|PubMed:27268051}.
FT   CARBOHYD    822    822       O-linked (GlcNAc...) threonine.
FT                                {ECO:0000269|PubMed:27268051}.
FT   CARBOHYD    843    843       O-linked (Fuc...) threonine.
FT                                {ECO:0000269|PubMed:27268051}.
FT   CARBOHYD    922    922       O-linked (Fuc...) serine.
FT                                {ECO:0000269|PubMed:27268051}.
FT   CARBOHYD    952    952       O-linked (Glc...) serine.
FT                                {ECO:0000269|PubMed:27268051}.
FT   CARBOHYD    960    960       O-linked (Fuc...) threonine.
FT                                {ECO:0000269|PubMed:27268051}.
FT   CARBOHYD    990    990       O-linked (Glc...) serine.
FT                                {ECO:0000269|PubMed:27268051}.
FT   CARBOHYD    998    998       O-linked (Fuc...) threonine.
FT                                {ECO:0000269|PubMed:27268051}.
FT   CARBOHYD   1036   1036       O-linked (Fuc...) serine.
FT                                {ECO:0000269|PubMed:27268051}.
FT   CARBOHYD   1045   1045       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1066   1066       O-linked (Glc...) serine.
FT                                {ECO:0000269|PubMed:27268051}.
FT   CARBOHYD   1074   1074       O-linked (Fuc...) threonine.
FT                                {ECO:0000269|PubMed:27268051}.
FT   CARBOHYD   1112   1112       O-linked (Fuc...) threonine.
FT                                {ECO:0000269|PubMed:27268051}.
FT   CARBOHYD   1157   1157       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1189   1189       O-linked (Glc...) serine.
FT                                {ECO:0000269|PubMed:27268051}.
FT   CARBOHYD   1197   1197       O-linked (Fuc...) threonine.
FT                                {ECO:0000269|PubMed:27268051}.
FT   CARBOHYD   1235   1235       O-linked (Fuc...) threonine.
FT                                {ECO:0000269|PubMed:27268051}.
FT   CARBOHYD   1242   1242       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1271   1271       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1273   1273       O-linked (Fuc...) serine.
FT                                {ECO:0000269|PubMed:27268051}.
FT   CARBOHYD   1303   1303       O-linked (Glc...) serine.
FT                                {ECO:0000269|PubMed:27268051}.
FT   CARBOHYD   1381   1381       O-linked (Glc...) serine.
FT                                {ECO:0000269|PubMed:27268051}.
FT   CARBOHYD   1521   1521       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1594   1594       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1627   1627       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     62     73       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID     67     83       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID     85     94       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    100    111       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    105    124       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    126    135       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    143    154       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    148    164       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    166    175       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    181    192       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    186    203       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    205    214       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    221    232       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    226    241       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    243    252       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    259    270       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    264    279       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    281    290       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    297    308       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    302    317       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    319    328       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    335    349       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    343    358       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    360    369       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    376    387       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    381    396       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    398    407       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    413    424       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    418    435       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    437    446       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    453    465       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    459    474       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    476    485       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    492    503       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    497    512       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    514    523       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    530    541       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    535    550       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    552    561       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    568    579       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    573    588       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    590    599       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    606    616       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    611    625       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    627    636       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    643    654       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    648    663       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    665    674       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    681    692       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    686    701       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    703    712       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    719    730       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    724    739       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    741    750       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    757    768       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    762    777       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    779    788       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    795    806       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    800    815       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    817    826       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    833    844       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    838    853       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    855    864       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    871    882       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    876    893       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    895    904       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    911    923       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    917    932       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    934    943       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    950    961       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    955    970       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    972    981       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    988    999       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    993   1008       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID   1010   1019       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID   1026   1037       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID   1031   1046       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID   1048   1057       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID   1064   1075       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID   1069   1084       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID   1086   1095       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID   1102   1113       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID   1107   1122       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID   1124   1133       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID   1155   1160       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID   1171   1180       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID   1187   1198       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID   1192   1207       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID   1209   1218       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID   1225   1236       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID   1230   1245       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID   1247   1256       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID   1263   1274       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID   1268   1283       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID   1285   1294       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID   1301   1314       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID   1306   1323       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID   1325   1334       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID   1341   1352       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID   1346   1361       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID   1363   1372       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID   1379   1389       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID   1384   1400       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID   1402   1411       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID   1419   1430       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID   1424   1439       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID   1441   1450       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID   1482   1505       {ECO:0000255|PROSITE-ProRule:PRU00525}.
FT   DISULFID   1487   1500       {ECO:0000255|PROSITE-ProRule:PRU00525}.
FT   DISULFID   1496   1512       {ECO:0000255|PROSITE-ProRule:PRU00525}.
FT   DISULFID   1522   1545       {ECO:0000255|PROSITE-ProRule:PRU00525}.
FT   DISULFID   1527   1540       {ECO:0000255|PROSITE-ProRule:PRU00525}.
FT   DISULFID   1536   1552       {ECO:0000255|PROSITE-ProRule:PRU00525}.
FT   DISULFID   1559   1585       {ECO:0000255|PROSITE-ProRule:PRU00525}.
FT   DISULFID   1567   1580       {ECO:0000255|PROSITE-ProRule:PRU00525}.
FT   DISULFID   1576   1592       {ECO:0000255|PROSITE-ProRule:PRU00525}.
FT   VARIANT     578    578       I -> T.
FT   VARIANT    2044   2044       I -> R.
FT   VARIANT    2265   2265       A -> V.
FT   VARIANT    2407   2407       H -> R.
FT   VARIANT    2445   2445       R -> L.
FT   VARIANT    2568   2568       Q -> QQQQQ.
FT   MUTAGEN     739    739       C->Y: In mcd5; induces loss of
FT                                microchaetae sensory precursors.
FT   MUTAGEN    2060   2060       A->V: In su42c; deltex-like mutation that
FT                                induces outstreched wings and
FT                                variability-fused ocelli.
FT   MUTAGEN    2328   2328       Y->F: Abolishes interaction with Nedd4
FT                                and reduces ubiquitination.
FT                                {ECO:0000269|PubMed:15620649}.
FT   CONFLICT      9      9       R -> G (in Ref. 5; CAB37610).
FT                                {ECO:0000305}.
FT   CONFLICT     84     84       A -> G (in Ref. 5; CAB37610).
FT                                {ECO:0000305}.
FT   CONFLICT    103    103       M -> I (in Ref. 1; AAB59220).
FT                                {ECO:0000305}.
FT   CONFLICT    119    119       R -> H (in Ref. 2; AAA28725).
FT                                {ECO:0000305}.
FT   CONFLICT    231    231       T -> I (in Ref. 1; AAB59220).
FT                                {ECO:0000305}.
FT   CONFLICT    240    240       Q -> R (in Ref. 5; CAB37610).
FT                                {ECO:0000305}.
FT   CONFLICT    267    267       G -> A (in Ref. 1; AAB59220).
FT                                {ECO:0000305}.
FT   CONFLICT   1561   1561       S -> T (in Ref. 1; AAB59220 and 2;
FT                                AAA28725). {ECO:0000305}.
FT   CONFLICT   2257   2257       G -> S (in Ref. 2; AAA28725).
FT                                {ECO:0000305}.
FT   CONFLICT   2577   2577       A -> E (in Ref. 7; AAA74496).
FT                                {ECO:0000305}.
FT   HELIX      1930   1950       {ECO:0000244|PDB:1OT8}.
FT   HELIX      1954   1960       {ECO:0000244|PDB:1OT8}.
FT   HELIX      1964   1972       {ECO:0000244|PDB:1OT8}.
FT   HELIX      1987   1993       {ECO:0000244|PDB:1OT8}.
FT   HELIX      1997   2004       {ECO:0000244|PDB:1OT8}.
FT   HELIX      2021   2027       {ECO:0000244|PDB:1OT8}.
FT   HELIX      2033   2039       {ECO:0000244|PDB:1OT8}.
FT   HELIX      2054   2060       {ECO:0000244|PDB:1OT8}.
FT   HELIX      2064   2072       {ECO:0000244|PDB:1OT8}.
FT   HELIX      2087   2093       {ECO:0000244|PDB:1OT8}.
FT   HELIX      2097   2105       {ECO:0000244|PDB:1OT8}.
FT   HELIX      2120   2126       {ECO:0000244|PDB:1OT8}.
FT   HELIX      2130   2136       {ECO:0000244|PDB:1OT8}.
SQ   SEQUENCE   2703 AA;  288853 MW;  0EAE23F426FECD7B CRC64;
     MQSQRSRRRS RAPNTWICFW INKMHAVASL PASLPLLLLT LAFANLPNTV RGTDTALVAA
     SCTSVGCQNG GTCVTQLNGK TYCACDSHYV GDYCEHRNPC NSMRCQNGGT CQVTFRNGRP
     GISCKCPLGF DESLCEIAVP NACDHVTCLN GGTCQLKTLE EYTCACANGY TGERCETKNL
     CASSPCRNGA TCTALAGSSS FTCSCPPGFT GDTCSYDIEE CQSNPCKYGG TCVNTHGSYQ
     CMCPTGYTGK DCDTKYKPCS PSPCQNGGIC RSNGLSYECK CPKGFEGKNC EQNYDDCLGH
     LCQNGGTCID GISDYTCRCP PNFTGRFCQD DVDECAQRDH PVCQNGATCT NTHGSYSCIC
     VNGWAGLDCS NNTDDCKQAA CFYGATCIDG VGSFYCQCTK GKTGLLCHLD DACTSNPCHA
     DAICDTSPIN GSYACSCATG YKGVDCSEDI DECDQGSPCE HNGICVNTPG SYRCNCSQGF
     TGPRCETNIN ECESHPCQNE GSCLDDPGTF RCVCMPGFTG TQCEIDIDEC QSNPCLNDGT
     CHDKINGFKC SCALGFTGAR CQINIDDCQS QPCRNRGICH DSIAGYSCEC PPGYTGTSCE
     ININDCDSNP CHRGKCIDDV NSFKCLCDPG YTGYICQKQI NECESNPCQF DGHCQDRVGS
     YYCQCQAGTS GKNCEVNVNE CHSNPCNNGA TCIDGINSYK CQCVPGFTGQ HCEKNVDECI
     SSPCANNGVC IDQVNGYKCE CPRGFYDAHC LSDVDECASN PCVNEGRCED GINEFICHCP
     PGYTGKRCEL DIDECSSNPC QHGGTCYDKL NAFSCQCMPG YTGQKCETNI DDCVTNPCGN
     GGTCIDKVNG YKCVCKVPFT GRDCESKMDP CASNRCKNEA KCTPSSNFLD FSCTCKLGYT
     GRYCDEDIDE CSLSSPCRNG ASCLNVPGSY RCLCTKGYEG RDCAINTDDC ASFPCQNGGT
     CLDGIGDYSC LCVDGFDGKH CETDINECLS QPCQNGATCS QYVNSYTCTC PLGFSGINCQ
     TNDEDCTESS CLNGGSCIDG INGYNCSCLA GYSGANCQYK LNKCDSNPCL NGATCHEQNN
     EYTCHCPSGF TGKQCSEYVD WCGQSPCENG ATCSQMKHQF SCKCSAGWTG KLCDVQTISC
     QDAADRKGLS LRQLCNNGTC KDYGNSHVCY CSQGYAGSYC QKEIDECQSQ PCQNGGTCRD
     LIGAYECQCR QGFQGQNCEL NIDDCAPNPC QNGGTCHDRV MNFSCSCPPG TMGIICEINK
     DDCKPGACHN NGSCIDRVGG FECVCQPGFV GARCEGDINE CLSNPCSNAG TLDCVQLVNN
     YHCNCRPGHM GRHCEHKVDF CAQSPCQNGG NCNIRQSGHH CICNNGFYGK NCELSGQDCD
     SNPCRVGNCV VADEGFGYRC ECPRGTLGEH CEIDTLDECS PNPCAQGAAC EDLLGDYECL
     CPSKWKGKRC DIYDANYPGW NGGSGSGNDR YAADLEQQRA MCDKRGCTEK QGNGICDSDC
     NTYACNFDGN DCSLGINPWA NCTANECWNK FKNGKCNEEC NNAACHYDGH DCERKLKSCD
     SLFDAYCQKH YGDGFCDYGC NNAECSWDGL DCENKTQSPV LAEGAMSVVM LMNVEAFREI
     QAQFLRNMSH MLRTTVRLKK DALGHDIIIN WKDNVRVPEI EDTDFARKNK ILYTQQVHQT
     GIQIYLEIDN RKCTECFTHA VEAAEFLAAT AAKHQLRNDF QIHSVRGIKN PGDEDNGEPP
     ANVKYVITGI ILVIIALAFF GMVLSTQRKR AHGVTWFPEG FRAPAAVMSR RRRDPHGQEM
     RNLNKQVAMQ SQGVGQPGAH WSDDESDMPL PKRQRSDPVS GVGLGNNGGY ASDHTMVSEY
     EEADQRVWSQ AHLDVVDVRA IMTPPAHQDG GKHDVDARGP CGLTPLMIAA VRGGGLDTGE
     DIENNEDSTA QVISDLLAQG AELNATMDKT GETSLHLAAR FARADAAKRL LDAGADANCQ
     DNTGRTPLHA AVAADAMGVF QILLRNRATN LNARMHDGTT PLILAARLAI EGMVEDLITA
     DADINAADNS GKTALHWAAA VNNTEAVNIL LMHHANRDAQ DDKDETPLFL AAREGSYEAC
     KALLDNFANR EITDHMDRLP RDVASERLHH DIVRLLDEHV PRSPQMLSMT PQAMIGSPPP
     GQQQPQLITQ PTVISAGNGG NNGNGNASGK QSNQTAKQKA AKKAKLIEGS PDNGLDATGS
     LRRKASSKKT SAASKKAANL NGLNPGQLTG GVSGVPGVPP TNSAAQAAAA AAAAVAAMSH
     ELEGSPVGVG MGGNLPSPYD TSSMYSNAMA APLANGNPNT GAKQPPSYED CIKNAQSMQS
     LQGNGLDMIK LDNYAYSMGS PFQQELLNGQ GLGMNGNGQR NGVGPGVLPG GLCGMGGLSG
     AGNGNSHEQG LSPPYSNQSP PHSVQSSLAL SPHAYLGSPS PAKSRPSLPT SPTHIQAMRH
     ATQQKQFGGS NLNSLLGGAN GGGVVGGGGG GGGGVGQGPQ NSPVSLGIIS PTGSDMGIML
     APPQSSKNSA IMQTISPQQQ QQQQQQQQQQ HQQQQQQQQQ QQQQQQQQLG GLEFGSAGLD
     LNGFCGSPDS FHSGQMNPPS IQSSMSGSSP STNMLSPSSQ HNQQAFYQYL TPSSQHSGGH
     TPQHLVQTLD SYPTPSPESP GHWSSSSPRS NSDWSEGVQS PAANNLYISG GHQANKGSEA
     IYI
//
ID   NOTC3_RAT               Reviewed;        2319 AA.
AC   Q9R172;
DT   27-MAR-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 2.
DT   20-DEC-2017, entry version 154.
DE   RecName: Full=Neurogenic locus notch homolog protein 3;
DE            Short=Notch 3;
DE   Contains:
DE     RecName: Full=Notch 3 extracellular truncation;
DE   Contains:
DE     RecName: Full=Notch 3 intracellular domain;
DE   Flags: Precursor;
GN   Name=Notch3;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Haritunians T., Boulter J., Weinmaster G., Schanen N.C.;
RT   "Rattus norvegicus mRNA for Notch 3.";
RL   Submitted (SEP-2000) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   FUNCTION.
RX   PubMed=11182080; DOI=10.1016/S0896-6273(01)00179-9;
RA   Tanigaki K., Nogaki F., Takahashi J., Tashiro K., Kurooka H.,
RA   Honjo T.;
RT   "Notch1 and Notch3 instructively restrict bFGF-responsive multipotent
RT   neural progenitor cells to an astroglial fate.";
RL   Neuron 29:45-55(2001).
RN   [3]
RP   TISSUE SPECIFICITY.
RX   PubMed=11438922; DOI=10.1002/cne.1059.abs;
RA   Irvin D.K., Zurcher S.D., Nguyen T., Weinmaster G., Kornblum H.I.;
RT   "Expression patterns of Notch1, Notch2, and Notch3 suggest multiple
RT   functional roles for the Notch-DSL signaling system during brain
RT   development.";
RL   J. Comp. Neurol. 436:167-181(2001).
CC   -!- FUNCTION: Functions as a receptor for membrane-bound ligands
CC       Jagged1, Jagged2 and Delta1 to regulate cell-fate determination.
CC       Upon ligand activation through the released notch intracellular
CC       domain (NICD) it forms a transcriptional activator complex with
CC       RBPJ/RBPSUH and activates genes of the enhancer of split locus.
CC       Affects the implementation of differentiation, proliferation and
CC       apoptotic programs (By similarity). Acts instructively to control
CC       the cell fate determination of CNS multipotent progenitor cells,
CC       resulting in astroglial induction and neuron/oligodendrocyte
CC       suppression. {ECO:0000250, ECO:0000269|PubMed:11182080}.
CC   -!- SUBUNIT: Heterodimer of a C-terminal fragment N(TM) and a N-
CC       terminal fragment N(EC) which are probably linked by disulfide
CC       bonds. Interacts with MAML1, MAML2 and MAML3 which act as
CC       transcriptional coactivators for NOTCH3. Interacts with PSMA1 (By
CC       similarity). Interacts with HIF1AN (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane
CC       protein.
CC   -!- SUBCELLULAR LOCATION: Notch 3 intracellular domain: Nucleus.
CC       Note=Following proteolytical processing NICD is translocated to
CC       the nucleus.
CC   -!- TISSUE SPECIFICITY: Expressed in postnatal central nervous system
CC       (CNS) germinal zones and, in early postnatal life, within numerous
CC       cells throughout the CNS. It is more highly localized to
CC       ventricular germinal zones. {ECO:0000269|PubMed:11438922}.
CC   -!- PTM: Synthesized in the endoplasmic reticulum as an inactive form
CC       which is proteolytically cleaved by a furin-like convertase in the
CC       trans-Golgi network before it reaches the plasma membrane to yield
CC       an active, ligand-accessible form. Cleavage results in a C-
CC       terminal fragment N(TM) and a N-terminal fragment N(EC). Following
CC       ligand binding, it is cleaved by TNF-alpha converting enzyme
CC       (TACE) to yield a membrane-associated intermediate fragment called
CC       notch extracellular truncation (NEXT). This fragment is then
CC       cleaved by presenilin dependent gamma-secretase to release a
CC       notch-derived peptide containing the intracellular domain (NICD)
CC       from the membrane (By similarity). {ECO:0000250}.
CC   -!- PTM: Phosphorylated. {ECO:0000250}.
CC   -!- PTM: Hydroxylated by HIF1AN. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the NOTCH family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF164486; AAD46653.2; -; mRNA.
DR   RefSeq; NP_064472.2; NM_020087.2.
DR   UniGene; Rn.228683; -.
DR   ProteinModelPortal; Q9R172; -.
DR   SMR; Q9R172; -.
DR   STRING; 10116.ENSRNOP00000037570; -.
DR   PaxDb; Q9R172; -.
DR   PRIDE; Q9R172; -.
DR   GeneID; 56761; -.
DR   KEGG; rno:56761; -.
DR   UCSC; RGD:620761; rat.
DR   CTD; 4854; -.
DR   RGD; 620761; Notch3.
DR   eggNOG; ENOG410KD9W; Eukaryota.
DR   eggNOG; COG0666; LUCA.
DR   HOGENOM; HOG000234369; -.
DR   HOVERGEN; HBG052650; -.
DR   InParanoid; Q9R172; -.
DR   KO; K20995; -.
DR   PhylomeDB; Q9R172; -.
DR   PRO; PR:Q9R172; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0043235; C:receptor complex; ISO:RGD.
DR   GO; GO:0045296; F:cadherin binding; ISO:RGD.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0019899; F:enzyme binding; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0004872; F:receptor activity; IEA:InterPro.
DR   GO; GO:0048844; P:artery morphogenesis; ISO:RGD.
DR   GO; GO:0030900; P:forebrain development; ISO:RGD.
DR   GO; GO:0072104; P:glomerular capillary formation; ISO:RGD.
DR   GO; GO:0045596; P:negative regulation of cell differentiation; ISO:RGD.
DR   GO; GO:0045665; P:negative regulation of neuron differentiation; ISO:RGD.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISO:RGD.
DR   GO; GO:0048663; P:neuron fate commitment; ISO:RGD.
DR   GO; GO:0007219; P:Notch signaling pathway; IDA:RGD.
DR   GO; GO:0048661; P:positive regulation of smooth muscle cell proliferation; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISO:RGD.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IDA:RGD.
DR   GO; GO:0042246; P:tissue regeneration; IEP:RGD.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00204; ANK; 2.
DR   Gene3D; 1.25.40.20; -; 3.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR024600; DUF3454_notch.
DR   InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR000152; EGF-type_Asp/Asn_hydroxyl_site.
DR   InterPro; IPR018097; EGF_Ca-bd_CS.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   InterPro; IPR008297; Notch.
DR   InterPro; IPR035993; Notch-like_dom_sf.
DR   InterPro; IPR022331; Notch_3.
DR   InterPro; IPR000800; Notch_dom.
DR   InterPro; IPR010660; Notch_NOD_dom.
DR   InterPro; IPR011656; Notch_NODP_dom.
DR   Pfam; PF12796; Ank_2; 2.
DR   Pfam; PF11936; DUF3454; 1.
DR   Pfam; PF00008; EGF; 18.
DR   Pfam; PF07645; EGF_CA; 5.
DR   Pfam; PF12661; hEGF; 6.
DR   Pfam; PF06816; NOD; 1.
DR   Pfam; PF07684; NODP; 1.
DR   Pfam; PF00066; Notch; 3.
DR   PIRSF; PIRSF002279; Notch; 1.
DR   PRINTS; PR01452; LNOTCHREPEAT.
DR   PRINTS; PR01986; NOTCH3.
DR   SMART; SM00248; ANK; 6.
DR   SMART; SM01334; DUF3454; 1.
DR   SMART; SM00181; EGF; 34.
DR   SMART; SM00179; EGF_CA; 30.
DR   SMART; SM00004; NL; 3.
DR   SMART; SM01338; NOD; 1.
DR   SMART; SM01339; NODP; 1.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   SUPFAM; SSF57184; SSF57184; 5.
DR   SUPFAM; SSF90193; SSF90193; 3.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 4.
DR   PROSITE; PS00010; ASX_HYDROXYL; 18.
DR   PROSITE; PS00022; EGF_1; 33.
DR   PROSITE; PS01186; EGF_2; 26.
DR   PROSITE; PS50026; EGF_3; 34.
DR   PROSITE; PS01187; EGF_CA; 16.
DR   PROSITE; PS50258; LNR; 3.
PE   2: Evidence at transcript level;
KW   Activator; ANK repeat; Cell membrane; Complete proteome;
KW   Developmental protein; Differentiation; Disulfide bond;
KW   EGF-like domain; Glycoprotein; Membrane; Methylation;
KW   Notch signaling pathway; Nucleus; Phosphoprotein; Receptor;
KW   Reference proteome; Repeat; Signal; Transcription;
KW   Transcription regulation; Transmembrane; Transmembrane helix.
FT   SIGNAL        1     40       {ECO:0000255}.
FT   CHAIN        41   2319       Neurogenic locus notch homolog protein 3.
FT                                /FTId=PRO_0000007698.
FT   CHAIN      1631   2319       Notch 3 extracellular truncation.
FT                                {ECO:0000250}.
FT                                /FTId=PRO_0000007699.
FT   CHAIN      1664   2319       Notch 3 intracellular domain.
FT                                {ECO:0000250}.
FT                                /FTId=PRO_0000007700.
FT   TOPO_DOM     41   1645       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1646   1666       Helical. {ECO:0000255}.
FT   TOPO_DOM   1667   2319       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       41     79       EGF-like 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN       80    120       EGF-like 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      121    158       EGF-like 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      160    197       EGF-like 4; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      199    236       EGF-like 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      238    274       EGF-like 6; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      276    314       EGF-like 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      316    352       EGF-like 8; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      353    391       EGF-like 9. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      393    431       EGF-like 10; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      433    469       EGF-like 11; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      471    507       EGF-like 12; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      509    545       EGF-like 13; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      547    582       EGF-like 14; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      584    620       EGF-like 15; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      622    657       EGF-like 16; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      659    695       EGF-like 17; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      697    732       EGF-like 18. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      736    772       EGF-like 19. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      773    810       EGF-like 20. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      812    849       EGF-like 21; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      851    887       EGF-like 22; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      889    924       EGF-like 23; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      926    962       EGF-like 24. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      964   1000       EGF-like 25. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN     1002   1036       EGF-like 26. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN     1038   1084       EGF-like 27. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN     1086   1122       EGF-like 28. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN     1124   1160       EGF-like 29; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN     1162   1205       EGF-like 30; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN     1207   1246       EGF-like 31. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN     1248   1289       EGF-like 32. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN     1291   1327       EGF-like 33. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN     1337   1375       EGF-like 34. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   REPEAT     1389   1429       LNR 1.
FT   REPEAT     1430   1467       LNR 2.
FT   REPEAT     1469   1507       LNR 3.
FT   REPEAT     1840   1869       ANK 1.
FT   REPEAT     1873   1903       ANK 2.
FT   REPEAT     1907   1936       ANK 3.
FT   REPEAT     1940   1969       ANK 4.
FT   REPEAT     1973   2002       ANK 5.
FT   SITE       1573   1574       Cleavage; by furin-like protease.
FT                                {ECO:0000250}.
FT   MOD_RES    2175   2175       Omega-N-methylarginine.
FT                                {ECO:0000250|UniProtKB:Q9UM47}.
FT   CARBOHYD   1181   1181       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1338   1338       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1440   1440       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     44     56       {ECO:0000250}.
FT   DISULFID     50     67       {ECO:0000250}.
FT   DISULFID     69     78       {ECO:0000250}.
FT   DISULFID     84     95       {ECO:0000250}.
FT   DISULFID     89    108       {ECO:0000250}.
FT   DISULFID    110    119       {ECO:0000250}.
FT   DISULFID    125    136       {ECO:0000250}.
FT   DISULFID    130    146       {ECO:0000250}.
FT   DISULFID    148    157       {ECO:0000250}.
FT   DISULFID    164    176       {ECO:0000250}.
FT   DISULFID    170    185       {ECO:0000250}.
FT   DISULFID    187    196       {ECO:0000250}.
FT   DISULFID    203    214       {ECO:0000250}.
FT   DISULFID    208    224       {ECO:0000250}.
FT   DISULFID    226    235       {ECO:0000250}.
FT   DISULFID    242    253       {ECO:0000250}.
FT   DISULFID    247    262       {ECO:0000250}.
FT   DISULFID    264    273       {ECO:0000250}.
FT   DISULFID    280    293       {ECO:0000250}.
FT   DISULFID    287    302       {ECO:0000250}.
FT   DISULFID    304    313       {ECO:0000250}.
FT   DISULFID    320    331       {ECO:0000250}.
FT   DISULFID    325    340       {ECO:0000250}.
FT   DISULFID    342    351       {ECO:0000250}.
FT   DISULFID    357    368       {ECO:0000250}.
FT   DISULFID    362    379       {ECO:0000250}.
FT   DISULFID    381    390       {ECO:0000250}.
FT   DISULFID    397    410       {ECO:0000250}.
FT   DISULFID    404    419       {ECO:0000250}.
FT   DISULFID    421    430       {ECO:0000250}.
FT   DISULFID    437    448       {ECO:0000250}.
FT   DISULFID    442    457       {ECO:0000250}.
FT   DISULFID    459    468       {ECO:0000250}.
FT   DISULFID    475    486       {ECO:0000250}.
FT   DISULFID    480    495       {ECO:0000250}.
FT   DISULFID    497    506       {ECO:0000250}.
FT   DISULFID    513    524       {ECO:0000250}.
FT   DISULFID    518    533       {ECO:0000250}.
FT   DISULFID    535    544       {ECO:0000250}.
FT   DISULFID    551    561       {ECO:0000250}.
FT   DISULFID    556    570       {ECO:0000250}.
FT   DISULFID    572    581       {ECO:0000250}.
FT   DISULFID    588    599       {ECO:0000250}.
FT   DISULFID    593    608       {ECO:0000250}.
FT   DISULFID    610    619       {ECO:0000250}.
FT   DISULFID    626    636       {ECO:0000250}.
FT   DISULFID    631    645       {ECO:0000250}.
FT   DISULFID    647    656       {ECO:0000250}.
FT   DISULFID    663    674       {ECO:0000250}.
FT   DISULFID    668    683       {ECO:0000250}.
FT   DISULFID    685    694       {ECO:0000250}.
FT   DISULFID    701    711       {ECO:0000250}.
FT   DISULFID    706    720       {ECO:0000250}.
FT   DISULFID    722    731       {ECO:0000250}.
FT   DISULFID    740    751       {ECO:0000250}.
FT   DISULFID    745    760       {ECO:0000250}.
FT   DISULFID    762    771       {ECO:0000250}.
FT   DISULFID    777    788       {ECO:0000250}.
FT   DISULFID    782    798       {ECO:0000250}.
FT   DISULFID    800    809       {ECO:0000250}.
FT   DISULFID    816    828       {ECO:0000250}.
FT   DISULFID    822    837       {ECO:0000250}.
FT   DISULFID    839    848       {ECO:0000250}.
FT   DISULFID    855    866       {ECO:0000250}.
FT   DISULFID    860    875       {ECO:0000250}.
FT   DISULFID    877    886       {ECO:0000250}.
FT   DISULFID    893    903       {ECO:0000250}.
FT   DISULFID    898    912       {ECO:0000250}.
FT   DISULFID    914    923       {ECO:0000250}.
FT   DISULFID    930    941       {ECO:0000250}.
FT   DISULFID    935    950       {ECO:0000250}.
FT   DISULFID    952    961       {ECO:0000250}.
FT   DISULFID    968    979       {ECO:0000250}.
FT   DISULFID    973    988       {ECO:0000250}.
FT   DISULFID    990    999       {ECO:0000250}.
FT   DISULFID   1006   1017       {ECO:0000250}.
FT   DISULFID   1011   1024       {ECO:0000250}.
FT   DISULFID   1026   1035       {ECO:0000250}.
FT   DISULFID   1042   1063       {ECO:0000250}.
FT   DISULFID   1057   1072       {ECO:0000250}.
FT   DISULFID   1074   1083       {ECO:0000250}.
FT   DISULFID   1090   1101       {ECO:0000250}.
FT   DISULFID   1095   1110       {ECO:0000250}.
FT   DISULFID   1112   1121       {ECO:0000250}.
FT   DISULFID   1128   1139       {ECO:0000250}.
FT   DISULFID   1133   1148       {ECO:0000250}.
FT   DISULFID   1150   1159       {ECO:0000250}.
FT   DISULFID   1166   1184       {ECO:0000250}.
FT   DISULFID   1178   1193       {ECO:0000250}.
FT   DISULFID   1195   1204       {ECO:0000250}.
FT   DISULFID   1211   1224       {ECO:0000250}.
FT   DISULFID   1216   1234       {ECO:0000250}.
FT   DISULFID   1236   1245       {ECO:0000250}.
FT   DISULFID   1252   1263       {ECO:0000250}.
FT   DISULFID   1257   1277       {ECO:0000250}.
FT   DISULFID   1279   1288       {ECO:0000250}.
FT   DISULFID   1295   1306       {ECO:0000250}.
FT   DISULFID   1300   1315       {ECO:0000250}.
FT   DISULFID   1317   1326       {ECO:0000250}.
FT   DISULFID   1341   1352       {ECO:0000250}.
FT   DISULFID   1346   1363       {ECO:0000250}.
FT   DISULFID   1365   1374       {ECO:0000250}.
FT   DISULFID   1389   1412       {ECO:0000250}.
FT   DISULFID   1394   1407       {ECO:0000250}.
FT   DISULFID   1403   1419       {ECO:0000250}.
FT   DISULFID   1430   1453       {ECO:0000250}.
FT   DISULFID   1435   1448       {ECO:0000250}.
FT   DISULFID   1444   1460       {ECO:0000250}.
FT   DISULFID   1469   1495       {ECO:0000250}.
FT   DISULFID   1477   1490       {ECO:0000250}.
FT   DISULFID   1486   1502       {ECO:0000250}.
SQ   SEQUENCE   2319 AA;  244301 MW;  243BCA02D7C3283D CRC64;
     MGPGARGRRR RRRLMALPPP PPPMRALPLL LLLLAGLGAA APPCLDGSPC ANGGRCTHQQ
     PSREAACLCL PGWVGERCQL EDPCHSGPCA GRGVCQSSVV AGVARFSCRC LRGFRGPDCS
     LPDPCFSSPC AHGAPCSVGS DGRYACACPP GYQGRNCRSD IDECRAGASC RHGGTCINTP
     GSFHCLCPLG YTGLLCENPI VPCAPSPCRN GGTCRQSSDV TYDCACLPGF EGQNCEVNVD
     DCPGHRCLNG GTCVDGVNTY NCQCPPEWTG QFCTEDVDEC QLQPNACHNG GTCFNLLGGH
     SCVCVNGWTG ESCSQNIDDC ATAVCFHGAT CHDRVASFYC ACPMGKTGLL CHLDDACVSN
     PCHEDAICDT NPVSGRAICT CPPGFTGGAC DQDVDECSIG ANPCEHLGRC VNTQGSFLCQ
     CGRGYTGPRC ETDVNECLSG PCRNQATCLD RIGQFTCICM AGFTGTFCEV DIDECQSSPC
     VNGGVCKDRV NGFSCTCPSG FSGSTCQLDV DECASTPCRN GAKCVDQPDG YECRCAEGFE
     GTLCERNVDD CSPDPCHHGR CVDGIASFSC ACAPGYTGIR CESQVDECRS QPCRYGGKCL
     DLVDKYLCRC PPGTTGVNCE VNIDDCASNP CTFGVCRDGI NRYDCVCQPG FTGPLCNVEI
     NECASSPCGE GGSCVDGENG FHCLCPPGSL PPLCLPANHP CAHKPCSHGV CHDAPGGFQC
     VCDPGWSGPR CSQSLAPDAC ESQPCQAGGT CTSDGIGFHC TCAPGFQGHQ CEVLSPCTPS
     LCEHGGHCES DPDQLTVCSC PPGWQGPRCQ QDVDECAGAS PCGPHGTCTN LPGSFRCICH
     GGYTGPFCDQ DIDDCDPNPC LNGGSCQDGV GSFSCSCLSG FAGPRCARDV DECLSSPCGP
     GTCTDHVASF TCTCPPGYGG FHCETDLLDC SPSSCFNGGT CVDGVNSFSC LCRPGYTGTH
     CQYKVDPCFS RPCLHGGICN PTHSGFECTC REGFTGNQCQ NPVDWCSQAP CQNGGRCVQT
     GAYCICPPEW SGPLCDIPSL PCTEAAAHMG VRLEQLCQAG GQCIDKDHSH YCVCPEGRMG
     SHCEQEVDPC TAQPCQHGGT CRGYMGGYVC ECPTGYSGDS CEDDVDECAS QPCQNGGSCI
     DLVAHYLCSC PPGTLGVLCE INEDDCGPGP SLDSGLRCLH NGTCVDLVGG FRCNCPPGYT
     GLHCEADINE CRPGTCHAAH TRDCLQDPGG HFRCICLPGF TGPRCQTALF PCESQPCQHG
     GQCRPSLGRG GGLTFTCHCV QPFWGLRCER VARSCRELQC PVGIPCQQTA RGPRCACPPG
     LSGPSCRVSR ASPSGATNTS CAATPCLHGG SCLPVQSVPF FRCVCAPGWG GPRCETPSAA
     PEVPEEPRCP RAACQAKRGD QNCDRECNSP GCGWDGGDCS LNVDDPWRQC EALQCWRLFN
     NSRCDPACSS PACLYDNFDC YSGGRDRTCN PVYKKYCADH FADGRCDQGC NTEECGWDGL
     DCASEVPALL ARGVLVLTVL LPPEELLRSS ADFLQRLSAI LRTSLRFRLD ARGQAMVFPY
     HRPSPGSESR VRRELGPEVI GSVVMLEIDN RLCLKSAEND HCFPDAQSAA DYLGALSAVE
     RLDFPYPLRD VRGEPLEPPE QSVPLLPLLV AGAVFLLVIF VLGVMVARRK REHSTLWFPE
     GFALHKDIAA GHKGRREPVG QDALGMKNMT KGESLMGEVA TDWNDSECPE AKRLKVEEPG
     MGAEEPVDCR QWTQHHLVAA DIRVAPAMAL TPPQGDADAD GMDVNVRGPD GFTPLMLASF
     CGGALEPMPA EEDEADDTSA SIISDLICQG AQLGARTDRT GETALHLAAR YARADAAKRL
     LDAGADTNAQ DHSGRTPLHT AVTADAQGVF QILIRNRSTD LDARMADGST ALILAARLAV
     EGMVEELIAS HADVNAVDEL GKSALHWAAA VNNVEATLAL LKNGANKDMQ DSKEETPLFL
     AAREGSYEAA KLLLDHFANR EITDHLDRLP RDVAQERLHQ DIVRLLDQPS GPRSPSGPHG
     LGPLLCPPGA FLPGLKAVQS GTKKSRRPPG KTGLGPQGTR GRGKKLTLAC PGPLADSSVT
     LSPVDSLDSP RPFGGPPASP GGFPLEGPYA TTATTVSLAQ LGASRAGPLG RQPPGGCVLS
     LGLLNPVAVP LDWARLPPPA PPGPSFLLPL APGSQLLNPA TPVSPHERPP PYLAAPGHGE
     EYPAAGTHSS PTKARFLRVP SEHPYLTPSP ESPEHWASPS PPSLSDWSDS TPSPATATSA
     TAAGALPAQP HPISVPSLPQ SQTQLGPQPE VTPKRQVMA
//
ID   NOTC4_HUMAN             Reviewed;        2003 AA.
AC   Q99466; B0V183; B0V1X5; O00306; Q5SSY7; Q99458; Q99940; Q9H3S8;
AC   Q9UII9; Q9UIJ0;
DT   27-MAR-2002, integrated into UniProtKB/Swiss-Prot.
DT   27-MAR-2002, sequence version 2.
DT   22-NOV-2017, entry version 190.
DE   RecName: Full=Neurogenic locus notch homolog protein 4;
DE            Short=Notch 4;
DE            Short=hNotch4;
DE   Contains:
DE     RecName: Full=Notch 4 extracellular truncation;
DE   Contains:
DE     RecName: Full=Notch 4 intracellular domain;
DE   Flags: Precursor;
GN   Name=NOTCH4; Synonyms=INT3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1), AND POLYMORPHISM
RP   OF POLY-LEU REGION.
RC   TISSUE=Placenta;
RX   PubMed=9168133; DOI=10.1016/S0378-1119(96)00857-8;
RA   Sugaya K., Sasanuma S., Nohata J., Kimura T., Fukagawa T.,
RA   Nakamura Y., Ando A., Inoko H., Ikemura T., Mita K.;
RT   "Gene organization of human NOTCH4 and (CTG)n polymorphism in this
RT   human counterpart gene of mouse proto-oncogene Int3.";
RL   Gene 189:235-244(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1; 2 AND 3).
RC   TISSUE=Bone marrow, and Heart;
RX   PubMed=9693032; DOI=10.1006/geno.1998.5330;
RA   Li L., Huang G.M., Banta A.B., Deng Y., Smith T., Dong P.,
RA   Friedman C., Chen L., Trask B.J., Spies T., Rowen L., Hood L.;
RT   "Cloning, characterization, and the complete 56.8-kilobase DNA
RT   sequence of the human NOTCH4 gene.";
RL   Genomics 51:45-58(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT GLN-117.
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-503, AND VARIANTS GLN-117 AND
RP   GLN-317.
RA   Miyagawa T., Tokunaga K., Hojho H.;
RT   "Human notch4 gene variant.";
RL   Submitted (FEB-1999) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   IDENTIFICATION OF LIGANDS.
RX   PubMed=10079256; DOI=10.1016/S0002-9440(10)65325-4;
RA   Gray G.E., Mann R.S., Mitsiadis E., Henrique D., Carcangiu M.-L.,
RA   Banks A., Leiman J., Ward D., Ish-Horowitz D., Artavanis-Tsakonas S.;
RT   "Human ligands of the Notch receptor.";
RL   Am. J. Pathol. 154:785-794(1999).
RN   [6]
RP   INTERACTION WITH MAML1.
RX   PubMed=11101851; DOI=10.1038/82644;
RA   Wu L., Aster J.C., Blacklow S.C., Lake R., Artavanis-Tsakonas S.,
RA   Griffin J.D.;
RT   "MAML1, a human homologue of Drosophila mastermind, is a
RT   transcriptional co-activator for NOTCH receptors.";
RL   Nat. Genet. 26:484-489(2000).
RN   [7]
RP   INTERACTION WITH MAML2 AND MAML3.
RX   PubMed=12370315; DOI=10.1128/MCB.22.21.7688-7700.2002;
RA   Wu L., Sun T., Kobayashi K., Gao P., Griffin J.D.;
RT   "Identification of a family of mastermind-like transcriptional
RT   coactivators for mammalian notch receptors.";
RL   Mol. Cell. Biol. 22:7688-7700(2002).
CC   -!- FUNCTION: Functions as a receptor for membrane-bound ligands
CC       Jagged1, Jagged2 and Delta1 to regulate cell-fate determination.
CC       Upon ligand activation through the released notch intracellular
CC       domain (NICD) it forms a transcriptional activator complex with
CC       RBPJ/RBPSUH and activates genes of the enhancer of split locus.
CC       Affects the implementation of differentiation, proliferation and
CC       apoptotic programs. May regulate branching morphogenesis in the
CC       developing vascular system (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Heterodimer of a C-terminal fragment N(TM) and a N-
CC       terminal fragment N(EC) which are probably linked by disulfide
CC       bonds (By similarity). Interacts with MAML1, MAML2 and MAML3 which
CC       act as transcriptional coactivators for NOTCH4. {ECO:0000250,
CC       ECO:0000269|PubMed:11101851, ECO:0000269|PubMed:12370315}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane
CC       protein.
CC   -!- SUBCELLULAR LOCATION: Notch 4 intracellular domain: Nucleus.
CC       Note=Following proteolytical processing NICD is translocated to
CC       the nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC         Comment=Experimental confirmation may be lacking for some
CC         isoforms.;
CC       Name=1;
CC         IsoId=Q99466-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q99466-2; Sequence=VSP_001406;
CC       Name=3;
CC         IsoId=Q99466-3; Sequence=VSP_001407;
CC   -!- TISSUE SPECIFICITY: Highly expressed in the heart, moderately in
CC       the lung and placenta and at low levels in the liver, skeletal
CC       muscle, kidney, pancreas, spleen, lymph node, thymus, bone marrow
CC       and fetal liver. No expression was seen in adult brain or
CC       peripheral blood leukocytes.
CC   -!- PTM: Synthesized in the endoplasmic reticulum as an inactive form
CC       which is proteolytically cleaved by a furin-like convertase in the
CC       trans-Golgi network before it reaches the plasma membrane to yield
CC       an active, ligand-accessible form. Cleavage results in a C-
CC       terminal fragment N(TM) and a N-terminal fragment N(EC). Following
CC       ligand binding, it is cleaved by TNF-alpha converting enzyme
CC       (TACE) to yield a membrane-associated intermediate fragment called
CC       notch extracellular truncation (NEXT). This fragment is then
CC       cleaved by presenilin dependent gamma-secretase to release a
CC       notch-derived peptide containing the intracellular domain (NICD)
CC       from the membrane (By similarity). {ECO:0000250}.
CC   -!- PTM: Phosphorylated. {ECO:0000250}.
CC   -!- POLYMORPHISM: The poly-Leu region of NOTCH4 (in the signal
CC       peptide) is polymorphic and the number of Leu varies in the
CC       population (from 6 to 12). {ECO:0000269|PubMed:9168133}.
CC   -!- SIMILARITY: Belongs to the NOTCH family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA09708.1; Type=Frameshift; Positions=1438, 1463; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D63395; BAA09708.1; ALT_FRAME; mRNA.
DR   EMBL; D86566; BAA13116.1; -; Genomic_DNA.
DR   EMBL; U95299; AAC32288.1; -; mRNA.
DR   EMBL; U89335; AAC63097.1; -; Genomic_DNA.
DR   EMBL; AL662884; CAI18362.1; -; Genomic_DNA.
DR   EMBL; BX284686; CAM26209.1; -; Genomic_DNA.
DR   EMBL; BX284927; CAM26209.1; JOINED; Genomic_DNA.
DR   EMBL; BX284927; CAM25850.1; -; Genomic_DNA.
DR   EMBL; BX284686; CAM25850.1; JOINED; Genomic_DNA.
DR   EMBL; CR812478; CAQ10706.1; -; Genomic_DNA.
DR   EMBL; CR933878; CAQ09631.1; -; Genomic_DNA.
DR   EMBL; AB023961; BAB20317.1; -; Genomic_DNA.
DR   EMBL; AB024520; BAA88951.1; -; Genomic_DNA.
DR   EMBL; AB024578; BAA88952.1; -; Genomic_DNA.
DR   CCDS; CCDS34420.1; -. [Q99466-1]
DR   RefSeq; NP_004548.3; NM_004557.3. [Q99466-1]
DR   UniGene; Hs.436100; -.
DR   ProteinModelPortal; Q99466; -.
DR   SMR; Q99466; -.
DR   BioGrid; 110917; 8.
DR   CORUM; Q99466; -.
DR   ELM; Q99466; -.
DR   IntAct; Q99466; 1.
DR   STRING; 9606.ENSP00000364163; -.
DR   BindingDB; Q99466; -.
DR   ChEMBL; CHEMBL3407321; -.
DR   iPTMnet; Q99466; -.
DR   PhosphoSitePlus; Q99466; -.
DR   BioMuta; NOTCH4; -.
DR   DMDM; 20139103; -.
DR   MaxQB; Q99466; -.
DR   PaxDb; Q99466; -.
DR   PeptideAtlas; Q99466; -.
DR   PRIDE; Q99466; -.
DR   Ensembl; ENST00000375023; ENSP00000364163; ENSG00000204301. [Q99466-1]
DR   Ensembl; ENST00000425600; ENSP00000401321; ENSG00000238196.
DR   Ensembl; ENST00000439349; ENSP00000408335; ENSG00000223355.
DR   Ensembl; ENST00000457094; ENSP00000403447; ENSG00000234876. [Q99466-1]
DR   GeneID; 4855; -.
DR   KEGG; hsa:4855; -.
DR   UCSC; uc003obb.3; human. [Q99466-1]
DR   CTD; 4855; -.
DR   DisGeNET; 4855; -.
DR   EuPathDB; HostDB:ENSG00000204301.6; -.
DR   GeneCards; NOTCH4; -.
DR   HGNC; HGNC:7884; NOTCH4.
DR   MIM; 164951; gene.
DR   neXtProt; NX_Q99466; -.
DR   OpenTargets; ENSG00000204301; -.
DR   PharmGKB; PA31686; -.
DR   eggNOG; ENOG410IR7G; Eukaryota.
DR   eggNOG; COG0666; LUCA.
DR   GeneTree; ENSGT00810000125346; -.
DR   HOVERGEN; HBG052650; -.
DR   InParanoid; Q99466; -.
DR   KO; K20996; -.
DR   OMA; CQSQPCH; -.
DR   OrthoDB; EOG09370C6Y; -.
DR   PhylomeDB; Q99466; -.
DR   TreeFam; TF351641; -.
DR   Reactome; R-HSA-1912399; Pre-NOTCH Processing in the Endoplasmic Reticulum.
DR   Reactome; R-HSA-1912408; Pre-NOTCH Transcription and Translation.
DR   Reactome; R-HSA-1912420; Pre-NOTCH Processing in Golgi.
DR   Reactome; R-HSA-1980150; Signaling by NOTCH4.
DR   Reactome; R-HSA-350054; Notch-HLH transcription pathway.
DR   Reactome; R-HSA-5083630; Defective LFNG causes SCDO3.
DR   SignaLink; Q99466; -.
DR   SIGNOR; Q99466; -.
DR   GeneWiki; NOTCH4; -.
DR   GenomeRNAi; 4855; -.
DR   PRO; PR:Q99466; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000204301; -.
DR   CleanEx; HS_NOTCH4; -.
DR   Genevisible; Q99466; HS.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; TAS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005509; F:calcium ion binding; TAS:UniProtKB.
DR   GO; GO:0046982; F:protein heterodimerization activity; TAS:UniProtKB.
DR   GO; GO:0004872; F:receptor activity; TAS:UniProtKB.
DR   GO; GO:0001569; P:branching involved in blood vessel morphogenesis; ISS:UniProtKB.
DR   GO; GO:0030154; P:cell differentiation; NAS:UniProtKB.
DR   GO; GO:0001709; P:cell fate determination; TAS:UniProtKB.
DR   GO; GO:0009790; P:embryo development; ISS:UniProtKB.
DR   GO; GO:0001886; P:endothelial cell morphogenesis; IEA:Ensembl.
DR   GO; GO:0030097; P:hemopoiesis; TAS:UniProtKB.
DR   GO; GO:0030879; P:mammary gland development; IDA:UniProtKB.
DR   GO; GO:0001763; P:morphogenesis of a branching structure; ISS:UniProtKB.
DR   GO; GO:0045596; P:negative regulation of cell differentiation; NAS:UniProtKB.
DR   GO; GO:0045602; P:negative regulation of endothelial cell differentiation; ISS:UniProtKB.
DR   GO; GO:0007220; P:Notch receptor processing; TAS:Reactome.
DR   GO; GO:0007219; P:Notch signaling pathway; TAS:Reactome.
DR   GO; GO:0007221; P:positive regulation of transcription of Notch receptor target; TAS:BHF-UCL.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; TAS:UniProtKB.
DR   GO; GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome.
DR   CDD; cd00204; ANK; 2.
DR   Gene3D; 1.25.40.20; -; 3.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR000152; EGF-type_Asp/Asn_hydroxyl_site.
DR   InterPro; IPR018097; EGF_Ca-bd_CS.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   InterPro; IPR008297; Notch.
DR   InterPro; IPR035993; Notch-like_dom_sf.
DR   InterPro; IPR022355; Notch_4.
DR   InterPro; IPR000800; Notch_dom.
DR   InterPro; IPR010660; Notch_NOD_dom.
DR   InterPro; IPR011656; Notch_NODP_dom.
DR   Pfam; PF00023; Ank; 1.
DR   Pfam; PF12796; Ank_2; 1.
DR   Pfam; PF00008; EGF; 12.
DR   Pfam; PF07645; EGF_CA; 5.
DR   Pfam; PF12661; hEGF; 3.
DR   Pfam; PF06816; NOD; 1.
DR   Pfam; PF07684; NODP; 1.
DR   Pfam; PF00066; Notch; 3.
DR   PIRSF; PIRSF002279; Notch; 1.
DR   PRINTS; PR01452; LNOTCHREPEAT.
DR   PRINTS; PR01987; NOTCH4.
DR   SMART; SM00248; ANK; 5.
DR   SMART; SM00181; EGF; 29.
DR   SMART; SM00179; EGF_CA; 22.
DR   SMART; SM00004; NL; 3.
DR   SMART; SM01338; NOD; 1.
DR   SMART; SM01339; NODP; 1.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   SUPFAM; SSF57184; SSF57184; 5.
DR   SUPFAM; SSF90193; SSF90193; 2.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 5.
DR   PROSITE; PS00010; ASX_HYDROXYL; 11.
DR   PROSITE; PS00022; EGF_1; 28.
DR   PROSITE; PS01186; EGF_2; 21.
DR   PROSITE; PS50026; EGF_3; 28.
DR   PROSITE; PS01187; EGF_CA; 9.
DR   PROSITE; PS50258; LNR; 3.
PE   1: Evidence at protein level;
KW   Activator; Alternative splicing; ANK repeat; Cell membrane;
KW   Complete proteome; Developmental protein; Differentiation;
KW   Disulfide bond; EGF-like domain; Glycoprotein; Membrane;
KW   Notch signaling pathway; Nucleus; Phosphoprotein; Polymorphism;
KW   Receptor; Reference proteome; Repeat; Signal; Transcription;
KW   Transcription regulation; Transmembrane; Transmembrane helix;
KW   Triplet repeat expansion.
FT   SIGNAL        1     23       {ECO:0000255}.
FT   CHAIN        24   2003       Neurogenic locus notch homolog protein 4.
FT                                /FTId=PRO_0000007701.
FT   CHAIN      1432   2003       Notch 4 extracellular truncation.
FT                                {ECO:0000250}.
FT                                /FTId=PRO_0000007702.
FT   CHAIN      1467   2003       Notch 4 intracellular domain.
FT                                {ECO:0000250}.
FT                                /FTId=PRO_0000007703.
FT   TOPO_DOM     24   1447       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1448   1468       Helical. {ECO:0000255}.
FT   TOPO_DOM   1469   2003       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       24     63       EGF-like 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN       64    115       EGF-like 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      118    155       EGF-like 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      156    192       EGF-like 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      194    232       EGF-like 5; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      234    274       EGF-like 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      276    312       EGF-like 7; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      314    353       EGF-like 8; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      355    391       EGF-like 9; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      392    430       EGF-like 10. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      432    473       EGF-like 11; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      475    511       EGF-like 12; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      513    549       EGF-like 13; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      551    587       EGF-like 14; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      589    625       EGF-like 15; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      626    659       EGF-like 16. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      661    689       EGF-like 17. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      691    727       EGF-like 18. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      729    765       EGF-like 19. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      767    803       EGF-like 20. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      806    842       EGF-like 21. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      844    880       EGF-like 22. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      882    928       EGF-like 23. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      930    966       EGF-like 24. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      968   1004       EGF-like 25. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN     1006   1044       EGF-like 26. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN     1046   1085       EGF-like 27. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN     1087   1126       EGF-like 28. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN     1130   1171       EGF-like 29. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   REPEAT     1170   1213       LNR 1.
FT   REPEAT     1214   1250       LNR 2.
FT   REPEAT     1251   1294       LNR 3.
FT   REPEAT     1633   1665       ANK 1.
FT   REPEAT     1666   1698       ANK 2.
FT   REPEAT     1700   1732       ANK 3.
FT   REPEAT     1733   1765       ANK 4.
FT   REPEAT     1766   1798       ANK 5.
FT   COMPBIAS   1472   1476       Poly-Arg.
FT   CARBOHYD    664    664       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    714    714       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    964    964       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1143   1143       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     28     41       {ECO:0000250}.
FT   DISULFID     35     51       {ECO:0000250}.
FT   DISULFID     53     62       {ECO:0000250}.
FT   DISULFID     68     80       {ECO:0000250}.
FT   DISULFID     74    103       {ECO:0000250}.
FT   DISULFID    105    114       {ECO:0000250}.
FT   DISULFID    122    133       {ECO:0000250}.
FT   DISULFID    127    143       {ECO:0000250}.
FT   DISULFID    145    154       {ECO:0000250}.
FT   DISULFID    160    171       {ECO:0000250}.
FT   DISULFID    165    180       {ECO:0000250}.
FT   DISULFID    182    191       {ECO:0000250}.
FT   DISULFID    198    211       {ECO:0000250}.
FT   DISULFID    205    220       {ECO:0000250}.
FT   DISULFID    222    231       {ECO:0000250}.
FT   DISULFID    238    249       {ECO:0000250}.
FT   DISULFID    243    262       {ECO:0000250}.
FT   DISULFID    264    273       {ECO:0000250}.
FT   DISULFID    280    291       {ECO:0000250}.
FT   DISULFID    285    300       {ECO:0000250}.
FT   DISULFID    302    311       {ECO:0000250}.
FT   DISULFID    318    332       {ECO:0000250}.
FT   DISULFID    326    341       {ECO:0000250}.
FT   DISULFID    343    352       {ECO:0000250}.
FT   DISULFID    359    370       {ECO:0000250}.
FT   DISULFID    364    379       {ECO:0000250}.
FT   DISULFID    381    390       {ECO:0000250}.
FT   DISULFID    396    407       {ECO:0000250}.
FT   DISULFID    401    418       {ECO:0000250}.
FT   DISULFID    420    429       {ECO:0000250}.
FT   DISULFID    436    452       {ECO:0000250}.
FT   DISULFID    446    461       {ECO:0000250}.
FT   DISULFID    463    472       {ECO:0000250}.
FT   DISULFID    479    490       {ECO:0000250}.
FT   DISULFID    484    499       {ECO:0000250}.
FT   DISULFID    501    510       {ECO:0000250}.
FT   DISULFID    517    528       {ECO:0000250}.
FT   DISULFID    522    537       {ECO:0000250}.
FT   DISULFID    539    548       {ECO:0000250}.
FT   DISULFID    555    566       {ECO:0000250}.
FT   DISULFID    560    575       {ECO:0000250}.
FT   DISULFID    577    586       {ECO:0000250}.
FT   DISULFID    593    604       {ECO:0000250}.
FT   DISULFID    598    613       {ECO:0000250}.
FT   DISULFID    615    624       {ECO:0000250}.
FT   DISULFID    629    640       {ECO:0000250}.
FT   DISULFID    634    649       {ECO:0000250}.
FT   DISULFID    651    658       {ECO:0000250}.
FT   DISULFID    665    672       {ECO:0000250}.
FT   DISULFID    667    677       {ECO:0000250}.
FT   DISULFID    679    688       {ECO:0000250}.
FT   DISULFID    695    706       {ECO:0000250}.
FT   DISULFID    700    715       {ECO:0000250}.
FT   DISULFID    717    726       {ECO:0000250}.
FT   DISULFID    733    744       {ECO:0000250}.
FT   DISULFID    738    753       {ECO:0000250}.
FT   DISULFID    755    764       {ECO:0000250}.
FT   DISULFID    771    782       {ECO:0000250}.
FT   DISULFID    776    791       {ECO:0000250}.
FT   DISULFID    793    802       {ECO:0000250}.
FT   DISULFID    810    821       {ECO:0000250}.
FT   DISULFID    815    830       {ECO:0000250}.
FT   DISULFID    832    841       {ECO:0000250}.
FT   DISULFID    848    859       {ECO:0000250}.
FT   DISULFID    853    868       {ECO:0000250}.
FT   DISULFID    870    879       {ECO:0000250}.
FT   DISULFID    886    907       {ECO:0000250}.
FT   DISULFID    901    916       {ECO:0000250}.
FT   DISULFID    918    927       {ECO:0000250}.
FT   DISULFID    934    945       {ECO:0000250}.
FT   DISULFID    939    954       {ECO:0000250}.
FT   DISULFID    956    965       {ECO:0000250}.
FT   DISULFID    972    983       {ECO:0000250}.
FT   DISULFID    977    992       {ECO:0000250}.
FT   DISULFID    994   1003       {ECO:0000250}.
FT   DISULFID   1010   1023       {ECO:0000250}.
FT   DISULFID   1015   1032       {ECO:0000250}.
FT   DISULFID   1034   1043       {ECO:0000250}.
FT   DISULFID   1050   1061       {ECO:0000250}.
FT   DISULFID   1055   1073       {ECO:0000250}.
FT   DISULFID   1075   1084       {ECO:0000250}.
FT   DISULFID   1091   1102       {ECO:0000250}.
FT   DISULFID   1096   1114       {ECO:0000250}.
FT   DISULFID   1116   1125       {ECO:0000250}.
FT   DISULFID   1134   1146       {ECO:0000250}.
FT   DISULFID   1140   1159       {ECO:0000250}.
FT   DISULFID   1161   1170       {ECO:0000250}.
FT   DISULFID   1178   1191       {ECO:0000250}.
FT   DISULFID   1187   1203       {ECO:0000250}.
FT   DISULFID   1214   1238       {ECO:0000250}.
FT   DISULFID   1220   1233       {ECO:0000250}.
FT   DISULFID   1229   1245       {ECO:0000250}.
FT   DISULFID   1251   1277       {ECO:0000250}.
FT   DISULFID   1259   1272       {ECO:0000250}.
FT   DISULFID   1268   1284       {ECO:0000250}.
FT   VAR_SEQ       1   1414       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:9693032}.
FT                                /FTId=VSP_001406.
FT   VAR_SEQ     378   2003       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:9693032}.
FT                                /FTId=VSP_001407.
FT   VARIANT     117    117       K -> Q (in dbSNP:rs915894).
FT                                {ECO:0000269|PubMed:14574404,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_012866.
FT   VARIANT     204    204       P -> L (in dbSNP:rs2071282).
FT                                /FTId=VAR_033828.
FT   VARIANT     206    206       P -> L (in dbSNP:rs2071282).
FT                                /FTId=VAR_033829.
FT   VARIANT     244    244       S -> L (in dbSNP:rs8192585).
FT                                /FTId=VAR_033830.
FT   VARIANT     272    272       D -> G (in dbSNP:rs520692).
FT                                /FTId=VAR_012867.
FT   VARIANT     284    284       Q -> H (in dbSNP:rs520803).
FT                                /FTId=VAR_059271.
FT   VARIANT     317    317       E -> Q. {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_012868.
FT   VARIANT     320    320       T -> A (in dbSNP:rs422951).
FT                                /FTId=VAR_012869.
FT   VARIANT     534    534       G -> S (in dbSNP:rs8192591).
FT                                /FTId=VAR_033831.
FT   VARIANT     809    809       S -> I (in dbSNP:rs3132961).
FT                                /FTId=VAR_048991.
FT   VARIANT     851    851       K -> R (in dbSNP:rs2022060).
FT                                /FTId=VAR_012870.
FT   VARIANT     942    942       G -> R (in dbSNP:rs17604492).
FT                                /FTId=VAR_048992.
FT   VARIANT    1346   1346       R -> P (in dbSNP:rs8192573).
FT                                /FTId=VAR_048993.
FT   CONFLICT   1431   1431       A -> V (in Ref. 1; BAA09708).
FT                                {ECO:0000305}.
FT   CONFLICT   1436   1436       A -> E (in Ref. 1; BAA09708).
FT                                {ECO:0000305}.
FT   CONFLICT   1445   1445       L -> F (in Ref. 1; BAA09708).
FT                                {ECO:0000305}.
FT   CONFLICT   1537   1539       Missing (in Ref. 2; AAC63097).
FT                                {ECO:0000305}.
FT   CONFLICT   1538   1538       G -> A (in Ref. 1; BAA09708).
FT                                {ECO:0000305}.
SQ   SEQUENCE   2003 AA;  209622 MW;  BED10283A43A0C14 CRC64;
     MQPPSLLLLL LLLLLLCVSV VRPRGLLCGS FPEPCANGGT CLSLSLGQGT CQCAPGFLGE
     TCQFPDPCQN AQLCQNGGSC QALLPAPLGL PSSPSPLTPS FLCTCLPGFT GERCQAKLED
     PCPPSFCSKR GRCHIQASGR PQCSCMPGWT GEQCQLRDFC SANPCVNGGV CLATYPQIQC
     HCPPGFEGHA CERDVNECFQ DPGPCPKGTS CHNTLGSFQC LCPVGQEGPR CELRAGPCPP
     RGCSNGGTCQ LMPEKDSTFH LCLCPPGFIG PDCEVNPDNC VSHQCQNGGT CQDGLDTYTC
     LCPETWTGWD CSEDVDECET QGPPHCRNGG TCQNSAGSFH CVCVSGWGGT SCEENLDDCI
     AATCAPGSTC IDRVGSFSCL CPPGRTGLLC HLEDMCLSQP CHGDAQCSTN PLTGSTLCLC
     QPGYSGPTCH QDLDECLMAQ QGPSPCEHGG SCLNTPGSFN CLCPPGYTGS RCEADHNECL
     SQPCHPGSTC LDLLATFHCL CPPGLEGQLC EVETNECASA PCLNHADCHD LLNGFQCICL
     PGFSGTRCEE DIDECRSSPC ANGGQCQDQP GAFHCKCLPG FEGPRCQTEV DECLSDPCPV
     GASCLDLPGA FFCLCPSGFT GQLCEVPLCA PNLCQPKQIC KDQKDKANCL CPDGSPGCAP
     PEDNCTCHHG HCQRSSCVCD VGWTGPECEA ELGGCISAPC AHGGTCYPQP SGYNCTCPTG
     YTGPTCSEEM TACHSGPCLN GGSCNPSPGG YYCTCPPSHT GPQCQTSTDY CVSAPCFNGG
     TCVNRPGTFS CLCAMGFQGP RCEGKLRPSC ADSPCRNRAT CQDSPQGPRC LCPTGYTGGS
     CQTLMDLCAQ KPCPRNSHCL QTGPSFHCLC LQGWTGPLCN LPLSSCQKAA LSQGIDVSSL
     CHNGGLCVDS GPSYFCHCPP GFQGSLCQDH VNPCESRPCQ NGATCMAQPS GYLCQCAPGY
     DGQNCSKELD ACQSQPCHNH GTCTPKPGGF HCACPPGFVG LRCEGDVDEC LDQPCHPTGT
     AACHSLANAF YCQCLPGHTG QWCEVEIDPC HSQPCFHGGT CEATAGSPLG FICHCPKGFE
     GPTCSHRAPS CGFHHCHHGG LCLPSPKPGF PPRCACLSGY GGPDCLTPPA PKGCGPPSPC
     LYNGSCSETT GLGGPGFRCS CPHSSPGPRC QKPGAKGCEG RSGDGACDAG CSGPGGNWDG
     GDCSLGVPDP WKGCPSHSRC WLLFRDGQCH PQCDSEECLF DGYDCETPPA CTPAYDQYCH
     DHFHNGHCEK GCNTAECGWD GGDCRPEDGD PEWGPSLALL VVLSPPALDQ QLFALARVLS
     LTLRVGLWVR KDRDGRDMVY PYPGARAEEK LGGTRDPTYQ ERAAPQTQPL GKETDSLSAG
     FVVVMGVDLS RCGPDHPASR CPWDPGLLLR FLAAMAAVGA LEPLLPGPLL AVHPHAGTAP
     PANQLPWPVL CSPVAGVILL ALGALLVLQL IRRRRREHGA LWLPPGFTRR PRTQSAPHRR
     RPPLGEDSIG LKALKPKAEV DEDGVVMCSG PEEGEEVGQA EETGPPSTCQ LWSLSGGCGA
     LPQAAMLTPP QESEMEAPDL DTRGPDGVTP LMSAVCCGEV QSGTFQGAWL GCPEPWEPLL
     DGGACPQAHT VGTGETPLHL AARFSRPTAA RRLLEAGANP NQPDRAGRTP LHAAVAADAR
     EVCQLLLRSR QTAVDARTED GTTPLMLAAR LAVEDLVEEL IAAQADVGAR DKWGKTALHW
     AAAVNNARAA RSLLQAGADK DAQDNREQTP LFLAAREGAV EVAQLLLGLG AARELRDQAG
     LAPADVAHQR NHWDLLTLLE GAGPPEARHK ATPGREAGPF PRARTVSVSV PPHGGGALPR
     CRTLSAGAGP RGGGACLQAR TWSVDLAARG GGAYSHCRSL SGVGAGGGPT PRGRRFSAGM
     RGPRPNPAIM RGRYGVAAGR GGRVSTDDWP CDWVALGACG SASNIPIPPP CLTPSPERGS
     PQLDCGPPAL QEMPINQGGE GKK
//
ID   PSN1_HUMAN              Reviewed;         467 AA.
AC   P49768; B2R6D3; O95465; Q14762; Q15719; Q15720; Q96P33; Q9UIF0;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   20-DEC-2017, entry version 211.
DE   RecName: Full=Presenilin-1;
DE            Short=PS-1;
DE            EC=3.4.23.- {ECO:0000269|PubMed:10206644, ECO:0000269|PubMed:10811883, ECO:0000269|PubMed:10899933, ECO:0000269|PubMed:12679784, ECO:0000269|PubMed:15274632, ECO:0000269|PubMed:26280335};
DE   AltName: Full=Protein S182;
DE   Contains:
DE     RecName: Full=Presenilin-1 NTF subunit;
DE   Contains:
DE     RecName: Full=Presenilin-1 CTF subunit;
DE   Contains:
DE     RecName: Full=Presenilin-1 CTF12;
DE              Short=PS1-CTF12;
GN   Name=PSEN1; Synonyms=AD3, PS1, PSNL1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1 AND 2), VARIANTS
RP   AD3 LEU-146; ARG-163; GLU-246 AND VAL-286, AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=7596406; DOI=10.1038/375754a0;
RA   Sherrington R., Rogaev E.I., Liang Y., Rogaeva E.A., Levesque G.,
RA   Ikeda M., Chi H., Lin C., Li G., Holman K., Tsuda T., Mar L.,
RA   Foncin J.-F., Bruni A.C., Montesi M.P., Sorbi S., Rainero I.,
RA   Pinessi L., Nee L., Chumakov I., Pollen D., Brookes A., Sanseau P.,
RA   Polinsky R.J., Wasco W., da Silva H.A.R., Haines J.L.,
RA   Pericak-Vance M.A., Tanzi R.E., Roses A.D., Fraser P.E., Rommens J.M.,
RA   St George-Hyslop P.H.;
RT   "Cloning of a gene bearing missense mutations in early-onset familial
RT   Alzheimer's disease.";
RL   Nature 375:754-760(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 3), AND TISSUE SPECIFICITY.
RC   TISSUE=Blood, and Brain;
RX   PubMed=8641442; DOI=10.1016/0014-5793(96)00054-3;
RA   Sahara N., Yahagi Y., Takagi H., Kondo T., Okochi M., Usami M.,
RA   Shirasawa T., Mori H.;
RT   "Identification and characterization of presenilin I-467, I-463 and I-
RT   374.";
RL   FEBS Lett. 381:7-11(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4).
RA   Powell C.S., Gegg M.E., Palmer M.S.;
RT   "Human presenilin 1 gene encodes an alternative protein-minilin.";
RL   Submitted (AUG-1998) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Rowen L., Madan A., Qin S., Abbasi N., Dors M., Ratcliffe A.,
RA   Madan A., Dickhoff R., Shaffer T., James R., Lasky S., Hood L.;
RT   "Complete sequence of the gene for presenilin 1.";
RL   Submitted (NOV-1998) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5).
RA   Kang L., Zhang B., Zhou Y., Peng X., Yuan J., Qiang B.;
RL   Submitted (SEP-2001) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S.,
RA   Sun H., Du H., Pepin K., Artiguenave F., Robert C., Cruaud C.,
RA   Bruels T., Jaillon O., Friedlander L., Samson G., Brottier P.,
RA   Cure S., Segurens B., Aniere F., Samain S., Crespeau H., Abbasi N.,
RA   Aiach N., Boscus D., Dickhoff R., Dors M., Dubois I., Friedman C.,
RA   Gouyvenoux M., James R., Madan A., Mairey-Estrada B., Mangenot S.,
RA   Martins N., Menard M., Oztas S., Ratcliffe A., Shaffer T., Trask B.,
RA   Vacherie B., Bellemere C., Belser C., Besnard-Gonnet M.,
RA   Bartol-Mavel D., Boutard M., Briez-Silla S., Combette S.,
RA   Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C., Muselet D.,
RA   Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P., Trybou A.,
RA   Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L.,
RA   Verdier J., Verdier-Discala C., Hillier L.W., Fulton L., McPherson J.,
RA   Matsuda F., Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W.,
RA   Quetier F., Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-113.
RX   PubMed=9070286; DOI=10.1006/bbrc.1996.6043;
RA   Tsujimura A., Yasojima K., Hashimoto-Gotoh T.;
RT   "Cloning of Xenopus presenilin-alpha and -beta cDNAs and their
RT   differential expression in oogenesis and embryogenesis.";
RL   Biochem. Biophys. Res. Commun. 231:392-396(1997).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 24-32, AND ALTERNATIVE SPLICING
RP   (ISOFORMS 6 AND 7).
RC   TISSUE=Megakaryocyte, and Platelet;
RX   PubMed=8804415; DOI=10.1016/0014-5793(96)00845-9;
RA   Vidal R., Ghiso J., Wisniewski T., Frangione B.;
RT   "Alzheimer's presenilin 1 gene expression in platelets and
RT   megakaryocytes. Identification of a novel splice variant.";
RL   FEBS Lett. 393:19-23(1996).
RN   [12]
RP   PROTEIN SEQUENCE OF 36-42; 61-76; 109-129; 217-239; 270-278; 315-320;
RP   345-352 AND 381-395 (ISOFORM 1), IDENTIFICATION BY MASS SPECTROMETRY,
RP   IDENTIFICATION IN GAMMA-SECRETASE COMPLEX, FUNCTION, CATALYTIC
RP   ACTIVITY, AND SUBCELLULAR LOCATION.
RX   PubMed=15274632; DOI=10.1021/bi0494976;
RA   Fraering P.C., Ye W., Strub J.-M., Dolios G., LaVoie M.J.,
RA   Ostaszewski B.L., van Dorsselaer A., Wang R., Selkoe D.J., Wolfe M.S.;
RT   "Purification and characterization of the human gamma-secretase
RT   complex.";
RL   Biochemistry 43:9774-9789(2004).
RN   [13]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=8574969; DOI=10.1038/nm0296-224;
RA   Kovacs D.M., Fausett H.J., Page K.J., Kim T.-W., Moir R.D.,
RA   Merriam D.E., Hollister R.D., Hallmark O.G., Mancini R.,
RA   Felsenstein K.M., Hyman B.T., Tanzi R.E., Wasco W.;
RT   "Alzheimer-associated presenilins 1 and 2: neuronal expression in
RT   brain and localization to intracellular membranes in mammalian
RT   cells.";
RL   Nat. Med. 2:224-229(1996).
RN   [14]
RP   PROTEOLYTIC PROCESSING.
RX   PubMed=9173929; DOI=10.1006/nbdi.1997.0129;
RA   Podlisny M.B., Citron M., Amarante P., Sherrington R., Xia W.,
RA   Zhang J., Diehl T., Levesque G., Fraser P., Haass C., Koo E.H.,
RA   Seubert P., St George-Hyslop P.H., Teplow D.B., Selkoe D.J.;
RT   "Presenilin proteins undergo heterogeneous endoproteolysis between
RT   Thr291 and Ala299 and occur as stable N- and C-terminal fragments in
RT   normal and Alzheimer brain tissue.";
RL   Neurobiol. Dis. 3:325-337(1997).
RN   [15]
RP   PHOSPHORYLATION.
RX   PubMed=9144240; DOI=10.1073/pnas.94.10.5349;
RA   Walter J., Gruenberg J., Capell A., Pesold B., Schindzielorz A.,
RA   Citron M., Mendla K., St George-Hyslop P.H., Multhaup G., Selkoe D.J.,
RA   Haass C.;
RT   "Proteolytic processing of the Alzheimer disease-associated
RT   presenilin-1 generates an in vivo substrate for protein kinase C.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:5349-5354(1997).
RN   [16]
RP   CASPASE CLEAVAGE SITE, AND MUTAGENESIS OF ASP-345; ASP-373 AND
RP   ASP-385.
RX   PubMed=9485372; DOI=10.1021/bi972106l;
RA   Gruenberg J., Walter J., Loetscher H., Deuschle U., Jacobsen H.,
RA   Haass C.;
RT   "Alzheimer's disease associated presenilin-1 holoprotein and its 18-20
RT   kDa C-terminal fragment are death substrates for proteases of the
RT   caspase family.";
RL   Biochemistry 37:2263-2270(1998).
RN   [17]
RP   FUNCTION, INTERACTION WITH CTNNB1, AND SUBCELLULAR LOCATION.
RX   PubMed=9738936; DOI=10.1016/S0014-5793(98)00886-2;
RA   Murayama M., Tanaka S., Palacino J., Murayama O., Honda T., Sun X.,
RA   Yasutake K., Nihonmatsu N., Wolozin B., Takashima A.;
RT   "Direct association of presenilin-1 with beta-catenin.";
RL   FEBS Lett. 433:73-77(1998).
RN   [18]
RP   INTERACTION WITH FLNA AND FLNB.
RX   PubMed=9437013;
RA   Zhang W., Han S.W., McKeel D.W., Goate A., Wu J.Y.;
RT   "Interaction of presenilins with the filamin family of actin-binding
RT   proteins.";
RL   J. Neurosci. 18:914-922(1998).
RN   [19]
RP   FUNCTION, MUTAGENESIS OF MET-292, AND PROTEOLYTIC PROCESSING.
RX   PubMed=10545183; DOI=10.1021/bi9914210;
RA   Steiner H., Romig H., Pesold B., Philipp U., Baader M., Citron M.,
RA   Loetscher H., Jacobsen H., Haass C.;
RT   "Amyloidogenic function of the Alzheimer's disease-associated
RT   presenilin 1 in the absence of endoproteolysis.";
RL   Biochemistry 38:14600-14605(1999).
RN   [20]
RP   INTERACTION WITH MTCH1.
RX   PubMed=10551805; DOI=10.1074/jbc.274.46.32543;
RA   Xu X., Shi Y.-C., Wu X., Gambetti P., Sui D., Cui M.-Z.;
RT   "Identification of a novel PSD-95/Dlg/ZO-1 (PDZ)-like protein
RT   interacting with the C terminus of presenilin-1.";
RL   J. Biol. Chem. 274:32543-32546(1999).
RN   [21]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH NOTCH.
RX   PubMed=10593990; DOI=10.1074/jbc.274.51.36801;
RA   Ray W.J., Yao M., Mumm J., Schroeter E.H., Saftig P., Wolfe M.,
RA   Selkoe D.J., Kopan R., Goate A.M.;
RT   "Cell surface presenilin-1 participates in the gamma-secretase-like
RT   proteolysis of Notch.";
RL   J. Biol. Chem. 274:36801-36807(1999).
RN   [22]
RP   INTERACTION WITH CTNND2 AND CTNNB1, AND SUBCELLULAR LOCATION.
RX   PubMed=10037471; DOI=10.1046/j.1471-4159.1999.0720999.x;
RA   Levesque G., Yu G., Nishimura M., Zhang D.M., Levesque L., Yu H.,
RA   Xu D., Liang Y., Rogaeva E.A., Ikeda M., Duthie M., Murgolo N.,
RA   Wang L., VanderVere P., Bayne M.L., Strader C.D., Rommens J.M.,
RA   Fraser P.E., St George-Hyslop P.H.;
RT   "Presenilins interact with armadillo proteins including neural-
RT   specific plakophilin-related protein and beta-catenin.";
RL   J. Neurochem. 72:999-1008(1999).
RN   [23]
RP   FUNCTION, CATALYTIC ACTIVITY, ACTIVE SITE, AND MUTAGENESIS OF ASP-257
RP   AND ASP-385.
RX   PubMed=10206644; DOI=10.1038/19077;
RA   Wolfe M.S., Xia W., Ostaszewski B.L., Diehl T.S., Kimberly W.T.,
RA   Selkoe D.J.;
RT   "Two transmembrane aspartates in presenilin-1 required for presenilin
RT   endoproteolysis and gamma-secretase activity.";
RL   Nature 398:513-517(1999).
RN   [24]
RP   FUNCTION, CATALYTIC ACTIVITY, ACTIVE SITE, AND MUTAGENESIS OF ASP-257
RP   AND ASP-385.
RX   PubMed=10899933; DOI=10.1046/j.1471-4159.2000.0750583.x;
RA   Berezovska O., Jack C., McLean P., Aster J.C., Hicks C., Xia W.,
RA   Wolfe M.S., Kimberly W.T., Weinmaster G., Selkoe D.J., Hyman B.T.;
RT   "Aspartate mutations in presenilin and gamma-secretase inhibitors both
RT   impair notch1 proteolysis and nuclear translocation with relative
RT   preservation of notch1 signaling.";
RL   J. Neurochem. 75:583-593(2000).
RN   [25]
RP   FUNCTION, CATALYTIC ACTIVITY, AND MUTAGENESIS OF LEU-286.
RX   PubMed=10811883; DOI=10.1073/pnas.100049897;
RA   Kulic L., Walter J., Multhaup G., Teplow D.B., Baumeister R.,
RA   Romig H., Capell A., Steiner H., Haass C.;
RT   "Separation of presenilin function in amyloid beta-peptide generation
RT   and endoproteolysis of Notch.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:5913-5918(2000).
RN   [26]
RP   TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=11987239; DOI=10.1006/bcmd.2002.0486;
RA   Mirinics Z.K., Calafat J., Udby L., Lovelock J., Kjeldsen L.,
RA   Rothermund K., Sisodia S.S., Borregaard N., Corey S.J.;
RT   "Identification of the presenilins in hematopoietic cells with
RT   localization of presenilin 1 to neutrophil and platelet granules.";
RL   Blood Cells Mol. Dis. 28:28-38(2002).
RN   [27]
RP   FUNCTION, SUBCELLULAR LOCATION, AND IDENTIFICATION IN A COMPLEX WITH
RP   CDH1 AND CTNNB1.
RX   PubMed=11953314; DOI=10.1093/emboj/21.8.1948;
RA   Marambaud P., Shioi J., Serban G., Georgakopoulos A., Sarner S.,
RA   Nagy V., Baki L., Wen P., Efthimiopoulos S., Shao Z., Wisniewski T.,
RA   Robakis N.K.;
RT   "A presenilin-1/gamma-secretase cleavage releases the E-cadherin
RT   intracellular domain and regulates disassembly of adherens
RT   junctions.";
RL   EMBO J. 21:1948-1956(2002).
RN   [28]
RP   INTERACTION WITH HERPUD1.
RX   PubMed=11799129; DOI=10.1074/jbc.M112372200;
RA   Sai X., Kawamura Y., Kokame K., Yamaguchi H., Shiraishi H., Suzuki R.,
RA   Suzuki T., Kawaichi M., Miyata T., Kitamura T., De Strooper B.,
RA   Yanagisawa K., Komano H.;
RT   "Endoplasmic reticulum stress-inducible protein, Herp, enhances
RT   presenilin-mediated generation of amyloid beta-protein.";
RL   J. Biol. Chem. 277:12915-12920(2002).
RN   [29]
RP   INTERACTION WITH GFAP, MUTAGENESIS OF 66-ASP--ASP-72; 76-LYS-TYR-77;
RP   82-VAL-ILE-83; VAL-82 AND 84-MET-LEU-85, AND CHARACTERIZATION OF
RP   VARIANTS AD3 VAL-79 AND LEU-82.
RX   PubMed=12058025; DOI=10.1074/jbc.M112121200;
RA   Nielsen A.L., Holm I.E., Johansen M., Bonven B., Jorgensen P.,
RA   Jorgensen A.L.;
RT   "A new splice variant of glial fibrillary acidic protein GFAPepsilon,
RT   interacts with the presenilin proteins.";
RL   J. Biol. Chem. 277:29983-29991(2002).
RN   [30]
RP   INTERACTION WITH CDH2, SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   ASP-385.
RX   PubMed=14515347; DOI=10.1002/jnr.10753;
RA   Uemura K., Kitagawa N., Kohno R., Kuzuya A., Kageyama T.,
RA   Chonabayashi K., Shibasaki H., Shimohama S.;
RT   "Presenilin 1 is involved in maturation and trafficking of N-cadherin
RT   to the plasma membrane.";
RL   J. Neurosci. Res. 74:184-191(2003).
RN   [31]
RP   ENZYME ACTIVITY OF A GAMMA-SECRETASE COMPLEX, CATALYTIC ACTIVITY,
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=12679784; DOI=10.1038/ncb960;
RA   Edbauer D., Winkler E., Regula J.T., Pesold B., Steiner H., Haass C.;
RT   "Reconstitution of gamma-secretase activity.";
RL   Nat. Cell Biol. 5:486-488(2003).
RN   [32]
RP   COMPONENT OF A GAMMA-SECRETASE COMPLEX WITH PEN2; PSEN1/PSEN2 AND
RP   NCSTN.
RX   PubMed=12740439; DOI=10.1073/pnas.1037392100;
RA   Kimberly W.T., LaVoie M.J., Ostaszewski B.L., Ye W., Wolfe M.S.,
RA   Selkoe D.J.;
RT   "Gamma-secretase is a membrane protein complex comprised of
RT   presenilin, nicastrin, Aph-1, and Pen-2.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:6382-6387(2003).
RN   [33]
RP   SPLICE ISOFORM(S) THAT ARE POTENTIAL NMD TARGET(S).
RX   PubMed=14759258; DOI=10.1186/gb-2004-5-2-r8;
RA   Hillman R.T., Green R.E., Brenner S.E.;
RT   "An unappreciated role for RNA surveillance.";
RL   Genome Biol. 5:R8.1-R8.16(2004).
RN   [34]
RP   PHOSPHORYLATION AT SER-310 AND SER-346, AND MUTAGENESIS OF SER-310 AND
RP   SER-346.
RX   PubMed=14576165; DOI=10.1074/jbc.M306653200;
RA   Fluhrer R., Friedlein A., Haass C., Walter J.;
RT   "Phosphorylation of presenilin 1 at the caspase recognition site
RT   regulates its proteolytic processing and the progression of
RT   apoptosis.";
RL   J. Biol. Chem. 279:1585-1593(2004).
RN   [35]
RP   TOPOLOGY.
RX   PubMed=15385547; DOI=10.1074/jbc.M407898200;
RA   Friedmann E., Lemberg M.K., Weihofen A., Dev K.K., Dengler U.,
RA   Rovelli G., Martoglio B.;
RT   "Consensus analysis of signal peptide peptidase and homologous human
RT   aspartic proteases reveals opposite topology of catalytic domains
RT   compared with presenilins.";
RL   J. Biol. Chem. 279:50790-50798(2004).
RN   [36]
RP   FUNCTION, ACTIVE SITES ASP-257 AND ASP-385, AND MUTAGENESIS OF
RP   TYR-256; ASP-257; ASP-385 AND TYR-389.
RX   PubMed=15341515; DOI=10.1111/j.1471-4159.2004.02596.x;
RA   Wrigley J.D., Nunn E.J., Nyabi O., Clarke E.E., Hunt P., Nadin A.,
RA   De Strooper B., Shearman M.S., Beher D.;
RT   "Conserved residues within the putative active site of gamma-secretase
RT   differentially influence enzyme activity and inhibitor binding.";
RL   J. Neurochem. 90:1312-1320(2004).
RN   [37]
RP   INTERACTION WITH CDH1 AND CTNNB1.
RX   PubMed=16126725; DOI=10.1074/jbc.M507503200;
RA   Serban G., Kouchi Z., Baki L., Georgakopoulos A., Litterst C.M.,
RA   Shioi J., Robakis N.K.;
RT   "Cadherins mediate both the association between PS1 and beta-catenin
RT   and the effects of PS1 on beta-catenin stability.";
RL   J. Biol. Chem. 280:36007-36012(2005).
RN   [38]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-43, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [39]
RP   FUNCTION OF PAL MOTIF, MUTAGENESIS OF PRO-433; ALA-434 AND LEU-435,
RP   AND CHARACTERIZATION OF VARIANT AD3 PHE-435.
RX   PubMed=16305624; DOI=10.1111/j.1471-4159.2005.03548.x;
RA   Wang J., Beher D., Nyborg A.C., Shearman M.S., Golde T.E., Goate A.;
RT   "C-terminal PAL motif of presenilin and presenilin homologues required
RT   for normal active site conformation.";
RL   J. Neurochem. 96:218-227(2006).
RN   [40]
RP   REVIEW ON VARIANTS.
RX   PubMed=8875251;
RA   Cruts M., Hendriks L., Van Broeckhoven C.;
RT   "The presenilin genes: a new gene family involved in Alzheimer disease
RT   pathology.";
RL   Hum. Mol. Genet. 5:1449-1455(1996).
RN   [41]
RP   REVIEW ON VARIANTS.
RX   PubMed=9521418;
RX   DOI=10.1002/(SICI)1098-1004(1998)11:3<183::AID-HUMU1>3.0.CO;2-J;
RA   Cruts M., van Broeckhoven C.;
RT   "Presenilin mutations in Alzheimer's disease.";
RL   Hum. Mutat. 11:183-190(1998).
RN   [42]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [43]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [44]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [45]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [46]
RP   INVOLVEMENT IN ACNINV3.
RX   PubMed=20929727; DOI=10.1126/science.1196284;
RA   Wang B., Yang W., Wen W., Sun J., Su B., Liu B., Ma D., Lv D., Wen Y.,
RA   Qu T., Chen M., Sun M., Shen Y., Zhang X.;
RT   "Gamma-secretase gene mutations in familial acne inversa.";
RL   Science 330:1065-1065(2010).
RN   [47]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-43 AND SER-367, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [48]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH UBQLN1.
RX   PubMed=21143716; DOI=10.1111/j.1600-0854.2010.01149.x;
RA   Viswanathan J., Haapasalo A., Bottcher C., Miettinen R.,
RA   Kurkinen K.M., Lu A., Thomas A., Maynard C.J., Romano D., Hyman B.T.,
RA   Berezovska O., Bertram L., Soininen H., Dantuma N.P., Tanzi R.E.,
RA   Hiltunen M.;
RT   "Alzheimer's disease-associated ubiquilin-1 regulates presenilin-1
RT   accumulation and aggresome formation.";
RL   Traffic 12:330-348(2011).
RN   [49]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-43 AND SER-367, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [50] {ECO:0000244|PDB:2KR6}
RP   STRUCTURE BY NMR OF 292-467.
RA   Doetsch V.;
RT   "Solution structure of presenilin-1 CTF subunit.";
RL   Submitted (DEC-2009) to the PDB data bank.
RN   [51]
RP   STRUCTURE BY ELECTRON MICROSCOPY (4.5 ANGSTROMS), FUNCTION,
RP   SUBCELLULAR LOCATION, SUBUNIT, AND TOPOLOGY.
RX   PubMed=25043039; DOI=10.1038/nature13567;
RA   Lu P., Bai X.C., Ma D., Xie T., Yan C., Sun L., Yang G., Zhao Y.,
RA   Zhou R., Scheres S.H., Shi Y.;
RT   "Three-dimensional structure of human gamma-secretase.";
RL   Nature 512:166-170(2014).
RN   [52] {ECO:0000244|PDB:5FN2, ECO:0000244|PDB:5FN3, ECO:0000244|PDB:5FN4, ECO:0000244|PDB:5FN5}
RP   STRUCTURE BY ELECTRON MICROSCOPY (4.00 ANGSTROMS), SUBUNIT, AND
RP   TOPOLOGY.
RX   PubMed=26623517; DOI=10.7554/eLife.11182;
RA   Bai X.C., Rajendra E., Yang G., Shi Y., Scheres S.H.;
RT   "Sampling the conformational space of the catalytic subunit of human
RT   gamma-secretase.";
RL   Elife 4:0-0(2015).
RN   [53] {ECO:0000244|PDB:5A63}
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.40 ANGSTROMS), SUBCELLULAR
RP   LOCATION, TOPOLOGY, SUBUNIT, FUNCTION, CATALYTIC ACTIVITY,
RP   CHARACTERIZATION OF VARIANTS AD3 LEU-213 AND PHE-261, AND MUTAGENESIS
RP   OF ILE-202; LEU-226; PHE-237; LEU-248 AND LEU-424.
RX   PubMed=26280335; DOI=10.1038/nature14892;
RA   Bai X.C., Yan C., Yang G., Lu P., Ma D., Sun L., Zhou R.,
RA   Scheres S.H., Shi Y.;
RT   "An atomic structure of human gamma-secretase.";
RL   Nature 525:212-217(2015).
RN   [54] {ECO:0000244|PDB:4UIS}
RP   STRUCTURE BY ELECTRON MICROSCOPY (4.40 ANGSTROMS) OF 81-463, SUBUNIT,
RP   AND TOPOLOGY.
RX   PubMed=25918421; DOI=10.1073/pnas.1506242112;
RA   Sun L., Zhao L., Yang G., Yan C., Zhou R., Zhou X., Xie T., Zhao Y.,
RA   Wu S., Li X., Shi Y.;
RT   "Structural basis of human gamma-secretase assembly.";
RL   Proc. Natl. Acad. Sci. U.S.A. 112:6003-6008(2015).
RN   [55]
RP   VARIANTS AD3 THR-143 AND ALA-384.
RX   PubMed=8634711; DOI=10.1093/hmg/4.12.2363;
RA   Cruts M., Backhovens H., Wang S.-Y., van Gassen G., Theuns J.,
RA   de Jonghe C., Wehnert A., de Voecht J., de Winter G., Cras P.,
RA   Bruyland M., Datson N., Weissenbach J., den Dunnen J.T., Martin J.-J.,
RA   Hendriks L., Van Broeckhoven C.;
RT   "Molecular genetic analysis of familial early-onset Alzheimer's
RT   disease linked to chromosome 14q24.3.";
RL   Hum. Mol. Genet. 4:2363-2372(1995).
RN   [56]
RP   VARIANTS AD3 LEU-82; HIS-115; THR-139; ARG-163; THR-231; LEU-264;
RP   VAL-392 AND TYR-410.
RX   PubMed=8634712; DOI=10.1093/hmg/4.12.2373;
RA   Campion D., Flaman J.-M., Brice A., Hannequin D., Dubois B.,
RA   Martin C., Moreau V., Charbonnier F., Didierjean O., Tardieu S.,
RA   Penet C., Puel M., Pasquier F., le Doze F., Bellis G., Calenda A.,
RA   Heilig R., Martinez M., Mallet J., Bellis M., Clerget-Darpoux F.,
RA   Agid Y., Frebourg T.;
RT   "Mutations of the presenilin I gene in families with early-onset
RT   Alzheimer's disease.";
RL   Hum. Mol. Genet. 4:2373-2377(1995).
RN   [57]
RP   VARIANTS AD3 VAL-260; VAL-285 AND VAL-392.
RX   PubMed=7651536; DOI=10.1038/376775a0;
RA   Rogaev E.I., Sherrington R., Rogaeva E.A., Levesque G., Ikeda M.,
RA   Liang Y., Chi H., Lin C., Holman K., Tsuda T., Mar L., Sorbi S.,
RA   Nacmias B., Piacentini S., Amaducci L., Chumakov I., Cohen D.,
RA   Lannfelt L., Fraser P.E., Rommens J.M., St George-Hyslop P.H.;
RT   "Familial Alzheimer's disease in kindreds with missense mutations in a
RT   gene on chromosome 1 related to the Alzheimer's disease type 3 gene.";
RL   Nature 376:775-778(1995).
RN   [58]
RP   VARIANTS AD3 VAL-139; VAL-146; TYR-163; THR-267; ALA-280 AND GLY-280.
RX   PubMed=7550356;
RA   Clark R.F., Hutton M., Fuldner R.A., Froelich S., Karran E.,
RA   Talbot C., Crook R., Lendon C.L., Prihar G., He C., Korenblat K.,
RA   Martinez A., Wragg M., Busfield F., Behrens M.I., Myers A., Norton J.,
RA   Morris J., Mehta N., Pearson C., Lincoln S., Baker M., Duff K.,
RA   Zehr C., Perez-Tur J., Houlden H., Ruiz A., Ossa J., Lopera F.,
RA   Arcos M., Madrigal L., Collinge J., Humphreys C., Asworth T.,
RA   Sarner S., Fox N.C., Harvey R., Kennedy A., Roques P.K., Cline R.T.,
RA   Phillips C.A., Venter J.C., Forsel L., Axelman K., Lilius L.,
RA   Johnston J., Cowburn R., Viitanen M., Winblad B., Kosik K.S.,
RA   Haltia M., Poyhonen M., Dickson D., Mann D., Neary D., Snowden J.,
RA   Lantos P., Lannfelt L., Rossor M.N., Roberts G.W., Adams M.D.,
RA   Hardy J., Goate A.M.;
RT   "The structure of the presenilin 1 (S182) gene and identification of
RT   six novel mutations in early onset AD families.";
RL   Nat. Genet. 11:219-222(1995).
RN   [59]
RP   VARIANTS AD3 PHE-96; ARG-163 AND THR-213.
RX   PubMed=8733303; DOI=10.1016/0304-3940(96)12587-8;
RA   Kamino K., Sato S., Sakaki Y., Yoshiiwa A., Nishiwaki Y., Takeda H.,
RA   Tanabe H., Nishimura T., Li K., St George-Hyslop P.H., Miki T.,
RA   Ogihara T.;
RT   "Three different mutations of presenilin 1 gene in early-onset
RT   Alzheimer's disease families.";
RL   Neurosci. Lett. 208:195-198(1996).
RN   [60]
RP   VARIANT AD3 ASP-135.
RX   PubMed=9225696; DOI=10.1002/ana.410420121;
RA   Crook R., Ellis R., Shanks M., Thal L.J., Perez-Tur J., Baker M.,
RA   Hutton M., Haltia T., Hardy J., Galasko D.;
RT   "Early-onset Alzheimer's disease with a presenilin-1 mutation at the
RT   site corresponding to the Volga German presenilin-2 mutation.";
RL   Ann. Neurol. 42:124-128(1997).
RN   [61]
RP   VARIANT AD3 ALA-280.
RX   PubMed=9298817;
RX   DOI=10.1002/(SICI)1098-1004(1997)10:3<186::AID-HUMU2>3.3.CO;2-K;
RA   Lendon C.L., Martinez A., Behrens I.M., Kosik K.S., Madrigal L.,
RA   Norton J., Neuman R., Myers A., Busfield F., Wragg M., Arcos M.,
RA   Arango-Viana J.C., Ossa J., Ruiz A., Goate A.M., Lopera F.;
RT   "E280A PS-1 mutation causes Alzheimer's disease but age of onset is
RT   not modified by ApoE alleles.";
RL   Hum. Mutat. 10:186-195(1997).
RN   [62]
RP   VARIANTS AD3 THR-233 AND THR-278.
RX   PubMed=9172170; DOI=10.1097/00001756-199704140-00043;
RA   Kwok J.B.J., Taddei K., Hallupp M., Fisher C., Brooks W.S., Broe G.A.,
RA   Hardy J., Fulham M.J., Nicholson G.A., Stell R.,
RA   St George-Hyslop P.H., Fraser P.E., Kakulas B., Clarnette R.,
RA   Relkin N., Gandy S.E., Schofield P.R., Martins R.N.;
RT   "Two novel (M233T and R278T) presenilin-1 mutations in early-onset
RT   Alzheimer's disease pedigrees and preliminary evidence for association
RT   of presenilin-1 mutations with a novel phenotype.";
RL   NeuroReport 8:1537-1542(1997).
RN   [63]
RP   VARIANT AD3 PRO-171.
RX   PubMed=9833068;
RA   Ramirez-Duenas M.G., Rogaeva E.A., Leal C.A., Lin C.,
RA   Ramirez-Casillas G.A., Hernandez-Romo J.A., St George-Hyslop P.H.,
RA   Cantu J.M.;
RT   "A novel Leu171Pro mutation in presenilin-1 gene in a Mexican family
RT   with early onset Alzheimer disease.";
RL   Ann. Genet. 41:149-153(1998).
RN   [64]
RP   VARIANT GLY-318.
RX   PubMed=9851443; DOI=10.1002/ana.410440617;
RA   Mattila K.M., Forsell C., Pirttila T., Rinne J.O., Lehtimaki T.,
RA   Roytta M., Lilius L., Eerola A., St George-Hyslop P.H., Frey H.,
RA   Lannfelt L.;
RT   "The Glu318Gly mutation of the presenilin-1 gene does not necessarily
RT   cause Alzheimer's disease.";
RL   Ann. Neurol. 44:965-967(1998).
RN   [65]
RP   VARIANT GLY-318.
RX   PubMed=9851450; DOI=10.1002/ana.410440624;
RA   Aldudo J., Bullido M.J., Frank A., Valdivieso F.;
RT   "Missense mutation E318G of the presenilin-1 gene appears to be a
RT   nonpathogenic polymorphism.";
RL   Ann. Neurol. 44:985-986(1998).
RN   [66]
RP   VARIANTS AD3 VAL-79; CYS-115 AND VAL-231, AND VARIANT GLY-318.
RX   PubMed=9384602; DOI=10.1093/hmg/7.1.43;
RA   Cruts M., van Duijn C.M., Backhovens H., van den Broeck M.,
RA   Wehnert A., Serneels S., Sherrington R., Hutton M., Hardy J.,
RA   St George-Hyslop P.H., Hofman A., van Broeckhoven C.;
RT   "Estimation of the genetic contribution of presenilin-1 and -2
RT   mutations in a population-based study of presenile Alzheimer
RT   disease.";
RL   Hum. Mol. Genet. 7:43-51(1998).
RN   [67]
RP   VARIANTS AD3 ASP-120; ARG-163; VAL-209; VAL-260; LEU-264; TYR-410 AND
RP   PRO-426.
RX   PubMed=9521423;
RX   DOI=10.1002/(SICI)1098-1004(1998)11:3<216::AID-HUMU6>3.3.CO;2-O;
RA   Poorkaj P., Sharma V., Anderson L., Nemens E., Alonso M.E., Orr H.,
RA   White J., Heston L., Bird T.D., Schellenberg G.D.;
RT   "Missense mutations in the chromosome 14 familial Alzheimer's disease
RT   presenilin 1 gene.";
RL   Hum. Mutat. 11:216-221(1998).
RN   [68]
RP   VARIANT AD3 GLU-378.
RX   PubMed=10200054;
RX   DOI=10.1002/(SICI)1098-1004(1998)11:6<481::AID-HUMU13>3.0.CO;2-N;
RA   Besancon R., Lorenzi A., Cruts M., Radawiec S., Sturtz F.,
RA   Broussolle E., Chazot G., van Broeckhoven C., Chamba G.,
RA   Vandenberghe A.;
RT   "Missense mutation in exon 11 (codon 378) of the presenilin-1 gene in
RT   a French family with early-onset Alzheimer's disease and transmission
RT   study by mismatch enhanced allele specific amplification.";
RL   Hum. Mutat. 11:481-481(1998).
RN   [69]
RP   VARIANT AD3 LYS-139.
RX   PubMed=9719376; DOI=10.1136/jmg.35.8.672;
RA   Dumanchin C., Brice A., Campion D., Hannequin D., Martin C.,
RA   Moreau V., Agid Y., Martinez M., Clerget-Darpoux F., Frebourg T.;
RT   "De novo presenilin 1 mutations are rare in clinically sporadic, early
RT   onset Alzheimer's disease cases.";
RL   J. Med. Genet. 35:672-673(1998).
RN   [70]
RP   VARIANT AD3 LEU-117.
RX   PubMed=9507958; DOI=10.1097/00001756-199801260-00008;
RA   Wisniewski T., Dowjat W.K., Buxbaum J.D., Khorkova O.,
RA   Efthimiopoulos S., Kulczycki J., Lojkowska W., Wegiel J.,
RA   Wisniewski H.M., Frangione B.;
RT   "A novel Polish presenilin-1 mutation (P117L) is associated with
RT   familial Alzheimer's disease and leads to death as early as the age of
RT   28 years.";
RL   NeuroReport 9:217-221(1998).
RN   [71]
RP   VARIANTS AD3 LEU-169 AND GLN-436.
RX   PubMed=9831473; DOI=10.1097/00001756-199810050-00034;
RA   Taddei K., Kwok J.B., Kril J.J., Halliday G.M., Creasey H.,
RA   Hallupp M., Fisher C., Brooks W.S., Chung C., Andrews C.,
RA   Masters C.L., Schofield P.R., Martins R.N.;
RT   "Two novel presenilin-1 mutations (Ser169Leu and Pro436Gln) associated
RT   with very early onset Alzheimer's disease.";
RL   NeuroReport 9:3335-3339(1998).
RN   [72]
RP   VARIANT GLY-318.
RX   PubMed=9915968; DOI=10.1086/302200;
RA   Dermaut B., Cruts M., Slooter A.J.C., van Gestel S., de Jonghe C.,
RA   Vanderstichele H., Vanmechelen E., Breteler M.M., Hofman A.,
RA   van Duijn C.M., van Broeckhoven C.;
RT   "The Glu318Gly substitution in presenilin 1 is not causally related to
RT   Alzheimer disease.";
RL   Am. J. Hum. Genet. 64:290-292(1999).
RN   [73]
RP   VARIANTS AD3 LEU-82; HIS-115; ASP-120; THR-139; LEU-146; ILE-147;
RP   ARG-163; CYS-165; TRP-173; THR-231; THR-233; PRO-235; LEU-264;
RP   ILE-390; VAL-392 AND TYR-410, AND VARIANT GLY-318.
RX   PubMed=10441572; DOI=10.1086/302553;
RA   Campion D., Dumanchin C., Hannequin D., Dubois B., Belliard S.,
RA   Puel M., Thomas-Anterion C., Michon A., Martin C., Charbonnier F.,
RA   Raux G., Camuzat A., Penet C., Mesnage V., Martinez M.,
RA   Clerget-Darpoux F., Brice A., Frebourg T.;
RT   "Early-onset autosomal dominant Alzheimer disease: prevalence, genetic
RT   heterogeneity, and mutation spectrum.";
RL   Am. J. Hum. Genet. 65:664-670(1999).
RN   [74]
RP   VARIANTS AD3 PHE-143 AND SER-436.
RX   PubMed=10090481;
RX   DOI=10.1002/(SICI)1098-1004(1999)13:3<256::AID-HUMU11>3.0.CO;2-P;
RA   Palmer M.S., Beck J.A., Campbell T.A., Humphries C.B., Roques P.K.,
RA   Fox N.C., Harvey R., Rossor M.N., Collinge J.;
RT   "Pathogenic presenilin 1 mutations (P436S and I143F) in early-onset
RT   Alzheimer's disease in the UK.";
RL   Hum. Mutat. 13:256-256(1999).
RN   [75]
RP   VARIANT AD3 ARG-209.
RX   PubMed=10447269;
RX   DOI=10.1002/(SICI)1098-1004(1999)14:1<90::AID-HUMU19>3.0.CO;2-S;
RA   Sugiyama N., Suzuki K., Matsumura T., Kawanishi C., Onishi H.,
RA   Yamada Y., Iseki E., Kosaka K.;
RT   "A novel missense mutation (G209R) in exon 8 of the presenilin 1 gene
RT   in a Japanese family with presenile familial Alzheimer's disease.";
RL   Hum. Mutat. 14:90-90(1999).
RN   [76]
RP   VARIANTS AD3 LEU-233; ARG-282 AND THR-409, AND VARIANT GLY-318.
RX   PubMed=10533070;
RX   DOI=10.1002/(SICI)1098-1004(199911)14:5<433::AID-HUMU10>3.0.CO;2-K;
RA   Aldudo J., Bullido M.J., Valdivieso F.;
RT   "DGGE method for the mutational analysis of the coding and proximal
RT   promoter regions of the Alzheimer's disease presenilin-1 gene: two
RT   novel mutations.";
RL   Hum. Mutat. 14:433-439(1999).
RN   [77]
RP   VARIANT AD3 PRO-169.
RX   PubMed=10025789; DOI=10.1212/WNL.52.3.566;
RA   Ezquerra M., Carnero C., Blesa R., Gelpi J.L., Ballesta F., Oliva R.;
RT   "A presenilin 1 mutation (Ser169Pro) associated with early-onset AD
RT   and myoclonic seizures.";
RL   Neurology 52:566-570(1999).
RN   [78]
RP   VARIANT AD3 PRO-219.
RX   PubMed=10208579; DOI=10.1097/00001756-199902250-00011;
RA   Smith M.J., Gardner R.J., Knight M.A., Forrest S.M., Beyreuther K.,
RA   Storey E., McLean C.A., Cotton R.G., Cappal R., Masters C.L.;
RT   "Early-onset Alzheimer's disease caused by a novel mutation at codon
RT   219 of the presenilin-1 gene.";
RL   NeuroReport 10:503-507(1999).
RN   [79]
RP   VARIANT AD3 ASN-116.
RX   PubMed=10439444; DOI=10.1097/00001756-199908020-00006;
RA   Romero I., Joergensen P., Bolwig G., Fraser P.E., Rogaeva E., Mann D.,
RA   Havsager A.-M., Joergensen A.L.;
RT   "A presenilin-1 Thr116Asn substitution in a family with early-onset
RT   Alzheimer's disease.";
RL   NeuroReport 10:2255-2260(1999).
RN   [80]
RP   VARIANTS AD3 VAL-79; LEU-105 AND VAL-139, AND VARIANT GLY-318.
RX   PubMed=10631141; DOI=10.1086/302702;
RA   Finckh U., Mueller-Thomsen T., Mann U., Eggers C., Marksteiner J.,
RA   Meins W., Binetti G., Alberici A., Hock C., Nitsch R.M., Gal A.;
RT   "High prevalence of pathogenic mutations in patients with early-onset
RT   dementia detected by sequence analyses of four different genes.";
RL   Am. J. Hum. Genet. 66:110-117(2000).
RN   [81]
RP   VARIANT AD3 SER-405.
RX   PubMed=10644793; DOI=10.1136/jnnp.68.2.220;
RA   Yasuda M., Maeda S., Kawamata T., Tamaoka A., Yamamoto Y., Kuroda S.,
RA   Maeda K., Tanaka C.;
RT   "Novel presenilin-1 mutation with widespread cortical amyloid
RT   deposition but limited cerebral amyloid angiopathy.";
RL   J. Neurol. Neurosurg. Psych. 68:220-223(2000).
RN   [82]
RP   VARIANT AD3 SER-92.
RX   PubMed=11027672; DOI=10.1006/bbrc.2000.3646;
RA   Lewis P.A., Perez-Tur J., Golde T.E., Hardy J.;
RT   "The presenilin 1 C92S mutation increases abeta 42 production.";
RL   Biochem. Biophys. Res. Commun. 277:261-263(2000).
RN   [83]
RP   VARIANT FRONTOTEMPORAL DEMENTIA PRO-113.
RX   PubMed=11094121; DOI=10.1212/WNL.55.10.1577;
RA   Raux G., Gantier R., Thomas-Anterion C., Boulliat J., Verpillat P.,
RA   Hannequin D., Brice A., Frebourg T., Campion D.;
RT   "Dementia with prominent frontotemporal features associated with L113P
RT   presenilin 1 mutation.";
RL   Neurology 55:1577-1578(2000).
RN   [84]
RP   ERRATUM, AND VARIANT AD3 GLU-431.
RA   Ringman J.M., Jain V., Murrell J., Ghetti B., Cochran E.J.;
RL   Hum. Genet. 109:242-242(2001).
RN   [85]
RP   VARIANT AD3 ALA-206.
RX   PubMed=11710891; DOI=10.1001/jama.286.18.2257;
RA   Athan E.S., Williamson J., Ciappa A., Santana V., Romas S.N.,
RA   Lee J.H., Rondon H., Lantigua R.A., Medrano M., Torres M., Arawaka S.,
RA   Rogaeva E., Song Y.-Q., Sato C., Kawarai T., Fafel K.C., Boss M.A.,
RA   Seltzer W.K., Stern Y., St George-Hyslop P.H., Tycko B., Mayeux R.;
RT   "A founder mutation in presenilin 1 causing early-onset Alzheimer
RT   disease in unrelated Caribbean Hispanic families.";
RL   JAMA 286:2257-2263(2001).
RN   [86]
RP   VARIANTS AD3 GLN-35; VAL-79; CYS-115; ASN-116; THR-143; ILE-146;
RP   LEU-146; VAL-146; TYR-156 DELINS PHE-THR-TYR; ARG-163; LEU-177;
RP   SER-177; PRO-178; ALA-206; SER-206; GLU-209; LEU-213; ARG-222;
RP   THR-231; LEU-233; PRO-235; PHE-261; ARG-274; ARG-352 INS; ILE-354;
RP   GLN-358; TYR-365; VAL-394; PHE-418; GLU-431; PHE-435 AND VAL-439, AND
RP   VARIANT GLY-318.
RX   PubMed=11524469; DOI=10.1212/WNL.57.4.621;
RA   Rogaeva E.A., Fafel K.C., Song Y.Q., Medeiros H., Sato C., Liang Y.,
RA   Richard E., Rogaev E.I., Frommelt P., Sadovnick A.D., Meschino W.,
RA   Rockwood K., Boss M.A., Mayeux R., St George-Hyslop P.;
RT   "Screening for PS1 mutations in a referral-based series of AD cases:
RT   21 novel mutations.";
RL   Neurology 57:621-625(2001).
RN   [87]
RP   VARIANT AD3 SER-266.
RX   PubMed=11920851; DOI=10.1002/ajmg.10250;
RA   Matsubara-Tsutsui M., Yasuda M., Yamagata H., Nomura T., Taguchi K.,
RA   Kohara K., Miyoshi K., Miki T.;
RT   "Molecular evidence of presenilin 1 mutation in familial early onset
RT   dementia.";
RL   Am. J. Med. Genet. 114:292-298(2002).
RN   [88]
RP   VARIANT AD3 PRO-166.
RX   PubMed=12048239; DOI=10.1073/pnas.112686799;
RA   Moehlmann T., Winkler E., Xia X., Edbauer D., Murrell J., Capell A.,
RA   Kaether C., Zheng H., Ghetti B., Haass C., Steiner H.;
RT   "Presenilin-1 mutations of leucine 166 equally affect the generation
RT   of the Notch and APP intracellular domains independent of their effect
RT   on Abeta 42 production.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:8025-8030(2002).
RN   [89]
RP   VARIANT AD3 MET-174.
RX   PubMed=12484344; DOI=10.1007/s10048-002-0136-6;
RA   Bertoli-Avella A.M., Marcheco Teruel B., Llibre Rodriguez J.J.,
RA   Gomez Viera N., Borrajero-Martinez I., Severijnen E.A., Joosse M.,
RA   van Duijn C.M., Heredero Baute L., Heutink P.;
RT   "A novel presenilin 1 mutation (L174 M) in a large Cuban family with
RT   early onset Alzheimer disease.";
RL   Neurogenetics 4:97-104(2002).
RN   [90]
RP   VARIANT AD3 VAL-271.
RX   PubMed=12493737; DOI=10.1074/jbc.M211827200;
RA   Kwok J.B.J., Halliday G.M., Brooks W.S., Dolios G., Laudon H.,
RA   Murayama O., Hallupp M., Badenhop R.F., Vickers J., Wang R.,
RA   Naslund J., Takashima A., Gandy S.E., Schofield P.R.;
RT   "Presenilin-1 mutation L271V results in altered exon 8 splicing and
RT   Alzheimer's disease with non-cored plaques and no neuritic
RT   dystrophy.";
RL   J. Biol. Chem. 278:6748-6754(2003).
RN   [91]
RP   VARIANT CMD1U GLY-333.
RX   PubMed=17186461; DOI=10.1086/509900;
RA   Li D., Parks S.B., Kushner J.D., Nauman D., Burgess D., Ludwigsen S.,
RA   Partain J., Nixon R.R., Allen C.N., Irwin R.P., Jakobs P.M., Litt M.,
RA   Hershberger R.E.;
RT   "Mutations of presenilin genes in dilated cardiomyopathy and heart
RT   failure.";
RL   Am. J. Hum. Genet. 79:1030-1039(2006).
RN   [92]
RP   VARIANT GLY-318.
RX   PubMed=18485326; DOI=10.1016/j.ajhg.2008.04.014;
RA   Cornier A.S., Staehling-Hampton K., Delventhal K.M., Saga Y.,
RA   Caubet J.-F., Sasaki N., Ellard S., Young E., Ramirez N., Carlo S.E.,
RA   Torres J., Emans J.B., Turnpenny P.D., Pourquie O.;
RT   "Mutations in the MESP2 gene cause spondylothoracic dysostosis/Jarcho-
RT   Levin syndrome.";
RL   Am. J. Hum. Genet. 82:1334-1341(2008).
RN   [93]
RP   VARIANT AD3 PHE-435, CHARACTERIZATION OF VARIANTS AD3 PHE-435; GLN-436
RP   AND SER-436, AND CHARACTERIZATION OF VARIANTS LEU-433 AND ARG-435.
RX   PubMed=20460383; DOI=10.1074/jbc.M110.116962;
RA   Heilig E.A., Xia W., Shen J., Kelleher R.J. III;
RT   "A presenilin-1 mutation identified in familial Alzheimer disease with
RT   cotton wool plaques causes a nearly complete loss of gamma-secretase
RT   activity.";
RL   J. Biol. Chem. 285:22350-22359(2010).
RN   [94]
RP   VARIANT CYS-315.
RX   PubMed=21248752; DOI=10.1038/nature09639;
RA   Varela I., Tarpey P., Raine K., Huang D., Ong C.K., Stephens P.,
RA   Davies H., Jones D., Lin M.L., Teague J., Bignell G., Butler A.,
RA   Cho J., Dalgliesh G.L., Galappaththige D., Greenman C., Hardy C.,
RA   Jia M., Latimer C., Lau K.W., Marshall J., McLaren S., Menzies A.,
RA   Mudie L., Stebbings L., Largaespada D.A., Wessels L.F.A., Richard S.,
RA   Kahnoski R.J., Anema J., Tuveson D.A., Perez-Mancera P.A.,
RA   Mustonen V., Fischer A., Adams D.J., Rust A., Chan-On W., Subimerb C.,
RA   Dykema K., Furge K., Campbell P.J., Teh B.T., Stratton M.R.,
RA   Futreal P.A.;
RT   "Exome sequencing identifies frequent mutation of the SWI/SNF complex
RT   gene PBRM1 in renal carcinoma.";
RL   Nature 469:539-542(2011).
RN   [95]
RP   VARIANTS AD3 ARG-134; ARG-163 AND VAL-262, AND VARIANT TYR-214.
RX   PubMed=22503161; DOI=10.1016/j.neurobiolaging.2012.02.020;
RA   Lohmann E., Guerreiro R.J., Erginel-Unaltuna N., Gurunlian N.,
RA   Bilgic B., Gurvit H., Hanagasi H.A., Luu N., Emre M., Singleton A.;
RT   "Identification of PSEN1 and PSEN2 gene mutations and variants in
RT   Turkish dementia patients.";
RL   Neurobiol. Aging 33:1850.E17-1850.E27(2012).
RN   [96]
RP   VARIANT AD3 THR-83.
RX   PubMed=26145164; DOI=10.1016/j.neurobiolaging.2015.06.007;
RA   Achouri-Rassas A., Ben Ali N., Fray S., Hadj Fredj S., Kechaou M.,
RA   Zakraoui N.O., Cherif A., Chabbi S., Anane N., Messaoud T.,
RA   Gouider R., Belal S.;
RT   "Novel presenilin 1 mutation (p.I83T) in Tunisian family with early-
RT   onset Alzheimer's disease.";
RL   Neurobiol. Aging 36:2904.E09-2904.E11(2015).
RN   [97]
RP   VARIANT AD3 THR-408.
RX   PubMed=26549787; DOI=10.1016/j.neulet.2015.11.004;
RA   Tedde A., Bartoli A., Piaceri I., Ferrara S., Bagnoli S., Serio A.,
RA   Sorbi S., Nacmias B.;
RT   "Novel presenilin 1 mutation (Ile408Thr) in an Italian family with
RT   late-onset Alzheimer's disease.";
RL   Neurosci. Lett. 610:150-153(2016).
CC   -!- FUNCTION: Catalytic subunit of the gamma-secretase complex, an
CC       endoprotease complex that catalyzes the intramembrane cleavage of
CC       integral membrane proteins such as Notch receptors and APP
CC       (amyloid-beta precursor protein) (PubMed:15274632,
CC       PubMed:10545183, PubMed:10593990, PubMed:10206644,
CC       PubMed:10899933, PubMed:10811883, PubMed:12679784,
CC       PubMed:12740439, PubMed:25043039, PubMed:26280335). Requires the
CC       presence of the other members of the gamma-secretase complex for
CC       protease activity (PubMed:15274632, PubMed:25043039,
CC       PubMed:26280335). Plays a role in Notch and Wnt signaling cascades
CC       and regulation of downstream processes via its role in processing
CC       key regulatory proteins, and by regulating cytosolic CTNNB1 levels
CC       (PubMed:9738936, PubMed:10593990, PubMed:10899933,
CC       PubMed:10811883). Stimulates cell-cell adhesion via its
CC       interaction with CDH1; this stabilizes the complexes between CDH1
CC       (E-cadherin) and its interaction partners CTNNB1 (beta-catenin),
CC       CTNND1 and JUP (gamma-catenin) (PubMed:11953314). Under conditions
CC       of apoptosis or calcium influx, cleaves CDH1 (PubMed:11953314).
CC       This promotes the disassembly of the complexes between CDH1 and
CC       CTNND1, JUP and CTNNB1, increases the pool of cytoplasmic CTNNB1,
CC       and thereby negatively regulates Wnt signaling (PubMed:9738936,
CC       PubMed:11953314). Required for normal embryonic brain and skeleton
CC       development, and for normal angiogenesis (By similarity).
CC       {ECO:0000250|UniProtKB:P49769, ECO:0000269|PubMed:10206644,
CC       ECO:0000269|PubMed:10545183, ECO:0000269|PubMed:10593990,
CC       ECO:0000269|PubMed:10811883, ECO:0000269|PubMed:10899933,
CC       ECO:0000269|PubMed:11953314, ECO:0000269|PubMed:12679784,
CC       ECO:0000269|PubMed:12740439, ECO:0000269|PubMed:15274632,
CC       ECO:0000269|PubMed:15341515, ECO:0000269|PubMed:16305624,
CC       ECO:0000269|PubMed:25043039, ECO:0000269|PubMed:26280335,
CC       ECO:0000269|PubMed:9738936}.
CC   -!- SUBUNIT: Homodimer. The functional gamma-secretase complex is
CC       composed of at least four polypeptides: a presenilin homodimer
CC       (PSEN1 or PSEN2), nicastrin (NCSTN), APH1 (APH1A or APH1B) and
CC       PEN2 (PubMed:15274632, PubMed:12679784, PubMed:12740439,
CC       PubMed:25043039, PubMed:26280335). Such minimal complex is
CC       sufficient for secretase activity (PubMed:15274632,
CC       PubMed:12679784, PubMed:12740439, PubMed:25043039,
CC       PubMed:26280335). Other components which are associated with the
CC       complex include SLC25A64, SLC5A7, PHB and PSEN1 isoform 3.
CC       Predominantly heterodimer of a N-terminal (NTF) and a C-terminal
CC       (CTF) endoproteolytical fragment (PubMed:15274632). Associates
CC       with proteolytic processed C-terminal fragments C83 and C99 of the
CC       amyloid precursor protein (APP). Associates with NOTCH1
CC       (PubMed:10593990). Associates with cadherin/catenin adhesion
CC       complexes through direct binding to CDH1 or CDH2 (PubMed:11953314,
CC       PubMed:14515347, PubMed:16126725). Interaction with CDH1
CC       stabilizes the complex and stimulates cell-cell aggregation
CC       (PubMed:11953314). Interaction with CDH2 is essential for
CC       trafficking of CDH2 from the endoplasmic reticulum to the plasma
CC       membrane (PubMed:14515347). Interacts with CTNND2, CTNNB1, CTNND1,
CC       JUP, HERPUD1, FLNA, FLNB, MTCH1, PKP4 and PARL (PubMed:9738936,
CC       PubMed:9437013, PubMed:10551805, PubMed:10037471, PubMed:11953314,
CC       PubMed:11799129, PubMed:16126725). Interacts through its N-
CC       terminus with isoform 3 of GFAP (PubMed:12058025). Interacts with
CC       DOCK3 (By similarity). Interacts with isoform 1 and isoform 3 of
CC       UBQLN1 (PubMed:21143716). {ECO:0000250|UniProtKB:P49769,
CC       ECO:0000269|PubMed:10037471, ECO:0000269|PubMed:10551805,
CC       ECO:0000269|PubMed:11799129, ECO:0000269|PubMed:11953314,
CC       ECO:0000269|PubMed:12058025, ECO:0000269|PubMed:12679784,
CC       ECO:0000269|PubMed:12740439, ECO:0000269|PubMed:14515347,
CC       ECO:0000269|PubMed:15274632, ECO:0000269|PubMed:16126725,
CC       ECO:0000269|PubMed:21143716, ECO:0000269|PubMed:25043039,
CC       ECO:0000269|PubMed:26280335, ECO:0000269|PubMed:9437013,
CC       ECO:0000269|PubMed:9738936}.
CC   -!- INTERACTION:
CC       Q02410:APBA1; NbExp=4; IntAct=EBI-297277, EBI-368690;
CC       P98084:Apba2 (xeno); NbExp=2; IntAct=EBI-297277, EBI-81669;
CC       P05067:APP; NbExp=6; IntAct=EBI-297277, EBI-77613;
CC       P05067-4:APP; NbExp=4; IntAct=EBI-297277, EBI-302641;
CC       Q63053:Arc (xeno); NbExp=3; IntAct=EBI-2606326, EBI-5275794;
CC       Q16543:CDC37; NbExp=3; IntAct=EBI-297277, EBI-295634;
CC       P35222:CTNNB1; NbExp=2; IntAct=EBI-297277, EBI-491549;
CC       Q02248:Ctnnb1 (xeno); NbExp=3; IntAct=EBI-297277, EBI-397872;
CC       Q9BQ95:ECSIT; NbExp=4; IntAct=EBI-297277, EBI-712452;
CC       P14923:JUP; NbExp=4; IntAct=EBI-297277, EBI-702484;
CC       Q92542:NCSTN; NbExp=3; IntAct=EBI-297277, EBI-998440;
CC       P50502:ST13; NbExp=3; IntAct=EBI-297277, EBI-357285;
CC       P49755:TMED10; NbExp=3; IntAct=EBI-297277, EBI-998422;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:10593990, ECO:0000269|PubMed:8574969,
CC       ECO:0000269|PubMed:9738936, ECO:0000305|PubMed:10037471,
CC       ECO:0000305|PubMed:15274632}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:25043039, ECO:0000269|PubMed:25918421,
CC       ECO:0000269|PubMed:26280335, ECO:0000269|PubMed:26623517}. Golgi
CC       apparatus membrane {ECO:0000269|PubMed:10593990,
CC       ECO:0000269|PubMed:8574969, ECO:0000305|PubMed:10037471,
CC       ECO:0000305|PubMed:15274632}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:25043039, ECO:0000269|PubMed:25918421,
CC       ECO:0000269|PubMed:26280335, ECO:0000269|PubMed:26623517}.
CC       Cytoplasmic granule {ECO:0000269|PubMed:11987239}. Cell membrane
CC       {ECO:0000269|PubMed:10593990, ECO:0000269|PubMed:11953314,
CC       ECO:0000269|PubMed:11987239, ECO:0000269|PubMed:21143716}.
CC       Note=Translocates with bound NOTCH1 from the endoplasmic reticulum
CC       and/or Golgi to the cell surface (PubMed:10593990). Colocalizes
CC       with CDH1/2 at sites of cell-cell contact. Colocalizes with CTNNB1
CC       in the endoplasmic reticulum and the proximity of the plasma
CC       membrane (PubMed:9738936). Also present in azurophil granules of
CC       neutrophils (PubMed:11987239). Colocalizes with UBQLN1 in the cell
CC       membrane and in cytoplasmic juxtanuclear structures called
CC       aggresomes (PubMed:21143716). {ECO:0000269|PubMed:10593990,
CC       ECO:0000269|PubMed:11987239, ECO:0000269|PubMed:21143716,
CC       ECO:0000269|PubMed:9738936}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=7;
CC       Name=1; Synonyms=I-467;
CC         IsoId=P49768-1; Sequence=Displayed;
CC       Name=2; Synonyms=I-463;
CC         IsoId=P49768-2; Sequence=VSP_005191;
CC       Name=3; Synonyms=I-374;
CC         IsoId=P49768-3; Sequence=VSP_005191, VSP_005192;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay.;
CC       Name=4; Synonyms=Minilin;
CC         IsoId=P49768-4; Sequence=VSP_007986, VSP_007987;
CC       Name=5;
CC         IsoId=P49768-5; Sequence=VSP_005192;
CC       Name=6;
CC         IsoId=P49768-6; Sequence=VSP_012288;
CC       Name=7;
CC         IsoId=P49768-7; Sequence=VSP_041440;
CC   -!- TISSUE SPECIFICITY: Detected in azurophile granules in neutrophils
CC       and in platelet cytoplasmic granules (at protein level)
CC       (PubMed:11987239). Expressed in a wide range of tissues including
CC       various regions of the brain, liver, spleen and lymph nodes
CC       (PubMed:7596406, PubMed:8641442, PubMed:8574969).
CC       {ECO:0000269|PubMed:11987239, ECO:0000269|PubMed:7596406,
CC       ECO:0000269|PubMed:8574969, ECO:0000269|PubMed:8641442}.
CC   -!- DOMAIN: The PAL motif is required for normal active site
CC       conformation. {ECO:0000269|PubMed:16305624}.
CC   -!- PTM: Heterogeneous proteolytic processing generates N-terminal
CC       (NTF) and C-terminal (CTF) fragments of approximately 35 and 20
CC       kDa, respectively. During apoptosis, the C-terminal fragment (CTF)
CC       is further cleaved by caspase-3 to produce the fragment, PS1-
CC       CTF12. {ECO:0000269|PubMed:10545183, ECO:0000269|PubMed:15274632,
CC       ECO:0000269|PubMed:9173929, ECO:0000269|PubMed:9485372}.
CC   -!- PTM: After endoproteolysis, the C-terminal fragment (CTF) is
CC       phosphorylated on serine residues by PKA and/or PKC.
CC       Phosphorylation on Ser-346 inhibits endoproteolysis.
CC       {ECO:0000269|PubMed:14576165, ECO:0000269|PubMed:9144240}.
CC   -!- DISEASE: Alzheimer disease 3 (AD3) [MIM:607822]: A familial early-
CC       onset form of Alzheimer disease. Alzheimer disease is a
CC       neurodegenerative disorder characterized by progressive dementia,
CC       loss of cognitive abilities, and deposition of fibrillar amyloid
CC       proteins as intraneuronal neurofibrillary tangles, extracellular
CC       amyloid plaques and vascular amyloid deposits. The major
CC       constituents of these plaques are neurotoxic amyloid-beta protein
CC       40 and amyloid-beta protein 42, that are produced by the
CC       proteolysis of the transmembrane APP protein. The cytotoxic C-
CC       terminal fragments (CTFs) and the caspase-cleaved products, such
CC       as C31, are also implicated in neuronal death.
CC       {ECO:0000269|PubMed:10025789, ECO:0000269|PubMed:10090481,
CC       ECO:0000269|PubMed:10200054, ECO:0000269|PubMed:10208579,
CC       ECO:0000269|PubMed:10439444, ECO:0000269|PubMed:10441572,
CC       ECO:0000269|PubMed:10447269, ECO:0000269|PubMed:10533070,
CC       ECO:0000269|PubMed:10631141, ECO:0000269|PubMed:10644793,
CC       ECO:0000269|PubMed:11027672, ECO:0000269|PubMed:11524469,
CC       ECO:0000269|PubMed:11710891, ECO:0000269|PubMed:11920851,
CC       ECO:0000269|PubMed:12048239, ECO:0000269|PubMed:12058025,
CC       ECO:0000269|PubMed:12484344, ECO:0000269|PubMed:12493737,
CC       ECO:0000269|PubMed:16305624, ECO:0000269|PubMed:20460383,
CC       ECO:0000269|PubMed:22503161, ECO:0000269|PubMed:26145164,
CC       ECO:0000269|PubMed:26280335, ECO:0000269|PubMed:26549787,
CC       ECO:0000269|PubMed:7550356, ECO:0000269|PubMed:7596406,
CC       ECO:0000269|PubMed:7651536, ECO:0000269|PubMed:8634711,
CC       ECO:0000269|PubMed:8634712, ECO:0000269|PubMed:8733303,
CC       ECO:0000269|PubMed:9172170, ECO:0000269|PubMed:9225696,
CC       ECO:0000269|PubMed:9298817, ECO:0000269|PubMed:9384602,
CC       ECO:0000269|PubMed:9507958, ECO:0000269|PubMed:9521423,
CC       ECO:0000269|PubMed:9719376, ECO:0000269|PubMed:9831473,
CC       ECO:0000269|PubMed:9833068, ECO:0000269|Ref.84}. Note=The disease
CC       is caused by mutations affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Frontotemporal dementia (FTD) [MIM:600274]: A form of
CC       dementia characterized by pathologic finding of frontotemporal
CC       lobar degeneration, presenile dementia with behavioral changes,
CC       deterioration of cognitive capacities and loss of memory. In some
CC       cases, parkinsonian symptoms are prominent. Neuropathological
CC       changes include frontotemporal atrophy often associated with
CC       atrophy of the basal ganglia, substantia nigra, amygdala. In most
CC       cases, protein tau deposits are found in glial cells and/or
CC       neurons. {ECO:0000269|PubMed:11094121}. Note=The disease is caused
CC       by mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Cardiomyopathy, dilated 1U (CMD1U) [MIM:613694]: A
CC       disorder characterized by ventricular dilation and impaired
CC       systolic function, resulting in congestive heart failure and
CC       arrhythmia. Patients are at risk of premature death.
CC       {ECO:0000269|PubMed:17186461}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Acne inversa, familial, 3 (ACNINV3) [MIM:613737]: A
CC       chronic relapsing inflammatory disease of the hair follicles
CC       characterized by recurrent draining sinuses, painful skin
CC       abscesses, and disfiguring scars. Manifestations typically appear
CC       after puberty. {ECO:0000269|PubMed:20929727}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the peptidase A22A family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Alzheimer Research Forum; Note=Presenilins
CC       mutations;
CC       URL="http://www.alzforum.org/mutations/search?genes%255B%255D=348";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L42110; AAB46416.1; -; mRNA.
DR   EMBL; L76517; AAB46370.1; -; mRNA.
DR   EMBL; L76528; AAB46371.1; -; Genomic_DNA.
DR   EMBL; L76519; AAB46371.1; JOINED; Genomic_DNA.
DR   EMBL; L76520; AAB46371.1; JOINED; Genomic_DNA.
DR   EMBL; L76521; AAB46371.1; JOINED; Genomic_DNA.
DR   EMBL; L76522; AAB46371.1; JOINED; Genomic_DNA.
DR   EMBL; L76523; AAB46371.1; JOINED; Genomic_DNA.
DR   EMBL; L76524; AAB46371.1; JOINED; Genomic_DNA.
DR   EMBL; L76525; AAB46371.1; JOINED; Genomic_DNA.
DR   EMBL; L76526; AAB46371.1; JOINED; Genomic_DNA.
DR   EMBL; L76527; AAB46371.1; JOINED; Genomic_DNA.
DR   EMBL; U40379; AAB05894.1; -; mRNA.
DR   EMBL; U40380; AAB05895.1; -; mRNA.
DR   EMBL; AJ008005; CAA07825.1; -; mRNA.
DR   EMBL; AF109907; AAC97960.1; -; Genomic_DNA.
DR   EMBL; AF416717; AAL16811.1; -; mRNA.
DR   EMBL; AK312531; BAG35430.1; -; mRNA.
DR   EMBL; AC004858; AAF19253.1; -; Genomic_DNA.
DR   EMBL; AC004858; AAF19254.1; -; Genomic_DNA.
DR   EMBL; CH471061; EAW81092.1; -; Genomic_DNA.
DR   EMBL; BC011729; AAH11729.1; -; mRNA.
DR   EMBL; D84149; BAA20883.1; -; Genomic_DNA.
DR   CCDS; CCDS9812.1; -. [P49768-1]
DR   CCDS; CCDS9813.1; -. [P49768-2]
DR   PIR; S58396; S58396.
DR   PIR; S63683; S63683.
DR   PIR; S63684; S63684.
DR   RefSeq; NP_000012.1; NM_000021.3. [P49768-1]
DR   RefSeq; NP_015557.2; NM_007318.2. [P49768-2]
DR   RefSeq; XP_005267921.1; XM_005267864.2. [P49768-1]
DR   RefSeq; XP_005267923.1; XM_005267866.1. [P49768-2]
DR   RefSeq; XP_011535273.1; XM_011536971.2. [P49768-1]
DR   RefSeq; XP_011535274.1; XM_011536972.2. [P49768-1]
DR   RefSeq; XP_011535275.1; XM_011536973.1. [P49768-2]
DR   RefSeq; XP_011535276.1; XM_011536974.1. [P49768-2]
DR   UniGene; Hs.3260; -.
DR   PDB; 2KR6; NMR; -; A=292-467.
DR   PDB; 4UIS; EM; 4.40 A; B=81-463.
DR   PDB; 5A63; EM; 3.40 A; B=1-467.
DR   PDB; 5FN2; EM; 4.20 A; B=1-467.
DR   PDB; 5FN3; EM; 4.10 A; B=1-467.
DR   PDB; 5FN4; EM; 4.00 A; B=1-467.
DR   PDB; 5FN5; EM; 4.30 A; B=1-467.
DR   PDBsum; 2KR6; -.
DR   PDBsum; 4UIS; -.
DR   PDBsum; 5A63; -.
DR   PDBsum; 5FN2; -.
DR   PDBsum; 5FN3; -.
DR   PDBsum; 5FN4; -.
DR   PDBsum; 5FN5; -.
DR   ProteinModelPortal; P49768; -.
DR   SMR; P49768; -.
DR   BioGrid; 111642; 88.
DR   CORUM; P49768; -.
DR   DIP; DIP-1134N; -.
DR   ELM; P49768; -.
DR   IntAct; P49768; 137.
DR   MINT; MINT-88325; -.
DR   STRING; 9606.ENSP00000326366; -.
DR   BindingDB; P49768; -.
DR   ChEMBL; CHEMBL2473; -.
DR   GuidetoPHARMACOLOGY; 2402; -.
DR   MEROPS; A22.001; -.
DR   TCDB; 1.A.54.1.1; the presenilin er ca(2+) leak channel (presenilin) family.
DR   iPTMnet; P49768; -.
DR   PhosphoSitePlus; P49768; -.
DR   SwissPalm; P49768; -.
DR   BioMuta; PSEN1; -.
DR   DMDM; 1709856; -.
DR   EPD; P49768; -.
DR   MaxQB; P49768; -.
DR   PaxDb; P49768; -.
DR   PeptideAtlas; P49768; -.
DR   PRIDE; P49768; -.
DR   DNASU; 5663; -.
DR   Ensembl; ENST00000324501; ENSP00000326366; ENSG00000080815. [P49768-1]
DR   Ensembl; ENST00000357710; ENSP00000350342; ENSG00000080815. [P49768-2]
DR   Ensembl; ENST00000394157; ENSP00000377712; ENSG00000080815. [P49768-4]
DR   Ensembl; ENST00000394164; ENSP00000377719; ENSG00000080815. [P49768-2]
DR   Ensembl; ENST00000553855; ENSP00000452242; ENSG00000080815. [P49768-5]
DR   Ensembl; ENST00000555386; ENSP00000450845; ENSG00000080815. [P49768-3]
DR   Ensembl; ENST00000557511; ENSP00000451429; ENSG00000080815. [P49768-6]
DR   GeneID; 5663; -.
DR   KEGG; hsa:5663; -.
DR   UCSC; uc001xnq.5; human. [P49768-1]
DR   CTD; 5663; -.
DR   DisGeNET; 5663; -.
DR   EuPathDB; HostDB:ENSG00000080815.18; -.
DR   GeneCards; PSEN1; -.
DR   GeneReviews; PSEN1; -.
DR   HGNC; HGNC:9508; PSEN1.
DR   HPA; CAB006844; -.
DR   HPA; HPA030760; -.
DR   HPA; HPA067496; -.
DR   MalaCards; PSEN1; -.
DR   MIM; 104311; gene.
DR   MIM; 600274; phenotype.
DR   MIM; 607822; phenotype.
DR   MIM; 613694; phenotype.
DR   MIM; 613737; phenotype.
DR   neXtProt; NX_P49768; -.
DR   OpenTargets; ENSG00000080815; -.
DR   Orphanet; 275864; Behavioral variant of frontotemporal dementia.
DR   Orphanet; 1020; Early-onset autosomal dominant Alzheimer disease.
DR   Orphanet; 154; Familial isolated dilated cardiomyopathy.
DR   Orphanet; 387; Hidradenitis suppurativa.
DR   Orphanet; 100070; Progressive non-fluent aphasia.
DR   Orphanet; 100069; Semantic dementia.
DR   PharmGKB; PA33855; -.
DR   eggNOG; KOG2736; Eukaryota.
DR   eggNOG; ENOG410XPZD; LUCA.
DR   GeneTree; ENSGT00390000016593; -.
DR   HOVERGEN; HBG011375; -.
DR   InParanoid; P49768; -.
DR   KO; K04505; -.
DR   OMA; IAIHWKG; -.
DR   OrthoDB; EOG091G0C72; -.
DR   PhylomeDB; P49768; -.
DR   TreeFam; TF315040; -.
DR   Reactome; R-HSA-1251985; Nuclear signaling by ERBB4.
DR   Reactome; R-HSA-1474228; Degradation of the extracellular matrix.
DR   Reactome; R-HSA-193692; Regulated proteolysis of p75NTR.
DR   Reactome; R-HSA-1980148; Signaling by NOTCH3.
DR   Reactome; R-HSA-1980150; Signaling by NOTCH4.
DR   Reactome; R-HSA-205043; NRIF signals cell death from the nucleus.
DR   Reactome; R-HSA-2122948; Activated NOTCH1 Transmits Signal to the Nucleus.
DR   Reactome; R-HSA-2644606; Constitutive Signaling by NOTCH1 PEST Domain Mutants.
DR   Reactome; R-HSA-2894862; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants.
DR   Reactome; R-HSA-2979096; NOTCH2 Activation and Transmission of Signal to the Nucleus.
DR   Reactome; R-HSA-3928665; EPH-ephrin mediated repulsion of cells.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   SignaLink; P49768; -.
DR   SIGNOR; P49768; -.
DR   ChiTaRS; PSEN1; human.
DR   EvolutionaryTrace; P49768; -.
DR   GeneWiki; PSEN1; -.
DR   GenomeRNAi; 5663; -.
DR   PMAP-CutDB; P49768; -.
DR   PRO; PR:P49768; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000080815; -.
DR   CleanEx; HS_PSEN1; -.
DR   ExpressionAtlas; P49768; baseline and differential.
DR   Genevisible; P49768; HS.
DR   GO; GO:0016235; C:aggresome; IDA:UniProtKB.
DR   GO; GO:0030424; C:axon; IBA:GO_Central.
DR   GO; GO:0035577; C:azurophil granule membrane; TAS:Reactome.
DR   GO; GO:0005938; C:cell cortex; IBA:GO_Central.
DR   GO; GO:0030054; C:cell junction; IDA:HPA.
DR   GO; GO:0009986; C:cell surface; IBA:GO_Central.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0035253; C:ciliary rootlet; IBA:GO_Central.
DR   GO; GO:0043198; C:dendritic shaft; IBA:GO_Central.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:HGNC.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0070765; C:gamma-secretase complex; IDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0030426; C:growth cone; IBA:GO_Central.
DR   GO; GO:0016021; C:integral component of membrane; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:HGNC.
DR   GO; GO:0000776; C:kinetochore; IDA:UniProtKB.
DR   GO; GO:0005765; C:lysosomal membrane; IBA:GO_Central.
DR   GO; GO:0016020; C:membrane; IDA:MGI.
DR   GO; GO:0045121; C:membrane raft; IDA:UniProtKB.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IBA:GO_Central.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0031594; C:neuromuscular junction; IBA:GO_Central.
DR   GO; GO:0043025; C:neuronal cell body; IBA:GO_Central.
DR   GO; GO:0031965; C:nuclear membrane; IDA:UniProtKB.
DR   GO; GO:0005640; C:nuclear outer membrane; IDA:MGI.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0098793; C:presynapse; IEA:GOC.
DR   GO; GO:0043234; C:protein complex; IMP:CAFA.
DR   GO; GO:0005791; C:rough endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005790; C:smooth endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0030018; C:Z disc; IBA:GO_Central.
DR   GO; GO:0042500; F:aspartic endopeptidase activity, intramembrane cleaving; IDA:UniProtKB.
DR   GO; GO:0004190; F:aspartic-type endopeptidase activity; TAS:Reactome.
DR   GO; GO:0008013; F:beta-catenin binding; IPI:UniProtKB.
DR   GO; GO:0045296; F:cadherin binding; IBA:GO_Central.
DR   GO; GO:0005262; F:calcium channel activity; IMP:UniProtKB.
DR   GO; GO:0004175; F:endopeptidase activity; IDA:MGI.
DR   GO; GO:0030165; F:PDZ domain binding; IPI:UniProtKB.
DR   GO; GO:0000186; P:activation of MAPKK activity; IEA:Ensembl.
DR   GO; GO:0042987; P:amyloid precursor protein catabolic process; TAS:HGNC.
DR   GO; GO:0042982; P:amyloid precursor protein metabolic process; IDA:UniProtKB.
DR   GO; GO:0034205; P:amyloid-beta formation; IMP:UniProtKB.
DR   GO; GO:0048143; P:astrocyte activation; IGI:ARUK-UCL.
DR   GO; GO:0002265; P:astrocyte activation involved in immune response; IGI:ARUK-UCL.
DR   GO; GO:0000045; P:autophagosome assembly; IEA:Ensembl.
DR   GO; GO:0001568; P:blood vessel development; IEA:Ensembl.
DR   GO; GO:0048854; P:brain morphogenesis; IEA:Ensembl.
DR   GO; GO:0021870; P:Cajal-Retzius cell differentiation; IEA:Ensembl.
DR   GO; GO:0060070; P:canonical Wnt signaling pathway; IBA:GO_Central.
DR   GO; GO:0001708; P:cell fate specification; IEA:Ensembl.
DR   GO; GO:0098609; P:cell-cell adhesion; IMP:MGI.
DR   GO; GO:1904646; P:cellular response to amyloid-beta; IGI:ARUK-UCL.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; IEA:Ensembl.
DR   GO; GO:0021795; P:cerebral cortex cell migration; IEA:Ensembl.
DR   GO; GO:0015871; P:choline transport; IEA:Ensembl.
DR   GO; GO:0021904; P:dorsal/ventral neural tube patterning; IEA:Ensembl.
DR   GO; GO:0030326; P:embryonic limb morphogenesis; IEA:Ensembl.
DR   GO; GO:0032469; P:endoplasmic reticulum calcium ion homeostasis; IDA:MGI.
DR   GO; GO:0048013; P:ephrin receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0050673; P:epithelial cell proliferation; IEA:Ensembl.
DR   GO; GO:0001947; P:heart looping; IEA:Ensembl.
DR   GO; GO:0002244; P:hematopoietic progenitor cell differentiation; IEA:Ensembl.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:InterPro.
DR   GO; GO:0015813; P:L-glutamate transport; IEA:Ensembl.
DR   GO; GO:0007611; P:learning or memory; IGI:ARUK-UCL.
DR   GO; GO:0006509; P:membrane protein ectodomain proteolysis; IDA:HGNC.
DR   GO; GO:0031293; P:membrane protein intracellular domain proteolysis; TAS:Reactome.
DR   GO; GO:0007613; P:memory; IGI:ARUK-UCL.
DR   GO; GO:0006839; P:mitochondrial transport; IEA:Ensembl.
DR   GO; GO:0090647; P:modulation of age-related behavioral decline; IGI:ARUK-UCL.
DR   GO; GO:0043011; P:myeloid dendritic cell differentiation; IEA:Ensembl.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB.
DR   GO; GO:2001234; P:negative regulation of apoptotic signaling pathway; IEA:Ensembl.
DR   GO; GO:0050771; P:negative regulation of axonogenesis; IEA:Ensembl.
DR   GO; GO:1904797; P:negative regulation of core promoter binding; IMP:CAFA.
DR   GO; GO:0007175; P:negative regulation of epidermal growth factor-activated receptor activity; IEA:Ensembl.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl.
DR   GO; GO:2000059; P:negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IEA:Ensembl.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:CAFA.
DR   GO; GO:0051444; P:negative regulation of ubiquitin-protein transferase activity; IEA:Ensembl.
DR   GO; GO:0003407; P:neural retina development; IEA:Ensembl.
DR   GO; GO:0051402; P:neuron apoptotic process; IEA:Ensembl.
DR   GO; GO:0048666; P:neuron development; IEA:Ensembl.
DR   GO; GO:0001764; P:neuron migration; IEA:Ensembl.
DR   GO; GO:1990535; P:neuron projection maintenance; IGI:ARUK-UCL.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0007220; P:Notch receptor processing; TAS:HGNC.
DR   GO; GO:0007219; P:Notch signaling pathway; TAS:Reactome.
DR   GO; GO:1905908; P:positive regulation of amyloid fibril formation; IGI:ARUK-UCL.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome.
DR   GO; GO:0043085; P:positive regulation of catalytic activity; IDA:HGNC.
DR   GO; GO:0050820; P:positive regulation of coagulation; IEA:Ensembl.
DR   GO; GO:0060999; P:positive regulation of dendritic spine development; IMP:CACAO.
DR   GO; GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; IEA:Ensembl.
DR   GO; GO:0032092; P:positive regulation of protein binding; IGI:ARUK-UCL.
DR   GO; GO:0033160; P:positive regulation of protein import into nucleus, translocation; IMP:CAFA.
DR   GO; GO:0001921; P:positive regulation of receptor recycling; IEA:Ensembl.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:CACAO.
DR   GO; GO:0009791; P:post-embryonic development; IEA:Ensembl.
DR   GO; GO:0006486; P:protein glycosylation; IEA:Ensembl.
DR   GO; GO:0016485; P:protein processing; IDA:HGNC.
DR   GO; GO:0015031; P:protein transport; IEA:Ensembl.
DR   GO; GO:0060828; P:regulation of canonical Wnt signaling pathway; ISS:UniProtKB.
DR   GO; GO:0042325; P:regulation of phosphorylation; IDA:UniProtKB.
DR   GO; GO:0060075; P:regulation of resting membrane potential; IEA:Ensembl.
DR   GO; GO:0048167; P:regulation of synaptic plasticity; IEA:Ensembl.
DR   GO; GO:0051966; P:regulation of synaptic transmission, glutamatergic; IEA:Ensembl.
DR   GO; GO:0006979; P:response to oxidative stress; IEA:Ensembl.
DR   GO; GO:0048705; P:skeletal system morphogenesis; IEA:Ensembl.
DR   GO; GO:0043589; P:skin morphogenesis; IEA:Ensembl.
DR   GO; GO:0051563; P:smooth endoplasmic reticulum calcium ion homeostasis; IBA:GO_Central.
DR   GO; GO:0001756; P:somitogenesis; IEA:Ensembl.
DR   GO; GO:0050808; P:synapse organization; IGI:ARUK-UCL.
DR   GO; GO:0016080; P:synaptic vesicle targeting; IEA:Ensembl.
DR   GO; GO:0002286; P:T cell activation involved in immune response; IEA:Ensembl.
DR   GO; GO:0050852; P:T cell receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0048538; P:thymus development; IEA:Ensembl.
DR   InterPro; IPR002031; Pept_A22A_PS1.
DR   InterPro; IPR001108; Peptidase_A22A.
DR   InterPro; IPR006639; Preselin/SPP.
DR   PANTHER; PTHR10202; PTHR10202; 1.
DR   Pfam; PF01080; Presenilin; 1.
DR   PRINTS; PR01072; PRESENILIN.
DR   PRINTS; PR01073; PRESENILIN1.
DR   SMART; SM00730; PSN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Alzheimer disease; Amyloidosis;
KW   Apoptosis; Cardiomyopathy; Cell adhesion; Cell membrane;
KW   Complete proteome; Direct protein sequencing; Disease mutation;
KW   Endoplasmic reticulum; Golgi apparatus; Hydrolase; Membrane;
KW   Neurodegeneration; Notch signaling pathway; Phosphoprotein;
KW   Polymorphism; Protease; Reference proteome; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1    298       Presenilin-1 NTF subunit.
FT                                /FTId=PRO_0000025591.
FT   CHAIN       299    467       Presenilin-1 CTF subunit.
FT                                /FTId=PRO_0000025592.
FT   CHAIN       346    467       Presenilin-1 CTF12.
FT                                /FTId=PRO_0000236055.
FT   TOPO_DOM      1     82       Cytoplasmic.
FT                                {ECO:0000269|PubMed:26280335}.
FT   TRANSMEM     83    103       Helical. {ECO:0000269|PubMed:26280335}.
FT   TOPO_DOM    104    132       Lumenal. {ECO:0000269|PubMed:26280335}.
FT   TRANSMEM    133    153       Helical. {ECO:0000269|PubMed:26280335}.
FT   TOPO_DOM    154    166       Cytoplasmic.
FT                                {ECO:0000269|PubMed:26280335}.
FT   TRANSMEM    167    189       Helical. {ECO:0000269|PubMed:26280335}.
FT   TOPO_DOM    190    194       Lumenal. {ECO:0000269|PubMed:26280335}.
FT   TRANSMEM    195    216       Helical. {ECO:0000269|PubMed:26280335}.
FT   TOPO_DOM    217    220       Cytoplasmic.
FT                                {ECO:0000269|PubMed:26280335}.
FT   TRANSMEM    221    241       Helical. {ECO:0000269|PubMed:26280335}.
FT   TOPO_DOM    242    248       Lumenal. {ECO:0000269|PubMed:26280335}.
FT   TRANSMEM    249    272       Helical. {ECO:0000269|PubMed:26280335}.
FT   TOPO_DOM    273    380       Cytoplasmic.
FT                                {ECO:0000269|PubMed:26280335}.
FT   TRANSMEM    381    401       Helical. {ECO:0000269|PubMed:26280335}.
FT   TOPO_DOM    402    407       Lumenal. {ECO:0000269|PubMed:26280335}.
FT   TRANSMEM    408    428       Helical. {ECO:0000269|PubMed:26280335}.
FT   TOPO_DOM    429    432       Cytoplasmic.
FT                                {ECO:0000269|PubMed:26280335}.
FT   TRANSMEM    433    453       Helical. {ECO:0000269|PubMed:26280335}.
FT   TOPO_DOM    454    467       Lumenal. {ECO:0000269|PubMed:26280335}.
FT   REGION      322    450       Required for interaction with CTNNB1.
FT                                {ECO:0000269|PubMed:9738936}.
FT   REGION      372    399       Required for interaction with CTNND2.
FT                                {ECO:0000269|PubMed:10037471}.
FT   REGION      464    467       Interaction with MTCH1.
FT                                {ECO:0000269|PubMed:10551805}.
FT   MOTIF       433    435       PAL. {ECO:0000305|PubMed:16305624}.
FT   COMPBIAS     94     97       Poly-Val.
FT   COMPBIAS    171    174       Poly-Leu.
FT   COMPBIAS    418    425       Poly-Leu.
FT   ACT_SITE    257    257       {ECO:0000305|PubMed:10206644,
FT                                ECO:0000305|PubMed:10899933,
FT                                ECO:0000305|PubMed:15341515}.
FT   ACT_SITE    385    385       {ECO:0000305|PubMed:10206644,
FT                                ECO:0000305|PubMed:10899933,
FT                                ECO:0000305|PubMed:15341515}.
FT   SITE        291    292       Cleavage; alternate.
FT                                {ECO:0000269|PubMed:9173929}.
FT   SITE        292    293       Cleavage; alternate.
FT                                {ECO:0000269|PubMed:9173929}.
FT   SITE        298    299       Cleavage. {ECO:0000269|PubMed:9173929}.
FT   SITE        345    346       Cleavage; by caspase.
FT                                {ECO:0000269|PubMed:9485372}.
FT   MOD_RES      43     43       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES      51     51       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P97887}.
FT   MOD_RES     310    310       Phosphoserine; by PKA.
FT                                {ECO:0000269|PubMed:14576165}.
FT   MOD_RES     346    346       Phosphoserine; by PKC.
FT                                {ECO:0000269|PubMed:14576165}.
FT   MOD_RES     367    367       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ      26     29       Missing (in isoform 2 and isoform 3).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:7596406,
FT                                ECO:0000303|PubMed:8641442}.
FT                                /FTId=VSP_005191.
FT   VAR_SEQ     162    184       IHAWLIISSLLLLFFFSFIYLGE -> SMRHRSLLSTLFFL
FT                                WLGILVTVT (in isoform 4).
FT                                {ECO:0000303|Ref.3}.
FT                                /FTId=VSP_007986.
FT   VAR_SEQ     185    467       Missing (in isoform 4).
FT                                {ECO:0000303|Ref.3}.
FT                                /FTId=VSP_007987.
FT   VAR_SEQ     257    289       Missing (in isoform 7). {ECO:0000305}.
FT                                /FTId=VSP_041440.
FT   VAR_SEQ     319    467       STERESQDTVAENDDGGFSEEWEAQRDSHLGPHRSTPESRA
FT                                AVQELSSSILAGEDPEERGVKLGLGDFIFYSVLVGKASATA
FT                                SGDWNTTIACFVAILIGLCLTLLLLAIFKKALPALPISITF
FT                                GLVFYFATDYLVQPFMDQLAFHQFYI -> RACLPPAAINL
FT                                LSIAPMAPRLFMPKGACRPTAQKGSHKTLLQRMMMAGSVRN
FT                                GKPRGTVI (in isoform 3 and isoform 5).
FT                                {ECO:0000303|PubMed:8641442,
FT                                ECO:0000303|Ref.5}.
FT                                /FTId=VSP_005192.
FT   VAR_SEQ     319    376       Missing (in isoform 6). {ECO:0000305}.
FT                                /FTId=VSP_012288.
FT   VARIANT      35     35       R -> Q (in AD3; unknown pathological
FT                                significance; dbSNP:rs63750592).
FT                                {ECO:0000269|PubMed:11524469}.
FT                                /FTId=VAR_075260.
FT   VARIANT      79     79       A -> V (in AD3; unknown pathological
FT                                significance; no effect on interaction
FT                                with GFAP; dbSNP:rs63749824).
FT                                {ECO:0000269|PubMed:10631141,
FT                                ECO:0000269|PubMed:11524469,
FT                                ECO:0000269|PubMed:12058025,
FT                                ECO:0000269|PubMed:9384602}.
FT                                /FTId=VAR_006413.
FT   VARIANT      82     82       V -> L (in AD3; no effect on interaction
FT                                with GFAP; dbSNP:rs63749967).
FT                                {ECO:0000269|PubMed:10441572,
FT                                ECO:0000269|PubMed:12058025,
FT                                ECO:0000269|PubMed:8634712}.
FT                                /FTId=VAR_006414.
FT   VARIANT      83     83       I -> T (in AD3).
FT                                {ECO:0000269|PubMed:26145164}.
FT                                /FTId=VAR_075261.
FT   VARIANT      92     92       C -> S (in AD3; dbSNP:rs63751141).
FT                                {ECO:0000269|PubMed:11027672}.
FT                                /FTId=VAR_016214.
FT   VARIANT      96     96       V -> F (in AD3; dbSNP:rs63750601).
FT                                {ECO:0000269|PubMed:8733303}.
FT                                /FTId=VAR_006415.
FT   VARIANT     105    105       F -> L (in AD3; dbSNP:rs63750321).
FT                                {ECO:0000269|PubMed:10631141}.
FT                                /FTId=VAR_009208.
FT   VARIANT     113    113       L -> P (in frontotemporal dementia;
FT                                dbSNP:rs63751399).
FT                                {ECO:0000269|PubMed:11094121}.
FT                                /FTId=VAR_016215.
FT   VARIANT     115    115       Y -> C (in AD3; dbSNP:rs63750450).
FT                                {ECO:0000269|PubMed:11524469,
FT                                ECO:0000269|PubMed:9384602}.
FT                                /FTId=VAR_006416.
FT   VARIANT     115    115       Y -> H (in AD3).
FT                                {ECO:0000269|PubMed:10441572,
FT                                ECO:0000269|PubMed:8634712}.
FT                                /FTId=VAR_006417.
FT   VARIANT     116    116       T -> N (in AD3).
FT                                {ECO:0000269|PubMed:10439444,
FT                                ECO:0000269|PubMed:11524469}.
FT                                /FTId=VAR_010120.
FT   VARIANT     117    117       P -> L (in AD3; dbSNP:rs63749805).
FT                                {ECO:0000269|PubMed:9507958}.
FT                                /FTId=VAR_009209.
FT   VARIANT     120    120       E -> D (in AD3; dbSNP:rs63751272).
FT                                {ECO:0000269|PubMed:10441572,
FT                                ECO:0000269|PubMed:9521423}.
FT                                /FTId=VAR_006418.
FT   VARIANT     120    120       E -> K (in AD3; dbSNP:rs63750800).
FT                                /FTId=VAR_006419.
FT   VARIANT     134    134       L -> R (in AD3; uncertain pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:22503161}.
FT                                /FTId=VAR_070023.
FT   VARIANT     135    135       N -> D (in AD3; dbSNP:rs63750353).
FT                                {ECO:0000269|PubMed:9225696}.
FT                                /FTId=VAR_010121.
FT   VARIANT     139    139       M -> I (in AD3; dbSNP:rs63750522).
FT                                /FTId=VAR_006420.
FT   VARIANT     139    139       M -> K (in AD3).
FT                                {ECO:0000269|PubMed:9719376}.
FT                                /FTId=VAR_010122.
FT   VARIANT     139    139       M -> T (in AD3; dbSNP:rs63751106).
FT                                {ECO:0000269|PubMed:10441572,
FT                                ECO:0000269|PubMed:8634712}.
FT                                /FTId=VAR_006421.
FT   VARIANT     139    139       M -> V (in AD3; dbSNP:rs63751037).
FT                                {ECO:0000269|PubMed:10631141,
FT                                ECO:0000269|PubMed:7550356}.
FT                                /FTId=VAR_006422.
FT   VARIANT     143    143       I -> F (in AD3; dbSNP:rs63750322).
FT                                {ECO:0000269|PubMed:10090481}.
FT                                /FTId=VAR_006423.
FT   VARIANT     143    143       I -> T (in AD3; dbSNP:rs63750004).
FT                                {ECO:0000269|PubMed:11524469,
FT                                ECO:0000269|PubMed:8634711}.
FT                                /FTId=VAR_006424.
FT   VARIANT     146    146       M -> I (in AD3; unknown pathological
FT                                significance; dbSNP:rs63750391).
FT                                {ECO:0000269|PubMed:11524469}.
FT                                /FTId=VAR_006425.
FT   VARIANT     146    146       M -> L (in AD3; dbSNP:rs63750306).
FT                                {ECO:0000269|PubMed:10441572,
FT                                ECO:0000269|PubMed:11524469,
FT                                ECO:0000269|PubMed:7596406}.
FT                                /FTId=VAR_006426.
FT   VARIANT     146    146       M -> V (in AD3; dbSNP:rs63750306).
FT                                {ECO:0000269|PubMed:11524469,
FT                                ECO:0000269|PubMed:7550356}.
FT                                /FTId=VAR_006427.
FT   VARIANT     147    147       T -> I (in AD3; dbSNP:rs63750907).
FT                                {ECO:0000269|PubMed:10441572}.
FT                                /FTId=VAR_010123.
FT   VARIANT     156    156       Y -> FTY (in AD3; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:11524469}.
FT                                /FTId=VAR_075262.
FT   VARIANT     163    163       H -> R (in AD3; dbSNP:rs63750590).
FT                                {ECO:0000269|PubMed:10441572,
FT                                ECO:0000269|PubMed:11524469,
FT                                ECO:0000269|PubMed:22503161,
FT                                ECO:0000269|PubMed:7596406,
FT                                ECO:0000269|PubMed:8634712,
FT                                ECO:0000269|PubMed:8733303,
FT                                ECO:0000269|PubMed:9521423}.
FT                                /FTId=VAR_006428.
FT   VARIANT     163    163       H -> Y (in AD3; dbSNP:rs63749885).
FT                                {ECO:0000269|PubMed:7550356}.
FT                                /FTId=VAR_006429.
FT   VARIANT     165    165       W -> C (in AD3; dbSNP:rs63751484).
FT                                {ECO:0000269|PubMed:10441572}.
FT                                /FTId=VAR_010124.
FT   VARIANT     166    166       L -> P (in AD3; onset in adolescence;
FT                                dbSNP:rs63750265).
FT                                {ECO:0000269|PubMed:12048239}.
FT                                /FTId=VAR_016216.
FT   VARIANT     169    169       S -> L (in AD3; dbSNP:rs63751210).
FT                                {ECO:0000269|PubMed:9831473}.
FT                                /FTId=VAR_006430.
FT   VARIANT     169    169       S -> P (in AD3; dbSNP:rs63750418).
FT                                {ECO:0000269|PubMed:10025789}.
FT                                /FTId=VAR_006431.
FT   VARIANT     171    171       L -> P (in AD3; dbSNP:rs63750963).
FT                                {ECO:0000269|PubMed:9833068}.
FT                                /FTId=VAR_006432.
FT   VARIANT     173    173       L -> W (in AD3; dbSNP:rs63750299).
FT                                {ECO:0000269|PubMed:10441572}.
FT                                /FTId=VAR_010125.
FT   VARIANT     174    174       L -> M (in AD3; dbSNP:rs63751144).
FT                                {ECO:0000269|PubMed:12484344}.
FT                                /FTId=VAR_016217.
FT   VARIANT     177    177       F -> L (in AD3; unknown pathological
FT                                significance; dbSNP:rs63749911).
FT                                {ECO:0000269|PubMed:11524469}.
FT                                /FTId=VAR_075263.
FT   VARIANT     177    177       F -> S (in AD3; unknown pathological
FT                                significance; dbSNP:rs63749806).
FT                                {ECO:0000269|PubMed:11524469}.
FT                                /FTId=VAR_075264.
FT   VARIANT     178    178       S -> P (in AD3; unknown pathological
FT                                significance; dbSNP:rs63750155).
FT                                {ECO:0000269|PubMed:11524469}.
FT                                /FTId=VAR_075265.
FT   VARIANT     205    205       F -> L (in dbSNP:rs1042864).
FT                                /FTId=VAR_011876.
FT   VARIANT     206    206       G -> A (in AD3; dbSNP:rs63750082).
FT                                {ECO:0000269|PubMed:11524469,
FT                                ECO:0000269|PubMed:11710891}.
FT                                /FTId=VAR_016218.
FT   VARIANT     206    206       G -> S (in AD3; unknown pathological
FT                                significance; dbSNP:rs63750569).
FT                                {ECO:0000269|PubMed:11524469}.
FT                                /FTId=VAR_075266.
FT   VARIANT     209    209       G -> E (in AD3; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:11524469}.
FT                                /FTId=VAR_075267.
FT   VARIANT     209    209       G -> R (in AD3; dbSNP:rs63749880).
FT                                {ECO:0000269|PubMed:10447269}.
FT                                /FTId=VAR_009210.
FT   VARIANT     209    209       G -> V (in AD3; dbSNP:rs63750053).
FT                                {ECO:0000269|PubMed:9521423}.
FT                                /FTId=VAR_006433.
FT   VARIANT     213    213       I -> L (in AD3; unknown pathological
FT                                significance; increases protease activity
FT                                with APP; dbSNP:rs63750861).
FT                                {ECO:0000269|PubMed:11524469,
FT                                ECO:0000269|PubMed:26280335}.
FT                                /FTId=VAR_075268.
FT   VARIANT     213    213       I -> T (in AD3; dbSNP:rs63751309).
FT                                {ECO:0000269|PubMed:8733303}.
FT                                /FTId=VAR_006434.
FT   VARIANT     214    214       H -> Y (probable disease-associated
FT                                mutation found in a patient with
FT                                dementia; dbSNP:rs63751003).
FT                                {ECO:0000269|PubMed:22503161}.
FT                                /FTId=VAR_070024.
FT   VARIANT     219    219       L -> P (in AD3; dbSNP:rs63750761).
FT                                {ECO:0000269|PubMed:10208579}.
FT                                /FTId=VAR_010126.
FT   VARIANT     222    222       Q -> R (in AD3; unknown pathological
FT                                significance; dbSNP:rs63750009).
FT                                {ECO:0000269|PubMed:11524469}.
FT                                /FTId=VAR_075269.
FT   VARIANT     231    231       A -> T (in AD3; dbSNP:rs63749836).
FT                                {ECO:0000269|PubMed:10441572,
FT                                ECO:0000269|PubMed:11524469,
FT                                ECO:0000269|PubMed:8634712}.
FT                                /FTId=VAR_006435.
FT   VARIANT     231    231       A -> V (in AD3; dbSNP:rs63750799).
FT                                {ECO:0000269|PubMed:9384602}.
FT                                /FTId=VAR_006436.
FT   VARIANT     233    233       M -> L (in AD3; dbSNP:rs63751287).
FT                                {ECO:0000269|PubMed:10533070,
FT                                ECO:0000269|PubMed:11524469}.
FT                                /FTId=VAR_009211.
FT   VARIANT     233    233       M -> T (in AD3; dbSNP:rs63751024).
FT                                {ECO:0000269|PubMed:10441572,
FT                                ECO:0000269|PubMed:9172170}.
FT                                /FTId=VAR_006437.
FT   VARIANT     235    235       L -> P (in AD3; dbSNP:rs63749835).
FT                                {ECO:0000269|PubMed:10441572,
FT                                ECO:0000269|PubMed:11524469}.
FT                                /FTId=VAR_006438.
FT   VARIANT     246    246       A -> E (in AD3; dbSNP:rs63750526).
FT                                {ECO:0000269|PubMed:7596406}.
FT                                /FTId=VAR_006439.
FT   VARIANT     250    250       L -> S (in AD3; dbSNP:rs63751163).
FT                                /FTId=VAR_006440.
FT   VARIANT     260    260       A -> V (in AD3; dbSNP:rs63751420).
FT                                {ECO:0000269|PubMed:7651536,
FT                                ECO:0000269|PubMed:9521423}.
FT                                /FTId=VAR_006441.
FT   VARIANT     261    261       V -> F (in AD3; unknown pathological
FT                                significance; nearly abolishes protease
FT                                activity with APP; dbSNP:rs63750964).
FT                                {ECO:0000269|PubMed:11524469,
FT                                ECO:0000269|PubMed:26280335}.
FT                                /FTId=VAR_075270.
FT   VARIANT     262    262       L -> F (in AD3; dbSNP:rs63750248).
FT                                /FTId=VAR_006442.
FT   VARIANT     262    262       L -> V (in AD3).
FT                                {ECO:0000269|PubMed:22503161}.
FT                                /FTId=VAR_070025.
FT   VARIANT     263    263       C -> R (in AD3; dbSNP:rs63750543).
FT                                /FTId=VAR_006443.
FT   VARIANT     264    264       P -> L (in AD3; dbSNP:rs63750301).
FT                                {ECO:0000269|PubMed:10441572,
FT                                ECO:0000269|PubMed:8634712,
FT                                ECO:0000269|PubMed:9521423}.
FT                                /FTId=VAR_006444.
FT   VARIANT     266    266       G -> S (in AD3; dbSNP:rs121917807).
FT                                {ECO:0000269|PubMed:11920851}.
FT                                /FTId=VAR_016219.
FT   VARIANT     267    267       P -> S (in AD3; dbSNP:rs63751229).
FT                                /FTId=VAR_006445.
FT   VARIANT     267    267       P -> T (in AD3).
FT                                {ECO:0000269|PubMed:7550356}.
FT                                /FTId=VAR_006446.
FT   VARIANT     269    269       R -> G (in AD3; dbSNP:rs63751019).
FT                                /FTId=VAR_006447.
FT   VARIANT     269    269       R -> H (in AD3; dbSNP:rs63750900).
FT                                /FTId=VAR_006448.
FT   VARIANT     271    271       L -> V (in AD3; dbSNP:rs63750886).
FT                                {ECO:0000269|PubMed:12493737}.
FT                                /FTId=VAR_016220.
FT   VARIANT     274    274       T -> R (in AD3; unknown pathological
FT                                significance; dbSNP:rs63750284).
FT                                {ECO:0000269|PubMed:11524469}.
FT                                /FTId=VAR_075271.
FT   VARIANT     278    278       R -> T (in AD3; dbSNP:rs63749891).
FT                                {ECO:0000269|PubMed:9172170}.
FT                                /FTId=VAR_006449.
FT   VARIANT     280    280       E -> A (in AD3; dbSNP:rs63750231).
FT                                {ECO:0000269|PubMed:7550356,
FT                                ECO:0000269|PubMed:9298817}.
FT                                /FTId=VAR_006450.
FT   VARIANT     280    280       E -> G (in AD3; dbSNP:rs63750231).
FT                                {ECO:0000269|PubMed:7550356}.
FT                                /FTId=VAR_006451.
FT   VARIANT     282    282       L -> R (in AD3; dbSNP:rs63750050).
FT                                {ECO:0000269|PubMed:10533070}.
FT                                /FTId=VAR_009212.
FT   VARIANT     285    285       A -> V (in AD3; dbSNP:rs63751139).
FT                                {ECO:0000269|PubMed:7651536}.
FT                                /FTId=VAR_006452.
FT   VARIANT     286    286       L -> V (in AD3; dbSNP:rs63751235).
FT                                {ECO:0000269|PubMed:7596406}.
FT                                /FTId=VAR_006453.
FT   VARIANT     289    289       S -> C (in AD3).
FT                                /FTId=VAR_010127.
FT   VARIANT     315    315       Y -> C (found in a renal cell carcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:21248752}.
FT                                /FTId=VAR_064747.
FT   VARIANT     318    318       E -> G (polymorphism; dbSNP:rs17125721).
FT                                {ECO:0000269|PubMed:10441572,
FT                                ECO:0000269|PubMed:10533070,
FT                                ECO:0000269|PubMed:10631141,
FT                                ECO:0000269|PubMed:11524469,
FT                                ECO:0000269|PubMed:18485326,
FT                                ECO:0000269|PubMed:9384602,
FT                                ECO:0000269|PubMed:9851443,
FT                                ECO:0000269|PubMed:9851450,
FT                                ECO:0000269|PubMed:9915968}.
FT                                /FTId=VAR_006454.
FT   VARIANT     333    333       D -> G (in CMD1U; dbSNP:rs121917809).
FT                                {ECO:0000269|PubMed:17186461}.
FT                                /FTId=VAR_064902.
FT   VARIANT     352    352       R -> RR (in AD3; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:11524469}.
FT                                /FTId=VAR_075272.
FT   VARIANT     354    354       T -> I (in AD3; unknown pathological
FT                                significance; dbSNP:rs63751164).
FT                                {ECO:0000269|PubMed:11524469}.
FT                                /FTId=VAR_075273.
FT   VARIANT     358    358       R -> Q (in AD3; unknown pathological
FT                                significance; dbSNP:rs63751174).
FT                                {ECO:0000269|PubMed:11524469}.
FT                                /FTId=VAR_075274.
FT   VARIANT     365    365       S -> Y (in AD3; unknown pathological
FT                                significance; dbSNP:rs63750941).
FT                                {ECO:0000269|PubMed:11524469}.
FT                                /FTId=VAR_075275.
FT   VARIANT     378    378       G -> E (in AD3).
FT                                {ECO:0000269|PubMed:10200054}.
FT                                /FTId=VAR_006455.
FT   VARIANT     384    384       G -> A (in AD3; dbSNP:rs63750646).
FT                                {ECO:0000269|PubMed:8634711}.
FT                                /FTId=VAR_006456.
FT   VARIANT     390    390       S -> I (in AD3; dbSNP:rs63750883).
FT                                {ECO:0000269|PubMed:10441572}.
FT                                /FTId=VAR_010128.
FT   VARIANT     392    392       L -> V (in AD3; dbSNP:rs63751416).
FT                                {ECO:0000269|PubMed:10441572,
FT                                ECO:0000269|PubMed:7651536,
FT                                ECO:0000269|PubMed:8634712}.
FT                                /FTId=VAR_006457.
FT   VARIANT     394    394       G -> V (in AD3; unknown pathological
FT                                significance; dbSNP:rs63750929).
FT                                {ECO:0000269|PubMed:11524469}.
FT                                /FTId=VAR_075276.
FT   VARIANT     396    396       A -> T (in AD3; uncertain pathological
FT                                significance).
FT                                /FTId=VAR_070026.
FT   VARIANT     405    405       N -> S (in AD3; dbSNP:rs63751254).
FT                                {ECO:0000269|PubMed:10644793}.
FT                                /FTId=VAR_010129.
FT   VARIANT     408    408       I -> T (in AD3; dbSNP:rs906454643).
FT                                {ECO:0000269|PubMed:26549787}.
FT                                /FTId=VAR_075277.
FT   VARIANT     409    409       A -> T (in AD3; dbSNP:rs63750227).
FT                                {ECO:0000269|PubMed:10533070}.
FT                                /FTId=VAR_009213.
FT   VARIANT     410    410       C -> Y (in AD3; dbSNP:rs661).
FT                                {ECO:0000269|PubMed:10441572,
FT                                ECO:0000269|PubMed:8634712,
FT                                ECO:0000269|PubMed:9521423}.
FT                                /FTId=VAR_006458.
FT   VARIANT     418    418       L -> F (in AD3; unknown pathological
FT                                significance; dbSNP:rs63751316).
FT                                {ECO:0000269|PubMed:11524469}.
FT                                /FTId=VAR_075278.
FT   VARIANT     426    426       A -> P (in AD3; dbSNP:rs63751223).
FT                                {ECO:0000269|PubMed:9521423}.
FT                                /FTId=VAR_006459.
FT   VARIANT     431    431       A -> E (in AD3; dbSNP:rs63750083).
FT                                {ECO:0000269|PubMed:11524469,
FT                                ECO:0000269|Ref.84}.
FT                                /FTId=VAR_025605.
FT   VARIANT     433    433       P -> L (abolishes gamma-secretase
FT                                activity). {ECO:0000269|PubMed:20460383}.
FT                                /FTId=VAR_075279.
FT   VARIANT     435    435       L -> F (in AD3; no endoproteolytic
FT                                cleavage; no APP nor NOTCH1 processing;
FT                                no detectable amyloid-beta; almost
FT                                abolishes gamma-secretase activity;
FT                                dbSNP:rs63750001).
FT                                {ECO:0000269|PubMed:11524469,
FT                                ECO:0000269|PubMed:16305624,
FT                                ECO:0000269|PubMed:21248752}.
FT                                /FTId=VAR_075280.
FT   VARIANT     435    435       L -> R (abolishes gamma-secretase
FT                                activity). {ECO:0000269|PubMed:21248752}.
FT                                /FTId=VAR_075281.
FT   VARIANT     436    436       P -> Q (in AD3; partially abolishes
FT                                gamma-secretase activity;
FT                                dbSNP:rs121917808).
FT                                {ECO:0000269|PubMed:21248752,
FT                                ECO:0000269|PubMed:9831473}.
FT                                /FTId=VAR_006460.
FT   VARIANT     436    436       P -> S (in AD3; partially abolishes
FT                                gamma-secretase activity;
FT                                dbSNP:rs63749925).
FT                                {ECO:0000269|PubMed:10090481,
FT                                ECO:0000269|PubMed:21248752}.
FT                                /FTId=VAR_008141.
FT   VARIANT     439    439       I -> V (in AD3; unknown pathological
FT                                significance; dbSNP:rs63750249).
FT                                {ECO:0000269|PubMed:11524469}.
FT                                /FTId=VAR_075282.
FT   MUTAGEN      66     72       Missing: No effect on interaction with
FT                                GFAP. {ECO:0000269|PubMed:12058025}.
FT   MUTAGEN      76     77       KY->AA: No effect on interaction with
FT                                GFAP. {ECO:0000269|PubMed:12058025}.
FT   MUTAGEN      82     83       VI->EE: Loss of interaction with GFAP.
FT                                {ECO:0000269|PubMed:12058025}.
FT   MUTAGEN      82     82       V->K,E: Loss of interaction with GFAP.
FT                                {ECO:0000269|PubMed:12058025}.
FT   MUTAGEN      84     85       ML->EE: Loss of interaction with GFAP.
FT                                {ECO:0000269|PubMed:12058025}.
FT   MUTAGEN     202    202       I->F: Nearly abolishes protease activity
FT                                with APP. {ECO:0000269|PubMed:26280335}.
FT   MUTAGEN     226    226       L->F: Increases protease activity with
FT                                APP. {ECO:0000269|PubMed:26280335}.
FT   MUTAGEN     237    237       F->I: Abolishes protease activity with
FT                                APP. {ECO:0000269|PubMed:26280335}.
FT   MUTAGEN     248    248       L->R: Nearly abolishes protease activity
FT                                with APP. {ECO:0000269|PubMed:26280335}.
FT   MUTAGEN     256    256       Y->F: Alters gamma-secretase cleavage
FT                                specificity. Increased production of
FT                                amyloid-beta protein 42. No effect on
FT                                enzymatic activity.
FT                                {ECO:0000269|PubMed:15341515}.
FT   MUTAGEN     257    257       D->A: Loss of endoproteolytic cleavage;
FT                                reduces production of amyloid-beta in APP
FT                                processing and of NICD in NOTCH1
FT                                processing. {ECO:0000269|PubMed:10206644,
FT                                ECO:0000269|PubMed:10899933,
FT                                ECO:0000269|PubMed:15341515}.
FT   MUTAGEN     257    257       D->E: Abolishes gamma-secretase activity.
FT                                Reduces production of amyloid-beta in APP
FT                                processing. Accumulation of full-length
FT                                PS1. Loss of binding of transition state
FT                                analog gamma-secretase inhibitor.
FT                                {ECO:0000269|PubMed:10206644,
FT                                ECO:0000269|PubMed:10899933,
FT                                ECO:0000269|PubMed:15341515}.
FT   MUTAGEN     286    286       L->A,E,P,Q,R,W: Increases production of
FT                                amyloid-beta in APP processing.
FT                                {ECO:0000269|PubMed:10811883}.
FT   MUTAGEN     286    286       L->E,R: Reduces production of NICD in
FT                                NOTCH1 processing.
FT                                {ECO:0000269|PubMed:10811883}.
FT   MUTAGEN     292    292       M->D: Loss of endoproteolytic cleavage.
FT                                {ECO:0000269|PubMed:10545183}.
FT   MUTAGEN     310    310       S->A: Abolishes PKA-mediated
FT                                phosphorylation; no effect on caspase-
FT                                mediated cleavage.
FT                                {ECO:0000269|PubMed:14576165}.
FT   MUTAGEN     345    345       D->N: Abolishes caspase cleavage.
FT                                {ECO:0000269|PubMed:9485372}.
FT   MUTAGEN     346    346       S->A: Abolishes PKC-mediated
FT                                phosphorylation; no effect on PKA-
FT                                mediated phosphorylation.
FT                                {ECO:0000269|PubMed:14576165}.
FT   MUTAGEN     346    346       S->E: Inhibits caspase-mediated cleavage.
FT                                Modulates progression of apoptosis.
FT                                {ECO:0000269|PubMed:14576165}.
FT   MUTAGEN     373    373       D->N: No effect on caspase cleavage.
FT                                {ECO:0000269|PubMed:9485372}.
FT   MUTAGEN     385    385       D->A: Loss of endoproteolytic cleavage.
FT                                Reduces production of amyloid-beta in APP
FT                                processing. Disassembly of the N-
FT                                cadherin/PS1 complex at the cell surface.
FT                                Impairs CDH2 processing.
FT                                {ECO:0000269|PubMed:10206644,
FT                                ECO:0000269|PubMed:10899933,
FT                                ECO:0000269|PubMed:14515347,
FT                                ECO:0000269|PubMed:15341515,
FT                                ECO:0000269|PubMed:9485372}.
FT   MUTAGEN     385    385       D->E: Abolishes gamma-secretase activity.
FT                                Reduces production of amyloid-beta in APP
FT                                processing. Accumulation of full-length
FT                                PS1. Loss of binding of transition state
FT                                analog gamma-secretase inhibitor.
FT                                {ECO:0000269|PubMed:10206644,
FT                                ECO:0000269|PubMed:10899933,
FT                                ECO:0000269|PubMed:14515347,
FT                                ECO:0000269|PubMed:15341515,
FT                                ECO:0000269|PubMed:9485372}.
FT   MUTAGEN     385    385       D->N: No effect on caspase cleavage.
FT                                {ECO:0000269|PubMed:10206644,
FT                                ECO:0000269|PubMed:10899933,
FT                                ECO:0000269|PubMed:14515347,
FT                                ECO:0000269|PubMed:15341515,
FT                                ECO:0000269|PubMed:9485372}.
FT   MUTAGEN     389    389       Y->F: Alters gamma-secretase cleavage
FT                                specificity. Increased production of
FT                                amyloid-beta protein 42. No effect on
FT                                enzymatic activity.
FT                                {ECO:0000269|PubMed:15341515}.
FT   MUTAGEN     424    424       L->V: Increases protease activity with
FT                                APP. {ECO:0000269|PubMed:26280335}.
FT   MUTAGEN     433    433       P->A: No effect on endoproteolytic
FT                                cleavage. No effect on APP nor NOTCH1
FT                                processing. Slightly increased amyloid-
FT                                beta protein 42/40 ratio.
FT                                {ECO:0000269|PubMed:16305624}.
FT   MUTAGEN     433    433       P->D,F,L,N,V: No endoproteolytic
FT                                cleavage; no APP, nor NOTCH1 processing.
FT                                No detectable amyloid-beta.
FT                                {ECO:0000269|PubMed:16305624}.
FT   MUTAGEN     433    433       P->G: Very little endoproteolysis. Little
FT                                APP processing. No NOTCH1 processing.
FT                                Very low levels amyloid-beta protein 40
FT                                and no detectable amyloid-beta protein
FT                                42. {ECO:0000269|PubMed:16305624}.
FT   MUTAGEN     434    434       A->C: Some loss of endoproteolytic
FT                                cleavage. Some loss of APP and NOTCH1
FT                                processing. Six-fold increase in amyloid-
FT                                beta protein 42/40 ratio.
FT                                {ECO:0000269|PubMed:16305624}.
FT   MUTAGEN     434    434       A->D,I,L,V: No endoproteolytic cleavage.
FT                                No APP nor NOTCH1 processing. No
FT                                detectable amyloid-beta.
FT                                {ECO:0000269|PubMed:16305624}.
FT   MUTAGEN     434    434       A->G: No effect on endoproteolytic
FT                                cleavage. No effect on APP nor NOTCH1
FT                                processing. Reduced amyloid-beta protein
FT                                42/40 ratio.
FT                                {ECO:0000269|PubMed:16305624}.
FT   MUTAGEN     435    435       L->A: No effect on endoproteolytic
FT                                cleavage. No effect on APP processing.
FT                                Impaired NOTCH1 processing. Greatly
FT                                reduced amyloid-beta protein 42/40 ratio.
FT                                {ECO:0000269|PubMed:16305624}.
FT   MUTAGEN     435    435       L->G: Greatly reduced endoproteolytic
FT                                cleavage. Very little APP and NOTCH1
FT                                processing. Very low levels of amyloid-
FT                                beta protein 40 and no detectable
FT                                amyloid-beta protein 42.
FT                                {ECO:0000269|PubMed:16305624}.
FT   MUTAGEN     435    435       L->I: No effect on endoproteolytic
FT                                cleavage. No effect on APP nor NOTCH1
FT                                processing.
FT                                {ECO:0000269|PubMed:16305624}.
FT   MUTAGEN     435    435       L->V: No effect on endoproteolytic
FT                                cleavage. No effect on APP processing.
FT                                Impaired NOTCH1 processing. Some increase
FT                                in amyloid-beta protein 42/40 ratio.
FT                                {ECO:0000269|PubMed:16305624}.
FT   CONFLICT    128    128       R -> G (in Ref. 7; AAL16811).
FT                                {ECO:0000305}.
FT   HELIX       293    299       {ECO:0000244|PDB:2KR6}.
FT   STRAND      341    345       {ECO:0000244|PDB:2KR6}.
FT   HELIX       356    368       {ECO:0000244|PDB:2KR6}.
FT   TURN        383    385       {ECO:0000244|PDB:2KR6}.
FT   HELIX       386    399       {ECO:0000244|PDB:2KR6}.
FT   TURN        403    406       {ECO:0000244|PDB:2KR6}.
FT   HELIX       407    428       {ECO:0000244|PDB:2KR6}.
FT   STRAND      433    437       {ECO:0000244|PDB:2KR6}.
FT   HELIX       442    449       {ECO:0000244|PDB:2KR6}.
FT   TURN        450    453       {ECO:0000244|PDB:2KR6}.
FT   HELIX       456    458       {ECO:0000244|PDB:2KR6}.
SQ   SEQUENCE   467 AA;  52668 MW;  5E0F451EF82BCF20 CRC64;
     MTELPAPLSY FQNAQMSEDN HLSNTVRSQN DNRERQEHND RRSLGHPEPL SNGRPQGNSR
     QVVEQDEEED EELTLKYGAK HVIMLFVPVT LCMVVVVATI KSVSFYTRKD GQLIYTPFTE
     DTETVGQRAL HSILNAAIMI SVIVVMTILL VVLYKYRCYK VIHAWLIISS LLLLFFFSFI
     YLGEVFKTYN VAVDYITVAL LIWNFGVVGM ISIHWKGPLR LQQAYLIMIS ALMALVFIKY
     LPEWTAWLIL AVISVYDLVA VLCPKGPLRM LVETAQERNE TLFPALIYSS TMVWLVNMAE
     GDPEAQRRVS KNSKYNAEST ERESQDTVAE NDDGGFSEEW EAQRDSHLGP HRSTPESRAA
     VQELSSSILA GEDPEERGVK LGLGDFIFYS VLVGKASATA SGDWNTTIAC FVAILIGLCL
     TLLLLAIFKK ALPALPISIT FGLVFYFATD YLVQPFMDQL AFHQFYI
//
ID   PSN_CAEEL               Reviewed;         444 AA.
AC   P52166; Q20076; Q9U9C7;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   27-MAY-2002, sequence version 2.
DT   22-NOV-2017, entry version 142.
DE   RecName: Full=Presenilin sel-12;
DE   AltName: Full=Suppressor/enhancer of lin-12 protein 12;
GN   Name=sel-12; ORFNames=F35H12.3;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND MUTAGENESIS OF CYS-60.
RC   STRAIN=Bristol N2;
RX   PubMed=7566091; DOI=10.1038/377351a0;
RA   Levitan D., Greenwald I.;
RT   "Facilitation of lin-12-mediated signalling by sel-12, a
RT   Caenorhabditis elegans S182 Alzheimer's disease gene.";
RL   Nature 377:351-354(1995).
RN   [2]
RP   SEQUENCE REVISION TO 84-85.
RA   Levitan D.;
RL   Submitted (JAN-1996) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND TISSUE SPECIFICITY.
RC   STRAIN=Bristol N2;
RX   PubMed=10917532; DOI=10.1038/35018575;
RA   Wittenburg N., Eimer S., Lakowski B., Roehrig S., Rudolph C.,
RA   Baumeister R.;
RT   "Presenilin is required for proper morphology and function of neurons
RT   in C. elegans.";
RL   Nature 406:306-309(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
RN   [5]
RP   INTERACTION WITH SEL-10.
RX   PubMed=9861048; DOI=10.1073/pnas.95.26.15787;
RA   Wu G., Hubbard E.J.A., Kitajewski J.K., Greenwald I.;
RT   "Evidence for functional and physical association between
RT   Caenorhabditis elegans SEL-10, a Cdc4p-related protein, and SEL-12
RT   presenilin.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:15787-15791(1998).
RN   [6]
RP   FUNCTION, AND MUTAGENESIS OF GLY-60.
RX   PubMed=12413907; DOI=10.1006/dbio.2002.0782;
RA   Eimer S., Donhauser R., Baumeister R.;
RT   "The Caenorhabditis elegans presenilin sel-12 is required for
RT   mesodermal patterning and muscle function.";
RL   Dev. Biol. 251:178-192(2002).
RN   [7]
RP   DEVELOPMENTAL STAGE.
RX   PubMed=12668626; DOI=10.1242/dev.00429;
RA   Lakowski B., Eimer S., Goebel C., Boettcher A., Wagler B.,
RA   Baumeister R.;
RT   "Two suppressors of sel-12 encode C2H2 zinc-finger proteins that
RT   regulate presenilin transcription in Caenorhabditis elegans.";
RL   Development 130:2117-2128(2003).
CC   -!- FUNCTION: Probable catalytic subunit of the gamma-secretase
CC       complex, an endoprotease complex that catalyzes the intramembrane
CC       cleavage of integral membrane proteins such as Notch receptors
CC       (lin-12 or glp-1). Provides the major presenilin function compared
CC       to hop-1 and spe-4. Required cell-autonomously for correct neurite
CC       connectivity of the AIY cholinergic interneurons and their correct
CC       functioning in thermotaxis. Required for mesodermal patterning of
CC       muscle function. {ECO:0000269|PubMed:10917532,
CC       ECO:0000269|PubMed:12413907}.
CC   -!- SUBUNIT: Homodimer. Component of the gamma-secretase complex, a
CC       complex probably composed of the presenilin homodimer (sel-12,
CC       hop-1 or spe-4), nicastrin (aph-2), aph-1 and pen-2 (Probable).
CC       Interacts with sel-10 (PubMed:9861048).
CC       {ECO:0000269|PubMed:9861048, ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}. Golgi
CC       apparatus membrane {ECO:0000250}; Multi-pass membrane protein
CC       {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Expressed in most neurons.
CC       {ECO:0000269|PubMed:10917532}.
CC   -!- DEVELOPMENTAL STAGE: Expressed both maternally and zygotically.
CC       Ubiquitously expressed throughout the development and in the
CC       adult. {ECO:0000269|PubMed:12668626}.
CC   -!- DOMAIN: The PAL motif is required for normal active site
CC       conformation. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the peptidase A22A family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA85511.1; Type=Frameshift; Positions=413; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U35660; AAA85511.1; ALT_FRAME; mRNA.
DR   EMBL; AF171064; AAD50991.1; -; mRNA.
DR   EMBL; FO081301; CCD70617.1; -; Genomic_DNA.
DR   RefSeq; NP_508175.1; NM_075774.5.
DR   UniGene; Cel.19557; -.
DR   ProteinModelPortal; P52166; -.
DR   BioGrid; 45394; 56.
DR   STRING; 6239.F35H12.3; -.
DR   MEROPS; A22.009; -.
DR   EPD; P52166; -.
DR   PaxDb; P52166; -.
DR   EnsemblMetazoa; F35H12.3; F35H12.3; WBGene00004769.
DR   GeneID; 180441; -.
DR   KEGG; cel:CELE_F35H12.3; -.
DR   UCSC; F35H12.3; c. elegans.
DR   CTD; 180441; -.
DR   WormBase; F35H12.3; CE24946; WBGene00004769; sel-12.
DR   eggNOG; KOG2736; Eukaryota.
DR   eggNOG; ENOG410XPZD; LUCA.
DR   GeneTree; ENSGT00390000016593; -.
DR   HOGENOM; HOG000240228; -.
DR   InParanoid; P52166; -.
DR   KO; K04505; -.
DR   OMA; VCDERTS; -.
DR   OrthoDB; EOG091G0C72; -.
DR   PhylomeDB; P52166; -.
DR   Reactome; R-CEL-3928665; EPH-ephrin mediated repulsion of cells.
DR   Reactome; R-CEL-6798695; Neutrophil degranulation.
DR   SignaLink; P52166; -.
DR   PRO; PR:P52166; -.
DR   Proteomes; UP000001940; Chromosome X.
DR   Bgee; WBGene00004769; -.
DR   GO; GO:0030424; C:axon; IBA:GO_Central.
DR   GO; GO:0005938; C:cell cortex; IBA:GO_Central.
DR   GO; GO:0009986; C:cell surface; IBA:GO_Central.
DR   GO; GO:0035253; C:ciliary rootlet; IBA:GO_Central.
DR   GO; GO:0043198; C:dendritic shaft; IBA:GO_Central.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0070765; C:gamma-secretase complex; ISS:WormBase.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0030426; C:growth cone; IBA:GO_Central.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005765; C:lysosomal membrane; IBA:GO_Central.
DR   GO; GO:0045121; C:membrane raft; IBA:GO_Central.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IBA:GO_Central.
DR   GO; GO:0031594; C:neuromuscular junction; IBA:GO_Central.
DR   GO; GO:0043025; C:neuronal cell body; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:WormBase.
DR   GO; GO:0030018; C:Z disc; IBA:GO_Central.
DR   GO; GO:0004190; F:aspartic-type endopeptidase activity; IEA:InterPro.
DR   GO; GO:0004175; F:endopeptidase activity; IBA:GO_Central.
DR   GO; GO:0042987; P:amyloid precursor protein catabolic process; IBA:GO_Central.
DR   GO; GO:0050435; P:amyloid-beta metabolic process; IBA:GO_Central.
DR   GO; GO:0045176; P:apical protein localization; IDA:WormBase.
DR   GO; GO:0006816; P:calcium ion transport; IBA:GO_Central.
DR   GO; GO:0001708; P:cell fate specification; IMP:WormBase.
DR   GO; GO:0016048; P:detection of temperature stimulus; IMP:UniProtKB.
DR   GO; GO:0006509; P:membrane protein ectodomain proteolysis; IBA:GO_Central.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IBA:GO_Central.
DR   GO; GO:0007399; P:nervous system development; IMP:UniProtKB.
DR   GO; GO:0007220; P:Notch receptor processing; IBA:GO_Central.
DR   GO; GO:0007219; P:Notch signaling pathway; NAS:UniProtKB.
DR   GO; GO:0018991; P:oviposition; IMP:WormBase.
DR   GO; GO:0045747; P:positive regulation of Notch signaling pathway; IGI:WormBase.
DR   GO; GO:0048563; P:post-embryonic animal organ morphogenesis; IMP:WormBase.
DR   GO; GO:0016485; P:protein processing; IEA:InterPro.
DR   GO; GO:0017015; P:regulation of transforming growth factor beta receptor signaling pathway; IGI:WormBase.
DR   InterPro; IPR001686; Pept_A22A_Ceel.
DR   InterPro; IPR001108; Peptidase_A22A.
DR   InterPro; IPR006639; Preselin/SPP.
DR   PANTHER; PTHR10202; PTHR10202; 1.
DR   Pfam; PF01080; Presenilin; 1.
DR   PRINTS; PR01072; PRESENILIN.
DR   PRINTS; PR01075; PRESENILNSEL.
DR   SMART; SM00730; PSN; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Endoplasmic reticulum; Golgi apparatus; Membrane;
KW   Notch signaling pathway; Reference proteome; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1    444       Presenilin sel-12.
FT                                /FTId=PRO_0000073903.
FT   TOPO_DOM      1     45       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     46     66       Helical. {ECO:0000255}.
FT   TOPO_DOM     67    101       Lumenal. {ECO:0000255}.
FT   TRANSMEM    102    122       Helical. {ECO:0000255}.
FT   TOPO_DOM    123    130       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    131    151       Helical. {ECO:0000255}.
FT   TOPO_DOM    152    163       Lumenal. {ECO:0000255}.
FT   TRANSMEM    164    184       Helical. {ECO:0000255}.
FT   TOPO_DOM    185    189       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    190    210       Helical. {ECO:0000255}.
FT   TOPO_DOM    211    212       Lumenal. {ECO:0000255}.
FT   TRANSMEM    213    233       Helical. {ECO:0000255}.
FT   TOPO_DOM    234    359       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    360    380       Helical. {ECO:0000255}.
FT   TOPO_DOM    381    384       Lumenal. {ECO:0000255}.
FT   TRANSMEM    385    405       Helical. {ECO:0000255}.
FT   TOPO_DOM    406    413       Cytoplasmic. {ECO:0000255}.
FT   INTRAMEM    414    434       Helical. {ECO:0000255}.
FT   TOPO_DOM    435    444       Cytoplasmic. {ECO:0000255}.
FT   MOTIF       410    412       PAL.
FT   ACT_SITE    226    226       {ECO:0000250}.
FT   ACT_SITE    364    364       {ECO:0000250}.
FT   MUTAGEN      60     60       C->S: In ar131; egg-laying-defective.
FT                                {ECO:0000269|PubMed:12413907,
FT                                ECO:0000269|PubMed:7566091}.
SQ   SEQUENCE   444 AA;  50034 MW;  37ADBC124E16429C CRC64;
     MPSTRRQQEG GGADAETHTV YGTNLITNRN SQEDENVVEE AELKYGASHV IHLFVPVSLC
     MALVVFTMNT ITFYSQNNGR HLLYTPFVRE TDSIVEKGLM SLGNALVMLC VVVLMTVLLI
     VFYKYKFYKL IHGWLIVSSF LLLFLFTTIY VQEVLKSFDV SPSALLVLFG LGNYGVLGMM
     CIHWKGPLRL QQFYLITMSA LMALVFIKYL PEWTVWFVLF VISVWDLVAV LTPKGPLRYL
     VETAQERNEP IFPALIYSSG VIYPYVLVTA VENTTDPREP TSSDSNTSTA FPGEASCSSE
     TPKRPKVKRI PQKVQIESNT TASTTQNSGV RVERELAAER PTVQDANFHR HEEEERGVKL
     GLGDFIFYSV LLGKASSYFD WNTTIACYVA ILIGLCFTLV LLAVFKRALP ALPISIFSGL
     IFYFCTRWII TPFVTQVSQK CLLY
//
ID   PSNA_ARATH              Reviewed;         453 AA.
AC   O64668; Q8L9V0;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1998, sequence version 1.
DT   07-JUN-2017, entry version 119.
DE   RecName: Full=Presenilin-like protein At1g08700;
GN   OrderedLocusNames=At1g08700; ORFNames=F22O13.18;
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; eudicotyledons; Gunneridae;
OC   Pentapetalae; rosids; malvids; Brassicales; Brassicaceae; Camelineae;
OC   Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=11130712; DOI=10.1038/35048500;
RA   Theologis A., Ecker J.R., Palm C.J., Federspiel N.A., Kaul S.,
RA   White O., Alonso J., Altafi H., Araujo R., Bowman C.L., Brooks S.Y.,
RA   Buehler E., Chan A., Chao Q., Chen H., Cheuk R.F., Chin C.W.,
RA   Chung M.K., Conn L., Conway A.B., Conway A.R., Creasy T.H., Dewar K.,
RA   Dunn P., Etgu P., Feldblyum T.V., Feng J.-D., Fong B., Fujii C.Y.,
RA   Gill J.E., Goldsmith A.D., Haas B., Hansen N.F., Hughes B., Huizar L.,
RA   Hunter J.L., Jenkins J., Johnson-Hopson C., Khan S., Khaykin E.,
RA   Kim C.J., Koo H.L., Kremenetskaia I., Kurtz D.B., Kwan A., Lam B.,
RA   Langin-Hooper S., Lee A., Lee J.M., Lenz C.A., Li J.H., Li Y.-P.,
RA   Lin X., Liu S.X., Liu Z.A., Luros J.S., Maiti R., Marziali A.,
RA   Militscher J., Miranda M., Nguyen M., Nierman W.C., Osborne B.I.,
RA   Pai G., Peterson J., Pham P.K., Rizzo M., Rooney T., Rowley D.,
RA   Sakano H., Salzberg S.L., Schwartz J.R., Shinn P., Southwick A.M.,
RA   Sun H., Tallon L.J., Tambunga G., Toriumi M.J., Town C.D.,
RA   Utterback T., Van Aken S., Vaysberg M., Vysotskaia V.S., Walker M.,
RA   Wu D., Yu G., Fraser C.M., Venter J.C., Davis R.W.;
RT   "Sequence and analysis of chromosome 1 of the plant Arabidopsis
RT   thaliana.";
RL   Nature 408:816-820(2000).
RN   [2]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RG   The Arabidopsis Information Portal (Araport);
RL   Submitted (MAY-2016) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=14593172; DOI=10.1126/science.1088305;
RA   Yamada K., Lim J., Dale J.M., Chen H., Shinn P., Palm C.J.,
RA   Southwick A.M., Wu H.C., Kim C.J., Nguyen M., Pham P.K., Cheuk R.F.,
RA   Karlin-Newmann G., Liu S.X., Lam B., Sakano H., Wu T., Yu G.,
RA   Miranda M., Quach H.L., Tripp M., Chang C.H., Lee J.M., Toriumi M.J.,
RA   Chan M.M., Tang C.C., Onodera C.S., Deng J.M., Akiyama K., Ansari Y.,
RA   Arakawa T., Banh J., Banno F., Bowser L., Brooks S.Y., Carninci P.,
RA   Chao Q., Choy N., Enju A., Goldsmith A.D., Gurjal M., Hansen N.F.,
RA   Hayashizaki Y., Johnson-Hopson C., Hsuan V.W., Iida K., Karnes M.,
RA   Khan S., Koesema E., Ishida J., Jiang P.X., Jones T., Kawai J.,
RA   Kamiya A., Meyers C., Nakajima M., Narusaka M., Seki M., Sakurai T.,
RA   Satou M., Tamse R., Vaysberg M., Wallender E.K., Wong C., Yamamura Y.,
RA   Yuan S., Shinozaki K., Davis R.W., Theologis A., Ecker J.R.;
RT   "Empirical analysis of transcriptional activity in the Arabidopsis
RT   genome.";
RL   Science 302:842-846(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Brover V.V., Troukhan M.E., Alexandrov N.A., Lu Y.-P., Flavell R.B.,
RA   Feldmann K.A.;
RT   "Full-length cDNA from Arabidopsis thaliana.";
RL   Submitted (MAR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-296, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   STRAIN=cv. Columbia;
RX   PubMed=19245862; DOI=10.1016/j.jprot.2009.02.004;
RA   Jones A.M.E., MacLean D., Studholme D.J., Serna-Sanz A.,
RA   Andreasson E., Rathjen J.P., Peck S.C.;
RT   "Phosphoproteomic analysis of nuclei-enriched fractions from
RT   Arabidopsis thaliana.";
RL   J. Proteomics 72:439-451(2009).
CC   -!- FUNCTION: Probable subunit of the gamma-secretase complex, an
CC       endoprotease complex that catalyzes the intramembrane cleavage of
CC       integral membrane proteins such as Notch receptors. {ECO:0000250}.
CC   -!- SUBUNIT: Homodimer. Probable component of the gamma-secretase
CC       complex, a complex composed of a presenilin homodimer, nicastrin,
CC       APH1 and PEN2 (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}. Golgi
CC       apparatus membrane {ECO:0000250}; Multi-pass membrane protein
CC       {ECO:0000250}.
CC   -!- DOMAIN: The PAL motif is required for normal active site
CC       conformation. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the peptidase A22A family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC003981; AAF99776.1; -; Genomic_DNA.
DR   EMBL; CP002684; AEE28336.1; -; Genomic_DNA.
DR   EMBL; AY058880; AAL24266.1; -; mRNA.
DR   EMBL; AY088208; AAM65750.1; -; mRNA.
DR   PIR; T00724; T00724.
DR   RefSeq; NP_172346.1; NM_100743.4.
DR   UniGene; At.26647; -.
DR   ProteinModelPortal; O64668; -.
DR   SMR; O64668; -.
DR   BioGrid; 22632; 3.
DR   STRING; 3702.AT1G08700.1; -.
DR   MEROPS; A22.A01; -.
DR   iPTMnet; O64668; -.
DR   PaxDb; O64668; -.
DR   PRIDE; O64668; -.
DR   EnsemblPlants; AT1G08700.1; AT1G08700.1; AT1G08700.
DR   GeneID; 837391; -.
DR   Gramene; AT1G08700.1; AT1G08700.1; AT1G08700.
DR   KEGG; ath:AT1G08700; -.
DR   Araport; AT1G08700; -.
DR   TAIR; locus:2025640; AT1G08700.
DR   eggNOG; KOG2736; Eukaryota.
DR   eggNOG; ENOG410XPZD; LUCA.
DR   HOGENOM; HOG000240228; -.
DR   InParanoid; O64668; -.
DR   KO; K04505; -.
DR   OMA; VCDERTS; -.
DR   OrthoDB; EOG09360DOM; -.
DR   PhylomeDB; O64668; -.
DR   Reactome; R-ATH-6798695; Neutrophil degranulation.
DR   PRO; PR:O64668; -.
DR   Proteomes; UP000006548; Chromosome 1.
DR   ExpressionAtlas; O64668; baseline and differential.
DR   Genevisible; O64668; AT.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005798; C:Golgi-associated vesicle; IDA:TAIR.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:TAIR.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0004190; F:aspartic-type endopeptidase activity; IEA:InterPro.
DR   GO; GO:0004175; F:endopeptidase activity; IBA:GO_Central.
DR   GO; GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0016485; P:protein processing; IEA:InterPro.
DR   InterPro; IPR001108; Peptidase_A22A.
DR   InterPro; IPR006639; Preselin/SPP.
DR   PANTHER; PTHR10202; PTHR10202; 1.
DR   Pfam; PF01080; Presenilin; 1.
DR   PRINTS; PR01072; PRESENILIN.
DR   SMART; SM00730; PSN; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Endoplasmic reticulum; Golgi apparatus; Membrane;
KW   Notch signaling pathway; Phosphoprotein; Reference proteome;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN         1    453       Presenilin-like protein At1g08700.
FT                                /FTId=PRO_0000073905.
FT   TOPO_DOM      1      8       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM      9     29       Helical. {ECO:0000255}.
FT   TOPO_DOM     30     68       Lumenal. {ECO:0000255}.
FT   TRANSMEM     69     89       Helical. {ECO:0000255}.
FT   TOPO_DOM     90    103       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    104    124       Helical. {ECO:0000255}.
FT   TOPO_DOM    125    132       Lumenal. {ECO:0000255}.
FT   TRANSMEM    133    153       Helical. {ECO:0000255}.
FT   TOPO_DOM    154    159       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    160    180       Helical. {ECO:0000255}.
FT   TRANSMEM    181    201       Helical. {ECO:0000255}.
FT   TOPO_DOM    202    369       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    370    390       Helical. {ECO:0000255}.
FT   TOPO_DOM    391    392       Lumenal. {ECO:0000255}.
FT   TRANSMEM    393    413       Helical. {ECO:0000255}.
FT   TOPO_DOM    414    417       Cytoplasmic. {ECO:0000255}.
FT   INTRAMEM    418    438       Helical. {ECO:0000255}.
FT   TOPO_DOM    439    453       Cytoplasmic. {ECO:0000255}.
FT   MOTIF       419    421       PAL.
FT   ACT_SITE    190    190       {ECO:0000250}.
FT   ACT_SITE    374    374       {ECO:0000250}.
FT   MOD_RES     296    296       Phosphoserine.
FT                                {ECO:0000244|PubMed:19245862}.
FT   CONFLICT     24     24       M -> I (in Ref. 4; AAM65750).
FT                                {ECO:0000305}.
SQ   SEQUENCE   453 AA;  49308 MW;  7FBDD9B86D97955E CRC64;
     MESSILDSLG VEIIGVMAPV SICMFLVVLL TYSLSVTSDP QIRSAANLIY IENPSDSTTV
     KLEGSLANAI VFVVLIAAVT FILVLLFYYN FTNFLKHYMR FSAFFVLGTM GGAIFLSIIQ
     HFSIPVDSIT CFILLFNFTI LGTLSVFAGG IPIVLRQCYM VVMGIVVAAW FTKLPEWTTW
     FILVALALYD LVAVLAPGGP LKLLVELASS RDEELPAMVY EARPTVSSGN QRRNRGSSLR
     ALVGGGGVSD SGSVELQAVR NHDVNQLGRE NSHNMDYNAI AVRDIDNVDD GIGNGSRGGL
     ERSPLVGSPS ASEHSTSVGT RGNMEDRESV MDEEMSPLVE LMGWGDNREE ARGLEESDNV
     VDISNRGIKL GLGDFIFYSV LVGRAAMYDL MTVYACYLAI ISGLGCTLIL LSVYNRALPA
     LPISIMLGVV FYFLTRLLME PFVVGVTTNL MMF
//
ID   PSN1_XENLA              Reviewed;         433 AA.
AC   O12976; Q6DD65;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1997, sequence version 1.
DT   25-OCT-2017, entry version 91.
DE   RecName: Full=Presenilin-1;
DE            Short=PS-1;
DE            EC=3.4.23.-;
DE   AltName: Full=Presenilin alpha;
DE            Short=PS-alpha;
GN   Name=psen1;
OS   Xenopus laevis (African clawed frog).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Amphibia; Batrachia; Anura; Pipoidea; Pipidae; Xenopodinae; Xenopus;
OC   Xenopus.
OX   NCBI_TaxID=8355;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND DEVELOPMENTAL
RP   STAGE.
RC   TISSUE=Brain;
RX   PubMed=9070286; DOI=10.1006/bbrc.1996.6043;
RA   Tsujimura A., Yasojima K., Hashimoto-Gotoh T.;
RT   "Cloning of Xenopus presenilin-alpha and -beta cDNAs and their
RT   differential expression in oogenesis and embryogenesis.";
RL   Biochem. Biophys. Res. Commun. 231:392-396(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Embryo;
RG   NIH - Xenopus Gene Collection (XGC) project;
RL   Submitted (JUL-2004) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Catalytic subunit of the gamma-secretase complex, an
CC       endoprotease complex that catalyzes the intramembrane cleavage of
CC       integral membrane proteins such as Notch receptors and APP
CC       (amyloid-beta precursor protein). Requires the presence of the
CC       other members of the gamma-secretase complex for protease
CC       activity. Plays a role in Notch and Wnt signaling cascades and
CC       regulation of downstream processes via its role in processing key
CC       regulatory proteins. {ECO:0000250|UniProtKB:P49768}.
CC   -!- SUBUNIT: Homodimer. The functional gamma-secretase complex is
CC       composed of at least four polypeptides: a presenilin homodimer
CC       (PSEN1 or PSEN2), nicastrin (NCSTN), APH1 (APH1A or APH1B) and
CC       PEN2. Such minimal complex is sufficient for secretase activity.
CC       {ECO:0000250|UniProtKB:P49768}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:P49768}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:P49768}. Golgi apparatus membrane
CC       {ECO:0000250|UniProtKB:P49768}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:P49768}. Cytoplasmic granule
CC       {ECO:0000250|UniProtKB:P49768}. Cell membrane
CC       {ECO:0000250|UniProtKB:P49768}. Cell projection, axon
CC       {ECO:0000250|UniProtKB:Q4JIM4}. Cell junction, synapse
CC       {ECO:0000250|UniProtKB:Q4JIM4}.
CC   -!- TISSUE SPECIFICITY: Highest expression in ovaries and to a lesser
CC       extent in testis, intestine, kidney, brain, eye and lung. Weak
CC       expression in liver and heart. Present in trace amounts in
CC       skeletal muscle. {ECO:0000269|PubMed:9070286}.
CC   -!- DEVELOPMENTAL STAGE: Abundant in early stages of oogenesis. The
CC       expression is rapidly reduced between meiotic maturation and
CC       fertilization stages. {ECO:0000269|PubMed:9070286}.
CC   -!- DOMAIN: The PAL motif is required for normal active site
CC       conformation. {ECO:0000250|UniProtKB:P49768}.
CC   -!- PTM: Heterogeneous proteolytic processing generates N-terminal
CC       (NTF) and C-terminal (CTF) fragments of approximately 35 and 20
CC       kDa, respectively. During apoptosis, the C-terminal fragment (CTF)
CC       is further cleaved by a caspase. {ECO:0000250|UniProtKB:P49768}.
CC   -!- SIMILARITY: Belongs to the peptidase A22A family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D84427; BAA19570.1; -; mRNA.
DR   EMBL; BC077762; AAH77762.1; -; mRNA.
DR   PIR; JC5390; JC5390.
DR   RefSeq; NP_001084023.1; NM_001090554.2.
DR   RefSeq; XP_018084271.1; XM_018228782.1.
DR   RefSeq; XP_018084272.1; XM_018228783.1.
DR   RefSeq; XP_018084273.1; XM_018228784.1.
DR   RefSeq; XP_018084274.1; XM_018228785.1.
DR   UniGene; Xl.55408; -.
DR   MEROPS; A22.001; -.
DR   GeneID; 399258; -.
DR   KEGG; xla:399258; -.
DR   CTD; 399258; -.
DR   Xenbase; XB-GENE-481920; psen1.
DR   HOVERGEN; HBG011375; -.
DR   KO; K04505; -.
DR   GO; GO:0030424; C:axon; IEA:UniProtKB-SubCell.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0070765; C:gamma-secretase complex; ISS:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; ISS:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; ISS:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISS:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0045202; C:synapse; IEA:UniProtKB-SubCell.
DR   GO; GO:0042500; F:aspartic endopeptidase activity, intramembrane cleaving; ISS:UniProtKB.
DR   GO; GO:0042982; P:amyloid precursor protein metabolic process; ISS:UniProtKB.
DR   GO; GO:0034205; P:amyloid-beta formation; ISS:UniProtKB.
DR   GO; GO:0006509; P:membrane protein ectodomain proteolysis; ISS:UniProtKB.
DR   GO; GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0043085; P:positive regulation of catalytic activity; ISS:UniProtKB.
DR   GO; GO:0016485; P:protein processing; ISS:UniProtKB.
DR   GO; GO:0060828; P:regulation of canonical Wnt signaling pathway; ISS:UniProtKB.
DR   InterPro; IPR001108; Peptidase_A22A.
DR   InterPro; IPR006639; Preselin/SPP.
DR   PANTHER; PTHR10202; PTHR10202; 1.
DR   Pfam; PF01080; Presenilin; 1.
DR   PRINTS; PR01072; PRESENILIN.
DR   SMART; SM00730; PSN; 1.
PE   2: Evidence at transcript level;
KW   Cell junction; Cell membrane; Cell projection; Endoplasmic reticulum;
KW   Glycoprotein; Golgi apparatus; Hydrolase; Membrane;
KW   Notch signaling pathway; Phosphoprotein; Protease; Synapse;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN         1    433       Presenilin-1.
FT                                /FTId=PRO_0000073898.
FT   TOPO_DOM      1     48       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P49768}.
FT   TRANSMEM     49     69       Helical. {ECO:0000250|UniProtKB:P49768}.
FT   TOPO_DOM     70     98       Lumenal. {ECO:0000250|UniProtKB:P49768}.
FT   TRANSMEM     99    119       Helical. {ECO:0000250|UniProtKB:P49768}.
FT   TOPO_DOM    120    132       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P49768}.
FT   TRANSMEM    133    155       Helical. {ECO:0000250|UniProtKB:P49768}.
FT   TOPO_DOM    156    160       Lumenal. {ECO:0000250|UniProtKB:P49768}.
FT   TRANSMEM    161    182       Helical. {ECO:0000250|UniProtKB:P49768}.
FT   TOPO_DOM    183    186       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P49768}.
FT   TRANSMEM    187    207       Helical. {ECO:0000250|UniProtKB:P49768}.
FT   TOPO_DOM    208    214       Lumenal. {ECO:0000250|UniProtKB:P49768}.
FT   TRANSMEM    215    238       Helical. {ECO:0000250|UniProtKB:P49768}.
FT   TOPO_DOM    239    346       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P49768}.
FT   TRANSMEM    347    367       Helical. {ECO:0000250|UniProtKB:P49768}.
FT   TOPO_DOM    368    373       Lumenal. {ECO:0000250|UniProtKB:P49768}.
FT   TRANSMEM    374    394       Helical. {ECO:0000250|UniProtKB:P49768}.
FT   TOPO_DOM    395    398       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P49768}.
FT   TRANSMEM    399    419       Helical. {ECO:0000250|UniProtKB:P49768}.
FT   TOPO_DOM    420    433       Lumenal. {ECO:0000250|UniProtKB:P49768}.
FT   MOTIF       399    401       PAL. {ECO:0000305}.
FT   ACT_SITE    223    223       {ECO:0000250|UniProtKB:P49768}.
FT   ACT_SITE    351    351       {ECO:0000250|UniProtKB:P49768}.
FT   SITE        257    258       Cleavage; alternate.
FT                                {ECO:0000250|UniProtKB:P49768}.
FT   SITE        258    259       Cleavage; alternate.
FT                                {ECO:0000250|UniProtKB:P49768}.
FT   SITE        264    265       Cleavage. {ECO:0000250|UniProtKB:P49768}.
FT   CARBOHYD    371    371       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   433 AA;  48301 MW;  71CCEE3F6BB9C0AF CRC64;
     MNDTSERRSN ENSESQSNGQ TQSSSQQVLE QDEEEDEELT LKYGAKHVIM LFVPVTLCMV
     VVVATIKSVS FYTRFDGQLI YTPFTEDTES VGQRALNSIL NATIMISVII VMTILLVVLY
     KYRCYKVIHG WLIISSLLLL FFFSYIYLGE VFKTYNVAVD YITLALLIWN FGVVGMICIH
     WKGPLLLQQA YLIMISALMA LVFIKYLPEW TTWLILAVIS VYDLVAVLSP KGPLRMLVET
     AQERNETLFP ALIYSSTMIW LVNMADGDPG LKQSASTKTY NTQAPTAHPR SDSAASDDNG
     GFDTTWEDHR NAQIGPINST PESRVAVQAL PSNSPPSEDP EERGVKLGLG DFIFYSVLVG
     KASATASGDW NTTLACFVAI LIGLCLTLLL LAIFKKALPA LPISITFGLV FYFATDYLVQ
     PFMDQLAFHQ FYI
//
ID   SPE4_CAEEL              Reviewed;         465 AA.
AC   Q01608;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1993, sequence version 1.
DT   20-DEC-2017, entry version 130.
DE   RecName: Full=Presenilin spe-4;
GN   Name=spe-4; ORFNames=ZK524.1;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RC   STRAIN=Bristol N2;
RX   PubMed=1527173; DOI=10.1083/jcb.119.1.55;
RA   L'Hernault S.W., Arduengo P.M.;
RT   "Mutation of a putative sperm membrane protein in Caenorhabditis
RT   elegans prevents sperm differentiation but not its associated meiotic
RT   divisions.";
RL   J. Cell Biol. 119:55-68(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
RN   [3]
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND MUTAGENESIS OF
RP   SER-177 AND PRO-440.
RX   PubMed=9819355;
RA   Arduengo P.M., Appleberry O.K., Chuang P., L'Hernault S.W.;
RT   "The presenilin protein family member SPE-4 localizes to an ER/Golgi
RT   derived organelle and is required for proper cytoplasmic partitioning
RT   during Caenorhabditis elegans spermatogenesis.";
RL   J. Cell Sci. 111:3645-3654(1998).
CC   -!- FUNCTION: Potential catalytic subunit of the gamma-secretase
CC       complex during spermatogenesis, an endoprotease complex that
CC       catalyzes the intramembrane cleavage of integral membrane proteins
CC       such as Notch receptors (lin-12 or glp-1). Involved in spermatid
CC       formation during meiosis II. May be required for proper
CC       localization of macromolecules that are subject to asymmetric
CC       partitioning during spermatogenesis. {ECO:0000269|PubMed:9819355}.
CC   -!- SUBUNIT: Homodimer. Potential component of the gamma-secretase
CC       complex, a complex probably composed of the presenilin homodimer
CC       (sel-12, hop-1 or spe-4), nicastrin (aph-2), aph-1 and pen-2
CC       (Probable). {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:9819355}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:9819355}. Golgi apparatus, cis-Golgi network
CC       membrane {ECO:0000269|PubMed:9819355}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:9819355}. Note=Predominantly located in the
CC       endoplasmic reticulum and in the cis-Golgi.
CC   -!- DEVELOPMENTAL STAGE: Expressed during L4 stage, during
CC       spermatogenesis, when hermaphrodites produces sperm.
CC   -!- DOMAIN: The PAL motif is required for normal active site
CC       conformation. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the peptidase A22A family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z14066; CAA78449.1; -; mRNA.
DR   EMBL; Z14067; CAA78450.1; -; Genomic_DNA.
DR   EMBL; Z73912; CAA98145.1; -; Genomic_DNA.
DR   PIR; T27885; T27885.
DR   RefSeq; NP_492095.1; NM_059694.5.
DR   UniGene; Cel.18295; -.
DR   ProteinModelPortal; Q01608; -.
DR   STRING; 6239.ZK524.1; -.
DR   MEROPS; A22.012; -.
DR   PaxDb; Q01608; -.
DR   PeptideAtlas; Q01608; -.
DR   EnsemblMetazoa; ZK524.1; ZK524.1; WBGene00004958.
DR   GeneID; 172498; -.
DR   KEGG; cel:CELE_ZK524.1; -.
DR   UCSC; ZK524.1; c. elegans.
DR   CTD; 172498; -.
DR   WormBase; ZK524.1; CE06618; WBGene00004958; spe-4.
DR   eggNOG; KOG2736; Eukaryota.
DR   eggNOG; ENOG410XPZD; LUCA.
DR   GeneTree; ENSGT00390000016593; -.
DR   InParanoid; Q01608; -.
DR   KO; K06060; -.
DR   OMA; CGTFCYF; -.
DR   OrthoDB; EOG091G0AV5; -.
DR   PhylomeDB; Q01608; -.
DR   Reactome; R-CEL-3928665; EPH-ephrin mediated repulsion of cells.
DR   Reactome; R-CEL-6798695; Neutrophil degranulation.
DR   PRO; PR:Q01608; -.
DR   Proteomes; UP000001940; Chromosome I.
DR   Bgee; WBGene00004958; -.
DR   GO; GO:0030424; C:axon; IBA:GO_Central.
DR   GO; GO:0005938; C:cell cortex; IBA:GO_Central.
DR   GO; GO:0009986; C:cell surface; IBA:GO_Central.
DR   GO; GO:0035253; C:ciliary rootlet; IBA:GO_Central.
DR   GO; GO:0043198; C:dendritic shaft; IBA:GO_Central.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell.
DR   GO; GO:0030426; C:growth cone; IBA:GO_Central.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:WormBase.
DR   GO; GO:0005765; C:lysosomal membrane; IBA:GO_Central.
DR   GO; GO:0045121; C:membrane raft; IBA:GO_Central.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IBA:GO_Central.
DR   GO; GO:0031594; C:neuromuscular junction; IBA:GO_Central.
DR   GO; GO:0043025; C:neuronal cell body; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IBA:GO_Central.
DR   GO; GO:0030018; C:Z disc; IBA:GO_Central.
DR   GO; GO:0004190; F:aspartic-type endopeptidase activity; IEA:InterPro.
DR   GO; GO:0004175; F:endopeptidase activity; IBA:GO_Central.
DR   GO; GO:0042987; P:amyloid precursor protein catabolic process; IBA:GO_Central.
DR   GO; GO:0050435; P:amyloid-beta metabolic process; IBA:GO_Central.
DR   GO; GO:0006816; P:calcium ion transport; IBA:GO_Central.
DR   GO; GO:0061024; P:membrane organization; IMP:WormBase.
DR   GO; GO:0006509; P:membrane protein ectodomain proteolysis; IBA:GO_Central.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IBA:GO_Central.
DR   GO; GO:0007220; P:Notch receptor processing; IBA:GO_Central.
DR   GO; GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0006996; P:organelle organization; IMP:WormBase.
DR   GO; GO:0008104; P:protein localization; IMP:WormBase.
DR   GO; GO:0016485; P:protein processing; IEA:InterPro.
DR   GO; GO:0007286; P:spermatid development; IMP:WormBase.
DR   InterPro; IPR001108; Peptidase_A22A.
DR   InterPro; IPR006639; Preselin/SPP.
DR   InterPro; IPR033153; SPE-4.
DR   PANTHER; PTHR10202; PTHR10202; 1.
DR   PANTHER; PTHR10202:SF17; PTHR10202:SF17; 1.
DR   Pfam; PF01080; Presenilin; 1.
DR   SMART; SM00730; PSN; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Endoplasmic reticulum; Golgi apparatus; Membrane;
KW   Notch signaling pathway; Reference proteome; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1    465       Presenilin spe-4.
FT                                /FTId=PRO_0000073904.
FT   TOPO_DOM      1     18       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     19     39       Helical. {ECO:0000255}.
FT   TOPO_DOM     40     71       Lumenal. {ECO:0000255}.
FT   TRANSMEM     72     92       Helical. {ECO:0000255}.
FT   TOPO_DOM     93     96       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     97    117       Helical. {ECO:0000255}.
FT   TOPO_DOM    118    136       Lumenal. {ECO:0000255}.
FT   TRANSMEM    137    157       Helical. {ECO:0000255}.
FT   TOPO_DOM    158    160       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    161    181       Helical. {ECO:0000255}.
FT   TOPO_DOM    182    190       Lumenal. {ECO:0000255}.
FT   TRANSMEM    191    211       Helical. {ECO:0000255}.
FT   TOPO_DOM    212    389       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    390    410       Helical. {ECO:0000255}.
FT   TOPO_DOM    411    411       Lumenal. {ECO:0000255}.
FT   TRANSMEM    412    432       Helical. {ECO:0000255}.
FT   TOPO_DOM    433    439       Cytoplasmic. {ECO:0000255}.
FT   INTRAMEM    440    460       Helical. {ECO:0000255}.
FT   TOPO_DOM    461    465       Cytoplasmic. {ECO:0000255}.
FT   MOTIF       440    442       PAL.
FT   ACT_SITE    200    200       {ECO:0000250}.
FT   ACT_SITE    394    394       {ECO:0000250}.
FT   MUTAGEN     177    177       S->F: In HC78; induces an aberrant
FT                                localization of tubulin in spermatids.
FT                                {ECO:0000269|PubMed:9819355}.
FT   MUTAGEN     440    440       P->L: In HC78; induces an aberrant
FT                                localization of tubulin in spermatids.
FT                                {ECO:0000269|PubMed:9819355}.
SQ   SEQUENCE   465 AA;  51830 MW;  65BE2A4DFDF3C844 CRC64;
     MDTLRSISSE LVRSSQLRWT LFSVIANMSL TLSIWIGVYN MEVNSELSKT YFLDPSFEQT
     TGNLLLDGFI NGVGTILVLG CVSFIMLAFV LFDFRRIVKA WLTLSCLLIL FGVSAQTLHD
     MFSQVFDQDD NNQYYMTIVL IVVPTVVYGF GGIYAFFSNS SLILHQIFVV TNCSLISVFY
     LRVFPSKTTW FVLWIVLFWD LFAVLAPMGP LKKVQEKASD YSKCVLNLIM FSANEKRLTA
     GSNQEETNEG EESTIRRTVK QTIEYYTKRE AQDDEFYQKI RQRRAAINPD SVPTEHSPLV
     EAEPSPIELK EKNSTEELSD DESDTSETSS GSSNLSSSDS STTVSTSDIS TAEECDQKEW
     DDLVSNSLPN NDKRPATAAD ALNDGEVLRL GFGDFVFYSL LIGQAAASGC PFAVISAALG
     ILFGLVVTLT VFSTEESTTP ALPLPVICGT FCYFSSMFFW EQLYG
//
ID   PSNB_DICDI              Reviewed;         473 AA.
AC   Q54DE8;
DT   29-APR-2008, integrated into UniProtKB/Swiss-Prot.
DT   24-MAY-2005, sequence version 1.
DT   22-NOV-2017, entry version 75.
DE   RecName: Full=Presenilin-B;
DE            Short=PS-B;
DE            EC=3.4.23.-;
GN   Name=psenB; ORFNames=DDB_G0292310;
OS   Dictyostelium discoideum (Slime mold).
OC   Eukaryota; Amoebozoa; Mycetozoa; Dictyosteliida; Dictyostelium.
OX   NCBI_TaxID=44689;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=AX4;
RX   PubMed=15875012; DOI=10.1038/nature03481;
RA   Eichinger L., Pachebat J.A., Gloeckner G., Rajandream M.A.,
RA   Sucgang R., Berriman M., Song J., Olsen R., Szafranski K., Xu Q.,
RA   Tunggal B., Kummerfeld S., Madera M., Konfortov B.A., Rivero F.,
RA   Bankier A.T., Lehmann R., Hamlin N., Davies R., Gaudet P., Fey P.,
RA   Pilcher K., Chen G., Saunders D., Sodergren E.J., Davis P.,
RA   Kerhornou A., Nie X., Hall N., Anjard C., Hemphill L., Bason N.,
RA   Farbrother P., Desany B., Just E., Morio T., Rost R., Churcher C.M.,
RA   Cooper J., Haydock S., van Driessche N., Cronin A., Goodhead I.,
RA   Muzny D.M., Mourier T., Pain A., Lu M., Harper D., Lindsay R.,
RA   Hauser H., James K.D., Quiles M., Madan Babu M., Saito T.,
RA   Buchrieser C., Wardroper A., Felder M., Thangavelu M., Johnson D.,
RA   Knights A., Loulseged H., Mungall K.L., Oliver K., Price C.,
RA   Quail M.A., Urushihara H., Hernandez J., Rabbinowitsch E., Steffen D.,
RA   Sanders M., Ma J., Kohara Y., Sharp S., Simmonds M.N., Spiegler S.,
RA   Tivey A., Sugano S., White B., Walker D., Woodward J.R., Winckler T.,
RA   Tanaka Y., Shaulsky G., Schleicher M., Weinstock G.M., Rosenthal A.,
RA   Cox E.C., Chisholm R.L., Gibbs R.A., Loomis W.F., Platzer M.,
RA   Kay R.R., Williams J.G., Dear P.H., Noegel A.A., Barrell B.G.,
RA   Kuspa A.;
RT   "The genome of the social amoeba Dictyostelium discoideum.";
RL   Nature 435:43-57(2005).
CC   -!- FUNCTION: Probable catalytic subunit of the gamma-secretase
CC       complex, an endoprotease complex that catalyzes the intramembrane
CC       cleavage of integral membrane proteins such as Notch receptors.
CC       Requires the other members of the gamma-secretase complex to have
CC       a protease activity (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Homodimer. Component of the gamma-secretase complex, a
CC       complex composed of a presenilin homodimer, nicastrin, aph1 and
CC       pen2 (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}. Golgi
CC       apparatus membrane {ECO:0000250}; Multi-pass membrane protein
CC       {ECO:0000250}.
CC   -!- DOMAIN: The PAL motif is required for normal active site
CC       conformation. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the peptidase A22A family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AAFI02000189; EAL61279.1; -; Genomic_DNA.
DR   RefSeq; XP_629693.1; XM_629691.1.
DR   STRING; 44689.DDB0231428; -.
DR   MEROPS; A22.A10; -.
DR   PaxDb; Q54DE8; -.
DR   EnsemblProtists; EAL61279; EAL61279; DDB_G0292310.
DR   GeneID; 8628609; -.
DR   KEGG; ddi:DDB_G0292310; -.
DR   dictyBase; DDB_G0292310; psenB.
DR   eggNOG; KOG2736; Eukaryota.
DR   eggNOG; ENOG410XPZD; LUCA.
DR   InParanoid; Q54DE8; -.
DR   KO; K04522; -.
DR   OMA; LPQWTIF; -.
DR   PhylomeDB; Q54DE8; -.
DR   Reactome; R-DDI-6798695; Neutrophil degranulation.
DR   PRO; PR:Q54DE8; -.
DR   Proteomes; UP000002195; Chromosome 6.
DR   Proteomes; UP000002195; Unassembled WGS sequence.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:dictyBase.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005635; C:nuclear envelope; IDA:dictyBase.
DR   GO; GO:0004190; F:aspartic-type endopeptidase activity; IEA:InterPro.
DR   GO; GO:0004175; F:endopeptidase activity; IBA:GO_Central.
DR   GO; GO:0055074; P:calcium ion homeostasis; IMP:dictyBase.
DR   GO; GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0006909; P:phagocytosis; IMP:dictyBase.
DR   GO; GO:0016485; P:protein processing; IEA:InterPro.
DR   GO; GO:0006508; P:proteolysis; IMP:dictyBase.
DR   GO; GO:0043949; P:regulation of cAMP-mediated signaling; IGI:dictyBase.
DR   GO; GO:0030587; P:sorocarp development; IGI:dictyBase.
DR   GO; GO:0044671; P:sorocarp spore cell differentiation; IMP:dictyBase.
DR   GO; GO:0031149; P:sorocarp stalk cell differentiation; IGI:dictyBase.
DR   InterPro; IPR001108; Peptidase_A22A.
DR   InterPro; IPR006639; Preselin/SPP.
DR   PANTHER; PTHR10202; PTHR10202; 3.
DR   Pfam; PF01080; Presenilin; 2.
DR   PRINTS; PR01072; PRESENILIN.
DR   SMART; SM00730; PSN; 1.
PE   3: Inferred from homology;
KW   Complete proteome; Endoplasmic reticulum; Glycoprotein;
KW   Golgi apparatus; Hydrolase; Membrane; Notch signaling pathway;
KW   Protease; Reference proteome; Transmembrane; Transmembrane helix.
FT   CHAIN         1    473       Presenilin-B.
FT                                /FTId=PRO_0000331268.
FT   TOPO_DOM      1    164       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    165    185       Helical. {ECO:0000255}.
FT   TOPO_DOM    186    224       Lumenal. {ECO:0000255}.
FT   TRANSMEM    225    245       Helical. {ECO:0000255}.
FT   TOPO_DOM    246    252       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    253    273       Helical. {ECO:0000255}.
FT   TOPO_DOM    274    286       Lumenal. {ECO:0000255}.
FT   TRANSMEM    287    307       Helical. {ECO:0000255}.
FT   TOPO_DOM    308    308       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    309    329       Helical. {ECO:0000255}.
FT   TOPO_DOM    330    334       Lumenal. {ECO:0000255}.
FT   TRANSMEM    335    355       Helical. {ECO:0000255}.
FT   TOPO_DOM    356    389       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    390    410       Helical. {ECO:0000255}.
FT   TOPO_DOM    411    413       Lumenal. {ECO:0000255}.
FT   TRANSMEM    414    434       Helical. {ECO:0000255}.
FT   TOPO_DOM    435    442       Cytoplasmic. {ECO:0000255}.
FT   INTRAMEM    443    463       Helical. {ECO:0000255}.
FT   TOPO_DOM    464    473       Cytoplasmic. {ECO:0000255}.
FT   MOTIF       439    441       PAL.
FT   COMPBIAS     47    117       Asn-rich.
FT   ACT_SITE    348    348       {ECO:0000250}.
FT   ACT_SITE    394    394       {ECO:0000250}.
FT   CARBOHYD    190    190       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   473 AA;  52559 MW;  CA2263FCFDFA2C54 CRC64;
     MSSDNNNDPF DLNEDGHDYF NRVSTTTSPN RQSINSSPKQ SSPKSTNNND DKNNIILDLN
     DNNNDNNNTN NYNDEDIDVD NKNKFENKDN TYNSNGGSNN KNKNKKKDNK SNNSSDNEEA
     DENTSLISDS EPLLNKKEKD DEQIEIENLD GEDYDDEVSL QDFSSMIVSI IIPVSITMMA
     VVFFVKYLNN QTLYASTLSY TIAGGSSGGG SGADSITGNS FVDSLIVAGI VLGMIIVTTV
     AFVLLYKYRC LKILYGWLFL SVGMMLGSFG TTFFQAMLSA ANLPLDYITF AFLIFNFTVC
     GIIGVFWYAH QYVNQLYLVI ISVLMAISLT RLPQWTIFTL LVIVAIYDLF AVLCPRGPLK
     VLVELSQERN ENIPALVYET GKGSDSNLKL GLGDFIFYSL LISRAALVHM SCVFSTFIAI
     LTGLFLTLLC LAIFKKALPA LPISIFLGIL FYYLSNNFLT PFIEALTLSQ IFV
//
ID   RFNG_DANRE              Reviewed;         362 AA.
AC   Q6KFX9;
DT   03-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   25-OCT-2017, entry version 77.
DE   RecName: Full=Beta-1,3-N-acetylglucosaminyltransferase radical fringe;
DE            EC=2.4.1.222;
DE   AltName: Full=O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase;
GN   Name=rfng {ECO:0000312|EMBL:AAQ08017.1,
GN   ECO:0000312|ZFIN:ZDB-GENE-030131-5418};
OS   Danio rerio (Zebrafish) (Brachydanio rerio).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Actinopterygii; Neopterygii; Teleostei; Ostariophysi; Cypriniformes;
OC   Cyprinidae; Danio.
OX   NCBI_TaxID=7955;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:AAQ08017.1}
RP   NUCLEOTIDE SEQUENCE [MRNA], AND DEVELOPMENTAL STAGE.
RC   TISSUE=Embryo {ECO:0000269|PubMed:15376327};
RX   PubMed=15376327; DOI=10.1002/dvdy.20155;
RA   Qiu X., Xu H., Haddon C., Lewis J., Jiang Y.-J.;
RT   "Sequence and embryonic expression of three zebrafish fringe genes:
RT   lunatic fringe, radical fringe, and manic fringe.";
RL   Dev. Dyn. 231:621-630(2004).
RN   [2] {ECO:0000305}
RP   FUNCTION, AND DEVELOPMENTAL STAGE.
RX   PubMed=15068793; DOI=10.1016/S1534-5807(04)00097-8;
RA   Cheng Y.-C., Amoyel M., Qiu X., Jiang Y.-J., Xu Q., Wilkinson D.G.;
RT   "Notch activation regulates the segregation and differentiation of
RT   rhombomere boundary cells in the zebrafish hindbrain.";
RL   Dev. Cell 6:539-550(2004).
RN   [3] {ECO:0000305}
RP   FUNCTION, AND DEVELOPMENTAL STAGE.
RX   PubMed=15659486; DOI=10.1242/dev.01616;
RA   Amoyel M., Cheng Y.-C., Jiang Y.-J., Wilkinson D.G.;
RT   "Wnt1 regulates neurogenesis and mediates lateral inhibition of
RT   boundary cell specification in the zebrafish hindbrain.";
RL   Development 132:775-785(2005).
CC   -!- FUNCTION: Glycosyltransferase that initiates the elongation of O-
CC       linked fucose residues attached to EGF-like repeats in the
CC       extracellular domain of Notch molecules (By similarity). Regulates
CC       neurogenesis in the hindbrain; involved in boundary cell
CC       specification via Notch-mediated activation of wnt1 expression
CC       (PubMed:15068793, PubMed:15659486). {ECO:0000250|UniProtKB:O09009,
CC       ECO:0000269|PubMed:15068793, ECO:0000269|PubMed:15659486}.
CC   -!- CATALYTIC ACTIVITY: Transfers a beta-D-GlcNAc residue from UDP-D-
CC       GlcNAc to the fucose residue of a fucosylated protein acceptor.
CC       {ECO:0000250|UniProtKB:Q9Y644}.
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250};
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000250};
CC       Single-pass type II membrane protein {ECO:0000250}.
CC   -!- DEVELOPMENTAL STAGE: Expressed both maternally and zygotically. At
CC       the tailbud stage, expressed weakly in the adaxial cells and the
CC       future brain. From the 3-somite stage, strong expression in the
CC       adaxial cells and weak expression in the somites and tailbud.
CC       During somitogenesis, expression in the brain is gradually
CC       restricted to and up-regulated in the tectum and rhombomere
CC       boundary cells. {ECO:0000269|PubMed:15068793,
CC       ECO:0000269|PubMed:15376327, ECO:0000269|PubMed:15659486}.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 31 family.
CC       {ECO:0000255}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF510993; AAQ08017.1; -; mRNA.
DR   UniGene; Dr.11937; -.
DR   ProteinModelPortal; Q6KFX9; -.
DR   SMR; Q6KFX9; -.
DR   STRING; 7955.ENSDARP00000105906; -.
DR   CAZy; GT31; Glycosyltransferase Family 31.
DR   PaxDb; Q6KFX9; -.
DR   PRIDE; Q6KFX9; -.
DR   ZFIN; ZDB-GENE-030131-5418; rfng.
DR   eggNOG; ENOG410II9W; Eukaryota.
DR   eggNOG; ENOG410XS8Y; LUCA.
DR   HOGENOM; HOG000046678; -.
DR   HOVERGEN; HBG007986; -.
DR   InParanoid; Q6KFX9; -.
DR   PhylomeDB; Q6KFX9; -.
DR   PRO; PR:Q6KFX9; -.
DR   Proteomes; UP000000437; Unplaced.
DR   GO; GO:0030173; C:integral component of Golgi membrane; IEA:InterPro.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0033829; F:O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0035284; P:brain segmentation; IMP:ZFIN.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0021592; P:fourth ventricle development; IMP:ZFIN.
DR   GO; GO:0030902; P:hindbrain development; IMP:ZFIN.
DR   GO; GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0036066; P:protein O-linked fucosylation; ISS:UniProtKB.
DR   GO; GO:0008593; P:regulation of Notch signaling pathway; ISS:UniProtKB.
DR   GO; GO:0021654; P:rhombomere boundary formation; IMP:ZFIN.
DR   InterPro; IPR017374; Fringe.
DR   InterPro; IPR003378; Fringe-like.
DR   Pfam; PF02434; Fringe; 1.
DR   PIRSF; PIRSF038073; B-acetylgalactosaminyltfrase; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Developmental protein; Differentiation;
KW   Disulfide bond; Glycoprotein; Glycosyltransferase; Golgi apparatus;
KW   Manganese; Membrane; Metal-binding; Neurogenesis;
KW   Notch signaling pathway; Reference proteome; Signal-anchor;
KW   Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN         1    362       Beta-1,3-N-acetylglucosaminyltransferase
FT                                radical fringe.
FT                                /FTId=PRO_0000250423.
FT   TOPO_DOM      1     11       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     12     32       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     33    362       Lumenal. {ECO:0000255}.
FT   ACT_SITE    273    273       {ECO:0000250}.
FT   METAL       185    185       Manganese. {ECO:0000250}.
FT   METAL       297    297       Manganese. {ECO:0000250}.
FT   BINDING     111    111       Substrate. {ECO:0000250}.
FT   BINDING     184    184       Substrate. {ECO:0000250}.
FT   CARBOHYD    150    150       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    151    162       {ECO:0000250}.
FT   DISULFID    180    243       {ECO:0000250}.
FT   DISULFID    347    356       {ECO:0000250}.
SQ   SEQUENCE   362 AA;  41019 MW;  A6CDCBFBC84C69C7 CRC64;
     MHLSHVASNK TCFLLSLAFC ALLVLLIPSL QPPQRQADLP QPRPHAKPAK HPLKNSLYRP
     NEDTRGGGFT QTPPPDNLEK MDDLNSHYRD FLDLRDIFIA VKTTRKYHKS RLQLLSQTWV
     SRAKEQTFIF TDGEDKELRL KAGLNIINTN CSAAHTRQAL CCKMSVEYDK FIESQKKWFC
     HVDDDNYVIL PSLLELLSSY SHTQDVYLGR PSLDHPIEAA ERVKSDGSVS VKFWFATGGA
     GFCISRGLAL KMSPWASLGN FITTAEKIRL PDDCTIGYII EALLEVPLTH TGLFHSHLEN
     LQRLPAENIL RQVTLSYGGF ENRRNVVSVG GAFSLAEDPT RFKTVHCKLY PDTEWCPRKT
     RH
//
ID   HOP1_CAEEL              Reviewed;         358 AA.
AC   O02100;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1997, sequence version 1.
DT   22-NOV-2017, entry version 129.
DE   RecName: Full=Presenilin hop-1;
GN   Name=hop-1; ORFNames=C18E3.8;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9342387; DOI=10.1073/pnas.94.22.12204;
RA   Li X., Greenwald I.;
RT   "HOP-1, a Caenorhabditis elegans presenilin, appears to be
RT   functionally redundant with SEL-12 presenilin and to facilitate LIN-12
RT   and GLP-1 signaling.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:12204-12209(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
RN   [3]
RP   FUNCTION.
RX   PubMed=10051671; DOI=10.1073/pnas.96.5.2497;
RA   Westlund B., Parry D., Clover R., Basson M., Johnson C.D.;
RT   "Reverse genetic analysis of Caenorhabditis elegans presenilins
RT   reveals redundant but unequal roles for sel-12 and hop-1 in Notch-
RT   pathway signaling.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:2497-2502(1999).
RN   [4]
RP   DOWN-REGULATION BY SPR-5.
RX   PubMed=12411496; DOI=10.1093/emboj/cdf561;
RA   Eimer S., Lakowski B., Donhauser R., Baumeister R.;
RT   "Loss of spr-5 bypasses the requirement for the C.elegans presenilin
RT   sel-12 by derepressing hop-1.";
RL   EMBO J. 21:5787-5796(2002).
RN   [5]
RP   DOWN-REGULATION BY SPR-1.
RX   PubMed=12381669; DOI=10.1101/gad.1022402;
RA   Jarriault S., Greenwald I.;
RT   "Suppressors of the egg-laying defective phenotype of sel-12
RT   presenilin mutants implicate the CoREST corepressor complex in LIN-
RT   12/Notch signaling in C. elegans.";
RL   Genes Dev. 16:2713-2728(2002).
RN   [6]
RP   DEVELOPMENTAL STAGE, AND DOWN-REGULATION BY SPR-3 AND SPR-4.
RX   PubMed=12668626; DOI=10.1242/dev.00429;
RA   Lakowski B., Eimer S., Goebel C., Boettcher A., Wagler B.,
RA   Baumeister R.;
RT   "Two suppressors of sel-12 encode C2H2 zinc-finger proteins that
RT   regulate presenilin transcription in Caenorhabditis elegans.";
RL   Development 130:2117-2128(2003).
CC   -!- FUNCTION: Probable catalytic subunit of the gamma-secretase
CC       complex, an endoprotease complex that catalyzes the intramembrane
CC       cleavage of integral membrane proteins such as Notch receptors
CC       (lin-12 or glp-1). Probably works redundantly of lin-12, which
CC       provides more presenilin function. {ECO:0000269|PubMed:10051671}.
CC   -!- SUBUNIT: Homodimer. Component of the gamma-secretase complex, a
CC       complex probably composed of the presenilin homodimer (sel-12,
CC       hop-1 or spe-4), nicastrin (aph-2), aph-1 and pen-2 (Probable).
CC       {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}. Golgi
CC       apparatus membrane {ECO:0000250}; Multi-pass membrane protein
CC       {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Weakly expressed.
CC   -!- DEVELOPMENTAL STAGE: Expressed both maternally and zygotically.
CC       Predominantly expressed in the adult. Weakly expressed in the
CC       embryo, L2 and L3 stages, and almost absent in L1 stage larvae.
CC       {ECO:0000269|PubMed:12668626}.
CC   -!- INDUCTION: Down-regulated by spr-1, spr-3, spr-4 and spr-5.
CC   -!- DOMAIN: The PAL motif is required for normal active site
CC       conformation. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the peptidase A22A family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF021905; AAB84394.1; -; Genomic_DNA.
DR   EMBL; FO080611; CCD65145.1; -; Genomic_DNA.
DR   PIR; T15184; T15184.
DR   RefSeq; NP_491328.1; NM_058927.1.
DR   UniGene; Cel.18540; -.
DR   ProteinModelPortal; O02100; -.
DR   SMR; O02100; -.
DR   STRING; 6239.C18E3.8; -.
DR   MEROPS; A22.010; -.
DR   EPD; O02100; -.
DR   PaxDb; O02100; -.
DR   EnsemblMetazoa; C18E3.8; C18E3.8; WBGene00001985.
DR   GeneID; 172017; -.
DR   KEGG; cel:CELE_C18E3.8; -.
DR   UCSC; C18E3.8; c. elegans.
DR   CTD; 172017; -.
DR   WormBase; C18E3.8; CE08317; WBGene00001985; hop-1.
DR   eggNOG; KOG2736; Eukaryota.
DR   eggNOG; ENOG410XPZD; LUCA.
DR   GeneTree; ENSGT00390000016593; -.
DR   InParanoid; O02100; -.
DR   KO; K06060; -.
DR   OMA; PVALCMI; -.
DR   OrthoDB; EOG091G0HUX; -.
DR   PhylomeDB; O02100; -.
DR   Reactome; R-CEL-3928665; EPH-ephrin mediated repulsion of cells.
DR   Reactome; R-CEL-6798695; Neutrophil degranulation.
DR   SignaLink; O02100; -.
DR   PRO; PR:O02100; -.
DR   Proteomes; UP000001940; Chromosome I.
DR   Bgee; WBGene00001985; -.
DR   GO; GO:0030424; C:axon; IBA:GO_Central.
DR   GO; GO:0005938; C:cell cortex; IBA:GO_Central.
DR   GO; GO:0009986; C:cell surface; IBA:GO_Central.
DR   GO; GO:0035253; C:ciliary rootlet; IBA:GO_Central.
DR   GO; GO:0043198; C:dendritic shaft; IBA:GO_Central.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0030426; C:growth cone; IBA:GO_Central.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005765; C:lysosomal membrane; IBA:GO_Central.
DR   GO; GO:0045121; C:membrane raft; IBA:GO_Central.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IBA:GO_Central.
DR   GO; GO:0031594; C:neuromuscular junction; IBA:GO_Central.
DR   GO; GO:0043025; C:neuronal cell body; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IBA:GO_Central.
DR   GO; GO:0030018; C:Z disc; IBA:GO_Central.
DR   GO; GO:0004190; F:aspartic-type endopeptidase activity; IEA:InterPro.
DR   GO; GO:0004175; F:endopeptidase activity; IBA:GO_Central.
DR   GO; GO:0042987; P:amyloid precursor protein catabolic process; IBA:GO_Central.
DR   GO; GO:0050435; P:amyloid-beta metabolic process; IBA:GO_Central.
DR   GO; GO:0006816; P:calcium ion transport; IBA:GO_Central.
DR   GO; GO:0009792; P:embryo development ending in birth or egg hatching; IGI:WormBase.
DR   GO; GO:0008406; P:gonad development; IGI:WormBase.
DR   GO; GO:0006509; P:membrane protein ectodomain proteolysis; IBA:GO_Central.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IBA:GO_Central.
DR   GO; GO:0002119; P:nematode larval development; IGI:WormBase.
DR   GO; GO:0007220; P:Notch receptor processing; IBA:GO_Central.
DR   GO; GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0018991; P:oviposition; IGI:WormBase.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IGI:WormBase.
DR   GO; GO:0045747; P:positive regulation of Notch signaling pathway; IGI:WormBase.
DR   GO; GO:0016485; P:protein processing; IEA:InterPro.
DR   GO; GO:0042659; P:regulation of cell fate specification; IGI:WormBase.
DR   GO; GO:0040028; P:regulation of vulval development; IGI:WormBase.
DR   GO; GO:0000003; P:reproduction; IMP:WormBase.
DR   InterPro; IPR033152; Pept_Hop-1.
DR   InterPro; IPR001108; Peptidase_A22A.
DR   InterPro; IPR006639; Preselin/SPP.
DR   PANTHER; PTHR10202; PTHR10202; 1.
DR   PANTHER; PTHR10202:SF14; PTHR10202:SF14; 1.
DR   Pfam; PF01080; Presenilin; 2.
DR   PRINTS; PR01072; PRESENILIN.
DR   SMART; SM00730; PSN; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Endoplasmic reticulum; Golgi apparatus; Membrane;
KW   Notch signaling pathway; Reference proteome; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1    358       Presenilin hop-1.
FT                                /FTId=PRO_0000073902.
FT   TOPO_DOM      1     12       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     13     33       Helical. {ECO:0000255}.
FT   TOPO_DOM     34     57       Lumenal. {ECO:0000255}.
FT   TRANSMEM     58     78       Helical. {ECO:0000255}.
FT   TOPO_DOM     79     86       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     87    107       Helical. {ECO:0000255}.
FT   TOPO_DOM    108    115       Lumenal. {ECO:0000255}.
FT   TRANSMEM    116    136       Helical. {ECO:0000255}.
FT   TOPO_DOM    137    148       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    149    169       Helical. {ECO:0000255}.
FT   TOPO_DOM    170    170       Lumenal. {ECO:0000255}.
FT   TRANSMEM    171    191       Helical. {ECO:0000255}.
FT   TOPO_DOM    192    273       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    274    294       Helical. {ECO:0000255}.
FT   TOPO_DOM    295    297       Lumenal. {ECO:0000255}.
FT   TRANSMEM    298    318       Helical. {ECO:0000255}.
FT   TOPO_DOM    319    321       Cytoplasmic. {ECO:0000255}.
FT   INTRAMEM    322    342       Helical. {ECO:0000255}.
FT   TOPO_DOM    343    358       Cytoplasmic. {ECO:0000255}.
FT   MOTIF       324    326       PAL.
FT   ACT_SITE    182    182       {ECO:0000250}.
FT   ACT_SITE    278    278       {ECO:0000250}.
SQ   SEQUENCE   358 AA;  39865 MW;  E811624695DB8E1A CRC64;
     MPRTKRVYSG KTITGVLYPV AICMLFVAIN VKLSQPEQQE QSKVVYGLFH SYDTADSGTI
     TLYLIGFLIL TTSLGVFCYQ MKFYKAIKVY VLANSIGILL VYSVFHFQRI AEAQSIPVSV
     PTFFFLILQF GGLGITCLHW KSHRRLHQFY LIMLAGLTAI FILNILPDWT VWMALTAISF
     WDIVAVLTPC GPLKMLVETA NRRGDDKFPA ILYNSSSYVN EVDSPDTTRS NSTPLTEFNN
     SSSSRLLESD SLLRPPVIPR QIREVREVEG TIRLGMGDFV FYSLMLGNTV QTCPLPTVVA
     CFVSNLVGLT ITLPIVTLSQ TALPALPFPL AIAAIFYFSS HIALTPFTDL CTSQLILI
//
ID   PSN_DROME               Reviewed;         541 AA.
AC   O02194; O02395; O76802; O96340; Q9TY80; Q9V3L9; Q9V3S1;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   15-JUL-1999, sequence version 2.
DT   22-NOV-2017, entry version 160.
DE   RecName: Full=Presenilin homolog;
DE            Short=DmPS;
DE            EC=3.4.23.-;
DE   AltName: Full=dPS;
GN   Name=Psn; Synonyms=PS; ORFNames=CG18803;
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha;
OC   Ephydroidea; Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], ALTERNATIVE SPLICING, AND DEVELOPMENTAL
RP   STAGE.
RC   TISSUE=Embryo;
RX   PubMed=9141085; DOI=10.1097/00001756-199703030-00041;
RA   Boulianne G.L., Livne-Bar I., Humphreys J.M., Liang Y., Lin C.,
RA   Rogaev E., St George-Hyslop P.H.;
RT   "Cloning and characterization of the Drosophila presenilin
RT   homologue.";
RL   NeuroReport 8:1025-1029(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND DEVELOPMENTAL STAGE.
RC   STRAIN=Canton-S; TISSUE=Embryo, and Head;
RX   PubMed=9106743; DOI=10.1097/00001756-199702100-00017;
RA   Hong C.-S., Koo E.H.;
RT   "Isolation and characterization of Drosophila presenilin homolog.";
RL   NeuroReport 8:665-668(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 1 AND 2), TISSUE
RP   SPECIFICITY, DEVELOPMENTAL STAGE, SUBCELLULAR LOCATION, AND
RP   ALTERNATIVE SPLICING.
RX   PubMed=10349633; DOI=10.1016/S0925-4773(98)00169-5;
RA   Ye Y., Fortini M.E.;
RT   "Characterization of Drosophila Presenilin and its colocalization with
RT   Notch during development.";
RL   Mech. Dev. 79:199-211(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE (ISOFORMS 1 AND 2), AND FUNCTION IN S3 CLEAVAGE OF
RP   NOTCH.
RX   PubMed=10206647; DOI=10.1038/19096;
RA   Ye Y., Lukinova N., Fortini M.E.;
RT   "Neurogenic phenotypes and altered Notch processing in Drosophila
RT   Presenilin mutants.";
RL   Nature 398:525-529(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], ALTERNATIVE SPLICING, AND
RP   DEVELOPMENTAL STAGE.
RC   STRAIN=Canton-S;
RX   PubMed=9666900; DOI=10.3109/01677069809108554;
RA   Marfany G., Del-Favero J., Valero R., De Jonghe C., Woodrow S.,
RA   Hendriks L., Van Broeckhoven C., Gonzalez-Duarte R.;
RT   "Identification of a Drosophila presenilin homologue: evidence of
RT   alternatively spliced forms.";
RL   J. Neurogenet. 12:41-54(1998).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 1 AND 2).
RX   PubMed=10493744;
RA   Guo Y., Livne-Bar I., Zhou L., Boulianne G.L.;
RT   "Drosophila presenilin is required for neuronal differentiation and
RT   affects notch subcellular localization and signaling.";
RL   J. Neurosci. 19:8435-8442(1999).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley;
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X.,
RA   Brandon R.C., Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D.,
RA   Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G.,
RA   Abril J.F., Agbayani A., An H.-J., Andrews-Pfannkoch C., Baldwin D.,
RA   Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M.,
RA   Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S.,
RA   Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P.,
RA   Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I.,
RA   Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P.,
RA   de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M.,
RA   Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P.,
RA   Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W.,
RA   Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K.,
RA   Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J.,
RA   Hostin D., Houston K.A., Howland T.J., Wei M.-H., Ibegwam C.,
RA   Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A.,
RA   Kimmel B.E., Kodira C.D., Kraft C.L., Kravitz S., Kulp D., Lai Z.,
RA   Lasko P., Lei Y., Levitsky A.A., Li J.H., Li Z., Liang Y., Lin X.,
RA   Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D.,
RA   Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A.,
RA   Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L.,
RA   Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M.,
RA   Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G.,
RA   Reinert K., Remington K., Saunders R.D.C., Scheeler F., Shen H.,
RA   Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E.,
RA   Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X.,
RA   Wang Z.-Y., Wassarman D.A., Weinstock G.M., Weissenbach J.,
RA   Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A.,
RA   Ye J., Yeh R.-F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L.,
RA   Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S.C., Zhu X.,
RA   Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [8]
RP   GENOME REANNOTATION, AND ALTERNATIVE SPLICING.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q.,
RA   Stapleton M., Yamada C., Ashburner M., Gelbart W.M., Rubin G.M.,
RA   Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a
RT   systematic review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   STRAIN=Berkeley; TISSUE=Embryo;
RX   PubMed=12537569; DOI=10.1186/gb-2002-3-12-research0080;
RA   Stapleton M., Carlson J.W., Brokstein P., Yu C., Champe M.,
RA   George R.A., Guarin H., Kronmiller B., Pacleb J.M., Park S., Wan K.H.,
RA   Rubin G.M., Celniker S.E.;
RT   "A Drosophila full-length cDNA resource.";
RL   Genome Biol. 3:RESEARCH0080.1-RESEARCH0080.8(2002).
RN   [10]
RP   ALTERNATIVE SPLICING (ISOFORM 3), AND CLEAVAGE.
RX   PubMed=10662508; DOI=10.1006/mcne.1999.0805;
RA   Nowotny P., Gorski S.M., Han S.W., Philips K., Ray W.J., Nowotny V.,
RA   Jones C.J., Clark R.F., Cagan R.L., Goate A.M.;
RT   "Posttranslational modification and plasma membrane localization of
RT   the Drosophila melanogaster presenilin.";
RL   Mol. Cell. Neurosci. 15:88-98(2000).
RN   [11]
RP   FUNCTION IN S3 CLEAVAGE OF NOTCH.
RX   PubMed=10206646; DOI=10.1038/19091;
RA   Struhl G., Greenwald I.;
RT   "Presenilin is required for activity and nuclear access of Notch in
RT   Drosophila.";
RL   Nature 398:522-525(1999).
RN   [12]
RP   INTERACTION WITH METL.
RX   PubMed=11738826; DOI=10.1016/S0378-1119(01)00770-3;
RA   Zhang S.X., Guo Y., Boulianne G.L.;
RT   "Identification of a novel family of putative methyltransferases that
RT   interact with human and Drosophila presenilins.";
RL   Gene 280:135-144(2001).
RN   [13]
RP   FUNCTION IN THE GAMMA-SECRETASE COMPLEX, AND INTERACTION WITH PEN-2;
RP   APH-1 AND NCT.
RX   PubMed=12660785; DOI=10.1038/nature01506;
RA   Takasugi N., Tomita T., Hayashi I., Tsuruoka M., Niimura M.,
RA   Takahashi Y., Thinakaran G., Iwatsubo T.;
RT   "The role of presenilin cofactors in the gamma-secretase complex.";
RL   Nature 422:438-441(2003).
CC   -!- FUNCTION: Probable catalytic subunit of the gamma-secretase
CC       complex, an endoprotease complex that catalyzes the intramembrane
CC       cleavage of integral membrane proteins such as Notch receptor.
CC       Required for S3 cleavage of Notch, which releases activated Notch
CC       protein from the cell membrane. Involved in the patterning of the
CC       optic lobes. {ECO:0000269|PubMed:10206646,
CC       ECO:0000269|PubMed:10206647, ECO:0000269|PubMed:12660785}.
CC   -!- SUBUNIT: Homodimer (By similarity). Component of the gamma-
CC       secretase complex, a complex composed of a presenilin (Psn)
CC       homodimer, nicastrin (Nct), Aph-1 and Pen-2. Interacts with Metl.
CC       Isoform 2 shows a better interaction with Metl than isoform 1.
CC       {ECO:0000250, ECO:0000269|PubMed:11738826,
CC       ECO:0000269|PubMed:12660785}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}. Golgi
CC       apparatus membrane {ECO:0000250}; Multi-pass membrane protein
CC       {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=A2, A, DLA-b;
CC         IsoId=O02194-1; Sequence=Displayed;
CC       Name=2; Synonyms=A1, B, PS-d, DLA-a;
CC         IsoId=O02194-2; Sequence=VSP_005195;
CC       Name=3;
CC         IsoId=O02194-3; Sequence=VSP_007988;
CC   -!- TISSUE SPECIFICITY: Maternally expressed in nurse and follicle
CC       cells. In early embryos, expressed in all or most cells and later
CC       increases in CNS and epidermal tissues. In larvae, expression is
CC       seen in all imaginal disks, brain and optic lobes. In pupae,
CC       expression is seen in eye disk and brain.
CC       {ECO:0000269|PubMed:10349633}.
CC   -!- DEVELOPMENTAL STAGE: Expressed both maternally and zygotically
CC       throughout development. {ECO:0000269|PubMed:10349633,
CC       ECO:0000269|PubMed:9106743, ECO:0000269|PubMed:9141085,
CC       ECO:0000269|PubMed:9666900}.
CC   -!- DOMAIN: The PAL motif is required for normal active site
CC       conformation. {ECO:0000250}.
CC   -!- PTM: Cleaved. The cleavage, which probably takes place between the
CC       6th and the 7th transmembrane regions, may be required for
CC       activation of the gamma-secretase activity.
CC       {ECO:0000269|PubMed:10662508}.
CC   -!- SIMILARITY: Belongs to the peptidase A22A family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U77934; AAB61139.1; -; mRNA.
DR   EMBL; U78084; AAB53369.1; -; mRNA.
DR   EMBL; AF084184; AAC33129.1; -; Genomic_DNA.
DR   EMBL; AF084184; AAC33128.1; -; Genomic_DNA.
DR   EMBL; AF017024; AAD01610.1; -; mRNA.
DR   EMBL; AF017025; AAD01611.1; -; mRNA.
DR   EMBL; AF017026; AAD01612.1; -; Genomic_DNA.
DR   EMBL; AF093402; AAD52707.1; -; Genomic_DNA.
DR   EMBL; AF093402; AAD52708.1; -; Genomic_DNA.
DR   EMBL; AE014296; AAN12132.1; -; Genomic_DNA.
DR   EMBL; AE014296; AAF51598.1; -; Genomic_DNA.
DR   EMBL; AY061316; AAL28864.1; -; mRNA.
DR   RefSeq; NP_001262110.1; NM_001275181.1. [O02194-2]
DR   RefSeq; NP_001262111.1; NM_001275182.1. [O02194-1]
DR   RefSeq; NP_524184.1; NM_079460.2. [O02194-1]
DR   RefSeq; NP_730535.1; NM_168856.3. [O02194-2]
DR   UniGene; Dm.3254; -.
DR   ProteinModelPortal; O02194; -.
DR   BioGrid; 65518; 39.
DR   DIP; DIP-1139N; -.
DR   STRING; 7227.FBpp0077850; -.
DR   MEROPS; A22.014; -.
DR   PaxDb; O02194; -.
DR   PRIDE; O02194; -.
DR   EnsemblMetazoa; FBtr0078192; FBpp0077850; FBgn0019947. [O02194-1]
DR   EnsemblMetazoa; FBtr0078193; FBpp0077851; FBgn0019947. [O02194-2]
DR   EnsemblMetazoa; FBtr0114517; FBpp0113009; FBgn0019947. [O02194-3]
DR   EnsemblMetazoa; FBtr0333478; FBpp0305665; FBgn0019947. [O02194-2]
DR   EnsemblMetazoa; FBtr0333479; FBpp0305666; FBgn0019947. [O02194-1]
DR   GeneID; 40260; -.
DR   KEGG; dme:Dmel_CG18803; -.
DR   UCSC; CG18803-RA; d. melanogaster. [O02194-1]
DR   CTD; 40260; -.
DR   FlyBase; FBgn0284421; Psn.
DR   eggNOG; KOG2736; Eukaryota.
DR   eggNOG; ENOG410XPZD; LUCA.
DR   GeneTree; ENSGT00390000016593; -.
DR   InParanoid; O02194; -.
DR   KO; K04505; -.
DR   OMA; VCDERTS; -.
DR   OrthoDB; EOG091G0C72; -.
DR   PhylomeDB; O02194; -.
DR   Reactome; R-DME-1251985; Nuclear signaling by ERBB4.
DR   Reactome; R-DME-1980148; Signaling by NOTCH3.
DR   Reactome; R-DME-1980150; Signaling by NOTCH4.
DR   Reactome; R-DME-3928665; EPH-ephrin mediated repulsion of cells.
DR   Reactome; R-DME-6798695; Neutrophil degranulation.
DR   SignaLink; O02194; -.
DR   GenomeRNAi; 40260; -.
DR   PRO; PR:O02194; -.
DR   Proteomes; UP000000803; Chromosome 3L.
DR   Bgee; FBgn0019947; -.
DR   ExpressionAtlas; O02194; differential.
DR   Genevisible; O02194; DM.
DR   GO; GO:0030424; C:axon; IBA:GO_Central.
DR   GO; GO:0005938; C:cell cortex; IBA:GO_Central.
DR   GO; GO:0009986; C:cell surface; IBA:GO_Central.
DR   GO; GO:0035253; C:ciliary rootlet; IBA:GO_Central.
DR   GO; GO:0043198; C:dendritic shaft; IBA:GO_Central.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0030426; C:growth cone; IBA:GO_Central.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005765; C:lysosomal membrane; IBA:GO_Central.
DR   GO; GO:0045121; C:membrane raft; IBA:GO_Central.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IBA:GO_Central.
DR   GO; GO:0031594; C:neuromuscular junction; IBA:GO_Central.
DR   GO; GO:0043025; C:neuronal cell body; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IBA:GO_Central.
DR   GO; GO:0030018; C:Z disc; IBA:GO_Central.
DR   GO; GO:0004190; F:aspartic-type endopeptidase activity; IEA:InterPro.
DR   GO; GO:0004175; F:endopeptidase activity; IDA:FlyBase.
DR   GO; GO:0042987; P:amyloid precursor protein catabolic process; IBA:GO_Central.
DR   GO; GO:0050435; P:amyloid-beta metabolic process; IBA:GO_Central.
DR   GO; GO:0006915; P:apoptotic process; IMP:CACAO.
DR   GO; GO:0006816; P:calcium ion transport; IBA:GO_Central.
DR   GO; GO:0006509; P:membrane protein ectodomain proteolysis; IBA:GO_Central.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IBA:GO_Central.
DR   GO; GO:0007220; P:Notch receptor processing; IBA:GO_Central.
DR   GO; GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0016485; P:protein processing; IEA:InterPro.
DR   InterPro; IPR001108; Peptidase_A22A.
DR   InterPro; IPR006639; Preselin/SPP.
DR   PANTHER; PTHR10202; PTHR10202; 1.
DR   Pfam; PF01080; Presenilin; 1.
DR   PRINTS; PR01072; PRESENILIN.
DR   SMART; SM00730; PSN; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Endoplasmic reticulum;
KW   Glycoprotein; Golgi apparatus; Hydrolase; Membrane;
KW   Notch signaling pathway; Protease; Reference proteome; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1    541       Presenilin homolog.
FT                                /FTId=PRO_0000073901.
FT   TOPO_DOM      1    106       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    107    127       Helical; Name=1. {ECO:0000255}.
FT   TOPO_DOM    128    154       Lumenal. {ECO:0000255}.
FT   TRANSMEM    155    175       Helical; Name=2. {ECO:0000255}.
FT   TOPO_DOM    176    182       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    183    203       Helical; Name=3. {ECO:0000255}.
FT   TOPO_DOM    204    216       Lumenal. {ECO:0000255}.
FT   TRANSMEM    217    237       Helical; Name=4. {ECO:0000255}.
FT   TOPO_DOM    238    242       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    243    263       Helical; Name=5. {ECO:0000255}.
FT   TOPO_DOM    264    265       Lumenal. {ECO:0000255}.
FT   TRANSMEM    266    286       Helical; Name=6. {ECO:0000255}.
FT   TOPO_DOM    287    453       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    454    474       Helical; Name=7. {ECO:0000255}.
FT   TOPO_DOM    475    481       Lumenal. {ECO:0000255}.
FT   TRANSMEM    482    502       Helical; Name=8. {ECO:0000255}.
FT   TOPO_DOM    503    506       Cytoplasmic. {ECO:0000255}.
FT   INTRAMEM    507    527       Helical; Name=9. {ECO:0000255}.
FT   TOPO_DOM    528    541       Cytoplasmic. {ECO:0000255}.
FT   REGION      320    481       Interaction with metl.
FT   MOTIF       507    509       PAL.
FT   ACT_SITE    279    279       {ECO:0000250}.
FT   ACT_SITE    461    461       {ECO:0000250}.
FT   CARBOHYD    129    129       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ     365    397       Missing (in isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_007988.
FT   VAR_SEQ     384    397       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:9106743}.
FT                                /FTId=VSP_005195.
FT   CONFLICT     80     81       GG -> RS (in Ref. 2; AAB53369).
FT                                {ECO:0000305}.
SQ   SEQUENCE   541 AA;  59304 MW;  A3B3D54348A2C03F CRC64;
     MAAVNLQASC SSGLASEDDA NVGSQIGAAE RLERPPRRQQ QRNNYGSSNQ DQPDAAILAV
     PNVVMREPCG SRPSRLTGGG GGSGGPPTNE MEEEQGLKYG AQHVIKLFVP VSLCMLVVVA
     TINSISFYNS TDVYLLYTPF HEQSPEPSVK FWSALANSLI LMSVVVVMTF LLIVLYKKRC
     YRIIHGWLIL SSFMLLFIFT YLYLEELLRA YNIPMDYPTA LLIMWNFGVV GMMSIHWQGP
     LRLQQGYLIF VAALMALVFI KYLPEWTAWA VLAAISIWDL IAVLSPRGPL RILVETAQER
     NEQIFPALIY SSTVVYALVN TVTPQQSQAT ASSSPSSSNS TTTTRATQNS LASPEAAAAS
     GQRTGNSHPR QNQRDDGSVL ATEGMPLVTF KSNLRGNAEA AGFTQEWSAN LSERVARRQI
     EVQSTQSGNA QRSNEYRTVT APDQNHPDGQ EERGIKLGLG DFIFYSVLVG KASSYGDWTT
     TIACFVAILI GLCLTLLLLA IWRKALPALP ISITFGLIFC FATSAVVKPF MEDLSAKQVF
     I
//
ID   PSN2_XENLA              Reviewed;         449 AA.
AC   O12977; Q6GQ85;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1997, sequence version 1.
DT   25-OCT-2017, entry version 83.
DE   RecName: Full=Presenilin-2;
DE            Short=PS-2;
DE            EC=3.4.23.-;
DE   AltName: Full=Presenilin beta;
DE            Short=PS-beta;
GN   Name=psen2;
OS   Xenopus laevis (African clawed frog).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Amphibia; Batrachia; Anura; Pipoidea; Pipidae; Xenopodinae; Xenopus;
OC   Xenopus.
OX   NCBI_TaxID=8355;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=9070286; DOI=10.1006/bbrc.1996.6043;
RA   Tsujimura A., Yasojima K., Hashimoto-Gotoh T.;
RT   "Cloning of Xenopus presenilin-alpha and -beta cDNAs and their
RT   differential expression in oogenesis and embryogenesis.";
RL   Biochem. Biophys. Res. Commun. 231:392-396(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Ovary;
RG   NIH - Xenopus Gene Collection (XGC) project;
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Probable catalytic subunit of the gamma-secretase
CC       complex, an endoprotease complex that catalyzes the intramembrane
CC       cleavage of integral membrane proteins such as Notch receptors (By
CC       similarity). May play a role in negative regulation of apoptotic
CC       cascades during oogenesis and embryogenesis, and in
CC       developmentally matured tissues such as brain tissue.
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Homodimer. Probable component of the gamma-secretase
CC       complex, a complex composed of a presenilin homodimer (PS-alpha or
CC       PS-beta), nicastrin (NCSTN), APH1 and PEN2 (Probable).
CC       {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}. Golgi
CC       apparatus membrane {ECO:0000250}; Multi-pass membrane protein
CC       {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Highest expression in ovaries and to a lesser
CC       extent in kidney, brain, eye and lung. Weak expression in testis,
CC       intestine, liver and heart. Present in trace amounts in skeletal
CC       muscle.
CC   -!- DEVELOPMENTAL STAGE: Abundant in early stages of oogenesis after
CC       which it is nearly constant.
CC   -!- DOMAIN: The PAL motif is required for normal active site
CC       conformation. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the peptidase A22A family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D84428; BAA19571.1; -; mRNA.
DR   EMBL; BC072862; AAH72862.1; -; mRNA.
DR   PIR; JC5391; JC5391.
DR   RefSeq; NP_001081211.1; NM_001087742.1.
DR   RefSeq; XP_018119744.1; XM_018264255.1.
DR   UniGene; Xl.1258; -.
DR   MEROPS; A22.002; -.
DR   GeneID; 397713; -.
DR   KEGG; xla:397713; -.
DR   CTD; 397713; -.
DR   Xenbase; XB-GENE-6252626; psen2.
DR   HOVERGEN; HBG011375; -.
DR   KO; K04522; -.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0004190; F:aspartic-type endopeptidase activity; IEA:InterPro.
DR   GO; GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0016485; P:protein processing; IEA:InterPro.
DR   InterPro; IPR001108; Peptidase_A22A.
DR   InterPro; IPR006639; Preselin/SPP.
DR   PANTHER; PTHR10202; PTHR10202; 2.
DR   Pfam; PF01080; Presenilin; 1.
DR   PRINTS; PR01072; PRESENILIN.
DR   SMART; SM00730; PSN; 1.
PE   2: Evidence at transcript level;
KW   Endoplasmic reticulum; Glycoprotein; Golgi apparatus; Hydrolase;
KW   Membrane; Notch signaling pathway; Protease; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1    449       Presenilin-2.
FT                                /FTId=PRO_0000073900.
FT   TOPO_DOM      1     90       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     91    111       Helical. {ECO:0000255}.
FT   TOPO_DOM    112    141       Lumenal. {ECO:0000255}.
FT   TRANSMEM    142    162       Helical. {ECO:0000255}.
FT   TOPO_DOM    163    169       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    170    190       Helical. {ECO:0000255}.
FT   TOPO_DOM    191    203       Lumenal. {ECO:0000255}.
FT   TRANSMEM    204    224       Helical. {ECO:0000255}.
FT   TOPO_DOM    225    226       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    227    247       Helical. {ECO:0000255}.
FT   TOPO_DOM    248    252       Lumenal. {ECO:0000255}.
FT   TRANSMEM    253    273       Helical. {ECO:0000255}.
FT   TOPO_DOM    274    362       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    363    383       Helical. {ECO:0000255}.
FT   TOPO_DOM    384    389       Lumenal. {ECO:0000255}.
FT   TRANSMEM    390    410       Helical. {ECO:0000255}.
FT   TOPO_DOM    411    414       Cytoplasmic. {ECO:0000255}.
FT   INTRAMEM    415    435       Helical. {ECO:0000255}.
FT   TOPO_DOM    436    449       Cytoplasmic. {ECO:0000255}.
FT   MOTIF       415    417       PAL.
FT   ACT_SITE    266    266       {ECO:0000250}.
FT   ACT_SITE    367    367       {ECO:0000250}.
FT   CARBOHYD    387    387       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   449 AA;  50274 MW;  2C2C105F5C723F2B CRC64;
     MIKLSDSEDE ECNERTSLIT SESPPLPSYQ DGVQASEGLE TSYHRERQPD STQNNEDVPN
     GRTSGADAYN SETTVENEEE ELTLKYGARH VIMLFVPVTL CMVVVVATIK SVSFYTEKDG
     QLIYTPFSED TTSVGERLLN SVLNTLIMIS VILVMTIFLV LLYKYRCYKF IHGWLILSSL
     MLLFMFTYIY LSEVFKTYNI AMDYPTLFMV IWNFGAVGMI CIHWKGPLQL QQAYLIMISA
     LMALVFIKYL PEWSAWVILG AISVYDLLAV LCPKGPLRML VETAQERNEP IFPALIYSSA
     MMWTVGMADS ATADGRMNQQ VQHIDRNTPE GANSTVEDAA ETRIQTQSNL SSEDPDEERG
     VKLGLGDFIF YSVLVGKAAA TASGDWNTTL ACFVAILIGL CLTLLLLAVF KKALPALPIS
     ITFGLIFYFS TDNIVRPFMD TLASHQMYI
//
ID   ADA10_HUMAN             Reviewed;         748 AA.
AC   O14672; B4DU28; Q10742; Q92650;
DT   28-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   20-DEC-2017, entry version 182.
DE   RecName: Full=Disintegrin and metalloproteinase domain-containing protein 10;
DE            Short=ADAM 10;
DE            EC=3.4.24.81 {ECO:0000269|PubMed:11477090, ECO:0000269|PubMed:11786905, ECO:0000269|PubMed:12475894, ECO:0000269|PubMed:16239146, ECO:0000269|PubMed:17557115, ECO:0000269|PubMed:19114711, ECO:0000269|PubMed:20592283};
DE   AltName: Full=CDw156;
DE   AltName: Full=Kuzbanian protein homolog;
DE   AltName: Full=Mammalian disintegrin-metalloprotease;
DE   AltName: CD_antigen=CD156c;
DE   Flags: Precursor;
GN   Name=ADAM10; Synonyms=KUZ, MADM;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND PROTEIN SEQUENCE OF
RP   216-237.
RX   PubMed=9305925; DOI=10.1074/jbc.272.39.24588;
RA   Rosendahl M.S., Ko S.C., Long D.L., Brewer M.T., Rosenzweig B.,
RA   Hedl E., Anderson L., Pyle S.M., Moreland J., Meyers M.A., Kohno T.,
RA   Lyons D., Lichenstein H.S.;
RT   "Identification and characterization of a pro-tumor necrosis factor-
RT   alpha-processing enzyme from the ADAM family of zinc
RT   metalloproteases.";
RL   J. Biol. Chem. 272:24588-24593(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 109-748 (ISOFORM 1).
RX   PubMed=8694785; DOI=10.1042/bj3170045;
RA   Howard L., Mitchell S., Lu X., Griffiths S., Glynn P.;
RT   "Molecular cloning of MADM: a catalytically active mammalian
RT   disintegrin-metalloprotease expressed in various cell types.";
RL   Biochem. J. 317:45-50(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R.,
RA   Fahey J., Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G.,
RA   Johnson E., Jones C., Kamat A., Kaur A., Locke D.P., Madan A.,
RA   Munson G., Jaffe D.B., Lui A., Macdonald P., Mauceli E., Naylor J.W.,
RA   Nesbitt R., Nicol R., O'Leary S.B., Ratcliffe A., Rounsley S., She X.,
RA   Sneddon K.M.B., Stewart S., Sougnez C., Stone S.M., Topham K.,
RA   Vincent D., Wang S., Zimmer A.R., Birren B.W., Hood L., Lander E.S.,
RA   Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human
RT   chromosome 15.";
RL   Nature 440:671-675(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   TISSUE SPECIFICITY.
RX   PubMed=9016778; DOI=10.1006/bbrc.1996.5957;
RA   McKie N., Edwards T., Dallas D.J., Houghton A., Stringer B.,
RA   Graham R., Russell G., Croucher P.I.;
RT   "Expression of members of a novel membrane linked metalloproteinase
RT   family (ADAM) in human articular chondrocytes.";
RL   Biochem. Biophys. Res. Commun. 230:335-339(1997).
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, AND SUBCELLULAR LOCATION.
RX   PubMed=12475894; DOI=10.1096/fj.02-0430fje;
RA   Gutwein P., Mechtersheimer S., Riedle S., Stoeck A., Gast D.,
RA   Joumaa S., Zentgraf H., Fogel M., Altevogt P.;
RT   "ADAM10-mediated cleavage of L1 adhesion molecule at the cell surface
RT   and in released membrane vesicles.";
RL   FASEB J. 17:292-294(2003).
RN   [7]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=11477090; DOI=10.1074/jbc.M105677200;
RA   Vincent B., Paitel E., Saftig P., Frobert Y., Hartmann D.,
RA   De Strooper B., Grassi J., Lopez-Perez E., Checler F.;
RT   "The disintegrins ADAM10 and TACE contribute to the constitutive and
RT   phorbol ester-regulated normal cleavage of the cellular prion
RT   protein.";
RL   J. Biol. Chem. 276:37743-37746(2001).
RN   [8]
RP   TISSUE SPECIFICITY.
RX   PubMed=11511685; DOI=10.1177/002215540104900910;
RA   Chubinskaya S., Mikhail R., Deutsch A., Tindal M.H.;
RT   "ADAM-10 protein is present in human articular cartilage primarily in
RT   the membrane-bound form and is upregulated in osteoarthritis and in
RT   response to IL-1alpha in bovine nasal cartilage.";
RL   J. Histochem. Cytochem. 49:1165-1176(2001).
RN   [9]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=11786905; DOI=10.1038/nm0102-41;
RA   Lemjabbar H., Basbaum C.;
RT   "Platelet-activating factor receptor and ADAM10 mediate responses to
RT   Staphylococcus aureus in epithelial cells.";
RL   Nat. Med. 8:41-46(2002).
RN   [10]
RP   IDENTIFICATION IN A COMPLEX WITH EFNA5 AND EPHA3, FUNCTION IN
RP   EFNA5-EPHA3 SIGNALING, AND CATALYTIC ACTIVITY.
RX   PubMed=16239146; DOI=10.1016/j.cell.2005.08.014;
RA   Janes P.W., Saha N., Barton W.A., Kolev M.V., Wimmer-Kleikamp S.H.,
RA   Nievergall E., Blobel C.P., Himanen J.P., Lackmann M., Nikolov D.B.;
RT   "Adam meets Eph: an ADAM substrate recognition module acts as a
RT   molecular switch for ephrin cleavage in trans.";
RL   Cell 123:291-304(2005).
RN   [11]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-278.
RC   TISSUE=Platelet;
RX   PubMed=16263699; DOI=10.1074/mcp.M500324-MCP200;
RA   Lewandrowski U., Moebius J., Walter U., Sickmann A.;
RT   "Elucidation of N-glycosylation sites on human platelet proteins: a
RT   glycoproteomic approach.";
RL   Mol. Cell. Proteomics 5:226-233(2006).
RN   [12]
RP   FUNCTION IN CLEAVAGE OF FASLG.
RX   PubMed=17557115; DOI=10.1038/sj.cdd.4402175;
RA   Kirkin V., Cahuzac N., Guardiola-Serrano F., Huault S., Luckerath K.,
RA   Friedmann E., Novac N., Wels W.S., Martoglio B., Hueber A.O.,
RA   Zornig M.;
RT   "The Fas ligand intracellular domain is released by ADAM10 and SPPL2a
RT   cleavage in T-cells.";
RL   Cell Death Differ. 14:1678-1687(2007).
RN   [13]
RP   FUNCTION IN CLEAVAGE OF ITM2B.
RX   PubMed=19114711; DOI=10.1074/jbc.M807485200;
RA   Martin L., Fluhrer R., Haass C.;
RT   "Substrate requirements for SPPL2b-dependent regulated intramembrane
RT   proteolysis.";
RL   J. Biol. Chem. 284:5662-5670(2009).
RN   [14]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-278.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [15]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-278.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19349973; DOI=10.1038/nbt.1532;
RA   Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,
RA   Schiess R., Aebersold R., Watts J.D.;
RT   "Mass-spectrometric identification and relative quantification of N-
RT   linked cell surface glycoproteins.";
RL   Nat. Biotechnol. 27:378-386(2009).
RN   [16]
RP   INTERACTION WITH NGF.
RX   PubMed=20164177; DOI=10.1074/jbc.M110.100479;
RA   Wijeyewickrema L.C., Gardiner E.E., Gladigau E.L., Berndt M.C.,
RA   Andrews R.K.;
RT   "Nerve growth factor inhibits metalloproteinase-disintegrins and
RT   blocks ectodomain shedding of platelet glycoprotein VI.";
RL   J. Biol. Chem. 285:11793-11799(2010).
RN   [17]
RP   FUNCTION IN CLEAVAGE OF JAM3.
RX   PubMed=20592283; DOI=10.4049/jimmunol.1000556;
RA   Rabquer B.J., Amin M.A., Teegala N., Shaheen M.K., Tsou P.S.,
RA   Ruth J.H., Lesch C.A., Imhof B.A., Koch A.E.;
RT   "Junctional adhesion molecule-C is a soluble mediator of
RT   angiogenesis.";
RL   J. Immunol. 185:1777-1785(2010).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [19]
RP   FUNCTION IN CLEAVAGE OF CORIN.
RX   PubMed=21288900; DOI=10.1074/jbc.M110.185082;
RA   Jiang J., Wu S., Wang W., Chen S., Peng J., Zhang X., Wu Q.;
RT   "Ectodomain shedding and autocleavage of the cardiac membrane protease
RT   corin.";
RL   J. Biol. Chem. 286:10066-10072(2011).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-719, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-719, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [22]
RP   PHOSPHORYLATION AT THR-719.
RX   PubMed=26091039; DOI=10.1016/j.cell.2015.05.028;
RA   Tagliabracci V.S., Wiley S.E., Guo X., Kinch L.N., Durrant E., Wen J.,
RA   Xiao J., Cui J., Nguyen K.B., Engel J.L., Coon J.J., Grishin N.,
RA   Pinna L.A., Pagliarini D.J., Dixon J.E.;
RT   "A single kinase generates the majority of the secreted
RT   phosphoproteome.";
RL   Cell 161:1619-1632(2015).
RN   [23]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [24]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, AND INTERACTION
RP   WITH TSPAN5; TSPAN14; TSPAN15 AND TSPAN33.
RX   PubMed=26686862; DOI=10.1007/s00018-015-2111-z;
RA   Jouannet S., Saint-Pol J., Fernandez L., Nguyen V., Charrin S.,
RA   Boucheix C., Brou C., Milhiet P.E., Rubinstein E.;
RT   "TspanC8 tetraspanins differentially regulate the cleavage of ADAM10
RT   substrates, Notch activation and ADAM10 membrane
RT   compartmentalization.";
RL   Cell. Mol. Life Sci. 73:1895-1915(2016).
RN   [25]
RP   INTERACTION WITH TSPAN14, AND DOMAIN.
RX   PubMed=26668317; DOI=10.1074/jbc.M115.703058;
RA   Noy P.J., Yang J., Reyat J.S., Matthews A.L., Charlton A.E.,
RA   Furmston J., Rogers D.A., Rainger G.E., Tomlinson M.G.;
RT   "TspanC8 tetraspanins and A disintegrin and metalloprotease 10
RT   (ADAM10) interact via their extracellular regions: evidence for
RT   distinct binding mechanisms for different TspanC8 proteins.";
RL   J. Biol. Chem. 291:3145-3157(2016).
RN   [26]
RP   VARIANTS AD18 HIS-170 AND GLY-181, AND CHARACTERIZATION OF VARIANTS
RP   AD18 HIS-170 AND GLY-181.
RX   PubMed=19608551; DOI=10.1093/hmg/ddp323;
RA   Kim M., Suh J., Romano D., Truong M.H., Mullin K., Hooli B.,
RA   Norton D., Tesco G., Elliott K., Wagner S.L., Moir R.D., Becker K.D.,
RA   Tanzi R.E.;
RT   "Potential late-onset Alzheimer's disease-associated mutations in the
RT   ADAM10 gene attenuate {alpha}-secretase activity.";
RL   Hum. Mol. Genet. 18:3987-3996(2009).
RN   [27]
RP   VARIANT TYR-176.
RX   PubMed=21618342; DOI=10.1002/humu.21477;
RA   Wei X., Moncada-Pazos A., Cal S., Soria-Valles C., Gartner J.,
RA   Rudloff U., Lin J.C., Rosenberg S.A., Lopez-Otin C., Samuels Y.;
RT   "Analysis of the disintegrin-metalloproteinases family reveals ADAM29
RT   and ADAM7 are often mutated in melanoma.";
RL   Hum. Mutat. 32:E2148-E2175(2011).
RN   [28]
RP   VARIANTS RAK SER-139 AND TYR-524.
RX   PubMed=23666529; DOI=10.1093/hmg/ddt207;
RA   Kono M., Sugiura K., Suganuma M., Hayashi M., Takama H., Suzuki T.,
RA   Matsunaga K., Tomita Y., Akiyama M.;
RT   "Whole-exome sequencing identifies ADAM10 mutations as a cause of
RT   reticulate acropigmentation of Kitamura, a clinical entity distinct
RT   from Dowling-Degos disease.";
RL   Hum. Mol. Genet. 22:3524-3533(2013).
RN   [29]
RP   CHARACTERIZATION OF VARIANTS AD18 HIS-170 AND GLY-181.
RX   PubMed=24055016; DOI=10.1016/j.neuron.2013.08.035;
RA   Suh J., Choi S.H., Romano D.M., Gannon M.A., Lesinski A.N., Kim D.Y.,
RA   Tanzi R.E.;
RT   "ADAM10 missense mutations potentiate beta-amyloid accumulation by
RT   impairing prodomain chaperone function.";
RL   Neuron 80:385-401(2013).
CC   -!- FUNCTION: Cleaves the membrane-bound precursor of TNF-alpha at
CC       '76-Ala-|-Val-77' to its mature soluble form. Responsible for the
CC       proteolytical release of soluble JAM3 from endothelial cells
CC       surface (PubMed:20592283). Responsible for the proteolytic release
CC       of several other cell-surface proteins, including heparin-binding
CC       epidermal growth-like factor, ephrin-A2, CD44, CDH2 and for
CC       constitutive and regulated alpha-secretase cleavage of amyloid
CC       precursor protein (APP) (PubMed:26686862, PubMed:11786905).
CC       Contributes to the normal cleavage of the cellular prion protein
CC       (PubMed:11477090). Involved in the cleavage of the adhesion
CC       molecule L1 at the cell surface and in released membrane vesicles,
CC       suggesting a vesicle-based protease activity (PubMed:12475894).
CC       Controls also the proteolytic processing of Notch and mediates
CC       lateral inhibition during neurogenesis (By similarity).
CC       Responsible for the FasL ectodomain shedding and for the
CC       generation of the remnant ADAM10-processed FasL (FasL APL)
CC       transmembrane form (PubMed:17557115). Also cleaves the ectodomain
CC       of the integral membrane proteins CORIN and ITM2B
CC       (PubMed:19114711, PubMed:21288900). May regulate the EFNA5-EPHA3
CC       signaling (PubMed:16239146). {ECO:0000250|UniProtKB:O35598,
CC       ECO:0000269|PubMed:11477090, ECO:0000269|PubMed:11786905,
CC       ECO:0000269|PubMed:12475894, ECO:0000269|PubMed:16239146,
CC       ECO:0000269|PubMed:17557115, ECO:0000269|PubMed:19114711,
CC       ECO:0000269|PubMed:20592283, ECO:0000269|PubMed:21288900,
CC       ECO:0000269|PubMed:26686862}.
CC   -!- CATALYTIC ACTIVITY: Endopeptidase of broad specificity.
CC       {ECO:0000269|PubMed:11477090, ECO:0000269|PubMed:11786905,
CC       ECO:0000269|PubMed:12475894, ECO:0000269|PubMed:16239146,
CC       ECO:0000269|PubMed:17557115, ECO:0000269|PubMed:19114711,
CC       ECO:0000269|PubMed:20592283, ECO:0000269|PubMed:21288900,
CC       ECO:0000269|PubMed:26686862}.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000250|UniProtKB:P78325};
CC       Note=Binds 1 zinc ion per subunit. {ECO:0000250|UniProtKB:P78325};
CC   -!- SUBUNIT: Interacts with EPHA2 (By similarity). Forms a ternary
CC       EFNA5-EPHA3-ADAM10 complex mediating EFNA5 extracellular domain
CC       shedding by ADAM10 which regulates the EFNA5-EPHA3 complex
CC       internalization and function, the cleavage occurs in trans, with
CC       ADAM10 and its substrate being on the membranes of opposing cells
CC       (PubMed:16239146). Interacts with NGF in a divalent cation-
CC       dependent manner (PubMed:20164177). Interacts with TSPAN14; the
CC       interaction promotes ADAM10 maturation and cell surface expression
CC       (PubMed:26668317, PubMed:26686862). Interacts with TSPAN5,
CC       TSPAN10, TSPAN15, TSPAN17 and TSPAN33; these interactions regulate
CC       ADAM10 substrate specificity (PubMed:26686862).
CC       {ECO:0000250|UniProtKB:O35598, ECO:0000269|PubMed:16239146,
CC       ECO:0000269|PubMed:20164177, ECO:0000269|PubMed:26668317}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:26686862};
CC       Single-pass type I membrane protein {ECO:0000305}. Golgi apparatus
CC       membrane {ECO:0000269|PubMed:12475894}; Single-pass type I
CC       membrane protein {ECO:0000305}. Note=Is localized in the plasma
CC       membrane but is predominantly expressed in the Golgi apparatus and
CC       in released membrane vesicles derived likely from the Golgi.
CC       {ECO:0000269|PubMed:12475894}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O14672-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O14672-2; Sequence=VSP_056401;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in spleen, lymph node, thymus,
CC       peripheral blood leukocyte, bone marrow, cartilage, chondrocytes
CC       and fetal liver. {ECO:0000269|PubMed:11511685,
CC       ECO:0000269|PubMed:9016778}.
CC   -!- INDUCTION: In osteoarthritis affected-cartilage.
CC   -!- DOMAIN: The conserved cysteine present in the cysteine-switch
CC       motif binds the catalytic zinc ion, thus inhibiting the enzyme.
CC       The dissociation of the cysteine from the zinc ion upon the
CC       activation-peptide release activates the enzyme.
CC   -!- DOMAIN: The Cys-rich region C-terminal to the disintegrin domain
CC       functions as a substrate-recognition module, it recognizes the
CC       EFNA5-EPHA3 Complex but not the individual proteins (By
CC       similarity). Both Cys-rich and stalk region are necessary for
CC       interaction with TSPAN5, TSPAN10, TSPAN14, TSPAN17, TSPAN33
CC       (PubMed:26668317). Stalk region is sufficient for interaction with
CC       TSPAN15 (By similarity). {ECO:0000250|UniProtKB:O35598,
CC       ECO:0000250|UniProtKB:Q10741, ECO:0000269|PubMed:26668317}.
CC   -!- PTM: The precursor is cleaved by a furin endopeptidase.
CC       {ECO:0000250}.
CC   -!- DISEASE: Reticulate acropigmentation of Kitamura (RAK)
CC       [MIM:615537]: A rare cutaneous pigmentation disorder characterized
CC       by reticulate, slightly depressed, sharply demarcated brown
CC       macules without hypopigmentation, affecting the dorsa of the hands
CC       and feet and appearing in the first or second decade of life. The
CC       macules gradually darken and extend to the proximal regions of the
CC       extremities. The manifestations tend to progress until middle age,
CC       after which progression of the eruptions stops. The pigmentary
CC       augmentation is found on the flexor aspects of the wrists, neck,
CC       patella and olecranon. Other features include breaks in the
CC       epidermal ridges on the palms and fingers, palmoplantar pits,
CC       occasionally plantar keratoderma, and partial alopecia.
CC       {ECO:0000269|PubMed:23666529}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Alzheimer disease 18 (AD18) [MIM:615590]: A late-onset
CC       form of Alzheimer disease. Alzheimer disease is a
CC       neurodegenerative disorder characterized by progressive dementia,
CC       loss of cognitive abilities, and deposition of fibrillar amyloid
CC       proteins as intraneuronal neurofibrillary tangles, extracellular
CC       amyloid plaques and vascular amyloid deposits. The major
CC       constituents of these plaques are neurotoxic amyloid-beta protein
CC       40 and amyloid-beta protein 42, that are produced by the
CC       proteolysis of the transmembrane APP protein. The cytotoxic C-
CC       terminal fragments (CTFs) and the caspase-cleaved products, such
CC       as C31, are also implicated in neuronal death.
CC       {ECO:0000269|PubMed:19608551, ECO:0000269|PubMed:24055016}.
CC       Note=Disease susceptibility is associated with variations
CC       affecting the gene represented in this entry.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/ADAM10ID44397ch15q21.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF009615; AAC51766.1; -; mRNA.
DR   EMBL; AK300472; BAG62190.1; -; mRNA.
DR   EMBL; AC018904; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC091046; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z48579; CAA88463.1; -; mRNA.
DR   CCDS; CCDS10167.1; -. [O14672-1]
DR   RefSeq; NP_001101.1; NM_001110.3. [O14672-1]
DR   UniGene; Hs.172028; -.
DR   UniGene; Hs.578508; -.
DR   UniGene; Hs.745136; -.
DR   PDB; 1M1I; Model; -; A=207-453.
DR   PDBsum; 1M1I; -.
DR   ProteinModelPortal; O14672; -.
DR   SMR; O14672; -.
DR   BioGrid; 106616; 35.
DR   DIP; DIP-39889N; -.
DR   IntAct; O14672; 10.
DR   MINT; MINT-5000775; -.
DR   STRING; 9606.ENSP00000260408; -.
DR   BindingDB; O14672; -.
DR   ChEMBL; CHEMBL5028; -.
DR   DrugBank; DB04991; XL784.
DR   GuidetoPHARMACOLOGY; 1658; -.
DR   MEROPS; M12.210; -.
DR   TCDB; 8.A.77.1.4; the sheddase (sheddase) family.
DR   iPTMnet; O14672; -.
DR   PhosphoSitePlus; O14672; -.
DR   SwissPalm; O14672; -.
DR   EPD; O14672; -.
DR   MaxQB; O14672; -.
DR   PaxDb; O14672; -.
DR   PeptideAtlas; O14672; -.
DR   PRIDE; O14672; -.
DR   Ensembl; ENST00000260408; ENSP00000260408; ENSG00000137845. [O14672-1]
DR   GeneID; 102; -.
DR   KEGG; hsa:102; -.
DR   UCSC; uc002afd.3; human. [O14672-1]
DR   CTD; 102; -.
DR   DisGeNET; 102; -.
DR   EuPathDB; HostDB:ENSG00000137845.14; -.
DR   GeneCards; ADAM10; -.
DR   HGNC; HGNC:188; ADAM10.
DR   HPA; CAB001709; -.
DR   HPA; HPA050670; -.
DR   MalaCards; ADAM10; -.
DR   MIM; 602192; gene.
DR   MIM; 615537; phenotype.
DR   MIM; 615590; phenotype.
DR   neXtProt; NX_O14672; -.
DR   OpenTargets; ENSG00000137845; -.
DR   Orphanet; 178307; Reticulate acropigmentation of Kitamura.
DR   PharmGKB; PA24505; -.
DR   eggNOG; KOG3658; Eukaryota.
DR   eggNOG; ENOG410XQWB; LUCA.
DR   GeneTree; ENSGT00670000097974; -.
DR   HOGENOM; HOG000008148; -.
DR   HOVERGEN; HBG050455; -.
DR   InParanoid; O14672; -.
DR   KO; K06704; -.
DR   OMA; EGFIQTH; -.
DR   OrthoDB; EOG091G01J4; -.
DR   PhylomeDB; O14672; -.
DR   TreeFam; TF352021; -.
DR   BioCyc; MetaCyc:ENSG00000137845-MONOMER; -.
DR   BRENDA; 3.4.24.81; 2681.
DR   Reactome; R-HSA-1442490; Collagen degradation.
DR   Reactome; R-HSA-1474228; Degradation of the extracellular matrix.
DR   Reactome; R-HSA-177929; Signaling by EGFR.
DR   Reactome; R-HSA-1980148; Signaling by NOTCH3.
DR   Reactome; R-HSA-1980150; Signaling by NOTCH4.
DR   Reactome; R-HSA-2122948; Activated NOTCH1 Transmits Signal to the Nucleus.
DR   Reactome; R-HSA-2644606; Constitutive Signaling by NOTCH1 PEST Domain Mutants.
DR   Reactome; R-HSA-2660826; Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant.
DR   Reactome; R-HSA-2691232; Constitutive Signaling by NOTCH1 HD Domain Mutants.
DR   Reactome; R-HSA-2894862; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants.
DR   Reactome; R-HSA-2979096; NOTCH2 Activation and Transmission of Signal to the Nucleus.
DR   Reactome; R-HSA-381426; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs).
DR   Reactome; R-HSA-3928665; EPH-ephrin mediated repulsion of cells.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-8957275; Post-translational protein phosphorylation.
DR   SignaLink; O14672; -.
DR   ChiTaRS; ADAM10; human.
DR   GeneWiki; ADAM10; -.
DR   GenomeRNAi; 102; -.
DR   PMAP-CutDB; O14672; -.
DR   PRO; PR:O14672; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000137845; -.
DR   CleanEx; HS_ADAM10; -.
DR   ExpressionAtlas; O14672; baseline and differential.
DR   Genevisible; O14672; HS.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; IDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005798; C:Golgi-associated vesicle; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; NAS:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0097038; C:perinuclear endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0014069; C:postsynaptic density; IEA:Ensembl.
DR   GO; GO:0035579; C:specific granule membrane; TAS:Reactome.
DR   GO; GO:0070821; C:tertiary granule membrane; TAS:Reactome.
DR   GO; GO:0097197; C:tetraspanin-enriched microdomain; IDA:UniProtKB.
DR   GO; GO:0004175; F:endopeptidase activity; ISS:UniProtKB.
DR   GO; GO:0005178; F:integrin binding; NAS:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004222; F:metalloendopeptidase activity; IMP:UniProtKB.
DR   GO; GO:0008237; F:metallopeptidase activity; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; ISS:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; ISS:UniProtKB.
DR   GO; GO:0005102; F:receptor binding; NAS:UniProtKB.
DR   GO; GO:0017124; F:SH3 domain binding; IEA:UniProtKB-KW.
DR   GO; GO:0007267; P:cell-cell signaling; NAS:UniProtKB.
DR   GO; GO:0044267; P:cellular protein metabolic process; TAS:Reactome.
DR   GO; GO:0051089; P:constitutive protein ectodomain proteolysis; IDA:UniProtKB.
DR   GO; GO:0022617; P:extracellular matrix disassembly; TAS:Reactome.
DR   GO; GO:0001701; P:in utero embryonic development; ISS:UniProtKB.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; NAS:UniProtKB.
DR   GO; GO:0006509; P:membrane protein ectodomain proteolysis; IDA:UniProtKB.
DR   GO; GO:0042117; P:monocyte activation; IMP:BHF-UCL.
DR   GO; GO:0007162; P:negative regulation of cell adhesion; IDA:UniProtKB.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0007220; P:Notch receptor processing; TAS:Reactome.
DR   GO; GO:0007219; P:Notch signaling pathway; ISS:UniProtKB.
DR   GO; GO:0051088; P:PMA-inducible membrane protein ectodomain proteolysis; IMP:BHF-UCL.
DR   GO; GO:0030307; P:positive regulation of cell growth; IMP:BHF-UCL.
DR   GO; GO:0030335; P:positive regulation of cell migration; IMP:BHF-UCL.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IMP:BHF-UCL.
DR   GO; GO:0010820; P:positive regulation of T cell chemotaxis; IMP:BHF-UCL.
DR   GO; GO:0043687; P:post-translational protein modification; TAS:Reactome.
DR   GO; GO:0006468; P:protein phosphorylation; ISS:UniProtKB.
DR   GO; GO:0016485; P:protein processing; IEA:Ensembl.
DR   GO; GO:0034612; P:response to tumor necrosis factor; IDA:BHF-UCL.
DR   CDD; cd04270; ZnMc_TACE_like; 1.
DR   Gene3D; 3.40.390.10; -; 1.
DR   Gene3D; 4.10.70.10; -; 1.
DR   InterPro; IPR034025; ADAM10_ADAM17.
DR   InterPro; IPR027053; ADAM_10.
DR   InterPro; IPR001762; Disintegrin_dom.
DR   InterPro; IPR036436; Disintegrin_dom_sf.
DR   InterPro; IPR024079; MetalloPept_cat_dom_sf.
DR   InterPro; IPR001590; Peptidase_M12B.
DR   InterPro; IPR002870; Peptidase_M12B_N.
DR   PANTHER; PTHR11905:SF4; PTHR11905:SF4; 1.
DR   Pfam; PF00200; Disintegrin; 1.
DR   Pfam; PF01562; Pep_M12B_propep; 1.
DR   SMART; SM00050; DISIN; 1.
DR   SUPFAM; SSF57552; SSF57552; 1.
DR   PROSITE; PS50215; ADAM_MEPRO; 1.
DR   PROSITE; PS50214; DISINTEGRIN_2; 1.
DR   PROSITE; PS00142; ZINC_PROTEASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Alzheimer disease; Amyloidosis;
KW   Cell membrane; Cleavage on pair of basic residues; Complete proteome;
KW   Direct protein sequencing; Disease mutation; Disulfide bond;
KW   Glycoprotein; Golgi apparatus; Hydrolase; Membrane; Metal-binding;
KW   Metalloprotease; Neurodegeneration; Notch signaling pathway;
KW   Phosphoprotein; Polymorphism; Protease; Reference proteome;
KW   SH3-binding; Signal; Transmembrane; Transmembrane helix; Zinc;
KW   Zymogen.
FT   SIGNAL        1     19       {ECO:0000255}.
FT   PROPEP       20    213       {ECO:0000250|UniProtKB:Q10741}.
FT                                /FTId=PRO_0000029066.
FT   CHAIN       214    748       Disintegrin and metalloproteinase domain-
FT                                containing protein 10.
FT                                /FTId=PRO_0000029067.
FT   TOPO_DOM     20    672       Extracellular. {ECO:0000255}.
FT   TRANSMEM    673    693       Helical. {ECO:0000255}.
FT   TOPO_DOM    694    748       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      220    456       Peptidase M12B. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00276}.
FT   DOMAIN      457    551       Disintegrin. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00068}.
FT   MOTIF       171    178       Cysteine switch. {ECO:0000250}.
FT   MOTIF       708    715       SH3-binding. {ECO:0000255}.
FT   MOTIF       722    728       SH3-binding. {ECO:0000255}.
FT   COMPBIAS    555    673       Cys-rich.
FT   ACT_SITE    384    384
FT   METAL       173    173       Zinc; in inhibited form. {ECO:0000250}.
FT   METAL       383    383       Zinc; catalytic.
FT                                {ECO:0000250|UniProtKB:P78325}.
FT   METAL       387    387       Zinc; catalytic.
FT                                {ECO:0000250|UniProtKB:P78325}.
FT   METAL       393    393       Zinc; catalytic.
FT                                {ECO:0000250|UniProtKB:P78325}.
FT   MOD_RES     719    719       Phosphothreonine; by FAM20C.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569,
FT                                ECO:0000269|PubMed:26091039}.
FT   CARBOHYD    267    267       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    278    278       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:16263699,
FT                                ECO:0000269|PubMed:19159218,
FT                                ECO:0000269|PubMed:19349973}.
FT   CARBOHYD    439    439       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    551    551       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    222    313       {ECO:0000250}.
FT   DISULFID    344    451       {ECO:0000250}.
FT   DISULFID    399    435       {ECO:0000250}.
FT   DISULFID    484    515       {ECO:0000250|UniProtKB:Q10741}.
FT   DISULFID    503    511       {ECO:0000250|UniProtKB:Q10741}.
FT   DISULFID    524    543       {ECO:0000250|UniProtKB:Q10741}.
FT   DISULFID    530    562       {ECO:0000250|UniProtKB:Q10741}.
FT   DISULFID    555    567       {ECO:0000250|UniProtKB:Q10741}.
FT   DISULFID    572    598       {ECO:0000250|UniProtKB:Q10741}.
FT   DISULFID    580    607       {ECO:0000250|UniProtKB:Q10741}.
FT   DISULFID    582    597       {ECO:0000250|UniProtKB:Q10741}.
FT   DISULFID    594    639       {ECO:0000250|UniProtKB:Q10741}.
FT   DISULFID    632    645       {ECO:0000250|UniProtKB:Q10741}.
FT   VAR_SEQ      19    319       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056401.
FT   VARIANT     139    139       P -> S (in RAK; dbSNP:rs483352912).
FT                                {ECO:0000269|PubMed:23666529}.
FT                                /FTId=VAR_070907.
FT   VARIANT     170    170       Q -> H (in AD18; associated with disease
FT                                susceptibility; significantly attenuates
FT                                alpha-secretase activity of the enzyme;
FT                                shifts APP processing toward beta-
FT                                secretase-mediated cleavage resulting in
FT                                enhanced amyloid-beta plaque load and
FT                                reactive gliosis; dbSNP:rs61751103).
FT                                {ECO:0000269|PubMed:19608551,
FT                                ECO:0000269|PubMed:24055016}.
FT                                /FTId=VAR_070908.
FT   VARIANT     176    176       H -> Y (in a cutaneous metastatic
FT                                melanoma sample; somatic mutation;
FT                                dbSNP:rs267604273).
FT                                {ECO:0000269|PubMed:21618342}.
FT                                /FTId=VAR_066309.
FT   VARIANT     181    181       R -> G (in AD18; associated with disease
FT                                susceptibility; significantly attenuates
FT                                alpha-secretase activity of the enzyme;
FT                                shifts APP processing toward beta-
FT                                secretase-mediated cleavage resulting in
FT                                enhanced amyloid-beta plaque load and
FT                                reactive gliosis; dbSNP:rs145518263).
FT                                {ECO:0000269|PubMed:19608551,
FT                                ECO:0000269|PubMed:24055016}.
FT                                /FTId=VAR_070909.
FT   VARIANT     524    524       C -> Y (in RAK; dbSNP:rs483352916).
FT                                {ECO:0000269|PubMed:23666529}.
FT                                /FTId=VAR_070910.
FT   CONFLICT    162    162       N -> SERLKLRLRKLMSLELWTSCCLPCALLLHSWKKAVN
FT                                SHCLYFKDFWGFSEIY (in Ref. 2; CAA88463).
FT                                {ECO:0000305}.
FT   CONFLICT    212    212       K -> R (in Ref. 2; CAA88463).
FT                                {ECO:0000305}.
FT   CONFLICT    296    296       G -> S (in Ref. 2; CAA88463).
FT                                {ECO:0000305}.
SQ   SEQUENCE   748 AA;  84142 MW;  0881E65B17022A71 CRC64;
     MVLLRVLILL LSWAAGMGGQ YGNPLNKYIR HYEGLSYNVD SLHQKHQRAK RAVSHEDQFL
     RLDFHAHGRH FNLRMKRDTS LFSDEFKVET SNKVLDYDTS HIYTGHIYGE EGSFSHGSVI
     DGRFEGFIQT RGGTFYVEPA ERYIKDRTLP FHSVIYHEDD INYPHKYGPQ GGCADHSVFE
     RMRKYQMTGV EEVTQIPQEE HAANGPELLR KKRTTSAEKN TCQLYIQTDH LFFKYYGTRE
     AVIAQISSHV KAIDTIYQTT DFSGIRNISF MVKRIRINTT ADEKDPTNPF RFPNIGVEKF
     LELNSEQNHD DYCLAYVFTD RDFDDGVLGL AWVGAPSGSS GGICEKSKLY SDGKKKSLNT
     GIITVQNYGS HVPPKVSHIT FAHEVGHNFG SPHDSGTECT PGESKNLGQK ENGNYIMYAR
     ATSGDKLNNN KFSLCSIRNI SQVLEKKRNN CFVESGQPIC GNGMVEQGEE CDCGYSDQCK
     DECCFDANQP EGRKCKLKPG KQCSPSQGPC CTAQCAFKSK SEKCRDDSDC AREGICNGFT
     ALCPASDPKP NFTDCNRHTQ VCINGQCAGS ICEKYGLEEC TCASSDGKDD KELCHVCCMK
     KMDPSTCAST GSVQWSRHFS GRTITLQPGS PCNDFRGYCD VFMRCRLVDA DGPLARLKKA
     IFSPELYENI AEWIVAHWWA VLLMGIALIM LMAGFIKICS VHTPSSNPKL PPPKPLPGTL
     KRRRPPQPIQ QPQRQRPRES YQMGHMRR
//
ID   APH1_CAEEL              Reviewed;         308 AA.
AC   O45876;
DT   26-SEP-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1998, sequence version 1.
DT   22-NOV-2017, entry version 110.
DE   RecName: Full=Gamma-secretase subunit aph-1;
DE   AltName: Full=Anterior-pharynx-defective protein 1;
DE   AltName: Full=Presenilin enhancer protein 1;
GN   Name=aph-1; Synonyms=pen-1; ORFNames=VF36H2L.1;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, AND MUTAGENESIS OF
RP   GLY-123.
RC   STRAIN=Bristol N2; TISSUE=Embryo;
RX   PubMed=11792846; DOI=10.1073/pnas.022523499;
RA   Goutte C., Tsunozaki M., Hale V.A., Priess J.R.;
RT   "APH-1 is a multipass membrane protein essential for the Notch
RT   signaling pathway in Caenorhabditis elegans embryos.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:775-779(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND FUNCTION.
RX   PubMed=12110170; DOI=10.1016/S1534-5807(02)00189-2;
RA   Francis R., McGrath G., Zhang J., Ruddy D.A., Sym M., Apfeld J.,
RA   Nicoll M., Maxwell M., Hai B., Ellis M.C., Parks A.L., Xu W., Li J.,
RA   Gurney M., Myers R.L., Himes C.S., Hiebsch R., Ruble C., Nye J.S.,
RA   Curtis D.;
RT   "aph-1 and pen-2 are required for Notch pathway signaling, gamma-
RT   secretase cleavage of betaAPP, and presenilin protein accumulation.";
RL   Dev. Cell 3:85-97(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
CC   -!- FUNCTION: Essential subunit of the gamma-secretase complex, an
CC       endoprotease complex that catalyzes the intramembrane cleavage of
CC       integral proteins such as Notch receptors (lin-12 or glp-1). It
CC       may represent a stabilizing cofactor for the presenilin homodimer
CC       that promotes the formation of a stable complex. Required for the
CC       localization of aph-2. {ECO:0000269|PubMed:11792846,
CC       ECO:0000269|PubMed:12110170}.
CC   -!- SUBUNIT: Component of the gamma-secretase complex, a complex
CC       probably composed of the presenilin homodimer (sel-12, hop-1 or
CC       spe-4), nicastrin (aph-2), aph-1 and pen-2. {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the APH-1 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL021466; CAA16282.1; -; Genomic_DNA.
DR   PIR; T26007; T26007.
DR   RefSeq; NP_492469.1; NM_060068.5.
DR   UniGene; Cel.16647; -.
DR   ProteinModelPortal; O45876; -.
DR   BioGrid; 38178; 3.
DR   STRING; 6239.VF36H2L.1; -.
DR   EPD; O45876; -.
DR   PaxDb; O45876; -.
DR   PeptideAtlas; O45876; -.
DR   EnsemblMetazoa; VF36H2L.1; VF36H2L.1; WBGene00000147.
DR   GeneID; 172747; -.
DR   KEGG; cel:CELE_VF36H2L.1; -.
DR   UCSC; VF36H2L.1; c. elegans.
DR   CTD; 33467; -.
DR   WormBase; VF36H2L.1; CE16526; WBGene00000147; aph-1.
DR   eggNOG; KOG3972; Eukaryota.
DR   eggNOG; ENOG4111FIJ; LUCA.
DR   GeneTree; ENSGT00390000002049; -.
DR   InParanoid; O45876; -.
DR   KO; K06172; -.
DR   OMA; IWFIAVK; -.
DR   OrthoDB; EOG091G0IH0; -.
DR   PhylomeDB; O45876; -.
DR   Reactome; R-CEL-3928665; EPH-ephrin mediated repulsion of cells.
DR   SignaLink; O45876; -.
DR   PRO; PR:O45876; -.
DR   Proteomes; UP000001940; Chromosome I.
DR   Bgee; WBGene00000147; -.
DR   GO; GO:0005783; C:endoplasmic reticulum; IBA:GO_Central.
DR   GO; GO:0070765; C:gamma-secretase complex; ISS:WormBase.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0004175; F:endopeptidase activity; IBA:GO_Central.
DR   GO; GO:0045165; P:cell fate commitment; IGI:WormBase.
DR   GO; GO:0060581; P:cell fate commitment involved in pattern specification; IMP:WormBase.
DR   GO; GO:0009792; P:embryo development ending in birth or egg hatching; IMP:WormBase.
DR   GO; GO:0048598; P:embryonic morphogenesis; IMP:WormBase.
DR   GO; GO:0007220; P:Notch receptor processing; IBA:GO_Central.
DR   GO; GO:0007219; P:Notch signaling pathway; IMP:WormBase.
DR   GO; GO:0048599; P:oocyte development; IMP:WormBase.
DR   GO; GO:0060465; P:pharynx development; IMP:WormBase.
DR   GO; GO:0043085; P:positive regulation of catalytic activity; IEA:InterPro.
DR   GO; GO:0034394; P:protein localization to cell surface; IMP:WormBase.
DR   GO; GO:0016485; P:protein processing; IBA:GO_Central.
DR   InterPro; IPR009294; Aph-1.
DR   PANTHER; PTHR12889; PTHR12889; 1.
DR   Pfam; PF06105; Aph-1; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Membrane; Notch signaling pathway;
KW   Reference proteome; Transmembrane; Transmembrane helix.
FT   CHAIN         1    308       Gamma-secretase subunit aph-1.
FT                                /FTId=PRO_0000221057.
FT   TRANSMEM      5     25       Helical; Name=1. {ECO:0000255}.
FT   TRANSMEM     32     52       Helical; Name=2. {ECO:0000255}.
FT   TRANSMEM     53     73       Helical; Name=3. {ECO:0000255}.
FT   TRANSMEM    122    142       Helical; Name=4. {ECO:0000255}.
FT   TRANSMEM    170    190       Helical; Name=5. {ECO:0000255}.
FT   TRANSMEM    200    220       Helical; Name=6. {ECO:0000255}.
FT   TRANSMEM    230    250       Helical; Name=7. {ECO:0000255}.
FT   MUTAGEN     123    123       G->D: In OR28; defects in localization of
FT                                aph-2. {ECO:0000269|PubMed:11792846}.
SQ   SEQUENCE   308 AA;  33548 MW;  6A2ACA6247022B34 CRC64;
     MGYLLTIACY IASFSPSIAL FCSFIAHDPV RIILFFLGSF FWLVSLLFSS LAWLGLSTVL
     PDTFLLSLTV CIIAQELSRV AYFMLLKKAQ RGLNKITRQG QISVAPGVSD LHNARHMLAL
     VCGLGMGVIS ALFYTMNAFA IFSGPGTIGL PNALKTGEID TNRAGKYLPL CYTLSAILLT
     LFHVTWTIMV WDSCHKIGRI PSAFVPGAAA VVSHLLVTFL SSLNSRGFHV LVFAVQFLIL
     LICIAYCNVI MGGTISSFVN GIGQSITDAV TLKQVRTLIE ERKLRTQRQS VPDEPMTERA
     GTSNTVNA
//
ID   A4_HUMAN                Reviewed;         770 AA.
AC   P05067; B2R5V1; B4DII8; D3DSD1; D3DSD2; D3DSD3; P09000; P78438;
AC   Q13764; Q13778; Q13793; Q16011; Q16014; Q16019; Q16020; Q6GSC0;
AC   Q8WZ99; Q9BT38; Q9UC33; Q9UCA9; Q9UCB6; Q9UCC8; Q9UCD1; Q9UQ58;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1991, sequence version 3.
DT   20-DEC-2017, entry version 267.
DE   RecName: Full=Amyloid-beta A4 protein;
DE   AltName: Full=ABPP;
DE   AltName: Full=APPI;
DE            Short=APP;
DE   AltName: Full=Alzheimer disease amyloid protein;
DE   AltName: Full=Amyloid precursor protein {ECO:0000305};
DE   AltName: Full=Amyloid-beta precursor protein {ECO:0000305};
DE   AltName: Full=Cerebral vascular amyloid peptide;
DE            Short=CVAP;
DE   AltName: Full=PreA4;
DE   AltName: Full=Protease nexin-II;
DE            Short=PN-II;
DE   Contains:
DE     RecName: Full=N-APP;
DE   Contains:
DE     RecName: Full=Soluble APP-alpha;
DE              Short=S-APP-alpha;
DE   Contains:
DE     RecName: Full=Soluble APP-beta;
DE              Short=S-APP-beta;
DE   Contains:
DE     RecName: Full=C99;
DE     AltName: Full=Beta-secretase C-terminal fragment;
DE              Short=Beta-CTF;
DE   Contains:
DE     RecName: Full=Amyloid-beta protein 42;
DE              Short=Abeta42;
DE     AltName: Full=Beta-APP42;
DE   Contains:
DE     RecName: Full=Amyloid-beta protein 40;
DE              Short=Abeta40;
DE     AltName: Full=Beta-APP40;
DE   Contains:
DE     RecName: Full=C83;
DE     AltName: Full=Alpha-secretase C-terminal fragment;
DE              Short=Alpha-CTF;
DE   Contains:
DE     RecName: Full=P3(42);
DE   Contains:
DE     RecName: Full=P3(40);
DE   Contains:
DE     RecName: Full=C80;
DE   Contains:
DE     RecName: Full=Gamma-secretase C-terminal fragment 59;
DE     AltName: Full=Amyloid intracellular domain 59;
DE              Short=AICD-59;
DE              Short=AID(59);
DE     AltName: Full=Gamma-CTF(59);
DE   Contains:
DE     RecName: Full=Gamma-secretase C-terminal fragment 57;
DE     AltName: Full=Amyloid intracellular domain 57;
DE              Short=AICD-57;
DE              Short=AID(57);
DE     AltName: Full=Gamma-CTF(57);
DE   Contains:
DE     RecName: Full=Gamma-secretase C-terminal fragment 50;
DE     AltName: Full=Amyloid intracellular domain 50;
DE              Short=AICD-50;
DE              Short=AID(50);
DE     AltName: Full=Gamma-CTF(50);
DE   Contains:
DE     RecName: Full=C31;
DE   Flags: Precursor;
GN   Name=APP; Synonyms=A4, AD1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM APP695).
RC   TISSUE=Brain;
RX   PubMed=2881207; DOI=10.1038/325733a0;
RA   Kang J., Lemaire H.-G., Unterbeck A., Salbaum J.M., Masters C.L.,
RA   Grzeschik K.-H., Multhaup G., Beyreuther K., Mueller-Hill B.;
RT   "The precursor of Alzheimer's disease amyloid A4 protein resembles a
RT   cell-surface receptor.";
RL   Nature 325:733-736(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM APP751).
RC   TISSUE=Brain;
RX   PubMed=2893289; DOI=10.1038/331525a0;
RA   Ponte P., Gonzalez-Dewhitt P., Schilling J., Miller J., Hsu D.,
RA   Greenberg B., Davis K., Wallace W., Lieberburg I., Fuller F.,
RA   Cordell B.;
RT   "A new A4 amyloid mRNA contains a domain homologous to serine
RT   proteinase inhibitors.";
RL   Nature 331:525-527(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM APP695).
RX   PubMed=2783775; DOI=10.1093/nar/17.2.517;
RA   Lemaire H.-G., Salbaum J.M., Multhaup G., Kang J., Bayney R.M.,
RA   Unterbeck A., Beyreuther K., Mueller-Hill B.;
RT   "The PreA4(695) precursor protein of Alzheimer's disease A4 amyloid is
RT   encoded by 16 exons.";
RL   Nucleic Acids Res. 17:517-522(1989).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM APP770).
RX   PubMed=2110105; DOI=10.1016/0378-1119(90)90310-N;
RA   Yoshikai S., Sasaki H., Doh-ura K., Furuya H., Sakaki Y.;
RT   "Genomic organization of the human amyloid beta-protein precursor
RT   gene.";
RL   Gene 87:257-263(1990).
RN   [5]
RP   ERRATUM.
RX   PubMed=1908403; DOI=10.1016/0378-1119(91)90093-Q;
RA   Yoshikai S., Sasaki H., Doh-ura K., Furuya H., Sakaki Y.;
RL   Gene 102:291-292(1991).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM L-APP733).
RC   TISSUE=Leukocyte;
RX   PubMed=1587857;
RA   Koenig G., Moenning U., Czech C., Prior R., Banati R.,
RA   Schreiter-Gasser U., Bauer J., Masters C.L., Beyreuther K.;
RT   "Identification and differential expression of a novel alternative
RT   splice isoform of the beta A4 amyloid precursor protein (APP) mRNA in
RT   leukocytes and brain microglial cells.";
RL   J. Biol. Chem. 267:10804-10809(1992).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM APP770).
RX   PubMed=9108164; DOI=10.1093/nar/25.9.1802;
RA   Hattori M., Tsukahara F., Furuhata Y., Tanahashi H., Hirose M.,
RA   Saito M., Tsukuni S., Sakaki Y.;
RT   "A novel method for making nested deletions and its application for
RT   sequencing of a 300 kb region of human APP locus.";
RL   Nucleic Acids Res. 25:1802-1808(1997).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM APP639), AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=12859342; DOI=10.1046/j.1460-9568.2003.02731.x;
RA   Tang K., Wang C., Shen C., Sheng S., Ravid R., Jing N.;
RT   "Identification of a novel alternative splicing isoform of human
RT   amyloid precursor protein gene, APP639.";
RL   Eur. J. Neurosci. 18:102-108(2003).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS APP770 AND 11).
RC   TISSUE=Cerebellum, and Hippocampus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT LYS-501.
RG   NIEHS SNPs program;
RL   Submitted (FEB-2005) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10830953; DOI=10.1038/35012518;
RA   Hattori M., Fujiyama A., Taylor T.D., Watanabe H., Yada T.,
RA   Park H.-S., Toyoda A., Ishii K., Totoki Y., Choi D.-K., Groner Y.,
RA   Soeda E., Ohki M., Takagi T., Sakaki Y., Taudien S., Blechschmidt K.,
RA   Polley A., Menzel U., Delabar J., Kumpf K., Lehmann R., Patterson D.,
RA   Reichwald K., Rump A., Schillhabel M., Schudy A., Zimmermann W.,
RA   Rosenthal A., Kudoh J., Shibuya K., Kawasaki K., Asakawa S.,
RA   Shintani A., Sasaki T., Nagamine K., Mitsuyama S., Antonarakis S.E.,
RA   Minoshima S., Shimizu N., Nordsiek G., Hornischer K., Brandt P.,
RA   Scharfe M., Schoen O., Desario A., Reichelt J., Kauer G., Bloecker H.,
RA   Ramser J., Beck A., Klages S., Hennig S., Riesselmann L., Dagand E.,
RA   Wehrmeyer S., Borzym K., Gardiner K., Nizetic D., Francis F.,
RA   Lehrach H., Reinhardt R., Yaspo M.-L.;
RT   "The DNA sequence of human chromosome 21.";
RL   Nature 405:311-319(2000).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [13]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS APP305 AND APP751).
RC   TISSUE=Eye, and Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [14]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-10.
RC   TISSUE=Liver;
RX   PubMed=3140222; DOI=10.1093/nar/16.19.9351;
RA   Schon E.A., Mita S., Sadlock J., Herbert J.;
RT   "A cDNA specifying the human amyloid beta precursor protein (ABPP)
RT   encodes a 95-kDa polypeptide.";
RL   Nucleic Acids Res. 16:9351-9351(1988).
RN   [15]
RP   ERRATUM, AND SEQUENCE REVISION.
RA   Schon E.A., Mita S., Sadlock J., Herbert J.;
RL   Nucleic Acids Res. 16:11402-11402(1988).
RN   [16]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-75.
RX   PubMed=2538123; DOI=10.1016/0006-291X(89)92437-6;
RA   La Fauci G., Lahiri D.K., Salton S.R., Robakis N.K.;
RT   "Characterization of the 5'-end region and the first two exons of the
RT   beta-protein precursor gene.";
RL   Biochem. Biophys. Res. Commun. 159:297-304(1989).
RN   [17]
RP   PROTEIN SEQUENCE OF 18-50.
RC   TISSUE=Fibroblast;
RX   PubMed=3597385;
RA   van Nostrand W.E., Cunningham D.D.;
RT   "Purification of protease nexin II from human fibroblasts.";
RL   J. Biol. Chem. 262:8508-8514(1987).
RN   [18]
RP   PROTEIN SEQUENCE OF 18-40.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [19]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 286-366.
RX   PubMed=2893290; DOI=10.1038/331528a0;
RA   Tanzi R.E., McClatchey A.I., Lamperti E.D., Villa-Komaroff L.,
RA   Gusella J.F., Neve R.L.;
RT   "Protease inhibitor domain encoded by an amyloid protein precursor
RT   mRNA associated with Alzheimer's disease.";
RL   Nature 331:528-530(1988).
RN   [20]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 287-367.
RX   PubMed=2893291; DOI=10.1038/331530a0;
RA   Kitaguchi N., Takahashi Y., Tokushima Y., Shiojiri S., Ito H.;
RT   "Novel precursor of Alzheimer's disease amyloid protein shows protease
RT   inhibitory activity.";
RL   Nature 331:530-532(1988).
RN   [21]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 507-770.
RC   TISSUE=Brain cortex;
RX   PubMed=2893379; DOI=10.1073/pnas.85.3.929;
RA   Zain S.B., Salim M., Chou W.G., Sajdel-Sulkowska E.M., Majocha R.E.,
RA   Marotta C.A.;
RT   "Molecular cloning of amyloid cDNA derived from mRNA of the Alzheimer
RT   disease brain: coding and noncoding regions of the fetal precursor
RT   mRNA are expressed in the cortex.";
RL   Proc. Natl. Acad. Sci. U.S.A. 85:929-933(1988).
RN   [22]
RP   PROTEIN SEQUENCE OF 523-555, AND DOMAIN COLLAGEN-BINDING.
RX   PubMed=8576160; DOI=10.1074/jbc.271.3.1613;
RA   Beher D., Hesse L., Masters C.L., Multhaup G.;
RT   "Regulation of amyloid protein precursor (APP) binding to collagen and
RT   mapping of the binding sites on APP and collagen type I.";
RL   J. Biol. Chem. 271:1613-1620(1996).
RN   [23]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 655-737, AND VARIANTS AD1 GLY-717;
RP   ILE-717 AND PHE-717.
RX   PubMed=8476439; DOI=10.1006/bbrc.1993.1386;
RA   Denman R.B., Rosenzcwaig R., Miller D.L.;
RT   "A system for studying the effect(s) of familial Alzheimer disease
RT   mutations on the processing of the beta-amyloid peptide precursor.";
RL   Biochem. Biophys. Res. Commun. 192:96-103(1993).
RN   [24]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 656-737.
RX   PubMed=2675837; DOI=10.1016/0006-291X(89)91112-1;
RA   Johnstone E.M., Chaney M.O., Moore R.E., Ward K.E., Norris F.H.,
RA   Little S.P.;
RT   "Alzheimer's disease amyloid peptide is encoded by two exons and shows
RT   similarity to soybean trypsin inhibitor.";
RL   Biochem. Biophys. Res. Commun. 163:1248-1255(1989).
RN   [25]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 672-723, AND VARIANT AD1 ASN-678.
RX   PubMed=15201367; DOI=10.1136/jnnp.2003.010611;
RA   Wakutani Y., Watanabe K., Adachi Y., Wada-Isoe K., Urakami K.,
RA   Ninomiya H., Saido T.C., Hashimoto T., Iwatsubo T., Nakashima K.;
RT   "Novel amyloid precursor protein gene missense mutation (D678N) in
RT   probable familial Alzheimer's disease.";
RL   J. Neurol. Neurosurg. Psych. 75:1039-1042(2004).
RN   [26]
RP   PROTEIN SEQUENCE OF 672-713.
RC   TISSUE=Blood vessel;
RX   PubMed=8248178; DOI=10.1073/pnas.90.22.10836;
RA   Roher A.E., Lowenson J.D., Clarke S., Woods A.S., Cotter R.J.,
RA   Gowing E., Ball M.J.;
RT   "Beta-amyloid-(1-42) is a major component of cerebrovascular amyloid
RT   deposits: implications for the pathology of Alzheimer disease.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:10836-10840(1993).
RN   [27]
RP   PROTEIN SEQUENCE OF 672-704, AND TISSUE SPECIFICITY.
RX   PubMed=1406936; DOI=10.1038/359325a0;
RA   Seubert P., Vigo-Pelfrey C., Esch F., Lee M., Dovey H., Davis D.,
RA   Sinha S., Schlossmacher M., Whaley J., Swindlehurst C.;
RT   "Isolation and quantification of soluble Alzheimer's beta-peptide from
RT   biological fluids.";
RL   Nature 359:325-327(1992).
RN   [28]
RP   PROTEIN SEQUENCE OF 672-701 AND 707-713.
RX   PubMed=8109908; DOI=10.1002/ana.410350223;
RA   Wisniewski T., Lalowski M., Levy E., Marques M.R.F., Frangione B.;
RT   "The amino acid sequence of neuritic plaque amyloid from a familial
RT   Alzheimer's disease patient.";
RL   Ann. Neurol. 35:245-246(1994).
RN   [29]
RP   PROTEIN SEQUENCE OF 672-701.
RC   TISSUE=Cerebrospinal fluid;
RX   PubMed=8229004; DOI=10.1111/j.1471-4159.1993.tb09841.x;
RA   Vigo-Pelfrey C., Lee D., Keim P., Lieberburg I., Schenk D.B.;
RT   "Characterization of beta-amyloid peptide from human cerebrospinal
RT   fluid.";
RL   J. Neurochem. 61:1965-1968(1993).
RN   [30]
RP   PROTEIN SEQUENCE OF 672-681.
RC   TISSUE=Brain cortex;
RX   PubMed=3312495; DOI=10.1111/j.1471-4159.1987.tb01005.x;
RA   Pardridge W.M., Vinters H.V., Yang J., Eisenberg J., Choi T.B.,
RA   Tourtellotte W.W., Huebner V., Shively J.E.;
RT   "Amyloid angiopathy of Alzheimer's disease: amino acid composition and
RT   partial sequence of a 4,200-dalton peptide isolated from cortical
RT   microvessels.";
RL   J. Neurochem. 49:1394-1401(1987).
RN   [31]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 674-770.
RC   TISSUE=Brain;
RX   PubMed=3810169; DOI=10.1126/science.3810169;
RA   Goldgaber D., Lerman M.I., McBride O.W., Saffiotti U., Gajdusek D.C.;
RT   "Characterization and chromosomal localization of a cDNA encoding
RT   brain amyloid of Alzheimer's disease.";
RL   Science 235:877-880(1987).
RN   [32]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 674-703.
RC   TISSUE=Fetal brain;
RX   PubMed=2949367; DOI=10.1126/science.2949367;
RA   Tanzi R.E., Gusella J.F., Watkins P.C., Bruns G.A.,
RA   St George-Hyslop P.H., Van Keuren M.L., Patterson D., Pagan S.,
RA   Kurnit D.M., Neve R.L.;
RT   "Amyloid beta protein gene: cDNA, mRNA distribution, and genetic
RT   linkage near the Alzheimer locus.";
RL   Science 235:880-884(1987).
RN   [33]
RP   PROTEIN SEQUENCE OF 609-713, AND GLYCOSYLATION AT THR-633; THR-651;
RP   THR-652; THR-659; THR-663; SER-667 AND TYR-681.
RC   TISSUE=Cerebrospinal fluid;
RX   PubMed=22576872; DOI=10.1002/jms.2987;
RA   Brinkmalm G., Portelius E., Ohrfelt A., Mattsson N., Persson R.,
RA   Gustavsson M.K., Vite C.H., Gobom J., Mansson J.E., Nilsson J.,
RA   Halim A., Larson G., Ruetschi U., Zetterberg H., Blennow K.,
RA   Brinkmalm A.;
RT   "An online nano-LC-ESI-FTICR-MS method for comprehensive
RT   characterization of endogenous fragments from amyloid beta and amyloid
RT   precursor protein in human and cat cerebrospinal fluid.";
RL   J. Mass Spectrom. 47:591-603(2012).
RN   [34]
RP   PROTEIN SEQUENCE OF 691-698, AND CLEAVAGE BY THETA-SECRETASE.
RX   PubMed=16816112; DOI=10.1096/fj.05-5632com;
RA   Sun X., He G., Song W.;
RT   "BACE2, as a novel APP theta-secretase, is not responsible for the
RT   pathogenesis of Alzheimer's disease in Down syndrome.";
RL   FASEB J. 20:1369-1376(2006).
RN   [35]
RP   PARTIAL NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM APP751).
RC   TISSUE=Brain;
RX   PubMed=2569763; DOI=10.1126/science.2569763;
RA   de Sauvage F., Octave J.-N.;
RT   "A novel mRNA of the A4 amyloid precursor gene coding for a possibly
RT   secreted protein.";
RL   Science 245:651-653(1989).
RN   [36]
RP   PARTIAL NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM APP695).
RC   TISSUE=Brain;
RX   PubMed=3035574; DOI=10.1073/pnas.84.12.4190;
RA   Robakis N.K., Ramakrishna N., Wolfe G., Wisniewski H.M.;
RT   "Molecular cloning and characterization of a cDNA encoding the
RT   cerebrovascular and the neuritic plaque amyloid peptides.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:4190-4194(1987).
RN   [37]
RP   CHARACTERIZATION OF L-APP733, AND MUTAGENESIS OF SER-656.
RX   PubMed=7737970; DOI=10.1074/jbc.270.18.10388;
RA   Pangalos M.N., Efthimiopoulos S., Shioi J., Robakis N.K.;
RT   "The chondroitin sulfate attachment site of appican is formed by
RT   splicing out exon 15 of the amyloid precursor gene.";
RL   J. Biol. Chem. 270:10388-10391(1995).
RN   [38]
RP   FUNCTION OF AMYLOID-BETA PEPTIDE AS LIPID PEROXIDATION INHIBITOR, AND
RP   MUTAGENESIS OF MET-706.
RX   PubMed=9168929; DOI=10.1006/bbrc.1997.6547;
RA   Walter M.F., Mason P.E., Mason R.P.;
RT   "Alzheimer's disease amyloid beta peptide 25-35 inhibits lipid
RT   peroxidation as a result of its membrane interactions.";
RL   Biochem. Biophys. Res. Commun. 233:760-764(1997).
RN   [39]
RP   REVIEW ON FUNCTION OF AMYLOID-BETA AS ANTIOXIDANT.
RX   PubMed=11775062; DOI=10.1023/A:1012629603390;
RA   Kontush A.;
RT   "Alzheimer's amyloid-beta as a preventive antioxidant for brain
RT   lipoproteins.";
RL   Cell. Mol. Neurobiol. 21:299-315(2001).
RN   [40]
RP   IDENTITY OF APP WITH NEXIN-II.
RX   PubMed=2506449; DOI=10.1038/341144a0;
RA   Oltersdorf T., Fritz L.C., Schenk D.B., Lieberburg I.,
RA   Johnson-Wood K.L., Beattie E.C., Ward P.J., Blacher R.W., Dovey H.F.,
RA   Sinha S.;
RT   "The secreted form of the Alzheimer's amyloid precursor protein with
RT   the Kunitz domain is protease nexin-II.";
RL   Nature 341:144-147(1989).
RN   [41]
RP   PROTEASE-SPECIFICITY OF INHIBITOR DOMAIN.
RX   PubMed=1969731; DOI=10.1016/0006-291X(90)92084-D;
RA   Kido H., Fukutomi A., Schilling J., Wang Y., Cordell B., Katunuma N.;
RT   "Protease-specificity of Kunitz inhibitor domain of Alzheimer's
RT   disease amyloid protein precursor.";
RL   Biochem. Biophys. Res. Commun. 167:716-721(1990).
RN   [42]
RP   EXTRACELLULAR ZINC-BINDING DOMAIN.
RX   PubMed=8344894;
RA   Bush A.I., Multhaup G., Moir R.D., Williamson T.G., Small D.H.,
RA   Rumble B., Pollwein P., Beyreuther K., Masters C.L.;
RT   "A novel zinc(II) binding site modulates the function of the beta A4
RT   amyloid protein precursor of Alzheimer's disease.";
RL   J. Biol. Chem. 268:16109-16112(1993).
RN   [43]
RP   INTERACTION WITH G(O).
RX   PubMed=8446172; DOI=10.1038/362075a0;
RA   Nishimoto I., Okamoto T., Matsuura Y., Takahashi S., Okamoto T.,
RA   Murayama Y., Ogata E.;
RT   "Alzheimer amyloid protein precursor complexes with brain GTP-binding
RT   protein G(o).";
RL   Nature 362:75-79(1993).
RN   [44]
RP   EXTRACELLULAR COPPER-BINDING DOMAIN, AND MUTAGENESIS OF HIS-137;
RP   MET-141; CYS-144; HIS-147 AND HIS-151.
RX   PubMed=7913895; DOI=10.1016/0014-5793(94)00658-X;
RA   Hesse L., Beher D., Masters C.L., Multhaup G.;
RT   "The beta A4 amyloid precursor protein binding to copper.";
RL   FEBS Lett. 349:109-116(1994).
RN   [45]
RP   N-TERMINAL HEPARIN-BINDING DOMAIN, AND MUTAGENESIS OF 99-LYS--ARG-102.
RX   PubMed=8158260;
RA   Small D.H., Nurcombe V., Reed G., Clarris H., Moir R., Beyreuther K.,
RA   Masters C.L.;
RT   "A heparin-binding domain in the amyloid protein precursor of
RT   Alzheimer's disease is involved in the regulation of neurite
RT   outgrowth.";
RL   J. Neurosci. 14:2117-2127(1994).
RN   [46]
RP   MUTAGENESIS OF VAL-717.
RX   PubMed=8886002; DOI=10.1006/bbrc.1996.1577;
RA   Maruyama K., Tomita T., Shinozaki K., Kume H., Asada H., Saido T.C.,
RA   Ishiura S., Iwatsubo T., Obata K.;
RT   "Familial Alzheimer's disease-linked mutations at Val717 of amyloid
RT   precursor protein are specific for the increased secretion of A beta
RT   42(43).";
RL   Biochem. Biophys. Res. Commun. 227:730-735(1996).
RN   [47]
RP   INTERACTION WITH APP-BP1.
RX   PubMed=8626687; DOI=10.1074/jbc.271.19.11339;
RA   Chow N., Korenberg J.R., Chen X.-N., Neve R.L.;
RT   "APP-BP1, a novel protein that binds to the carboxyl-terminal region
RT   of the amyloid precursor protein.";
RL   J. Biol. Chem. 271:11339-11346(1996).
RN   [48]
RP   INTERACTION WITH APBA1 AND APBB1, AND MUTAGENESIS OF TYR-728; TYR-757;
RP   ASN-759 AND TYR-762.
RX   PubMed=8887653; DOI=10.1128/MCB.16.11.6229;
RA   Borg J.-P., Ooi J., Levy E., Margolis B.;
RT   "The phosphotyrosine interaction domains of X11 and FE65 bind to
RT   distinct sites on the YENPTY motif of amyloid precursor protein.";
RL   Mol. Cell. Biol. 16:6229-6241(1996).
RN   [49]
RP   INTERACTION WITH APBB2.
RX   PubMed=8855266; DOI=10.1073/pnas.93.20.10832;
RA   Guenette S.Y., Chen J., Jondro P.D., Tanzi R.E.;
RT   "Association of a novel human FE65-like protein with the cytoplasmic
RT   domain of the amyloid-beta precursor protein.";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:10832-10837(1996).
RN   [50]
RP   HEPARIN-BINDING DOMAINS.
RX   PubMed=9357988; DOI=10.1016/S0014-5793(97)01146-0;
RA   Mok S.S., Sberna G., Heffernan D., Cappai R., Galatis D.,
RA   Clarris H.J., Sawyer W.H., Beyreuther K., Masters C.L., Small D.H.;
RT   "Expression and analysis of heparin-binding regions of the amyloid
RT   precursor protein of Alzheimer's disease.";
RL   FEBS Lett. 415:303-307(1997).
RN   [51]
RP   INTERACTION OF AMYLOID-BETA PEPTIDE WITH HADH2.
RC   TISSUE=Brain;
RX   PubMed=9338779; DOI=10.1038/39522;
RA   Yan S.D., Fu J., Soto C., Chen X., Zhu H., Al-Mohanna F.,
RA   Collinson K., Zhu A., Stern E., Saido T., Tohyama M., Ogawa S.,
RA   Roher A., Stern D.;
RT   "An intracellular protein that binds amyloid-beta peptide and mediates
RT   neurotoxicity in Alzheimer's disease.";
RL   Nature 389:689-695(1997).
RN   [52]
RP   INTERACTION WITH APPBP2, AND MUTAGENESIS OF TYR-728.
RX   PubMed=9843960; DOI=10.1073/pnas.95.25.14745;
RA   Zheng P., Eastman J., Vande Pol S., Pimplikar S.W.;
RT   "PAT1, a microtubule-interacting protein, recognizes the basolateral
RT   sorting signal of amyloid precursor protein.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:14745-14750(1998).
RN   [53]
RP   AMYLOID-BETA ZINC-BINDING, AND MUTAGENESIS OF ARG-676; TYR-681 AND
RP   HIS-684.
RX   PubMed=10413512; DOI=10.1021/bi990205o;
RA   Liu S.T., Howlett G., Barrow C.J.;
RT   "Histidine-13 is a crucial residue in the zinc ion-induced aggregation
RT   of the A beta peptide of Alzheimer's disease.";
RL   Biochemistry 38:9373-9378(1999).
RN   [54]
RP   IMPORTANCE OF MET-706 IN FREE RADICAL OXIDATIVE STRESS, AND
RP   MUTAGENESIS OF MET-706.
RX   PubMed=10535332; DOI=10.1016/S0361-9230(99)00093-3;
RA   Varadarajan S., Yatin S., Kanski J., Jahanshahi F., Butterfield D.A.;
RT   "Methionine residue 35 is important in amyloid beta-peptide-associated
RT   free radical oxidative stress.";
RL   Brain Res. Bull. 50:133-141(1999).
RN   [55]
RP   INTERACTION WITH APBA2.
RX   PubMed=9890987; DOI=10.1074/jbc.274.4.2243;
RA   Tomita S., Ozaki T., Taru H., Oguchi S., Takeda S., Yagi Y.,
RA   Sakiyama S., Kirino Y., Suzuki T.;
RT   "Interaction of a neuron-specific protein containing PDZ domains with
RT   Alzheimer's amyloid precursor protein.";
RL   J. Biol. Chem. 274:2243-2254(1999).
RN   [56]
RP   ENDOCYTOSIS SIGNAL, AND MUTAGENESIS OF TYR-728; GLY-756; TYR-757;
RP   ASN-759; PRO-760 AND TYR-762.
RX   PubMed=10383380; DOI=10.1074/jbc.274.27.18851;
RA   Perez R.G., Soriano S., Hayes J.D., Ostaszewski B., Xia W.,
RA   Selkoe D.J., Chen X., Stokin G.B., Koo E.H.;
RT   "Mutagenesis identifies new signals for beta-amyloid precursor protein
RT   endocytosis, turnover, and the generation of secreted fragments,
RT   including Abeta42.";
RL   J. Biol. Chem. 274:18851-18856(1999).
RN   [57]
RP   IMPORTANCE OF CYS-144 IN COPPER REDUCTION, AND MUTAGENESIS OF CYS-144
RP   AND 147-HIS--HIS-149.
RX   PubMed=10461923; DOI=10.1046/j.1471-4159.1999.0731288.x;
RA   Ruiz F.H., Gonzalez M., Bodini M., Opazo C., Inestrosa N.C.;
RT   "Cysteine 144 is a key residue in the copper reduction by the beta-
RT   amyloid precursor protein.";
RL   J. Neurochem. 73:1288-1292(1999).
RN   [58]
RP   INTERACTION OF AMYLOID-BETA WITH APOE.
RX   PubMed=10816430; DOI=10.1042/bj3480359;
RA   Tokuda T., Calero M., Matsubara E., Vidal R., Kumar A., Permanne B.,
RA   Zlokovic B., Smith J.D., Ladu M.J., Rostagno A., Frangione B.,
RA   Ghiso J.;
RT   "Lipidation of apolipoprotein E influences its isoform-specific
RT   interaction with Alzheimer's amyloid beta peptides.";
RL   Biochem. J. 348:359-365(2000).
RN   [59]
RP   INTERACTION OF APP42-BETA WITH CHRNA7.
RX   PubMed=10681545; DOI=10.1074/jbc.275.8.5626;
RA   Wang H.-Y., Lee D.H.S., D'Andrea M.R., Peterson P.A., Shank R.P.,
RA   Reitz A.B.;
RT   "Beta-amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor
RT   with high affinity. Implications for Alzheimer's disease pathology.";
RL   J. Biol. Chem. 275:5626-5632(2000).
RN   [60]
RP   IDENTIFICATION OF GAMMA-CTFS BY MASS SPECTROMETRY, AND MUTAGENESIS OF
RP   ASP-739.
RX   PubMed=12214090;
RA   Passer B., Pellegrini L., Russo C., Siegel R.M., Lenardo M.J.,
RA   Schettini G., Bachmann M., Tabaton M., D'Adamio L.;
RT   "Generation of an apoptotic intracellular peptide by gamma-secretase
RT   cleavage of Alzheimer's amyloid beta protein precursor.";
RL   J. Alzheimers Dis. 2:289-301(2000).
RN   [61]
RP   INTERACTION WITH FPRL1.
RX   PubMed=11689470; DOI=10.1096/fj.01-0251com;
RA   Yazawa H., Yu Z.-X., Takeda K., Le Y., Gong W., Ferrans V.J.,
RA   Oppenheim J.J., Li C.C.H., Wang J.M.;
RT   "Beta amyloid peptide (Abeta42) is internalized via the G-protein-
RT   coupled receptor FPRL1 and forms fibrillar aggregates in
RT   macrophages.";
RL   FASEB J. 15:2454-2462(2001).
RN   [62]
RP   INTERACTION WITH BBP.
RX   PubMed=11278849; DOI=10.1074/jbc.M011161200;
RA   Kajkowski E.M., Lo C.F., Ning X., Walker S., Sofia H.J., Wang W.,
RA   Edris W., Chanda P., Wagner E., Vile S., Ryan K., McHendry-Rinde B.,
RA   Smith S.C., Wood A., Rhodes K.J., Kennedy J.D., Bard J.,
RA   Jacobsen J.S., Ozenberger B.A.;
RT   "Beta-amyloid peptide-induced apoptosis regulated by a novel protein
RT   containing a G protein activation module.";
RL   J. Biol. Chem. 276:18748-18756(2001).
RN   [63]
RP   AMYLOID-BETA COPPER AND ZINC-BINDING.
RX   PubMed=11274207; DOI=10.1074/jbc.M100175200;
RA   Curtain C.C., Ali F., Volitakis I., Cherny R.A., Norton R.S.,
RA   Beyreuther K., Barrow C.J., Masters C.L., Bush A.I., Barnham K.J.;
RT   "Alzheimer's disease amyloid-beta binds copper and zinc to generate an
RT   allosterically ordered structure containing superoxide dismutase-like
RT   subunits.";
RL   J. Biol. Chem. 276:20466-20473(2001).
RN   [64]
RP   SUBUNIT.
RX   PubMed=11438549; DOI=10.1074/jbc.M105410200;
RA   Scheuermann S., Hambsch B., Hesse L., Stumm J., Schmidt C., Beher D.,
RA   Bayer T.A., Beyreuther K., Multhaup G.;
RT   "Homodimerization of amyloid precursor protein and its implication in
RT   the amyloidogenic pathway of Alzheimer's disease.";
RL   J. Biol. Chem. 276:33923-33929(2001).
RN   [65]
RP   INTERACTION WITH APBB1, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=11544248; DOI=10.1074/jbc.C100447200;
RA   Kimberly W.T., Zheng J.B., Guenette S.Y., Selkoe D.J.;
RT   "The intracellular domain of the beta-amyloid precursor protein is
RT   stabilized by Fe65 and translocates to the nucleus in a notch-like
RT   manner.";
RL   J. Biol. Chem. 276:40288-40292(2001).
RN   [66]
RP   INTERACTION WITH FBLN1.
RX   PubMed=11238726; DOI=10.1046/j.1471-4159.2001.00144.x;
RA   Ohsawa I., Takamura C., Kohsaka S.;
RT   "Fibulin-1 binds the amino-terminal head of beta-amyloid precursor
RT   protein and modulates its physiological function.";
RL   J. Neurochem. 76:1411-1420(2001).
RN   [67]
RP   INTERACTION WITH MAPT, AND FUNCTION.
RX   PubMed=11943163; DOI=10.1016/S0014-5793(02)02376-1;
RA   Rank K.B., Pauley A.M., Bhattacharya K., Wang Z., Evans D.B.,
RA   Fleck T.J., Johnston J.A., Sharma S.K.;
RT   "Direct interaction of soluble human recombinant tau protein with
RT   Abeta 1-42 results in tau aggregation and hyperphosphorylation by tau
RT   protein kinase II.";
RL   FEBS Lett. 514:263-268(2002).
RN   [68]
RP   INTERACTION WITH MAPK8IP1, AND MUTAGENESIS OF TYR-757.
RX   PubMed=11724784; DOI=10.1074/jbc.M108357200;
RA   Scheinfeld M.H., Roncarati R., Vito P., Lopez P.A., Abdallah M.,
RA   D'Adamio L.;
RT   "Jun NH2-terminal kinase (JNK) interacting protein 1 (JIP1) binds the
RT   cytoplasmic domain of the Alzheimer's beta-amyloid precursor protein
RT   (APP).";
RL   J. Biol. Chem. 277:3767-3775(2002).
RN   [69]
RP   COPPER-MEDIATED LIPID PEROXIDATION, AND MUTAGENESIS OF HIS-147 AND
RP   HIS-151.
RX   PubMed=11784781;
RA   White A.R., Multhaup G., Galatis D., McKinstry W.J., Parker M.W.,
RA   Pipkorn R., Beyreuther K., Masters C.L., Cappai R.;
RT   "Contrasting species-dependent modulation of copper-mediated
RT   neurotoxicity by the Alzheimer's disease amyloid precursor protein.";
RL   J. Neurosci. 22:365-376(2002).
RN   [70]
RP   REVIEW ON ZINC-BINDING.
RX   PubMed=12032279; DOI=10.1073/pnas.122249699;
RA   Bush A.I., Tanzi R.E.;
RT   "The galvanization of beta-amyloid in Alzheimer's disease.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:7317-7319(2002).
RN   [71]
RP   SUBCELLULAR LOCATION, AND ASSOCIATION OF AMYLOID FIBRILS WITH GCP1.
RX   PubMed=15084524; DOI=10.1096/fj.03-1040fje;
RA   Watanabe N., Araki W., Chui D.H., Makifuchi T., Ihara Y., Tabira T.;
RT   "Glypican-1 as an Abeta binding HSPG in the human brain: its
RT   localization in DIG domains and possible roles in the pathogenesis of
RT   Alzheimer's disease.";
RL   FASEB J. 18:1013-1015(2004).
RN   [72]
RP   INTERACTION WITH ANKS1B.
RX   PubMed=15347684; DOI=10.1074/jbc.M405329200;
RA   Ghersi E., Noviello C., D'Adamio L.;
RT   "Amyloid-beta protein precursor (AbetaPP) intracellular domain-
RT   associated protein-1 proteins bind to AbetaPP and modulate its
RT   processing in an isoform-specific manner.";
RL   J. Biol. Chem. 279:49105-49112(2004).
RN   [73]
RP   PHOSPHORYLATION AT THR-743.
RX   PubMed=8131745;
RA   Suzuki T., Oishi M., Marshak D.R., Czernik A.J., Nairn A.C.,
RA   Greengard P.;
RT   "Cell cycle-dependent regulation of the phosphorylation and metabolism
RT   of the Alzheimer amyloid precursor protein.";
RL   EMBO J. 13:1114-1122(1994).
RN   [74]
RP   PHOSPHORYLATION AT SER-198 AND SER-206 BY CASEIN KINASES, AND
RP   MUTAGENESIS OF SER-198 AND SER-206.
RX   PubMed=8999878; DOI=10.1074/jbc.272.3.1896;
RA   Walter J., Capell A., Hung A.Y., Langen H., Schnoelzer M.,
RA   Thinakaran G., Sisodia S.S., Selkoe D.J., Haass C.;
RT   "Ectodomain phosphorylation of beta-amyloid precursor protein at two
RT   distinct cellular locations.";
RL   J. Biol. Chem. 272:1896-1903(1997).
RN   [75]
RP   COPPER-BINDING, AND DISULFIDE BOND FORMATION.
RX   PubMed=9585534; DOI=10.1021/bi980022m;
RA   Multhaup G., Ruppert T., Schlicksupp A., Hesse L., Bill E.,
RA   Pipkorn R., Masters C.L., Beyreuther K.;
RT   "Copper-binding amyloid precursor protein undergoes a site-specific
RT   fragmentation in the reduction of hydrogen peroxide.";
RL   Biochemistry 37:7224-7230(1998).
RN   [76]
RP   CLEAVAGE BY CASPASES, AND MUTAGENESIS OF ASP-739.
RX   PubMed=10319819; DOI=10.1016/S0092-8674(00)80748-5;
RA   Gervais F.G., Xu D., Robertson G.S., Vaillancourt J.P., Zhu Y.,
RA   Huang J., LeBlanc A., Smith D., Rigby M., Shearman M.S., Clarke E.E.,
RA   Zheng H., van der Ploeg L.H.T., Ruffolo S.C., Thornberry N.A.,
RA   Xanthoudakis S., Zamboni R.J., Roy S., Nicholson D.W.;
RT   "Involvement of caspases in proteolytic cleavage of Alzheimer's
RT   amyloid-beta precursor protein and amyloidogenic A beta peptide
RT   formation.";
RL   Cell 97:395-406(1999).
RN   [77]
RP   PHOSPHORYLATION, AND MUTAGENESIS OF THR-743.
RX   PubMed=10341243;
RA   Ando K., Oishi M., Takeda S., Iijima K., Isohara T., Nairn A.C.,
RA   Kirino Y., Greengard P., Suzuki T.;
RT   "Role of phosphorylation of Alzheimer's amyloid precursor protein
RT   during neuronal differentiation.";
RL   J. Neurosci. 19:4421-4427(1999).
RN   [78]
RP   CHARACTERIZATION OF CASEIN KINASE PHOSPHORYLATION, AND MUTAGENESIS OF
RP   SER-198 AND SER-206.
RX   PubMed=10806211; DOI=10.1074/jbc.M002850200;
RA   Walter J., Schindzielorz A., Hartung B., Haass C.;
RT   "Phosphorylation of the beta-amyloid precursor protein at the cell
RT   surface by ectocasein kinases 1 and 2.";
RL   J. Biol. Chem. 275:23523-23529(2000).
RN   [79]
RP   CLEAVAGE BY CASPASES, AND MUTAGENESIS OF ASP-739.
RX   PubMed=10742146; DOI=10.1038/74656;
RA   Lu D.C., Rabizadeh S., Chandra S., Shayya R.F., Ellerby L.M., Ye X.,
RA   Salvesen G.S., Koo E.H., Bredesen D.E.;
RT   "A second cytotoxic proteolytic peptide derived from amyloid beta-
RT   protein precursor.";
RL   Nat. Med. 6:397-404(2000).
RN   [80]
RP   PHOSPHORYLATION, INTERACTION WITH APBB1, AND MUTAGENESIS OF THR-743.
RX   PubMed=11517218; DOI=10.1074/jbc.M104059200;
RA   Ando K., Iijima K., Elliott J.I., Kirino Y., Suzuki T.;
RT   "Phosphorylation-dependent regulation of the interaction of amyloid
RT   precursor protein with Fe65 affects the production of beta-amyloid.";
RL   J. Biol. Chem. 276:40353-40361(2001).
RN   [81]
RP   PHOSPHORYLATION BY MAPK10, AND MUTAGENESIS OF THR-743.
RX   PubMed=11146006; DOI=10.1046/j.1471-4159.2001.00102.x;
RA   Standen C.L., Brownlees J., Grierson A.J., Kesavapany S., Lau K.-F.,
RA   McLoughlin D.M., Miller C.C.J.;
RT   "Phosphorylation of thr(668) in the cytoplasmic domain of the
RT   Alzheimer's disease amyloid precursor protein by stress-activated
RT   protein kinase 1b (Jun N-terminal kinase-3).";
RL   J. Neurochem. 76:316-320(2001).
RN   [82]
RP   CLEAVAGE AT LEU-720.
RX   PubMed=11851430; DOI=10.1021/bi015794o;
RA   Weidemann A., Eggert S., Reinhard F.B.M., Vogel M., Paliga K.,
RA   Baier G., Masters C.L., Beyreuther K., Evin G.;
RT   "A novel epsilon-cleavage within the transmembrane domain of the
RT   Alzheimer amyloid precursor protein demonstrates homology with Notch
RT   processing.";
RL   Biochemistry 41:2825-2835(2002).
RN   [83]
RP   PHOSPHORYLATION AT TYR-757, INTERACTION WITH SHC1, AND MUTAGENESIS OF
RP   THR-743 AND TYR-757.
RX   PubMed=11877420; DOI=10.1074/jbc.M110286200;
RA   Tarr P.E., Roncarati R., Pelicci G., Pelicci P.G., D'Adamio L.;
RT   "Tyrosine phosphorylation of the beta-amyloid precursor protein
RT   cytoplasmic tail promotes interaction with Shc.";
RL   J. Biol. Chem. 277:16798-16804(2002).
RN   [84]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-542.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,
RA   Moore R.J., Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [85]
RP   SIGNAL SEQUENCE CLEAVAGE SITE, AND TOPOLOGY.
RX   PubMed=2900137;
RA   Dyrks T., Weidemann A., Multhaup G., Salbaum J.M., Lemaire H.-G.,
RA   Kang J., Mueller-Hill B., Masters C.L., Beyreuther K.;
RT   "Identification, transmembrane orientation and biogenesis of the
RT   amyloid A4 precursor of Alzheimer's disease.";
RL   EMBO J. 7:949-957(1988).
RN   [86]
RP   REVIEW.
RX   PubMed=12142279; DOI=10.1146/annurev.cellbio.18.020402.142302;
RA   Annaert W., De Strooper B.;
RT   "A cell biological perspective on Alzheimer's disease.";
RL   Annu. Rev. Cell Dev. Biol. 18:25-51(2002).
RN   [87]
RP   INTERACTION WITH SORL1, AND SUBCELLULAR LOCATION.
RX   PubMed=16174740; DOI=10.1073/pnas.0503689102;
RA   Andersen O.M., Reiche J., Schmidt V., Gotthardt M., Spoelgen R.,
RA   Behlke J., von Arnim C.A., Breiderhoff T., Jansen P., Wu X.,
RA   Bales K.R., Cappai R., Masters C.L., Gliemann J., Mufson E.J.,
RA   Hyman B.T., Paul S.M., Nykjaer A., Willnow T.E.;
RT   "Neuronal sorting protein-related receptor sorLA/LR11 regulates
RT   processing of the amyloid precursor protein.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:13461-13466(2005).
RN   [88]
RP   INTERACTION WITH APBB1.
RX   PubMed=18468999; DOI=10.1074/jbc.M801827200;
RA   Nakaya T., Kawai T., Suzuki T.;
RT   "Regulation of FE65 nuclear translocation and function by amyloid
RT   beta-protein precursor in osmotically stressed cells.";
RL   J. Biol. Chem. 283:19119-19131(2008).
RN   [89]
RP   INTERACTION WITH ITM2C.
RX   PubMed=19366692; DOI=10.1074/jbc.M109.006403;
RA   Matsuda S., Matsuda Y., D'Adamio L.;
RT   "BRI3 inhibits amyloid precursor protein processing in a
RT   mechanistically distinct manner from its homologue dementia gene
RT   BRI2.";
RL   J. Biol. Chem. 284:15815-15825(2009).
RN   [90]
RP   FUNCTION, CLEAVAGE, AND INTERACTION WITH TNFRSF21.
RX   PubMed=19225519; DOI=10.1038/nature07767;
RA   Nikolaev A., McLaughlin T., O'Leary D.D.M., Tessier-Lavigne M.;
RT   "APP binds DR6 to trigger axon pruning and neuron death via distinct
RT   caspases.";
RL   Nature 457:981-989(2009).
RN   [91]
RP   FUNCTION, AND INTERACTION WITH AGER.
RX   PubMed=19901339; DOI=10.1073/pnas.0905686106;
RA   Takuma K., Fang F., Zhang W., Yan S., Fukuzaki E., Du H., Sosunov A.,
RA   McKhann G., Funatsu Y., Nakamichi N., Nagai T., Mizoguchi H., Ibi D.,
RA   Hori O., Ogawa S., Stern D.M., Yamada K., Yan S.S.;
RT   "RAGE-mediated signaling contributes to intraneuronal transport of
RT   amyloid-{beta} and neuronal dysfunction.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:20021-20026(2009).
RN   [92]
RP   INTERACTION WITH GSAP.
RX   PubMed=20811458; DOI=10.1038/nature09325;
RA   He G., Luo W., Li P., Remmers C., Netzer W.J., Hendrick J.,
RA   Bettayeb K., Flajolet M., Gorelick F., Wennogle L.P., Greengard P.;
RT   "Gamma-secretase activating protein is a therapeutic target for
RT   Alzheimer's disease.";
RL   Nature 467:95-98(2010).
RN   [93]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [94]
RP   GLYCOSYLATION AT THR-633; THR-651; THR-652; SER-656; THR-663 AND
RP   SER-667 PROTEOLYTIC PROCESSING, STRUCTURE OF CARBOHYDRATES, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=21712440; DOI=10.1073/pnas.1102664108;
RA   Halim A., Brinkmalm G., Ruetschi U., Westman-Brinkmalm A.,
RA   Portelius E., Zetterberg H., Blennow K., Larson G., Nilsson J.;
RT   "Site-specific characterization of threonine, serine, and tyrosine
RT   glycosylations of amyloid precursor protein/amyloid beta-peptides in
RT   human cerebrospinal fluid.";
RL   Proc. Natl. Acad. Sci. U.S.A. 108:11848-11853(2011).
RN   [95]
RP   INTERACTION WITH S100A9.
RX   PubMed=22457725; DOI=10.1371/journal.pone.0032953;
RA   Zhang C., Liu Y., Gilthorpe J., van der Maarel J.R.;
RT   "MRP14 (S100A9) protein interacts with Alzheimer beta-amyloid peptide
RT   and induces its fibrillization.";
RL   PLoS ONE 7:E32953-E32953(2012).
RN   [96]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-743, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [97]
RP   INTERACTION WITH PLD3.
RX   PubMed=24336208; DOI=10.1038/nature12825;
RG   UK Brain Expression Consortium;
RA   Cruchaga C., Karch C.M., Jin S.C., Benitez B.A., Cai Y., Guerreiro R.,
RA   Harari O., Norton J., Budde J., Bertelsen S., Jeng A.T., Cooper B.,
RA   Skorupa T., Carrell D., Levitch D., Hsu S., Choi J., Ryten M.,
RA   Hardy J., Ryten M., Trabzuni D., Weale M.E., Ramasamy A., Smith C.,
RA   Sassi C., Bras J., Gibbs J.R., Hernandez D.G., Lupton M.K., Powell J.,
RA   Forabosco P., Ridge P.G., Corcoran C.D., Tschanz J.T., Norton M.C.,
RA   Munger R.G., Schmutz C., Leary M., Demirci F.Y., Bamne M.N., Wang X.,
RA   Lopez O.L., Ganguli M., Medway C., Turton J., Lord J., Braae A.,
RA   Barber I., Brown K., Passmore P., Craig D., Johnston J.,
RA   McGuinness B., Todd S., Heun R., Kolsch H., Kehoe P.G., Hooper N.M.,
RA   Vardy E.R., Mann D.M., Pickering-Brown S., Brown K., Kalsheker N.,
RA   Lowe J., Morgan K., David Smith A., Wilcock G., Warden D., Holmes C.,
RA   Pastor P., Lorenzo-Betancor O., Brkanac Z., Scott E., Topol E.,
RA   Morgan K., Rogaeva E., Singleton A.B., Hardy J., Kamboh M.I.,
RA   St George-Hyslop P., Cairns N., Morris J.C., Kauwe J.S., Goate A.M.;
RT   "Rare coding variants in the phospholipase D3 gene confer risk for
RT   Alzheimer's disease.";
RL   Nature 505:550-554(2014).
RN   [98]
RP   INTERACTION WITH VDAC1.
RX   PubMed=25168729; DOI=10.1016/j.neuroscience.2014.07.079;
RA   Fernandez-Echevarria C., Diaz M., Ferrer I., Canerina-Amaro A.,
RA   Marin R.;
RT   "Abeta promotes VDAC1 channel dephosphorylation in neuronal lipid
RT   rafts. Relevance to the mechanisms of neurotoxicity in Alzheimer's
RT   disease.";
RL   Neuroscience 278:354-366(2014).
RN   [99]
RP   PHOSPHORYLATION AT SER-441 AND TYR-497.
RX   PubMed=26091039; DOI=10.1016/j.cell.2015.05.028;
RA   Tagliabracci V.S., Wiley S.E., Guo X., Kinch L.N., Durrant E., Wen J.,
RA   Xiao J., Cui J., Nguyen K.B., Engel J.L., Coon J.J., Grishin N.,
RA   Pinna L.A., Pagliarini D.J., Dixon J.E.;
RT   "A single kinase generates the majority of the secreted
RT   phosphoproteome.";
RL   Cell 161:1619-1632(2015).
RN   [100]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 287-344.
RX   PubMed=2125487; DOI=10.1021/bi00495a002;
RA   Hynes T.R., Randal M., Kennedy L.A., Eigenbrot C., Kossiakof A.A.;
RT   "X-ray crystal structure of the protease inhibitor domain of
RT   Alzheimer's amyloid beta-protein precursor.";
RL   Biochemistry 29:10018-10022(1990).
RN   [101]
RP   STRUCTURE BY NMR OF 289-344.
RX   PubMed=1718421; DOI=10.1021/bi00107a015;
RA   Heald S.L., Tilton R.F. Jr., Hammond L.S., Lee A., Bayney R.M.,
RA   Kamarck M.E., Ramabhadran T.V., Dreyer R.N., Davis G., Unterbeck A.,
RA   Tamburini P.P.;
RT   "Sequential NMR resonance assignment and structure determination of
RT   the Kunitz-type inhibitor domain of the Alzheimer's beta-amyloid
RT   precursor protein.";
RL   Biochemistry 30:10467-10478(1991).
RN   [102]
RP   STRUCTURE BY NMR OF 672-699.
RX   PubMed=7516706; DOI=10.1021/bi00191a006;
RA   Talafous J., Marcinowski K.J., Klopman G., Zagorski M.G.;
RT   "Solution structure of residues 1-28 of the amyloid beta-peptide.";
RL   Biochemistry 33:7788-7796(1994).
RN   [103]
RP   STRUCTURE BY NMR OF 672-711.
RX   PubMed=7588758; DOI=10.1111/j.1432-1033.1995.293_1.x;
RA   Sticht H., Bayer P., Willbold D., Dames S., Hilbich C., Beyreuther K.,
RA   Frank R.W., Rosch P.;
RT   "Structure of amyloid A4-(1-40)-peptide of Alzheimer's disease.";
RL   Eur. J. Biochem. 233:293-298(1995).
RN   [104]
RP   STRUCTURE BY NMR OF 696-706.
RX   PubMed=8973180; DOI=10.1021/bi961598j;
RA   Kohno T., Kobayashi K., Maeda T., Sato K., Takashima A.;
RT   "Three-dimensional structures of the amyloid beta peptide (25-35) in
RT   membrane-mimicking environment.";
RL   Biochemistry 35:16094-16104(1996).
RN   [105]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF KUNITZ DOMAIN IN COMPLEX WITH
RP   CHYMOTRYPSIN; TRYPSIN AND BASIC PANCREATIC TRYPSIN INHIBITOR.
RX   PubMed=9300481; DOI=10.1002/pro.5560060902;
RA   Scheidig A.J., Hynes T.R., Pelletier L.A., Wells J.A.,
RA   Kossiakoff A.A.;
RT   "Crystal structures of bovine chymotrypsin and trypsin complexed to
RT   the inhibitor domain of Alzheimer's amyloid beta-protein precursor
RT   (APPI) and basic pancreatic trypsin inhibitor (BPTI): engineering of
RT   inhibitors with altered specificities.";
RL   Protein Sci. 6:1806-1824(1997).
RN   [106]
RP   STRUCTURE BY NMR OF 672-711.
RX   PubMed=9693002; DOI=10.1021/bi972979f;
RA   Coles M., Bicknell W., Watson A.A., Fairlie D.P., Craik D.J.;
RT   "Solution structure of amyloid beta-peptide(1-40) in a water-micelle
RT   environment. Is the membrane-spanning domain where we think it is?";
RL   Biochemistry 37:11064-11077(1998).
RN   [107]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 28-123.
RX   PubMed=10201399; DOI=10.1038/7562;
RA   Rossjohn J., Cappai R., Feil S.C., Henry A., McKinstry W.J.,
RA   Galatis D., Hesse L., Multhaup G., Beyreuther K., Masters C.L.,
RA   Parker M.W.;
RT   "Crystal structure of the N-terminal, growth factor-like domain of
RT   Alzheimer amyloid precursor protein.";
RL   Nat. Struct. Biol. 6:327-331(1999).
RN   [108]
RP   STRUCTURE OF CAA-APP VARIANTS.
RX   PubMed=10821838; DOI=10.1074/jbc.M003154200;
RA   Miravalle L., Tokuda T., Chiarle R., Giaccone G., Bugiani O.,
RA   Tagliavini F., Frangione B., Ghiso J.;
RT   "Substitutions at codon 22 of Alzheimer's Abeta peptide induce diverse
RT   conformational changes and apoptotic effects in human cerebral
RT   endothelial cells.";
RL   J. Biol. Chem. 275:27110-27116(2000).
RN   [109]
RP   STRUCTURE BY NMR OF 681-706.
RX   PubMed=10940221; DOI=10.1006/jsbi.2000.4288;
RA   Zhang S., Iwata K., Lachenmann M.J., Peng J.W., Li S., Stimson E.R.,
RA   Lu Y., Felix A.M., Maggio J.E., Lee J.P.;
RT   "The Alzheimer's peptide a beta adopts a collapsed coil structure in
RT   water.";
RL   J. Struct. Biol. 130:130-141(2000).
RN   [110]
RP   STRUCTURE BY NMR OF 672-699.
RX   PubMed=10940222; DOI=10.1006/jsbi.2000.4267;
RA   Poulsen S.-A., Watson A.A., Craik D.J.;
RT   "Solution structures in aqueous SDS micelles of two amyloid beta
RT   peptides of Abeta(1-28) mutated at the alpha-secretase cleavage
RT   site.";
RL   J. Struct. Biol. 130:142-152(2000).
RN   [111]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 346-551, PARTIAL PROTEIN
RP   SEQUENCE, MUTAGENESIS OF ARG-499 AND LYS-503, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RX   PubMed=15304215; DOI=10.1016/j.molcel.2004.06.037;
RA   Wang Y., Ha Y.;
RT   "The X-ray structure of an antiparallel dimer of the human amyloid
RT   precursor protein E2 domain.";
RL   Mol. Cell 15:343-353(2004).
RN   [112]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 672-711 IN COMPLEX WITH IDE.
RX   PubMed=17051221; DOI=10.1038/nature05143;
RA   Shen Y., Joachimiak A., Rosner M.R., Tang W.-J.;
RT   "Structures of human insulin-degrading enzyme reveal a new substrate
RT   recognition mechanism.";
RL   Nature 443:870-874(2006).
RN   [113]
RP   X-RAY CRYSTALLOGRAPHY (0.85 ANGSTROMS) OF 133-189, AND DISULFIDE
RP   BONDS.
RX   PubMed=17909280; DOI=10.1107/S1744309107041139;
RA   Kong G.K., Adams J.J., Cappai R., Parker M.W.;
RT   "Structure of Alzheimer's disease amyloid precursor protein copper-
RT   binding domain at atomic resolution.";
RL   Acta Crystallogr. F 63:819-824(2007).
RN   [114]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 133-189 IN COMPLEXES WITH
RP   COPPER IONS, AND DISULFIDE BONDS.
RX   PubMed=17239395; DOI=10.1016/j.jmb.2006.12.041;
RA   Kong G.K., Adams J.J., Harris H.H., Boas J.F., Curtain C.C.,
RA   Galatis D., Masters C.L., Barnham K.J., McKinstry W.J., Cappai R.,
RA   Parker M.W.;
RT   "Structural studies of the Alzheimer's amyloid precursor protein
RT   copper-binding domain reveal how it binds copper ions.";
RL   J. Mol. Biol. 367:148-161(2007).
RN   [115]
RP   X-RAY CRYSTALLOGRAPHY (1.65 ANGSTROMS) OF 672-679 IN COMPLEX WITH IGG.
RX   PubMed=17895381; DOI=10.1073/pnas.0705888104;
RA   Gardberg A.S., Dice L.T., Ou S., Rich R.L., Helmbrecht E., Ko J.,
RA   Wetzel R., Myszka D.G., Patterson P.H., Dealwis C.;
RT   "Molecular basis for passive immunotherapy of Alzheimer's disease.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:15659-15664(2007).
RN   [116]
RP   X-RAY CRYSTALLOGRAPHY (2.15 ANGSTROMS) OF 672-678 IN COMPLEXES WITH
RP   ANTIBODY FAB FRAGMENTS.
RX   PubMed=19923222; DOI=10.1074/jbc.M109.045187;
RA   Basi G.S., Feinberg H., Oshidari F., Anderson J., Barbour R.,
RA   Baker J., Comery T.A., Diep L., Gill D., Johnson-Wood K., Goel A.,
RA   Grantcharova K., Lee M., Li J., Partridge A., Griswold-Prenner I.,
RA   Piot N., Walker D., Widom A., Pangalos M.N., Seubert P.,
RA   Jacobsen J.S., Schenk D., Weis W.I.;
RT   "Structural correlates of antibodies associated with acute reversal of
RT   amyloid beta-related behavioral deficits in a mouse model of Alzheimer
RT   disease.";
RL   J. Biol. Chem. 285:3417-3427(2010).
RN   [117]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 18-190, PARTIAL PROTEIN
RP   SEQUENCE, SUBUNIT, DISULFIDE BONDS, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=20212142; DOI=10.1073/pnas.0911326107;
RA   Dahms S.O., Hoefgen S., Roeser D., Schlott B., Guhrs K.H., Than M.E.;
RT   "Structure and biochemical analysis of the heparin-induced E1 dimer of
RT   the amyloid precursor protein.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:5381-5386(2010).
RN   [118]
RP   REVIEW ON VARIANTS.
RX   PubMed=1363811; DOI=10.1038/ng0792-233;
RA   Hardy J.;
RT   "Framing beta-amyloid.";
RL   Nat. Genet. 1:233-234(1992).
RN   [119]
RP   VARIANT CAA-APP GLN-693.
RX   PubMed=2111584; DOI=10.1126/science.2111584;
RA   Levy E., Carman M.D., Fernandez-Madrid I.J., Power M.D.,
RA   Lieberburg I., van Duinen S.G., Bots G.T.A.M., Luyendijk W.,
RA   Frangione B.;
RT   "Mutation of the Alzheimer's disease amyloid gene in hereditary
RT   cerebral hemorrhage, Dutch type.";
RL   Science 248:1124-1126(1990).
RN   [120]
RP   VARIANT AD1 ILE-717.
RX   PubMed=1671712; DOI=10.1038/349704a0;
RA   Goate A., Chartier-Harlin M.-C., Mullan M., Brown J., Crawford F.,
RA   Fidani L., Giuffra L., Haynes A., Irving N., James L., Mant R.,
RA   Newton P., Rooke K., Roques P., Talbot C., Pericak-Vance M.,
RA   Roses A.D., Williamson R., Rossor M., Owen M., Hardy J.;
RT   "Segregation of a missense mutation in the amyloid precursor protein
RT   gene with familial Alzheimer's disease.";
RL   Nature 349:704-706(1991).
RN   [121]
RP   VARIANT AD1 ILE-717.
RX   PubMed=1908231; DOI=10.1016/0006-291X(91)91011-Z;
RA   Yoshioka K., Miki T., Katsuya T., Ogihara T., Sakaki Y.;
RT   "The 717Val-->Ile substitution in amyloid precursor protein is
RT   associated with familial Alzheimer's disease regardless of ethnic
RT   groups.";
RL   Biochem. Biophys. Res. Commun. 178:1141-1146(1991).
RN   [122]
RP   VARIANT AD1 ILE-717.
RX   PubMed=1678058; DOI=10.1016/0140-6736(91)91612-X;
RA   Naruse S., Igarashi S., Kobayashi H., Aoki K., Inuzuka T., Kaneko K.,
RA   Shimizu T., Iihara K., Kojima T., Miyatake T., Tsuji S.;
RT   "Mis-sense mutation Val->Ile in exon 17 of amyloid precursor protein
RT   gene in Japanese familial Alzheimer's disease.";
RL   Lancet 337:978-979(1991).
RN   [123]
RP   VARIANT AD1 GLY-717.
RX   PubMed=1944558; DOI=10.1038/353844a0;
RA   Chartier-Harlin M.-C., Crawford F., Houlden H., Warren A., Hughes D.,
RA   Fidani L., Goate A., Rossor M., Roques P., Hardy J., Mullan M.;
RT   "Early-onset Alzheimer's disease caused by mutations at codon 717 of
RT   the beta-amyloid precursor protein gene.";
RL   Nature 353:844-846(1991).
RN   [124]
RP   VARIANT AD1 PHE-717.
RX   PubMed=1925564; DOI=10.1126/science.1925564;
RA   Murrell J.R., Farlow M., Ghetti B., Benson M.D.;
RT   "A mutation in the amyloid precursor protein associated with
RT   hereditary Alzheimer's disease.";
RL   Science 254:97-99(1991).
RN   [125]
RP   VARIANT AD1 GLY-693.
RX   PubMed=1415269;
RA   Kamino K., Orr H.T., Payami H., Wijsman E.M., Alonso M.E., Pulst S.M.,
RA   Anderson L., O'Dahl S., Nemens E., White J.A., Sadovnick A.D.,
RA   Ball M.J., Kaye J., Warren A., McInnis M.G., Antonarakis S.E.,
RA   Korenberg J.R., Sharma V., Kukull W., Larson E., Heston L.L.,
RA   Martin G.M., Bird T.D., Schellenberg G.D.;
RT   "Linkage and mutational analysis of familial Alzheimer disease
RT   kindreds for the APP gene region.";
RL   Am. J. Hum. Genet. 51:998-1014(1992).
RN   [126]
RP   VARIANT AD1 GLY-692.
RX   PubMed=1303239; DOI=10.1038/ng0692-218;
RA   Hendriks L., van Duijn C.M., Cras P., Cruts M., Van Hul W.,
RA   van Harskamp F., Warren A., McInnis M.G., Antonarakis S.E.,
RA   Martin J.J., Hofman A., Van Broeckhoven C.;
RT   "Presenile dementia and cerebral haemorrhage linked to a mutation at
RT   codon 692 of the beta-amyloid precursor protein gene.";
RL   Nat. Genet. 1:218-221(1992).
RN   [127]
RP   VARIANT AD1 670-ASN-LEU-671.
RX   PubMed=1302033; DOI=10.1038/ng0892-345;
RA   Mullan M., Crawford F., Axelman K., Houlden H., Lilius L., Winblad B.,
RA   Lannfelt L.;
RT   "A pathogenic mutation for probable Alzheimer's disease in the APP
RT   gene at the N-terminus of beta-amyloid.";
RL   Nat. Genet. 1:345-347(1992).
RN   [128]
RP   VARIANT VAL-713.
RX   PubMed=1307241; DOI=10.1038/ng0792-306;
RA   Jones C.T., Morris S., Yates C.M., Moffoot A., Sharpe C.,
RA   Brock D.J.H., St Clair D.;
RT   "Mutation in codon 713 of the beta amyloid precursor protein gene
RT   presenting with schizophrenia.";
RL   Nat. Genet. 1:306-309(1992).
RN   [129]
RP   VARIANT AD1 THR-713.
RX   PubMed=1303275; DOI=10.1038/ng1292-255;
RA   Carter D.A., Desmarais E., Bellis M., Campion D., Clerget-Darpoux F.,
RA   Brice A., Agid Y., Jaillard-Serradt A., Mallet J.;
RT   "More missense in amyloid gene.";
RL   Nat. Genet. 2:255-256(1992).
RN   [130]
RP   VARIANTS AD1 ILE-717 AND PHE-717.
RX   PubMed=8267572; DOI=10.1006/bbrc.1993.2491;
RA   Liepnieks J.J., Ghetti B., Farlow M., Roses A.D., Benson M.D.;
RT   "Characterization of amyloid fibril beta-peptide in familial
RT   Alzheimer's disease with APP717 mutations.";
RL   Biochem. Biophys. Res. Commun. 197:386-392(1993).
RN   [131]
RP   VARIANT ASP-665.
RX   PubMed=8154870; DOI=10.1002/ana.410350410;
RA   Peacock M.L., Murman D.L., Sima A.A.F., Warren J.T. Jr., Roses A.D.,
RA   Fink J.K.;
RT   "Novel amyloid precursor protein gene mutation (codon 665Asp) in a
RT   patient with late-onset Alzheimer's disease.";
RL   Ann. Neurol. 35:432-438(1994).
RN   [132]
RP   VARIANT AD1 PHE-717.
RX   PubMed=8290042; DOI=10.1212/WNL.44.1.105;
RA   Farlow M., Murrell J., Ghetti B., Unverzagt F., Zeldenrust S.,
RA   Benson M.D.;
RT   "Clinical characteristics in a kindred with early-onset Alzheimer's
RT   disease and their linkage to a G-->T change at position 2149 of the
RT   amyloid precursor protein gene.";
RL   Neurology 44:105-111(1994).
RN   [133]
RP   VARIANT AD1 ILE-717.
RX   PubMed=8577393; DOI=10.1016/0304-3940(95)12046-7;
RA   Brooks W.S., Martins R.N., De Voecht J., Nicholson G.A.,
RA   Schofield P.R., Kwok J.B.J., Fisher C., Yeung L.U.,
RA   Van Broeckhoven C.;
RT   "A mutation in codon 717 of the amyloid precursor protein gene in an
RT   Australian family with Alzheimer's disease.";
RL   Neurosci. Lett. 199:183-186(1995).
RN   [134]
RP   VARIANT AD1 VAL-716.
RX   PubMed=9328472; DOI=10.1093/hmg/6.12.2087;
RA   Eckman C.B., Mehta N.D., Crook R., Perez-Tur J., Prihar G.,
RA   Pfeiffer E., Graff-Radford N., Hinder P., Yager D., Zenk B.,
RA   Refolo L.M., Prada C.M., Younkin S.G., Hutton M., Hardy J.;
RT   "A new pathogenic mutation in the APP gene (I716V) increases the
RT   relative proportion of A beta 42(43).";
RL   Hum. Mol. Genet. 6:2087-2089(1997).
RN   [135]
RP   VARIANT AD1 GLY-692, AND CHARACTERIZATION OF PHENOTYPE.
RX   PubMed=9754958; DOI=10.1007/s004010050892;
RA   Cras P., van Harskamp F., Hendriks L., Ceuterick C., van Duijn C.M.,
RA   Stefanko S.Z., Hofman A., Kros J.M., Van Broeckhoven C., Martin J.J.;
RT   "Presenile Alzheimer dementia characterized by amyloid angiopathy and
RT   large amyloid core type senile plaques in the APP 692Ala-->Gly
RT   mutation.";
RL   Acta Neuropathol. 96:253-260(1998).
RN   [136]
RP   VARIANT AD1 MET-715, AND CHARACTERIZATION OF VARIANT AD1 MET-715.
RX   PubMed=10097173; DOI=10.1073/pnas.96.7.4119;
RA   Ancolio K., Dumanchin C., Barelli H., Warter J.-M., Brice A.,
RA   Campion D., Frebourg T., Checler F.;
RT   "Unusual phenotypic alteration of beta amyloid precursor protein
RT   (betaAPP) maturation by a new Val-715 --> Met betaAPP-770 mutation
RT   responsible for probable early-onset Alzheimer's disease.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:4119-4124(1999).
RN   [137]
RP   VARIANT AD1 ILE-717.
RX   PubMed=10631141; DOI=10.1086/302702;
RA   Finckh U., Mueller-Thomsen T., Mann U., Eggers C., Marksteiner J.,
RA   Meins W., Binetti G., Alberici A., Hock C., Nitsch R.M., Gal A.;
RT   "High prevalence of pathogenic mutations in patients with early-onset
RT   dementia detected by sequence analyses of four different genes.";
RL   Am. J. Hum. Genet. 66:110-117(2000).
RN   [138]
RP   VARIANT AD1 PRO-723.
RX   PubMed=10665499;
RX   DOI=10.1002/1531-8249(200002)47:2<249::AID-ANA18>3.0.CO;2-8;
RA   Kwok J.B.J., Li Q.X., Hallupp M., Whyte S., Ames D., Beyreuther K.,
RA   Masters C.L., Schofield P.R.;
RT   "Novel Leu723Pro amyloid precursor protein mutation increases amyloid
RT   beta42(43) peptide levels and induces apoptosis.";
RL   Ann. Neurol. 47:249-253(2000).
RN   [139]
RP   VARIANT AD1 LEU-717.
RX   PubMed=10867787; DOI=10.1001/archneur.57.6.885;
RA   Murrell J.R., Hake A.M., Quaid K.A., Farlow M.R., Ghetti B.;
RT   "Early-onset Alzheimer disease caused by a new mutation (V717L) in the
RT   amyloid precursor protein gene.";
RL   Arch. Neurol. 57:885-887(2000).
RN   [140]
RP   VARIANT AD1 ILE-714, CHARACTERIZATION OF VARIANT AD1 ILE-714, AND
RP   MUTAGENESIS OF VAL-717.
RX   PubMed=11063718; DOI=10.1093/hmg/9.18.2589;
RA   Kumar-Singh S., De Jonghe C., Cruts M., Kleinert R., Wang R.,
RA   Mercken M., De Strooper B., Vanderstichele H., Loefgren A.,
RA   Vanderhoeven I., Backhovens H., Vanmechelen E., Kroisel P.M.,
RA   Van Broeckhoven C.;
RT   "Nonfibrillar diffuse amyloid deposition due to a gamma(42)-secretase
RT   site mutation points to an essential role for N-truncated A beta(42)
RT   in Alzheimer's disease.";
RL   Hum. Mol. Genet. 9:2589-2598(2000).
RN   [141]
RP   VARIANT CAA-APP ASN-694.
RX   PubMed=11409420; DOI=10.1002/ana.1009;
RA   Grabowski T.J., Cho H.S., Vonsattel J.P.G., Rebeck G.W.,
RA   Greenberg S.M.;
RT   "Novel amyloid precursor protein mutation in an Iowa family with
RT   dementia and severe cerebral amyloid angiopathy.";
RL   Ann. Neurol. 49:697-705(2001).
RN   [142]
RP   CHARACTERIZATION OF VARIANT AD1 GLY-692.
RX   PubMed=11311152;
RA   Walsh D.M., Hartley D.M., Condron M.M., Selkoe D.J., Teplow D.B.;
RT   "In vitro studies of amyloid beta-protein fibril assembly and toxicity
RT   provide clues to the aetiology of Flemish variant (Ala692-->Gly)
RT   Alzheimer's disease.";
RL   Biochem. J. 355:869-877(2001).
RN   [143]
RP   VARIANT AD1 GLY-693.
RX   PubMed=11528419; DOI=10.1038/nn0901-887;
RA   Nilsberth C., Westlind-Danielsson A., Eckman C.B., Condron M.M.,
RA   Axelman K., Forsell C., Stenh C., Luthman J., Teplow D.B.,
RA   Younkin S.G., Naeslund J., Lannfelt L.;
RT   "The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by
RT   enhanced Abeta protofibril formation.";
RL   Nat. Neurosci. 4:887-893(2001).
RN   [144]
RP   VARIANT AD1 ALA-714.
RX   PubMed=12034808; DOI=10.1212/WNL.58.10.1574;
RA   Pasalar P., Najmabadi H., Noorian A.R., Moghimi B., Jannati A.,
RA   Soltanzadeh A., Krefft T., Crook R., Hardy J.;
RT   "An Iranian family with Alzheimer's disease caused by a novel APP
RT   mutation (Thr714Ala).";
RL   Neurology 58:1574-1575(2002).
RN   [145]
RP   VARIANT CAA-APP ASN-694.
RX   PubMed=12654973; DOI=10.1212/01.WNL.0000050140.10044.A8;
RA   Greenberg S.M., Shin Y., Grabowski T.J., Cooper G.E., Rebeck G.W.,
RA   Iglesias S., Chapon F., Tournier-Lasserve E., Baron J.-C.;
RT   "Hemorrhagic stroke associated with the Iowa amyloid precursor protein
RT   mutation.";
RL   Neurology 60:1020-1022(2003).
RN   [146]
RP   VARIANT AD1 THR-713.
RX   PubMed=15365148; DOI=10.1212/01.WNL.0000137048.80666.86;
RA   Rossi G., Giaccone G., Maletta R., Morbin M., Capobianco R.,
RA   Mangieri M., Giovagnoli A.R., Bizzi A., Tomaino C., Perri M.,
RA   Di Natale M., Tagliavini F., Bugiani O., Bruni A.C.;
RT   "A family with Alzheimer disease and strokes associated with A713T
RT   mutation of the APP gene.";
RL   Neurology 63:910-912(2004).
RN   [147]
RP   VARIANT CAA-APP VAL-705.
RX   PubMed=16178030; DOI=10.1002/ana.20571;
RA   Obici L., Demarchi A., de Rosa G., Bellotti V., Marciano S.,
RA   Donadei S., Arbustini E., Palladini G., Diegoli M., Genovese E.,
RA   Ferrari G., Coverlizza S., Merlini G.;
RT   "A novel AbetaPP mutation exclusively associated with cerebral amyloid
RT   angiopathy.";
RL   Ann. Neurol. 58:639-644(2005).
RN   [148]
RP   VARIANT AD1 ILE-714.
RX   PubMed=15668448; DOI=10.1212/01.WNL.0000149761.70566.3E;
RA   Edwards-Lee T., Ringman J.M., Chung J., Werner J., Morgan A.,
RA   St George-Hyslop P.H., Thompson P., Dutton R., Mlikotic A.,
RA   Rogaeva E., Hardy J.;
RT   "An African American family with early-onset Alzheimer disease and an
RT   APP (T714I) mutation.";
RL   Neurology 64:377-379(2005).
RN   [149]
RP   VARIANT CAA-APP LYS-693.
RX   PubMed=20697050; DOI=10.1001/archneurol.2010.178;
RA   Bugiani O., Giaccone G., Rossi G., Mangieri M., Capobianco R.,
RA   Morbin M., Mazzoleni G., Cupidi C., Marcon G., Giovagnoli A.,
RA   Bizzi A., Di Fede G., Puoti G., Carella F., Salmaggi A., Romorini A.,
RA   Patruno G.M., Magoni M., Padovani A., Tagliavini F.;
RT   "Hereditary cerebral hemorrhage with amyloidosis associated with the
RT   E693K mutation of APP.";
RL   Arch. Neurol. 67:987-995(2010).
CC   -!- FUNCTION: Functions as a cell surface receptor and performs
CC       physiological functions on the surface of neurons relevant to
CC       neurite growth, neuronal adhesion and axonogenesis. Involved in
CC       cell mobility and transcription regulation through protein-protein
CC       interactions. Can promote transcription activation through binding
CC       to APBB1-KAT5 and inhibits Notch signaling through interaction
CC       with Numb. Couples to apoptosis-inducing pathways such as those
CC       mediated by G(O) and JIP. Inhibits G(o) alpha ATPase activity (By
CC       similarity). Acts as a kinesin I membrane receptor, mediating the
CC       axonal transport of beta-secretase and presenilin 1. Involved in
CC       copper homeostasis/oxidative stress through copper ion reduction.
CC       In vitro, copper-metallated APP induces neuronal death directly or
CC       is potentiated through Cu(2+)-mediated low-density lipoprotein
CC       oxidation. Can regulate neurite outgrowth through binding to
CC       components of the extracellular matrix such as heparin and
CC       collagen I and IV. The splice isoforms that contain the BPTI
CC       domain possess protease inhibitor activity. Induces a AGER-
CC       dependent pathway that involves activation of p38 MAPK, resulting
CC       in internalization of amyloid-beta peptide and leading to
CC       mitochondrial dysfunction in cultured cortical neurons. Provides
CC       Cu(2+) ions for GPC1 which are required for release of nitric
CC       oxide (NO) and subsequent degradation of the heparan sulfate
CC       chains on GPC1. {ECO:0000250}.
CC   -!- FUNCTION: Amyloid-beta peptides are lipophilic metal chelators
CC       with metal-reducing activity. Bind transient metals such as
CC       copper, zinc and iron. In vitro, can reduce Cu(2+) and Fe(3+) to
CC       Cu(+) and Fe(2+), respectively. Amyloid-beta protein 42 is a more
CC       effective reductant than amyloid-beta protein 40. Amyloid-beta
CC       peptides bind to lipoproteins and apolipoproteins E and J in the
CC       CSF and to HDL particles in plasma, inhibiting metal-catalyzed
CC       oxidation of lipoproteins. APP42-beta may activate mononuclear
CC       phagocytes in the brain and elicit inflammatory responses.
CC       Promotes both tau aggregation and TPK II-mediated phosphorylation.
CC       Interaction with overexpressed HADH2 leads to oxidative stress and
CC       neurotoxicity. Also binds GPC1 in lipid rafts.
CC   -!- FUNCTION: Appicans elicit adhesion of neural cells to the
CC       extracellular matrix and may regulate neurite outgrowth in the
CC       brain. {ECO:0000250}.
CC   -!- FUNCTION: The gamma-CTF peptides as well as the caspase-cleaved
CC       peptides, including C31, are potent enhancers of neuronal
CC       apoptosis.
CC   -!- FUNCTION: N-APP binds TNFRSF21 triggering caspase activation and
CC       degeneration of both neuronal cell bodies (via caspase-3) and
CC       axons (via caspase-6).
CC   -!- SUBUNIT: Binds, via its C-terminus, to the PID domain of several
CC       cytoplasmic proteins, including APBB family members, the APBA
CC       family, MAPK8IP1, SHC1 and, NUMB and DAB1 (By similarity). Binding
CC       to DAB1 inhibits its serine phosphorylation (By similarity).
CC       Interacts (via NPXY motif) with DAB2 (via PID domain); the
CC       interaction is impaired by tyrosine phosphorylation of the NPXY
CC       motif. Also interacts with GPCR-like protein BPP, FPRL1, APPBP1,
CC       IB1, KNS2 (via its TPR domains) (By similarity), APPBP2 (via BaSS)
CC       and DDB1. In vitro, it binds MAPT via the MT-binding domains (By
CC       similarity). Associates with microtubules in the presence of ATP
CC       and in a kinesin-dependent manner (By similarity). Interacts,
CC       through a C-terminal domain, with GNAO1. Amyloid-beta protein 42
CC       binds CHRNA7 in hippocampal neurons. Amyloid-beta associates with
CC       HADH2. Soluble APP binds, via its N-terminal head, to FBLN1.
CC       Interacts with CPEB1 and AGER (By similarity). Interacts with
CC       ANKS1B and TNFRSF21. Interacts with ITM2B. Interacts with ITM2C.
CC       Interacts with IDE. Can form homodimers; this is promoted by
CC       heparin binding. Amyloid-beta protein 40 interacts with S100A9.
CC       CTF-alpha product of APP interacts with GSAP. Interacts with
CC       SORL1. Interacts with PLD3. Interacts with VDAC1
CC       (PubMed:25168729). Interacts with NSG1; could regulate APP
CC       processing (By similarity). {ECO:0000250,
CC       ECO:0000250|UniProtKB:P12023, ECO:0000269|PubMed:10681545,
CC       ECO:0000269|PubMed:10816430, ECO:0000269|PubMed:11238726,
CC       ECO:0000269|PubMed:11278849, ECO:0000269|PubMed:11438549,
CC       ECO:0000269|PubMed:11517218, ECO:0000269|PubMed:11544248,
CC       ECO:0000269|PubMed:11689470, ECO:0000269|PubMed:11724784,
CC       ECO:0000269|PubMed:11877420, ECO:0000269|PubMed:11943163,
CC       ECO:0000269|PubMed:15347684, ECO:0000269|PubMed:16174740,
CC       ECO:0000269|PubMed:17051221, ECO:0000269|PubMed:17895381,
CC       ECO:0000269|PubMed:18468999, ECO:0000269|PubMed:19225519,
CC       ECO:0000269|PubMed:19366692, ECO:0000269|PubMed:19901339,
CC       ECO:0000269|PubMed:20212142, ECO:0000269|PubMed:20811458,
CC       ECO:0000269|PubMed:22457725, ECO:0000269|PubMed:24336208,
CC       ECO:0000269|PubMed:25168729, ECO:0000269|PubMed:8446172,
CC       ECO:0000269|PubMed:8626687, ECO:0000269|PubMed:8855266,
CC       ECO:0000269|PubMed:8887653, ECO:0000269|PubMed:9300481,
CC       ECO:0000269|PubMed:9338779, ECO:0000269|PubMed:9843960,
CC       ECO:0000269|PubMed:9890987}.
CC   -!- INTERACTION:
CC       Self; NbExp=106; IntAct=EBI-77613, EBI-77613;
CC       Q306T3:- (xeno); NbExp=3; IntAct=EBI-77613, EBI-8294101;
CC       P31696:AGRN (xeno); NbExp=3; IntAct=EBI-2431589, EBI-457650;
CC       Q02410:APBA1; NbExp=3; IntAct=EBI-77613, EBI-368690;
CC       O00213:APBB1; NbExp=5; IntAct=EBI-77613, EBI-81694;
CC       Q92870:APBB2; NbExp=2; IntAct=EBI-77613, EBI-79277;
CC       P51693:APLP1; NbExp=2; IntAct=EBI-302641, EBI-74648;
CC       Q06481:APLP2; NbExp=2; IntAct=EBI-302641, EBI-79306;
CC       P02647:APOA1; NbExp=5; IntAct=EBI-77613, EBI-701692;
CC       Q13867:BLMH; NbExp=2; IntAct=EBI-302641, EBI-718504;
CC       P15253:CALR (xeno); NbExp=3; IntAct=EBI-77613, EBI-9005200;
CC       P27797:CALR; NbExp=2; IntAct=EBI-77613, EBI-1049597;
CC       Q8K3H7:CALR (xeno); NbExp=2; IntAct=EBI-3894543, EBI-9005068;
CC       P39060:COL18A1; NbExp=2; IntAct=EBI-821758, EBI-2566375;
CC       P07339:CTSD; NbExp=2; IntAct=EBI-77613, EBI-2115097;
CC       O75955:FLOT1; NbExp=5; IntAct=EBI-77613, EBI-603643;
CC       P01100:FOS; NbExp=3; IntAct=EBI-77613, EBI-852851;
CC       P46089:GPR3; NbExp=2; IntAct=EBI-302641, EBI-3909653;
CC       A4D1B5:GSAP; NbExp=3; IntAct=EBI-77613, EBI-15875313;
CC       Q9NSC5:HOMER3; NbExp=3; IntAct=EBI-302661, EBI-748420;
CC       Q99714:HSD17B10; NbExp=4; IntAct=EBI-77613, EBI-79964;
CC       O43736:ITM2A; NbExp=3; IntAct=EBI-302641, EBI-2431769;
CC       P05412:JUN; NbExp=2; IntAct=EBI-77613, EBI-852823;
CC       Q99683:MAP3K5; NbExp=2; IntAct=EBI-77613, EBI-476263;
CC       P10636:MAPT; NbExp=5; IntAct=EBI-77613, EBI-366182;
CC       Q93074:MED12; NbExp=2; IntAct=EBI-77613, EBI-394357;
CC       P03897:MT-ND3; NbExp=2; IntAct=EBI-821758, EBI-1246249;
CC       P07196:NEFL; NbExp=2; IntAct=EBI-77613, EBI-475646;
CC       P21359:NF1; NbExp=3; IntAct=EBI-77613, EBI-1172917;
CC       P08138:NGFR; NbExp=2; IntAct=EBI-77613, EBI-1387782;
CC       P07174:Ngfr (xeno); NbExp=2; IntAct=EBI-2431589, EBI-1038810;
CC       P61457:PCBD1; NbExp=2; IntAct=EBI-77613, EBI-740475;
CC       Q15113:PCOLCE; NbExp=4; IntAct=EBI-821758, EBI-8869614;
CC       P30101:PDIA3; NbExp=3; IntAct=EBI-77613, EBI-979862;
CC       Q13526:PIN1; NbExp=2; IntAct=EBI-302641, EBI-714158;
CC       P04156:PRNP; NbExp=3; IntAct=EBI-77613, EBI-977302;
CC       P49768:PSEN1; NbExp=6; IntAct=EBI-77613, EBI-297277;
CC       P29353:SHC1; NbExp=5; IntAct=EBI-77613, EBI-78835;
CC       Q92529:SHC3; NbExp=2; IntAct=EBI-77613, EBI-79084;
CC       Q9NP59:SLC40A1; NbExp=5; IntAct=EBI-77613, EBI-725153;
CC       Q8BGY9:Slc5a7 (xeno); NbExp=2; IntAct=EBI-77613, EBI-2010752;
CC       Q9HCB6:SPON1; NbExp=3; IntAct=EBI-302641, EBI-2431846;
CC       P01137:TGFB1; NbExp=3; IntAct=EBI-77613, EBI-779636;
CC       P61812:TGFB2; NbExp=7; IntAct=EBI-77613, EBI-779581;
CC       P21980:TGM2; NbExp=2; IntAct=EBI-821758, EBI-727668;
CC       Q13625:TP53BP2; NbExp=3; IntAct=EBI-77613, EBI-77642;
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein. Membrane, clathrin-coated pit. Note=Cell surface protein
CC       that rapidly becomes internalized via clathrin-coated pits. During
CC       maturation, the immature APP (N-glycosylated in the endoplasmic
CC       reticulum) moves to the Golgi complex where complete maturation
CC       occurs (O-glycosylated and sulfated). After alpha-secretase
CC       cleavage, soluble APP is released into the extracellular space and
CC       the C-terminal is internalized to endosomes and lysosomes. Some
CC       APP accumulates in secretory transport vesicles leaving the late
CC       Golgi compartment and returns to the cell surface. Gamma-CTF(59)
CC       peptide is located to both the cytoplasm and nuclei of neurons. It
CC       can be translocated to the nucleus through association with APBB1
CC       (Fe65). Amyloid-beta protein 42 associates with FRPL1 at the cell
CC       surface and the complex is then rapidly internalized. APP sorts to
CC       the basolateral surface in epithelial cells. During neuronal
CC       differentiation, the Thr-743 phosphorylated form is located mainly
CC       in growth cones, moderately in neurites and sparingly in the cell
CC       body. Casein kinase phosphorylation can occur either at the cell
CC       surface or within a post-Golgi compartment. Associates with GPC1
CC       in perinuclear compartments. Colocalizes with SORL1 in a vesicular
CC       pattern in cytoplasm and perinuclear regions.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=11;
CC         Comment=Additional isoforms seem to exist. Experimental
CC         confirmation may be lacking for some isoforms.;
CC       Name=APP770; Synonyms=PreA4 770;
CC         IsoId=P05067-1; Sequence=Displayed;
CC         Note=A major isoform.;
CC       Name=APP305;
CC         IsoId=P05067-2; Sequence=VSP_000005, VSP_000006;
CC       Name=L-APP677;
CC         IsoId=P05067-3; Sequence=VSP_000002, VSP_000004, VSP_000009;
CC         Note=The L-isoforms are referred to as appicans.;
CC       Name=APP695; Synonyms=PreA4 695;
CC         IsoId=P05067-4; Sequence=VSP_000002, VSP_000004;
CC         Note=A major isoform.;
CC       Name=L-APP696;
CC         IsoId=P05067-5; Sequence=VSP_000002, VSP_000003, VSP_000009;
CC         Note=The L-isoforms are referred to as appicans.;
CC       Name=APP714;
CC         IsoId=P05067-6; Sequence=VSP_000002, VSP_000003;
CC       Name=L-APP733;
CC         IsoId=P05067-7; Sequence=VSP_000007, VSP_000008, VSP_000009;
CC         Note=The L-isoforms are referred to as appicans.;
CC       Name=APP751; Synonyms=PreA4 751;
CC         IsoId=P05067-8; Sequence=VSP_000007, VSP_000008;
CC         Note=A major isoform.;
CC       Name=L-APP752;
CC         IsoId=P05067-9; Sequence=VSP_000009;
CC       Name=APP639;
CC         IsoId=P05067-10; Sequence=VSP_009116, VSP_009117, VSP_009118;
CC       Name=11;
CC         IsoId=P05067-11; Sequence=VSP_045446, VSP_045447;
CC   -!- TISSUE SPECIFICITY: Expressed in all fetal tissues examined with
CC       highest levels in brain, kidney, heart and spleen. Weak expression
CC       in liver. In adult brain, highest expression found in the frontal
CC       lobe of the cortex and in the anterior perisylvian cortex-
CC       opercular gyri. Moderate expression in the cerebellar cortex, the
CC       posterior perisylvian cortex-opercular gyri and the temporal
CC       associated cortex. Weak expression found in the striate, extra-
CC       striate and motor cortices. Expressed in cerebrospinal fluid, and
CC       plasma. Isoform APP695 is the predominant form in neuronal tissue,
CC       isoform APP751 and isoform APP770 are widely expressed in non-
CC       neuronal cells. Isoform APP751 is the most abundant form in T-
CC       lymphocytes. Appican is expressed in astrocytes.
CC       {ECO:0000269|PubMed:12859342, ECO:0000269|PubMed:1406936}.
CC   -!- INDUCTION: Increased levels during neuronal differentiation.
CC   -!- DOMAIN: The basolateral sorting signal (BaSS) is required for
CC       sorting of membrane proteins to the basolateral surface of
CC       epithelial cells. {ECO:0000269|PubMed:8576160}.
CC   -!- DOMAIN: The NPXY sequence motif found in many tyrosine-
CC       phosphorylated proteins is required for the specific binding of
CC       the PID domain. However, additional amino acids either N- or C-
CC       terminal to the NPXY motif are often required for complete
CC       interaction. The PID domain-containing proteins which bind APP
CC       require the YENPTY motif for full interaction. These interactions
CC       are independent of phosphorylation on the terminal tyrosine
CC       residue. The NPXY site is also involved in clathrin-mediated
CC       endocytosis. {ECO:0000269|PubMed:8576160}.
CC   -!- PTM: Proteolytically processed under normal cellular conditions.
CC       Cleavage either by alpha-secretase, beta-secretase or theta-
CC       secretase leads to generation and extracellular release of soluble
CC       APP peptides, S-APP-alpha and S-APP-beta, and the retention of
CC       corresponding membrane-anchored C-terminal fragments, C80, C83 and
CC       C99. Subsequent processing of C80 and C83 by gamma-secretase
CC       yields P3 peptides. This is the major secretory pathway and is
CC       non-amyloidogenic. Alternatively, presenilin/nicastrin-mediated
CC       gamma-secretase processing of C99 releases the amyloid-beta
CC       proteins, amyloid-beta protein 40 and amyloid-beta protein 42,
CC       major components of amyloid plaques, and the cytotoxic C-terminal
CC       fragments, gamma-CTF(50), gamma-CTF(57) and gamma-CTF(59). Many
CC       other minor amyloid-beta peptides, amyloid-beta 1-X peptides, are
CC       found in cerebral spinal fluid (CSF) including the amyloid-beta X-
CC       15 peptides, produced from the cleavage by alpha-secretase and all
CC       terminating at Gln-686.
CC   -!- PTM: Proteolytically cleaved by caspases during neuronal
CC       apoptosis. Cleavage at Asp-739 by either caspase-6, -8 or -9
CC       results in the production of the neurotoxic C31 peptide and the
CC       increased production of amyloid-beta peptides.
CC   -!- PTM: N- and O-glycosylated. O-glycosylation on Ser and Thr
CC       residues with core 1 or possibly core 8 glycans. Partial tyrosine
CC       glycosylation (Tyr-681) is found on some minor, short amyloid-beta
CC       peptides (amyloid-beta 1-15, 1-16, 1-17, 1-18, 1-19 and 1-20) but
CC       not found on amyloid-beta protein 38, amyloid-beta protein 40 nor
CC       on amyloid-beta protein 42. Modification on a tyrosine is unusual
CC       and is more prevelant in AD patients. Glycans had
CC       Neu5AcHex(Neu5Ac)HexNAc-O-Tyr, Neu5AcNeu5AcHex(Neu5Ac)HexNAc-O-Tyr
CC       and O-AcNeu5AcNeu5AcHex(Neu5Ac)HexNAc-O-Tyr structures, where O-Ac
CC       is O-acetylation of Neu5Ac. Neu5AcNeu5Ac is most likely Neu5Ac
CC       2,8Neu5Ac linked. O-glycosylations in the vicinity of the cleavage
CC       sites may influence the proteolytic processing. Appicans are L-APP
CC       isoforms with O-linked chondroitin sulfate.
CC       {ECO:0000269|PubMed:16335952, ECO:0000269|PubMed:21712440,
CC       ECO:0000269|PubMed:22576872}.
CC   -!- PTM: Phosphorylation in the C-terminal on tyrosine, threonine and
CC       serine residues is neuron-specific. Phosphorylation can affect APP
CC       processing, neuronal differentiation and interaction with other
CC       proteins. Phosphorylated on Thr-743 in neuronal cells by Cdc5
CC       kinase and Mapk10, in dividing cells by Cdc2 kinase in a cell-
CC       cycle dependent manner with maximal levels at the G2/M phase and,
CC       in vitro, by GSK-3-beta. The Thr-743 phosphorylated form causes a
CC       conformational change which reduces binding of Fe65 family
CC       members. Phosphorylation on Tyr-757 is required for SHC binding.
CC       Phosphorylated in the extracellular domain by casein kinases on
CC       both soluble and membrane-bound APP. This phosphorylation is
CC       inhibited by heparin. {ECO:0000269|PubMed:10341243,
CC       ECO:0000269|PubMed:11146006, ECO:0000269|PubMed:11517218,
CC       ECO:0000269|PubMed:11877420, ECO:0000269|PubMed:8131745,
CC       ECO:0000269|PubMed:8999878}.
CC   -!- PTM: Extracellular binding and reduction of copper, results in a
CC       corresponding oxidation of Cys-144 and Cys-158, and the formation
CC       of a disulfide bond. In vitro, the APP-Cu(+) complex in the
CC       presence of hydrogen peroxide results in an increased production
CC       of amyloid-beta-containing peptides.
CC   -!- PTM: Trophic-factor deprivation triggers the cleavage of surface
CC       APP by beta-secretase to release sAPP-beta which is further
CC       cleaved to release an N-terminal fragment of APP (N-APP).
CC   -!- PTM: Amyloid-beta peptides are degraded by IDE.
CC   -!- MASS SPECTROMETRY: Mass=6461.6; Method=MALDI; Range=712-767;
CC       Evidence={ECO:0000269|PubMed:12214090};
CC   -!- MASS SPECTROMETRY: Mass=6451.6; Method=MALDI; Range=714-770;
CC       Evidence={ECO:0000269|PubMed:12214090};
CC   -!- MASS SPECTROMETRY: Mass=6436.8; Method=MALDI; Range=715-769;
CC       Evidence={ECO:0000269|PubMed:12214090};
CC   -!- MASS SPECTROMETRY: Mass=5752.5; Method=MALDI; Range=719-767;
CC       Evidence={ECO:0000269|PubMed:12214090};
CC   -!- DISEASE: Alzheimer disease 1 (AD1) [MIM:104300]: A familial early-
CC       onset form of Alzheimer disease. It can be associated with
CC       cerebral amyloid angiopathy. Alzheimer disease is a
CC       neurodegenerative disorder characterized by progressive dementia,
CC       loss of cognitive abilities, and deposition of fibrillar amyloid
CC       proteins as intraneuronal neurofibrillary tangles, extracellular
CC       amyloid plaques and vascular amyloid deposits. The major
CC       constituents of these plaques are neurotoxic amyloid-beta protein
CC       40 and amyloid-beta protein 42, that are produced by the
CC       proteolysis of the transmembrane APP protein. The cytotoxic C-
CC       terminal fragments (CTFs) and the caspase-cleaved products, such
CC       as C31, are also implicated in neuronal death.
CC       {ECO:0000269|PubMed:10097173, ECO:0000269|PubMed:10631141,
CC       ECO:0000269|PubMed:10665499, ECO:0000269|PubMed:10867787,
CC       ECO:0000269|PubMed:11063718, ECO:0000269|PubMed:11311152,
CC       ECO:0000269|PubMed:11528419, ECO:0000269|PubMed:12034808,
CC       ECO:0000269|PubMed:1302033, ECO:0000269|PubMed:1303239,
CC       ECO:0000269|PubMed:1303275, ECO:0000269|PubMed:1415269,
CC       ECO:0000269|PubMed:15201367, ECO:0000269|PubMed:15365148,
CC       ECO:0000269|PubMed:15668448, ECO:0000269|PubMed:1671712,
CC       ECO:0000269|PubMed:1678058, ECO:0000269|PubMed:1908231,
CC       ECO:0000269|PubMed:1925564, ECO:0000269|PubMed:1944558,
CC       ECO:0000269|PubMed:8267572, ECO:0000269|PubMed:8290042,
CC       ECO:0000269|PubMed:8476439, ECO:0000269|PubMed:8577393,
CC       ECO:0000269|PubMed:9328472, ECO:0000269|PubMed:9754958}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- DISEASE: Cerebral amyloid angiopathy, APP-related (CAA-APP)
CC       [MIM:605714]: A hereditary localized amyloidosis due to amyloid-
CC       beta A4 peptide(s) deposition in the cerebral vessels. The
CC       principal clinical characteristics are recurrent cerebral and
CC       cerebellar hemorrhages, recurrent strokes, cerebral ischemia,
CC       cerebral infarction, and progressive mental deterioration.
CC       Patients develop cerebral hemorrhage because of the severe
CC       cerebral amyloid angiopathy. Parenchymal amyloid deposits are rare
CC       and largely in the form of pre-amyloid lesions or diffuse plaque-
CC       like structures. They are Congo red negative and lack the dense
CC       amyloid cores commonly present in Alzheimer disease. Some affected
CC       individuals manifest progressive aphasic dementia,
CC       leukoencephalopathy, and occipital calcifications.
CC       {ECO:0000269|PubMed:11409420, ECO:0000269|PubMed:12654973,
CC       ECO:0000269|PubMed:16178030, ECO:0000269|PubMed:20697050,
CC       ECO:0000269|PubMed:2111584}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: Chelation of metal ions, notably copper, iron and
CC       zinc, can induce histidine-bridging between amyloid-beta molecules
CC       resulting in amyloid-beta-metal aggregates. The affinity for
CC       copper is much higher than for other transient metals and is
CC       increased under acidic conditions. Extracellular zinc-binding
CC       increases binding of heparin to APP and inhibits collagen-binding.
CC   -!- SIMILARITY: Belongs to the APP family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA58727.1; Type=Miscellaneous discrepancy; Note=Contamination by an Alu repeat.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Alzforum; Note=APP mutations;
CC       URL="http://www.alzforum.org/mutations/search?genes%255B%255D=348";
CC   -!- WEB RESOURCE: Name=AD mutations;
CC       URL="http://www.molgen.ua.ac.be/ADmutations/";
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/app/";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Amyloid beta entry;
CC       URL="https://en.wikipedia.org/wiki/Amyloid_beta";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y00264; CAA68374.1; -; mRNA.
DR   EMBL; X13466; CAA31830.1; -; Genomic_DNA.
DR   EMBL; X13467; CAA31830.1; JOINED; Genomic_DNA.
DR   EMBL; X13468; CAA31830.1; JOINED; Genomic_DNA.
DR   EMBL; X13469; CAA31830.1; JOINED; Genomic_DNA.
DR   EMBL; X13470; CAA31830.1; JOINED; Genomic_DNA.
DR   EMBL; X13471; CAA31830.1; JOINED; Genomic_DNA.
DR   EMBL; X13472; CAA31830.1; JOINED; Genomic_DNA.
DR   EMBL; X13473; CAA31830.1; JOINED; Genomic_DNA.
DR   EMBL; X13474; CAA31830.1; JOINED; Genomic_DNA.
DR   EMBL; X13475; CAA31830.1; JOINED; Genomic_DNA.
DR   EMBL; X13476; CAA31830.1; JOINED; Genomic_DNA.
DR   EMBL; X13477; CAA31830.1; JOINED; Genomic_DNA.
DR   EMBL; X13478; CAA31830.1; JOINED; Genomic_DNA.
DR   EMBL; X13479; CAA31830.1; JOINED; Genomic_DNA.
DR   EMBL; X13487; CAA31830.1; JOINED; Genomic_DNA.
DR   EMBL; X13488; CAA31830.1; JOINED; Genomic_DNA.
DR   EMBL; X06989; CAA30050.1; -; mRNA.
DR   EMBL; M33112; AAB59502.1; -; Genomic_DNA.
DR   EMBL; M34862; AAB59502.1; JOINED; Genomic_DNA.
DR   EMBL; M34863; AAB59502.1; JOINED; Genomic_DNA.
DR   EMBL; M34864; AAB59502.1; JOINED; Genomic_DNA.
DR   EMBL; M34865; AAB59502.1; JOINED; Genomic_DNA.
DR   EMBL; M34866; AAB59502.1; JOINED; Genomic_DNA.
DR   EMBL; M34867; AAB59502.1; JOINED; Genomic_DNA.
DR   EMBL; M34868; AAB59502.1; JOINED; Genomic_DNA.
DR   EMBL; M34869; AAB59502.1; JOINED; Genomic_DNA.
DR   EMBL; M34870; AAB59502.1; JOINED; Genomic_DNA.
DR   EMBL; M34871; AAB59502.1; JOINED; Genomic_DNA.
DR   EMBL; M34872; AAB59502.1; JOINED; Genomic_DNA.
DR   EMBL; M34873; AAB59502.1; JOINED; Genomic_DNA.
DR   EMBL; M34874; AAB59502.1; JOINED; Genomic_DNA.
DR   EMBL; M34876; AAB59502.1; JOINED; Genomic_DNA.
DR   EMBL; M34877; AAB59502.1; JOINED; Genomic_DNA.
DR   EMBL; M34878; AAB59502.1; JOINED; Genomic_DNA.
DR   EMBL; M34879; AAB59502.1; JOINED; Genomic_DNA.
DR   EMBL; M34875; AAB59501.1; ALT_TERM; Genomic_DNA.
DR   EMBL; M34862; AAB59501.1; JOINED; Genomic_DNA.
DR   EMBL; M34863; AAB59501.1; JOINED; Genomic_DNA.
DR   EMBL; M34864; AAB59501.1; JOINED; Genomic_DNA.
DR   EMBL; M34865; AAB59501.1; JOINED; Genomic_DNA.
DR   EMBL; M34866; AAB59501.1; JOINED; Genomic_DNA.
DR   EMBL; M34867; AAB59501.1; JOINED; Genomic_DNA.
DR   EMBL; M34868; AAB59501.1; JOINED; Genomic_DNA.
DR   EMBL; M34869; AAB59501.1; JOINED; Genomic_DNA.
DR   EMBL; M34870; AAB59501.1; JOINED; Genomic_DNA.
DR   EMBL; M34871; AAB59501.1; JOINED; Genomic_DNA.
DR   EMBL; M34872; AAB59501.1; JOINED; Genomic_DNA.
DR   EMBL; M34873; AAB59501.1; JOINED; Genomic_DNA.
DR   EMBL; D87675; BAA22264.1; -; Genomic_DNA.
DR   EMBL; AK312326; BAG35248.1; -; mRNA.
DR   EMBL; AK295621; BAG58500.1; -; mRNA.
DR   EMBL; AY919674; AAW82435.1; -; Genomic_DNA.
DR   EMBL; AP001439; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP001440; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP001441; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP001442; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP001443; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471079; EAX09958.1; -; Genomic_DNA.
DR   EMBL; CH471079; EAX09959.1; -; Genomic_DNA.
DR   EMBL; CH471079; EAX09960.1; -; Genomic_DNA.
DR   EMBL; CH471079; EAX09961.1; -; Genomic_DNA.
DR   EMBL; CH471079; EAX09963.1; -; Genomic_DNA.
DR   EMBL; CH471079; EAX09965.1; -; Genomic_DNA.
DR   EMBL; BC004369; AAH04369.1; -; mRNA.
DR   EMBL; BC065529; AAH65529.1; -; mRNA.
DR   EMBL; M35675; AAA60163.1; ALT_SEQ; mRNA.
DR   EMBL; M24547; AAC13654.1; -; Genomic_DNA.
DR   EMBL; M24546; AAC13654.1; JOINED; Genomic_DNA.
DR   EMBL; M28373; AAA58727.1; ALT_SEQ; mRNA.
DR   EMBL; X06982; CAA30042.1; -; mRNA.
DR   EMBL; X06981; CAA30041.1; -; mRNA.
DR   EMBL; M18734; AAA51726.1; -; mRNA.
DR   EMBL; M29270; AAA51768.1; -; Genomic_DNA.
DR   EMBL; M29269; AAA51768.1; JOINED; Genomic_DNA.
DR   EMBL; AB066441; BAB71958.2; -; mRNA.
DR   EMBL; M15533; AAA35540.1; -; mRNA.
DR   EMBL; M15532; AAA51564.1; -; mRNA.
DR   EMBL; M37896; AAA51727.1; -; Genomic_DNA.
DR   EMBL; M37895; AAA51727.1; JOINED; Genomic_DNA.
DR   EMBL; S45136; AAB23646.1; -; Genomic_DNA.
DR   EMBL; S60317; AAC60601.2; -; Genomic_DNA.
DR   EMBL; AF282245; AAQ14327.1; -; mRNA.
DR   EMBL; S60721; AAB26263.2; -; mRNA.
DR   EMBL; S61380; AAB26264.2; -; mRNA.
DR   EMBL; S61383; AAB26265.2; -; mRNA.
DR   EMBL; M16765; AAA51722.1; -; mRNA.
DR   CCDS; CCDS13576.1; -. [P05067-1]
DR   CCDS; CCDS13577.1; -. [P05067-4]
DR   CCDS; CCDS33523.1; -. [P05067-8]
DR   CCDS; CCDS46638.1; -. [P05067-10]
DR   CCDS; CCDS56212.1; -. [P05067-11]
DR   CCDS; CCDS56213.1; -. [P05067-9]
DR   PIR; S01442; S01442.
DR   PIR; S02260; QRHUA4.
DR   RefSeq; NP_000475.1; NM_000484.3. [P05067-1]
DR   RefSeq; NP_001129488.1; NM_001136016.3. [P05067-11]
DR   RefSeq; NP_001129601.1; NM_001136129.2. [P05067-10]
DR   RefSeq; NP_001129602.1; NM_001136130.2.
DR   RefSeq; NP_001129603.1; NM_001136131.2.
DR   RefSeq; NP_001191230.1; NM_001204301.1. [P05067-9]
DR   RefSeq; NP_001191231.1; NM_001204302.1. [P05067-7]
DR   RefSeq; NP_001191232.1; NM_001204303.1. [P05067-3]
DR   RefSeq; NP_958816.1; NM_201413.2. [P05067-8]
DR   RefSeq; NP_958817.1; NM_201414.2. [P05067-4]
DR   UniGene; Hs.434980; -.
DR   PDB; 1AAP; X-ray; 1.50 A; A/B=287-344.
DR   PDB; 1AMB; NMR; -; A=672-699.
DR   PDB; 1AMC; NMR; -; A=672-699.
DR   PDB; 1AML; NMR; -; A=672-711.
DR   PDB; 1BA4; NMR; -; A=672-711.
DR   PDB; 1BA6; NMR; -; A=672-711.
DR   PDB; 1BJB; NMR; -; A=672-699.
DR   PDB; 1BJC; NMR; -; A=672-699.
DR   PDB; 1BRC; X-ray; 2.50 A; I=287-342.
DR   PDB; 1CA0; X-ray; 2.10 A; D/I=289-342.
DR   PDB; 1HZ3; NMR; -; A=681-706.
DR   PDB; 1IYT; NMR; -; A=672-713.
DR   PDB; 1MWP; X-ray; 1.80 A; A=28-123.
DR   PDB; 1OWT; NMR; -; A=124-189.
DR   PDB; 1QCM; NMR; -; A=696-706.
DR   PDB; 1QWP; NMR; -; A=696-706.
DR   PDB; 1QXC; NMR; -; A=696-706.
DR   PDB; 1QYT; NMR; -; A=696-706.
DR   PDB; 1TAW; X-ray; 1.80 A; B=287-344.
DR   PDB; 1TKN; NMR; -; A=460-569.
DR   PDB; 1UO7; Model; -; A=672-713.
DR   PDB; 1UO8; Model; -; A=672-713.
DR   PDB; 1UOA; Model; -; A=672-713.
DR   PDB; 1UOI; Model; -; A=672-713.
DR   PDB; 1X11; X-ray; 2.50 A; C/D=754-766.
DR   PDB; 1Z0Q; NMR; -; A=672-713.
DR   PDB; 1ZE7; NMR; -; A=672-687.
DR   PDB; 1ZE9; NMR; -; A=672-687.
DR   PDB; 1ZJD; X-ray; 2.60 A; B=289-344.
DR   PDB; 2BEG; NMR; -; A/B/C/D/E=672-713.
DR   PDB; 2BOM; Model; -; A/B=681-713.
DR   PDB; 2BP4; NMR; -; A=672-687.
DR   PDB; 2FJZ; X-ray; 1.61 A; A=133-189.
DR   PDB; 2FK1; X-ray; 1.60 A; A=133-189.
DR   PDB; 2FK2; X-ray; 1.65 A; A=133-189.
DR   PDB; 2FK3; X-ray; 2.40 A; A/B/C/D/E/F/G/H=133-189.
DR   PDB; 2FKL; X-ray; 2.50 A; A/B=124-189.
DR   PDB; 2FMA; X-ray; 0.85 A; A=133-189.
DR   PDB; 2G47; X-ray; 2.10 A; C/D=672-711.
DR   PDB; 2IPU; X-ray; 1.65 A; P/Q=672-679.
DR   PDB; 2LFM; NMR; -; A=672-711.
DR   PDB; 2LLM; NMR; -; A=686-726.
DR   PDB; 2LMN; NMR; -; A/B/C/D/E/F/G/H/I/J/K/L=672-711.
DR   PDB; 2LMO; NMR; -; A/B/C/D/E/F/G/H/I/J/K/L=672-711.
DR   PDB; 2LMP; NMR; -; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R=672-711.
DR   PDB; 2LMQ; NMR; -; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R=672-711.
DR   PDB; 2LNQ; NMR; -; A/B/C/D/E/F/G/H=672-711.
DR   PDB; 2LOH; NMR; -; A/B=686-726.
DR   PDB; 2LP1; NMR; -; A=671-770.
DR   PDB; 2LZ3; NMR; -; A/B=699-726.
DR   PDB; 2LZ4; NMR; -; A/B=699-726.
DR   PDB; 2M4J; NMR; -; A/B/C/D/E/F/G/H/I=672-711.
DR   PDB; 2M9R; NMR; -; A=672-711.
DR   PDB; 2M9S; NMR; -; A=672-711.
DR   PDB; 2MGT; NMR; -; A/B=672-687.
DR   PDB; 2MJ1; NMR; -; A=688-705.
DR   PDB; 2MPZ; NMR; -; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T/U/V/W/X/Y/Z/a=686-711.
DR   PDB; 2MVX; NMR; -; A/B/C/D/E/F/G/H/I/J=672-711.
DR   PDB; 2MXU; NMR; -; A/B/C/D/E/F/G/H/I/J/K/L=672-713.
DR   PDB; 2NAO; NMR; -; A/B/C/D/E/F=672-713.
DR   PDB; 2OTK; NMR; -; C=672-711.
DR   PDB; 2R0W; X-ray; 2.50 A; Q=672-679.
DR   PDB; 2WK3; X-ray; 2.59 A; C/D=672-713.
DR   PDB; 2Y29; X-ray; 2.30 A; A=687-692.
DR   PDB; 2Y2A; X-ray; 1.91 A; A=687-692.
DR   PDB; 2Y3J; X-ray; 1.99 A; A/B/C/D/E/F/G/H=701-706.
DR   PDB; 2Y3K; X-ray; 1.90 A; A/B/C/D/E/F/G/H=706-713.
DR   PDB; 2Y3L; X-ray; 2.10 A; A/B/C/G=706-713.
DR   PDB; 3AYU; X-ray; 2.00 A; B=586-595.
DR   PDB; 3BAE; X-ray; 1.59 A; A=672-699.
DR   PDB; 3BKJ; X-ray; 1.59 A; A=672-687.
DR   PDB; 3DXC; X-ray; 2.10 A; B/D=739-770.
DR   PDB; 3DXD; X-ray; 2.20 A; B/D=739-770.
DR   PDB; 3DXE; X-ray; 2.00 A; B/D=739-770.
DR   PDB; 3GCI; X-ray; 2.04 A; P=707-713.
DR   PDB; 3IFL; X-ray; 1.50 A; P=672-678.
DR   PDB; 3IFN; X-ray; 1.50 A; P=672-711.
DR   PDB; 3IFO; X-ray; 2.15 A; P/Q=672-678.
DR   PDB; 3IFP; X-ray; 2.95 A; P/Q/R/S=672-678.
DR   PDB; 3JQ5; X-ray; 2.03 A; B=672-679.
DR   PDB; 3JQL; X-ray; 1.20 A; B=687-692.
DR   PDB; 3JTI; X-ray; 1.80 A; B=699-706.
DR   PDB; 3KTM; X-ray; 2.70 A; A/B/C/D/E/F/G/H=18-190.
DR   PDB; 3L33; X-ray; 2.48 A; E/F/G/H=290-341.
DR   PDB; 3L81; X-ray; 1.60 A; B=761-767.
DR   PDB; 3MOQ; X-ray; 2.05 A; A/B/C/D=689-712.
DR   PDB; 3MXC; X-ray; 2.00 A; L=754-762.
DR   PDB; 3MXY; X-ray; 2.30 A; L=754-762.
DR   PDB; 3NYJ; X-ray; 3.20 A; A=365-567.
DR   PDB; 3NYL; X-ray; 2.80 A; A=365-570.
DR   PDB; 3OVJ; X-ray; 1.80 A; A/B/C/D=687-692.
DR   PDB; 3OW9; X-ray; 1.80 A; A/B=687-692.
DR   PDB; 3PZZ; X-ray; 1.29 A; A/B=700-705.
DR   PDB; 3Q2X; X-ray; 1.45 A; A=698-703.
DR   PDB; 3SV1; X-ray; 3.30 A; D/E/F=754-767.
DR   PDB; 3U0T; X-ray; 2.50 A; E/F=701-711.
DR   PDB; 3UMH; X-ray; 2.00 A; A=370-575.
DR   PDB; 3UMI; X-ray; 2.40 A; A=370-575.
DR   PDB; 3UMK; X-ray; 2.60 A; A=370-575.
DR   PDB; 4HIX; X-ray; 2.20 A; A=672-699.
DR   PDB; 4JFN; X-ray; 1.75 A; A=23-185.
DR   PDB; 4M1C; X-ray; 3.50 A; G/H=672-711.
DR   PDB; 4MDR; X-ray; 1.85 A; B=758-767.
DR   PDB; 4MVI; X-ray; 1.70 A; B=672-711.
DR   PDB; 4MVK; X-ray; 1.50 A; B=689-694.
DR   PDB; 4MVL; X-ray; 2.30 A; E/F/G/H=672-711.
DR   PDB; 4NGE; X-ray; 2.70 A; B/E=672-711.
DR   PDB; 4OJF; X-ray; 2.00 A; A=672-679.
DR   PDB; 4ONF; X-ray; 2.00 A; P=672-678.
DR   PDB; 4ONG; X-ray; 2.20 A; P=672-711.
DR   PDB; 4PQD; X-ray; 1.33 A; A=22-126.
DR   PDB; 4PWQ; X-ray; 1.40 A; A/B=18-190.
DR   PDB; 4XXD; X-ray; 2.41 A; C/F=683-699.
DR   PDB; 5AEF; EM; 5.00 A; A/B=686-713.
DR   PDB; 5AM8; X-ray; 1.90 A; P/Q/R/S=675-681.
DR   PDB; 5AMB; X-ray; 1.55 A; P/Q=706-713.
DR   PDB; 5BUO; X-ray; 2.31 A; A/B=370-710.
DR   PDB; 5C67; X-ray; 1.83 A; C/E=294-344.
DR   PDB; 5CSZ; X-ray; 1.80 A; D/E=672-682.
DR   PDB; 5HOW; X-ray; 2.29 A; A/B/C/D/E/F=688-705.
DR   PDB; 5HOX; X-ray; 1.90 A; A/B/C/D/E/F=688-707.
DR   PDB; 5HOY; X-ray; 2.29 A; A/B/C/D/E/F=688-707.
DR   PDB; 5KK3; NMR; -; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R=672-713.
DR   PDB; 5MY4; X-ray; 2.21 A; C=674-683.
DR   PDB; 5MYO; X-ray; 1.59 A; E=674-683.
DR   PDB; 5MYX; X-ray; 1.49 A; E/F=674-689.
DR   PDB; 5OQV; EM; 4.00 A; A/B/C/D/E/F/G/H/I=672-713.
DR   PDB; 5VZY; X-ray; 2.32 A; A=682-696.
DR   PDB; 5W3P; X-ray; 1.92 A; P=672-687.
DR   PDBsum; 1AAP; -.
DR   PDBsum; 1AMB; -.
DR   PDBsum; 1AMC; -.
DR   PDBsum; 1AML; -.
DR   PDBsum; 1BA4; -.
DR   PDBsum; 1BA6; -.
DR   PDBsum; 1BJB; -.
DR   PDBsum; 1BJC; -.
DR   PDBsum; 1BRC; -.
DR   PDBsum; 1CA0; -.
DR   PDBsum; 1HZ3; -.
DR   PDBsum; 1IYT; -.
DR   PDBsum; 1MWP; -.
DR   PDBsum; 1OWT; -.
DR   PDBsum; 1QCM; -.
DR   PDBsum; 1QWP; -.
DR   PDBsum; 1QXC; -.
DR   PDBsum; 1QYT; -.
DR   PDBsum; 1TAW; -.
DR   PDBsum; 1TKN; -.
DR   PDBsum; 1UO7; -.
DR   PDBsum; 1UO8; -.
DR   PDBsum; 1UOA; -.
DR   PDBsum; 1UOI; -.
DR   PDBsum; 1X11; -.
DR   PDBsum; 1Z0Q; -.
DR   PDBsum; 1ZE7; -.
DR   PDBsum; 1ZE9; -.
DR   PDBsum; 1ZJD; -.
DR   PDBsum; 2BEG; -.
DR   PDBsum; 2BOM; -.
DR   PDBsum; 2BP4; -.
DR   PDBsum; 2FJZ; -.
DR   PDBsum; 2FK1; -.
DR   PDBsum; 2FK2; -.
DR   PDBsum; 2FK3; -.
DR   PDBsum; 2FKL; -.
DR   PDBsum; 2FMA; -.
DR   PDBsum; 2G47; -.
DR   PDBsum; 2IPU; -.
DR   PDBsum; 2LFM; -.
DR   PDBsum; 2LLM; -.
DR   PDBsum; 2LMN; -.
DR   PDBsum; 2LMO; -.
DR   PDBsum; 2LMP; -.
DR   PDBsum; 2LMQ; -.
DR   PDBsum; 2LNQ; -.
DR   PDBsum; 2LOH; -.
DR   PDBsum; 2LP1; -.
DR   PDBsum; 2LZ3; -.
DR   PDBsum; 2LZ4; -.
DR   PDBsum; 2M4J; -.
DR   PDBsum; 2M9R; -.
DR   PDBsum; 2M9S; -.
DR   PDBsum; 2MGT; -.
DR   PDBsum; 2MJ1; -.
DR   PDBsum; 2MPZ; -.
DR   PDBsum; 2MVX; -.
DR   PDBsum; 2MXU; -.
DR   PDBsum; 2NAO; -.
DR   PDBsum; 2OTK; -.
DR   PDBsum; 2R0W; -.
DR   PDBsum; 2WK3; -.
DR   PDBsum; 2Y29; -.
DR   PDBsum; 2Y2A; -.
DR   PDBsum; 2Y3J; -.
DR   PDBsum; 2Y3K; -.
DR   PDBsum; 2Y3L; -.
DR   PDBsum; 3AYU; -.
DR   PDBsum; 3BAE; -.
DR   PDBsum; 3BKJ; -.
DR   PDBsum; 3DXC; -.
DR   PDBsum; 3DXD; -.
DR   PDBsum; 3DXE; -.
DR   PDBsum; 3GCI; -.
DR   PDBsum; 3IFL; -.
DR   PDBsum; 3IFN; -.
DR   PDBsum; 3IFO; -.
DR   PDBsum; 3IFP; -.
DR   PDBsum; 3JQ5; -.
DR   PDBsum; 3JQL; -.
DR   PDBsum; 3JTI; -.
DR   PDBsum; 3KTM; -.
DR   PDBsum; 3L33; -.
DR   PDBsum; 3L81; -.
DR   PDBsum; 3MOQ; -.
DR   PDBsum; 3MXC; -.
DR   PDBsum; 3MXY; -.
DR   PDBsum; 3NYJ; -.
DR   PDBsum; 3NYL; -.
DR   PDBsum; 3OVJ; -.
DR   PDBsum; 3OW9; -.
DR   PDBsum; 3PZZ; -.
DR   PDBsum; 3Q2X; -.
DR   PDBsum; 3SV1; -.
DR   PDBsum; 3U0T; -.
DR   PDBsum; 3UMH; -.
DR   PDBsum; 3UMI; -.
DR   PDBsum; 3UMK; -.
DR   PDBsum; 4HIX; -.
DR   PDBsum; 4JFN; -.
DR   PDBsum; 4M1C; -.
DR   PDBsum; 4MDR; -.
DR   PDBsum; 4MVI; -.
DR   PDBsum; 4MVK; -.
DR   PDBsum; 4MVL; -.
DR   PDBsum; 4NGE; -.
DR   PDBsum; 4OJF; -.
DR   PDBsum; 4ONF; -.
DR   PDBsum; 4ONG; -.
DR   PDBsum; 4PQD; -.
DR   PDBsum; 4PWQ; -.
DR   PDBsum; 4XXD; -.
DR   PDBsum; 5AEF; -.
DR   PDBsum; 5AM8; -.
DR   PDBsum; 5AMB; -.
DR   PDBsum; 5BUO; -.
DR   PDBsum; 5C67; -.
DR   PDBsum; 5CSZ; -.
DR   PDBsum; 5HOW; -.
DR   PDBsum; 5HOX; -.
DR   PDBsum; 5HOY; -.
DR   PDBsum; 5KK3; -.
DR   PDBsum; 5MY4; -.
DR   PDBsum; 5MYO; -.
DR   PDBsum; 5MYX; -.
DR   PDBsum; 5OQV; -.
DR   PDBsum; 5VZY; -.
DR   PDBsum; 5W3P; -.
DR   ProteinModelPortal; P05067; -.
DR   SMR; P05067; -.
DR   BioGrid; 106848; 2112.
DR   CORUM; P05067; -.
DR   DIP; DIP-574N; -.
DR   ELM; P05067; -.
DR   IntAct; P05067; 163.
DR   MINT; MINT-150767; -.
DR   STRING; 9606.ENSP00000284981; -.
DR   BindingDB; P05067; -.
DR   ChEMBL; CHEMBL2487; -.
DR   DrugBank; DB05150; CAD106.
DR   DrugBank; DB09148; Florbetaben (18F).
DR   DrugBank; DB09149; Florbetapir (18F).
DR   DrugBank; DB09151; Flutemetamol (18F).
DR   DrugBank; DB02235; L-methionine (R)-S-oxide.
DR   DrugBank; DB05846; Mito-4509.
DR   MEROPS; I02.015; -.
DR   TCDB; 1.C.50.1.2; the amyloid Beta-protein peptide (aBetapp) family.
DR   iPTMnet; P05067; -.
DR   PhosphoSitePlus; P05067; -.
DR   SwissPalm; P05067; -.
DR   UniCarbKB; P05067; -.
DR   BioMuta; APP; -.
DR   DMDM; 112927; -.
DR   SWISS-2DPAGE; P05067; -.
DR   EPD; P05067; -.
DR   MaxQB; P05067; -.
DR   PaxDb; P05067; -.
DR   PeptideAtlas; P05067; -.
DR   PRIDE; P05067; -.
DR   DNASU; 351; -.
DR   Ensembl; ENST00000346798; ENSP00000284981; ENSG00000142192. [P05067-1]
DR   Ensembl; ENST00000348990; ENSP00000345463; ENSG00000142192. [P05067-4]
DR   Ensembl; ENST00000354192; ENSP00000346129; ENSG00000142192. [P05067-10]
DR   Ensembl; ENST00000357903; ENSP00000350578; ENSG00000142192. [P05067-8]
DR   Ensembl; ENST00000358918; ENSP00000351796; ENSG00000142192. [P05067-9]
DR   Ensembl; ENST00000440126; ENSP00000387483; ENSG00000142192. [P05067-11]
DR   GeneID; 351; -.
DR   KEGG; hsa:351; -.
DR   UCSC; uc002ylz.4; human. [P05067-1]
DR   CTD; 351; -.
DR   DisGeNET; 351; -.
DR   EuPathDB; HostDB:ENSG00000142192.20; -.
DR   GeneCards; APP; -.
DR   GeneReviews; APP; -.
DR   HGNC; HGNC:620; APP.
DR   HPA; CAB000157; -.
DR   HPA; HPA001462; -.
DR   MalaCards; APP; -.
DR   MIM; 104300; phenotype.
DR   MIM; 104760; gene.
DR   MIM; 605714; phenotype.
DR   neXtProt; NX_P05067; -.
DR   OpenTargets; ENSG00000142192; -.
DR   Orphanet; 1020; Early-onset autosomal dominant Alzheimer disease.
DR   Orphanet; 324723; Hereditary cerebral hemorrhage with amyloidosis, Arctic type.
DR   Orphanet; 100006; Hereditary cerebral hemorrhage with amyloidosis, Dutch type.
DR   Orphanet; 324718; Hereditary cerebral hemorrhage with amyloidosis, Flemish type.
DR   Orphanet; 324708; Hereditary cerebral hemorrhage with amyloidosis, Iowa type.
DR   Orphanet; 324713; Hereditary cerebral hemorrhage with amyloidosis, Italian type.
DR   Orphanet; 324703; Hereditary cerebral hemorrhage with amyloidosis, Piedmont type.
DR   PharmGKB; PA24910; -.
DR   eggNOG; KOG3540; Eukaryota.
DR   eggNOG; ENOG410ZW2A; LUCA.
DR   GeneTree; ENSGT00530000063252; -.
DR   HOGENOM; HOG000232190; -.
DR   HOVERGEN; HBG000051; -.
DR   InParanoid; P05067; -.
DR   KO; K04520; -.
DR   OMA; REVCSEQ; -.
DR   OrthoDB; EOG091G0UW4; -.
DR   PhylomeDB; P05067; -.
DR   TreeFam; TF317274; -.
DR   BioCyc; MetaCyc:ENSG00000142192-MONOMER; -.
DR   Reactome; R-HSA-114608; Platelet degranulation.
DR   Reactome; R-HSA-1810476; RIP-mediated NFkB activation via ZBP1.
DR   Reactome; R-HSA-3000178; ECM proteoglycans.
DR   Reactome; R-HSA-3134963; DEx/H-box helicases activate type I IFN and inflammatory cytokines production.
DR   Reactome; R-HSA-381426; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs).
DR   Reactome; R-HSA-416476; G alpha (q) signalling events.
DR   Reactome; R-HSA-418594; G alpha (i) signalling events.
DR   Reactome; R-HSA-432720; Lysosome Vesicle Biogenesis.
DR   Reactome; R-HSA-444473; Formyl peptide receptors bind formyl peptides and many other ligands.
DR   Reactome; R-HSA-445989; TAK1 activates NFkB by phosphorylation and activation of IKKs complex.
DR   Reactome; R-HSA-844456; The NLRP3 inflammasome.
DR   Reactome; R-HSA-879415; Advanced glycosylation endproduct receptor signaling.
DR   Reactome; R-HSA-8862803; Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models.
DR   Reactome; R-HSA-8957275; Post-translational protein phosphorylation.
DR   Reactome; R-HSA-933542; TRAF6 mediated NF-kB activation.
DR   Reactome; R-HSA-977225; Amyloid fiber formation.
DR   SABIO-RK; P05067; -.
DR   SIGNOR; P05067; -.
DR   ChiTaRS; APP; human.
DR   EvolutionaryTrace; P05067; -.
DR   GeneWiki; Amyloid_precursor_protein; -.
DR   GenomeRNAi; 351; -.
DR   PMAP-CutDB; P05067; -.
DR   PRO; PR:P05067; -.
DR   Proteomes; UP000005640; Chromosome 21.
DR   Bgee; ENSG00000142192; -.
DR   ExpressionAtlas; P05067; baseline and differential.
DR   Genevisible; P05067; HS.
DR   GO; GO:0106003; C:amyloid-beta complex; IMP:ARUK-UCL.
DR   GO; GO:0045177; C:apical part of cell; IEA:Ensembl.
DR   GO; GO:0097449; C:astrocyte projection; IEA:Ensembl.
DR   GO; GO:0030424; C:axon; ISS:UniProtKB.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0005911; C:cell-cell junction; IEA:Ensembl.
DR   GO; GO:0035253; C:ciliary rootlet; IEA:Ensembl.
DR   GO; GO:0005905; C:clathrin-coated pit; IEA:UniProtKB-SubCell.
DR   GO; GO:0030134; C:COPII-coated ER to Golgi transport vesicle; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IDA:ARUK-UCL.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0043198; C:dendritic shaft; IDA:MGI.
DR   GO; GO:0043197; C:dendritic spine; IDA:MGI.
DR   GO; GO:0005769; C:early endosome; IDA:ARUK-UCL.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome.
DR   GO; GO:0005768; C:endosome; IDA:UniProtKB.
DR   GO; GO:0031904; C:endosome lumen; TAS:Reactome.
DR   GO; GO:0070381; C:endosome to plasma membrane transport vesicle; IDA:ARUK-UCL.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:ARUK-UCL.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB.
DR   GO; GO:0005796; C:Golgi lumen; TAS:Reactome.
DR   GO; GO:1990812; C:growth cone filopodium; IEA:Ensembl.
DR   GO; GO:1990761; C:growth cone lamellipodium; IEA:Ensembl.
DR   GO; GO:0034364; C:high-density lipoprotein particle; IDA:ARUK-UCL.
DR   GO; GO:0016021; C:integral component of membrane; ISS:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0034363; C:intermediate-density lipoprotein particle; IDA:ARUK-UCL.
DR   GO; GO:0005622; C:intracellular; IDA:ARUK-UCL.
DR   GO; GO:1990777; C:lipoprotein particle; IDA:ARUK-UCL.
DR   GO; GO:0044304; C:main axon; IEA:Ensembl.
DR   GO; GO:0016020; C:membrane; IDA:ARUK-UCL.
DR   GO; GO:0045121; C:membrane raft; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0031594; C:neuromuscular junction; IEA:Ensembl.
DR   GO; GO:0005641; C:nuclear envelope lumen; IDA:Alzheimers_University_of_Toronto.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:ARUK-UCL.
DR   GO; GO:0031093; C:platelet alpha granule lumen; TAS:Reactome.
DR   GO; GO:0043234; C:protein complex; IDA:ARUK-UCL.
DR   GO; GO:0043235; C:receptor complex; IDA:MGI.
DR   GO; GO:0005791; C:rough endoplasmic reticulum; IEA:Ensembl.
DR   GO; GO:0005790; C:smooth endoplasmic reticulum; IEA:GOC.
DR   GO; GO:0051233; C:spindle midzone; IEA:Ensembl.
DR   GO; GO:0045202; C:synapse; IDA:MGI.
DR   GO; GO:0043195; C:terminal bouton; IEA:Ensembl.
DR   GO; GO:0032588; C:trans-Golgi network membrane; TAS:Reactome.
DR   GO; GO:0030549; F:acetylcholine receptor activator activity; TAS:ARUK-UCL.
DR   GO; GO:0033130; F:acetylcholine receptor binding; IPI:UniProtKB.
DR   GO; GO:0097645; F:amylin binding; TAS:ARUK-UCL.
DR   GO; GO:0034185; F:apolipoprotein binding; IPI:ARUK-UCL.
DR   GO; GO:0051087; F:chaperone binding; IPI:ARUK-UCL.
DR   GO; GO:0042056; F:chemoattractant activity; IGI:ARUK-UCL.
DR   GO; GO:0003677; F:DNA binding; ISS:UniProtKB.
DR   GO; GO:0019899; F:enzyme binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0046875; F:ephrin receptor binding; IPI:ARUK-UCL.
DR   GO; GO:0005109; F:frizzled binding; IPI:ARUK-UCL.
DR   GO; GO:0070851; F:growth factor receptor binding; IEA:Ensembl.
DR   GO; GO:1904399; F:heparan sulfate binding; TAS:ARUK-UCL.
DR   GO; GO:0043395; F:heparan sulfate proteoglycan binding; IMP:ARUK-UCL.
DR   GO; GO:0008201; F:heparin binding; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0005158; F:insulin receptor binding; IPI:ARUK-UCL.
DR   GO; GO:0005178; F:integrin binding; IDA:ARUK-UCL.
DR   GO; GO:0050750; F:low-density lipoprotein particle receptor binding; ISS:ARUK-UCL.
DR   GO; GO:0016504; F:peptidase activator activity; IEA:Ensembl.
DR   GO; GO:0046983; F:protein dimerization activity; IDA:ARUK-UCL.
DR   GO; GO:0046982; F:protein heterodimerization activity; IPI:ARUK-UCL.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:ARUK-UCL.
DR   GO; GO:0051425; F:PTB domain binding; IPI:BHF-UCL.
DR   GO; GO:0030546; F:receptor activator activity; IDA:ARUK-UCL.
DR   GO; GO:0005102; F:receptor binding; IPI:ARUK-UCL.
DR   GO; GO:0004867; F:serine-type endopeptidase inhibitor activity; IDA:UniProtKB.
DR   GO; GO:0046914; F:transition metal ion binding; IEA:InterPro.
DR   GO; GO:0000187; P:activation of MAPK activity; ISS:ARUK-UCL.
DR   GO; GO:0000185; P:activation of MAPKKK activity; IGI:ARUK-UCL.
DR   GO; GO:0008344; P:adult locomotory behavior; ISS:UniProtKB.
DR   GO; GO:1990000; P:amyloid fibril formation; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0019731; P:antibacterial humoral response; IDA:UniProtKB.
DR   GO; GO:0019732; P:antifungal humoral response; IMP:UniProtKB.
DR   GO; GO:0061844; P:antimicrobial humoral immune response mediated by antimicrobial peptide; IMP:UniProtKB.
DR   GO; GO:0008306; P:associative learning; IGI:ARUK-UCL.
DR   GO; GO:0048143; P:astrocyte activation; IGI:ARUK-UCL.
DR   GO; GO:0002265; P:astrocyte activation involved in immune response; IGI:ARUK-UCL.
DR   GO; GO:0008088; P:axo-dendritic transport; ISS:UniProtKB.
DR   GO; GO:0016199; P:axon midline choice point recognition; ISS:UniProtKB.
DR   GO; GO:0007409; P:axonogenesis; ISS:UniProtKB.
DR   GO; GO:0019722; P:calcium-mediated signaling; IDA:ARUK-UCL.
DR   GO; GO:0007155; P:cell adhesion; IEA:UniProtKB-KW.
DR   GO; GO:0006878; P:cellular copper ion homeostasis; ISS:UniProtKB.
DR   GO; GO:0009987; P:cellular process; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0044267; P:cellular protein metabolic process; TAS:Reactome.
DR   GO; GO:1904646; P:cellular response to amyloid-beta; IGI:ARUK-UCL.
DR   GO; GO:0071320; P:cellular response to cAMP; IEA:Ensembl.
DR   GO; GO:1990090; P:cellular response to nerve growth factor stimulus; IEA:Ensembl.
DR   GO; GO:0071874; P:cellular response to norepinephrine stimulus; IEA:Ensembl.
DR   GO; GO:0008203; P:cholesterol metabolic process; IEA:Ensembl.
DR   GO; GO:0048669; P:collateral sprouting in absence of injury; ISS:UniProtKB.
DR   GO; GO:0050829; P:defense response to Gram-negative bacterium; IDA:UniProtKB.
DR   GO; GO:0050830; P:defense response to Gram-positive bacterium; IDA:UniProtKB.
DR   GO; GO:0016358; P:dendrite development; ISS:UniProtKB.
DR   GO; GO:0006897; P:endocytosis; ISS:UniProtKB.
DR   GO; GO:0030198; P:extracellular matrix organization; ISS:UniProtKB.
DR   GO; GO:0030900; P:forebrain development; IEA:Ensembl.
DR   GO; GO:0007186; P:G-protein coupled receptor signaling pathway; IDA:ARUK-UCL.
DR   GO; GO:0045087; P:innate immune response; IMP:UniProtKB.
DR   GO; GO:0035235; P:ionotropic glutamate receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0007612; P:learning; IMP:ARUK-UCL.
DR   GO; GO:0007611; P:learning or memory; IMP:ARUK-UCL.
DR   GO; GO:0042157; P:lipoprotein metabolic process; IC:ARUK-UCL.
DR   GO; GO:0007626; P:locomotory behavior; ISS:UniProtKB.
DR   GO; GO:0007617; P:mating behavior; ISS:UniProtKB.
DR   GO; GO:0007613; P:memory; IGI:ARUK-UCL.
DR   GO; GO:0014005; P:microglia development; IGI:ARUK-UCL.
DR   GO; GO:0001774; P:microglial cell activation; IGI:ARUK-UCL.
DR   GO; GO:0090647; P:modulation of age-related behavioral decline; IMP:ARUK-UCL.
DR   GO; GO:0098815; P:modulation of excitatory postsynaptic potential; IGI:ARUK-UCL.
DR   GO; GO:0006378; P:mRNA polyadenylation; ISS:UniProtKB.
DR   GO; GO:0007194; P:negative regulation of adenylate cyclase activity; IGI:ARUK-UCL.
DR   GO; GO:0090090; P:negative regulation of canonical Wnt signaling pathway; IDA:ARUK-UCL.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB.
DR   GO; GO:0010629; P:negative regulation of gene expression; IGI:ARUK-UCL.
DR   GO; GO:1900272; P:negative regulation of long-term synaptic potentiation; IGI:ARUK-UCL.
DR   GO; GO:0010823; P:negative regulation of mitochondrion organization; TAS:ARUK-UCL.
DR   GO; GO:1901215; P:negative regulation of neuron death; IDA:ARUK-UCL.
DR   GO; GO:0045665; P:negative regulation of neuron differentiation; IEA:Ensembl.
DR   GO; GO:1900181; P:negative regulation of protein localization to nucleus; IGI:ARUK-UCL.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IGI:ARUK-UCL.
DR   GO; GO:0050885; P:neuromuscular process controlling balance; IEA:Ensembl.
DR   GO; GO:0051402; P:neuron apoptotic process; IMP:UniProtKB.
DR   GO; GO:0031175; P:neuron projection development; ISS:UniProtKB.
DR   GO; GO:1990535; P:neuron projection maintenance; IGI:ARUK-UCL.
DR   GO; GO:0016322; P:neuron remodeling; ISS:UniProtKB.
DR   GO; GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0002576; P:platelet degranulation; TAS:Reactome.
DR   GO; GO:0061903; P:positive regulation of 1-phosphatidylinositol-3-kinase activity; IGI:ARUK-UCL.
DR   GO; GO:1905908; P:positive regulation of amyloid fibril formation; IMP:ARUK-UCL.
DR   GO; GO:1902004; P:positive regulation of amyloid-beta formation; IGI:ARUK-UCL.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IDA:ARUK-UCL.
DR   GO; GO:0061890; P:positive regulation of astrocyte activation; IGI:ARUK-UCL.
DR   GO; GO:0030816; P:positive regulation of cAMP metabolic process; IGI:ARUK-UCL.
DR   GO; GO:0050867; P:positive regulation of cell activation; NAS:ARUK-UCL.
DR   GO; GO:1905893; P:positive regulation of cellular response to thapsigargin; IDA:ARUK-UCL.
DR   GO; GO:1905896; P:positive regulation of cellular response to tunicamycin; IDA:ARUK-UCL.
DR   GO; GO:0043280; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:ARUK-UCL.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; NAS:ARUK-UCL.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IGI:ARUK-UCL.
DR   GO; GO:2000463; P:positive regulation of excitatory postsynaptic potential; IGI:ARUK-UCL.
DR   GO; GO:1904022; P:positive regulation of G-protein coupled receptor internalization; IDA:ARUK-UCL.
DR   GO; GO:0045745; P:positive regulation of G-protein coupled receptor protein signaling pathway; IDA:ARUK-UCL.
DR   GO; GO:0010971; P:positive regulation of G2/M transition of mitotic cell cycle; IEA:Ensembl.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:ARUK-UCL.
DR   GO; GO:0046330; P:positive regulation of JNK cascade; IGI:ARUK-UCL.
DR   GO; GO:1900273; P:positive regulation of long-term synaptic potentiation; IGI:ARUK-UCL.
DR   GO; GO:0043410; P:positive regulation of MAPK cascade; IGI:ARUK-UCL.
DR   GO; GO:0051044; P:positive regulation of membrane protein ectodomain proteolysis; IDA:ARUK-UCL.
DR   GO; GO:1903980; P:positive regulation of microglial cell activation; IGI:ARUK-UCL.
DR   GO; GO:0045931; P:positive regulation of mitotic cell cycle; ISS:UniProtKB.
DR   GO; GO:0090026; P:positive regulation of monocyte chemotaxis; IDA:ARUK-UCL.
DR   GO; GO:1901216; P:positive regulation of neuron death; IDA:ARUK-UCL.
DR   GO; GO:0045666; P:positive regulation of neuron differentiation; IGI:ARUK-UCL.
DR   GO; GO:0042346; P:positive regulation of NF-kappaB import into nucleus; IGI:ARUK-UCL.
DR   GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IGI:ARUK-UCL.
DR   GO; GO:1901224; P:positive regulation of NIK/NF-kappaB signaling; IGI:ARUK-UCL.
DR   GO; GO:0045429; P:positive regulation of nitric oxide biosynthetic process; IGI:ARUK-UCL.
DR   GO; GO:1903223; P:positive regulation of oxidative stress-induced neuron death; IGI:ARUK-UCL.
DR   GO; GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IMP:ARUK-UCL.
DR   GO; GO:0010800; P:positive regulation of peptidyl-threonine phosphorylation; IMP:ARUK-UCL.
DR   GO; GO:0032092; P:positive regulation of protein binding; IDA:ARUK-UCL.
DR   GO; GO:1904591; P:positive regulation of protein import; IDA:ARUK-UCL.
DR   GO; GO:0010739; P:positive regulation of protein kinase A signaling; NAS:ARUK-UCL.
DR   GO; GO:0051897; P:positive regulation of protein kinase B signaling; NAS:ARUK-UCL.
DR   GO; GO:0051247; P:positive regulation of protein metabolic process; IMP:ARUK-UCL.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; IDA:ARUK-UCL.
DR   GO; GO:0061098; P:positive regulation of protein tyrosine kinase activity; IGI:ARUK-UCL.
DR   GO; GO:1900122; P:positive regulation of receptor binding; IDA:ARUK-UCL.
DR   GO; GO:1905898; P:positive regulation of response to endoplasmic reticulum stress; IDA:ARUK-UCL.
DR   GO; GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IGI:ARUK-UCL.
DR   GO; GO:0032930; P:positive regulation of superoxide anion generation; IGI:ARUK-UCL.
DR   GO; GO:2000406; P:positive regulation of T cell migration; IMP:ARUK-UCL.
DR   GO; GO:1902949; P:positive regulation of tau-protein kinase activity; IGI:ARUK-UCL.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IGI:ARUK-UCL.
DR   GO; GO:0043687; P:post-translational protein modification; TAS:Reactome.
DR   GO; GO:0051260; P:protein homooligomerization; IDA:ARUK-UCL.
DR   GO; GO:0006468; P:protein phosphorylation; ISS:UniProtKB.
DR   GO; GO:0051262; P:protein tetramerization; IMP:ARUK-UCL.
DR   GO; GO:0070206; P:protein trimerization; IMP:ARUK-UCL.
DR   GO; GO:1903048; P:regulation of acetylcholine-gated cation channel activity; IGI:ARUK-UCL.
DR   GO; GO:1905906; P:regulation of amyloid fibril formation; IGI:ARUK-UCL.
DR   GO; GO:1902950; P:regulation of dendritic spine maintenance; IGI:ARUK-UCL.
DR   GO; GO:0007176; P:regulation of epidermal growth factor-activated receptor activity; ISS:UniProtKB.
DR   GO; GO:0048169; P:regulation of long-term neuronal synaptic plasticity; IGI:ARUK-UCL.
DR   GO; GO:0040014; P:regulation of multicellular organism growth; ISS:UniProtKB.
DR   GO; GO:2000310; P:regulation of NMDA receptor activity; TAS:ARUK-UCL.
DR   GO; GO:1905945; P:regulation of response to calcium ion; ISS:ARUK-UCL.
DR   GO; GO:0050803; P:regulation of synapse structure or activity; ISS:UniProtKB.
DR   GO; GO:0034121; P:regulation of toll-like receptor signaling pathway; IGI:ARUK-UCL.
DR   GO; GO:0006417; P:regulation of translation; ISS:UniProtKB.
DR   GO; GO:0010288; P:response to lead ion; IEA:Ensembl.
DR   GO; GO:0006979; P:response to oxidative stress; IEA:Ensembl.
DR   GO; GO:0001878; P:response to yeast; IMP:UniProtKB.
DR   GO; GO:0051563; P:smooth endoplasmic reticulum calcium ion homeostasis; IEA:Ensembl.
DR   GO; GO:0001967; P:suckling behavior; IEA:Ensembl.
DR   GO; GO:0050808; P:synapse organization; IGI:ARUK-UCL.
DR   GO; GO:0051124; P:synaptic growth at neuromuscular junction; IEA:Ensembl.
DR   GO; GO:0032640; P:tumor necrosis factor production; IGI:ARUK-UCL.
DR   GO; GO:0008542; P:visual learning; ISS:UniProtKB.
DR   CDD; cd00109; KU; 1.
DR   Gene3D; 3.30.1490.140; -; 1.
DR   Gene3D; 3.90.570.10; -; 1.
DR   Gene3D; 4.10.230.10; -; 1.
DR   Gene3D; 4.10.410.10; -; 1.
DR   InterPro; IPR036669; Amyloid_Cu-bd_sf.
DR   InterPro; IPR008155; Amyloid_glyco.
DR   InterPro; IPR013803; Amyloid_glyco_Abeta.
DR   InterPro; IPR037071; Amyloid_glyco_Abeta_sf.
DR   InterPro; IPR011178; Amyloid_glyco_Cu-bd.
DR   InterPro; IPR024329; Amyloid_glyco_E2_domain.
DR   InterPro; IPR008154; Amyloid_glyco_extra.
DR   InterPro; IPR019744; Amyloid_glyco_extracell_CS.
DR   InterPro; IPR015849; Amyloid_glyco_heparin-bd.
DR   InterPro; IPR036454; Amyloid_glyco_heparin-bd_sf.
DR   InterPro; IPR019745; Amyloid_glyco_intracell_CS.
DR   InterPro; IPR028866; APP.
DR   InterPro; IPR019543; APP_amyloid_C.
DR   InterPro; IPR036176; E2_sf.
DR   InterPro; IPR002223; Kunitz_BPTI.
DR   InterPro; IPR036880; Kunitz_BPTI_sf.
DR   InterPro; IPR020901; Prtase_inh_Kunz-CS.
DR   PANTHER; PTHR23103; PTHR23103; 1.
DR   PANTHER; PTHR23103:SF7; PTHR23103:SF7; 1.
DR   Pfam; PF10515; APP_amyloid; 1.
DR   Pfam; PF12924; APP_Cu_bd; 1.
DR   Pfam; PF12925; APP_E2; 1.
DR   Pfam; PF02177; APP_N; 1.
DR   Pfam; PF03494; Beta-APP; 1.
DR   Pfam; PF00014; Kunitz_BPTI; 1.
DR   PRINTS; PR00203; AMYLOIDA4.
DR   PRINTS; PR00759; BASICPTASE.
DR   PRINTS; PR00204; BETAAMYLOID.
DR   SMART; SM00006; A4_EXTRA; 1.
DR   SMART; SM00131; KU; 1.
DR   SUPFAM; SSF109843; SSF109843; 1.
DR   SUPFAM; SSF56491; SSF56491; 1.
DR   SUPFAM; SSF57362; SSF57362; 1.
DR   SUPFAM; SSF89811; SSF89811; 1.
DR   PROSITE; PS00319; A4_EXTRA; 1.
DR   PROSITE; PS00320; A4_INTRA; 1.
DR   PROSITE; PS00280; BPTI_KUNITZ_1; 1.
DR   PROSITE; PS50279; BPTI_KUNITZ_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Alzheimer disease; Amyloid;
KW   Amyloidosis; Apoptosis; Cell adhesion; Coated pit; Complete proteome;
KW   Copper; Direct protein sequencing; Disease mutation; Disulfide bond;
KW   Endocytosis; Glycoprotein; Heparin-binding; Iron; Isopeptide bond;
KW   Membrane; Metal-binding; Neurodegeneration; Notch signaling pathway;
KW   Oxidation; Phosphoprotein; Polymorphism; Protease inhibitor;
KW   Proteoglycan; Reference proteome; Serine protease inhibitor; Signal;
KW   Transmembrane; Transmembrane helix; Ubl conjugation; Zinc.
FT   SIGNAL        1     17       {ECO:0000269|PubMed:12665801,
FT                                ECO:0000269|PubMed:2900137,
FT                                ECO:0000269|PubMed:3597385}.
FT   CHAIN        18    770       Amyloid-beta A4 protein.
FT                                /FTId=PRO_0000000088.
FT   CHAIN        18    687       Soluble APP-alpha.
FT                                /FTId=PRO_0000000089.
FT   CHAIN        18    671       Soluble APP-beta.
FT                                /FTId=PRO_0000000090.
FT   CHAIN        18    286       N-APP.
FT                                /FTId=PRO_0000381966.
FT   CHAIN       672    770       C99.
FT                                /FTId=PRO_0000000091.
FT   CHAIN       672    713       Amyloid-beta protein 42.
FT                                /FTId=PRO_0000000092.
FT   CHAIN       672    711       Amyloid-beta protein 40.
FT                                /FTId=PRO_0000000093.
FT   CHAIN       688    770       C83.
FT                                /FTId=PRO_0000000094.
FT   PEPTIDE     688    713       P3(42).
FT                                /FTId=PRO_0000000095.
FT   PEPTIDE     688    711       P3(40).
FT                                /FTId=PRO_0000000096.
FT   CHAIN       691    770       C80.
FT                                /FTId=PRO_0000384574.
FT   CHAIN       712    770       Gamma-secretase C-terminal fragment 59.
FT                                /FTId=PRO_0000000097.
FT   CHAIN       714    770       Gamma-secretase C-terminal fragment 57.
FT                                /FTId=PRO_0000000098.
FT   CHAIN       721    770       Gamma-secretase C-terminal fragment 50.
FT                                {ECO:0000250}.
FT                                /FTId=PRO_0000000099.
FT   CHAIN       740    770       C31.
FT                                /FTId=PRO_0000000100.
FT   TOPO_DOM     18    699       Extracellular. {ECO:0000255}.
FT   TRANSMEM    700    723       Helical. {ECO:0000255}.
FT   TOPO_DOM    724    770       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      291    341       BPTI/Kunitz inhibitor.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00031}.
FT   REGION       96    110       Heparin-binding.
FT   REGION      181    188       Zinc-binding.
FT   REGION      391    423       Heparin-binding.
FT   REGION      491    522       Heparin-binding.
FT   REGION      523    540       Collagen-binding.
FT   REGION      732    751       Interaction with G(o)-alpha.
FT   MOTIF       724    734       Basolateral sorting signal.
FT   MOTIF       759    762       NPXY motif; contains endocytosis signal.
FT   COMPBIAS    230    260       Asp/Glu-rich (acidic).
FT   COMPBIAS    274    280       Poly-Thr.
FT   METAL       147    147       Copper 1.
FT   METAL       151    151       Copper 1.
FT   METAL       168    168       Copper 1.
FT   METAL       677    677       Copper or zinc 2.
FT   METAL       681    681       Copper or zinc 2. {ECO:0000305}.
FT   METAL       684    684       Copper or zinc 2.
FT   METAL       685    685       Copper or zinc 2.
FT   SITE        144    144       Required for Cu(2+) reduction.
FT   SITE        301    302       Reactive bond.
FT   SITE        671    672       Cleavage; by beta-secretase.
FT   SITE        672    673       Cleavage; by caspase-6; when associated
FT                                with variant 670-N-L-671.
FT   SITE        687    688       Cleavage; by alpha-secretase.
FT   SITE        690    691       Cleavage; by theta-secretase.
FT                                {ECO:0000269|PubMed:16816112}.
FT   SITE        704    704       Implicated in free radical propagation.
FT                                {ECO:0000250}.
FT   SITE        706    706       Susceptible to oxidation.
FT                                {ECO:0000269|PubMed:10535332}.
FT   SITE        711    712       Cleavage; by gamma-secretase; site 1.
FT   SITE        713    714       Cleavage; by gamma-secretase; site 2.
FT   SITE        720    721       Cleavage; by gamma-secretase; site 3.
FT   SITE        739    740       Cleavage; by caspase-6, caspase-8 or
FT                                caspase-9.
FT   MOD_RES     198    198       Phosphoserine; by CK2.
FT                                {ECO:0000269|PubMed:8999878}.
FT   MOD_RES     206    206       Phosphoserine; by CK1.
FT                                {ECO:0000269|PubMed:8999878}.
FT   MOD_RES     441    441       Phosphoserine; by FAM20C.
FT                                {ECO:0000269|PubMed:26091039}.
FT   MOD_RES     497    497       Phosphotyrosine.
FT                                {ECO:0000269|PubMed:26091039}.
FT   MOD_RES     729    729       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P08592}.
FT   MOD_RES     730    730       Phosphoserine; by APP-kinase I.
FT                                {ECO:0000250|UniProtKB:P08592}.
FT   MOD_RES     743    743       Phosphothreonine; by CDK5 and MAPK10.
FT                                {ECO:0000244|PubMed:24275569,
FT                                ECO:0000269|PubMed:8131745}.
FT   MOD_RES     757    757       Phosphotyrosine.
FT                                {ECO:0000269|PubMed:11877420}.
FT   CARBOHYD    542    542       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:16335952}.
FT   CARBOHYD    571    571       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000305}.
FT   CARBOHYD    633    633       O-linked (GalNAc...) threonine; partial.
FT                                {ECO:0000269|PubMed:21712440,
FT                                ECO:0000269|PubMed:22576872}.
FT   CARBOHYD    651    651       O-linked (GalNAc...) threonine; partial.
FT                                {ECO:0000269|PubMed:21712440,
FT                                ECO:0000269|PubMed:22576872}.
FT   CARBOHYD    652    652       O-linked (GalNAc...) threonine; partial.
FT                                {ECO:0000269|PubMed:21712440,
FT                                ECO:0000269|PubMed:22576872}.
FT   CARBOHYD    656    656       O-linked (Xyl...) (chondroitin sulfate)
FT                                serine; in L-APP isoforms.
FT                                {ECO:0000269|PubMed:21712440}.
FT   CARBOHYD    659    659       O-linked (HexNAc...) threonine; partial.
FT                                {ECO:0000269|PubMed:22576872}.
FT   CARBOHYD    663    663       O-linked (GalNAc...) threonine; partial.
FT                                {ECO:0000269|PubMed:22576872,
FT                                ECO:0000305|PubMed:21712440}.
FT   CARBOHYD    667    667       O-linked (GalNAc...) serine; partial.
FT                                {ECO:0000269|PubMed:22576872,
FT                                ECO:0000305|PubMed:21712440}.
FT   CARBOHYD    681    681       O-linked (HexNAc...) tyrosine; partial.
FT                                {ECO:0000269|PubMed:22576872}.
FT   DISULFID     38     62
FT   DISULFID     73    117
FT   DISULFID     98    105
FT   DISULFID    133    187
FT   DISULFID    144    174
FT   DISULFID    158    186
FT   DISULFID    291    341
FT   DISULFID    300    324
FT   DISULFID    316    337
FT   CROSSLNK    763    763       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000250|UniProtKB:P08592}.
FT   VAR_SEQ       1     19       MLPGLALLLLAAWTARALE -> MDQLEDLLVLFINY (in
FT                                isoform 11).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045446.
FT   VAR_SEQ      19     74       Missing (in isoform APP639).
FT                                {ECO:0000303|PubMed:12859342}.
FT                                /FTId=VSP_009116.
FT   VAR_SEQ     289    363       Missing (in isoform APP639).
FT                                {ECO:0000303|PubMed:12859342}.
FT                                /FTId=VSP_009117.
FT   VAR_SEQ     289    289       E -> V (in isoform APP695, isoform L-
FT                                APP696, isoform L-APP677 and isoform
FT                                APP714). {ECO:0000303|PubMed:2881207}.
FT                                /FTId=VSP_000002.
FT   VAR_SEQ     290    364       Missing (in isoform APP695 and isoform L-
FT                                APP677). {ECO:0000303|PubMed:2881207}.
FT                                /FTId=VSP_000004.
FT   VAR_SEQ     290    345       Missing (in isoform L-APP696 and isoform
FT                                APP714). {ECO:0000305}.
FT                                /FTId=VSP_000003.
FT   VAR_SEQ     290    305       VCSEQAETGPCRAMIS -> KWYKEVHSGQARWLML (in
FT                                isoform APP305).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_000005.
FT   VAR_SEQ     306    770       Missing (in isoform APP305).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_000006.
FT   VAR_SEQ     345    364       MSQSLLKTTQEPLARDPVKL -> I (in isoform
FT                                11). {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045447.
FT   VAR_SEQ     345    345       M -> I (in isoform L-APP733 and isoform
FT                                APP751). {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:1587857,
FT                                ECO:0000303|PubMed:2893289}.
FT                                /FTId=VSP_000007.
FT   VAR_SEQ     346    364       Missing (in isoform L-APP733 and isoform
FT                                APP751). {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:1587857,
FT                                ECO:0000303|PubMed:2893289}.
FT                                /FTId=VSP_000008.
FT   VAR_SEQ     364    364       L -> V (in isoform APP639).
FT                                {ECO:0000303|PubMed:12859342}.
FT                                /FTId=VSP_009118.
FT   VAR_SEQ     637    654       Missing (in isoform L-APP677, isoform L-
FT                                APP696, isoform L-APP733 and isoform L-
FT                                APP752). {ECO:0000303|PubMed:1587857}.
FT                                /FTId=VSP_000009.
FT   VARIANT     501    501       E -> K (in dbSNP:rs45588932).
FT                                {ECO:0000269|Ref.10}.
FT                                /FTId=VAR_022315.
FT   VARIANT     665    665       E -> D (in a patient with late onset
FT                                Alzheimer disease; dbSNP:rs63750363).
FT                                {ECO:0000269|PubMed:8154870}.
FT                                /FTId=VAR_010107.
FT   VARIANT     670    671       KM -> NL (in AD1; dbSNP:rs281865161).
FT                                /FTId=VAR_000015.
FT   VARIANT     678    678       D -> N (in AD1; dbSNP:rs63750064).
FT                                {ECO:0000269|PubMed:15201367}.
FT                                /FTId=VAR_044424.
FT   VARIANT     692    692       A -> G (in AD1; Flemish mutation;
FT                                increases the solubility of processed
FT                                amyloid-beta peptides and increases the
FT                                stability of peptide oligomers;
FT                                dbSNP:rs63750671).
FT                                {ECO:0000269|PubMed:11311152,
FT                                ECO:0000269|PubMed:1303239,
FT                                ECO:0000269|PubMed:9754958}.
FT                                /FTId=VAR_000016.
FT   VARIANT     693    693       E -> G (in AD1; dbSNP:rs63751039).
FT                                {ECO:0000269|PubMed:11528419,
FT                                ECO:0000269|PubMed:1415269}.
FT                                /FTId=VAR_014215.
FT   VARIANT     693    693       E -> K (in CAA-APP; Italian type;
FT                                dbSNP:rs63750579).
FT                                {ECO:0000269|PubMed:20697050}.
FT                                /FTId=VAR_014216.
FT   VARIANT     693    693       E -> Q (in CAA-APP; Dutch type;
FT                                dbSNP:rs63750579).
FT                                {ECO:0000269|PubMed:2111584}.
FT                                /FTId=VAR_000017.
FT   VARIANT     694    694       D -> N (in CAA-APP; Iowa type;
FT                                dbSNP:rs63749810).
FT                                {ECO:0000269|PubMed:11409420,
FT                                ECO:0000269|PubMed:12654973}.
FT                                /FTId=VAR_014217.
FT   VARIANT     705    705       L -> V (in CAA-APP; Italian type;
FT                                dbSNP:rs63750921).
FT                                {ECO:0000269|PubMed:16178030}.
FT                                /FTId=VAR_032276.
FT   VARIANT     713    713       A -> T (in AD1; dbSNP:rs63750066).
FT                                {ECO:0000269|PubMed:1303275,
FT                                ECO:0000269|PubMed:15365148}.
FT                                /FTId=VAR_000019.
FT   VARIANT     713    713       A -> V (in one chronic schizophrenia
FT                                patient; unknown pathological
FT                                significance; dbSNP:rs1800557).
FT                                {ECO:0000269|PubMed:1307241}.
FT                                /FTId=VAR_000018.
FT   VARIANT     714    714       T -> A (in AD1; dbSNP:rs63750643).
FT                                {ECO:0000269|PubMed:12034808}.
FT                                /FTId=VAR_032277.
FT   VARIANT     714    714       T -> I (in AD1; increased amyloid-beta
FT                                protein 42/40 ratio; dbSNP:rs63750973).
FT                                {ECO:0000269|PubMed:11063718,
FT                                ECO:0000269|PubMed:15668448}.
FT                                /FTId=VAR_014218.
FT   VARIANT     715    715       V -> M (in AD1; decreased amyloid-beta
FT                                protein 40/total amyloid-beta;
FT                                dbSNP:rs63750734).
FT                                {ECO:0000269|PubMed:10097173}.
FT                                /FTId=VAR_010108.
FT   VARIANT     716    716       I -> V (in AD1; dbSNP:rs63750399).
FT                                {ECO:0000269|PubMed:9328472}.
FT                                /FTId=VAR_000020.
FT   VARIANT     717    717       V -> F (in AD1; dbSNP:rs63750264).
FT                                {ECO:0000269|PubMed:1925564,
FT                                ECO:0000269|PubMed:8267572,
FT                                ECO:0000269|PubMed:8290042,
FT                                ECO:0000269|PubMed:8476439}.
FT                                /FTId=VAR_000023.
FT   VARIANT     717    717       V -> G (in AD1; dbSNP:rs63749964).
FT                                {ECO:0000269|PubMed:1944558,
FT                                ECO:0000269|PubMed:8476439}.
FT                                /FTId=VAR_000022.
FT   VARIANT     717    717       V -> I (in AD1; dbSNP:rs63750264).
FT                                {ECO:0000269|PubMed:10631141,
FT                                ECO:0000269|PubMed:1671712,
FT                                ECO:0000269|PubMed:1678058,
FT                                ECO:0000269|PubMed:1908231,
FT                                ECO:0000269|PubMed:8267572,
FT                                ECO:0000269|PubMed:8476439,
FT                                ECO:0000269|PubMed:8577393}.
FT                                /FTId=VAR_000021.
FT   VARIANT     717    717       V -> L (in AD1; dbSNP:rs63750264).
FT                                {ECO:0000269|PubMed:10867787}.
FT                                /FTId=VAR_014219.
FT   VARIANT     723    723       L -> P (in AD1; dbSNP:rs63751122).
FT                                {ECO:0000269|PubMed:10665499}.
FT                                /FTId=VAR_010109.
FT   MUTAGEN      99    102       KRGR->NQGG: Reduced heparin-binding.
FT                                {ECO:0000269|PubMed:8158260}.
FT   MUTAGEN     137    137       H->N: Binds copper. Forms dimer.
FT                                {ECO:0000269|PubMed:7913895}.
FT   MUTAGEN     141    141       M->T: Binds copper. Forms dimer.
FT                                {ECO:0000269|PubMed:7913895}.
FT   MUTAGEN     144    144       C->S: Binds copper. No dimer formation.
FT                                No copper reducing activity.
FT                                {ECO:0000269|PubMed:10461923,
FT                                ECO:0000269|PubMed:7913895}.
FT   MUTAGEN     147    149       HLH->ALA: 50% decrease in copper reducing
FT                                activity. {ECO:0000269|PubMed:10461923}.
FT   MUTAGEN     147    147       H->A: Some decrease in copper reducing
FT                                activity. {ECO:0000269|PubMed:11784781,
FT                                ECO:0000269|PubMed:7913895}.
FT   MUTAGEN     147    147       H->N: Binds copper. Forms dimer.
FT                                {ECO:0000269|PubMed:11784781,
FT                                ECO:0000269|PubMed:7913895}.
FT   MUTAGEN     147    147       H->Y: Greatly reduced copper-mediated
FT                                low-density lipoprotein oxidation.
FT                                {ECO:0000269|PubMed:11784781,
FT                                ECO:0000269|PubMed:7913895}.
FT   MUTAGEN     151    151       H->K: Greatly reduced copper-mediated
FT                                low-density lipoprotein oxidation.
FT                                {ECO:0000269|PubMed:11784781,
FT                                ECO:0000269|PubMed:7913895}.
FT   MUTAGEN     151    151       H->N: Binds copper. Forms dimer.
FT                                {ECO:0000269|PubMed:11784781,
FT                                ECO:0000269|PubMed:7913895}.
FT   MUTAGEN     198    198       S->A: Greatly reduced casein kinase
FT                                phosphorylation.
FT                                {ECO:0000269|PubMed:10806211,
FT                                ECO:0000269|PubMed:8999878}.
FT   MUTAGEN     206    206       S->A: Reduced casein kinase
FT                                phosphorylation.
FT                                {ECO:0000269|PubMed:10806211,
FT                                ECO:0000269|PubMed:8999878}.
FT   MUTAGEN     499    499       R->A: Reduced affinity for heparin; when
FT                                associated with A-503.
FT                                {ECO:0000269|PubMed:15304215}.
FT   MUTAGEN     503    503       K->A: Reduced affinity for heparin; when
FT                                associated with A-499.
FT                                {ECO:0000269|PubMed:15304215}.
FT   MUTAGEN     656    656       S->A: Abolishes chondroitin sulfate
FT                                binding in L-APP733 isoform.
FT                                {ECO:0000269|PubMed:7737970}.
FT   MUTAGEN     676    676       R->G: 60-70% zinc-induced amyloid-beta
FT                                protein 28 aggregation.
FT                                {ECO:0000269|PubMed:10413512}.
FT   MUTAGEN     681    681       Y->F: 60-70% zinc-induced amyloid-beta
FT                                protein 28 aggregation.
FT                                {ECO:0000269|PubMed:10413512}.
FT   MUTAGEN     684    684       H->R: Only 23% zinc-induced amyloid-beta
FT                                protein 28 aggregation.
FT                                {ECO:0000269|PubMed:10413512}.
FT   MUTAGEN     704    704       G->V: Reduced protein oxidation. No
FT                                hippocampal neuron toxicity.
FT   MUTAGEN     706    706       M->L: Reduced lipid peroxidation
FT                                inhibition. {ECO:0000269|PubMed:10535332,
FT                                ECO:0000269|PubMed:9168929}.
FT   MUTAGEN     706    706       M->V: No free radical production. No
FT                                hippocampal neuron toxicity.
FT                                {ECO:0000269|PubMed:10535332,
FT                                ECO:0000269|PubMed:9168929}.
FT   MUTAGEN     717    717       V->C,S: Unchanged amyloid-beta protein
FT                                42/total amyloid-beta ratio.
FT                                {ECO:0000269|PubMed:11063718,
FT                                ECO:0000269|PubMed:8886002}.
FT   MUTAGEN     717    717       V->F,G,I: Increased amyloid-beta protein
FT                                42/40 ratio.
FT                                {ECO:0000269|PubMed:11063718,
FT                                ECO:0000269|PubMed:8886002}.
FT   MUTAGEN     717    717       V->K: Decreased amyloid-beta protein
FT                                42/total amyloid-beta ratio.
FT                                {ECO:0000269|PubMed:11063718,
FT                                ECO:0000269|PubMed:8886002}.
FT   MUTAGEN     717    717       V->M: Increased amyloid-beta protein
FT                                42/40 ratio. No change in apoptosis after
FT                                caspase cleavage.
FT                                {ECO:0000269|PubMed:11063718,
FT                                ECO:0000269|PubMed:8886002}.
FT   MUTAGEN     728    728       Y->A: No effect on APBA1 nor APBB1
FT                                binding. Greatly reduces the binding to
FT                                APPBP2. APP internalization unchanged. No
FT                                change in amyloid-beta protein 42
FT                                secretion. {ECO:0000269|PubMed:10383380,
FT                                ECO:0000269|PubMed:8887653,
FT                                ECO:0000269|PubMed:9843960}.
FT   MUTAGEN     739    739       D->A: No cleavage by caspases during
FT                                apoptosis. {ECO:0000269|PubMed:10319819,
FT                                ECO:0000269|PubMed:10742146,
FT                                ECO:0000269|PubMed:12214090}.
FT   MUTAGEN     739    739       D->N: No effect on FADD-induced
FT                                apoptosis. {ECO:0000269|PubMed:10319819,
FT                                ECO:0000269|PubMed:10742146,
FT                                ECO:0000269|PubMed:12214090}.
FT   MUTAGEN     743    743       T->A: Greatly reduces the binding to SHC1
FT                                and APBB family members; no effect on
FT                                NGF-stimulated neurite extension.
FT                                {ECO:0000269|PubMed:10341243,
FT                                ECO:0000269|PubMed:11146006,
FT                                ECO:0000269|PubMed:11517218,
FT                                ECO:0000269|PubMed:11877420}.
FT   MUTAGEN     743    743       T->E: Reduced NGF-stimulated neurite
FT                                extension. No effect on APP maturation.
FT                                {ECO:0000269|PubMed:10341243,
FT                                ECO:0000269|PubMed:11146006,
FT                                ECO:0000269|PubMed:11517218,
FT                                ECO:0000269|PubMed:11877420}.
FT   MUTAGEN     756    756       G->A: APP internalization unchanged. No
FT                                change in amyloid-beta protein 42
FT                                secretion. {ECO:0000269|PubMed:10383380}.
FT   MUTAGEN     757    757       Y->A: Little APP internalization. Reduced
FT                                amyloid-beta protein 42 secretion.
FT                                {ECO:0000269|PubMed:10383380,
FT                                ECO:0000269|PubMed:11724784,
FT                                ECO:0000269|PubMed:11877420,
FT                                ECO:0000269|PubMed:8887653}.
FT   MUTAGEN     757    757       Y->G: Loss of binding to MAPK8IP1, APBA1,
FT                                APBB1, APPBP2 and SHC1.
FT                                {ECO:0000269|PubMed:10383380,
FT                                ECO:0000269|PubMed:11724784,
FT                                ECO:0000269|PubMed:11877420,
FT                                ECO:0000269|PubMed:8887653}.
FT   MUTAGEN     759    759       N->A: No binding to APBA1, no effect on
FT                                APBB1 binding. Little APP
FT                                internalization. Reduced amyloid-beta
FT                                protein 42 secretion.
FT                                {ECO:0000269|PubMed:10383380,
FT                                ECO:0000269|PubMed:8887653}.
FT   MUTAGEN     760    760       P->A: Little APP internalization. Reduced
FT                                amyloid-beta protein 42 secretion.
FT                                {ECO:0000269|PubMed:10383380}.
FT   MUTAGEN     762    762       Y->A: Loss of binding to APBA1 and APBB1.
FT                                APP internalization unchanged. No change
FT                                in amyloid-beta protein 42 secretion.
FT                                {ECO:0000269|PubMed:10383380,
FT                                ECO:0000269|PubMed:8887653}.
FT   CONFLICT     15     16       AR -> VW (in Ref. 3; CAA31830).
FT                                {ECO:0000305}.
FT   CONFLICT    647    647       D -> E (in Ref. 36; AAA51722).
FT                                {ECO:0000305}.
FT   CONFLICT    724    724       Missing (in Ref. 23; AAB26263/AAB26264).
FT                                {ECO:0000305}.
FT   CONFLICT    731    731       I -> N (in Ref. 23; AAB26263/AAB26264/
FT                                AAB26265). {ECO:0000305}.
FT   CONFLICT    757    757       Y -> S (in Ref. 31; AAA35540).
FT                                {ECO:0000305}.
FT   HELIX        26     28       {ECO:0000244|PDB:4PQD}.
FT   STRAND       33     35       {ECO:0000244|PDB:4PQD}.
FT   STRAND       43     45       {ECO:0000244|PDB:4PQD}.
FT   TURN         47     49       {ECO:0000244|PDB:4PQD}.
FT   STRAND       52     54       {ECO:0000244|PDB:4PQD}.
FT   STRAND       56     58       {ECO:0000244|PDB:4PWQ}.
FT   HELIX        66     76       {ECO:0000244|PDB:4PQD}.
FT   STRAND       82     87       {ECO:0000244|PDB:4PQD}.
FT   STRAND       92     94       {ECO:0000244|PDB:4PQD}.
FT   STRAND       97     99       {ECO:0000244|PDB:4PQD}.
FT   TURN        100    102       {ECO:0000244|PDB:4PQD}.
FT   STRAND      103    106       {ECO:0000244|PDB:4PQD}.
FT   STRAND      110    112       {ECO:0000244|PDB:4PQD}.
FT   STRAND      115    119       {ECO:0000244|PDB:4PQD}.
FT   STRAND      134    139       {ECO:0000244|PDB:2FMA}.
FT   HELIX       147    160       {ECO:0000244|PDB:2FMA}.
FT   STRAND      163    174       {ECO:0000244|PDB:2FMA}.
FT   TURN        175    177       {ECO:0000244|PDB:2FMA}.
FT   STRAND      178    188       {ECO:0000244|PDB:2FMA}.
FT   HELIX       288    292       {ECO:0000244|PDB:1AAP}.
FT   STRAND      299    301       {ECO:0000244|PDB:1AAP}.
FT   STRAND      304    310       {ECO:0000244|PDB:1AAP}.
FT   TURN        311    314       {ECO:0000244|PDB:1AAP}.
FT   STRAND      315    321       {ECO:0000244|PDB:1AAP}.
FT   STRAND      323    325       {ECO:0000244|PDB:1AAP}.
FT   STRAND      331    333       {ECO:0000244|PDB:1AAP}.
FT   HELIX       334    341       {ECO:0000244|PDB:1AAP}.
FT   HELIX       374    380       {ECO:0000244|PDB:3NYL}.
FT   HELIX       389    418       {ECO:0000244|PDB:3UMH}.
FT   STRAND      421    423       {ECO:0000244|PDB:3UMH}.
FT   HELIX       425    480       {ECO:0000244|PDB:3UMH}.
FT   STRAND      482    484       {ECO:0000244|PDB:3NYJ}.
FT   HELIX       487    518       {ECO:0000244|PDB:3UMH}.
FT   HELIX       520    546       {ECO:0000244|PDB:3UMH}.
FT   HELIX       547    550       {ECO:0000244|PDB:3UMH}.
FT   HELIX       552    566       {ECO:0000244|PDB:3UMH}.
FT   HELIX       615    618       {ECO:0000244|PDB:5BUO}.
FT   STRAND      620    622       {ECO:0000244|PDB:5BUO}.
FT   HELIX       673    675       {ECO:0000244|PDB:4OJF}.
FT   TURN        677    680       {ECO:0000244|PDB:5MYO}.
FT   STRAND      683    685       {ECO:0000244|PDB:1BA4}.
FT   STRAND      688    691       {ECO:0000244|PDB:3OVJ}.
FT   STRAND      692    694       {ECO:0000244|PDB:4MVI}.
FT   TURN        695    698       {ECO:0000244|PDB:4MVI}.
FT   STRAND      701    703       {ECO:0000244|PDB:3PZZ}.
FT   STRAND      707    712       {ECO:0000244|PDB:2Y3K}.
FT   HELIX       744    754       {ECO:0000244|PDB:3DXE}.
FT   STRAND      755    758       {ECO:0000244|PDB:1X11}.
FT   STRAND      763    765       {ECO:0000244|PDB:3L81}.
SQ   SEQUENCE   770 AA;  86943 MW;  A12EE761403740F5 CRC64;
     MLPGLALLLL AAWTARALEV PTDGNAGLLA EPQIAMFCGR LNMHMNVQNG KWDSDPSGTK
     TCIDTKEGIL QYCQEVYPEL QITNVVEANQ PVTIQNWCKR GRKQCKTHPH FVIPYRCLVG
     EFVSDALLVP DKCKFLHQER MDVCETHLHW HTVAKETCSE KSTNLHDYGM LLPCGIDKFR
     GVEFVCCPLA EESDNVDSAD AEEDDSDVWW GGADTDYADG SEDKVVEVAE EEEVAEVEEE
     EADDDEDDED GDEVEEEAEE PYEEATERTT SIATTTTTTT ESVEEVVREV CSEQAETGPC
     RAMISRWYFD VTEGKCAPFF YGGCGGNRNN FDTEEYCMAV CGSAMSQSLL KTTQEPLARD
     PVKLPTTAAS TPDAVDKYLE TPGDENEHAH FQKAKERLEA KHRERMSQVM REWEEAERQA
     KNLPKADKKA VIQHFQEKVE SLEQEAANER QQLVETHMAR VEAMLNDRRR LALENYITAL
     QAVPPRPRHV FNMLKKYVRA EQKDRQHTLK HFEHVRMVDP KKAAQIRSQV MTHLRVIYER
     MNQSLSLLYN VPAVAEEIQD EVDELLQKEQ NYSDDVLANM ISEPRISYGN DALMPSLTET
     KTTVELLPVN GEFSLDDLQP WHSFGADSVP ANTENEVEPV DARPAADRGL TTRPGSGLTN
     IKTEEISEVK MDAEFRHDSG YEVHHQKLVF FAEDVGSNKG AIIGLMVGGV VIATVIVITL
     VMLKKKQYTS IHHGVVEVDA AVTPEERHLS KMQQNGYENP TYKFFEQMQN
//
ID   DL_DROME                Reviewed;         833 AA.
AC   P10041; Q6T3F7; Q6T3G1; Q6T3G7; Q6T3G8; Q6T3H0; Q6T3H3; Q6T3I3;
AC   Q6T3I5; Q6T3I7; Q6T3J1; Q6T3J2; Q6T3J3; Q6T3J4; Q6T3K0; Q6T3K1;
AC   Q6T3K9; Q6T3L5; Q6T3L7; Q6T3L9; Q6T3M2; Q6T3M4; Q6T3M7; Q6T3N1;
AC   Q6T3N3; Q6T3N5; Q6T3N7; Q6T4M9; Q6T4N0; Q6T4N1; Q6T4N2; Q6T4N3;
AC   Q6T4N4; Q6T4N6; Q95RM9; Q99108; Q9VDY2;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2000, sequence version 2.
DT   22-NOV-2017, entry version 196.
DE   RecName: Full=Neurogenic locus protein delta;
DE   Flags: Precursor;
GN   Name=Dl; ORFNames=CG3619;
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha;
OC   Ephydroidea; Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, DEVELOPMENTAL STAGE,
RP   AND VARIANTS ALA-652 AND MET-662.
RC   TISSUE=Embryo;
RX   PubMed=16453806;
RA   Vaessin H., Bremer K.A., Knust E., Campos-Ortega J.A.;
RT   "The neurogenic gene Delta of Drosophila melanogaster is expressed in
RT   neurogenic territories and encodes a putative transmembrane protein
RT   with EGF-like repeats.";
RL   EMBO J. 6:3431-3440(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT ALA-812.
RC   STRAIN=Oregon-R; TISSUE=Embryo;
RX   PubMed=3149249; DOI=10.1101/gad.2.12b.1723;
RA   Kopczynski C.C., Alton A.K., Fechtel K., Kooh P.J., Muskavitch M.A.T.;
RT   "Delta, a Drosophila neurogenic gene, is transcriptionally complex and
RT   encodes a protein related to blood coagulation factors and epidermal
RT   growth factor of vertebrates.";
RL   Genes Dev. 2:1723-1735(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=NapaValley1, NapaValley10, NapaValley11, NapaValley12,
RC   NapaValley2, NapaValley3, NapaValley4, NapaValley5, NapaValley6,
RC   NapaValley7, NapaValley8, NapaValley9, nps_1, nps_13, nps_14, nps_15,
RC   nps_16, nps_17, nps_18, nps_19, nps_2, nps_20, nps_21, nps_23, nps_24,
RC   nps_25, nps_26, nps_27, nps_28, nps_29, nps_3, nps_30, nps_31, nps_32,
RC   nps_33, nps_34, nps_35, nps_36, nps_37, nps_38, nps_39, nps_4, nps_40,
RC   nps_41, nps_42, nps_43, nps_44, nps_45, nps_46, nps_47, nps_48,
RC   nps_49, nps_5, nps_50, nps_6, sonoma_002, sonoma_003, sonoma_004,
RC   sonoma_005, sonoma_006, sonoma_007, sonoma_008, sonoma_009,
RC   sonoma_010, sonoma_013, sonoma_014, sonoma_015, sonoma_016,
RC   sonoma_017, sonoma_019, sonoma_022, sonoma_023, sonoma_024,
RC   sonoma_031, sonoma_032, sonoma_033, sonoma_034, sonoma_036,
RC   sonoma_038, sonoma_039, sonoma_040, sonoma_045, sonoma_046,
RC   sonoma_048, sonoma_050, sonoma_051, sonoma_053, sonoma_054,
RC   sonoma_055, sonoma_058, sonoma_059, sonoma_061, sonoma_064,
RC   sonoma_073, sonoma_074, sonoma_081, sonoma_085, sonoma_086,
RC   sonoma_087, sonoma_094, sonoma_095, sonoma_097, sonoma_101,
RC   sonoma_106, sonoma_107, sonoma_111, sonoma_116, sonoma_117, and
RC   sonoma_119;
RX   PubMed=15020426; DOI=10.1534/genetics.166.1.291;
RA   Genissel A., Pastinen T., Dowell A., Mackay T.F.C., Long A.D.;
RT   "No evidence for an association between common nonsynonymous
RT   polymorphisms in delta and bristle number variation in natural and
RT   laboratory populations of Drosophila melanogaster.";
RL   Genetics 166:291-306(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley;
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X.,
RA   Brandon R.C., Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D.,
RA   Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G.,
RA   Abril J.F., Agbayani A., An H.-J., Andrews-Pfannkoch C., Baldwin D.,
RA   Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M.,
RA   Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S.,
RA   Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P.,
RA   Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I.,
RA   Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P.,
RA   de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M.,
RA   Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P.,
RA   Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W.,
RA   Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K.,
RA   Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J.,
RA   Hostin D., Houston K.A., Howland T.J., Wei M.-H., Ibegwam C.,
RA   Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A.,
RA   Kimmel B.E., Kodira C.D., Kraft C.L., Kravitz S., Kulp D., Lai Z.,
RA   Lasko P., Lei Y., Levitsky A.A., Li J.H., Li Z., Liang Y., Lin X.,
RA   Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D.,
RA   Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A.,
RA   Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L.,
RA   Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M.,
RA   Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G.,
RA   Reinert K., Remington K., Saunders R.D.C., Scheeler F., Shen H.,
RA   Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E.,
RA   Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X.,
RA   Wang Z.-Y., Wassarman D.A., Weinstock G.M., Weissenbach J.,
RA   Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A.,
RA   Ye J., Yeh R.-F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L.,
RA   Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S.C., Zhu X.,
RA   Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [5]
RP   GENOME REANNOTATION.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q.,
RA   Stapleton M., Yamada C., Ashburner M., Gelbart W.M., Rubin G.M.,
RA   Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a
RT   systematic review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=Berkeley; TISSUE=Embryo;
RA   Stapleton M., Brokstein P., Hong L., Agbayani A., Carlson J.W.,
RA   Champe M., Chavez C., Dorsett V., Dresnek D., Farfan D., Frise E.,
RA   George R.A., Gonzalez M., Guarin H., Kronmiller B., Li P.W., Liao G.,
RA   Miranda A., Mungall C.J., Nunoo J., Pacleb J.M., Paragas V., Park S.,
RA   Patel S., Phouanenavong S., Wan K.H., Yu C., Lewis S.E., Rubin G.M.,
RA   Celniker S.E.;
RL   Submitted (JAN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 195-833.
RC   STRAIN=Berkeley; TISSUE=Embryo;
RX   PubMed=12537569; DOI=10.1186/gb-2002-3-12-research0080;
RA   Stapleton M., Carlson J.W., Brokstein P., Yu C., Champe M.,
RA   George R.A., Guarin H., Kronmiller B., Pacleb J.M., Park S., Wan K.H.,
RA   Rubin G.M., Celniker S.E.;
RT   "A Drosophila full-length cDNA resource.";
RL   Genome Biol. 3:RESEARCH0080.1-RESEARCH0080.8(2002).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 422-621.
RC   TISSUE=Embryo;
RX   PubMed=3107986;
RA   Knust E., Dietrich U., Tepass U., Bremer K.A., Weigel D., Vaessin H.,
RA   Campos-Ortega J.A.;
RT   "EGF homologous sequences encoded in the genome of Drosophila
RT   melanogaster, and their relation to neurogenic genes.";
RL   EMBO J. 6:761-766(1987).
RN   [9]
RP   FUNCTION, AND INTERACTION WITH DL.
RX   PubMed=10935637; DOI=10.1038/35019075;
RA   Bruckner K., Perez L., Clausen H., Cohen S.;
RT   "Glycosyltransferase activity of Fringe modulates Notch-Delta
RT   interactions.";
RL   Nature 406:411-415(2000).
RN   [10]
RP   PATTERN OF TRANSCRIPTION, AND CHARACTERIZATION.
RX   PubMed=2128477;
RA   Haenlin M., Kramatschek B., Campos-Ortega J.A.;
RT   "The pattern of transcription of the neurogenic gene Delta of
RT   Drosophila melanogaster.";
RL   Development 110:905-914(1990).
RN   [11]
RP   INTERACTION WITH MIB, AND UBIQUITINATION.
RX   PubMed=15829515; DOI=10.1242/dev.01825;
RA   Lai E.C., Roegiers F., Qin X., Jan Y.N., Rubin G.M.;
RT   "The ubiquitin ligase Drosophila Mind bomb promotes Notch signaling by
RT   regulating the localization and activity of Serrate and Delta.";
RL   Development 132:2319-2332(2005).
RN   [12]
RP   UBIQUITINATION.
RX   PubMed=15760269; DOI=10.1371/journal.pbio.0030096;
RA   Le Borgne R., Remaud S., Hamel S., Schweisguth F.;
RT   "Two distinct E3 ubiquitin ligases have complementary functions in the
RT   regulation of delta and serrate signaling in Drosophila.";
RL   PLoS Biol. 3:688-696(2005).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-666, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY.
RC   TISSUE=Embryo;
RX   PubMed=18327897; DOI=10.1021/pr700696a;
RA   Zhai B., Villen J., Beausoleil S.A., Mintseris J., Gygi S.P.;
RT   "Phosphoproteome analysis of Drosophila melanogaster embryos.";
RL   J. Proteome Res. 7:1675-1682(2008).
CC   -!- FUNCTION: Acts as a ligand for Notch (N) receptor. Essential for
CC       proper differentiation of ectoderm. Dl is required for the correct
CC       separation of neural and epidermal cell lineages. Fringe (fng)
CC       acts in the Golgi to determine the type of O-linked fucose on the
CC       EGF modules in N, altering the ability of N to bind with Delta
CC       (Dl). O-fut1 also has a role in modulating the interaction.
CC       {ECO:0000269|PubMed:10935637}.
CC   -!- SUBUNIT: Interacts with N via the EGF repeats and the N EGF
CC       repeats. {ECO:0000269|PubMed:10935637,
CC       ECO:0000269|PubMed:15829515}.
CC   -!- INTERACTION:
CC       P07207:N; NbExp=2; IntAct=EBI-115346, EBI-103438;
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- TISSUE SPECIFICITY: Detected in all areas with neurogenic
CC       abilities, for example the neurogenic ectoderm and the primordia
CC       of the sense organs. Later expression is restricted to those cells
CC       that have adopted a neural fate. {ECO:0000269|PubMed:16453806}.
CC   -!- DEVELOPMENTAL STAGE: Expressed both maternally and zygotically.
CC       Expression is highest early in embryonic development (stage 5) and
CC       reduces to a low level during larval stages.
CC       {ECO:0000269|PubMed:16453806}.
CC   -!- PTM: Ubiquitinated by Mib, leading to its endocytosis and
CC       subsequent degradation. {ECO:0000269|PubMed:15760269,
CC       ECO:0000269|PubMed:15829515}.
CC   -!- MISCELLANEOUS: Separation of neuroblasts from the ectoderm into
CC       the inner part of embryo is one of the first steps of CNS
CC       development in insects, this process is under control of the
CC       neurogenic genes.
CC   -!- MISCELLANEOUS: Notch and Serrate may interact at the protein
CC       level, it is conceivable that the Serrate and Delta proteins may
CC       compete for binding with the Notch protein.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAL28817.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X06289; CAA29617.1; -; mRNA.
DR   EMBL; Y00222; CAA68369.1; -; mRNA.
DR   EMBL; AY437145; AAR21453.1; -; Genomic_DNA.
DR   EMBL; AY437140; AAR21453.1; JOINED; Genomic_DNA.
DR   EMBL; AY437141; AAR21453.1; JOINED; Genomic_DNA.
DR   EMBL; AY437142; AAR21453.1; JOINED; Genomic_DNA.
DR   EMBL; AY437143; AAR21453.1; JOINED; Genomic_DNA.
DR   EMBL; AY437144; AAR21453.1; JOINED; Genomic_DNA.
DR   EMBL; AY437151; AAR21454.1; -; Genomic_DNA.
DR   EMBL; AY437146; AAR21454.1; JOINED; Genomic_DNA.
DR   EMBL; AY437147; AAR21454.1; JOINED; Genomic_DNA.
DR   EMBL; AY437148; AAR21454.1; JOINED; Genomic_DNA.
DR   EMBL; AY437149; AAR21454.1; JOINED; Genomic_DNA.
DR   EMBL; AY437150; AAR21454.1; JOINED; Genomic_DNA.
DR   EMBL; AY437157; AAR21455.1; -; Genomic_DNA.
DR   EMBL; AY437152; AAR21455.1; JOINED; Genomic_DNA.
DR   EMBL; AY437153; AAR21455.1; JOINED; Genomic_DNA.
DR   EMBL; AY437154; AAR21455.1; JOINED; Genomic_DNA.
DR   EMBL; AY437155; AAR21455.1; JOINED; Genomic_DNA.
DR   EMBL; AY437156; AAR21455.1; JOINED; Genomic_DNA.
DR   EMBL; AY437163; AAR21456.1; -; Genomic_DNA.
DR   EMBL; AY437158; AAR21456.1; JOINED; Genomic_DNA.
DR   EMBL; AY437159; AAR21456.1; JOINED; Genomic_DNA.
DR   EMBL; AY437160; AAR21456.1; JOINED; Genomic_DNA.
DR   EMBL; AY437161; AAR21456.1; JOINED; Genomic_DNA.
DR   EMBL; AY437162; AAR21456.1; JOINED; Genomic_DNA.
DR   EMBL; AY437169; AAR21457.1; -; Genomic_DNA.
DR   EMBL; AY437164; AAR21457.1; JOINED; Genomic_DNA.
DR   EMBL; AY437165; AAR21457.1; JOINED; Genomic_DNA.
DR   EMBL; AY437166; AAR21457.1; JOINED; Genomic_DNA.
DR   EMBL; AY437167; AAR21457.1; JOINED; Genomic_DNA.
DR   EMBL; AY437168; AAR21457.1; JOINED; Genomic_DNA.
DR   EMBL; AY437175; AAR21458.1; -; Genomic_DNA.
DR   EMBL; AY437170; AAR21458.1; JOINED; Genomic_DNA.
DR   EMBL; AY437171; AAR21458.1; JOINED; Genomic_DNA.
DR   EMBL; AY437172; AAR21458.1; JOINED; Genomic_DNA.
DR   EMBL; AY437173; AAR21458.1; JOINED; Genomic_DNA.
DR   EMBL; AY437174; AAR21458.1; JOINED; Genomic_DNA.
DR   EMBL; AY437181; AAR21459.1; -; Genomic_DNA.
DR   EMBL; AY437176; AAR21459.1; JOINED; Genomic_DNA.
DR   EMBL; AY437177; AAR21459.1; JOINED; Genomic_DNA.
DR   EMBL; AY437178; AAR21459.1; JOINED; Genomic_DNA.
DR   EMBL; AY437179; AAR21459.1; JOINED; Genomic_DNA.
DR   EMBL; AY437180; AAR21459.1; JOINED; Genomic_DNA.
DR   EMBL; AY437187; AAR21460.1; -; Genomic_DNA.
DR   EMBL; AY437182; AAR21460.1; JOINED; Genomic_DNA.
DR   EMBL; AY437183; AAR21460.1; JOINED; Genomic_DNA.
DR   EMBL; AY437184; AAR21460.1; JOINED; Genomic_DNA.
DR   EMBL; AY437185; AAR21460.1; JOINED; Genomic_DNA.
DR   EMBL; AY437186; AAR21460.1; JOINED; Genomic_DNA.
DR   EMBL; AY437193; AAR21461.1; -; Genomic_DNA.
DR   EMBL; AY437188; AAR21461.1; JOINED; Genomic_DNA.
DR   EMBL; AY437189; AAR21461.1; JOINED; Genomic_DNA.
DR   EMBL; AY437190; AAR21461.1; JOINED; Genomic_DNA.
DR   EMBL; AY437191; AAR21461.1; JOINED; Genomic_DNA.
DR   EMBL; AY437192; AAR21461.1; JOINED; Genomic_DNA.
DR   EMBL; AY437199; AAR21462.1; -; Genomic_DNA.
DR   EMBL; AY437194; AAR21462.1; JOINED; Genomic_DNA.
DR   EMBL; AY437195; AAR21462.1; JOINED; Genomic_DNA.
DR   EMBL; AY437196; AAR21462.1; JOINED; Genomic_DNA.
DR   EMBL; AY437197; AAR21462.1; JOINED; Genomic_DNA.
DR   EMBL; AY437198; AAR21462.1; JOINED; Genomic_DNA.
DR   EMBL; AY437205; AAR21463.1; -; Genomic_DNA.
DR   EMBL; AY437200; AAR21463.1; JOINED; Genomic_DNA.
DR   EMBL; AY437201; AAR21463.1; JOINED; Genomic_DNA.
DR   EMBL; AY437202; AAR21463.1; JOINED; Genomic_DNA.
DR   EMBL; AY437203; AAR21463.1; JOINED; Genomic_DNA.
DR   EMBL; AY437204; AAR21463.1; JOINED; Genomic_DNA.
DR   EMBL; AY437211; AAR21464.1; -; Genomic_DNA.
DR   EMBL; AY437206; AAR21464.1; JOINED; Genomic_DNA.
DR   EMBL; AY437207; AAR21464.1; JOINED; Genomic_DNA.
DR   EMBL; AY437208; AAR21464.1; JOINED; Genomic_DNA.
DR   EMBL; AY437209; AAR21464.1; JOINED; Genomic_DNA.
DR   EMBL; AY437210; AAR21464.1; JOINED; Genomic_DNA.
DR   EMBL; AY437217; AAR21465.1; -; Genomic_DNA.
DR   EMBL; AY437212; AAR21465.1; JOINED; Genomic_DNA.
DR   EMBL; AY437213; AAR21465.1; JOINED; Genomic_DNA.
DR   EMBL; AY437214; AAR21465.1; JOINED; Genomic_DNA.
DR   EMBL; AY437215; AAR21465.1; JOINED; Genomic_DNA.
DR   EMBL; AY437216; AAR21465.1; JOINED; Genomic_DNA.
DR   EMBL; AY437223; AAR21466.1; -; Genomic_DNA.
DR   EMBL; AY437218; AAR21466.1; JOINED; Genomic_DNA.
DR   EMBL; AY437219; AAR21466.1; JOINED; Genomic_DNA.
DR   EMBL; AY437220; AAR21466.1; JOINED; Genomic_DNA.
DR   EMBL; AY437221; AAR21466.1; JOINED; Genomic_DNA.
DR   EMBL; AY437222; AAR21466.1; JOINED; Genomic_DNA.
DR   EMBL; AY437229; AAR21467.1; -; Genomic_DNA.
DR   EMBL; AY437224; AAR21467.1; JOINED; Genomic_DNA.
DR   EMBL; AY437225; AAR21467.1; JOINED; Genomic_DNA.
DR   EMBL; AY437226; AAR21467.1; JOINED; Genomic_DNA.
DR   EMBL; AY437227; AAR21467.1; JOINED; Genomic_DNA.
DR   EMBL; AY437228; AAR21467.1; JOINED; Genomic_DNA.
DR   EMBL; AY437235; AAR21468.1; -; Genomic_DNA.
DR   EMBL; AY437230; AAR21468.1; JOINED; Genomic_DNA.
DR   EMBL; AY437231; AAR21468.1; JOINED; Genomic_DNA.
DR   EMBL; AY437232; AAR21468.1; JOINED; Genomic_DNA.
DR   EMBL; AY437233; AAR21468.1; JOINED; Genomic_DNA.
DR   EMBL; AY437234; AAR21468.1; JOINED; Genomic_DNA.
DR   EMBL; AY438104; AAR21469.1; -; Genomic_DNA.
DR   EMBL; AY438105; AAR21470.1; -; Genomic_DNA.
DR   EMBL; AY438106; AAR21471.1; -; Genomic_DNA.
DR   EMBL; AY438107; AAR21472.1; -; Genomic_DNA.
DR   EMBL; AY438108; AAR21473.1; -; Genomic_DNA.
DR   EMBL; AY438109; AAR21474.1; -; Genomic_DNA.
DR   EMBL; AY438110; AAR21475.1; -; Genomic_DNA.
DR   EMBL; AY438111; AAR21476.1; -; Genomic_DNA.
DR   EMBL; AY438112; AAR21477.1; -; Genomic_DNA.
DR   EMBL; AY438113; AAR21478.1; -; Genomic_DNA.
DR   EMBL; AY438114; AAR21479.1; -; Genomic_DNA.
DR   EMBL; AY438115; AAR21480.1; -; Genomic_DNA.
DR   EMBL; AY438116; AAR21481.1; -; Genomic_DNA.
DR   EMBL; AY438117; AAR21482.1; -; Genomic_DNA.
DR   EMBL; AY438118; AAR21483.1; -; Genomic_DNA.
DR   EMBL; AY438119; AAR21484.1; -; Genomic_DNA.
DR   EMBL; AY438120; AAR21485.1; -; Genomic_DNA.
DR   EMBL; AY438121; AAR21486.1; -; Genomic_DNA.
DR   EMBL; AY438122; AAR21487.1; -; Genomic_DNA.
DR   EMBL; AY438123; AAR21488.1; -; Genomic_DNA.
DR   EMBL; AY438124; AAR21489.1; -; Genomic_DNA.
DR   EMBL; AY438125; AAR21490.1; -; Genomic_DNA.
DR   EMBL; AY438126; AAR21491.1; -; Genomic_DNA.
DR   EMBL; AY438127; AAR21492.1; -; Genomic_DNA.
DR   EMBL; AY438128; AAR21493.1; -; Genomic_DNA.
DR   EMBL; AY438129; AAR21494.1; -; Genomic_DNA.
DR   EMBL; AY438130; AAR21495.1; -; Genomic_DNA.
DR   EMBL; AY438131; AAR21496.1; -; Genomic_DNA.
DR   EMBL; AY438132; AAR21497.1; -; Genomic_DNA.
DR   EMBL; AY438133; AAR21498.1; -; Genomic_DNA.
DR   EMBL; AY438134; AAR21499.1; -; Genomic_DNA.
DR   EMBL; AY438135; AAR21500.1; -; Genomic_DNA.
DR   EMBL; AY438136; AAR21501.1; -; Genomic_DNA.
DR   EMBL; AY438137; AAR21502.1; -; Genomic_DNA.
DR   EMBL; AY438138; AAR21503.1; -; Genomic_DNA.
DR   EMBL; AY438139; AAR21504.1; -; Genomic_DNA.
DR   EMBL; AY438140; AAR21505.1; -; Genomic_DNA.
DR   EMBL; AY438141; AAR21506.1; -; Genomic_DNA.
DR   EMBL; AY438147; AAR09172.1; -; Genomic_DNA.
DR   EMBL; AY438148; AAR09173.1; -; Genomic_DNA.
DR   EMBL; AY438149; AAR09174.1; -; Genomic_DNA.
DR   EMBL; AY438150; AAR09175.1; -; Genomic_DNA.
DR   EMBL; AY438151; AAR09176.1; -; Genomic_DNA.
DR   EMBL; AY438152; AAR09177.1; -; Genomic_DNA.
DR   EMBL; AY438153; AAR09178.1; -; Genomic_DNA.
DR   EMBL; AY438154; AAR09179.1; -; Genomic_DNA.
DR   EMBL; AY438155; AAR09180.1; -; Genomic_DNA.
DR   EMBL; AY438156; AAR09181.1; -; Genomic_DNA.
DR   EMBL; AY438157; AAR09182.1; -; Genomic_DNA.
DR   EMBL; AY438158; AAR09183.1; -; Genomic_DNA.
DR   EMBL; AY438159; AAR09184.1; -; Genomic_DNA.
DR   EMBL; AY438160; AAR09185.1; -; Genomic_DNA.
DR   EMBL; AY438161; AAR09186.1; -; Genomic_DNA.
DR   EMBL; AY438162; AAR09187.1; -; Genomic_DNA.
DR   EMBL; AY438163; AAR09188.1; -; Genomic_DNA.
DR   EMBL; AY438164; AAR09189.1; -; Genomic_DNA.
DR   EMBL; AY438165; AAR09190.1; -; Genomic_DNA.
DR   EMBL; AY438166; AAR09191.1; -; Genomic_DNA.
DR   EMBL; AY438167; AAR09192.1; -; Genomic_DNA.
DR   EMBL; AY438168; AAR09193.1; -; Genomic_DNA.
DR   EMBL; AY438169; AAR09194.1; -; Genomic_DNA.
DR   EMBL; AY438170; AAR09195.1; -; Genomic_DNA.
DR   EMBL; AY438171; AAR09196.1; -; Genomic_DNA.
DR   EMBL; AY438172; AAR09197.1; -; Genomic_DNA.
DR   EMBL; AY438173; AAR09198.1; -; Genomic_DNA.
DR   EMBL; AY438174; AAR09199.1; -; Genomic_DNA.
DR   EMBL; AY438175; AAR09200.1; -; Genomic_DNA.
DR   EMBL; AY438176; AAR09201.1; -; Genomic_DNA.
DR   EMBL; AY438177; AAR09202.1; -; Genomic_DNA.
DR   EMBL; AY438178; AAR09203.1; -; Genomic_DNA.
DR   EMBL; AY438179; AAR09204.1; -; Genomic_DNA.
DR   EMBL; AY438180; AAR09205.1; -; Genomic_DNA.
DR   EMBL; AY438181; AAR09206.1; -; Genomic_DNA.
DR   EMBL; AY438182; AAR09207.1; -; Genomic_DNA.
DR   EMBL; AY438183; AAR09208.1; -; Genomic_DNA.
DR   EMBL; AY438184; AAR09209.1; -; Genomic_DNA.
DR   EMBL; AY438185; AAR09210.1; -; Genomic_DNA.
DR   EMBL; AY438186; AAR09211.1; -; Genomic_DNA.
DR   EMBL; AY438187; AAR09212.1; -; Genomic_DNA.
DR   EMBL; AY438188; AAR09213.1; -; Genomic_DNA.
DR   EMBL; AY438189; AAR09214.1; -; Genomic_DNA.
DR   EMBL; AY438190; AAR09215.1; -; Genomic_DNA.
DR   EMBL; AY438191; AAR09216.1; -; Genomic_DNA.
DR   EMBL; AY438192; AAR09217.1; -; Genomic_DNA.
DR   EMBL; AY438193; AAR09218.1; -; Genomic_DNA.
DR   EMBL; AY438194; AAR09219.1; -; Genomic_DNA.
DR   EMBL; AY438195; AAR09220.1; -; Genomic_DNA.
DR   EMBL; AY438196; AAR09221.1; -; Genomic_DNA.
DR   EMBL; AY438197; AAR09222.1; -; Genomic_DNA.
DR   EMBL; AY438198; AAR09223.1; -; Genomic_DNA.
DR   EMBL; AY438199; AAR09224.1; -; Genomic_DNA.
DR   EMBL; AY438200; AAR09225.1; -; Genomic_DNA.
DR   EMBL; AY438201; AAR09226.1; -; Genomic_DNA.
DR   EMBL; AY438202; AAR09227.1; -; Genomic_DNA.
DR   EMBL; BK004004; DAA02303.1; -; Genomic_DNA.
DR   EMBL; AE014297; AAF55657.1; -; Genomic_DNA.
DR   EMBL; BT003267; AAO25024.1; -; mRNA.
DR   EMBL; AY061269; AAL28817.1; ALT_INIT; mRNA.
DR   EMBL; X05140; CAA28786.1; -; mRNA.
DR   PIR; A31246; A31246.
DR   PIR; A43564; A43564.
DR   PIR; S00670; S00670.
DR   PIR; S19087; S19087.
DR   RefSeq; NP_001247193.1; NM_001260264.2.
DR   RefSeq; NP_477264.1; NM_057916.4.
DR   RefSeq; NP_732412.1; NM_169853.3.
DR   UniGene; Dm.7687; -.
DR   PDB; 4XIB; X-ray; 2.15 A; C=680-690.
DR   PDBsum; 4XIB; -.
DR   ProteinModelPortal; P10041; -.
DR   SMR; P10041; -.
DR   BioGrid; 67310; 119.
DR   DIP; DIP-22726N; -.
DR   IntAct; P10041; 2.
DR   MINT; MINT-773349; -.
DR   STRING; 7227.FBpp0083153; -.
DR   iPTMnet; P10041; -.
DR   PaxDb; P10041; -.
DR   PRIDE; P10041; -.
DR   EnsemblMetazoa; FBtr0083739; FBpp0083153; FBgn0000463.
DR   EnsemblMetazoa; FBtr0083740; FBpp0083154; FBgn0000463.
DR   EnsemblMetazoa; FBtr0304658; FBpp0293200; FBgn0000463.
DR   GeneID; 42313; -.
DR   KEGG; dme:Dmel_CG3619; -.
DR   FlyBase; FBgn0000463; Dl.
DR   eggNOG; ENOG410IR7B; Eukaryota.
DR   eggNOG; ENOG410XUNS; LUCA.
DR   GeneTree; ENSGT00810000125346; -.
DR   InParanoid; P10041; -.
DR   KO; K06051; -.
DR   OMA; DKPCHQG; -.
DR   OrthoDB; EOG091G07YQ; -.
DR   PhylomeDB; P10041; -.
DR   Reactome; R-DME-1980148; Signaling by NOTCH3.
DR   Reactome; R-DME-1980150; Signaling by NOTCH4.
DR   Reactome; R-DME-2979096; NOTCH2 Activation and Transmission of Signal to the Nucleus.
DR   SignaLink; P10041; -.
DR   ChiTaRS; Dl; fly.
DR   GenomeRNAi; 42313; -.
DR   PMAP-CutDB; P10041; -.
DR   PRO; PR:P10041; -.
DR   Proteomes; UP000000803; Chromosome 3R.
DR   Bgee; FBgn0000463; -.
DR   ExpressionAtlas; P10041; differential.
DR   Genevisible; P10041; DM.
DR   GO; GO:0005912; C:adherens junction; IDA:FlyBase.
DR   GO; GO:0009986; C:cell surface; IDA:FlyBase.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IDA:FlyBase.
DR   GO; GO:0030139; C:endocytic vesicle; IDA:FlyBase.
DR   GO; GO:0005768; C:endosome; IDA:FlyBase.
DR   GO; GO:0016021; C:integral component of membrane; TAS:FlyBase.
DR   GO; GO:0005886; C:plasma membrane; IDA:FlyBase.
DR   GO; GO:0035003; C:subapical complex; IDA:FlyBase.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0005112; F:Notch binding; IDA:FlyBase.
DR   GO; GO:0005102; F:receptor binding; NAS:FlyBase.
DR   GO; GO:0007015; P:actin filament organization; IMP:FlyBase.
DR   GO; GO:0048800; P:antennal morphogenesis; IMP:FlyBase.
DR   GO; GO:0007475; P:apposition of dorsal and ventral imaginal disc-derived wing surfaces; IMP:FlyBase.
DR   GO; GO:0008356; P:asymmetric cell division; TAS:FlyBase.
DR   GO; GO:0007298; P:border follicle cell migration; IMP:FlyBase.
DR   GO; GO:0007155; P:cell adhesion; TAS:FlyBase.
DR   GO; GO:0001708; P:cell fate specification; TAS:FlyBase.
DR   GO; GO:0008407; P:chaeta morphogenesis; IMP:FlyBase.
DR   GO; GO:0042676; P:compound eye cone cell fate commitment; TAS:FlyBase.
DR   GO; GO:0048749; P:compound eye development; TAS:FlyBase.
DR   GO; GO:0046667; P:compound eye retinal cell programmed cell death; TAS:FlyBase.
DR   GO; GO:0007451; P:dorsal/ventral lineage restriction, imaginal disc; TAS:FlyBase.
DR   GO; GO:0007398; P:ectoderm development; TAS:FlyBase.
DR   GO; GO:0042067; P:establishment of ommatidial planar polarity; TAS:FlyBase.
DR   GO; GO:0001736; P:establishment of planar polarity; NAS:FlyBase.
DR   GO; GO:0030718; P:germ-line stem cell population maintenance; IMP:FlyBase.
DR   GO; GO:0008347; P:glial cell migration; IMP:FlyBase.
DR   GO; GO:0007480; P:imaginal disc-derived leg morphogenesis; IMP:FlyBase.
DR   GO; GO:0036011; P:imaginal disc-derived leg segmentation; IMP:FlyBase.
DR   GO; GO:0007476; P:imaginal disc-derived wing morphogenesis; IMP:FlyBase.
DR   GO; GO:0008586; P:imaginal disc-derived wing vein morphogenesis; TAS:FlyBase.
DR   GO; GO:0007474; P:imaginal disc-derived wing vein specification; NAS:FlyBase.
DR   GO; GO:0046331; P:lateral inhibition; IMP:FlyBase.
DR   GO; GO:0007498; P:mesoderm development; IMP:FlyBase.
DR   GO; GO:0035157; P:negative regulation of fusion cell fate specification; NAS:FlyBase.
DR   GO; GO:0050768; P:negative regulation of neurogenesis; IMP:FlyBase.
DR   GO; GO:0035155; P:negative regulation of terminal cell fate specification, open tracheal system; NAS:FlyBase.
DR   GO; GO:0007399; P:nervous system development; NAS:FlyBase.
DR   GO; GO:0007219; P:Notch signaling pathway; IMP:FlyBase.
DR   GO; GO:0016318; P:ommatidial rotation; NAS:FlyBase.
DR   GO; GO:0007314; P:oocyte anterior/posterior axis specification; TAS:FlyBase.
DR   GO; GO:0030720; P:oocyte localization involved in germarium-derived egg chamber formation; IMP:FlyBase.
DR   GO; GO:0048477; P:oogenesis; IMP:FlyBase.
DR   GO; GO:0007424; P:open tracheal system development; NAS:FlyBase.
DR   GO; GO:0030707; P:ovarian follicle cell development; IMP:FlyBase.
DR   GO; GO:0030713; P:ovarian follicle cell stalk formation; IMP:FlyBase.
DR   GO; GO:0007422; P:peripheral nervous system development; IMP:FlyBase.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IMP:FlyBase.
DR   GO; GO:0045931; P:positive regulation of mitotic cell cycle; IMP:FlyBase.
DR   GO; GO:0007464; P:R3/R4 cell fate commitment; NAS:FlyBase.
DR   GO; GO:0045465; P:R8 cell differentiation; NAS:FlyBase.
DR   GO; GO:0007460; P:R8 cell fate commitment; TAS:FlyBase.
DR   GO; GO:0045468; P:regulation of R8 cell spacing in compound eye; NAS:FlyBase.
DR   GO; GO:0016330; P:second mitotic wave involved in compound eye morphogenesis; IMP:FlyBase.
DR   GO; GO:0007423; P:sensory organ development; IMP:FlyBase.
DR   GO; GO:0030431; P:sleep; IEP:FlyBase.
DR   GO; GO:0048863; P:stem cell differentiation; IMP:FlyBase.
DR   GO; GO:0007419; P:ventral cord development; NAS:FlyBase.
DR   GO; GO:0048190; P:wing disc dorsal/ventral pattern formation; IMP:FlyBase.
DR   InterPro; IPR001774; DSL.
DR   InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR000152; EGF-type_Asp/Asn_hydroxyl_site.
DR   InterPro; IPR018097; EGF_Ca-bd_CS.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   InterPro; IPR011651; Notch_ligand_N.
DR   Pfam; PF01414; DSL; 1.
DR   Pfam; PF00008; EGF; 6.
DR   Pfam; PF12661; hEGF; 1.
DR   Pfam; PF07657; MNNL; 1.
DR   SMART; SM00051; DSL; 1.
DR   SMART; SM00181; EGF; 9.
DR   SMART; SM00179; EGF_CA; 7.
DR   SUPFAM; SSF57184; SSF57184; 1.
DR   PROSITE; PS00010; ASX_HYDROXYL; 3.
DR   PROSITE; PS51051; DSL; 1.
DR   PROSITE; PS00022; EGF_1; 9.
DR   PROSITE; PS01186; EGF_2; 9.
DR   PROSITE; PS50026; EGF_3; 7.
DR   PROSITE; PS01187; EGF_CA; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Developmental protein;
KW   Differentiation; Disulfide bond; EGF-like domain; Glycoprotein;
KW   Membrane; Neurogenesis; Notch signaling pathway; Phosphoprotein;
KW   Reference proteome; Repeat; Signal; Transmembrane;
KW   Transmembrane helix; Ubl conjugation.
FT   SIGNAL        1     18       {ECO:0000255}.
FT   CHAIN        19    833       Neurogenic locus protein delta.
FT                                /FTId=PRO_0000007505.
FT   TOPO_DOM     19    594       Extracellular. {ECO:0000255}.
FT   TRANSMEM    595    617       Helical. {ECO:0000255}.
FT   TOPO_DOM    618    833       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      182    226       DSL. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00377}.
FT   DOMAIN      227    258       EGF-like 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      256    289       EGF-like 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      291    329       EGF-like 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      331    372       EGF-like 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      374    416       EGF-like 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      418    451       EGF-like 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      453    489       EGF-like 7; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      491    527       EGF-like 8. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      529    565       EGF-like 9; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   MOD_RES     666    666       Phosphothreonine.
FT                                {ECO:0000269|PubMed:18327897}.
FT   CARBOHYD     98     98       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    137    137       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    167    167       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     46     61       {ECO:0000250|UniProtKB:D3ZHH1}.
FT   DISULFID     68     82       {ECO:0000250|UniProtKB:D3ZHH1}.
FT   DISULFID    184    193       {ECO:0000250|UniProtKB:D3ZHH1,
FT                                ECO:0000255|PROSITE-ProRule:PRU00377}.
FT   DISULFID    197    209       {ECO:0000250|UniProtKB:D3ZHH1,
FT                                ECO:0000255|PROSITE-ProRule:PRU00377}.
FT   DISULFID    217    226       {ECO:0000250|UniProtKB:D3ZHH1,
FT                                ECO:0000255|PROSITE-ProRule:PRU00377}.
FT   DISULFID    231    240       {ECO:0000250|UniProtKB:D3ZHH1,
FT                                ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    235    246       {ECO:0000250|UniProtKB:D3ZHH1,
FT                                ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    248    257       {ECO:0000250|UniProtKB:D3ZHH1,
FT                                ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    260    271       {ECO:0000250|UniProtKB:D3ZHH1}.
FT   DISULFID    266    277       {ECO:0000250|UniProtKB:D3ZHH1}.
FT   DISULFID    279    288       {ECO:0000250|UniProtKB:D3ZHH1,
FT                                ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    295    307       {ECO:0000250}.
FT   DISULFID    301    317       {ECO:0000250}.
FT   DISULFID    319    328       {ECO:0000250}.
FT   DISULFID    335    348       {ECO:0000250}.
FT   DISULFID    342    360       {ECO:0000250}.
FT   DISULFID    362    371       {ECO:0000250}.
FT   DISULFID    378    388       {ECO:0000250}.
FT   DISULFID    383    404       {ECO:0000250}.
FT   DISULFID    406    415       {ECO:0000250}.
FT   DISULFID    422    433       {ECO:0000250}.
FT   DISULFID    427    439       {ECO:0000250}.
FT   DISULFID    441    450       {ECO:0000250}.
FT   DISULFID    457    468       {ECO:0000250}.
FT   DISULFID    462    477       {ECO:0000250}.
FT   DISULFID    479    488       {ECO:0000250}.
FT   DISULFID    495    506       {ECO:0000250}.
FT   DISULFID    500    515       {ECO:0000250}.
FT   DISULFID    517    526       {ECO:0000250}.
FT   DISULFID    533    544       {ECO:0000250}.
FT   DISULFID    538    553       {ECO:0000250}.
FT   DISULFID    555    564       {ECO:0000250}.
FT   VARIANT     398    398       K -> R (in strain: sonoma_017).
FT   VARIANT     443    443       A -> T (in strain: sonoma_009,
FT                                sonoma_051, sonoma_053 and sonoma_054).
FT   VARIANT     461    461       Q -> K (in strain: sonoma_010,
FT                                sonoma_013, sonoma_019 and sonoma_117).
FT   VARIANT     652    652       G -> A (in strain: NapaValley5,
FT                                NapaValley12, sonoma_015, sonoma_016,
FT                                sonoma_023, sonoma_032, sonoma_034,
FT                                sonoma_038, sonoma_040, sonoma_045,
FT                                sonoma_048, sonoma_050, sonoma_061,
FT                                sonoma_073, sonoma_081, sonoma_085,
FT                                sonoma_094, sonoma_097 and sonoma_119).
FT                                {ECO:0000269|PubMed:16453806}.
FT   VARIANT     662    662       L -> M (in strain: sonoma_008,
FT                                sonoma_015, sonoma_016, sonoma_032,
FT                                sonoma_034, sonoma_038, sonoma_040,
FT                                sonoma_045, sonoma_048, sonoma_050,
FT                                sonoma_061, sonoma_073, sonoma_081,
FT                                sonoma_085, sonoma_094 and sonoma_097).
FT                                {ECO:0000269|PubMed:16453806}.
FT   VARIANT     761    761       A -> T (in strain: sonoma_006, sonoma_022
FT                                and sonoma_040).
FT   VARIANT     787    787       S -> G (in strain: nps_6, nps_18, nps_34,
FT                                sonoma_048 and sonoma_050).
FT   VARIANT     800    800       G -> R (in strain: sonoma_002).
FT   VARIANT     812    812       V -> A (in strain: nps_19, nps_21,
FT                                nps_25, nps_26, nps_27, nps_30, nps_31,
FT                                nps_33, nps_35, nps_42, nps_43, nps_45,
FT                                nps_47, sonoma_002, sonoma_003,
FT                                sonoma_004, sonoma_005, sonoma_006,
FT                                sonoma_007, sonoma_008, sonoma_009,
FT                                sonoma_014, sonoma_016, sonoma_017,
FT                                sonoma_022, sonoma_024, sonoma_032,
FT                                sonoma_033, sonoma_036, sonoma_038,
FT                                sonoma_045, sonoma_051, sonoma_053,
FT                                sonoma_054, sonoma_055, sonoma_059,
FT                                sonoma_061, sonoma_064, sonoma_081,
FT                                sonoma_086, sonoma_087, sonoma_094,
FT                                sonoma_095, sonoma_097, sonoma_106,
FT                                sonoma_107 and sonoma_119).
FT                                {ECO:0000269|PubMed:3149249}.
FT   CONFLICT    437    438       GK -> ET (in Ref. 8; CAA28786).
FT                                {ECO:0000305}.
FT   CONFLICT    443    443       A -> S (in Ref. 8; CAA28786).
FT                                {ECO:0000305}.
FT   CONFLICT    459    459       G -> A (in Ref. 8; CAA28786).
FT                                {ECO:0000305}.
FT   CONFLICT    490    490       S -> T (in Ref. 8; CAA28786).
FT                                {ECO:0000305}.
FT   CONFLICT    591    591       T -> A (in Ref. 8; CAA28786).
FT                                {ECO:0000305}.
SQ   SEQUENCE   833 AA;  88841 MW;  EDBA107A0003D9A1 CRC64;
     MHWIKCLLTA FICFTVIVQV HSSGSFELRL KYFSNDHGRD NEGRCCSGES DGATGKCLGS
     CKTRFRVCLK HYQATIDTTS QCTYGDVITP ILGENSVNLT DAQRFQNKGF TNPIQFPFSF
     SWPGTFSLIV EAWHDTNNSG NARTNKLLIQ RLLVQQVLEV SSEWKTNKSE SQYTSLEYDF
     RVTCDLNYYG SGCAKFCRPR DDSFGHSTCS ETGEIICLTG WQGDYCHIPK CAKGCEHGHC
     DKPNQCVCQL GWKGALCNEC VLEPNCIHGT CNKPWTCICN EGWGGLYCNQ DLNYCTNHRP
     CKNGGTCFNT GEGLYTCKCA PGYSGDDCEN EIYSCDADVN PCQNGGTCID EPHTKTGYKC
     HCANGWSGKM CEEKVLTCSD KPCHQGICRN VRPGLGSKGQ GYQCECPIGY SGPNCDLQLD
     NCSPNPCING GSCQPSGKCI CPAGFSGTRC ETNIDDCLGH QCENGGTCID MVNQYRCQCV
     PGFHGTHCSS KVDLCLIRPC ANGGTCLNLN NDYQCTCRAG FTGKDCSVDI DECSSGPCHN
     GGTCMNRVNS FECVCANGFR GKQCDEESYD SVTFDAHQYG ATTQARADGL TNAQVVLIAV
     FSVAMPLVAV IAACVVFCMK RKRKRAQEKD DAEARKQNEQ NAVATMHHNG SGVGVALASA
     SLGGKTGSNS GLTFDGGNPN IIKNTWDKSV NNICASAAAA AAAAAAADEC LMYGGYVASV
     ADNNNANSDF CVAPLQRAKS QKQLNTDPTL MHRGSPAGSS AKGASGGGPG AAEGKRISVL
     GEGSYCSQRW PSLAAAGVAG ACSSQLMAAA SVAGSGAGTA QQQRSVVCGT PHM
//
ID   JAG1_HUMAN              Reviewed;        1218 AA.
AC   P78504; A0AV43; B4DYR1; E9PCF9; O14902; O15122; Q15816;
DT   02-MAY-2002, integrated into UniProtKB/Swiss-Prot.
DT   02-MAY-2002, sequence version 3.
DT   20-DEC-2017, entry version 191.
DE   RecName: Full=Protein jagged-1;
DE            Short=Jagged1;
DE            Short=hJ1;
DE   AltName: CD_antigen=CD339;
DE   Flags: Precursor;
GN   Name=JAG1; Synonyms=JAGL1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=9268641; DOI=10.1006/geno.1997.4820;
RA   Oda T., Elkahloun A.G., Meltzer P.S., Chandrasekharappa S.C.;
RT   "Identification and cloning of the human homolog (JAG1) of the rat
RT   Jagged1 gene from the Alagille syndrome critical region at 20p12.";
RL   Genomics 43:376-379(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INVOLVEMENT IN ALGS1, AND
RP   VARIANT ALGS1 CYS-184.
RC   TISSUE=Bone marrow;
RX   PubMed=9207788; DOI=10.1038/ng0797-243;
RA   Li L., Krantz I.D., Deng Y., Genin A., Banta A.B., Collins C.C.,
RA   Qi M., Trask B.J., Kuo W.L., Cochran J., Costa T., Pierpont M.E.M.,
RA   Rand E.B., Piccoli D.A., Hood L., Spinner N.B.;
RT   "Alagille syndrome is caused by mutations in human Jagged1, which
RT   encodes a ligand for Notch1.";
RL   Nat. Genet. 16:243-251(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND FUNCTION.
RX   PubMed=9462510; DOI=10.1016/S1074-7613(00)80457-4;
RA   Li L., Milner L.A., Deng Y., Iwata M., Banta A.B., Graf L.,
RA   Marcovina S., Friedman C., Trask B.J., Hood L., Torok-Storb B.;
RT   "The human homolog of rat Jagged1 expressed by marrow stroma inhibits
RT   differentiation of 32D cells through interaction with Notch1.";
RL   Immunity 8:43-55(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Cervix carcinoma;
RX   PubMed=10329626; DOI=10.1093/emboj/18.10.2803;
RA   Bash J., Zong W.-X., Banga S., Rivera A., Ballard D.W., Ron Y.,
RA   Gelinas C.;
RT   "Rel/NF-kappaB can trigger the Notch signaling pathway by inducing the
RT   expression of Jagged1, a ligand for Notch receptors.";
RL   EMBO J. 18:2803-2811(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=10079256; DOI=10.1016/S0002-9440(10)65325-4;
RA   Gray G.E., Mann R.S., Mitsiadis E., Henrique D., Carcangiu M.-L.,
RA   Banks A., Leiman J., Ward D., Ish-Horowitz D., Artavanis-Tsakonas S.;
RT   "Human ligands of the Notch receptor.";
RL   Am. J. Pathol. 154:785-794(1999).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 14-1218 (ISOFORM 1).
RC   TISSUE=Umbilical vein endothelial cell;
RX   PubMed=8955070; DOI=10.1074/jbc.271.51.32499;
RA   Zimrin A.B., Pepper M.S., McMahon G.A., Nguyen F., Montesano R.,
RA   Maciag T.;
RT   "An antisense oligonucleotide to the notch ligand Jagged enhances
RT   fibroblast growth factor-induced angiogenesis in vitro.";
RL   J. Biol. Chem. 271:32499-32502(1996).
RN   [10]
RP   DISEASE.
RX   PubMed=9207787; DOI=10.1038/ng0797-235;
RA   Oda T., Elkahloun A.G., Pike B.L., Okajima K., Krantz I.D., Genin A.,
RA   Piccoli D.A., Meltzer P.S., Spinner N.B., Collins F.S.,
RA   Chandrasekharappa S.C.;
RT   "Mutations in the human Jagged1 gene are responsible for Alagille
RT   syndrome.";
RL   Nat. Genet. 16:235-242(1997).
RN   [11]
RP   DEVELOPMENTAL STAGE.
RX   PubMed=10978356; DOI=10.1136/jmg.37.9.658;
RA   Jones E.A., Clement-Jones M., Wilson D.I.;
RT   "JAGGED1 expression in human embryos: correlation with the Alagille
RT   syndrome phenotype.";
RL   J. Med. Genet. 37:658-662(2000).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 185-335, FUNCTION,
RP   INTERACTION WITH NOTCH1, DOMAIN, MUTAGENESIS OF PHE-207, AND DISULFIDE
RP   BONDS.
RX   PubMed=18660822; DOI=10.1038/nsmb.1457;
RA   Cordle J., Johnson S., Tay J.Z., Roversi P., Wilkin M.B.,
RA   de Madrid B.H., Shimizu H., Jensen S., Whiteman P., Jin B.,
RA   Redfield C., Baron M., Lea S.M., Handford P.A.;
RT   "A conserved face of the Jagged/Serrate DSL domain is involved in
RT   Notch trans-activation and cis-inhibition.";
RL   Nat. Struct. Mol. Biol. 15:849-857(2008).
RN   [14]
RP   STRUCTURE BY NMR OF 252-295, DOMAIN, AND DISULFIDE BONDS.
RX   PubMed=19586525; DOI=10.1186/1472-6807-9-43;
RA   Pintar A., Guarnaccia C., Dhir S., Pongor S.;
RT   "Exon 6 of human JAG1 encodes a conserved structural unit.";
RL   BMC Struct. Biol. 9:43-43(2009).
RN   [15]
RP   VARIANTS ALGS1 CYS-184 AND HIS-184.
RX   PubMed=9585603; DOI=10.1086/301875;
RA   Krantz I.D., Colliton R.P., Genin A., Rand E.B., Li L., Piccoli D.A.,
RA   Spinner N.B.;
RT   "Spectrum and frequency of Jagged1 (JAG1) mutations in Alagille
RT   syndrome patients and their families.";
RL   Am. J. Hum. Genet. 62:1361-1369(1998).
RN   [16]
RP   VARIANTS ALGS1 HIS-79; THR-127; ARG-129; LEU-163; GLY-184; SER-187;
RP   GLY-229; PHE-284; CYS-288; PHE-438; SER-731 AND ARG-740.
RX   PubMed=10220506; DOI=10.1016/S0016-5085(99)70017-X;
RA   Crosnier C., Driancourt C., Raynaud N., Dhorne-Pollet S., Pollet N.,
RA   Bernard O., Hadchouel M., Meunier-Rotival M.;
RT   "Mutations in JAGGED1 gene are predominantly sporadic in Alagille
RT   syndrome.";
RL   Gastroenterology 116:1141-1148(1999).
RN   [17]
RP   VARIANTS ALGS1 THR-152 AND LEU-184.
RX   PubMed=10533065;
RX   DOI=10.1002/(SICI)1098-1004(199911)14:5<394::AID-HUMU5>3.0.CO;2-1;
RA   Pilia G., Uda M., Macis D., Frau F., Crisponi L., Balli F.,
RA   Barbera C., Colombo C., Frediani T., Gatti R., Iorio R., Marazzi M.G.,
RA   Marcellini M., Musumeci S., Nebbia G., Vajro P., Ruffa G., Zancan L.,
RA   Cao A., DeVirgilis S.;
RT   "Jagged-1 mutation analysis in Italian Alagille syndrome patients.";
RL   Hum. Mutat. 14:394-400(1999).
RN   [18]
RP   VARIANTS ALGS1 TYR-229 AND ARG-386.
RX   PubMed=11058898;
RX   DOI=10.1002/1098-1004(200011)16:5<408::AID-HUMU5>3.0.CO;2-9;
RA   Heritage M.L., MacMillan J.C., Colliton R.P., Genin A., Spinner N.B.,
RA   Anderson G.J.;
RT   "Jagged1 (JAG1) mutation detection in an Australian Alagille syndrome
RT   population.";
RL   Hum. Mutat. 16:408-416(2000).
RN   [19]
RP   VARIANT TOF ASP-274.
RX   PubMed=11152664; DOI=10.1093/hmg/10.2.163;
RA   Eldadah Z.A., Hamosh A., Biery N.J., Montgomery R.A., Duke M.,
RA   Elkins R., Dietz H.C.;
RT   "Familial tetralogy of Fallot caused by mutation in the Jagged1
RT   gene.";
RL   Hum. Mol. Genet. 10:163-169(2001).
RN   [20]
RP   VARIANT ALGS1 SER-37.
RX   PubMed=11157803; DOI=10.1093/hmg/10.4.405;
RA   Morrissette J.J.D., Colliton R.P., Spinner N.B.;
RT   "Defective intracellular transport and processing of JAG1 missense
RT   mutations in Alagille syndrome.";
RL   Hum. Mol. Genet. 10:405-413(2001).
RN   [21]
RP   VARIANTS ALGS1 PHE-220 AND ARG-753.
RX   PubMed=11139247;
RX   DOI=10.1002/1098-1004(2001)17:1<72::AID-HUMU11>3.0.CO;2-U;
RA   Crosnier C., Driancourt C., Raynaud N., Hadchouel M.,
RA   Meunier-Rotival M.;
RT   "Fifteen novel mutations in the JAGGED1 gene of patients with Alagille
RT   syndrome.";
RL   Hum. Mutat. 17:72-73(2001).
RN   [22]
RP   VARIANTS ALGS1 ASP-33; SER-37; SER-78; ASN-181; TYR-714 AND SER-902.
RX   PubMed=11180599;
RX   DOI=10.1002/1098-1004(200102)17:2<151::AID-HUMU8>3.3.CO;2-K;
RA   Colliton R.P., Bason L., Lu F.-M., Piccoli D.A., Krantz I.D.,
RA   Spinner N.B.;
RT   "Mutation analysis of Jagged1 (JAG1) in Alagille syndrome patients.";
RL   Hum. Mutat. 17:151-152(2001).
RN   [23]
RP   VARIANT DEAFNESS TYR-234.
RX   PubMed=12022040; DOI=10.1086/341327;
RA   Le Caignec C., Lefevre M., Schott J.J., Chaventre A., Gayet M.,
RA   Calais C., Moisan J.P.;
RT   "Familial deafness, congenital heart defects, and posterior
RT   embryotoxon caused by cysteine substitution in the first epidermal-
RT   growth-factor-like domain of Jagged 1.";
RL   Am. J. Hum. Genet. 71:180-186(2002).
RN   [24]
RP   VARIANTS BILIARY ATRESIA LEU-45; ASP-53; MET-65; LYS-203; ASP-690;
RP   ARG-871; GLN-908; PRO-921 AND GLN-1213.
RX   PubMed=12297837; DOI=10.1053/jhep.2002.35820;
RA   Kohsaka T., Yuan Z.-R., Guo S.-X., Tagawa M., Nakamura A., Nakano M.,
RA   Kawasasaki H., Inomata Y., Tanaka K., Miyauchi J.;
RT   "The significance of human Jagged 1 mutations detected in severe cases
RT   of extrahepatic biliary atresia.";
RL   Hepatology 36:904-912(2002).
RN   [25]
RP   VARIANTS ALGS1 SER-39; HIS-184 AND ARG-913.
RX   PubMed=12442286; DOI=10.1002/humu.9095;
RA   Heritage M.L., MacMillan J.C., Anderson G.J.;
RT   "DHPLC mutation analysis of Jagged1 (JAG1) reveals six novel mutations
RT   in Australian Alagille syndrome patients.";
RL   Hum. Mutat. 20:481-481(2002).
RN   [26]
RP   CHARACTERIZATION OF VARIANT ASP-274.
RX   PubMed=12649809; DOI=10.1086/374386;
RA   Lu F., Morrissette J.J.D., Spinner N.B.;
RT   "Conditional JAG1 mutation shows the developing heart is more
RT   sensitive than developing liver to JAG1 dosage.";
RL   Am. J. Hum. Genet. 72:1065-1070(2003).
RN   [27]
RP   VARIANTS ALGS1 VAL-31; PRO-40; SER-75; SER-123; ARG-163; CYS-224;
RP   LEU-269 AND GLN-937.
RX   PubMed=12497640; DOI=10.1002/humu.9102;
RA   Roepke A., Kujat A., Graeber M., Giannakudis J., Hansmann I.;
RT   "Identification of 36 novel Jagged1 (JAG1) mutations in patients with
RT   Alagille syndrome.";
RL   Hum. Mutat. 21:100-100(2003).
RN   [28]
RP   VARIANTS ALGS1 ASN-120 AND TYR-187.
RX   PubMed=15712272; DOI=10.1002/humu.9313;
RA   Jurkiewicz D., Popowska E., Glaeser C., Hansmann I.,
RA   Krajewska-Walasek M.;
RT   "Twelve novel JAG1 gene mutations in Polish Alagille syndrome
RT   patients.";
RL   Hum. Mutat. 25:321-321(2005).
RN   [29]
RP   VARIANTS ALGS1 22-CYS--ARG-25 DEL; SER-33; VAL-33; ARG-92; TYR-92;
RP   PRO-155; GLY-252; SER-256; ARG-271; SER-504; TYR-693; GLN-889; TYR-911
RP   AND 1055-VAL-ARG-1056 GLY DELINS, AND VARIANT LYS-818.
RX   PubMed=16575836; DOI=10.1002/humu.20310;
RA   Warthen D.M., Moore E.C., Kamath B.M., Morrissette J.J.D., Sanchez P.,
RA   Piccoli D.A., Krantz I.D., Spinner N.B.;
RT   "Jagged1 (JAG1) mutations in Alagille syndrome: increasing the
RT   mutation detection rate.";
RL   Hum. Mutat. 27:436-443(2006).
RN   [30]
RP   VARIANT ALGS1 TRP-436.
RX   PubMed=23801938; DOI=10.1159/000347231;
RA   Vozzi D., Licastro D., Martelossi S., Athanasakis E., Gasparini P.,
RA   Fabretto A.;
RT   "Alagille Syndrome: A new missense mutation detected by whole-exome
RT   sequencing in a case previously found to be negative by DHPLC and
RT   MLPA.";
RL   Mol. Syndromol. 4:207-210(2013).
CC   -!- FUNCTION: Ligand for multiple Notch receptors and involved in the
CC       mediation of Notch signaling. May be involved in cell-fate
CC       decisions during hematopoiesis. Seems to be involved in early and
CC       late stages of mammalian cardiovascular development. Inhibits
CC       myoblast differentiation (By similarity). Enhances fibroblast
CC       growth factor-induced angiogenesis (in vitro). {ECO:0000250,
CC       ECO:0000269|PubMed:18660822, ECO:0000269|PubMed:9462510}.
CC   -!- SUBUNIT: Interacts with NOTCH2 and NOTCH3 (By similarity).
CC       Interacts with NOTCH1 (in the presence of calcium ions)
CC       (PubMed:18660822). {ECO:0000250|UniProtKB:Q9QXX0,
CC       ECO:0000269|PubMed:18660822}.
CC   -!- INTERACTION:
CC       P15529:CD46; NbExp=5; IntAct=EBI-2847071, EBI-2623451;
CC       P46531:NOTCH1; NbExp=6; IntAct=EBI-2847071, EBI-636374;
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P78504-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P78504-2; Sequence=VSP_056532;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Widely expressed in adult and fetal tissues.
CC       In cervix epithelium expressed in undifferentiated subcolumnar
CC       reserve cells and squamous metaplasia. Expression is up-regulated
CC       in cervical squamous cell carcinoma. Expressed in bone marrow cell
CC       line HS-27a which supports the long-term maintenance of immature
CC       progenitor cells.
CC   -!- DEVELOPMENTAL STAGE: Expressed in 32-52 days embryos in the distal
CC       cardiac outflow tract and pulmonary artery, major arteries, portal
CC       vein, optic vesicle, otocyst, branchial arches, metanephros,
CC       pancreas, mesocardium, around the major bronchial branches, and in
CC       the neural tube. {ECO:0000269|PubMed:10978356}.
CC   -!- DOMAIN: The second EGF-like domain is atypical.
CC       {ECO:0000269|PubMed:18660822, ECO:0000269|PubMed:19586525}.
CC   -!- DISEASE: Alagille syndrome 1 (ALGS1) [MIM:118450]: A form of
CC       Alagille syndrome, an autosomal dominant multisystem disorder. It
CC       is clinically defined by hepatic bile duct paucity and cholestasis
CC       in association with cardiac, skeletal, and ophthalmologic
CC       manifestations. There are characteristic facial features and less
CC       frequent clinical involvement of the renal and vascular systems.
CC       {ECO:0000269|PubMed:10220506, ECO:0000269|PubMed:10533065,
CC       ECO:0000269|PubMed:11058898, ECO:0000269|PubMed:11139247,
CC       ECO:0000269|PubMed:11157803, ECO:0000269|PubMed:11180599,
CC       ECO:0000269|PubMed:12442286, ECO:0000269|PubMed:12497640,
CC       ECO:0000269|PubMed:15712272, ECO:0000269|PubMed:16575836,
CC       ECO:0000269|PubMed:23801938, ECO:0000269|PubMed:9207788,
CC       ECO:0000269|PubMed:9585603}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Tetralogy of Fallot (TOF) [MIM:187500]: A congenital
CC       heart anomaly which consists of pulmonary stenosis, ventricular
CC       septal defect, dextroposition of the aorta (aorta is on the right
CC       side instead of the left) and hypertrophy of the right ventricle.
CC       In this condition, blood from both ventricles (oxygen-rich and
CC       oxygen-poor) is pumped into the body often causing cyanosis.
CC       {ECO:0000269|PubMed:11152664}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC51323.1; Type=Frameshift; Positions=1187; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/JAG1ID41029ch20p12.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF003837; AAC51731.1; -; mRNA.
DR   EMBL; U73936; AAC52020.1; -; mRNA.
DR   EMBL; AF028593; AAB84053.1; -; mRNA.
DR   EMBL; U61276; AAB39007.1; -; mRNA.
DR   EMBL; AK302554; BAG63823.1; -; mRNA.
DR   EMBL; AL035456; CAC07198.1; -; Genomic_DNA.
DR   EMBL; BC126205; AAI26206.1; -; mRNA.
DR   EMBL; BC126207; AAI26208.1; -; mRNA.
DR   EMBL; U77720; AAC51323.1; ALT_FRAME; mRNA.
DR   CCDS; CCDS13112.1; -. [P78504-1]
DR   RefSeq; NP_000205.1; NM_000214.2. [P78504-1]
DR   RefSeq; XP_016883196.1; XM_017027707.1. [P78504-2]
DR   UniGene; Hs.224012; -.
DR   UniGene; Hs.626544; -.
DR   PDB; 2KB9; NMR; -; A=252-295.
DR   PDB; 2VJ2; X-ray; 2.50 A; A/B=185-335.
DR   PDB; 4CBZ; X-ray; 2.50 A; A/B=32-335.
DR   PDB; 4CC0; X-ray; 2.32 A; A/B=32-335.
DR   PDB; 4CC1; X-ray; 2.84 A; A/B=32-335.
DR   PDB; 4XI7; X-ray; 2.05 A; C=1120-1130.
DR   PDB; 5BO1; X-ray; 2.56 A; A/B=186-335.
DR   PDBsum; 2KB9; -.
DR   PDBsum; 2VJ2; -.
DR   PDBsum; 4CBZ; -.
DR   PDBsum; 4CC0; -.
DR   PDBsum; 4CC1; -.
DR   PDBsum; 4XI7; -.
DR   PDBsum; 5BO1; -.
DR   DisProt; DP00418; -.
DR   ProteinModelPortal; P78504; -.
DR   SMR; P78504; -.
DR   BioGrid; 106689; 9.
DR   DIP; DIP-46371N; -.
DR   IntAct; P78504; 10.
DR   MINT; MINT-2804836; -.
DR   STRING; 9606.ENSP00000254958; -.
DR   ChEMBL; CHEMBL3217396; -.
DR   iPTMnet; P78504; -.
DR   PhosphoSitePlus; P78504; -.
DR   SwissPalm; P78504; -.
DR   BioMuta; JAG1; -.
DR   DMDM; 20455033; -.
DR   EPD; P78504; -.
DR   MaxQB; P78504; -.
DR   PaxDb; P78504; -.
DR   PeptideAtlas; P78504; -.
DR   PRIDE; P78504; -.
DR   DNASU; 182; -.
DR   Ensembl; ENST00000254958; ENSP00000254958; ENSG00000101384. [P78504-1]
DR   GeneID; 182; -.
DR   KEGG; hsa:182; -.
DR   UCSC; uc002wnw.3; human. [P78504-1]
DR   CTD; 182; -.
DR   DisGeNET; 182; -.
DR   EuPathDB; HostDB:ENSG00000101384.11; -.
DR   GeneCards; JAG1; -.
DR   GeneReviews; JAG1; -.
DR   HGNC; HGNC:6188; JAG1.
DR   HPA; CAB010343; -.
DR   HPA; HPA021555; -.
DR   MalaCards; JAG1; -.
DR   MIM; 118450; phenotype.
DR   MIM; 187500; phenotype.
DR   MIM; 601920; gene+phenotype.
DR   neXtProt; NX_P78504; -.
DR   OpenTargets; ENSG00000101384; -.
DR   Orphanet; 261600; Alagille syndrome due to 20p12 microdeletion.
DR   Orphanet; 261619; Alagille syndrome due to a JAG1 point mutation.
DR   Orphanet; 3303; Tetralogy of Fallot.
DR   PharmGKB; PA29986; -.
DR   eggNOG; KOG1217; Eukaryota.
DR   eggNOG; ENOG410XP6K; LUCA.
DR   GeneTree; ENSGT00810000125346; -.
DR   HOGENOM; HOG000113124; -.
DR   HOVERGEN; HBG031645; -.
DR   InParanoid; P78504; -.
DR   KO; K06052; -.
DR   OMA; CLCETNW; -.
DR   OrthoDB; EOG091G0A88; -.
DR   PhylomeDB; P78504; -.
DR   TreeFam; TF351835; -.
DR   Reactome; R-HSA-1980148; Signaling by NOTCH3.
DR   Reactome; R-HSA-1980150; Signaling by NOTCH4.
DR   Reactome; R-HSA-2122948; Activated NOTCH1 Transmits Signal to the Nucleus.
DR   Reactome; R-HSA-2644606; Constitutive Signaling by NOTCH1 PEST Domain Mutants.
DR   Reactome; R-HSA-2660826; Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant.
DR   Reactome; R-HSA-2691232; Constitutive Signaling by NOTCH1 HD Domain Mutants.
DR   Reactome; R-HSA-2894862; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants.
DR   Reactome; R-HSA-2979096; NOTCH2 Activation and Transmission of Signal to the Nucleus.
DR   Reactome; R-HSA-8941856; RUNX3 regulates NOTCH signaling.
DR   SignaLink; P78504; -.
DR   SIGNOR; P78504; -.
DR   ChiTaRS; JAG1; human.
DR   EvolutionaryTrace; P78504; -.
DR   GeneWiki; JAG1; -.
DR   GenomeRNAi; 182; -.
DR   PRO; PR:P78504; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   Bgee; ENSG00000101384; -.
DR   CleanEx; HS_JAG1; -.
DR   ExpressionAtlas; P78504; baseline and differential.
DR   Genevisible; P78504; HS.
DR   GO; GO:0005912; C:adherens junction; ISS:UniProtKB.
DR   GO; GO:0016324; C:apical plasma membrane; ISS:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; NAS:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; NAS:UniProtKB.
DR   GO; GO:0016020; C:membrane; TAS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0008083; F:growth factor activity; NAS:UniProtKB.
DR   GO; GO:0005112; F:Notch binding; IPI:UniProtKB.
DR   GO; GO:0005543; F:phospholipid binding; IMP:CAFA.
DR   GO; GO:0005198; F:structural molecule activity; NAS:UniProtKB.
DR   GO; GO:0001525; P:angiogenesis; NAS:UniProtKB.
DR   GO; GO:0035909; P:aorta morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0042491; P:auditory receptor cell differentiation; IEA:Ensembl.
DR   GO; GO:0001974; P:blood vessel remodeling; IEA:Ensembl.
DR   GO; GO:0061309; P:cardiac neural crest cell development involved in outflow tract morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0003215; P:cardiac right ventricle morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0060411; P:cardiac septum morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0001709; P:cell fate determination; NAS:UniProtKB.
DR   GO; GO:0061073; P:ciliary body morphogenesis; IEA:Ensembl.
DR   GO; GO:0072017; P:distal tubule development; IEA:Ensembl.
DR   GO; GO:0061444; P:endocardial cushion cell development; ISS:BHF-UCL.
DR   GO; GO:0045446; P:endothelial cell differentiation; NAS:UniProtKB.
DR   GO; GO:0072015; P:glomerular visceral epithelial cell development; ISS:UniProtKB.
DR   GO; GO:0030097; P:hemopoiesis; NAS:UniProtKB.
DR   GO; GO:0030216; P:keratinocyte differentiation; NAS:UniProtKB.
DR   GO; GO:0072070; P:loop of Henle development; IEA:Ensembl.
DR   GO; GO:0002011; P:morphogenesis of an epithelial sheet; IEA:Ensembl.
DR   GO; GO:0045445; P:myoblast differentiation; NAS:UniProtKB.
DR   GO; GO:0045602; P:negative regulation of endothelial cell differentiation; IEA:Ensembl.
DR   GO; GO:0045599; P:negative regulation of fat cell differentiation; IEA:Ensembl.
DR   GO; GO:0045665; P:negative regulation of neuron differentiation; IEA:Ensembl.
DR   GO; GO:2000737; P:negative regulation of stem cell differentiation; IMP:UniProtKB.
DR   GO; GO:0072006; P:nephron development; ISS:UniProtKB.
DR   GO; GO:0007399; P:nervous system development; NAS:UniProtKB.
DR   GO; GO:0097150; P:neuronal stem cell population maintenance; IEP:UniProtKB.
DR   GO; GO:0007220; P:Notch receptor processing; TAS:Reactome.
DR   GO; GO:0061314; P:Notch signaling involved in heart development; IMP:BHF-UCL.
DR   GO; GO:0007219; P:Notch signaling pathway; IMP:UniProtKB.
DR   GO; GO:0045639; P:positive regulation of myeloid cell differentiation; IEA:Ensembl.
DR   GO; GO:0045747; P:positive regulation of Notch signaling pathway; ISS:UniProtKB.
DR   GO; GO:0045669; P:positive regulation of osteoblast differentiation; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL.
DR   GO; GO:0061156; P:pulmonary artery morphogenesis; IMP:BHF-UCL.
DR   GO; GO:0003184; P:pulmonary valve morphogenesis; IMP:BHF-UCL.
DR   GO; GO:0030334; P:regulation of cell migration; NAS:UniProtKB.
DR   GO; GO:0042127; P:regulation of cell proliferation; NAS:UniProtKB.
DR   GO; GO:0032495; P:response to muramyl dipeptide; IEA:Ensembl.
DR   GO; GO:0002456; P:T cell mediated immunity; IMP:UniProtKB.
DR   InterPro; IPR001774; DSL.
DR   InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR000152; EGF-type_Asp/Asn_hydroxyl_site.
DR   InterPro; IPR018097; EGF_Ca-bd_CS.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   InterPro; IPR026219; Jagged/Serrate.
DR   InterPro; IPR011651; Notch_ligand_N.
DR   InterPro; IPR001007; VWF_dom.
DR   Pfam; PF01414; DSL; 1.
DR   Pfam; PF00008; EGF; 10.
DR   Pfam; PF07645; EGF_CA; 1.
DR   Pfam; PF12661; hEGF; 1.
DR   Pfam; PF07657; MNNL; 1.
DR   PRINTS; PR02059; JAGGEDFAMILY.
DR   SMART; SM00051; DSL; 1.
DR   SMART; SM00181; EGF; 16.
DR   SMART; SM00179; EGF_CA; 14.
DR   SMART; SM00214; VWC; 1.
DR   SMART; SM00215; VWC_out; 1.
DR   SUPFAM; SSF57184; SSF57184; 3.
DR   PROSITE; PS00010; ASX_HYDROXYL; 10.
DR   PROSITE; PS51051; DSL; 1.
DR   PROSITE; PS00022; EGF_1; 16.
DR   PROSITE; PS01186; EGF_2; 12.
DR   PROSITE; PS50026; EGF_3; 15.
DR   PROSITE; PS01187; EGF_CA; 8.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Complete proteome;
KW   Developmental protein; Disease mutation; Disulfide bond;
KW   EGF-like domain; Glycoprotein; Membrane; Notch signaling pathway;
KW   Polymorphism; Reference proteome; Repeat; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     33       {ECO:0000255}.
FT   CHAIN        34   1218       Protein jagged-1.
FT                                /FTId=PRO_0000007625.
FT   TOPO_DOM     34   1067       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1068   1093       Helical. {ECO:0000255}.
FT   TOPO_DOM   1094   1218       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      185    229       DSL. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00377}.
FT   DOMAIN      230    263       EGF-like 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      264    294       EGF-like 2; atypical.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      296    334       EGF-like 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      336    372       EGF-like 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      374    410       EGF-like 5; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      412    448       EGF-like 6; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      450    485       EGF-like 7; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      487    523       EGF-like 8; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      525    561       EGF-like 9. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      586    627       EGF-like 10. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      629    665       EGF-like 11; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      667    703       EGF-like 12; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      705    741       EGF-like 13. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      744    780       EGF-like 14. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      782    818       EGF-like 15; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      820    856       EGF-like 16; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   REGION      199    207       Important for interaction with NOTCH1.
FT                                {ECO:0000269|PubMed:18660822}.
FT   CARBOHYD    143    143       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    217    217       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    382    382       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    559    559       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    745    745       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    960    960       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    991    991       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1045   1045       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1064   1064       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    187    196
FT   DISULFID    200    212
FT   DISULFID    220    229
FT   DISULFID    234    245
FT   DISULFID    238    251
FT   DISULFID    253    262
FT   DISULFID    265    276
FT   DISULFID    271    282
FT   DISULFID    284    293
FT   DISULFID    300    312
FT   DISULFID    306    322
FT   DISULFID    324    333
FT   DISULFID    340    351       {ECO:0000250}.
FT   DISULFID    345    360       {ECO:0000250}.
FT   DISULFID    362    371       {ECO:0000250}.
FT   DISULFID    378    389       {ECO:0000250}.
FT   DISULFID    383    398       {ECO:0000250}.
FT   DISULFID    400    409       {ECO:0000250}.
FT   DISULFID    416    427       {ECO:0000250}.
FT   DISULFID    421    436       {ECO:0000250}.
FT   DISULFID    438    447       {ECO:0000250}.
FT   DISULFID    454    464       {ECO:0000250}.
FT   DISULFID    458    473       {ECO:0000250}.
FT   DISULFID    475    484       {ECO:0000250}.
FT   DISULFID    491    502       {ECO:0000250}.
FT   DISULFID    496    511       {ECO:0000250}.
FT   DISULFID    513    522       {ECO:0000250}.
FT   DISULFID    529    540       {ECO:0000250}.
FT   DISULFID    534    549       {ECO:0000250}.
FT   DISULFID    551    560       {ECO:0000250}.
FT   DISULFID    578    605       {ECO:0000250}.
FT   DISULFID    599    615       {ECO:0000250}.
FT   DISULFID    617    626       {ECO:0000250}.
FT   DISULFID    633    644       {ECO:0000250}.
FT   DISULFID    638    653       {ECO:0000250}.
FT   DISULFID    655    664       {ECO:0000250}.
FT   DISULFID    671    682       {ECO:0000250}.
FT   DISULFID    676    691       {ECO:0000250}.
FT   DISULFID    693    702       {ECO:0000250}.
FT   DISULFID    709    720       {ECO:0000250}.
FT   DISULFID    714    729       {ECO:0000250}.
FT   DISULFID    731    740       {ECO:0000250}.
FT   DISULFID    748    759       {ECO:0000250}.
FT   DISULFID    753    768       {ECO:0000250}.
FT   DISULFID    770    779       {ECO:0000250}.
FT   DISULFID    786    797       {ECO:0000250}.
FT   DISULFID    791    806       {ECO:0000250}.
FT   DISULFID    808    817       {ECO:0000250}.
FT   DISULFID    824    835       {ECO:0000250}.
FT   DISULFID    829    844       {ECO:0000250}.
FT   DISULFID    846    855       {ECO:0000250}.
FT   VAR_SEQ       1    159       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056532.
FT   VARIANT      22     25       Missing (in ALGS1).
FT                                {ECO:0000269|PubMed:16575836}.
FT                                /FTId=VAR_026296.
FT   VARIANT      31     31       A -> V (in ALGS1).
FT                                {ECO:0000269|PubMed:12497640}.
FT                                /FTId=VAR_026297.
FT   VARIANT      33     33       G -> D (in ALGS1).
FT                                {ECO:0000269|PubMed:11180599}.
FT                                /FTId=VAR_026298.
FT   VARIANT      33     33       G -> S (in ALGS1; dbSNP:rs876661123).
FT                                {ECO:0000269|PubMed:16575836}.
FT                                /FTId=VAR_026299.
FT   VARIANT      33     33       G -> V (in ALGS1).
FT                                {ECO:0000269|PubMed:16575836}.
FT                                /FTId=VAR_026300.
FT   VARIANT      37     37       L -> S (in ALGS1; dbSNP:rs121918352).
FT                                {ECO:0000269|PubMed:11157803,
FT                                ECO:0000269|PubMed:11180599}.
FT                                /FTId=VAR_013186.
FT   VARIANT      39     39       I -> S (in ALGS1).
FT                                {ECO:0000269|PubMed:12442286}.
FT                                /FTId=VAR_026301.
FT   VARIANT      40     40       L -> P (in ALGS1).
FT                                {ECO:0000269|PubMed:12497640}.
FT                                /FTId=VAR_026302.
FT   VARIANT      45     45       V -> L (in biliary atresia; extrahepatic;
FT                                dbSNP:rs183974372).
FT                                {ECO:0000269|PubMed:12297837}.
FT                                /FTId=VAR_026303.
FT   VARIANT      53     53       N -> D (in biliary atresia;
FT                                extrahepatic).
FT                                {ECO:0000269|PubMed:12297837}.
FT                                /FTId=VAR_026304.
FT   VARIANT      65     65       K -> M (in biliary atresia;
FT                                extrahepatic).
FT                                {ECO:0000269|PubMed:12297837}.
FT                                /FTId=VAR_026305.
FT   VARIANT      75     75       F -> S (in ALGS1).
FT                                {ECO:0000269|PubMed:12497640}.
FT                                /FTId=VAR_026306.
FT   VARIANT      78     78       C -> S (in ALGS1).
FT                                {ECO:0000269|PubMed:11180599}.
FT                                /FTId=VAR_026307.
FT   VARIANT      79     79       L -> H (in ALGS1).
FT                                {ECO:0000269|PubMed:10220506}.
FT                                /FTId=VAR_013187.
FT   VARIANT      92     92       C -> R (in ALGS1).
FT                                {ECO:0000269|PubMed:16575836}.
FT                                /FTId=VAR_026308.
FT   VARIANT      92     92       C -> Y (in ALGS1).
FT                                {ECO:0000269|PubMed:16575836}.
FT                                /FTId=VAR_026309.
FT   VARIANT     120    120       I -> N (in ALGS1).
FT                                {ECO:0000269|PubMed:15712272}.
FT                                /FTId=VAR_026310.
FT   VARIANT     123    123       P -> S (in ALGS1).
FT                                {ECO:0000269|PubMed:12497640}.
FT                                /FTId=VAR_026311.
FT   VARIANT     127    127       A -> T (in ALGS1; dbSNP:rs930247415).
FT                                {ECO:0000269|PubMed:10220506}.
FT                                /FTId=VAR_013188.
FT   VARIANT     129    129       P -> R (in ALGS1; dbSNP:rs1032920906).
FT                                {ECO:0000269|PubMed:10220506}.
FT                                /FTId=VAR_013189.
FT   VARIANT     146    146       V -> I (in dbSNP:rs6040067).
FT                                /FTId=VAR_048985.
FT   VARIANT     152    152       I -> T (in ALGS1).
FT                                {ECO:0000269|PubMed:10533065}.
FT                                /FTId=VAR_013190.
FT   VARIANT     155    155       A -> P (in ALGS1).
FT                                {ECO:0000269|PubMed:16575836}.
FT                                /FTId=VAR_026312.
FT   VARIANT     163    163       P -> L (in ALGS1).
FT                                {ECO:0000269|PubMed:10220506}.
FT                                /FTId=VAR_013191.
FT   VARIANT     163    163       P -> R (in ALGS1).
FT                                {ECO:0000269|PubMed:12497640}.
FT                                /FTId=VAR_026313.
FT   VARIANT     181    181       Y -> N (in ALGS1).
FT                                {ECO:0000269|PubMed:11180599}.
FT                                /FTId=VAR_026314.
FT   VARIANT     184    184       R -> C (in ALGS1; dbSNP:rs121918350).
FT                                {ECO:0000269|PubMed:9207788,
FT                                ECO:0000269|PubMed:9585603}.
FT                                /FTId=VAR_013192.
FT   VARIANT     184    184       R -> G (in ALGS1).
FT                                {ECO:0000269|PubMed:10220506}.
FT                                /FTId=VAR_013193.
FT   VARIANT     184    184       R -> H (in ALGS1; dbSNP:rs121918351).
FT                                {ECO:0000269|PubMed:12442286,
FT                                ECO:0000269|PubMed:9585603}.
FT                                /FTId=VAR_013194.
FT   VARIANT     184    184       R -> L (in ALGS1).
FT                                {ECO:0000269|PubMed:10533065}.
FT                                /FTId=VAR_013195.
FT   VARIANT     187    187       C -> S (in ALGS1).
FT                                {ECO:0000269|PubMed:10220506}.
FT                                /FTId=VAR_013196.
FT   VARIANT     187    187       C -> Y (in ALGS1).
FT                                {ECO:0000269|PubMed:15712272}.
FT                                /FTId=VAR_026315.
FT   VARIANT     203    203       R -> K (in biliary atresia;
FT                                extrahepatic).
FT                                {ECO:0000269|PubMed:12297837}.
FT                                /FTId=VAR_026316.
FT   VARIANT     220    220       C -> F (in ALGS1).
FT                                {ECO:0000269|PubMed:11139247}.
FT                                /FTId=VAR_013197.
FT   VARIANT     224    224       W -> C (in ALGS1).
FT                                {ECO:0000269|PubMed:12497640}.
FT                                /FTId=VAR_026317.
FT   VARIANT     229    229       C -> G (in ALGS1).
FT                                {ECO:0000269|PubMed:10220506}.
FT                                /FTId=VAR_013198.
FT   VARIANT     229    229       C -> Y (in ALGS1).
FT                                {ECO:0000269|PubMed:11058898}.
FT                                /FTId=VAR_013199.
FT   VARIANT     234    234       C -> Y (in deafness; with congenital
FT                                heart defects and posterior embryotoxon;
FT                                dbSNP:rs121918353).
FT                                {ECO:0000269|PubMed:12022040}.
FT                                /FTId=VAR_026318.
FT   VARIANT     252    252       R -> G (in ALGS1).
FT                                {ECO:0000269|PubMed:16575836}.
FT                                /FTId=VAR_026319.
FT   VARIANT     256    256       G -> S (in ALGS1).
FT                                {ECO:0000269|PubMed:16575836}.
FT                                /FTId=VAR_026320.
FT   VARIANT     269    269       P -> L (in ALGS1; dbSNP:rs797044956).
FT                                {ECO:0000269|PubMed:12497640}.
FT                                /FTId=VAR_026321.
FT   VARIANT     271    271       C -> R (in ALGS1).
FT                                {ECO:0000269|PubMed:16575836}.
FT                                /FTId=VAR_026322.
FT   VARIANT     274    274       G -> D (in TOF; temperature sensitive
FT                                mutation; the protein is abnormally
FT                                glycosylated and retained
FT                                intracellularly; dbSNP:rs28939668).
FT                                {ECO:0000269|PubMed:11152664,
FT                                ECO:0000269|PubMed:12649809}.
FT                                /FTId=VAR_013200.
FT   VARIANT     284    284       C -> F (in ALGS1).
FT                                {ECO:0000269|PubMed:10220506}.
FT                                /FTId=VAR_013201.
FT   VARIANT     288    288       W -> C (in ALGS1).
FT                                {ECO:0000269|PubMed:10220506}.
FT                                /FTId=VAR_013202.
FT   VARIANT     386    386       G -> R (in ALGS1; dbSNP:rs863223650).
FT                                {ECO:0000269|PubMed:11058898}.
FT                                /FTId=VAR_013203.
FT   VARIANT     436    436       C -> W (in ALGS1).
FT                                {ECO:0000269|PubMed:23801938}.
FT                                /FTId=VAR_071513.
FT   VARIANT     438    438       C -> F (in ALGS1).
FT                                {ECO:0000269|PubMed:10220506}.
FT                                /FTId=VAR_013204.
FT   VARIANT     504    504       N -> S (in ALGS1; dbSNP:rs527236046).
FT                                {ECO:0000269|PubMed:16575836}.
FT                                /FTId=VAR_026323.
FT   VARIANT     690    690       Y -> D (in biliary atresia;
FT                                extrahepatic).
FT                                {ECO:0000269|PubMed:12297837}.
FT                                /FTId=VAR_026324.
FT   VARIANT     693    693       C -> Y (in ALGS1; dbSNP:rs566563238).
FT                                {ECO:0000269|PubMed:16575836}.
FT                                /FTId=VAR_026325.
FT   VARIANT     714    714       C -> Y (in ALGS1).
FT                                {ECO:0000269|PubMed:11180599}.
FT                                /FTId=VAR_026326.
FT   VARIANT     731    731       C -> S (in ALGS1).
FT                                {ECO:0000269|PubMed:10220506}.
FT                                /FTId=VAR_013205.
FT   VARIANT     740    740       C -> R (in ALGS1).
FT                                {ECO:0000269|PubMed:10220506}.
FT                                /FTId=VAR_013206.
FT   VARIANT     753    753       C -> R (in ALGS1).
FT                                {ECO:0000269|PubMed:11139247}.
FT                                /FTId=VAR_013207.
FT   VARIANT     818    818       R -> K. {ECO:0000269|PubMed:16575836}.
FT                                /FTId=VAR_026327.
FT   VARIANT     871    871       P -> R (in biliary atresia; extrahepatic;
FT                                dbSNP:rs35761929).
FT                                {ECO:0000269|PubMed:12297837}.
FT                                /FTId=VAR_026328.
FT   VARIANT     889    889       R -> Q (in ALGS1; dbSNP:rs149419694).
FT                                {ECO:0000269|PubMed:16575836}.
FT                                /FTId=VAR_026329.
FT   VARIANT     902    902       C -> S (in ALGS1; dbSNP:rs876661122).
FT                                {ECO:0000269|PubMed:11180599}.
FT                                /FTId=VAR_026330.
FT   VARIANT     908    908       H -> Q (in biliary atresia;
FT                                extrahepatic).
FT                                {ECO:0000269|PubMed:12297837}.
FT                                /FTId=VAR_026331.
FT   VARIANT     911    911       C -> Y (in ALGS1).
FT                                {ECO:0000269|PubMed:16575836}.
FT                                /FTId=VAR_026332.
FT   VARIANT     913    913       S -> R (in ALGS1).
FT                                {ECO:0000269|PubMed:12442286}.
FT                                /FTId=VAR_026333.
FT   VARIANT     921    921       L -> P (in biliary atresia;
FT                                extrahepatic).
FT                                {ECO:0000269|PubMed:12297837}.
FT                                /FTId=VAR_026334.
FT   VARIANT     937    937       R -> Q (in ALGS1; dbSNP:rs145895196).
FT                                {ECO:0000269|PubMed:12497640}.
FT                                /FTId=VAR_026335.
FT   VARIANT    1055   1056       VR -> G (in ALGS1).
FT                                /FTId=VAR_026336.
FT   VARIANT    1213   1213       R -> Q (in biliary atresia; extrahepatic;
FT                                dbSNP:rs138007561).
FT                                {ECO:0000269|PubMed:12297837}.
FT                                /FTId=VAR_026337.
FT   MUTAGEN     207    207       F->A: Strongly reduced NOTCH1 binding.
FT                                {ECO:0000269|PubMed:18660822}.
FT   CONFLICT    117    117       R -> P (in Ref. 5; AAB39007).
FT                                {ECO:0000305}.
FT   CONFLICT    227    227       P -> R (in Ref. 1; AAC51731).
FT                                {ECO:0000305}.
FT   CONFLICT    498    498       N -> D (in Ref. 1; AAC51731).
FT                                {ECO:0000305}.
FT   STRAND       33     43       {ECO:0000244|PDB:4CC0}.
FT   STRAND       52     57       {ECO:0000244|PDB:4CC0}.
FT   TURN         61     63       {ECO:0000244|PDB:4CC0}.
FT   STRAND       73     81       {ECO:0000244|PDB:4CC0}.
FT   STRAND       88     90       {ECO:0000244|PDB:4CC0}.
FT   STRAND       95     98       {ECO:0000244|PDB:4CC0}.
FT   STRAND      103    105       {ECO:0000244|PDB:4CC0}.
FT   STRAND      118    124       {ECO:0000244|PDB:4CC0}.
FT   STRAND      130    140       {ECO:0000244|PDB:4CC0}.
FT   STRAND      143    147       {ECO:0000244|PDB:4CC0}.
FT   STRAND      150    160       {ECO:0000244|PDB:4CC0}.
FT   STRAND      163    172       {ECO:0000244|PDB:4CC0}.
FT   STRAND      174    187       {ECO:0000244|PDB:4CC0}.
FT   TURN        193    196       {ECO:0000244|PDB:4CC0}.
FT   STRAND      203    205       {ECO:0000244|PDB:4CC0}.
FT   STRAND      208    212       {ECO:0000244|PDB:4CC0}.
FT   STRAND      218    220       {ECO:0000244|PDB:4CC0}.
FT   TURN        226    229       {ECO:0000244|PDB:4CC0}.
FT   TURN        240    242       {ECO:0000244|PDB:4CC0}.
FT   STRAND      257    259       {ECO:0000244|PDB:4CC0}.
FT   TURN        268    270       {ECO:0000244|PDB:2KB9}.
FT   STRAND      273    275       {ECO:0000244|PDB:4CC0}.
FT   STRAND      277    280       {ECO:0000244|PDB:2KB9}.
FT   STRAND      286    289       {ECO:0000244|PDB:2KB9}.
FT   TURN        290    293       {ECO:0000244|PDB:4CC0}.
FT   STRAND      295    297       {ECO:0000244|PDB:4CC0}.
FT   HELIX       299    303       {ECO:0000244|PDB:4CC0}.
FT   STRAND      311    316       {ECO:0000244|PDB:4CC0}.
FT   STRAND      319    323       {ECO:0000244|PDB:4CC0}.
FT   STRAND      328    330       {ECO:0000244|PDB:4CC0}.
SQ   SEQUENCE   1218 AA;  133799 MW;  F36EE9FBF64DF162 CRC64;
     MRSPRTRGRS GRPLSLLLAL LCALRAKVCG ASGQFELEIL SMQNVNGELQ NGNCCGGARN
     PGDRKCTRDE CDTYFKVCLK EYQSRVTAGG PCSFGSGSTP VIGGNTFNLK ASRGNDRNRI
     VLPFSFAWPR SYTLLVEAWD SSNDTVQPDS IIEKASHSGM INPSRQWQTL KQNTGVAHFE
     YQIRVTCDDY YYGFGCNKFC RPRDDFFGHY ACDQNGNKTC MEGWMGPECN RAICRQGCSP
     KHGSCKLPGD CRCQYGWQGL YCDKCIPHPG CVHGICNEPW QCLCETNWGG QLCDKDLNYC
     GTHQPCLNGG TCSNTGPDKY QCSCPEGYSG PNCEIAEHAC LSDPCHNRGS CKETSLGFEC
     ECSPGWTGPT CSTNIDDCSP NNCSHGGTCQ DLVNGFKCVC PPQWTGKTCQ LDANECEAKP
     CVNAKSCKNL IASYYCDCLP GWMGQNCDIN INDCLGQCQN DASCRDLVNG YRCICPPGYA
     GDHCERDIDE CASNPCLNGG HCQNEINRFQ CLCPTGFSGN LCQLDIDYCE PNPCQNGAQC
     YNRASDYFCK CPEDYEGKNC SHLKDHCRTT PCEVIDSCTV AMASNDTPEG VRYISSNVCG
     PHGKCKSQSG GKFTCDCNKG FTGTYCHENI NDCESNPCRN GGTCIDGVNS YKCICSDGWE
     GAYCETNIND CSQNPCHNGG TCRDLVNDFY CDCKNGWKGK TCHSRDSQCD EATCNNGGTC
     YDEGDAFKCM CPGGWEGTTC NIARNSSCLP NPCHNGGTCV VNGESFTCVC KEGWEGPICA
     QNTNDCSPHP CYNSGTCVDG DNWYRCECAP GFAGPDCRIN INECQSSPCA FGATCVDEIN
     GYRCVCPPGH SGAKCQEVSG RPCITMGSVI PDGAKWDDDC NTCQCLNGRI ACSKVWCGPR
     PCLLHKGHSE CPSGQSCIPI LDDQCFVHPC TGVGECRSSS LQPVKTKCTS DSYYQDNCAN
     ITFTFNKEMM SPGLTTEHIC SELRNLNILK NVSAEYSIYI ACEPSPSANN EIHVAISAED
     IRDDGNPIKE ITDKIIDLVS KRDGNSSLIA AVAEVRVQRR PLKNRTDFLV PLLSSVLTVA
     WICCLVTAFY WCLRKRRKPG SHTHSASEDN TTNNVREQLN QIKNPIEKHG ANTVPIKDYE
     NKNSKMSKIR THNSEVEEDD MDKHQQKARF AKQPAYTLVD REEKPPNGTP TKHPNWTNKQ
     DNRDLESAQS LNRMEYIV
//
ID   ADA17_HUMAN             Reviewed;         824 AA.
AC   P78536; O60226;
DT   20-JUN-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1997, sequence version 1.
DT   22-NOV-2017, entry version 203.
DE   RecName: Full=Disintegrin and metalloproteinase domain-containing protein 17;
DE            Short=ADAM 17;
DE            EC=3.4.24.86 {ECO:0000269|PubMed:12441351, ECO:0000269|PubMed:20592283, ECO:0000269|PubMed:24227843};
DE   AltName: Full=Snake venom-like protease;
DE   AltName: Full=TNF-alpha convertase;
DE   AltName: Full=TNF-alpha-converting enzyme;
DE   AltName: CD_antigen=CD156b;
DE   Flags: Precursor;
GN   Name=ADAM17; Synonyms=CSVP, TACE;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A), AND PARTIAL PROTEIN SEQUENCE.
RC   TISSUE=Leukocyte, and Monocyte;
RX   PubMed=9034191; DOI=10.1038/385733a0;
RA   Moss M.L., Jin S.-L.C., Milla M.E., Burkhart W., Carter H.L.,
RA   Chen W.-J., Clay W.C., Didsbury J.R., Hassler D., Hoffman C.R.,
RA   Kost T.A., Lambert M.H., Leesnitzer M.A., McCauley P., McGeehan G.,
RA   Mitchell J., Moyer M., Pahel G., Rocque W., Overton L.K., Schoenen F.,
RA   Seaton T., Su J.-L., Warner J., Willard D., Becherer J.D.;
RT   "Cloning of a disintegrin metalloproteinase that processes precursor
RT   tumour-necrosis factor-alpha.";
RL   Nature 385:733-736(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS A AND B).
RX   PubMed=9034190; DOI=10.1038/385729a0;
RA   Black R.A., Rauch C.T., Kozlosky C.J., Peschon J.J., Slack J.L.,
RA   Wolfson M.F., Castner B.J., Stocking K.L., Reddy P., Srinivasan S.,
RA   Nelson N., Bioani N., Schooley K.A., Gerhart M., Davis R.,
RA   Fitzner J.N., Johnson R.S., Paxton R.J., March C.J., Cerretti D.P.;
RT   "A metalloproteinase disintegrin that releases tumour-necrosis factor-
RT   alpha from cells.";
RL   Nature 385:729-733(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A).
RC   TISSUE=Cartilage;
RX   PubMed=9574564;
RA   Patel I.R., Attur M.G., Patel R.N., Stuchin S.A., Abagyan R.A.,
RA   Abramson S.B., Amin A.R.;
RT   "TNF-alpha convertase enzyme from human arthritis-affected cartilage:
RT   isolation of cDNA by differential display, expression of the active
RT   enzyme, and regulation of TNF-alpha.";
RL   J. Immunol. 160:4570-4579(1998).
RN   [4]
RP   PHOSPHORYLATION AT THR-735.
RX   PubMed=12058067; DOI=10.1091/mbc.01-11-0561;
RA   Diaz-Rodriguez E., Montero J.C., Esparis-Ogando A., Yuste L.,
RA   Pandiella A.;
RT   "Extracellular signal-regulated kinase phosphorylates tumor necrosis
RT   factor alpha-converting enzyme at threonine 735: a potential role in
RT   regulated shedding.";
RL   Mol. Biol. Cell 13:2031-2044(2002).
RN   [5]
RP   FUNCTION, CATALYTIC ACTIVITY, AND INTERACTION WITH MUC1.
RX   PubMed=12441351; DOI=10.1074/jbc.M208326200;
RA   Thathiah A., Blobel C.P., Carson D.D.;
RT   "Tumor necrosis factor-alpha converting enzyme/ADAM 17 mediates MUC1
RT   shedding.";
RL   J. Biol. Chem. 278:3386-3394(2003).
RN   [6]
RP   PHOSPHORYLATION AT SER-819.
RX   PubMed=12621058; DOI=10.1074/jbc.M300331200;
RA   Fan H., Turck C.W., Derynck R.;
RT   "Characterization of growth factor-induced serine phosphorylation of
RT   tumor necrosis factor-alpha converting enzyme and of an alternatively
RT   translated polypeptide.";
RL   J. Biol. Chem. 278:18617-18627(2003).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-791, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-791, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   ROLE IN PROTEOLYTICAL RELEASE OF JAM3.
RX   PubMed=20592283; DOI=10.4049/jimmunol.1000556;
RA   Rabquer B.J., Amin M.A., Teegala N., Shaheen M.K., Tsou P.S.,
RA   Ruth J.H., Lesch C.A., Imhof B.A., Koch A.E.;
RT   "Junctional adhesion molecule-C is a soluble mediator of
RT   angiogenesis.";
RL   J. Immunol. 185:1777-1785(2010).
RN   [10]
RP   PHOSPHORYLATION AT THR-735, AND INTERACTION WITH MAPK14.
RX   PubMed=20188673; DOI=10.1016/j.molcel.2010.01.034;
RA   Xu P., Derynck R.;
RT   "Direct activation of TACE-mediated ectodomain shedding by p38 MAP
RT   kinase regulates EGF receptor-dependent cell proliferation.";
RL   Mol. Cell 37:551-566(2010).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-791, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   INVOLVEMENT IN NISBD1.
RX   PubMed=22010916; DOI=10.1056/NEJMoa1100721;
RA   Blaydon D.C., Biancheri P., Di W.L., Plagnol V., Cabral R.M.,
RA   Brooke M.A., van Heel D.A., Ruschendorf F., Toynbee M., Walne A.,
RA   O'Toole E.A., Martin J.E., Lindley K., Vulliamy T., Abrams D.J.,
RA   MacDonald T.T., Harper J.I., Kelsell D.P.;
RT   "Inflammatory skin and bowel disease linked to ADAM17 deletion.";
RL   N. Engl. J. Med. 365:1502-1508(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-791, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-761 AND SER-791, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   FUNCTION.
RX   PubMed=24226769; DOI=10.1038/nature12723;
RA   Boskovski M.T., Yuan S., Pedersen N.B., Goth C.K., Makova S.,
RA   Clausen H., Brueckner M., Khokha M.K.;
RT   "The heterotaxy gene GALNT11 glycosylates Notch to orchestrate cilia
RT   type and laterality.";
RL   Nature 504:456-459(2013).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-791, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [17]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=24227843; DOI=10.1128/JVI.02202-13;
RA   Heurich A., Hofmann-Winkler H., Gierer S., Liepold T., Jahn O.,
RA   Poehlmann S.;
RT   "TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by
RT   TMPRSS2 augments entry driven by the severe acute respiratory syndrome
RT   coronavirus spike protein.";
RL   J. Virol. 88:1293-1307(2014).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 219-473 IN COMPLEX WITH ZINC,
RP   COFACTOR, ACTIVE SITE, AND DISULFIDE BONDS.
RX   PubMed=9520379; DOI=10.1073/pnas.95.7.3408;
RA   Maskos K., Fernandez-Catalan C., Huber R., Bourenkov G.P.,
RA   Bartunik H., Ellestad G.A., Reddy P., Wolfson M.F., Rauch C.T.,
RA   Castner B.J., Davis R., Clarke H.R.G., Petersen M., Fitzner J.N.,
RA   Cerretti D.P., March C.J., Paxton R.J., Black R.A., Bode W.;
RT   "Crystal structure of the catalytic domain of human tumor necrosis
RT   factor-alpha-converting enzyme.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:3408-3412(1998).
CC   -!- FUNCTION: Cleaves the membrane-bound precursor of TNF-alpha to its
CC       mature soluble form. Responsible for the proteolytical release of
CC       soluble JAM3 from endothelial cells surface. Responsible for the
CC       proteolytic release of several other cell-surface proteins,
CC       including p75 TNF-receptor, interleukin 1 receptor type II, p55
CC       TNF-receptor, transforming growth factor-alpha, L-selectin, growth
CC       hormone receptor, MUC1 and the amyloid precursor protein. Acts as
CC       an activator of Notch pathway by mediating cleavage of Notch,
CC       generating the membrane-associated intermediate fragment called
CC       Notch extracellular truncation (NEXT). Plays a role in the
CC       proteolytic processing of ACE2. {ECO:0000269|PubMed:12441351,
CC       ECO:0000269|PubMed:20592283, ECO:0000269|PubMed:24226769,
CC       ECO:0000269|PubMed:24227843}.
CC   -!- CATALYTIC ACTIVITY: Narrow endopeptidase specificity. Cleaves Pro-
CC       Leu-Ala-Gln-Ala-|-Val-Arg-Ser-Ser-Ser in the membrane-bound, 26-
CC       kDa form of tumor necrosis factor alpha (TNF-alpha). Similarly
CC       cleaves other membrane-anchored, cell-surface proteins to 'shed'
CC       the extracellular domains. {ECO:0000269|PubMed:12441351,
CC       ECO:0000269|PubMed:20592283, ECO:0000269|PubMed:24227843}.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000269|PubMed:9520379};
CC       Note=Binds 1 zinc ion per subunit. {ECO:0000269|PubMed:9520379};
CC   -!- SUBUNIT: Interacts with MAD2L1, MAPK14 and MUC1.
CC       {ECO:0000269|PubMed:12441351, ECO:0000269|PubMed:20188673}.
CC   -!- INTERACTION:
CC       Q12959:DLG1; NbExp=7; IntAct=EBI-78188, EBI-357481;
CC       Q13257:MAD2L1; NbExp=3; IntAct=EBI-78188, EBI-78203;
CC       Q80WQ6:Rhbdf2 (xeno); NbExp=2; IntAct=EBI-78188, EBI-647271;
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=A;
CC         IsoId=P78536-1; Sequence=Displayed;
CC       Name=B;
CC         IsoId=P78536-2; Sequence=VSP_005478;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed. Expressed at highest
CC       levels in adult heart, placenta, skeletal muscle, pancreas,
CC       spleen, thymus, prostate, testes, ovary and small intestine, and
CC       in fetal brain, lung, liver and kidney.
CC   -!- INDUCTION: In arthritis-affected cartilage.
CC   -!- DOMAIN: Must be membrane anchored to cleave the different
CC       substrates. The cytoplasmic domain is not required for the this
CC       activity. Only the catalytic domain is essential to shed TNF and
CC       p75 TNFR (By similarity). {ECO:0000250}.
CC   -!- DOMAIN: The conserved cysteine present in the cysteine-switch
CC       motif binds the catalytic zinc ion, thus inhibiting the enzyme.
CC       The dissociation of the cysteine from the zinc ion upon the
CC       activation-peptide release activates the enzyme.
CC   -!- PTM: The precursor is cleaved by a furin endopeptidase.
CC       {ECO:0000250}.
CC   -!- PTM: Phosphorylated. Stimulation by growth factor or phorbol 12-
CC       myristate 13-acetate induces phosphorylation of Ser-819 but
CC       decreases phosphorylation of Ser-791. Phosphorylation at THR-735
CC       by MAPK14 is required for ADAM17-mediated ectodomain shedding.
CC       {ECO:0000269|PubMed:12058067, ECO:0000269|PubMed:12621058,
CC       ECO:0000269|PubMed:20188673}.
CC   -!- DISEASE: Inflammatory skin and bowel disease, neonatal, 1 (NISBD1)
CC       [MIM:614328]: A disorder characterized by inflammatory features
CC       with neonatal onset, involving the skin, hair, and gut. The skin
CC       lesions involve perioral and perianal erythema, psoriasiform
CC       erythroderma, with flares of erythema, scaling, and widespread
CC       pustules. Gastrointestinal symptoms include malabsorptive diarrhea
CC       that is exacerbated by intercurrent gastrointestinal infections.
CC       The hair is short or broken, and the eyelashes and eyebrows are
CC       wiry and disorganized. {ECO:0000269|PubMed:22010916}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Tumor necrosis factor alpha-
CC       converting enzyme entry;
CC       URL="https://en.wikipedia.org/wiki/Tumor_Necrosis_Factor_Alpha_Converting_Enzyme";
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/ADAM17ID572ch2p25.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U86755; AAB51586.1; -; mRNA.
DR   EMBL; U69611; AAB51514.1; -; mRNA.
DR   EMBL; U69612; AAB53014.1; -; mRNA.
DR   EMBL; U92649; AAC39721.1; -; mRNA.
DR   CCDS; CCDS1665.1; -. [P78536-1]
DR   RefSeq; NP_003174.3; NM_003183.5. [P78536-1]
DR   UniGene; Hs.404914; -.
DR   UniGene; Hs.570189; -.
DR   UniGene; Hs.744980; -.
DR   PDB; 1BKC; X-ray; 2.00 A; A/C/E/I=219-474.
DR   PDB; 1ZXC; X-ray; 2.28 A; A/B=215-477.
DR   PDB; 2A8H; X-ray; 2.30 A; A/B=215-477.
DR   PDB; 2DDF; X-ray; 1.70 A; A/B=218-474.
DR   PDB; 2FV5; X-ray; 2.10 A; A/B=216-475.
DR   PDB; 2FV9; X-ray; 2.02 A; A/B=218-475.
DR   PDB; 2I47; X-ray; 1.90 A; A/B/C/D=212-492.
DR   PDB; 2M2F; NMR; -; A=581-642.
DR   PDB; 2OI0; X-ray; 2.00 A; A=216-477.
DR   PDB; 3B92; X-ray; 2.00 A; A=216-474.
DR   PDB; 3CKI; X-ray; 2.30 A; A=219-474.
DR   PDB; 3E8R; X-ray; 1.90 A; A/B=215-477.
DR   PDB; 3EDZ; X-ray; 1.90 A; A/B=215-477.
DR   PDB; 3EWJ; X-ray; 1.80 A; A/B=215-477.
DR   PDB; 3G42; X-ray; 2.10 A; A/B/C/D=212-492.
DR   PDB; 3KMC; X-ray; 1.80 A; A/B=215-476.
DR   PDB; 3KME; X-ray; 1.85 A; A/B=215-476.
DR   PDB; 3L0T; X-ray; 1.92 A; A/B=215-476.
DR   PDB; 3L0V; X-ray; 1.75 A; A/B=215-476.
DR   PDB; 3LE9; X-ray; 1.85 A; A/B=215-476.
DR   PDB; 3LEA; X-ray; 2.00 A; A/B=215-476.
DR   PDB; 3LGP; X-ray; 1.90 A; A/B=215-476.
DR   PDB; 3O64; X-ray; 1.88 A; A/B=215-476.
DR   PDBsum; 1BKC; -.
DR   PDBsum; 1ZXC; -.
DR   PDBsum; 2A8H; -.
DR   PDBsum; 2DDF; -.
DR   PDBsum; 2FV5; -.
DR   PDBsum; 2FV9; -.
DR   PDBsum; 2I47; -.
DR   PDBsum; 2M2F; -.
DR   PDBsum; 2OI0; -.
DR   PDBsum; 3B92; -.
DR   PDBsum; 3CKI; -.
DR   PDBsum; 3E8R; -.
DR   PDBsum; 3EDZ; -.
DR   PDBsum; 3EWJ; -.
DR   PDBsum; 3G42; -.
DR   PDBsum; 3KMC; -.
DR   PDBsum; 3KME; -.
DR   PDBsum; 3L0T; -.
DR   PDBsum; 3L0V; -.
DR   PDBsum; 3LE9; -.
DR   PDBsum; 3LEA; -.
DR   PDBsum; 3LGP; -.
DR   PDBsum; 3O64; -.
DR   ProteinModelPortal; P78536; -.
DR   SMR; P78536; -.
DR   BioGrid; 112731; 21.
DR   DIP; DIP-31044N; -.
DR   IntAct; P78536; 12.
DR   MINT; MINT-108290; -.
DR   STRING; 9606.ENSP00000309968; -.
DR   BindingDB; P78536; -.
DR   ChEMBL; CHEMBL3706; -.
DR   DrugBank; DB07145; (2R)-N-HYDROXY-2-[(3S)-3-METHYL-3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}-2-OXOPYRROLIDIN-1-YL]PROPANAMIDE.
DR   DrugBank; DB06943; (3S)-1-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}pyrrolidine-3-thiol.
DR   DrugBank; DB07079; 3-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}propane-1-thiol.
DR   DrugBank; DB07233; N-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}-5-methyl-D-tryptophan.
DR   GuidetoPHARMACOLOGY; 1662; -.
DR   MEROPS; M12.217; -.
DR   TCDB; 8.A.77.1.2; the sheddase (sheddase) family.
DR   iPTMnet; P78536; -.
DR   PhosphoSitePlus; P78536; -.
DR   SwissPalm; P78536; -.
DR   BioMuta; ADAM17; -.
DR   DMDM; 14423632; -.
DR   EPD; P78536; -.
DR   MaxQB; P78536; -.
DR   PaxDb; P78536; -.
DR   PeptideAtlas; P78536; -.
DR   PRIDE; P78536; -.
DR   DNASU; 6868; -.
DR   Ensembl; ENST00000310823; ENSP00000309968; ENSG00000151694. [P78536-1]
DR   GeneID; 6868; -.
DR   KEGG; hsa:6868; -.
DR   UCSC; uc002qzu.5; human. [P78536-1]
DR   CTD; 6868; -.
DR   DisGeNET; 6868; -.
DR   EuPathDB; HostDB:ENSG00000151694.12; -.
DR   GeneCards; ADAM17; -.
DR   HGNC; HGNC:195; ADAM17.
DR   HPA; CAB025906; -.
DR   HPA; HPA010738; -.
DR   HPA; HPA051575; -.
DR   MalaCards; ADAM17; -.
DR   MIM; 603639; gene.
DR   MIM; 614328; phenotype.
DR   neXtProt; NX_P78536; -.
DR   OpenTargets; ENSG00000151694; -.
DR   Orphanet; 294023; Neonatal inflammatory skin and bowel disease.
DR   PharmGKB; PA24512; -.
DR   eggNOG; KOG3658; Eukaryota.
DR   eggNOG; ENOG410XQWB; LUCA.
DR   GeneTree; ENSGT00670000097974; -.
DR   HOGENOM; HOG000033797; -.
DR   HOVERGEN; HBG050457; -.
DR   InParanoid; P78536; -.
DR   KO; K06059; -.
DR   OMA; DGTPCIQ; -.
DR   OrthoDB; EOG091G03AL; -.
DR   PhylomeDB; P78536; -.
DR   TreeFam; TF314733; -.
DR   BRENDA; 3.4.24.86; 2681.
DR   Reactome; R-HSA-1251985; Nuclear signaling by ERBB4.
DR   Reactome; R-HSA-1442490; Collagen degradation.
DR   Reactome; R-HSA-177929; Signaling by EGFR.
DR   Reactome; R-HSA-193692; Regulated proteolysis of p75NTR.
DR   Reactome; R-HSA-2122948; Activated NOTCH1 Transmits Signal to the Nucleus.
DR   Reactome; R-HSA-2644606; Constitutive Signaling by NOTCH1 PEST Domain Mutants.
DR   Reactome; R-HSA-2660826; Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant.
DR   Reactome; R-HSA-2691232; Constitutive Signaling by NOTCH1 HD Domain Mutants.
DR   Reactome; R-HSA-2894862; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants.
DR   Reactome; R-HSA-5362798; Release of Hh-Np from the secreting cell.
DR   Reactome; R-HSA-75893; TNF signaling.
DR   Reactome; R-HSA-982772; Growth hormone receptor signaling.
DR   SignaLink; P78536; -.
DR   SIGNOR; P78536; -.
DR   ChiTaRS; ADAM17; human.
DR   EvolutionaryTrace; P78536; -.
DR   GeneWiki; ADAM17; -.
DR   GenomeRNAi; 6868; -.
DR   PRO; PR:P78536; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000151694; -.
DR   CleanEx; HS_ADAM17; -.
DR   ExpressionAtlas; P78536; baseline and differential.
DR   Genevisible; P78536; HS.
DR   GO; GO:0015629; C:actin cytoskeleton; IDA:BHF-UCL.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0009986; C:cell surface; IDA:BHF-UCL.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0045121; C:membrane raft; IDA:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005178; F:integrin binding; IPI:BHF-UCL.
DR   GO; GO:0005138; F:interleukin-6 receptor binding; IPI:BHF-UCL.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004222; F:metalloendopeptidase activity; IDA:UniProtKB.
DR   GO; GO:0008237; F:metallopeptidase activity; IDA:BHF-UCL.
DR   GO; GO:0005112; F:Notch binding; IDA:UniProtKB.
DR   GO; GO:0030165; F:PDZ domain binding; IPI:BHF-UCL.
DR   GO; GO:0017124; F:SH3 domain binding; IEA:UniProtKB-KW.
DR   GO; GO:0030183; P:B cell differentiation; ISS:BHF-UCL.
DR   GO; GO:0007155; P:cell adhesion; IDA:BHF-UCL.
DR   GO; GO:0033627; P:cell adhesion mediated by integrin; IDA:BHF-UCL.
DR   GO; GO:0048870; P:cell motility; ISS:BHF-UCL.
DR   GO; GO:0050830; P:defense response to Gram-positive bacterium; IMP:BHF-UCL.
DR   GO; GO:0007173; P:epidermal growth factor receptor signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0035625; P:epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway; IMP:BHF-UCL.
DR   GO; GO:0002467; P:germinal center formation; ISS:BHF-UCL.
DR   GO; GO:0006509; P:membrane protein ectodomain proteolysis; IDA:BHF-UCL.
DR   GO; GO:0031293; P:membrane protein intracellular domain proteolysis; TAS:Reactome.
DR   GO; GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; IMP:UniProtKB.
DR   GO; GO:0002446; P:neutrophil mediated immunity; IC:BHF-UCL.
DR   GO; GO:0007220; P:Notch receptor processing; IDA:UniProtKB.
DR   GO; GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0051088; P:PMA-inducible membrane protein ectodomain proteolysis; IDA:BHF-UCL.
DR   GO; GO:0030307; P:positive regulation of cell growth; IMP:BHF-UCL.
DR   GO; GO:0030335; P:positive regulation of cell migration; IMP:BHF-UCL.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IMP:BHF-UCL.
DR   GO; GO:0051272; P:positive regulation of cellular component movement; ISS:BHF-UCL.
DR   GO; GO:0032722; P:positive regulation of chemokine production; IMP:BHF-UCL.
DR   GO; GO:0031659; P:positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle; IDA:BHF-UCL.
DR   GO; GO:0045741; P:positive regulation of epidermal growth factor-activated receptor activity; IDA:BHF-UCL.
DR   GO; GO:0002690; P:positive regulation of leukocyte chemotaxis; IC:BHF-UCL.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; IMP:BHF-UCL.
DR   GO; GO:0010820; P:positive regulation of T cell chemotaxis; IMP:BHF-UCL.
DR   GO; GO:0030511; P:positive regulation of transforming growth factor beta receptor signaling pathway; ISS:BHF-UCL.
DR   GO; GO:0006508; P:proteolysis; IDA:UniProtKB.
DR   GO; GO:0033025; P:regulation of mast cell apoptotic process; ISS:BHF-UCL.
DR   GO; GO:0042493; P:response to drug; ISS:BHF-UCL.
DR   GO; GO:0055099; P:response to high density lipoprotein particle; IDA:BHF-UCL.
DR   GO; GO:0001666; P:response to hypoxia; IDA:BHF-UCL.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IDA:BHF-UCL.
DR   GO; GO:0048536; P:spleen development; ISS:BHF-UCL.
DR   GO; GO:0033077; P:T cell differentiation in thymus; ISS:BHF-UCL.
DR   GO; GO:0033209; P:tumor necrosis factor-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0035313; P:wound healing, spreading of epidermal cells; IEP:BHF-UCL.
DR   CDD; cd14246; ADAM17_MPD; 1.
DR   CDD; cd04270; ZnMc_TACE_like; 1.
DR   Gene3D; 3.40.390.10; -; 1.
DR   Gene3D; 4.10.70.10; -; 1.
DR   InterPro; IPR034025; ADAM10_ADAM17.
DR   InterPro; IPR032029; ADAM17_MPD.
DR   InterPro; IPR001762; Disintegrin_dom.
DR   InterPro; IPR036436; Disintegrin_dom_sf.
DR   InterPro; IPR024079; MetalloPept_cat_dom_sf.
DR   InterPro; IPR001590; Peptidase_M12B.
DR   InterPro; IPR002870; Peptidase_M12B_N.
DR   Pfam; PF16698; ADAM17_MPD; 1.
DR   Pfam; PF00200; Disintegrin; 1.
DR   Pfam; PF01562; Pep_M12B_propep; 1.
DR   SMART; SM00050; DISIN; 1.
DR   SUPFAM; SSF57552; SSF57552; 1.
DR   PROSITE; PS50215; ADAM_MEPRO; 1.
DR   PROSITE; PS50214; DISINTEGRIN_2; 1.
DR   PROSITE; PS00142; ZINC_PROTEASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing;
KW   Cleavage on pair of basic residues; Complete proteome;
KW   Direct protein sequencing; Disulfide bond; Glycoprotein; Hydrolase;
KW   Membrane; Metal-binding; Metalloprotease; Notch signaling pathway;
KW   Phosphoprotein; Polymorphism; Protease; Reference proteome;
KW   SH3-binding; Signal; Transmembrane; Transmembrane helix; Zinc;
KW   Zymogen.
FT   SIGNAL        1     17       {ECO:0000250|UniProtKB:Q9Z1K9}.
FT   PROPEP       18    214       {ECO:0000269|PubMed:9034191}.
FT                                /FTId=PRO_0000029088.
FT   CHAIN       215    824       Disintegrin and metalloproteinase domain-
FT                                containing protein 17.
FT                                /FTId=PRO_0000029089.
FT   TOPO_DOM    215    671       Extracellular. {ECO:0000255}.
FT   TRANSMEM    672    692       Helical. {ECO:0000255}.
FT   TOPO_DOM    693    824       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      223    474       Peptidase M12B. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00276}.
FT   DOMAIN      475    563       Disintegrin. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00068}.
FT   REGION      603    671       Crambin-like.
FT   MOTIF       182    189       Cysteine switch. {ECO:0000250}.
FT   MOTIF       731    738       SH3-binding. {ECO:0000255}.
FT   MOTIF       741    748       SH3-binding. {ECO:0000255}.
FT   COMPBIAS     96     99       Poly-Val.
FT   COMPBIAS    564    602       Cys-rich.
FT   ACT_SITE    406    406       {ECO:0000255|PROSITE-ProRule:PRU00276,
FT                                ECO:0000255|PROSITE-ProRule:PRU10095,
FT                                ECO:0000269|PubMed:9520379}.
FT   METAL       184    184       Zinc; in inhibited form. {ECO:0000250}.
FT   METAL       405    405       Zinc; catalytic.
FT                                {ECO:0000269|PubMed:9520379}.
FT   METAL       409    409       Zinc; catalytic.
FT                                {ECO:0000269|PubMed:9520379}.
FT   METAL       415    415       Zinc; catalytic.
FT                                {ECO:0000269|PubMed:9520379}.
FT   MOD_RES     735    735       Phosphothreonine; by MAPK14.
FT                                {ECO:0000269|PubMed:12058067,
FT                                ECO:0000269|PubMed:20188673}.
FT   MOD_RES     761    761       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     767    767       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9Z1K9}.
FT   MOD_RES     791    791       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     819    819       Phosphoserine.
FT                                {ECO:0000269|PubMed:12621058}.
FT   CARBOHYD    103    103       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    157    157       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    174    174       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    264    264       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    452    452       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    498    498       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    539    539       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    551    551       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    594    594       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    225    333       {ECO:0000269|PubMed:9520379}.
FT   DISULFID    365    469       {ECO:0000269|PubMed:9520379}.
FT   DISULFID    423    453       {ECO:0000269|PubMed:9520379}.
FT   DISULFID    534    555       {ECO:0000250}.
FT   DISULFID    573    582       {ECO:0000250}.
FT   DISULFID    578    591       {ECO:0000250}.
FT   DISULFID    593    600       {ECO:0000250}.
FT   VAR_SEQ     695    824       Missing (in isoform B).
FT                                {ECO:0000303|PubMed:9034190}.
FT                                /FTId=VSP_005478.
FT   VARIANT     162    162       K -> E (in dbSNP:rs34431503).
FT                                /FTId=VAR_051586.
FT   VARIANT     202    202       R -> G (in dbSNP:rs2230818).
FT                                /FTId=VAR_051587.
FT   CONFLICT    109    109       V -> A (in Ref. 3; AAC39721).
FT                                {ECO:0000305}.
FT   CONFLICT    563    563       D -> N (in Ref. 3; AAC39721).
FT                                {ECO:0000305}.
FT   CONFLICT    801    801       T -> A (in Ref. 3; AAC39721).
FT                                {ECO:0000305}.
FT   CONFLICT    818    818       D -> N (in Ref. 3; AAC39721).
FT                                {ECO:0000305}.
FT   HELIX       220    222       {ECO:0000244|PDB:3L0V}.
FT   STRAND      224    231       {ECO:0000244|PDB:2DDF}.
FT   HELIX       233    238       {ECO:0000244|PDB:2DDF}.
FT   TURN        239    242       {ECO:0000244|PDB:3EDZ}.
FT   HELIX       244    263       {ECO:0000244|PDB:2DDF}.
FT   STRAND      269    271       {ECO:0000244|PDB:2DDF}.
FT   STRAND      276    284       {ECO:0000244|PDB:2DDF}.
FT   STRAND      300    302       {ECO:0000244|PDB:2DDF}.
FT   STRAND      309    311       {ECO:0000244|PDB:2DDF}.
FT   HELIX       314    324       {ECO:0000244|PDB:2DDF}.
FT   HELIX       326    329       {ECO:0000244|PDB:2DDF}.
FT   STRAND      332    339       {ECO:0000244|PDB:2DDF}.
FT   HELIX       344    346       {ECO:0000244|PDB:2DDF}.
FT   STRAND      349    354       {ECO:0000244|PDB:2DDF}.
FT   STRAND      355    357       {ECO:0000244|PDB:3O64}.
FT   STRAND      363    365       {ECO:0000244|PDB:3O64}.
FT   STRAND      368    371       {ECO:0000244|PDB:2DDF}.
FT   TURN        372    375       {ECO:0000244|PDB:2DDF}.
FT   STRAND      376    379       {ECO:0000244|PDB:2DDF}.
FT   STRAND      382    389       {ECO:0000244|PDB:2DDF}.
FT   HELIX       396    410       {ECO:0000244|PDB:2DDF}.
FT   STRAND      418    420       {ECO:0000244|PDB:3CKI}.
FT   TURN        421    423       {ECO:0000244|PDB:2DDF}.
FT   HELIX       427    429       {ECO:0000244|PDB:2DDF}.
FT   STRAND      436    438       {ECO:0000244|PDB:3CKI}.
FT   STRAND      442    444       {ECO:0000244|PDB:3LGP}.
FT   TURN        445    448       {ECO:0000244|PDB:2DDF}.
FT   HELIX       452    469       {ECO:0000244|PDB:2DDF}.
FT   HELIX       583    586       {ECO:0000244|PDB:2M2F}.
FT   STRAND      589    591       {ECO:0000244|PDB:2M2F}.
FT   HELIX       597    600       {ECO:0000244|PDB:2M2F}.
FT   STRAND      603    605       {ECO:0000244|PDB:2M2F}.
FT   STRAND      611    613       {ECO:0000244|PDB:2M2F}.
FT   STRAND      631    636       {ECO:0000244|PDB:2M2F}.
FT   TURN        637    639       {ECO:0000244|PDB:2M2F}.
SQ   SEQUENCE   824 AA;  93021 MW;  5B1032F6B88A837F CRC64;
     MRQSLLFLTS VVPFVLAPRP PDDPGFGPHQ RLEKLDSLLS DYDILSLSNI QQHSVRKRDL
     QTSTHVETLL TFSALKRHFK LYLTSSTERF SQNFKVVVVD GKNESEYTVK WQDFFTGHVV
     GEPDSRVLAH IRDDDVIIRI NTDGAEYNIE PLWRFVNDTK DKRMLVYKSE DIKNVSRLQS
     PKVCGYLKVD NEELLPKGLV DREPPEELVH RVKRRADPDP MKNTCKLLVV ADHRFYRYMG
     RGEESTTTNY LIELIDRVDD IYRNTSWDNA GFKGYGIQIE QIRILKSPQE VKPGEKHYNM
     AKSYPNEEKD AWDVKMLLEQ FSFDIAEEAS KVCLAHLFTY QDFDMGTLGL AYVGSPRANS
     HGGVCPKAYY SPVGKKNIYL NSGLTSTKNY GKTILTKEAD LVTTHELGHN FGAEHDPDGL
     AECAPNEDQG GKYVMYPIAV SGDHENNKMF SNCSKQSIYK TIESKAQECF QERSNKVCGN
     SRVDEGEECD PGIMYLNNDT CCNSDCTLKE GVQCSDRNSP CCKNCQFETA QKKCQEAINA
     TCKGVSYCTG NSSECPPPGN AEDDTVCLDL GKCKDGKCIP FCEREQQLES CACNETDNSC
     KVCCRDLSGR CVPYVDAEQK NLFLRKGKPC TVGFCDMNGK CEKRVQDVIE RFWDFIDQLS
     INTFGKFLAD NIVGSVLVFS LIFWIPFSIL VHCVDKKLDK QYESLSLFHP SNVEMLSSMD
     SASVRIIKPF PAPQTPGRLQ PAPVIPSAPA APKLDHQRMD TIQEDPSTDS HMDEDGFEKD
     PFPNSSTAAK SFEDLTDHPV TRSEKAASFK LQRQNRVDSK ETEC
//
ID   PSN2_PIG                Reviewed;         448 AA.
AC   Q0MS45;
DT   25-NOV-2008, integrated into UniProtKB/Swiss-Prot.
DT   19-SEP-2006, sequence version 1.
DT   22-NOV-2017, entry version 84.
DE   RecName: Full=Presenilin-2;
DE            Short=PS-2;
DE            EC=3.4.23.-;
DE   Contains:
DE     RecName: Full=Presenilin-2 NTF subunit;
DE   Contains:
DE     RecName: Full=Presenilin-2 CTF subunit;
GN   Name=PSEN2;
OS   Sus scrofa (Pig).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Suina; Suidae;
OC   Sus.
OX   NCBI_TaxID=9823;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Brain, Liver, and Lymphocyte;
RX   PubMed=17854491; DOI=10.1186/1471-2202-8-72;
RA   Madsen L.B., Thomsen B., Larsen K., Bendixen C., Holm I.E.,
RA   Fredholm M., Joergensen A.L., Nielsen A.L.;
RT   "Molecular characterization and temporal expression profiling of
RT   presenilins in the developing porcine brain.";
RL   BMC Neurosci. 8:72-72(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Wang G.;
RL   Submitted (NOV-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Probable catalytic subunit of the gamma-secretase
CC       complex, an endoprotease complex that catalyzes the intramembrane
CC       cleavage of integral membrane proteins such as Notch receptors and
CC       APP (amyloid-beta precursor protein). Requires the other members
CC       of the gamma-secretase complex to have a protease activity. May
CC       play a role in intracellular signaling and gene expression or in
CC       linking chromatin to the nuclear membrane. May function in the
CC       cytoplasmic partitioning of proteins (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Homodimer. Component of the gamma-secretase complex, a
CC       complex composed of a presenilin homodimer (PSEN1 or PSEN2),
CC       nicastrin (NCSTN), APH1 (APH1A or APH1B) and PEN2. Such minimal
CC       complex is sufficient for secretase activity, although other
CC       components may exist. Interacts with DOCK3. Interacts with
CC       HERPUD1, FLNA, FLNB and PARL (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}. Golgi
CC       apparatus membrane {ECO:0000250}; Multi-pass membrane protein
CC       {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Detected in the embryonic brain in frontal
CC       cortex (at protein level). Expressed in the developing brain:
CC       frontal cortex, cerebellum, hippocampus, basal ganglia and brain
CC       stem. Localized mainly in neuronal cells and astrocytes.
CC       {ECO:0000269|PubMed:17854491}.
CC   -!- DOMAIN: The PAL motif is required for normal active site
CC       conformation. {ECO:0000250}.
CC   -!- PTM: Phosphorylated on serine residues. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the peptidase A22A family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; DQ853415; ABI15722.1; -; mRNA.
DR   EMBL; EU287432; ABX84376.1; -; mRNA.
DR   RefSeq; NP_001072134.1; NM_001078666.1.
DR   RefSeq; XP_005668005.1; XM_005667948.2.
DR   RefSeq; XP_005668006.1; XM_005667949.2.
DR   RefSeq; XP_013835506.1; XM_013980052.1.
DR   RefSeq; XP_013835507.1; XM_013980053.1.
DR   RefSeq; XP_013835508.1; XM_013980054.1.
DR   RefSeq; XP_013835509.1; XM_013980055.1.
DR   RefSeq; XP_013835510.1; XM_013980056.1.
DR   UniGene; Ssc.54979; -.
DR   SMR; Q0MS45; -.
DR   STRING; 9823.ENSSSCP00000011578; -.
DR   MEROPS; A22.002; -.
DR   PaxDb; Q0MS45; -.
DR   Ensembl; ENSSSCT00000051056; ENSSSCP00000058747; ENSSSCG00000010860.
DR   GeneID; 780410; -.
DR   KEGG; ssc:780410; -.
DR   CTD; 5664; -.
DR   eggNOG; KOG2736; Eukaryota.
DR   eggNOG; ENOG410XPZD; LUCA.
DR   GeneTree; ENSGT00390000016593; -.
DR   HOGENOM; HOG000240228; -.
DR   HOVERGEN; HBG011375; -.
DR   InParanoid; Q0MS45; -.
DR   KO; K04522; -.
DR   OMA; VCDERTS; -.
DR   OrthoDB; EOG091G0C72; -.
DR   TreeFam; TF315040; -.
DR   Reactome; R-SSC-1251985; Nuclear signaling by ERBB4.
DR   Reactome; R-SSC-193692; Regulated proteolysis of p75NTR.
DR   Reactome; R-SSC-1980148; Signaling by NOTCH3.
DR   Reactome; R-SSC-1980150; Signaling by NOTCH4.
DR   Reactome; R-SSC-3928665; EPH-ephrin mediated repulsion of cells.
DR   Proteomes; UP000008227; Chromosome 10.
DR   Bgee; ENSSSCG00000010860; -.
DR   Genevisible; Q0MS45; SS.
DR   GO; GO:0030424; C:axon; IBA:GO_Central.
DR   GO; GO:0005938; C:cell cortex; IBA:GO_Central.
DR   GO; GO:0009986; C:cell surface; IBA:GO_Central.
DR   GO; GO:0035253; C:ciliary rootlet; IBA:GO_Central.
DR   GO; GO:0043198; C:dendritic shaft; IBA:GO_Central.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0030426; C:growth cone; IBA:GO_Central.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005765; C:lysosomal membrane; IBA:GO_Central.
DR   GO; GO:0045121; C:membrane raft; IBA:GO_Central.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IBA:GO_Central.
DR   GO; GO:0031594; C:neuromuscular junction; IBA:GO_Central.
DR   GO; GO:0043025; C:neuronal cell body; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IBA:GO_Central.
DR   GO; GO:0030018; C:Z disc; IBA:GO_Central.
DR   GO; GO:0042500; F:aspartic endopeptidase activity, intramembrane cleaving; IEA:InterPro.
DR   GO; GO:0004175; F:endopeptidase activity; IBA:GO_Central.
DR   GO; GO:0042987; P:amyloid precursor protein catabolic process; IBA:GO_Central.
DR   GO; GO:0050435; P:amyloid-beta metabolic process; IBA:GO_Central.
DR   GO; GO:0006816; P:calcium ion transport; IBA:GO_Central.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:InterPro.
DR   GO; GO:0006509; P:membrane protein ectodomain proteolysis; IBA:GO_Central.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IBA:GO_Central.
DR   GO; GO:0007220; P:Notch receptor processing; IBA:GO_Central.
DR   GO; GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0016485; P:protein processing; IEA:InterPro.
DR   InterPro; IPR001493; Pept_A22A_PS2.
DR   InterPro; IPR001108; Peptidase_A22A.
DR   InterPro; IPR006639; Preselin/SPP.
DR   PANTHER; PTHR10202; PTHR10202; 2.
DR   Pfam; PF01080; Presenilin; 2.
DR   PRINTS; PR01072; PRESENILIN.
DR   PRINTS; PR01074; PRESENILIN2.
DR   SMART; SM00730; PSN; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Endoplasmic reticulum; Golgi apparatus; Hydrolase;
KW   Membrane; Notch signaling pathway; Phosphoprotein; Protease;
KW   Reference proteome; Transmembrane; Transmembrane helix.
FT   CHAIN         1    297       Presenilin-2 NTF subunit. {ECO:0000250}.
FT                                /FTId=PRO_0000354669.
FT   CHAIN       298    448       Presenilin-2 CTF subunit. {ECO:0000250}.
FT                                /FTId=PRO_0000354670.
FT   TOPO_DOM      1     87       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     88    108       Helical. {ECO:0000255}.
FT   TOPO_DOM    109    138       Lumenal. {ECO:0000255}.
FT   TRANSMEM    139    159       Helical. {ECO:0000255}.
FT   TOPO_DOM    160    166       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    167    187       Helical. {ECO:0000255}.
FT   TOPO_DOM    188    200       Lumenal. {ECO:0000255}.
FT   TRANSMEM    201    221       Helical. {ECO:0000255}.
FT   TOPO_DOM    222    223       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    224    244       Helical. {ECO:0000255}.
FT   TOPO_DOM    245    249       Lumenal. {ECO:0000255}.
FT   TRANSMEM    250    270       Helical. {ECO:0000255}.
FT   TOPO_DOM    271    361       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    362    382       Helical. {ECO:0000255}.
FT   TOPO_DOM    383    388       Lumenal. {ECO:0000255}.
FT   TRANSMEM    389    409       Helical. {ECO:0000255}.
FT   TOPO_DOM    410    413       Cytoplasmic. {ECO:0000255}.
FT   INTRAMEM    414    434       Helical. {ECO:0000255}.
FT   TOPO_DOM    435    448       Cytoplasmic. {ECO:0000255}.
FT   MOTIF       414    416       PAL.
FT   ACT_SITE    263    263       {ECO:0000250}.
FT   ACT_SITE    366    366       {ECO:0000250}.
FT   MOD_RES      22     22       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P49810}.
FT   MOD_RES      25     25       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P49810}.
FT   MOD_RES      30     30       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q61144}.
FT   MOD_RES      52     52       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q61144}.
SQ   SEQUENCE   448 AA;  50138 MW;  734999D64407A86D CRC64;
     MLTFMASDSE EEVCDERTSL MSAESPTPRS CQEGRQGLED GESAAQWRSQ DSEEDHEEDP
     DRYVCSGVPG RPPGLEEELT LKYGAKHVIM LFVPVTLCMI VVVATIKSVR FYTEKNGQLI
     YTPFTEDTPS VGQRLLNSVL NTLIMISVIV VMTIFLVVLY KYRCYKFIHG WLITSSLMLL
     FLFTYIYLGE VLKTYNVAMD YPTLFLTVWN FGAVGMVCIH WKGPLVLQQA YLIMISALMA
     LVFIKYLPEW SAWVILGAIS VYDLVAVLCP KGPLRMLVET AQERNEPIFP ALIYSSAMVW
     TVGMAKLDPS SQGALQLPYD PEMEEDSYDS FGEPSYPEVF EPPLPGYPGE ELEEEEERGV
     KLGLGDFIFY SVLVGKAAAT GSGDWNTTLA CFVAILIGLC LTLLLLAVFK KALPALPISI
     TFGLIFYFST DNLVRPFMDT LASHQLYI
//
ID   BRN_DROME               Reviewed;         325 AA.
AC   Q24157; Q5BIH4; Q8SZS9; Q9W4N0;
DT   10-MAY-2004, integrated into UniProtKB/Swiss-Prot.
DT   10-MAY-2004, sequence version 2.
DT   20-DEC-2017, entry version 140.
DE   RecName: Full=Beta-1,3-galactosyltransferase brn;
DE            EC=2.4.1.62;
DE   AltName: Full=Brainiac protein;
DE   AltName: Full=Neurogenic secreted-signaling protein brn;
GN   Name=brn; ORFNames=CG4934;
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha;
OC   Ephydroidea; Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227 {ECO:0000312|EMBL:AAL48007.1};
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA], AND FUNCTION.
RX   PubMed=9012507;
RA   Goode S., Melnick M., Chou T.-B., Perrimon N.;
RT   "The neurogenic genes egghead and brainiac define a novel signaling
RT   pathway essential for epithelial morphogenesis during Drosophila
RT   oogenesis.";
RL   Development 122:3863-3879(1996).
RN   [2] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley {ECO:0000269|PubMed:10731132};
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X.,
RA   Brandon R.C., Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D.,
RA   Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G.,
RA   Abril J.F., Agbayani A., An H.-J., Andrews-Pfannkoch C., Baldwin D.,
RA   Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M.,
RA   Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S.,
RA   Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P.,
RA   Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I.,
RA   Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P.,
RA   de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M.,
RA   Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P.,
RA   Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W.,
RA   Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K.,
RA   Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J.,
RA   Hostin D., Houston K.A., Howland T.J., Wei M.-H., Ibegwam C.,
RA   Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A.,
RA   Kimmel B.E., Kodira C.D., Kraft C.L., Kravitz S., Kulp D., Lai Z.,
RA   Lasko P., Lei Y., Levitsky A.A., Li J.H., Li Z., Liang Y., Lin X.,
RA   Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D.,
RA   Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A.,
RA   Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L.,
RA   Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M.,
RA   Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G.,
RA   Reinert K., Remington K., Saunders R.D.C., Scheeler F., Shen H.,
RA   Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E.,
RA   Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X.,
RA   Wang Z.-Y., Wassarman D.A., Weinstock G.M., Weissenbach J.,
RA   Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A.,
RA   Ye J., Yeh R.-F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L.,
RA   Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S.C., Zhu X.,
RA   Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q.,
RA   Stapleton M., Yamada C., Ashburner M., Gelbart W.M., Rubin G.M.,
RA   Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a
RT   systematic review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [4] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Oregon-R {ECO:0000269|PubMed:10731137};
RX   PubMed=10731137; DOI=10.1126/science.287.5461.2220;
RA   Benos P.V., Gatt M.K., Ashburner M., Murphy L., Harris D.,
RA   Barrell B.G., Ferraz C., Vidal S., Brun C., Demailles J., Cadieu E.,
RA   Dreano S., Gloux S., Lelaure V., Mottier S., Galibert F., Borkova D.,
RA   Minana B., Kafatos F.C., Louis C., Siden-Kiamos I., Bolshakov S.,
RA   Papagiannakis G., Spanos L., Cox S., Madueno E., de Pablos B.,
RA   Modolell J., Peter A., Schoettler P., Werner M., Mourkioti F.,
RA   Beinert N., Dowe G., Schaefer U., Jaeckle H., Bucheton A.,
RA   Callister D.M., Campbell L.A., Darlamitsou A., Henderson N.S.,
RA   McMillan P.J., Salles C., Tait E.A., Valenti P., Saunders R.D.C.,
RA   Glover D.M.;
RT   "From sequence to chromosome: the tip of the X chromosome of D.
RT   melanogaster.";
RL   Science 287:2220-2222(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=Berkeley; TISSUE=Embryo;
RA   Stapleton M., Carlson J.W., Chavez C., Frise E., George R.A.,
RA   Pacleb J.M., Park S., Wan K.H., Yu C., Rubin G.M., Celniker S.E.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 2-325.
RC   STRAIN=Berkeley {ECO:0000269|PubMed:12537569};
RC   TISSUE=Embryo {ECO:0000269|PubMed:12537569};
RX   PubMed=12537569; DOI=10.1186/gb-2002-3-12-research0080;
RA   Stapleton M., Carlson J.W., Brokstein P., Yu C., Champe M.,
RA   George R.A., Guarin H., Kronmiller B., Pacleb J.M., Park S., Wan K.H.,
RA   Rubin G.M., Celniker S.E.;
RT   "A Drosophila full-length cDNA resource.";
RL   Genome Biol. 3:RESEARCH0080.1-RESEARCH0080.8(2002).
CC   -!- FUNCTION: Neurogenic protein essential for the development and
CC       maintenance of epithelial structure. Required in the germline for
CC       establishing the follicular epithelium and for determining the
CC       dorsal-ventral polarity. Collaborates with Notch on the apical
CC       surface of follicle cells to mediate germline-follicle cell
CC       adhesion. Brn has a role in chorion formation.
CC       {ECO:0000269|PubMed:9012507}.
CC   -!- CATALYTIC ACTIVITY: UDP-alpha-D-galactose + an N-acetyl-beta-D-
CC       galactosaminyl-(1->4)-(alpha-N-acetylneuraminyl-(2->3))-beta-D-
CC       galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide = UDP + a beta-
CC       D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-(alpha-
CC       N-acetylneuraminyl-(2->3))-beta-D-galactosyl-(1->4)-beta-D-
CC       glucosyl-(1<->1)-ceramide.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000305};
CC       Single-pass type II membrane protein {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 31 family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAL48007.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U41449; AAA85211.1; -; mRNA.
DR   EMBL; AE014298; AAF45918.1; -; Genomic_DNA.
DR   EMBL; AL033125; CAA21833.1; -; Genomic_DNA.
DR   EMBL; BT021250; AAX33398.1; -; mRNA.
DR   EMBL; AY070536; AAL48007.1; ALT_INIT; mRNA.
DR   RefSeq; NP_476901.1; NM_057553.5.
DR   UniGene; Dm.1589; -.
DR   ProteinModelPortal; Q24157; -.
DR   SMR; Q24157; -.
DR   BioGrid; 57876; 2.
DR   IntAct; Q24157; 2.
DR   MINT; MINT-283889; -.
DR   STRING; 7227.FBpp0070606; -.
DR   CAZy; GT31; Glycosyltransferase Family 31.
DR   PaxDb; Q24157; -.
DR   PRIDE; Q24157; -.
DR   EnsemblMetazoa; FBtr0070638; FBpp0070606; FBgn0000221.
DR   GeneID; 31358; -.
DR   KEGG; dme:Dmel_CG4934; -.
DR   CTD; 31358; -.
DR   FlyBase; FBgn0000221; brn.
DR   eggNOG; KOG2287; Eukaryota.
DR   eggNOG; ENOG410ZZ1B; LUCA.
DR   GeneTree; ENSGT00900000141150; -.
DR   InParanoid; Q24157; -.
DR   KO; K02175; -.
DR   OMA; IRRTWGY; -.
DR   OrthoDB; EOG091G0BM6; -.
DR   PhylomeDB; Q24157; -.
DR   BRENDA; 2.4.1.62; 1994.
DR   SignaLink; Q24157; -.
DR   GenomeRNAi; 31358; -.
DR   PRO; PR:Q24157; -.
DR   Proteomes; UP000000803; Chromosome X.
DR   Bgee; FBgn0000221; -.
DR   Genevisible; Q24157; DM.
DR   GO; GO:0005576; C:extracellular region; ISS:FlyBase.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005795; C:Golgi stack; ISS:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0008375; F:acetylglucosaminyltransferase activity; TAS:FlyBase.
DR   GO; GO:0046981; F:beta-1,4-mannosylglycolipid beta-1,3-N-acetylglucosaminyltransferase activity; IDA:FlyBase.
DR   GO; GO:0047915; F:ganglioside galactosyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0007298; P:border follicle cell migration; IMP:FlyBase.
DR   GO; GO:0007293; P:germarium-derived egg chamber formation; IMP:FlyBase.
DR   GO; GO:0006688; P:glycosphingolipid biosynthetic process; IDA:FlyBase.
DR   GO; GO:0042248; P:maintenance of polarity of follicular epithelium; IMP:FlyBase.
DR   GO; GO:0016333; P:morphogenesis of follicular epithelium; IMP:FlyBase.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   GO; GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0048477; P:oogenesis; NAS:FlyBase.
DR   GO; GO:0001744; P:optic lobe placode formation; IMP:FlyBase.
DR   GO; GO:0030707; P:ovarian follicle cell development; IMP:FlyBase.
DR   GO; GO:0007299; P:ovarian follicle cell-cell adhesion; IMP:FlyBase.
DR   GO; GO:0006486; P:protein glycosylation; IEA:InterPro.
DR   Gene3D; 3.90.550.10; -; 1.
DR   InterPro; IPR002659; Glyco_trans_31.
DR   InterPro; IPR029044; Nucleotide-diphossugar_trans.
DR   PANTHER; PTHR11214; PTHR11214; 1.
DR   Pfam; PF01762; Galactosyl_T; 1.
DR   SUPFAM; SSF53448; SSF53448; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Developmental protein; Glycoprotein;
KW   Glycosyltransferase; Golgi apparatus; Membrane;
KW   Notch signaling pathway; Reference proteome; Signal-anchor;
KW   Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN         1    325       Beta-1,3-galactosyltransferase brn.
FT                                /FTId=PRO_0000219174.
FT   TOPO_DOM      1      7       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM      8     28       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     29    325       Lumenal. {ECO:0000255}.
FT   CARBOHYD    149    149       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    166    166       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CONFLICT    142    142       E -> D (in Ref. 1; AAA85211).
FT                                {ECO:0000305}.
FT   CONFLICT    163    163       D -> E (in Ref. 1; AAA85211).
FT                                {ECO:0000305}.
SQ   SEQUENCE   325 AA;  37620 MW;  0DF89B720F43657B CRC64;
     MQSKHRKLLL RCLLVLPLIL LVDYCGLLTH LHELNFERHF HYPLNDDTGS GSASSGLDKF
     AYLRVPSFTA EVPVDQPARL TMLIKSAVGN SRRREAIRRT WGYEGRFSDV HLRRVFLLGT
     AEDSEKDVAW ESREHGDILQ AEFTDAYFNN TLKTMLGMRW ASDQFNRSEF YLFVDDDYYV
     SAKNVLKFLG RGRQSHQPEL LFAGHVFQTS PLRHKFSKWY VSLEEYPFDR WPPYVTAGAF
     ILSQKALRQL YAASVHLPLF RFDDVYLGIV ALKAGISLQH CDDFRFHRPA YKGPDSYSSV
     IASHEFGDPE EMTRVWNECR SANYA
//
ID   PEN2_DICDI              Reviewed;          97 AA.
AC   Q54BR1;
DT   08-APR-2008, integrated into UniProtKB/Swiss-Prot.
DT   08-APR-2008, sequence version 2.
DT   05-JUL-2017, entry version 51.
DE   RecName: Full=Probable gamma-secretase subunit PEN-2;
GN   Name=psenen; ORFNames=DDB_G0293484;
OS   Dictyostelium discoideum (Slime mold).
OC   Eukaryota; Amoebozoa; Mycetozoa; Dictyosteliida; Dictyostelium.
OX   NCBI_TaxID=44689;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=AX4;
RX   PubMed=15875012; DOI=10.1038/nature03481;
RA   Eichinger L., Pachebat J.A., Gloeckner G., Rajandream M.A.,
RA   Sucgang R., Berriman M., Song J., Olsen R., Szafranski K., Xu Q.,
RA   Tunggal B., Kummerfeld S., Madera M., Konfortov B.A., Rivero F.,
RA   Bankier A.T., Lehmann R., Hamlin N., Davies R., Gaudet P., Fey P.,
RA   Pilcher K., Chen G., Saunders D., Sodergren E.J., Davis P.,
RA   Kerhornou A., Nie X., Hall N., Anjard C., Hemphill L., Bason N.,
RA   Farbrother P., Desany B., Just E., Morio T., Rost R., Churcher C.M.,
RA   Cooper J., Haydock S., van Driessche N., Cronin A., Goodhead I.,
RA   Muzny D.M., Mourier T., Pain A., Lu M., Harper D., Lindsay R.,
RA   Hauser H., James K.D., Quiles M., Madan Babu M., Saito T.,
RA   Buchrieser C., Wardroper A., Felder M., Thangavelu M., Johnson D.,
RA   Knights A., Loulseged H., Mungall K.L., Oliver K., Price C.,
RA   Quail M.A., Urushihara H., Hernandez J., Rabbinowitsch E., Steffen D.,
RA   Sanders M., Ma J., Kohara Y., Sharp S., Simmonds M.N., Spiegler S.,
RA   Tivey A., Sugano S., White B., Walker D., Woodward J.R., Winckler T.,
RA   Tanaka Y., Shaulsky G., Schleicher M., Weinstock G.M., Rosenthal A.,
RA   Cox E.C., Chisholm R.L., Gibbs R.A., Loomis W.F., Platzer M.,
RA   Kay R.R., Williams J.G., Dear P.H., Noegel A.A., Barrell B.G.,
RA   Kuspa A.;
RT   "The genome of the social amoeba Dictyostelium discoideum.";
RL   Nature 435:43-57(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=10048482; DOI=10.1093/dnares/5.6.335;
RA   Morio T., Urushihara H., Saito T., Ugawa Y., Mizuno H., Yoshida M.,
RA   Yoshino R., Mitra B.N., Pi M., Sato T., Takemoto K., Yasukawa H.,
RA   Williams J., Maeda M., Takeuchi I., Ochiai H., Tanaka Y.;
RT   "The Dictyostelium developmental cDNA project: generation and analysis
RT   of expressed sequence tags from the first-finger stage of
RT   development.";
RL   DNA Res. 5:335-340(1998).
CC   -!- FUNCTION: Essential subunit of the gamma-secretase complex, an
CC       endoprotease complex that catalyzes the intramembrane cleavage of
CC       integral membrane proteins such as Notch receptors. The gamma-
CC       secretase complex plays a role in Notch and Wnt signaling cascades
CC       and regulation of downstream processes via its role in processing
CC       key regulatory proteins. {ECO:0000250|UniProtKB:Q9NZ42}.
CC   -!- SUBUNIT: The functional gamma-secretase complex is composed of at
CC       least four polypeptides: a presenilin homodimer, nicastrin, aph1
CC       and pen2. {ECO:0000250|UniProtKB:Q9NZ42}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:Q9NZ42}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q9NZ42}. Golgi apparatus, Golgi stack
CC       membrane {ECO:0000250|UniProtKB:Q9NZ42}; Multi-pass membrane
CC       protein {ECO:0000250|UniProtKB:Q9NZ42}. Cell membrane
CC       {ECO:0000250|UniProtKB:Q9NZ42}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q9NZ42}. Membrane
CC       {ECO:0000250|UniProtKB:Q9NZ42}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q9NZ42}. Note=Predominantly located in the
CC       endoplasmic reticulum and in the cis-Golgi.
CC       {ECO:0000250|UniProtKB:Q9NZ42}.
CC   -!- SIMILARITY: Belongs to the PEN-2 family. {ECO:0000305}.
CC   -!- CAUTION: 3D-structure analysis of the human homolog indicates that
CC       the membrane topology differs from the predictions. Contrary to
CC       predictions, the N-terminus contains two short helices that dip
CC       into the membrane, but do not cross it. The C-terminus contains
CC       the single transmembrane helix. This gives rise to a topology
CC       where the N-terminus is cytoplasmic and the C-terminus is lumenal.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AAFI02000213; EAL60704.1; -; Genomic_DNA.
DR   EMBL; C92437; -; NOT_ANNOTATED_CDS; mRNA.
DR   RefSeq; XP_629118.1; XM_629116.1.
DR   SMR; Q54BR1; -.
DR   PaxDb; Q54BR1; -.
DR   EnsemblProtists; EAL60704; EAL60704; DDB_G0293484.
DR   GeneID; 8629248; -.
DR   KEGG; ddi:DDB_G0293484; -.
DR   dictyBase; DDB_G0293484; psenen.
DR   InParanoid; Q54BR1; -.
DR   KO; K06170; -.
DR   PhylomeDB; Q54BR1; -.
DR   PRO; PR:Q54BR1; -.
DR   Proteomes; UP000002195; Chromosome 6.
DR   Proteomes; UP000002195; Unassembled WGS sequence.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0070765; C:gamma-secretase complex; IBA:GO_Central.
DR   GO; GO:0032580; C:Golgi cisterna membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW.
DR   InterPro; IPR019379; Gamma_Secretase_Asp_P_PEN2.
DR   PANTHER; PTHR16318; PTHR16318; 1.
DR   Pfam; PF10251; PEN-2; 1.
PE   3: Inferred from homology;
KW   Cell membrane; Complete proteome; Endoplasmic reticulum;
KW   Golgi apparatus; Membrane; Notch signaling pathway;
KW   Reference proteome; Transmembrane; Transmembrane helix.
FT   CHAIN         1     97       Probable gamma-secretase subunit PEN-2.
FT                                /FTId=PRO_0000328268.
FT   TOPO_DOM      1     20       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:Q9NZ42}.
FT   INTRAMEM     21     39       Helical. {ECO:0000250|UniProtKB:Q9NZ42}.
FT   TOPO_DOM     40     55       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:Q9NZ42}.
FT   TRANSMEM     56     76       Helical. {ECO:0000250|UniProtKB:Q9NZ42}.
FT   TOPO_DOM     77     97       Lumenal. {ECO:0000250|UniProtKB:Q9NZ42}.
FT   CONFLICT     30     30       P -> T (in Ref. 1; EAL60704).
FT                                {ECO:0000305}.
SQ   SEQUENCE   97 AA;  11585 MW;  F9CF2280E92F9625 CRC64;
     MLIPEDDKLD DEKMINIAKK LWFIGFFFLP WVWLINILYF IPYRNSLNDK VKWYLKFSLI
     GFLGYSTIFM GWMGIYLVNR NKWGAFGDDI SITIPFG
//
ID   APH1_DICDI              Reviewed;         328 AA.
AC   Q55FS3;
DT   29-APR-2008, integrated into UniProtKB/Swiss-Prot.
DT   24-MAY-2005, sequence version 1.
DT   22-NOV-2017, entry version 56.
DE   RecName: Full=Gamma-secretase subunit Aph-1;
GN   Name=aph1; ORFNames=DDB_G0267976;
OS   Dictyostelium discoideum (Slime mold).
OC   Eukaryota; Amoebozoa; Mycetozoa; Dictyosteliida; Dictyostelium.
OX   NCBI_TaxID=44689;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=AX4;
RX   PubMed=15875012; DOI=10.1038/nature03481;
RA   Eichinger L., Pachebat J.A., Gloeckner G., Rajandream M.A.,
RA   Sucgang R., Berriman M., Song J., Olsen R., Szafranski K., Xu Q.,
RA   Tunggal B., Kummerfeld S., Madera M., Konfortov B.A., Rivero F.,
RA   Bankier A.T., Lehmann R., Hamlin N., Davies R., Gaudet P., Fey P.,
RA   Pilcher K., Chen G., Saunders D., Sodergren E.J., Davis P.,
RA   Kerhornou A., Nie X., Hall N., Anjard C., Hemphill L., Bason N.,
RA   Farbrother P., Desany B., Just E., Morio T., Rost R., Churcher C.M.,
RA   Cooper J., Haydock S., van Driessche N., Cronin A., Goodhead I.,
RA   Muzny D.M., Mourier T., Pain A., Lu M., Harper D., Lindsay R.,
RA   Hauser H., James K.D., Quiles M., Madan Babu M., Saito T.,
RA   Buchrieser C., Wardroper A., Felder M., Thangavelu M., Johnson D.,
RA   Knights A., Loulseged H., Mungall K.L., Oliver K., Price C.,
RA   Quail M.A., Urushihara H., Hernandez J., Rabbinowitsch E., Steffen D.,
RA   Sanders M., Ma J., Kohara Y., Sharp S., Simmonds M.N., Spiegler S.,
RA   Tivey A., Sugano S., White B., Walker D., Woodward J.R., Winckler T.,
RA   Tanaka Y., Shaulsky G., Schleicher M., Weinstock G.M., Rosenthal A.,
RA   Cox E.C., Chisholm R.L., Gibbs R.A., Loomis W.F., Platzer M.,
RA   Kay R.R., Williams J.G., Dear P.H., Noegel A.A., Barrell B.G.,
RA   Kuspa A.;
RT   "The genome of the social amoeba Dictyostelium discoideum.";
RL   Nature 435:43-57(2005).
CC   -!- FUNCTION: Essential subunit of the gamma-secretase complex, an
CC       endoprotease complex that catalyzes the intramembrane cleavage of
CC       integral proteins such as Notch receptors precursor protein. It
CC       probably represents a stabilizing cofactor for the presenilin
CC       homodimer that promotes the formation of a stable complex (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Component of the gamma-secretase complex, a complex
CC       composed of a presenilin homodimer, nicastrin, aph1 and pen2.
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the APH-1 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AAFI02000003; EAL73441.1; -; Genomic_DNA.
DR   RefSeq; XP_647460.1; XM_642368.1.
DR   STRING; 44689.DDB0266683; -.
DR   PaxDb; Q55FS3; -.
DR   EnsemblProtists; EAL73441; EAL73441; DDB_G0267976.
DR   GeneID; 8616267; -.
DR   KEGG; ddi:DDB_G0267976; -.
DR   dictyBase; DDB_G0267976; aph1.
DR   eggNOG; KOG3972; Eukaryota.
DR   eggNOG; ENOG4111FIJ; LUCA.
DR   InParanoid; Q55FS3; -.
DR   KO; K06172; -.
DR   OMA; WSVIFFN; -.
DR   PhylomeDB; Q55FS3; -.
DR   PRO; PR:Q55FS3; -.
DR   Proteomes; UP000002195; Chromosome 1.
DR   Proteomes; UP000002195; Unassembled WGS sequence.
DR   GO; GO:0005783; C:endoplasmic reticulum; IBA:GO_Central.
DR   GO; GO:0070765; C:gamma-secretase complex; IBA:GO_Central.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0004175; F:endopeptidase activity; IBA:GO_Central.
DR   GO; GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0006909; P:phagocytosis; IGI:dictyBase.
DR   GO; GO:0043085; P:positive regulation of catalytic activity; IEA:InterPro.
DR   GO; GO:0016485; P:protein processing; IBA:GO_Central.
DR   GO; GO:0006508; P:proteolysis; IMP:dictyBase.
DR   GO; GO:0044671; P:sorocarp spore cell differentiation; IMP:dictyBase.
DR   Gene3D; 2.130.10.10; -; 1.
DR   InterPro; IPR009294; Aph-1.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom_sf.
DR   PANTHER; PTHR12889; PTHR12889; 1.
DR   Pfam; PF06105; Aph-1; 1.
PE   3: Inferred from homology;
KW   Complete proteome; Glycoprotein; Membrane; Notch signaling pathway;
KW   Reference proteome; Transmembrane; Transmembrane helix.
FT   CHAIN         1    328       Gamma-secretase subunit Aph-1.
FT                                /FTId=PRO_0000331266.
FT   TRANSMEM      5     25       Helical. {ECO:0000255}.
FT   TRANSMEM     36     56       Helical. {ECO:0000255}.
FT   TRANSMEM     62     82       Helical. {ECO:0000255}.
FT   TRANSMEM    199    219       Helical. {ECO:0000255}.
FT   TRANSMEM    235    255       Helical. {ECO:0000255}.
FT   TRANSMEM    270    290       Helical. {ECO:0000255}.
FT   TRANSMEM    299    319       Helical. {ECO:0000255}.
FT   COMPBIAS    140    154       Poly-Asn.
FT   CARBOHYD    141    141       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    193    193       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   328 AA;  37605 MW;  322C29649EED87E5 CRC64;
     MTQVLFYGCL FITFSPILAF FFMVIAKNSQ LVILTIGGSF FWLVSILIAA IWWYIIPPMR
     EHWWFIISFS VLFQEIFRYI FFRLYSYGFN DRPSLNQIKE TQHQMALDSM RKRKQAQQQK
     QQPPTNEIES INNEIIDTTN NNTNNNNNNN NNINDDDNKE ITEEEKEKRK IEKQKQREIE
     INARLETLSA RPNHTLSSAA IGVGSGVAYG FIMFGSILWE STGPGTLFSP ACPSVNLFML
     SSIITLFMTL LHVVYNVLAF QGYRSKKYHL VAFVIITHFV TTYLTLLNLP TKTTSCVGSI
     LPIGIITVFS VGFCIFSLLK SDSITKIH
//
ID   DLL1_MOUSE              Reviewed;         722 AA.
AC   Q61483; Q6PFV7;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   27-JUL-2011, sequence version 2.
DT   20-DEC-2017, entry version 169.
DE   RecName: Full=Delta-like protein 1 {ECO:0000305};
DE   AltName: Full=Drosophila Delta homolog 1;
DE            Short=Delta1 {ECO:0000303|PubMed:12794186};
DE   Contains:
DE     RecName: Full=Dll1-soluble form {ECO:0000303|PubMed:12794186};
DE              Short=Dll1-EC {ECO:0000305|PubMed:12794186};
DE              Short=Shed form {ECO:0000303|PubMed:12794186};
DE   Contains:
DE     RecName: Full=Dll1-derived cell-associated form {ECO:0000303|PubMed:12794186};
DE              Short=Dll1-TMIC {ECO:0000305|PubMed:12794186};
DE              Short=Membrane-associated fragment {ECO:0000303|PubMed:12794186};
DE   Contains:
DE     RecName: Full=Dll1-intracellular form {ECO:0000303|PubMed:12794186};
DE              Short=Dll1-IC {ECO:0000305|PubMed:12794186};
DE   Flags: Precursor;
GN   Name=Dll1;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], DEVELOPMENTAL STAGE, TISSUE SPECIFICITY,
RP   AND FUNCTION.
RC   STRAIN=C57BL/6 X BALB/c; TISSUE=Embryo;
RX   PubMed=7671806;
RA   Bettenhausen B., de Angelis M.H., Simon D., Guenet J.-L., Gossler A.;
RT   "Transient and restricted expression during mouse embryogenesis of
RT   Dll1, a murine gene closely related to Drosophila Delta.";
RL   Development 121:2407-2418(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S.,
RA   She X., Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W.,
RA   Kapustin Y., Meric P., Maglott D., Birtle Z., Marques A.C., Graves T.,
RA   Zhou S., Teague B., Potamousis K., Churas C., Place M., Herschleb J.,
RA   Runnheim R., Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z.,
RA   Lindblad-Toh K., Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of
RT   the mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Embryonic brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 527-534 AND 536-543, PROTEOLYTIC CLEAVAGE BY
RP   MMP14, INTERACTION WITH MMP14, IDENTIFICATION BY MASS SPECTROMETRY,
RP   AND FUNCTION.
RX   PubMed=21572390; DOI=10.1038/emboj.2011.136;
RA   Jin G., Zhang F., Chan K.M., Xavier Wong H.L., Liu B., Cheah K.S.,
RA   Liu X., Mauch C., Liu D., Zhou Z.;
RT   "MT1-MMP cleaves Dll1 to negatively regulate Notch signalling to
RT   maintain normal B-cell development.";
RL   EMBO J. 30:2281-2293(2011).
RN   [6]
RP   PROTEIN SEQUENCE OF 536-554, PROTEOLYTIC CLEAVAGE, HOMODIMERIZATION,
RP   INTERACTION WITH PSEN1, AND SUBCELLULAR LOCATION.
RX   PubMed=12794186; DOI=10.1073/pnas.1230693100;
RA   Six E., Ndiaye D., Laabi Y., Brou C., Gupta-Rossi N., Israel A.,
RA   Logeat F.;
RT   "The Notch ligand Delta1 is sequentially cleaved by an ADAM protease
RT   and gamma-secretase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:7638-7643(2003).
RN   [7]
RP   FUNCTION.
RX   PubMed=10958687; DOI=10.1128/MCB.20.18.6913-6922.2000;
RA   Shimizu K., Chiba S., Hosoya N., Kumano K., Saito T., Kurokawa M.,
RA   Kanda Y., Hamada Y., Hirai H.;
RT   "Binding of Delta1, Jagged1, and Jagged2 to Notch2 rapidly induces
RT   cleavage, nuclear translocation, and hyperphosphorylation of Notch2.";
RL   Mol. Cell. Biol. 20:6913-6922(2000).
RN   [8]
RP   FUNCTION.
RX   PubMed=15146182; DOI=10.1038/ni1075;
RA   Hozumi K., Negishi N., Suzuki D., Abe N., Sotomaru Y., Tamaoki N.,
RA   Mailhos C., Ish-Horowicz D., Habu S., Owen M.J.;
RT   "Delta-like 1 is necessary for the generation of marginal zone B cells
RT   but not T cells in vivo.";
RL   Nat. Immunol. 5:638-644(2004).
RN   [9]
RP   INTERACTION WITH MFAP5.
RX   PubMed=15788413; DOI=10.1074/jbc.M500273200;
RA   Nehring L.C., Miyamoto A., Hein P.W., Weinmaster G., Shipley J.M.;
RT   "The extracellular matrix protein MAGP-2 interacts with Jagged1 and
RT   induces its shedding from the cell surface.";
RL   J. Biol. Chem. 280:20349-20355(2005).
RN   [10]
RP   INTERACTION WITH MAGI1, AND SUBCELLULAR LOCATION.
RX   PubMed=15908431; DOI=10.1074/jbc.M500375200;
RA   Mizuhara E., Nakatani T., Minaki Y., Sakamoto Y., Ono Y., Takai Y.;
RT   "MAGI1 recruits Dll1 to cadherin-based adherens junctions and
RT   stabilizes it on the cell surface.";
RL   J. Biol. Chem. 280:26499-26507(2005).
RN   [11]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=16495313; DOI=10.1242/dev.02284;
RA   Brooker R., Hozumi K., Lewis J.;
RT   "Notch ligands with contrasting functions: Jagged1 and Delta1 in the
RT   mouse inner ear.";
RL   Development 133:1277-1286(2006).
RN   [12]
RP   INTERACTION WITH NEURL1B, AND UBIQUITINATION.
RX   PubMed=17003037; DOI=10.1074/jbc.M606601200;
RA   Song R., Koo B.-K., Yoon K.-J., Yoon M.-J., Yoo K.-W., Kim H.-T.,
RA   Oh H.-J., Kim Y.-Y., Han J.-K., Kim C.-H., Kong Y.-Y.;
RT   "Neuralized-2 regulates a Notch ligand in cooperation with Mind bomb-
RT   1.";
RL   J. Biol. Chem. 281:36391-36400(2006).
RN   [13]
RP   DEVELOPMENTAL STAGE, DISRUPTION PHENOTYPE, AND FUNCTION.
RX   PubMed=17194759; DOI=10.1073/pnas.0608281104;
RA   Schuster-Gossler K., Cordes R., Gossler A.;
RT   "Premature myogenic differentiation and depletion of progenitor cells
RT   cause severe muscle hypotrophy in Delta1 mutants.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:537-542(2007).
RN   [14]
RP   FUNCTION, DEVELOPMENTAL STAGE, AND DISRUPTION PHENOTYPE.
RX   PubMed=18997111; DOI=10.1242/dev.024570;
RA   Kawaguchi D., Yoshimatsu T., Hozumi K., Gotoh Y.;
RT   "Selection of differentiating cells by different levels of delta-like
RT   1 among neural precursor cells in the developing mouse
RT   telencephalon.";
RL   Development 135:3849-3858(2008).
RN   [15]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=17960184; DOI=10.1038/sj.jid.5701113;
RA   Estrach S., Cordes R., Hozumi K., Gossler A., Watt F.M.;
RT   "Role of the Notch ligand Delta1 in embryonic and adult mouse
RT   epidermis.";
RL   J. Invest. Dermatol. 128:825-832(2008).
RN   [16]
RP   UBIQUITINATION, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=18676613; DOI=10.1073/pnas.0800695105;
RA   Heuss S.F., Ndiaye-Lobry D., Six E.M., Israel A., Logeat F.;
RT   "The intracellular region of Notch ligands Dll1 and Dll3 regulates
RT   their trafficking and signaling activity.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:11212-11217(2008).
RN   [17]
RP   INTERACTION WITH NEURL1 AND NEURL1B.
RX   PubMed=19723503; DOI=10.1016/j.bbrc.2009.08.147;
RA   Rullinkov G., Tamme R., Sarapuu A., Lauren J., Sepp M., Palm K.,
RA   Timmusk T.;
RT   "Neuralized-2: Expression in human and rodents and interaction with
RT   Delta-like ligands.";
RL   Biochem. Biophys. Res. Commun. 389:420-425(2009).
RN   [18]
RP   DEVELOPMENTAL STAGE, DISRUPTION PHENOTYPE, AND FUNCTION.
RX   PubMed=19144989; DOI=10.1182/blood-2008-08-174508;
RA   Soerensen I., Adams R.H., Gossler A.;
RT   "DLL1-mediated Notch activation regulates endothelial identity in
RT   mouse fetal arteries.";
RL   Blood 113:5680-5688(2009).
RN   [19]
RP   FUNCTION, AND DEVELOPMENTAL STAGE.
RX   PubMed=19389377; DOI=10.1016/j.ydbio.2009.01.011;
RA   Rocha S.F., Lopes S.S., Gossler A., Henrique D.;
RT   "Dll1 and Dll4 function sequentially in the retina and pV2 domain of
RT   the spinal cord to regulate neurogenesis and create cell diversity.";
RL   Dev. Biol. 328:54-65(2009).
RN   [20]
RP   FUNCTION.
RX   PubMed=19217325; DOI=10.1016/j.immuni.2008.12.016;
RA   Tan J.B., Xu K., Cretegny K., Visan I., Yuan J.S., Egan S.E.,
RA   Guidos C.J.;
RT   "Lunatic and manic fringe cooperatively enhance marginal zone B cell
RT   precursor competition for delta-like 1 in splenic endothelial
RT   niches.";
RL   Immunity 30:254-263(2009).
RN   [21]
RP   DISRUPTION PHENOTYPE, AND FUNCTION.
RX   PubMed=19562077; DOI=10.1371/journal.pone.0006054;
RA   Rubio-Aliaga I., Przemeck G.K., Fuchs H., Gailus-Durner V., Adler T.,
RA   Hans W., Horsch M., Rathkolb B., Rozman J., Schrewe A., Wagner S.,
RA   Hoelter S.M., Becker L., Klopstock T., Wurst W., Wolf E.,
RA   Klingenspor M., Ivandic B.T., Busch D.H., Beckers J.,
RA   Hrabe de Angelis M.;
RT   "Dll1 haploinsufficiency in adult mice leads to a complex phenotype
RT   affecting metabolic and immunological processes.";
RL   PLoS ONE 4:E6054-E6054(2009).
RN   [22]
RP   FUNCTION.
RX   PubMed=20081190; DOI=10.1242/dev.036806;
RA   Marklund U., Hansson E.M., Sundstroem E., de Angelis M.H.,
RA   Przemeck G.K., Lendahl U., Muhr J., Ericson J.;
RT   "Domain-specific control of neurogenesis achieved through patterned
RT   regulation of Notch ligand expression.";
RL   Development 137:437-445(2010).
RN   [23]
RP   MUTAGENESIS OF 613-LYS--LYS-618; LYS-613; LYS-689; LYS-699 AND
RP   LYS-713, INTERACTION WITH MIB1, SUBCELLULAR LOCATION, FUNCTION, AND
RP   UBIQUITINATION AT LYS-613.
RX   PubMed=21985982; DOI=10.1016/j.bbamcr.2011.08.019;
RA   Zhang L., Widau R.C., Herring B.P., Gallagher P.J.;
RT   "Delta-like 1-Lysine613 regulates notch signaling.";
RL   Biochim. Biophys. Acta 1813:2036-2043(2011).
RN   [24]
RP   FUNCTION.
RX   PubMed=21238454; DOI=10.1053/j.gastro.2011.01.005;
RA   Pellegrinet L., Rodilla V., Liu Z., Chen S., Koch U., Espinosa L.,
RA   Kaestner K.H., Kopan R., Lewis J., Radtke F.;
RT   "Dll1- and dll4-mediated notch signaling are required for homeostasis
RT   of intestinal stem cells.";
RL   Gastroenterology 140:1230-1240(2011).
RN   [25]
RP   FUNCTION.
RX   PubMed=21915337; DOI=10.1371/journal.pone.0024484;
RA   Stamataki D., Holder M., Hodgetts C., Jeffery R., Nye E.,
RA   Spencer-Dene B., Winton D.J., Lewis J.;
RT   "Delta1 expression, cell cycle exit, and commitment to a specific
RT   secretory fate coincide within a few hours in the mouse intestinal
RT   stem cell system.";
RL   PLoS ONE 6:E24484-E24484(2011).
RN   [26]
RP   FUNCTION.
RX   PubMed=22282195; DOI=10.1161/CIRCRESAHA.111.263319;
RA   Napp L.C., Augustynik M., Paesler F., Krishnasamy K., Woiterski J.,
RA   Limbourg A., Bauersachs J., Drexler H., Le Noble F., Limbourg F.P.;
RT   "Extrinsic Notch ligand Delta-like 1 regulates tip cell selection and
RT   vascular branching morphogenesis.";
RL   Circ. Res. 110:530-535(2012).
RN   [27]
RP   FUNCTION, AND INDUCTION.
RX   PubMed=22096075; DOI=10.1242/dev.071761;
RA   Ahnfelt-Roenne J., Joergensen M.C., Klinck R., Jensen J.N.,
RA   Fuechtbauer E.M., Deering T., MacDonald R.J., Wright C.V.,
RA   Madsen O.D., Serup P.;
RT   "Ptf1a-mediated control of Dll1 reveals an alternative to the lateral
RT   inhibition mechanism.";
RL   Development 139:33-45(2012).
RN   [28]
RP   INDUCTION.
RX   PubMed=22015720; DOI=10.1016/j.ydbio.2011.09.034;
RA   Grainger S., Lam J., Savory J.G., Mears A.J., Rijli F.M., Lohnes D.;
RT   "Cdx regulates Dll1 in multiple lineages.";
RL   Dev. Biol. 361:1-11(2012).
RN   [29]
RP   FUNCTION.
RX   PubMed=22940113; DOI=10.1016/j.devcel.2012.07.014;
RA   Broehl D., Vasyutina E., Czajkowski M.T., Griger J., Rassek C.,
RA   Rahn H.P., Purfuerst B., Wende H., Birchmeier C.;
RT   "Colonization of the satellite cell niche by skeletal muscle
RT   progenitor cells depends on Notch signals.";
RL   Dev. Cell 23:469-481(2012).
RN   [30]
RP   FUNCTION.
RX   PubMed=22529374; DOI=10.1073/pnas.1203605109;
RA   Horn S., Kobberup S., Joergensen M.C., Kalisz M., Klein T.,
RA   Kageyama R., Gegg M., Lickert H., Lindner J., Magnuson M.A.,
RA   Kong Y.Y., Serup P., Ahnfelt-Roenne J., Jensen J.N.;
RT   "Mind bomb 1 is required for pancreatic beta-cell formation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:7356-7361(2012).
RN   [31]
RP   FUNCTION.
RX   PubMed=23806616; DOI=10.1016/j.devcel.2013.05.022;
RA   Liu Z., Chen S., Boyle S., Zhu Y., Zhang A., Piwnica-Worms D.R.,
RA   Ilagan M.X., Kopan R.;
RT   "The extracellular domain of Notch2 increases its cell-surface
RT   abundance and ligand responsiveness during kidney development.";
RL   Dev. Cell 25:585-598(2013).
RN   [32]
RP   FUNCTION.
RX   PubMed=23699523; DOI=10.1523/JNEUROSCI.0791-13.2013;
RA   Nelson B.R., Hodge R.D., Bedogni F., Hevner R.F.;
RT   "Dynamic interactions between intermediate neurogenic progenitors and
RT   radial glia in embryonic mouse neocortex: potential role in Dll1-Notch
RT   signaling.";
RL   J. Neurosci. 33:9122-9139(2013).
RN   [33]
RP   DISRUPTION PHENOTYPE, AND FUNCTION.
RX   PubMed=23688253; DOI=10.1186/1756-6606-6-25;
RA   Hiraoka Y., Komine O., Nagaoka M., Bai N., Hozumi K., Tanaka K.;
RT   "Delta-like 1 regulates Bergmann glial monolayer formation during
RT   cerebellar development.";
RL   Mol. Brain 6:25-25(2013).
RN   [34]
RP   FUNCTION.
RX   PubMed=23695674; DOI=10.1038/ncomms2895;
RA   Kawaguchi D., Furutachi S., Kawai H., Hozumi K., Gotoh Y.;
RT   "Dll1 maintains quiescence of adult neural stem cells and segregates
RT   asymmetrically during mitosis.";
RL   Nat. Commun. 4:1880-1880(2013).
RN   [35]
RP   INTERACTION WITH TJP1, AND SUBCELLULAR LOCATION.
RX   PubMed=24715457; DOI=10.1242/dev.102988;
RA   Hatakeyama J., Wakamatsu Y., Nagafuchi A., Kageyama R., Shigemoto R.,
RA   Shimamura K.;
RT   "Cadherin-based adhesions in the apical endfoot are required for
RT   active Notch signaling to control neurogenesis in vertebrates.";
RL   Development 141:1671-1682(2014).
RN   [36]
RP   FUNCTION, DEVELOPMENTAL STAGE, DISRUPTION PHENOTYPE, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=25220152; DOI=10.1016/j.ydbio.2014.09.005;
RA   Czajkowski M.T., Rassek C., Lenhard D.C., Broehl D., Birchmeier C.;
RT   "Divergent and conserved roles of Dll1 signaling in development of
RT   craniofacial and trunk muscle.";
RL   Dev. Biol. 395:307-316(2014).
RN   [37]
RP   IDENTIFICATION BY MASS SPECTROMETRY, PHOSPHORYLATION AT THR-638;
RP   SER-693 AND SER-696, AND MUTAGENESIS OF THR-638; SER-693 AND SER-696.
RX   PubMed=24449764; DOI=10.1128/MCB.00965-13;
RA   Braune E.B., Schuster-Gossler K., Lyszkiewicz M., Serth K.,
RA   Preusse K., Madlung J., Macek B., Krueger A., Gossler A.;
RT   "S/T phosphorylation of DLL1 is required for full ligand activity in
RT   vitro but dispensable for DLL1 function in vivo during embryonic
RT   patterning and marginal zone B cell development.";
RL   Mol. Cell. Biol. 34:1221-1233(2014).
RN   [38]
RP   FUNCTION.
RX   PubMed=26114479; DOI=10.1371/journal.pgen.1005328;
RA   Preusse K., Tveriakhina L., Schuster-Gossler K., Gaspar C., Rosa A.I.,
RA   Henrique D., Gossler A., Stauber M.;
RT   "Context-dependent functional divergence of the Notch ligands DLL1 and
RT   DLL4 in vivo.";
RL   PLoS Genet. 11:E1005328-E1005328(2015).
CC   -!- FUNCTION: Transmembrane ligand protein of NOTCH1, NOTCH2 and
CC       NOTCH3 receptors that binds the extracellular domain (ECD) of
CC       Notch receptor in a cis and trans fashion manner (PubMed:21985982,
CC       PubMed:10958687). Following transinteraction, ligand cells produce
CC       mechanical force that depends of a clathrin-mediated endocytosis,
CC       requiring ligand ubiquitination, EPN1 interaction, and actin
CC       polymerisation; these events promote Notch receptor extracellular
CC       domain (NECD) transendocytosis and triggers Notch signaling
CC       through induction of cleavage, hyperphosphorylation, and nuclear
CC       accumulation of the intracellular domain of Notch receptors (NICD)
CC       (PubMed:10958687, PubMed:18676613). Is required for embryonic
CC       development and maintenance of adult stem cells in many different
CC       tissues and immune systeme; the DLL1-induced Notch signaling is
CC       mediated through an intercellular communication that regulates
CC       cell lineage, cell specification, cell patterning and
CC       morphogenesis through effects on differentiation and proliferation
CC       (PubMed:17194759, PubMed:19562077, PubMed:18997111,
CC       PubMed:23695674, PubMed:16495313, PubMed:21238454,
CC       PubMed:22282195, PubMed:7671806, PubMed:17960184, PubMed:22529374,
CC       PubMed:19389377, PubMed:23699523, PubMed:19144989,
CC       PubMed:23688253, PubMed:23806616, PubMed:26114479,
CC       PubMed:22940113, PubMed:25220152, PubMed:20081190,
CC       PubMed:21572390, PubMed:22096075). Plays a role in brain
CC       development at different level, namely by regulating neuronal
CC       differentiation of neural precursor cells via cell-cell
CC       interaction, most likely through the lateral inhibitory system in
CC       an endogenous level dependent-manner (PubMed:7671806,
CC       PubMed:18997111). During neocortex development, Dll1-Notch
CC       signaling transmission is mediated by dynamic interactions between
CC       intermediate neurogenic progenitors and radial glia; the cell-cell
CC       interactions are mediated via dynamic and transient elongation
CC       processes, likely to reactivate/maintain Notch activity in
CC       neighboring progenitors, and coordinate progenitor cell division
CC       and differentiation across radial and zonal boundaries
CC       (PubMed:23699523). During cerebellar development, regulates
CC       Bergmann glial monolayer formation and its morphological
CC       maturation through a Notch signaling pathway (PubMed:23688253). At
CC       the retina and spinal cord level, regulates neurogenesis by
CC       preventing the premature differentiation of neural progenitors and
CC       also by maintaining progenitors in spinal cord through Notch
CC       signaling pathway (PubMed:19389377, PubMed:26114479). Also
CC       controls neurogenesis of the neural tube in a progenitor domain-
CC       specific fashion along the dorsoventral axis (PubMed:20081190).
CC       Maintains quiescence of neural stem cells and plays a role as a
CC       fate determinant that segregates asymmetrically to one daughter
CC       cell during neural stem cells mitosis, resulting in neuronal
CC       differentiation in Dll1-inheriting cell (PubMed:23695674). Plays a
CC       role in immune systeme development, namely the development of all
CC       T-cells and marginal zone (MZ) B cells (PubMed:15146182,
CC       PubMed:19217325). Blocks the differentiation of progenitor cells
CC       into the B-cell lineage while promoting the emergence of a
CC       population of cells with the characteristics of a T-cell/NK-cell
CC       precursor (By similarity). Upon MMP14 cleavage, negatively
CC       regulates Notch signaling in haematopoietic progenitor cells to
CC       specifically maintain normal B-cell development in bone marrow
CC       (PubMed:21572390). Also plays a role during muscle development.
CC       During early development, inhibits myoblasts differentiation from
CC       the medial dermomyotomal lip and later regulates progenitor cell
CC       differentiation (PubMed:17194759). Directly modulates cell
CC       adhesion and basal lamina formation in satellite cells through
CC       Notch signaling. Maintains myogenic progenitors pool by
CC       suppressing differentiation through down-regulation of MYOD1 and
CC       is required for satellite cell homing and PAX7 expression
CC       (PubMed:22940113). During craniofacial and trunk myogenesis
CC       suppresses differentiation of cranial mesoderm-derived and somite-
CC       derived muscle via MYOD1 regulation but in cranial mesoderm-
CC       derived progenitors, is neither required for satellite cell homing
CC       nor for PAX7 expression (PubMed:25220152). Also plays a role
CC       during pancreatic cell development. During type B pancreatic cell
CC       development, may be involved in the initiation of proximodistal
CC       patterning in the early pancreatic epithelium (PubMed:22529374).
CC       Stimulates multipotent pancreatic progenitor cells proliferation
CC       and pancreatic growth by maintaining HES1 expression and PTF1A
CC       protein levels (PubMed:22096075). During fetal stages of
CC       development, is required to maintain arterial identity and the
CC       responsiveness of arterial endothelial cells for VEGFA through
CC       regulation of KDR activation and NRP1 expression
CC       (PubMed:19144989). Controls sprouting angiogenesis and subsequent
CC       vertical branch formation througth regulation on tip cell
CC       differentiation (PubMed:22282195). Negatively regulates goblet
CC       cell differentiation in intestine and controls secretory fat
CC       commitment through lateral inhibition in small intestine
CC       (PubMed:21238454, PubMed:21915337). Plays a role during inner ear
CC       development; negatively regulates auditory hair cell
CC       differentiation (PubMed:16495313). Plays a role during nephron
CC       development through Notch signaling pathway (PubMed:23806616).
CC       Regulates growth, blood pressure and energy homeostasis
CC       (PubMed:19562077). {ECO:0000250|UniProtKB:O00548,
CC       ECO:0000250|UniProtKB:P97677, ECO:0000269|PubMed:10958687,
CC       ECO:0000269|PubMed:15146182, ECO:0000269|PubMed:16495313,
CC       ECO:0000269|PubMed:17194759, ECO:0000269|PubMed:17960184,
CC       ECO:0000269|PubMed:18676613, ECO:0000269|PubMed:18997111,
CC       ECO:0000269|PubMed:19144989, ECO:0000269|PubMed:19217325,
CC       ECO:0000269|PubMed:19389377, ECO:0000269|PubMed:19562077,
CC       ECO:0000269|PubMed:20081190, ECO:0000269|PubMed:21238454,
CC       ECO:0000269|PubMed:21572390, ECO:0000269|PubMed:21915337,
CC       ECO:0000269|PubMed:21985982, ECO:0000269|PubMed:22096075,
CC       ECO:0000269|PubMed:22282195, ECO:0000269|PubMed:22529374,
CC       ECO:0000269|PubMed:22940113, ECO:0000269|PubMed:23688253,
CC       ECO:0000269|PubMed:23695674, ECO:0000269|PubMed:23699523,
CC       ECO:0000269|PubMed:23806616, ECO:0000269|PubMed:25220152,
CC       ECO:0000269|PubMed:26114479, ECO:0000269|PubMed:7671806}.
CC   -!- SUBUNIT: Homodimer (PubMed:12794186). Interacts with TJP1
CC       (PubMed:24715457). Interacts with MMP14; inhibits DLL1-induced
CC       Notch signaling (PubMed:21572390). Interacts with MAGI1 (via PDZ
CC       domain); forms a complex with CTNNB1 and CDH2 and promotes
CC       recruitment to the adherens junction and stabilization on the cell
CC       surface (PubMed:15908431). Interacts with PSEN1; undergoes a
CC       presenilin-dependent gamma-secretase cleavage that releases a
CC       Dll1-intracellular form (PubMed:12794186). Interacts with MFAP5
CC       (PubMed:15788413). Interacts with MIB1 (PubMed:21985982).
CC       Interacts with NEURL1B; leads to ubiquitination (PubMed:17003037,
CC       PubMed:19723503). Interacts with NEURL1 (PubMed:19723503).
CC       Interacts with SYNJ2BP; enhances DLL1 protein stability, and
CC       promotes Notch signaling in endothelial cells (By similarity).
CC       Interacts with MAGI1, MAGI2, MAGI3 and MPDZ (By similarity).
CC       Interacts (via ubiquitin) with EPN1 (via IUM domain); binding with
CC       NOTCH1 attached to neighboring cell, promotes ligand
CC       ubiquitination and EPN1 interaction, leading to NECD
CC       transendocytosis and Notch signaling. Interacts with NOTCH1 (By
CC       similarity). {ECO:0000250|UniProtKB:O00548,
CC       ECO:0000250|UniProtKB:P97677, ECO:0000269|PubMed:12794186,
CC       ECO:0000269|PubMed:15788413, ECO:0000269|PubMed:15908431,
CC       ECO:0000269|PubMed:17003037, ECO:0000269|PubMed:19723503,
CC       ECO:0000269|PubMed:21572390, ECO:0000269|PubMed:21985982,
CC       ECO:0000269|PubMed:24715457}.
CC   -!- INTERACTION:
CC       Q9WVQ1:Magi2; NbExp=3; IntAct=EBI-297125, EBI-297151;
CC   -!- SUBCELLULAR LOCATION: Apical cell membrane
CC       {ECO:0000269|PubMed:24715457}; Single-pass type I membrane protein
CC       {ECO:0000269|PubMed:24715457}. Cell junction, adherens junction
CC       {ECO:0000269|PubMed:15908431, ECO:0000269|PubMed:24715457}.
CC       Membrane raft {ECO:0000269|PubMed:18676613,
CC       ECO:0000269|PubMed:21985982}. Note=Distributed around adherens
CC       junction in the apical endfeet through interactions with MAGI1.
CC       {ECO:0000269|PubMed:15908431, ECO:0000269|PubMed:24715457}.
CC   -!- SUBCELLULAR LOCATION: Dll1-derived cell-associated form: Cell
CC       membrane {ECO:0000269|PubMed:12794186}.
CC   -!- SUBCELLULAR LOCATION: Dll1-intracellular form: Nucleus
CC       {ECO:0000269|PubMed:12794186}.
CC   -!- TISSUE SPECIFICITY: In the embryo, expressed in the paraxial
CC       mesoderm and nervous system. Expressed at high levels in adult
CC       heart and at lower levels, in adult lung. Highly expressed in
CC       satellite cells from masseter and tongue than in satellite cells
CC       from leg and extraocular muscle.? (PubMed:25220152).
CC       {ECO:0000269|PubMed:25220152, ECO:0000269|PubMed:7671806}.
CC   -!- DEVELOPMENTAL STAGE: Expressed until E15. Expression then
CC       decreases and increases again in the adult. In differentiating
CC       somites, is expressed at low levels in cells emerging from the
CC       dorsomedial lip and subsequently throughout myotomes. In the limb
CC       buds, is found in myoblasts and myocytes but not in the progenitor
CC       cells (PubMed:17194759). Highly expressed in the endothelium and
CC       in the smooth muscle layer starting at E13.5 in arterial vessels,
CC       but not in veins. At E12.5, there is no detectable expression in
CC       arteries or veins. This pattern persists until E18.5
CC       (PubMed:19144989). Strongly expressed in developing muscle of
CC       tongue, cheek, and in extraocular muscle at E11.5. Found at E18
CC       and P21 in head muscle (PubMed:25220152). Detected in a subset of
CC       cells in the ventricular zone (VZ), the intermediate zone (IZ) and
CC       the cortical plate (CP) of neocortex and in the ganglionic
CC       eminences at E13.5. At later stages, such as at E16.5, found in
CC       the VZ and IZ, but at very low levels in the CP of the neocortex
CC       (PubMed:18997111). Highly expressed in embryonic cells located in
CC       the ventricular zone (VZ) of the retinal neuroepithelium that form
CC       clusters; is first detected in cells located in the central
CC       retina. As the retina grows, expression spreads peripherally along
CC       the expanding neurogenic region, being always absent from the
CC       ciliary margin zone (CMZ) (PubMed:19389377).
CC       {ECO:0000269|PubMed:17194759, ECO:0000269|PubMed:18997111,
CC       ECO:0000269|PubMed:19144989, ECO:0000269|PubMed:19389377,
CC       ECO:0000269|PubMed:25220152, ECO:0000269|PubMed:7671806}.
CC   -!- INDUCTION: Induced by PTF1A in multipotent pancreatic progenitor
CC       cells (PubMed:22096075). Induced by CDX1 and CDX2 during
CC       somitogenesis and goblet cell differentiation (PubMed:22015720).
CC       {ECO:0000269|PubMed:22015720, ECO:0000269|PubMed:22096075}.
CC   -!- PTM: Ubiquitinated by MIB (MIB1 or MIB2), leading to its
CC       endocytosis and subsequent degradation. Ubiquitinated; promotes
CC       recycling back to the plasma membrane and confers a strong
CC       affinity for NOTCH1 (PubMed:18676613). Multi-ubiquitination of
CC       LYS-613 by MIB1 promotes both cis and trans-interaction with
CC       NOTCH1, as well as activation of Notch signaling
CC       (PubMed:21985982). Ubiquitinated by NEURL1B (PubMed:17003037).
CC       {ECO:0000250|UniProtKB:P10041, ECO:0000269|PubMed:17003037,
CC       ECO:0000269|PubMed:18676613, ECO:0000269|PubMed:21985982}.
CC   -!- PTM: Phosphorylated in a membrane association-dependent manner.
CC       Phosphorylation at Ser-696 requires the presence of Ser-693,
CC       whereas phosphorylation at Thr-638 and Ser-693 occurs
CC       independently of the other sites. Phosphorylation is required for
CC       full ligand activity in vitro and affects surface presentation,
CC       ectodomain shedding, and endocytosis.
CC       {ECO:0000269|PubMed:24449764}.
CC   -!- PTM: Cleaved by MMP14; negatively regulates DLL1-induced Notch
CC       signaling in HPCs, modulating B-lymphocyte differentiation in bone
CC       marrow (PubMed:21572390). Undergoes two consecutive processing
CC       events: a shedding event, partially by ADAM10, that generates a
CC       soluble extracellular form and an intracellular membrane-anchored
CC       form, followed by a gamma-secretase cleavage releasing an
CC       intracellular fragment (PubMed:12794186).
CC       {ECO:0000269|PubMed:12794186, ECO:0000269|PubMed:21572390}.
CC   -!- PTM: O-fucosylated. Can be elongated to a disaccharide by MFNG.
CC       {ECO:0000250|UniProtKB:P97677}.
CC   -!- DISRUPTION PHENOTYPE: Heterozygous Dll1 mice mutants are lighter
CC       and smaller, with altered fat to lean ratio and have increased
CC       blood pressure and a slight bradycardia. The animals have reduced
CC       cholesterol and triglyceride levels in blood (PubMed:19562077).
CC       Heterozygous Dll1 mice mutants and hypomorphic Dll1 mice mutants
CC       survive until birth, despite significantly reduced Notch activity
CC       (PubMed:17194759). Conditional knockout in inner ear leads to an
CC       early and excessive production of hair cells and have vestibular
CC       defects (PubMed:16495313). Conditional knockout in a small
CC       proportion of neural precursor cells reduces neurogenesis, whereas
CC       conditional knockout in a large proportion promotes premature
CC       neurogenesis (PubMed:18997111). Hypomorph Dll1 pups mutant survive
CC       until birth but are smaller. Conditional knockout Dll1 mice mutant
CC       in epidermis, survive and have no gross abnormalities
CC       (PubMed:17960184). Hypomorph Dll1 mice mutant survive until birth
CC       and have severe skeletal muscle defects (PubMed:19144989).
CC       Heterozygous Dll1 mutant embryos show disrupted muscle growth
CC       (PubMed:25220152). Conditional knockout Dll1 mice mutant show
CC       disorganization of Bergmann fibers, ectopic localization of
CC       Bergmann glia in the molecular layer and a reduction in the number
CC       of Bergmann glia (PubMed:23688253). {ECO:0000269|PubMed:16495313,
CC       ECO:0000269|PubMed:17194759, ECO:0000269|PubMed:17960184,
CC       ECO:0000269|PubMed:18997111, ECO:0000269|PubMed:19144989,
CC       ECO:0000269|PubMed:19562077, ECO:0000269|PubMed:23688253,
CC       ECO:0000269|PubMed:25220152}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X80903; CAA56865.1; -; mRNA.
DR   EMBL; AY497019; AAR30869.1; -; Genomic_DNA.
DR   EMBL; CH466630; EDL20466.1; -; Genomic_DNA.
DR   EMBL; BC057400; AAH57400.1; -; mRNA.
DR   EMBL; BC065063; AAH65063.1; -; mRNA.
DR   CCDS; CCDS37452.1; -.
DR   PIR; I48324; I48324.
DR   RefSeq; NP_031891.2; NM_007865.3.
DR   UniGene; Mm.4875; -.
DR   ProteinModelPortal; Q61483; -.
DR   SMR; Q61483; -.
DR   BioGrid; 199232; 6.
DR   DIP; DIP-32600N; -.
DR   IntAct; Q61483; 8.
DR   MINT; MINT-8187263; -.
DR   STRING; 10090.ENSMUSP00000014917; -.
DR   iPTMnet; Q61483; -.
DR   PhosphoSitePlus; Q61483; -.
DR   PaxDb; Q61483; -.
DR   PRIDE; Q61483; -.
DR   Ensembl; ENSMUST00000014917; ENSMUSP00000014917; ENSMUSG00000014773.
DR   GeneID; 13388; -.
DR   KEGG; mmu:13388; -.
DR   UCSC; uc008aoi.2; mouse.
DR   CTD; 28514; -.
DR   MGI; MGI:104659; Dll1.
DR   eggNOG; ENOG410IR7B; Eukaryota.
DR   eggNOG; ENOG410XUNS; LUCA.
DR   GeneTree; ENSGT00810000125346; -.
DR   HOGENOM; HOG000267024; -.
DR   HOVERGEN; HBG007139; -.
DR   InParanoid; Q61483; -.
DR   KO; K06051; -.
DR   OMA; DKPCHQG; -.
DR   OrthoDB; EOG091G07YQ; -.
DR   TreeFam; TF351835; -.
DR   Reactome; R-MMU-1980148; Signaling by NOTCH3.
DR   Reactome; R-MMU-1980150; Signaling by NOTCH4.
DR   PMAP-CutDB; Q6PFV7; -.
DR   PRO; PR:Q61483; -.
DR   Proteomes; UP000000589; Chromosome 17.
DR   Bgee; ENSMUSG00000014773; -.
DR   CleanEx; MM_DLL1; -.
DR   Genevisible; Q61483; MM.
DR   GO; GO:0005912; C:adherens junction; IDA:UniProtKB.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:UniProtKB.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IDA:MGI.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0045121; C:membrane raft; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IDA:MGI.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0005112; F:Notch binding; IPI:UniProtKB.
DR   GO; GO:0097110; F:scaffold protein binding; IPI:UniProtKB.
DR   GO; GO:0030957; F:Tat protein binding; ISO:MGI.
DR   GO; GO:0009887; P:animal organ morphogenesis; NAS:UniProtKB.
DR   GO; GO:0014002; P:astrocyte development; IMP:UniProtKB.
DR   GO; GO:0042491; P:auditory receptor cell differentiation; NAS:UniProtKB.
DR   GO; GO:0009912; P:auditory receptor cell fate commitment; NAS:UniProtKB.
DR   GO; GO:0007267; P:cell-cell signaling; IDA:MGI.
DR   GO; GO:0021688; P:cerebellar molecular layer formation; IMP:UniProtKB.
DR   GO; GO:0021693; P:cerebellar Purkinje cell layer structural organization; IMP:UniProtKB.
DR   GO; GO:0072583; P:clathrin-dependent endocytosis; ISS:UniProtKB.
DR   GO; GO:0007386; P:compartment pattern specification; IMP:MGI.
DR   GO; GO:0007368; P:determination of left/right symmetry; IMP:MGI.
DR   GO; GO:0097102; P:endothelial tip cell fate specification; IMP:UniProtKB.
DR   GO; GO:0001947; P:heart looping; IMP:BHF-UCL.
DR   GO; GO:0001701; P:in utero embryonic development; NAS:UniProtKB.
DR   GO; GO:0048839; P:inner ear development; IMP:MGI.
DR   GO; GO:0042472; P:inner ear morphogenesis; NAS:UniProtKB.
DR   GO; GO:0046331; P:lateral inhibition; IDA:UniProtKB.
DR   GO; GO:0070986; P:left/right axis specification; IMP:BHF-UCL.
DR   GO; GO:0072070; P:loop of Henle development; IEP:UniProtKB.
DR   GO; GO:0002315; P:marginal zone B cell differentiation; IMP:UniProtKB.
DR   GO; GO:0045608; P:negative regulation of auditory receptor cell differentiation; IMP:MGI.
DR   GO; GO:2000726; P:negative regulation of cardiac muscle cell differentiation; IMP:BHF-UCL.
DR   GO; GO:0045596; P:negative regulation of cell differentiation; IMP:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IMP:UniProtKB.
DR   GO; GO:0045605; P:negative regulation of epidermal cell differentiation; IMP:UniProtKB.
DR   GO; GO:0030857; P:negative regulation of epithelial cell differentiation; IMP:UniProtKB.
DR   GO; GO:0034351; P:negative regulation of glial cell apoptotic process; IMP:UniProtKB.
DR   GO; GO:0032693; P:negative regulation of interleukin-10 production; ISO:MGI.
DR   GO; GO:0045638; P:negative regulation of myeloid cell differentiation; IDA:MGI.
DR   GO; GO:0045662; P:negative regulation of myoblast differentiation; IMP:UniProtKB.
DR   GO; GO:0045665; P:negative regulation of neuron differentiation; IMP:UniProtKB.
DR   GO; GO:0072006; P:nephron development; IMP:UniProtKB.
DR   GO; GO:0007399; P:nervous system development; NAS:UniProtKB.
DR   GO; GO:0048665; P:neuron fate specification; IDA:UniProtKB.
DR   GO; GO:0097150; P:neuronal stem cell population maintenance; IMP:UniProtKB.
DR   GO; GO:0061314; P:Notch signaling involved in heart development; IC:BHF-UCL.
DR   GO; GO:0007219; P:Notch signaling pathway; IMP:UniProtKB.
DR   GO; GO:0060853; P:Notch signaling pathway involved in arterial endothelial cell fate commitment; IMP:UniProtKB.
DR   GO; GO:0042475; P:odontogenesis of dentin-containing tooth; NAS:UniProtKB.
DR   GO; GO:0035265; P:organ growth; IMP:UniProtKB.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IMP:UniProtKB.
DR   GO; GO:0045807; P:positive regulation of endocytosis; IDA:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:MGI.
DR   GO; GO:0045747; P:positive regulation of Notch signaling pathway; IDA:UniProtKB.
DR   GO; GO:0048633; P:positive regulation of skeletal muscle tissue growth; IMP:UniProtKB.
DR   GO; GO:1903672; P:positive regulation of sprouting angiogenesis; IMP:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL.
DR   GO; GO:0072014; P:proximal tubule development; IEP:UniProtKB.
DR   GO; GO:0009954; P:proximal/distal pattern formation; IMP:UniProtKB.
DR   GO; GO:0008217; P:regulation of blood pressure; IMP:UniProtKB.
DR   GO; GO:0030155; P:regulation of cell adhesion; IMP:UniProtKB.
DR   GO; GO:0051302; P:regulation of cell division; IMP:UniProtKB.
DR   GO; GO:2000505; P:regulation of energy homeostasis; IMP:UniProtKB.
DR   GO; GO:0040008; P:regulation of growth; IMP:UniProtKB.
DR   GO; GO:0050767; P:regulation of neurogenesis; IMP:UniProtKB.
DR   GO; GO:0048631; P:regulation of skeletal muscle tissue growth; IMP:UniProtKB.
DR   GO; GO:0014807; P:regulation of somitogenesis; IMP:UniProtKB.
DR   GO; GO:1900746; P:regulation of vascular endothelial growth factor signaling pathway; IMP:UniProtKB.
DR   GO; GO:0060041; P:retina development in camera-type eye; IMP:UniProtKB.
DR   GO; GO:0060042; P:retina morphogenesis in camera-type eye; IMP:UniProtKB.
DR   GO; GO:0048630; P:skeletal muscle tissue growth; IMP:UniProtKB.
DR   GO; GO:0098773; P:skin epidermis development; IMP:UniProtKB.
DR   GO; GO:0001757; P:somite specification; IMP:MGI.
DR   GO; GO:0001756; P:somitogenesis; IMP:UniProtKB.
DR   GO; GO:0021510; P:spinal cord development; IMP:UniProtKB.
DR   GO; GO:0003323; P:type B pancreatic cell development; IMP:UniProtKB.
DR   InterPro; IPR001774; DSL.
DR   InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR000152; EGF-type_Asp/Asn_hydroxyl_site.
DR   InterPro; IPR018097; EGF_Ca-bd_CS.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   InterPro; IPR011651; Notch_ligand_N.
DR   Pfam; PF01414; DSL; 1.
DR   Pfam; PF00008; EGF; 5.
DR   Pfam; PF07645; EGF_CA; 1.
DR   Pfam; PF07657; MNNL; 1.
DR   SMART; SM00051; DSL; 1.
DR   SMART; SM00181; EGF; 8.
DR   SMART; SM00179; EGF_CA; 6.
DR   SUPFAM; SSF57184; SSF57184; 1.
DR   PROSITE; PS00010; ASX_HYDROXYL; 3.
DR   PROSITE; PS51051; DSL; 1.
DR   PROSITE; PS00022; EGF_1; 8.
DR   PROSITE; PS01186; EGF_2; 8.
DR   PROSITE; PS50026; EGF_3; 7.
DR   PROSITE; PS01187; EGF_CA; 2.
PE   1: Evidence at protein level;
KW   Cell junction; Cell membrane; Complete proteome;
KW   Developmental protein; Differentiation; Direct protein sequencing;
KW   Disulfide bond; EGF-like domain; Glycoprotein; Isopeptide bond;
KW   Membrane; Notch signaling pathway; Nucleus; Phosphoprotein;
KW   Reference proteome; Repeat; Signal; Transmembrane;
KW   Transmembrane helix; Ubl conjugation.
FT   SIGNAL        1     17       {ECO:0000255}.
FT   CHAIN        18    722       Delta-like protein 1.
FT                                /FTId=PRO_0000007507.
FT   CHAIN        18    535       Dll1-soluble form.
FT                                {ECO:0000269|PubMed:12794186}.
FT                                /FTId=PRO_0000434830.
FT   CHAIN       536    722       Dll1-derived cell-associated form.
FT                                {ECO:0000269|PubMed:12794186}.
FT                                /FTId=PRO_0000434831.
FT   CHAIN         ?    722       Dll1-intracellular form.
FT                                {ECO:0000269|PubMed:12794186}.
FT                                /FTId=PRO_0000434832.
FT   TOPO_DOM     18    545       Extracellular. {ECO:0000255}.
FT   TRANSMEM    546    568       Helical. {ECO:0000255}.
FT   TOPO_DOM    569    722       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      176    220       DSL. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00377}.
FT   DOMAIN      225    253       EGF-like 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      256    284       EGF-like 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      291    324       EGF-like 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      331    362       EGF-like 4; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      369    401       EGF-like 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      408    439       EGF-like 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      446    477       EGF-like 7; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      484    515       EGF-like 8. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   REGION      719    722       Interaction with MAGI1.
FT                                {ECO:0000269|PubMed:15908431}.
FT   SITE        527    528       Cleavage; by MMP14.
FT                                {ECO:0000269|PubMed:21572390}.
FT   SITE        535    536       Cleavage; by ADAM protease.
FT                                {ECO:0000269|PubMed:12794186}.
FT   MOD_RES     638    638       Phosphothreonine.
FT                                {ECO:0000269|PubMed:24449764}.
FT   MOD_RES     693    693       Phosphoserine; by PKB.
FT                                {ECO:0000269|PubMed:24449764}.
FT   MOD_RES     696    696       Phosphoserine.
FT                                {ECO:0000269|PubMed:24449764}.
FT   CARBOHYD    476    476       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    178    187       {ECO:0000250}.
FT   DISULFID    191    203       {ECO:0000250}.
FT   DISULFID    211    220       {ECO:0000250}.
FT   DISULFID    225    236       {ECO:0000250}.
FT   DISULFID    229    242       {ECO:0000250}.
FT   DISULFID    244    253       {ECO:0000250}.
FT   DISULFID    256    267       {ECO:0000250}.
FT   DISULFID    262    273       {ECO:0000250}.
FT   DISULFID    275    284       {ECO:0000250}.
FT   DISULFID    291    303       {ECO:0000250}.
FT   DISULFID    297    313       {ECO:0000250}.
FT   DISULFID    315    324       {ECO:0000250}.
FT   DISULFID    331    342       {ECO:0000250}.
FT   DISULFID    336    351       {ECO:0000250}.
FT   DISULFID    353    362       {ECO:0000250}.
FT   DISULFID    369    380       {ECO:0000250}.
FT   DISULFID    374    390       {ECO:0000250}.
FT   DISULFID    392    401       {ECO:0000250}.
FT   DISULFID    408    419       {ECO:0000250}.
FT   DISULFID    413    428       {ECO:0000250}.
FT   DISULFID    430    439       {ECO:0000250}.
FT   DISULFID    446    457       {ECO:0000250}.
FT   DISULFID    451    466       {ECO:0000250}.
FT   DISULFID    468    477       {ECO:0000250}.
FT   DISULFID    484    495       {ECO:0000250}.
FT   DISULFID    489    504       {ECO:0000250}.
FT   DISULFID    506    515       {ECO:0000250}.
FT   CROSSLNK    613    613       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:21985982}.
FT   MUTAGEN     613    618       KNTNKK->RNTNRR: Highly decreases Notch
FT                                signaling pathway. Multi-ubiquitination
FT                                pattern is reduced, although it does
FT                                appear to be mono-ubiquitinated.
FT                                Interacts with MIB1. Loss of cis
FT                                interaction with NOTCH1.
FT                                {ECO:0000269|PubMed:21985982}.
FT   MUTAGEN     613    613       K->R: Highly decreases Notch signaling
FT                                pathway. Multi-ubiquitination pattern is
FT                                reduced, although it does appear to be
FT                                mono-ubiquitinated. Interacts with MIB1.
FT                                Loss of cis and trans interaction with
FT                                NOTCH1. Increases its association with
FT                                lipid raft microdomains.
FT                                {ECO:0000269|PubMed:21985982}.
FT   MUTAGEN     638    638       T->V: Not phosphorylated; when associated
FT                                with A-693 and A-696. Not phosphorylated
FT                                and doesn't prevent phosphorylation at S-
FT                                693 and S-696. Reduces NOTCH1
FT                                transactivation; when associated with A-
FT                                693 and A-696. Reduces cell surface
FT                                levels of proteins; when associated with
FT                                A-693 and A-696. Increases ectodomain
FT                                shedding; when associated with A-693 and
FT                                A-696. {ECO:0000269|PubMed:24449764}.
FT   MUTAGEN     689    689       K->R: Decreases Notch signaling pathway.
FT                                {ECO:0000269|PubMed:21985982}.
FT   MUTAGEN     693    693       S->A: Not phosphorylated; when associated
FT                                with V-638 and A-696. Not phosphorylated
FT                                and prevents phosphorylation at S-696.
FT                                Reduces NOTCH1 transactivation; when
FT                                associated with V-638 and A-696. Reduces
FT                                cell surface levels of proteins; when
FT                                associated with V-638 and A-696.
FT                                Increases ectodomain shedding; when
FT                                associated with V-638 and A-696.
FT                                {ECO:0000269|PubMed:24449764}.
FT   MUTAGEN     696    696       S->A: Not phosphorylated; when associated
FT                                with V-638 and A-693. Not phosphorylated
FT                                and doesn't prevent phosphorylation at T-
FT                                638 and S-693, Reduces NOTCH1
FT                                transactivation; when associated with V-
FT                                638 and A-693. Reduces cell surface
FT                                levels of proteins; when associated with
FT                                V-638 and A-693. Increases ectodomain
FT                                shedding; when associated with V-638 and
FT                                A-693. {ECO:0000269|PubMed:24449764}.
FT   MUTAGEN     699    699       K->R: Decreases Notch signaling pathway.
FT                                {ECO:0000269|PubMed:21985982}.
FT   MUTAGEN     713    713       K->R: Decreases Notch signaling pathway.
FT                                {ECO:0000269|PubMed:21985982}.
FT   CONFLICT    628    628       E -> K (in Ref. 1; CAA56865).
FT                                {ECO:0000305}.
SQ   SEQUENCE   722 AA;  78449 MW;  9D570B9DC7EEC75E CRC64;
     MGRRSALALA VVSALLCQVW SSGVFELKLQ EFVNKKGLLG NRNCCRGGSG PPCACRTFFR
     VCLKHYQASV SPEPPCTYGS AVTPVLGVDS FSLPDGAGID PAFSNPIRFP FGFTWPGTFS
     LIIEALHTDS PDDLATENPE RLISRLTTQR HLTVGEEWSQ DLHSSGRTDL RYSYRFVCDE
     HYYGEGCSVF CRPRDDAFGH FTCGDRGEKM CDPGWKGQYC TDPICLPGCD DQHGYCDKPG
     ECKCRVGWQG RYCDECIRYP GCLHGTCQQP WQCNCQEGWG GLFCNQDLNY CTHHKPCRNG
     ATCTNTGQGS YTCSCRPGYT GANCELEVDE CAPSPCKNGA SCTDLEDSFS CTCPPGFYGK
     VCELSAMTCA DGPCFNGGRC SDNPDGGYTC HCPLGFSGFN CEKKMDLCGS SPCSNGAKCV
     DLGNSYLCRC QAGFSGRYCE DNVDDCASSP CANGGTCRDS VNDFSCTCPP GYTGKNCSAP
     VSRCEHAPCH NGATCHQRGQ RYMCECAQGY GGPNCQFLLP EPPPGPMVVD LSERHMESQG
     GPFPWVAVCA GVVLVLLLLL GCAAVVVCVR LKLQKHQPPP EPCGGETETM NNLANCQREK
     DVSVSIIGAT QIKNTNKKAD FHGDHGAEKS SFKVRYPTVD YNLVRDLKGD EATVRDTHSK
     RDTKCQSQSS AGEEKIAPTL RGGEIPDRKR PESVYSTSKD TKYQSVYVLS AEKDECVIAT
     EV
//
ID   PEN2_DROME              Reviewed;         101 AA.
AC   Q86BE9; A8E6Z8; Q8MUT4;
DT   26-SEP-2003, integrated into UniProtKB/Swiss-Prot.
DT   19-JUL-2004, sequence version 3.
DT   25-OCT-2017, entry version 111.
DE   RecName: Full=Gamma-secretase subunit pen-2;
DE   AltName: Full=Presenilin enhancer protein 2;
GN   Name=pen-2; ORFNames=CG33198;
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha;
OC   Ephydroidea; Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND FUNCTION.
RX   PubMed=12110170; DOI=10.1016/S1534-5807(02)00189-2;
RA   Francis R., McGrath G., Zhang J., Ruddy D.A., Sym M., Apfeld J.,
RA   Nicoll M., Maxwell M., Hai B., Ellis M.C., Parks A.L., Xu W., Li J.,
RA   Gurney M., Myers R.L., Himes C.S., Hiebsch R., Ruble C., Nye J.S.,
RA   Curtis D.;
RT   "aph-1 and pen-2 are required for Notch pathway signaling, gamma-
RT   secretase cleavage of betaAPP, and presenilin protein accumulation.";
RL   Dev. Cell 3:85-97(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley;
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X.,
RA   Brandon R.C., Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D.,
RA   Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G.,
RA   Abril J.F., Agbayani A., An H.-J., Andrews-Pfannkoch C., Baldwin D.,
RA   Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M.,
RA   Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S.,
RA   Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P.,
RA   Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I.,
RA   Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P.,
RA   de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M.,
RA   Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P.,
RA   Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W.,
RA   Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K.,
RA   Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J.,
RA   Hostin D., Houston K.A., Howland T.J., Wei M.-H., Ibegwam C.,
RA   Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A.,
RA   Kimmel B.E., Kodira C.D., Kraft C.L., Kravitz S., Kulp D., Lai Z.,
RA   Lasko P., Lei Y., Levitsky A.A., Li J.H., Li Z., Liang Y., Lin X.,
RA   Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D.,
RA   Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A.,
RA   Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L.,
RA   Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M.,
RA   Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G.,
RA   Reinert K., Remington K., Saunders R.D.C., Scheeler F., Shen H.,
RA   Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E.,
RA   Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X.,
RA   Wang Z.-Y., Wassarman D.A., Weinstock G.M., Weissenbach J.,
RA   Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A.,
RA   Ye J., Yeh R.-F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L.,
RA   Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S.C., Zhu X.,
RA   Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q.,
RA   Stapleton M., Yamada C., Ashburner M., Gelbart W.M., Rubin G.M.,
RA   Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a
RT   systematic review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=Berkeley;
RA   Stapleton M., Carlson J.W., Frise E., Kapadia B., Park S., Wan K.H.,
RA   Yu C., Celniker S.E.;
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   FUNCTION IN THE GAMMA-SECRETASE COMPLEX, AND INTERACTION WITH APH-1;
RP   PSN AND NCT.
RX   PubMed=12660785; DOI=10.1038/nature01506;
RA   Takasugi N., Tomita T., Hayashi I., Tsuruoka M., Niimura M.,
RA   Takahashi Y., Thinakaran G., Iwatsubo T.;
RT   "The role of presenilin cofactors in the gamma-secretase complex.";
RL   Nature 422:438-441(2003).
CC   -!- FUNCTION: Essential subunit of the gamma-secretase complex, an
CC       endoprotease complex that catalyzes the intramembrane cleavage of
CC       integral membrane proteins such as Notch. It probably represents
CC       the last step of maturation of gamma-secretase, facilitating
CC       endoproteolysis of presenilin and conferring gamma-secretase
CC       activity. {ECO:0000269|PubMed:12110170,
CC       ECO:0000269|PubMed:12660785}.
CC   -!- SUBUNIT: Component of the gamma-secretase complex, a complex
CC       composed of a presenilin (Psn) homodimer, nicastrin (Nct), Aph-1
CC       and Pen-2.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the PEN-2 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF512426; AAM88323.1; -; mRNA.
DR   EMBL; AE013599; AAO41356.2; -; Genomic_DNA.
DR   EMBL; BT030940; ABV82322.1; -; mRNA.
DR   EMBL; BT030980; ABV82362.1; -; mRNA.
DR   RefSeq; NP_001286566.1; NM_001299637.1.
DR   RefSeq; NP_788401.2; NM_176221.4.
DR   UniGene; Dm.14392; -.
DR   ProteinModelPortal; Q86BE9; -.
DR   SMR; Q86BE9; -.
DR   BioGrid; 75540; 7.
DR   MINT; MINT-973227; -.
DR   STRING; 7227.FBpp0088783; -.
DR   PaxDb; Q86BE9; -.
DR   PRIDE; Q86BE9; -.
DR   EnsemblMetazoa; FBtr0089842; FBpp0088783; FBgn0053198.
DR   EnsemblMetazoa; FBtr0340331; FBpp0309291; FBgn0053198.
DR   GeneID; 251430; -.
DR   KEGG; dme:Dmel_CG33198; -.
DR   CTD; 251430; -.
DR   FlyBase; FBgn0053198; pen-2.
DR   eggNOG; KOG3402; Eukaryota.
DR   eggNOG; ENOG4111W09; LUCA.
DR   GeneTree; ENSGT00390000016319; -.
DR   InParanoid; Q86BE9; -.
DR   KO; K06170; -.
DR   OMA; WFFQEAF; -.
DR   OrthoDB; EOG091G0X8A; -.
DR   PhylomeDB; Q86BE9; -.
DR   Reactome; R-DME-1251985; Nuclear signaling by ERBB4.
DR   Reactome; R-DME-1980148; Signaling by NOTCH3.
DR   Reactome; R-DME-1980150; Signaling by NOTCH4.
DR   Reactome; R-DME-3928665; EPH-ephrin mediated repulsion of cells.
DR   SignaLink; Q86BE9; -.
DR   ChiTaRS; Pen; fly.
DR   GenomeRNAi; 251430; -.
DR   PRO; PR:Q86BE9; -.
DR   Proteomes; UP000000803; Chromosome 2R.
DR   Bgee; FBgn0053198; -.
DR   ExpressionAtlas; Q86BE9; differential.
DR   Genevisible; Q86BE9; DM.
DR   GO; GO:0070765; C:gamma-secretase complex; IPI:FlyBase.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005770; C:late endosome; IDA:FlyBase.
DR   GO; GO:0055037; C:recycling endosome; IDA:FlyBase.
DR   GO; GO:0007220; P:Notch receptor processing; IBA:GO_Central.
DR   GO; GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW.
DR   InterPro; IPR019379; Gamma_Secretase_Asp_P_PEN2.
DR   PANTHER; PTHR16318; PTHR16318; 1.
DR   Pfam; PF10251; PEN-2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Membrane; Notch signaling pathway;
KW   Reference proteome; Transmembrane; Transmembrane helix.
FT   CHAIN         1    101       Gamma-secretase subunit pen-2.
FT                                /FTId=PRO_0000190904.
FT   TOPO_DOM      1     17       Lumenal. {ECO:0000255}.
FT   TRANSMEM     18     38       Helical. {ECO:0000255}.
FT   TOPO_DOM     39     57       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     58     78       Helical. {ECO:0000255}.
FT   TOPO_DOM     79    101       Lumenal. {ECO:0000255}.
FT   CONFLICT      2      2       D -> N (in Ref. 1; AAM88323).
FT                                {ECO:0000305}.
SQ   SEQUENCE   101 AA;  11725 MW;  AE7A84CC4899ECE8 CRC64;
     MDISKAPNPR KLELCRKYFF AGFAFLPFVW AINVCWFFTE AFHKPPFSEQ SQIKRYVIYS
     AVGTLFWLIV LTAWIIIFQT NRTAWGATAD YMSFIIPLGS A
//
ID   NICA_ARATH              Reviewed;         676 AA.
AC   Q8GUM5; Q9LXJ9; Q9LXK0;
DT   26-SEP-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   20-DEC-2017, entry version 89.
DE   RecName: Full=Nicastrin;
DE   Flags: Precursor;
GN   OrderedLocusNames=At3g52640/At3g52650; ORFNames=F3C22.40/F3C22.50;
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; eudicotyledons; Gunneridae;
OC   Pentapetalae; rosids; malvids; Brassicales; Brassicaceae; Camelineae;
OC   Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=11130713; DOI=10.1038/35048706;
RA   Salanoubat M., Lemcke K., Rieger M., Ansorge W., Unseld M.,
RA   Fartmann B., Valle G., Bloecker H., Perez-Alonso M., Obermaier B.,
RA   Delseny M., Boutry M., Grivell L.A., Mache R., Puigdomenech P.,
RA   De Simone V., Choisne N., Artiguenave F., Robert C., Brottier P.,
RA   Wincker P., Cattolico L., Weissenbach J., Saurin W., Quetier F.,
RA   Schaefer M., Mueller-Auer S., Gabel C., Fuchs M., Benes V.,
RA   Wurmbach E., Drzonek H., Erfle H., Jordan N., Bangert S.,
RA   Wiedelmann R., Kranz H., Voss H., Holland R., Brandt P., Nyakatura G.,
RA   Vezzi A., D'Angelo M., Pallavicini A., Toppo S., Simionati B.,
RA   Conrad A., Hornischer K., Kauer G., Loehnert T.-H., Nordsiek G.,
RA   Reichelt J., Scharfe M., Schoen O., Bargues M., Terol J., Climent J.,
RA   Navarro P., Collado C., Perez-Perez A., Ottenwaelder B., Duchemin D.,
RA   Cooke R., Laudie M., Berger-Llauro C., Purnelle B., Masuy D.,
RA   de Haan M., Maarse A.C., Alcaraz J.-P., Cottet A., Casacuberta E.,
RA   Monfort A., Argiriou A., Flores M., Liguori R., Vitale D.,
RA   Mannhaupt G., Haase D., Schoof H., Rudd S., Zaccaria P., Mewes H.-W.,
RA   Mayer K.F.X., Kaul S., Town C.D., Koo H.L., Tallon L.J., Jenkins J.,
RA   Rooney T., Rizzo M., Walts A., Utterback T., Fujii C.Y., Shea T.P.,
RA   Creasy T.H., Haas B., Maiti R., Wu D., Peterson J., Van Aken S.,
RA   Pai G., Militscher J., Sellers P., Gill J.E., Feldblyum T.V.,
RA   Preuss D., Lin X., Nierman W.C., Salzberg S.L., White O., Venter J.C.,
RA   Fraser C.M., Kaneko T., Nakamura Y., Sato S., Kato T., Asamizu E.,
RA   Sasamoto S., Kimura T., Idesawa K., Kawashima K., Kishida Y.,
RA   Kiyokawa C., Kohara M., Matsumoto M., Matsuno A., Muraki A.,
RA   Nakayama S., Nakazaki N., Shinpo S., Takeuchi C., Wada T.,
RA   Watanabe A., Yamada M., Yasuda M., Tabata S.;
RT   "Sequence and analysis of chromosome 3 of the plant Arabidopsis
RT   thaliana.";
RL   Nature 408:820-822(2000).
RN   [2]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RG   The Arabidopsis Information Portal (Araport);
RL   Submitted (MAY-2016) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=14593172; DOI=10.1126/science.1088305;
RA   Yamada K., Lim J., Dale J.M., Chen H., Shinn P., Palm C.J.,
RA   Southwick A.M., Wu H.C., Kim C.J., Nguyen M., Pham P.K., Cheuk R.F.,
RA   Karlin-Newmann G., Liu S.X., Lam B., Sakano H., Wu T., Yu G.,
RA   Miranda M., Quach H.L., Tripp M., Chang C.H., Lee J.M., Toriumi M.J.,
RA   Chan M.M., Tang C.C., Onodera C.S., Deng J.M., Akiyama K., Ansari Y.,
RA   Arakawa T., Banh J., Banno F., Bowser L., Brooks S.Y., Carninci P.,
RA   Chao Q., Choy N., Enju A., Goldsmith A.D., Gurjal M., Hansen N.F.,
RA   Hayashizaki Y., Johnson-Hopson C., Hsuan V.W., Iida K., Karnes M.,
RA   Khan S., Koesema E., Ishida J., Jiang P.X., Jones T., Kawai J.,
RA   Kamiya A., Meyers C., Nakajima M., Narusaka M., Seki M., Sakurai T.,
RA   Satou M., Tamse R., Vaysberg M., Wallender E.K., Wong C., Yamamura Y.,
RA   Yuan S., Shinozaki K., Davis R.W., Theologis A., Ecker J.R.;
RT   "Empirical analysis of transcriptional activity in the Arabidopsis
RT   genome.";
RL   Science 302:842-846(2003).
CC   -!- FUNCTION: Probable subunit of the gamma-secretase complex, an
CC       endoprotease complex that catalyzes the intramembrane cleavage of
CC       integral membrane proteins such as Notch. {ECO:0000250}.
CC   -!- SUBUNIT: Probable component of the gamma-secretase complex, a
CC       complex composed of a presenilin homodimer, nicastrin, APH1 and
CC       PEN2. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I
CC       membrane protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=1;
CC         Comment=A number of isoforms are produced. According to EST
CC         sequences.;
CC       Name=1;
CC         IsoId=Q8GUM5-1; Sequence=Displayed;
CC   -!- SIMILARITY: Belongs to the nicastrin family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAB89225.1; Type=Erroneous gene model prediction; Note=Was originally thought to correspond to two different genes At3g52640 and At3g52650.; Evidence={ECO:0000305};
CC       Sequence=CAB89226.1; Type=Erroneous gene model prediction; Note=Was originally thought to correspond to two different genes At3g52640 and At3g52650.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL353912; CAB89225.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL353912; CAB89226.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; CP002686; AEE78974.1; -; Genomic_DNA.
DR   EMBL; BT002382; AAO00742.1; -; mRNA.
DR   EMBL; BT008417; AAP37776.1; -; mRNA.
DR   PIR; T49017; T49017.
DR   PIR; T49018; T49018.
DR   RefSeq; NP_190832.3; NM_115124.5. [Q8GUM5-1]
DR   UniGene; At.43576; -.
DR   ProteinModelPortal; Q8GUM5; -.
DR   BioGrid; 9748; 37.
DR   STRING; 3702.AT3G52640.2; -.
DR   PaxDb; Q8GUM5; -.
DR   EnsemblPlants; AT3G52640.1; AT3G52640.1; AT3G52640. [Q8GUM5-1]
DR   GeneID; 824430; -.
DR   Gramene; AT3G52640.1; AT3G52640.1; AT3G52640. [Q8GUM5-1]
DR   KEGG; ath:AT3G52640; -.
DR   Araport; AT3G52640; -.
DR   eggNOG; KOG2657; Eukaryota.
DR   eggNOG; ENOG410XT6X; LUCA.
DR   HOGENOM; HOG000030067; -.
DR   InParanoid; Q8GUM5; -.
DR   KO; K06171; -.
DR   PhylomeDB; Q8GUM5; -.
DR   Reactome; R-ATH-6798695; Neutrophil degranulation.
DR   PRO; PR:Q8GUM5; -.
DR   Proteomes; UP000006548; Chromosome 3.
DR   ExpressionAtlas; Q8GUM5; baseline and differential.
DR   Genevisible; Q8GUM5; AT.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0004175; F:endopeptidase activity; IBA:GO_Central.
DR   GO; GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0016485; P:protein processing; IBA:GO_Central.
DR   InterPro; IPR008710; Nicastrin.
DR   PANTHER; PTHR21092; PTHR21092; 1.
DR   Pfam; PF05450; Nicastrin; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Complete proteome; Glycoprotein; Membrane;
KW   Notch signaling pathway; Reference proteome; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     28       {ECO:0000255}.
FT   CHAIN        29    676       Nicastrin.
FT                                /FTId=PRO_0000019686.
FT   TOPO_DOM     29    644       Extracellular. {ECO:0000255}.
FT   TRANSMEM    645    665       Helical. {ECO:0000255}.
FT   TOPO_DOM    666    676       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD     58     58       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    336    336       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    371    371       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    444    444       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    480    480       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    555    555       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    611    611       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   676 AA;  73007 MW;  14632691C5A0A0A8 CRC64;
     MAMGLIRLLS IAFTLVLLSI LPLHLSLADE ITSIESVPDL QKLMYVAVDG FPCVRLLNLS
     GEIGCSNPGI NKVVAPIIKL KDVKDLVQPH TILVTADEME DFFTRVSTDL SFASKIGGVL
     VESGSNFQQK LKGFSPDKRF PQAQFSPYEN VEYKWNSAAS SIMWRNYNFP VYLLSESGIS
     AVHEILSKKK MKHGTYTSDV AEFNMVMETT KAGTHNSEAC LQEGTCLPLG GYSVWSSLPP
     ISVSSSNNRK PVVLTVASMD TASFFRDKSF GADSPISGLV ALLGAVDALS RVDGISNLKK
     QLVFLVLTGE TWGYLGSRRF LHELDLHSDA VAGLSNTSIE TVLEIGSVGK GLSGGINTFF
     AHKTRVSSVT NMTLDALKIA QDSLASKNIK ILSADTANPG IPPSSLMAFM RKNPQTSAVV
     LEDFDTNFVN KFYHSHLDDL SNINSSSVVA AASVVARTLY ILASDNKDTS NSALGSIHVN
     ASFVEELLTC LLACEPGLSC NLVKDYISPT NTCPGNYAGV ILGEPSSKPY LGYVGDVSRF
     LWNFLADKTS VQKGNTTSVC SKGVCSKTDE VCIKAESNKE GTCVVSTTRY VPAYSTRLKY
     NDGAWTILPQ NSSDSMGMVD PVWTESNWDT LRVHVYTVQH SAYDNAVLVA GITVTTLAYI
     GILAAKSIIT KALKQD
//
ID   ADA10_XENLA             Reviewed;         749 AA.
AC   Q8JIY1; O42568;
DT   28-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   22-NOV-2017, entry version 98.
DE   RecName: Full=Disintegrin and metalloproteinase domain-containing protein 10;
DE            Short=ADAM 10;
DE            EC=3.4.24.81;
DE   AltName: Full=Kuzbanian protein homolog;
DE            Short=xKuz;
DE   Flags: Precursor;
GN   Name=adam10; Synonyms=kuz;
OS   Xenopus laevis (African clawed frog).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Amphibia; Batrachia; Anura; Pipoidea; Pipidae; Xenopodinae; Xenopus;
OC   Xenopus.
OX   NCBI_TaxID=8355;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=12460986; DOI=10.1083/jcb.200206023;
RA   Smith K.M., Gaultier A., Cousin H., Alfandari D., White J.M.,
RA   DeSimone D.W.;
RT   "The cysteine-rich domain regulates ADAM protease function in vivo.";
RL   J. Cell Biol. 159:893-902(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 476-637, AND FUNCTION.
RX   PubMed=9244301; DOI=10.1016/S0092-8674(00)80335-9;
RA   Pan D., Rubin G.M.;
RT   "Kuzbanian controls proteolytic processing of Notch and mediates
RT   lateral inhibition during Drosophila and vertebrate neurogenesis.";
RL   Cell 90:271-280(1997).
CC   -!- FUNCTION: Controls the proteolytic processing of Notch and
CC       mediates lateral inhibition during neurogenesis. {ECO:0000250,
CC       ECO:0000269|PubMed:9244301}.
CC   -!- CATALYTIC ACTIVITY: Endopeptidase of broad specificity.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000250|UniProtKB:P78325};
CC       Note=Binds 1 zinc ion per subunit. {ECO:0000250|UniProtKB:P78325};
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- DEVELOPMENTAL STAGE: Expressed maternally throughout the embryo
CC       and then becomes restricted to a pan-neural expression pattern.
CC   -!- DOMAIN: The conserved cysteine present in the cysteine-switch
CC       motif binds the catalytic zinc ion, thus inhibiting the enzyme.
CC       The dissociation of the cysteine from the zinc ion upon the
CC       activation-peptide release activates the enzyme.
CC   -!- PTM: The precursor is cleaved by a furin endopeptidase.
CC       {ECO:0000250}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF508151; AAM34686.1; -; mRNA.
DR   EMBL; AF011380; AAC60248.1; -; mRNA.
DR   RefSeq; NP_001083912.1; NM_001090443.1.
DR   UniGene; Xl.51047; -.
DR   ProteinModelPortal; Q8JIY1; -.
DR   SMR; Q8JIY1; -.
DR   MEROPS; M12.210; -.
DR   GeneID; 399187; -.
DR   KEGG; xla:399187; -.
DR   CTD; 399187; -.
DR   Xenbase; XB-GENE-945394; adam10.
DR   HOVERGEN; HBG050455; -.
DR   KO; K06704; -.
DR   GO; GO:0009986; C:cell surface; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; ISS:UniProtKB.
DR   GO; GO:0005798; C:Golgi-associated vesicle; ISS:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004222; F:metalloendopeptidase activity; IEA:InterPro.
DR   GO; GO:0008237; F:metallopeptidase activity; ISS:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; ISS:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; ISS:UniProtKB.
DR   GO; GO:0017124; F:SH3 domain binding; IEA:UniProtKB-KW.
DR   GO; GO:0006509; P:membrane protein ectodomain proteolysis; ISS:UniProtKB.
DR   GO; GO:0007162; P:negative regulation of cell adhesion; ISS:UniProtKB.
DR   GO; GO:0007219; P:Notch signaling pathway; ISS:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; ISS:UniProtKB.
DR   CDD; cd04270; ZnMc_TACE_like; 1.
DR   Gene3D; 3.40.390.10; -; 1.
DR   Gene3D; 4.10.70.10; -; 1.
DR   InterPro; IPR034025; ADAM10_ADAM17.
DR   InterPro; IPR027053; ADAM_10.
DR   InterPro; IPR001762; Disintegrin_dom.
DR   InterPro; IPR036436; Disintegrin_dom_sf.
DR   InterPro; IPR024079; MetalloPept_cat_dom_sf.
DR   InterPro; IPR001590; Peptidase_M12B.
DR   InterPro; IPR002870; Peptidase_M12B_N.
DR   PANTHER; PTHR11905:SF4; PTHR11905:SF4; 1.
DR   Pfam; PF00200; Disintegrin; 1.
DR   Pfam; PF01562; Pep_M12B_propep; 1.
DR   SMART; SM00050; DISIN; 1.
DR   SUPFAM; SSF57552; SSF57552; 1.
DR   PROSITE; PS50215; ADAM_MEPRO; 1.
DR   PROSITE; PS50214; DISINTEGRIN_2; 1.
DR   PROSITE; PS00142; ZINC_PROTEASE; 1.
PE   2: Evidence at transcript level;
KW   Cleavage on pair of basic residues; Disulfide bond; Glycoprotein;
KW   Hydrolase; Membrane; Metal-binding; Metalloprotease;
KW   Notch signaling pathway; Protease; SH3-binding; Signal; Transmembrane;
KW   Transmembrane helix; Zinc; Zymogen.
FT   SIGNAL        1     18       {ECO:0000255}.
FT   PROPEP       19    213       {ECO:0000250}.
FT                                /FTId=PRO_0000029072.
FT   CHAIN       214    749       Disintegrin and metalloproteinase domain-
FT                                containing protein 10.
FT                                /FTId=PRO_0000029073.
FT   TOPO_DOM     19    673       Extracellular. {ECO:0000255}.
FT   TRANSMEM    674    694       Helical. {ECO:0000255}.
FT   TOPO_DOM    695    749       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      220    457       Peptidase M12B. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00276}.
FT   DOMAIN      458    552       Disintegrin. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00068}.
FT   MOTIF       170    177       Cysteine switch. {ECO:0000250}.
FT   MOTIF       709    716       SH3-binding. {ECO:0000255}.
FT   MOTIF       723    729       SH3-binding. {ECO:0000255}.
FT   COMPBIAS    555    673       Cys-rich.
FT   ACT_SITE    385    385       {ECO:0000255|PROSITE-ProRule:PRU00276,
FT                                ECO:0000255|PROSITE-ProRule:PRU10095}.
FT   METAL       172    172       Zinc; in inhibited form. {ECO:0000250}.
FT   METAL       384    384       Zinc; catalytic.
FT                                {ECO:0000250|UniProtKB:P78325}.
FT   METAL       388    388       Zinc; catalytic.
FT                                {ECO:0000250|UniProtKB:P78325}.
FT   METAL       394    394       Zinc; catalytic.
FT                                {ECO:0000250|UniProtKB:P78325}.
FT   CARBOHYD    268    268       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    279    279       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    440    440       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    552    552       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    222    314       {ECO:0000250}.
FT   DISULFID    345    452       {ECO:0000250}.
FT   DISULFID    400    436       {ECO:0000250}.
FT   DISULFID    485    516       {ECO:0000250|UniProtKB:Q10741}.
FT   DISULFID    504    512       {ECO:0000250|UniProtKB:Q10741}.
FT   DISULFID    525    544       {ECO:0000250|UniProtKB:Q10741}.
FT   DISULFID    531    563       {ECO:0000250|UniProtKB:Q10741}.
FT   DISULFID    556    568       {ECO:0000250|UniProtKB:Q10741}.
FT   DISULFID    573    599       {ECO:0000250|UniProtKB:Q10741}.
FT   DISULFID    581    608       {ECO:0000250|UniProtKB:Q10741}.
FT   DISULFID    583    598       {ECO:0000250|UniProtKB:Q10741}.
FT   DISULFID    595    640       {ECO:0000250|UniProtKB:Q10741}.
FT   DISULFID    633    646       {ECO:0000250|UniProtKB:Q10741}.
FT   CONFLICT    515    515       D -> G (in Ref. 2; AAC60248).
FT                                {ECO:0000305}.
FT   CONFLICT    522    522       S -> G (in Ref. 2; AAC60248).
FT                                {ECO:0000305}.
FT   CONFLICT    604    604       K -> I (in Ref. 2; AAC60248).
FT                                {ECO:0000305}.
FT   CONFLICT    615    615       A -> V (in Ref. 2; AAC60248).
FT                                {ECO:0000305}.
SQ   SEQUENCE   749 AA;  84068 MW;  FC7A2FEEE7016A6A CRC64;
     MGLLRLVFLL SWAASAGGLY GNPLNKYIRH YEGLSYNVDS LHQKHQRAKR AVSQEDQFVH
     LDFQAHGRQF NLRMKKDTSL FSPDFKLEVG GETVNYDTSH IYTGQLFGEQ GTLSHGSVVD
     GKSKGLLKPL KAHSYVEPSE RFFKDQAVPF HSVMYHEDDI KYPHKYGSEG GCADSSVFKR
     MKEYQMSVQE EPEKHDHKED HEDSGPVILR KKRAAQAEKN TCQLFIQTDH LFYKRYGETR
     EAVIAQISSH VKAIDTIYQS TDFSGIRNIS FMVKRIRINV TSDEKDPTNP FRFPNIGVEK
     FLELNSEQNH DDYCLAYVFT DRDFDDGVLG LAWVGAPSGS SGGICERNKL YSDGKKKSLN
     TGIITVQNYG SHVPPKVSHI TFAHEVGHNF GSPHDSGNEC TPGEAKNLGF KENGNFIMYA
     RTTSGDKLNN NKFSICSVRN ISQVLDKKEN SCFVESGQPI CGNGLVEPGE QCDCGYSDQC
     KDECCYDANQ PENLKCTLKP GKQCSPSQGP CCTTDCTFKR ASENCREESD CAKMGTCNGN
     SAQCPPSEPR ENLTECNRAT QVCIKGQCSG SICERYDLEE CTCGSTDEKD DKELCHVCCM
     EKMKPHTCAS TGSEAWKAYF KGKTITLQPG SPCNEFKGYC DVFMRCRLVD ADGPLARLKK
     AIFNPELYEN IAEWIVAHWW AVLLMGIALI MLMAGFIKIC SVHTPSSNPK LPPPKPLPGT
     LKRRRPPQTT QQPSRQRPRE NYQMGHMRH
//
ID   DNER_MOUSE              Reviewed;         737 AA.
AC   Q8JZM4; Q3U697; Q8R226; Q8R4T6; Q8VD97;
DT   17-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   20-DEC-2017, entry version 134.
DE   RecName: Full=Delta and Notch-like epidermal growth factor-related receptor;
DE   AltName: Full=Brain EGF repeat-containing transmembrane protein;
DE   Flags: Precursor;
GN   Name=Dner; Synonyms=Bet, Bret;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, DEVELOPMENTAL STAGE,
RP   SUBCELLULAR LOCATION, MUTAGENESIS OF TYR-677, AND INTERACTION WITH
RP   AP1G1.
RC   STRAIN=ICR; TISSUE=Brain;
RX   PubMed=11950833; DOI=10.1074/jbc.M110793200;
RA   Eiraku M., Hirata Y., Takeshima H., Hirano T., Kengaku M.;
RT   "Delta/notch-like epidermal growth factor (EGF)-related receptor, a
RT   novel EGF-like repeat-containing protein targeted to dendrites of
RT   developing and adult central nervous system neurons.";
RL   J. Biol. Chem. 277:25400-25407(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], SUBCELLULAR LOCATION, TISSUE SPECIFICITY,
RP   DEVELOPMENTAL STAGE, AND GLYCOSYLATION.
RC   STRAIN=C57BL/6J; TISSUE=Brain;
RX   PubMed=11997712; DOI=10.1097/00001756-200205070-00035;
RA   Nishizumi H., Komiyama T., Miyabayashi T., Sakano S., Sakano H.;
RT   "BET, a novel neuronal transmembrane protein with multiple EGF-like
RT   motifs.";
RL   NeuroReport 13:909-915(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Bone marrow, and Retina;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=FVB/N; TISSUE=Colon, and Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   INTERACTION WITH NOTCH1, AND FUNCTION.
RX   PubMed=15965470; DOI=10.1038/nn1492;
RA   Eiraku M., Tohgo A., Ono K., Kaneko M., Fujishima K., Hirano T.,
RA   Kengaku M.;
RT   "DNER acts as a neuron-specific Notch ligand during Bergmann glial
RT   development.";
RL   Nat. Neurosci. 8:873-880(2005).
RN   [6]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=16298139; DOI=10.1016/j.mcn.2005.10.003;
RA   Tohgo A., Eiraku M., Miyazaki T., Miura E., Kawaguchi S.Y., Nishi M.,
RA   Watanabe M., Hirano T., Kengaku M., Takeshima H.;
RT   "Impaired cerebellar functions in mutant mice lacking DNER.";
RL   Mol. Cell. Neurosci. 31:326-333(2006).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-711 AND TYR-721, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain;
RX   PubMed=18034455; DOI=10.1021/pr0701254;
RA   Ballif B.A., Carey G.R., Sunyaev S.R., Gygi S.P.;
RT   "Large-scale identification and evolution indexing of tyrosine
RT   phosphorylation sites from murine brain.";
RL   J. Proteome Res. 7:311-318(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-685; THR-714 AND
RP   SER-722, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Brain;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and
RT   expression.";
RL   Cell 143:1174-1189(2010).
CC   -!- FUNCTION: Mediates neuron-glia interaction during
CC       astrocytogenesis. May promote differentiation of Bergmann glia
CC       during cerebellar development by activating DELTEX-dependent
CC       NOTCH1 signaling. {ECO:0000269|PubMed:15965470,
CC       ECO:0000269|PubMed:16298139}.
CC   -!- SUBUNIT: Interacts with AP1G1. Interacts with NOTCH1.
CC       {ECO:0000269|PubMed:11950833, ECO:0000269|PubMed:15965470}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:11950833,
CC       ECO:0000269|PubMed:11997712}; Single-pass type I membrane protein
CC       {ECO:0000269|PubMed:11950833, ECO:0000269|PubMed:11997712}.
CC       Note=Present on the membrane of dendrites and cell bodies but
CC       excluded from axonal membrane. Also found in early endosomes in
CC       the somatodendritic region.
CC   -!- TISSUE SPECIFICITY: Specifically expressed in brain neurons (at
CC       protein level). {ECO:0000269|PubMed:11950833,
CC       ECO:0000269|PubMed:11997712}.
CC   -!- DEVELOPMENTAL STAGE: Expression in the central nervous system
CC       starts at E11, peaks during postnatal development and declines in
CC       the adult brain. At P7 and P20, present in several types of post-
CC       mitotic neurons, including cortical and hippocampal pyramidal
CC       neurons, cerebellar granule cells and Purkinje cells. Absent from
CC       mitotic neuroblasts in the ventricular zones.
CC       {ECO:0000269|PubMed:11950833, ECO:0000269|PubMed:11997712}.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:11997712}.
CC   -!- DISRUPTION PHENOTYPE: Mice show no obvious abnormality and no
CC       apparent survival disadvantage. However, they have delayed
CC       cerebellar histogenesis and exhibit motor discoordination at adult
CC       stages. {ECO:0000269|PubMed:16298139}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAE31470.1; Type=Frameshift; Positions=631; Evidence={ECO:0000305};
CC       Sequence=BAE31828.1; Type=Frameshift; Positions=631; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY032924; AAK50342.1; -; mRNA.
DR   EMBL; AF370126; AAM14419.1; -; mRNA.
DR   EMBL; AB067650; BAB72175.1; -; mRNA.
DR   EMBL; AK044597; BAC31995.1; -; mRNA.
DR   EMBL; AK152755; BAE31470.1; ALT_FRAME; mRNA.
DR   EMBL; AK153235; BAE31828.1; ALT_FRAME; mRNA.
DR   EMBL; BC022636; AAH22636.1; -; mRNA.
DR   EMBL; BC034634; AAH34634.1; -; mRNA.
DR   CCDS; CCDS15105.1; -.
DR   RefSeq; NP_690879.1; NM_152915.1.
DR   UniGene; Mm.292560; -.
DR   ProteinModelPortal; Q8JZM4; -.
DR   SMR; Q8JZM4; -.
DR   BioGrid; 230612; 1.
DR   STRING; 10090.ENSMUSP00000042927; -.
DR   iPTMnet; Q8JZM4; -.
DR   PhosphoSitePlus; Q8JZM4; -.
DR   MaxQB; Q8JZM4; -.
DR   PaxDb; Q8JZM4; -.
DR   PeptideAtlas; Q8JZM4; -.
DR   PRIDE; Q8JZM4; -.
DR   Ensembl; ENSMUST00000049126; ENSMUSP00000042927; ENSMUSG00000036766.
DR   GeneID; 227325; -.
DR   KEGG; mmu:227325; -.
DR   UCSC; uc007bsw.1; mouse.
DR   CTD; 92737; -.
DR   MGI; MGI:2152889; Dner.
DR   eggNOG; ENOG410IR71; Eukaryota.
DR   eggNOG; ENOG410ZUAK; LUCA.
DR   GeneTree; ENSGT00890000139375; -.
DR   HOGENOM; HOG000112241; -.
DR   HOVERGEN; HBG060866; -.
DR   InParanoid; Q8JZM4; -.
DR   OMA; KDPCANV; -.
DR   OrthoDB; EOG091G01VZ; -.
DR   PhylomeDB; Q8JZM4; -.
DR   TreeFam; TF351322; -.
DR   ChiTaRS; Dner; mouse.
DR   PRO; PR:Q8JZM4; -.
DR   Proteomes; UP000000589; Chromosome 1.
DR   Bgee; ENSMUSG00000036766; -.
DR   CleanEx; MM_DNER; -.
DR   ExpressionAtlas; Q8JZM4; baseline and differential.
DR   Genevisible; Q8JZM4; MM.
DR   GO; GO:0030425; C:dendrite; IDA:MGI.
DR   GO; GO:0005769; C:early endosome; ISO:MGI.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0043025; C:neuronal cell body; IDA:MGI.
DR   GO; GO:0005886; C:plasma membrane; ISO:MGI.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0005112; F:Notch binding; IPI:MGI.
DR   GO; GO:0007417; P:central nervous system development; IEA:Ensembl.
DR   GO; GO:0010001; P:glial cell differentiation; IDA:MGI.
DR   GO; GO:0007220; P:Notch receptor processing; IDA:MGI.
DR   GO; GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0048741; P:skeletal muscle fiber development; IDA:MGI.
DR   InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR000152; EGF-type_Asp/Asn_hydroxyl_site.
DR   InterPro; IPR018097; EGF_Ca-bd_CS.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   Pfam; PF00008; EGF; 6.
DR   Pfam; PF12661; hEGF; 1.
DR   SMART; SM00181; EGF; 10.
DR   SMART; SM00179; EGF_CA; 7.
DR   SUPFAM; SSF57184; SSF57184; 2.
DR   PROSITE; PS00010; ASX_HYDROXYL; 2.
DR   PROSITE; PS00022; EGF_1; 10.
DR   PROSITE; PS01186; EGF_2; 7.
DR   PROSITE; PS50026; EGF_3; 10.
DR   PROSITE; PS01187; EGF_CA; 2.
PE   1: Evidence at protein level;
KW   Activator; Calcium; Cell membrane; Complete proteome;
KW   Developmental protein; Differentiation; Disulfide bond;
KW   EGF-like domain; Glycoprotein; Membrane; Notch signaling pathway;
KW   Phosphoprotein; Receptor; Reference proteome; Repeat; Signal;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL        1     25       {ECO:0000255}.
FT   CHAIN        26    737       Delta and Notch-like epidermal growth
FT                                factor-related receptor.
FT                                /FTId=PRO_0000253558.
FT   TOPO_DOM     26    640       Extracellular. {ECO:0000255}.
FT   TRANSMEM    641    661       Helical. {ECO:0000255}.
FT   TOPO_DOM    662    737       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       44     92       EGF-like 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN       94    133       EGF-like 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      309    348       EGF-like 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      349    390       EGF-like 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      392    428       EGF-like 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      430    466       EGF-like 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      468    503       EGF-like 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      505    541       EGF-like 8; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      543    579       EGF-like 9. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      581    617       EGF-like 10; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   REGION       44    133       Interaction with NOTCH1.
FT                                {ECO:0000269|PubMed:15965470}.
FT   REGION      677    680       Interaction with AP1G1 and
FT                                somatodendritic targeting.
FT                                {ECO:0000269|PubMed:11950833}.
FT   MOD_RES     685    685       Phosphoserine.
FT                                {ECO:0000244|PubMed:21183079}.
FT   MOD_RES     711    711       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:18034455}.
FT   MOD_RES     714    714       Phosphothreonine.
FT                                {ECO:0000244|PubMed:21183079}.
FT   MOD_RES     721    721       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:18034455}.
FT   MOD_RES     722    722       Phosphoserine.
FT                                {ECO:0000244|PubMed:21183079}.
FT   CARBOHYD    204    204       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    564    564       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     48     59       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID     53     80       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID     82     91       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID     98    108       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    103    121       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    123    132       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    319    336       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    338    347       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    353    364       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    358    378       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    380    389       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    396    407       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    401    416       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    418    427       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    434    445       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    439    454       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    456    465       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    472    482       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    477    491       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    493    502       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    509    520       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    514    529       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    531    540       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    547    558       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    552    567       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    569    578       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    585    596       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    590    605       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    607    616       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   MUTAGEN     677    677       Y->A: Fails to be restricted to the
FT                                somatodendritic compartment.
FT                                {ECO:0000269|PubMed:11950833}.
FT   CONFLICT    424    424       G -> A (in Ref. 2; BAB72175).
FT                                {ECO:0000305}.
FT   CONFLICT    509    510       CL -> SV (in Ref. 1; AAM14419).
FT                                {ECO:0000305}.
SQ   SEQUENCE   737 AA;  78747 MW;  8C85694EB7420756 CRC64;
     MPPRRAQAPG APLLPVLALL PLLLGAGPQS GCLASPVSAA PLPAPGPCAS QPCRNGGVCT
     PRSVTDQEHP AADAEPRYSC TCPAGVSGTY CQFVADPCAS NPCHHGNCSS SSSSSSDSYL
     CICNDGYEGL NCEQPLPSIP TSGWTESTAP RQLQPVPATQ EPDIILPRSQ ATVTLPTWQP
     KTGQKVVEMK WDQVEVVPDV ACGNASSNNS AGGRLVSFEV PQNTSVKIRQ DANSLLILLW
     KVTATGFQQC SLIDGRSVTP LQAPGGLVLL EEMLALGPNH FIGFVNDSVA KSIVALRLTL
     VVKASNCVPG DSHSNDLECS GKGKCATKPS EATFSCTCQD QYIGTFCEEF DACQRKPCQN
     EASCIDANEK QDGSNFTCLC LPGYTGELCQ SKIDYCVLDP CRNGATCVSS LSGFTCQCLE
     GYFGSACEEK VDPCMSSPCQ NNGTCYVDGV HFTCSCSPGF TGPTCAQLVD FCALSPCAHG
     MCRSVGTSYK CLCDPGYHGL YCEEEYNECL SAPCLNAATC RDLINGYECV CLAEYKGTHC
     ELYKDPCANI SCLNGGTCDS EGLNGTCICA PGFTGEECDI DINECDSNPC HHAGTCLDQP
     NGYTCHCPHG WVGANCEIHL QWKSGHMAES LTNMPRHSLY IIIGALCVAF ILMLIILIVG
     ICRISRIEYQ GSSRPAYEEF YNCRSIDSEF SNAIASIRHA RFGKKSRPAM YDVTPIAYED
     YSPDDKPLVT LIKTKDL
//
ID   APH1_ARATH              Reviewed;         250 AA.
AC   Q8L9G7; Q8VZI0; Q9SIC5;
DT   26-SEP-2003, integrated into UniProtKB/Swiss-Prot.
DT   26-SEP-2003, sequence version 2.
DT   07-JUN-2017, entry version 91.
DE   RecName: Full=Gamma-secretase subunit APH1-like;
GN   OrderedLocusNames=At2g31440; ORFNames=T28P16.7;
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; eudicotyledons; Gunneridae;
OC   Pentapetalae; rosids; malvids; Brassicales; Brassicaceae; Camelineae;
OC   Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=10617197; DOI=10.1038/45471;
RA   Lin X., Kaul S., Rounsley S.D., Shea T.P., Benito M.-I., Town C.D.,
RA   Fujii C.Y., Mason T.M., Bowman C.L., Barnstead M.E., Feldblyum T.V.,
RA   Buell C.R., Ketchum K.A., Lee J.J., Ronning C.M., Koo H.L.,
RA   Moffat K.S., Cronin L.A., Shen M., Pai G., Van Aken S., Umayam L.,
RA   Tallon L.J., Gill J.E., Adams M.D., Carrera A.J., Creasy T.H.,
RA   Goodman H.M., Somerville C.R., Copenhaver G.P., Preuss D.,
RA   Nierman W.C., White O., Eisen J.A., Salzberg S.L., Fraser C.M.,
RA   Venter J.C.;
RT   "Sequence and analysis of chromosome 2 of the plant Arabidopsis
RT   thaliana.";
RL   Nature 402:761-768(1999).
RN   [2]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RG   The Arabidopsis Information Portal (Araport);
RL   Submitted (MAY-2016) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=14593172; DOI=10.1126/science.1088305;
RA   Yamada K., Lim J., Dale J.M., Chen H., Shinn P., Palm C.J.,
RA   Southwick A.M., Wu H.C., Kim C.J., Nguyen M., Pham P.K., Cheuk R.F.,
RA   Karlin-Newmann G., Liu S.X., Lam B., Sakano H., Wu T., Yu G.,
RA   Miranda M., Quach H.L., Tripp M., Chang C.H., Lee J.M., Toriumi M.J.,
RA   Chan M.M., Tang C.C., Onodera C.S., Deng J.M., Akiyama K., Ansari Y.,
RA   Arakawa T., Banh J., Banno F., Bowser L., Brooks S.Y., Carninci P.,
RA   Chao Q., Choy N., Enju A., Goldsmith A.D., Gurjal M., Hansen N.F.,
RA   Hayashizaki Y., Johnson-Hopson C., Hsuan V.W., Iida K., Karnes M.,
RA   Khan S., Koesema E., Ishida J., Jiang P.X., Jones T., Kawai J.,
RA   Kamiya A., Meyers C., Nakajima M., Narusaka M., Seki M., Sakurai T.,
RA   Satou M., Tamse R., Vaysberg M., Wallender E.K., Wong C., Yamamura Y.,
RA   Yuan S., Shinozaki K., Davis R.W., Theologis A., Ecker J.R.;
RT   "Empirical analysis of transcriptional activity in the Arabidopsis
RT   genome.";
RL   Science 302:842-846(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Brover V.V., Troukhan M.E., Alexandrov N.A., Lu Y.-P., Flavell R.B.,
RA   Feldmann K.A.;
RT   "Full-length cDNA from Arabidopsis thaliana.";
RL   Submitted (MAR-2002) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Probable subunit of the gamma-secretase complex, an
CC       endoprotease complex that catalyzes the intramembrane cleavage of
CC       integral proteins such as Notch receptors. {ECO:0000250}.
CC   -!- SUBUNIT: Probable component of the gamma-secretase complex, a
CC       complex composed of a presenilin homodimer, nicastrin, APH1 and
CC       PEN2. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the APH-1 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC007169; AAD26475.2; -; Genomic_DNA.
DR   EMBL; CP002685; AEC08548.1; -; Genomic_DNA.
DR   EMBL; CP002685; ANM62984.1; -; Genomic_DNA.
DR   EMBL; AY064157; AAL36063.1; -; mRNA.
DR   EMBL; AY097412; AAM19928.1; -; mRNA.
DR   EMBL; AY088444; AAM65980.1; -; mRNA.
DR   PIR; G84720; G84720.
DR   RefSeq; NP_001325103.1; NM_001336332.1.
DR   RefSeq; NP_565724.1; NM_128701.3.
DR   UniGene; At.20784; -.
DR   ProteinModelPortal; Q8L9G7; -.
DR   BioGrid; 3049; 4.
DR   IntAct; Q8L9G7; 2.
DR   STRING; 3702.AT2G31440.1; -.
DR   PaxDb; Q8L9G7; -.
DR   EnsemblPlants; AT2G31440.1; AT2G31440.1; AT2G31440.
DR   EnsemblPlants; AT2G31440.2; AT2G31440.2; AT2G31440.
DR   GeneID; 817702; -.
DR   Gramene; AT2G31440.1; AT2G31440.1; AT2G31440.
DR   Gramene; AT2G31440.2; AT2G31440.2; AT2G31440.
DR   KEGG; ath:AT2G31440; -.
DR   Araport; AT2G31440; -.
DR   TAIR; locus:2061265; AT2G31440.
DR   eggNOG; ENOG410IGH9; Eukaryota.
DR   eggNOG; ENOG4111FIJ; LUCA.
DR   HOGENOM; HOG000006375; -.
DR   InParanoid; Q8L9G7; -.
DR   OMA; WSVIFFN; -.
DR   OrthoDB; EOG09360MQ2; -.
DR   PhylomeDB; Q8L9G7; -.
DR   PRO; PR:Q8L9G7; -.
DR   Proteomes; UP000006548; Chromosome 2.
DR   ExpressionAtlas; Q8L9G7; baseline and differential.
DR   Genevisible; Q8L9G7; AT.
DR   GO; GO:0005783; C:endoplasmic reticulum; IBA:GO_Central.
DR   GO; GO:0070765; C:gamma-secretase complex; IBA:GO_Central.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0004175; F:endopeptidase activity; IBA:GO_Central.
DR   GO; GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0043085; P:positive regulation of catalytic activity; IEA:InterPro.
DR   GO; GO:0016485; P:protein processing; IBA:GO_Central.
DR   InterPro; IPR009294; Aph-1.
DR   PANTHER; PTHR12889; PTHR12889; 1.
DR   Pfam; PF06105; Aph-1; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Membrane; Notch signaling pathway;
KW   Reference proteome; Transmembrane; Transmembrane helix.
FT   CHAIN         1    250       Gamma-secretase subunit APH1-like.
FT                                /FTId=PRO_0000221059.
FT   TRANSMEM      5     25       Helical; Name=1. {ECO:0000255}.
FT   TRANSMEM     29     49       Helical; Name=2. {ECO:0000255}.
FT   TRANSMEM     57     77       Helical; Name=3. {ECO:0000255}.
FT   TRANSMEM    116    136       Helical; Name=4. {ECO:0000255}.
FT   TRANSMEM    157    177       Helical; Name=5. {ECO:0000255}.
FT   TRANSMEM    191    211       Helical; Name=6. {ECO:0000255}.
FT   TRANSMEM    212    232       Helical; Name=7. {ECO:0000255}.
FT   CONFLICT     69     69       L -> V (in Ref. 4; AAM65980).
FT                                {ECO:0000305}.
SQ   SEQUENCE   250 AA;  27536 MW;  D6CB4061C2C16D8E CRC64;
     MTVAAGIGYA LVALGPSLSL FVSVISRKPF LILTVLSSTL LWLVSLIILS GLWRPFLPLK
     ANVWWPYALL VITSVCFQEG LRFLFWKVYK RLEDVLDSFA DRISRPRLFL TDKLQIALAG
     GLGHGVAHAV FFCLSLLTPA FGPATFYVER CSKVPFFLIS AIIALAFVTI HTFSMVIAFE
     GYAKGNKVDQ IIVPVIHLTA GMLTLVNFAS EGCVIGVPLL YLVASLTLVH CGKMVWQRLL
     ESRNQSSASR
//
ID   GLT11_HUMAN             Reviewed;         608 AA.
AC   Q8NCW6; B3KWF4; Q6PCD1; Q9H6C2; Q9H6Z5; Q9UDR8;
DT   16-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   16-AUG-2004, sequence version 2.
DT   25-OCT-2017, entry version 134.
DE   RecName: Full=Polypeptide N-acetylgalactosaminyltransferase 11;
DE            EC=2.4.1.41;
DE   AltName: Full=Polypeptide GalNAc transferase 11;
DE            Short=GalNAc-T11;
DE            Short=pp-GaNTase 11;
DE   AltName: Full=Protein-UDP acetylgalactosaminyltransferase 11;
DE   AltName: Full=UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 11;
GN   Name=GALNT11;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, ENZYME ACTIVITY,
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=11925450; DOI=10.1074/jbc.M202684200;
RA   Schwientek T., Bennett E.P., Flores C., Thacker J., Hollmann M.,
RA   Reis C.A., Behrens J., Mandel U., Keck B., Schaefer M.A.,
RA   Haselmann K., Zubarev R., Roepstorff P., Burchell J.M.,
RA   Taylor-Papadimitriou J., Hollingsworth M.A., Clausen H.;
RT   "Functional conservation of subfamilies of putative UDP-N-
RT   acetylgalactosamine:polypeptide N-acetylgalactosaminyltransferases in
RT   Drosophila, Caenorhabditis elegans, and mammals. One subfamily
RT   composed of l(2)35Aa is essential in Drosophila.";
RL   J. Biol. Chem. 277:22623-22638(2002).
RN   [2]
RP   SEQUENCE REVISION TO 14-15; 119; 295; 310; 365 AND 369.
RA   Bennett E.P.;
RL   Submitted (SEP-2011) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Colon, Kidney epithelium, and Subthalamic nucleus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   POSSIBLE INVOLVEMENT IN HETEROTAXY.
RX   PubMed=21282601; DOI=10.1073/pnas.1019645108;
RA   Fakhro K.A., Choi M., Ware S.M., Belmont J.W., Towbin J.A.,
RA   Lifton R.P., Khokha M.K., Brueckner M.;
RT   "Rare copy number variations in congenital heart disease patients
RT   identify unique genes in left-right patterning.";
RL   Proc. Natl. Acad. Sci. U.S.A. 108:2915-2920(2011).
RN   [7]
RP   FUNCTION, MUTAGENESIS OF HIS-247, AND INTERACTION WITH NOTCH1.
RX   PubMed=24226769; DOI=10.1038/nature12723;
RA   Boskovski M.T., Yuan S., Pedersen N.B., Goth C.K., Makova S.,
RA   Clausen H., Brueckner M., Khokha M.K.;
RT   "The heterotaxy gene GALNT11 glycosylates Notch to orchestrate cilia
RT   type and laterality.";
RL   Nature 504:456-459(2013).
RN   [8]
RP   VARIANT TYR-197.
RX   PubMed=20547088; DOI=10.1016/j.legalmed.2010.04.001;
RA   Yuasa I., Umetsu K., Matsusue A., Nishimukai H., Harihara S.,
RA   Fukumori Y., Saitou N., Jin F., Chattopadhyay P.K., Henke L.,
RA   Henke J.;
RT   "A Japanese-specific allele in the GALNT11 gene.";
RL   Leg. Med. 12:208-211(2010).
CC   -!- FUNCTION: Polypeptide N-acetylgalactosaminyltransferase that
CC       catalyzes the initiation of protein O-linked glycosylation and is
CC       involved in left/right asymmetry by mediating O-glycosylation of
CC       NOTCH1. O-glycosylation of NOTCH1 promotes activation of NOTCH1,
CC       modulating the balance between motile and immotile (sensory) cilia
CC       at the left-right organiser (LRO). Polypeptide N-
CC       acetylgalactosaminyltransferases catalyze the transfer of an N-
CC       acetyl-D-galactosamine residue to a serine or threonine residue on
CC       the protein receptor. Displays the same enzyme activity toward
CC       MUC1, MUC4, and EA2 than GALNT1. Not involved in glycosylation of
CC       erythropoietin (EPO). {ECO:0000269|PubMed:11925450,
CC       ECO:0000269|PubMed:24226769}.
CC   -!- CATALYTIC ACTIVITY: UDP-N-acetyl-alpha-D-galactosamine +
CC       polypeptide = UDP + N-acetyl-alpha-D-galactosaminyl-polypeptide.
CC       {ECO:0000269|PubMed:11925450}.
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250};
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC   -!- SUBUNIT: Interacts with NOTCH1. {ECO:0000269|PubMed:24226769}.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus membrane
CC       {ECO:0000269|PubMed:11925450}; Single-pass type II membrane
CC       protein {ECO:0000269|PubMed:11925450}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8NCW6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8NCW6-2; Sequence=VSP_011215, VSP_011216;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Highly expressed in kidney. Expressed at
CC       intermediate level in brain, heart and skeletal muscle. Weakly
CC       expressed other tissues. In kidney, it is strongly expressed in
CC       tubules but not expressed in glomeruli.
CC       {ECO:0000269|PubMed:11925450}.
CC   -!- DOMAIN: There are two conserved domains in the glycosyltransferase
CC       region: the N-terminal domain (domain A, also called GT1 motif),
CC       which is probably involved in manganese coordination and substrate
CC       binding and the C-terminal domain (domain B, also called
CC       Gal/GalNAc-T motif), which is probably involved in catalytic
CC       reaction and UDP-Gal binding. {ECO:0000250}.
CC   -!- DOMAIN: The ricin B-type lectin domain binds to GalNAc and
CC       contributes to the glycopeptide specificity. {ECO:0000250}.
CC   -!- DISEASE: Note=Defects in GALNT11 may be a cause of heterotaxy, a
CC       congenital heart disease resulting from abnormalities in left-
CC       right (LR) body patterning. {ECO:0000269|PubMed:21282601}.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 2 family. GalNAc-T
CC       subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB15338.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - GTase;
CC       Note=Polypeptide N-acetylgalactosaminyltransferase 11;
CC       URL="http://www.functionalglycomics.org/glycomics/molecule/jsp/glycoEnzyme/viewGlycoEnzyme.jsp?gbpId=gt_hum_494";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y12434; CAC79625.3; -; mRNA.
DR   EMBL; AK025287; BAB15105.1; -; mRNA.
DR   EMBL; AK026056; BAB15338.1; ALT_INIT; mRNA.
DR   EMBL; AK124934; BAG54116.1; -; mRNA.
DR   EMBL; AC006017; AAD45821.1; -; Genomic_DNA.
DR   EMBL; BC059377; AAH59377.1; -; mRNA.
DR   CCDS; CCDS5930.1; -. [Q8NCW6-1]
DR   RefSeq; NP_071370.2; NM_022087.3. [Q8NCW6-1]
DR   RefSeq; XP_006716145.1; XM_006716082.2. [Q8NCW6-1]
DR   RefSeq; XP_006716146.1; XM_006716083.2. [Q8NCW6-1]
DR   RefSeq; XP_006716147.1; XM_006716084.2. [Q8NCW6-1]
DR   RefSeq; XP_016867989.1; XM_017012500.1.
DR   UniGene; Hs.647109; -.
DR   ProteinModelPortal; Q8NCW6; -.
DR   SMR; Q8NCW6; -.
DR   BioGrid; 121988; 25.
DR   IntAct; Q8NCW6; 1.
DR   STRING; 9606.ENSP00000315835; -.
DR   CAZy; CBM13; Carbohydrate-Binding Module Family 13.
DR   CAZy; GT27; Glycosyltransferase Family 27.
DR   iPTMnet; Q8NCW6; -.
DR   PhosphoSitePlus; Q8NCW6; -.
DR   BioMuta; GALNT11; -.
DR   DMDM; 51316030; -.
DR   MaxQB; Q8NCW6; -.
DR   PaxDb; Q8NCW6; -.
DR   PeptideAtlas; Q8NCW6; -.
DR   PRIDE; Q8NCW6; -.
DR   DNASU; 63917; -.
DR   Ensembl; ENST00000415421; ENSP00000410093; ENSG00000178234. [Q8NCW6-2]
DR   Ensembl; ENST00000422997; ENSP00000389449; ENSG00000178234. [Q8NCW6-2]
DR   Ensembl; ENST00000430044; ENSP00000395122; ENSG00000178234. [Q8NCW6-1]
DR   Ensembl; ENST00000434507; ENSP00000416787; ENSG00000178234. [Q8NCW6-1]
DR   GeneID; 63917; -.
DR   KEGG; hsa:63917; -.
DR   UCSC; uc003wku.3; human. [Q8NCW6-1]
DR   CTD; 63917; -.
DR   DisGeNET; 63917; -.
DR   EuPathDB; HostDB:ENSG00000178234.12; -.
DR   GeneCards; GALNT11; -.
DR   H-InvDB; HIX0007236; -.
DR   HGNC; HGNC:19875; GALNT11.
DR   HPA; HPA039330; -.
DR   MIM; 615130; gene.
DR   neXtProt; NX_Q8NCW6; -.
DR   OpenTargets; ENSG00000178234; -.
DR   PharmGKB; PA134911149; -.
DR   eggNOG; KOG3736; Eukaryota.
DR   eggNOG; ENOG410XPMK; LUCA.
DR   GeneTree; ENSGT00760000118828; -.
DR   HOGENOM; HOG000038227; -.
DR   HOVERGEN; HBG051699; -.
DR   InParanoid; Q8NCW6; -.
DR   KO; K00710; -.
DR   OMA; GPFRSPT; -.
DR   OrthoDB; EOG091G085O; -.
DR   PhylomeDB; Q8NCW6; -.
DR   TreeFam; TF313267; -.
DR   BRENDA; 2.4.1.41; 2681.
DR   Reactome; R-HSA-913709; O-linked glycosylation of mucins.
DR   SABIO-RK; Q8NCW6; -.
DR   UniPathway; UPA00378; -.
DR   ChiTaRS; GALNT11; human.
DR   GenomeRNAi; 63917; -.
DR   PRO; PR:Q8NCW6; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000178234; -.
DR   CleanEx; HS_GALNT11; -.
DR   ExpressionAtlas; Q8NCW6; baseline and differential.
DR   Genevisible; Q8NCW6; HS.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005112; F:Notch binding; IDA:UniProtKB.
DR   GO; GO:0004653; F:polypeptide N-acetylgalactosaminyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0060271; P:cilium assembly; ISS:UniProtKB.
DR   GO; GO:0007368; P:determination of left/right symmetry; ISS:UniProtKB.
DR   GO; GO:0007220; P:Notch receptor processing; ISS:UniProtKB.
DR   GO; GO:0061314; P:Notch signaling involved in heart development; ISS:UniProtKB.
DR   GO; GO:0016266; P:O-glycan processing; TAS:Reactome.
DR   GO; GO:0018243; P:protein O-linked glycosylation via threonine; IDA:UniProtKB.
DR   GO; GO:0008593; P:regulation of Notch signaling pathway; ISS:UniProtKB.
DR   CDD; cd00161; RICIN; 1.
DR   Gene3D; 3.90.550.10; -; 1.
DR   InterPro; IPR001173; Glyco_trans_2-like.
DR   InterPro; IPR029044; Nucleotide-diphossugar_trans.
DR   InterPro; IPR035992; Ricin_B-like_lectins.
DR   InterPro; IPR000772; Ricin_B_lectin.
DR   Pfam; PF00535; Glycos_transf_2; 1.
DR   Pfam; PF00652; Ricin_B_lectin; 1.
DR   SMART; SM00458; RICIN; 1.
DR   SUPFAM; SSF50370; SSF50370; 1.
DR   SUPFAM; SSF53448; SSF53448; 1.
DR   PROSITE; PS50231; RICIN_B_LECTIN; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Disulfide bond; Glycoprotein;
KW   Glycosyltransferase; Golgi apparatus; Heterotaxy; Lectin; Manganese;
KW   Membrane; Metal-binding; Notch signaling pathway; Phosphoprotein;
KW   Polymorphism; Reference proteome; Signal-anchor; Transferase;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN         1    608       Polypeptide N-
FT                                acetylgalactosaminyltransferase 11.
FT                                /FTId=PRO_0000059125.
FT   TOPO_DOM      1      6       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM      7     29       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     30    608       Lumenal. {ECO:0000255}.
FT   DOMAIN      476    607       Ricin B-type lectin.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00174}.
FT   REGION      150    261       Catalytic subdomain A.
FT   REGION      319    381       Catalytic subdomain B.
FT   METAL       245    245       Manganese. {ECO:0000250}.
FT   METAL       247    247       Manganese. {ECO:0000250}.
FT   METAL       378    378       Manganese. {ECO:0000250}.
FT   BINDING     191    191       Substrate. {ECO:0000250}.
FT   BINDING     222    222       Substrate. {ECO:0000250}.
FT   BINDING     246    246       Substrate. {ECO:0000250}.
FT   BINDING     350    350       Substrate. {ECO:0000250}.
FT   BINDING     381    381       Substrate. {ECO:0000250}.
FT   BINDING     386    386       Substrate. {ECO:0000250}.
FT   MOD_RES      95     95       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q921L8}.
FT   CARBOHYD    428    428       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    141    373       {ECO:0000255|PROSITE-ProRule:PRU00174}.
FT   DISULFID    364    441       {ECO:0000255|PROSITE-ProRule:PRU00174}.
FT   DISULFID    493    512       {ECO:0000255|PROSITE-ProRule:PRU00174}.
FT   DISULFID    536    553       {ECO:0000255|PROSITE-ProRule:PRU00174}.
FT   DISULFID    578    596       {ECO:0000255|PROSITE-ProRule:PRU00174}.
FT   VAR_SEQ     196    202       DDLKGEL -> GKECCTW (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_011215.
FT   VAR_SEQ     203    608       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_011216.
FT   VARIANT     151    151       P -> S (in dbSNP:rs6464201).
FT                                /FTId=VAR_019589.
FT   VARIANT     197    197       D -> Y (in dbSNP:rs3778922).
FT                                {ECO:0000269|PubMed:20547088}.
FT                                /FTId=VAR_019590.
FT   MUTAGEN     247    247       H->A: Abolishes glycosyltransferase
FT                                activity and ability to rescue left-right
FT                                patterning defects induced by galnt11
FT                                knockdown in X.tropicalis.
FT                                {ECO:0000269|PubMed:24226769}.
FT   CONFLICT     94     94       F -> L (in Ref. 3; BAG54116).
FT                                {ECO:0000305}.
FT   CONFLICT    551    551       M -> V (in Ref. 3; BAB15105).
FT                                {ECO:0000305}.
FT   CONFLICT    577    577       Q -> L (in Ref. 3; BAB15105).
FT                                {ECO:0000305}.
SQ   SEQUENCE   608 AA;  68919 MW;  075D7B839A8D5607 CRC64;
     MGSVTVRYFC YGCLFTSATW TVLLFVYFNF SEVTQPLKNV PVKGSGPHGP SPKKFYPRFT
     RGPSRVLEPQ FKANKIDDVI DSRVEDPEEG HLKFSSELGM IFNERDQELR DLGYQKHAFN
     MLISDRLGYH RDVPDTRNAA CKEKFYPPDL PAASVVICFY NEAFSALLRT VHSVIDRTPA
     HLLHEIILVD DDSDFDDLKG ELDEYVQKYL PGKIKVIRNT KREGLIRGRM IGAAHATGEV
     LVFLDSHCEV NVMWLQPLLA AIREDRHTVV CPVIDIISAD TLAYSSSPVV RGGFNWGLHF
     KWDLVPLSEL GRAEGATAPI KSPTMAGGLF AMNRQYFHEL GQYDSGMDIW GGENLEISFR
     IWMCGGKLFI IPCSRVGHIF RKRRPYGSPE GQDTMTHNSL RLAHVWLDEY KEQYFSLRPD
     LKTKSYGNIS ERVELRKKLG CKSFKWYLDN VYPEMQISGS HAKPQQPIFV NRGPKRPKVL
     QRGRLYHLQT NKCLVAQGRP SQKGGLVVLK ACDYSDPNQI WIYNEEHELV LNSLLCLDMS
     ETRSSDPPRL MKCHGSGGSQ QWTFGKNNRL YQVSVGQCLR AVDPLGQKGS VAMAICDGSS
     SQQWHLEG
//
ID   DLLD_DANRE              Reviewed;         717 AA.
AC   Q8UWJ4; P87357;
DT   05-JUL-2005, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2005, sequence version 2.
DT   22-NOV-2017, entry version 110.
DE   RecName: Full=Delta-like protein D;
DE            Short=DeltaD;
DE   AltName: Full=After eight protein;
DE   Flags: Precursor;
GN   Name=dld; Synonyms=aei;
OS   Danio rerio (Zebrafish) (Brachydanio rerio).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Actinopterygii; Neopterygii; Teleostei; Ostariophysi; Cypriniformes;
OC   Cyprinidae; Danio.
OX   NCBI_TaxID=7955;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RX   PubMed=9203139; DOI=10.1016/S0925-4773(97)00037-3;
RA   Dornseifer P., Takke C., Campos-Ortega J.A.;
RT   "Overexpression of a zebrafish homologue of the Drosophila neurogenic
RT   gene delta perturbs differentiation of primary neurons and somitic
RT   development.";
RL   Mech. Dev. 63:159-171(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND TISSUE SPECIFICITY.
RX   PubMed=12361969;
RA   Hans S., Campos-Ortega J.A.;
RT   "On the organisation of the regulatory region of the zebrafish deltaD
RT   gene.";
RL   Development 129:4773-4784(2002).
RN   [3]
RP   TISSUE SPECIFICITY.
RX   PubMed=9425132;
RA   Haddon C., Smithers L., Schneider-Maunoury S., Coche T., Henrique D.,
RA   Lewis J.;
RT   "Multiple delta genes and lateral inhibition in zebrafish primary
RT   neurogenesis.";
RL   Development 125:359-370(1998).
RN   [4]
RP   FUNCTION.
RX   PubMed=11100729; DOI=10.1038/35044091;
RA   Jiang Y.-J., Aerne B.L., Smithers L., Haddon C., Ish-Horowicz D.,
RA   Lewis J.;
RT   "Notch signalling and the synchronization of the somite segmentation
RT   clock.";
RL   Nature 408:475-479(2000).
RN   [5]
RP   INTERACTION WITH MIB.
RX   PubMed=15013799; DOI=10.1016/j.ydbio.2003.11.010;
RA   Chen W., Corliss D.C.;
RT   "Three modules of zebrafish Mind bomb work cooperatively to promote
RT   Delta ubiquitination and endocytosis.";
RL   Dev. Biol. 267:361-373(2004).
RN   [6]
RP   UBIQUITINATION.
RX   PubMed=12530964; DOI=10.1016/S1534-5807(02)00409-4;
RA   Itoh M., Kim C.-H., Palardy G., Oda T., Jiang Y.-J., Maust D.,
RA   Yeo S.-Y., Lorick K., Wright G.J., Ariza-McNaughton L., Weissman A.M.,
RA   Lewis J., Chandrasekharappa S.C., Chitnis A.B.;
RT   "Mind bomb is a ubiquitin ligase that is essential for efficient
RT   activation of Notch signaling by Delta.";
RL   Dev. Cell 4:67-82(2003).
RN   [7]
RP   TISSUE SPECIFICITY.
RX   PubMed=15068793; DOI=10.1016/S1534-5807(04)00097-8;
RA   Cheng Y.-C., Amoyel M., Qiu X., Jiang Y.-J., Xu Q., Wilkinson D.G.;
RT   "Notch activation regulates the segregation and differentiation of
RT   rhombomere boundary cells in the zebrafish hindbrain.";
RL   Dev. Cell 6:539-550(2004).
CC   -!- FUNCTION: Acts as a ligand for Notch receptors and is involved in
CC       primary neurogenesis and somitogenesis. Can activate Notch
CC       receptors, thereby playing a key role in lateral inhibition, a
CC       process that prevents the immediate neighbors of each nascent
CC       neural cell from simultaneously embarking on neural
CC       differentiation. Required in somite segmentation to keep the
CC       oscillations of neighboring presomitic mesoderm cells
CC       synchronized. {ECO:0000269|PubMed:11100729}.
CC   -!- SUBUNIT: Interacts with mib. {ECO:0000269|PubMed:15013799}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250}; Single-pass type I
CC       membrane protein {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Expressed in both mesodermal and
CC       neuroectodermal regions. In the developing nervous system, it is
CC       expressed in overlapping regions with deltaB (dlb) and deltaA
CC       (dla); in the neural plate, dld is expressed in patches of
CC       contiguous cells with dla, while dlb is confined to scattered
CC       cells within those patches that will differentiate as neurons. In
CC       somites, it marks the anterior part of each formed somite, while
CC       deltaC (dlc) marks the posterior part. In 24 hours embryos,
CC       expressed in the hindbrain in stripes adjacent to rhombomere
CC       boundaries, but not in the actual boundary cells.
CC       {ECO:0000269|PubMed:12361969, ECO:0000269|PubMed:15068793,
CC       ECO:0000269|PubMed:9203139, ECO:0000269|PubMed:9425132}.
CC   -!- PTM: Ubiquitinated by mib, leading to its endocytosis and
CC       subsequent degradation. {ECO:0000269|PubMed:12530964}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y11760; CAA72425.1; -; mRNA.
DR   EMBL; AF426384; AAL31528.1; -; Genomic_DNA.
DR   UniGene; Dr.75102; -.
DR   ProteinModelPortal; Q8UWJ4; -.
DR   SMR; Q8UWJ4; -.
DR   STRING; 7955.ENSDARP00000089996; -.
DR   PaxDb; Q8UWJ4; -.
DR   ZFIN; ZDB-GENE-990415-47; dld.
DR   eggNOG; ENOG410IR7B; Eukaryota.
DR   eggNOG; ENOG410XUNS; LUCA.
DR   HOGENOM; HOG000267024; -.
DR   HOVERGEN; HBG007139; -.
DR   InParanoid; Q8UWJ4; -.
DR   PhylomeDB; Q8UWJ4; -.
DR   PRO; PR:Q8UWJ4; -.
DR   Proteomes; UP000000437; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; IDA:ZFIN.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; IDA:ZFIN.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IGI:ZFIN.
DR   GO; GO:0005886; C:plasma membrane; IDA:ZFIN.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0030165; F:PDZ domain binding; IDA:ZFIN.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; IMP:ZFIN.
DR   GO; GO:0060271; P:cilium assembly; IMP:ZFIN.
DR   GO; GO:0003140; P:determination of left/right asymmetry in lateral mesoderm; IGI:ZFIN.
DR   GO; GO:0007368; P:determination of left/right symmetry; IMP:ZFIN.
DR   GO; GO:0071910; P:determination of liver left/right asymmetry; IMP:ZFIN.
DR   GO; GO:0035469; P:determination of pancreatic left/right asymmetry; IMP:ZFIN.
DR   GO; GO:0048546; P:digestive tract morphogenesis; IMP:ZFIN.
DR   GO; GO:0002244; P:hematopoietic progenitor cell differentiation; IGI:ZFIN.
DR   GO; GO:0060218; P:hematopoietic stem cell differentiation; IMP:ZFIN.
DR   GO; GO:0046331; P:lateral inhibition; IMP:ZFIN.
DR   GO; GO:0007219; P:Notch signaling pathway; IMP:ZFIN.
DR   GO; GO:0061056; P:sclerotome development; IGI:ZFIN.
DR   GO; GO:0021523; P:somatic motor neuron differentiation; IMP:ZFIN.
DR   GO; GO:0001756; P:somitogenesis; IMP:ZFIN.
DR   GO; GO:0021514; P:ventral spinal cord interneuron differentiation; IMP:ZFIN.
DR   InterPro; IPR001774; DSL.
DR   InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR000152; EGF-type_Asp/Asn_hydroxyl_site.
DR   InterPro; IPR018097; EGF_Ca-bd_CS.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   InterPro; IPR011651; Notch_ligand_N.
DR   Pfam; PF01414; DSL; 1.
DR   Pfam; PF00008; EGF; 5.
DR   Pfam; PF12661; hEGF; 1.
DR   Pfam; PF07657; MNNL; 1.
DR   SMART; SM00051; DSL; 1.
DR   SMART; SM00181; EGF; 8.
DR   SMART; SM00179; EGF_CA; 6.
DR   SUPFAM; SSF57184; SSF57184; 1.
DR   PROSITE; PS00010; ASX_HYDROXYL; 3.
DR   PROSITE; PS51051; DSL; 1.
DR   PROSITE; PS00022; EGF_1; 8.
DR   PROSITE; PS01186; EGF_2; 8.
DR   PROSITE; PS50026; EGF_3; 8.
DR   PROSITE; PS01187; EGF_CA; 2.
PE   1: Evidence at protein level;
KW   Calcium; Complete proteome; Developmental protein; Differentiation;
KW   Disulfide bond; EGF-like domain; Glycoprotein; Membrane; Neurogenesis;
KW   Notch signaling pathway; Reference proteome; Repeat; Signal;
KW   Transmembrane; Transmembrane helix; Ubl conjugation.
FT   SIGNAL        1     19       {ECO:0000255}.
FT   CHAIN        20    717       Delta-like protein D.
FT                                /FTId=PRO_0000007517.
FT   TOPO_DOM     20    547       Extracellular. {ECO:0000255}.
FT   TRANSMEM    548    568       Helical. {ECO:0000255}.
FT   TOPO_DOM    569    717       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      175    219       DSL. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00377}.
FT   DOMAIN      220    253       EGF-like 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      257    284       EGF-like 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      286    324       EGF-like 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      326    362       EGF-like 4; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      364    401       EGF-like 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      403    439       EGF-like 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      441    477       EGF-like 7; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      479    515       EGF-like 8. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   CARBOHYD    475    475       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    177    186       {ECO:0000250}.
FT   DISULFID    190    202       {ECO:0000250}.
FT   DISULFID    210    219       {ECO:0000250}.
FT   DISULFID    224    235       {ECO:0000250}.
FT   DISULFID    228    241       {ECO:0000250}.
FT   DISULFID    243    252       {ECO:0000250}.
FT   DISULFID    261    266       {ECO:0000250}.
FT   DISULFID    274    283       {ECO:0000250}.
FT   DISULFID    290    302       {ECO:0000250}.
FT   DISULFID    296    312       {ECO:0000250}.
FT   DISULFID    314    323       {ECO:0000250}.
FT   DISULFID    330    341       {ECO:0000250}.
FT   DISULFID    335    350       {ECO:0000250}.
FT   DISULFID    352    361       {ECO:0000250}.
FT   DISULFID    368    379       {ECO:0000250}.
FT   DISULFID    373    389       {ECO:0000250}.
FT   DISULFID    391    400       {ECO:0000250}.
FT   DISULFID    407    418       {ECO:0000250}.
FT   DISULFID    412    427       {ECO:0000250}.
FT   DISULFID    429    438       {ECO:0000250}.
FT   DISULFID    445    456       {ECO:0000250}.
FT   DISULFID    450    465       {ECO:0000250}.
FT   DISULFID    467    476       {ECO:0000250}.
FT   DISULFID    483    494       {ECO:0000250}.
FT   DISULFID    488    503       {ECO:0000250}.
FT   DISULFID    505    514       {ECO:0000250}.
FT   CONFLICT     95     95       E -> D (in Ref. 2; AAL31528).
FT                                {ECO:0000305}.
FT   CONFLICT    717    717       V -> ISEC (in Ref. 2; AAL31528).
FT                                {ECO:0000305}.
SQ   SEQUENCE   717 AA;  79061 MW;  9C5A0162504593E4 CRC64;
     MGRLMIAVLL CVMISQGFCS GVFELKLQEF LNKKGVTGNA NCCKGSAAEG HQCECKTFFR
     ICLKHYQANV SPDPPCTYGG AVTPVLGSNS FQVPESFPDS SFTNPIPFAF GFTWPGTFSL
     IIEALHTDST DDLSTENPDR LISRMTTQRH LTVGEEWSQD LQVGGRTELK YSYRFVCDEH
     YYGEGCSVFC RPRDDTFGHF TCGERGEIIC NSGWKGQYCT EPICLPGCDE DHGFCDKPGE
     CKCRVGFSGK YCDDCIRYPG CLHGTCQQPW QCNCQEGWGG LFCNQDLNYC THHKPCQNGA
     TCTNTGQGSY TCSCRPGFTG DSCEIEVNEC SGSPCRNGGS CTDLENTYSC TCPPGFYGRN
     CELSAMTCAD GPCFNGGHCA DNPEGGYFCQ CPMGYAGFNC EKKIDHCSSN PCSNDAQCLD
     LVDSYLCQCP EGFTGTHCED NIDECATYPC QNGGTCQDGL SDYTCTCPPG YTGKNCTSAV
     NKCLHNPCHN GATCHEMDNR YVCACIPGYG GRNCQFLLPE NPQGQAIVEG ADKRYSYEED
     DGGFPWTAVC AGIILVLLVL IGGSVFVIYI RLKLQQRSQQ IDSHSEIETM NNLTNNRSRE
     KDLSVSIIGA TQVKNINKKV DFQSDGDKNG FKSRYSLVDY NLVHELKQED LGKEDSERSE
     ATKCEPLDSD SEEKHRNHLK SDSSERKRTE SLCKDTKYQS VFVLSEEKDE CIIATEV
//
ID   APH1B_HUMAN             Reviewed;         257 AA.
AC   Q8WW43; A8K589; Q564N3; Q6UWQ1; Q9H0S0;
DT   26-SEP-2003, integrated into UniProtKB/Swiss-Prot.
DT   15-MAR-2005, sequence version 3.
DT   27-SEP-2017, entry version 131.
DE   RecName: Full=Gamma-secretase subunit APH-1B;
DE            Short=APH-1b;
DE   AltName: Full=Aph-1beta;
DE   AltName: Full=Presenilin-stabilization factor-like;
GN   Name=APH1B; Synonyms=PSFL; ORFNames=UNQ688/PRO1328;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Lee H.-J., Kim T.-W.;
RT   "PSF is essential for gamma-secretase activity and stabilization of
RT   presenilin and nicastrin.";
RL   Submitted (MAY-2002) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND ALTERNATIVE SPLICING.
RX   PubMed=15823552; DOI=10.1016/j.bbrc.2005.03.096;
RA   Saito S., Takahashi-Sasaki N., Araki W.;
RT   "Identification and characterization of a novel human APH-1b splice
RT   variant lacking exon 4.";
RL   Biochem. Biophys. Res. Commun. 330:1068-1072(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=11230166; DOI=10.1101/gr.GR1547R;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H.,
RA   Lauber J., Duesterhoeft A., Beyer A., Koehrer K., Strack N.,
RA   Mewes H.-W., Ottenwaelder B., Obermaier B., Tampe J., Heubner D.,
RA   Wambutt R., Korn B., Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and
RT   analysis of 500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R.,
RA   Fahey J., Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G.,
RA   Johnson E., Jones C., Kamat A., Kaur A., Locke D.P., Madan A.,
RA   Munson G., Jaffe D.B., Lui A., Macdonald P., Mauceli E., Naylor J.W.,
RA   Nesbitt R., Nicol R., O'Leary S.B., Ratcliffe A., Rounsley S., She X.,
RA   Sneddon K.M.B., Stewart S., Sougnez C., Stone S.M., Topham K.,
RA   Vincent D., Wang S., Zimmer A.R., Birren B.W., Hood L., Lander E.S.,
RA   Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human
RT   chromosome 15.";
RL   Nature 440:671-675(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   FUNCTION, AND INTERACTION WITH PSEN1 AND PSEN2.
RC   TISSUE=Glioblastoma;
RX   PubMed=12297508; DOI=10.1074/jbc.M208164200;
RA   Lee S.-F., Shah S., Li H., Yu C., Han W., Yu G.;
RT   "Mammalian APH-1 interacts with presenilin and nicastrin and is
RT   required for intramembrane proteolysis of amyloid-beta precursor
RT   protein and Notch.";
RL   J. Biol. Chem. 277:45013-45019(2002).
RN   [10]
RP   TISSUE SPECIFICITY.
RX   PubMed=12740439; DOI=10.1073/pnas.1037392100;
RA   Kimberly W.T., LaVoie M.J., Ostaszewski B.L., Ye W., Wolfe M.S.,
RA   Selkoe D.J.;
RT   "Gamma-secretase is a membrane protein complex comprised of
RT   presenilin, nicastrin, Aph-1, and Pen-2.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:6382-6387(2003).
CC   -!- FUNCTION: Probable subunit of the gamma-secretase complex, an
CC       endoprotease complex that catalyzes the intramembrane cleavage of
CC       integral proteins such as Notch receptors and APP (amyloid-beta
CC       precursor protein). It probably represents a stabilizing cofactor
CC       for the presenilin homodimer that promotes the formation of a
CC       stable complex. Probably present in a minority of gamma-secretase
CC       complexes compared to APH1A. {ECO:0000269|PubMed:12297508}.
CC   -!- SUBUNIT: Probable component of the gamma-secretase complex, a
CC       complex composed of a presenilin homodimer (PSEN1 or PSEN2),
CC       nicastrin (NCSTN), APH1 (APH1A or APH1B) and PEN2. Such minimal
CC       complex is sufficient for secretase activity, although other
CC       components may exist (By similarity). Interacts with PSEN1 and
CC       PSEN2. {ECO:0000250, ECO:0000269|PubMed:12297508}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8WW43-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8WW43-2; Sequence=VSP_042945;
CC         Note=Expressed at low levels in most tissues.;
CC   -!- TISSUE SPECIFICITY: Weakly or not expressed in leukocytes, lung,
CC       placenta, small intestine, liver, kidney, spleen thymus, colon,
CC       skeletal muscle, heart and brain. {ECO:0000269|PubMed:12740439}.
CC   -!- SIMILARITY: Belongs to the APH-1 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF508794; AAN63817.1; -; mRNA.
DR   EMBL; AB189172; BAD95573.1; -; mRNA.
DR   EMBL; AL136671; CAB66606.1; -; mRNA.
DR   EMBL; AY358698; AAQ89061.1; -; mRNA.
DR   EMBL; AK291204; BAF83893.1; -; mRNA.
DR   EMBL; AC016207; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471082; EAW77645.1; -; Genomic_DNA.
DR   EMBL; BC020905; AAH20905.1; -; mRNA.
DR   CCDS; CCDS10184.1; -. [Q8WW43-1]
DR   CCDS; CCDS45276.1; -. [Q8WW43-2]
DR   RefSeq; NP_001139118.1; NM_001145646.1. [Q8WW43-2]
DR   RefSeq; NP_112591.2; NM_031301.3. [Q8WW43-1]
DR   UniGene; Hs.511703; -.
DR   ProteinModelPortal; Q8WW43; -.
DR   SMR; Q8WW43; -.
DR   BioGrid; 123659; 4.
DR   CORUM; Q8WW43; -.
DR   IntAct; Q8WW43; 1.
DR   MINT; MINT-4721718; -.
DR   STRING; 9606.ENSP00000261879; -.
DR   BindingDB; Q8WW43; -.
DR   ChEMBL; CHEMBL2094135; -.
DR   iPTMnet; Q8WW43; -.
DR   PhosphoSitePlus; Q8WW43; -.
DR   BioMuta; APH1B; -.
DR   DMDM; 61252592; -.
DR   PaxDb; Q8WW43; -.
DR   PeptideAtlas; Q8WW43; -.
DR   PRIDE; Q8WW43; -.
DR   DNASU; 83464; -.
DR   Ensembl; ENST00000261879; ENSP00000261879; ENSG00000138613. [Q8WW43-1]
DR   Ensembl; ENST00000380343; ENSP00000369700; ENSG00000138613. [Q8WW43-2]
DR   GeneID; 83464; -.
DR   KEGG; hsa:83464; -.
DR   UCSC; uc002ama.4; human. [Q8WW43-1]
DR   CTD; 83464; -.
DR   DisGeNET; 83464; -.
DR   EuPathDB; HostDB:ENSG00000138613.13; -.
DR   GeneCards; APH1B; -.
DR   HGNC; HGNC:24080; APH1B.
DR   MIM; 607630; gene.
DR   neXtProt; NX_Q8WW43; -.
DR   OpenTargets; ENSG00000138613; -.
DR   PharmGKB; PA142672600; -.
DR   eggNOG; KOG3972; Eukaryota.
DR   eggNOG; ENOG4111FIJ; LUCA.
DR   GeneTree; ENSGT00390000002049; -.
DR   HOGENOM; HOG000007541; -.
DR   HOVERGEN; HBG050541; -.
DR   InParanoid; Q8WW43; -.
DR   KO; K06172; -.
DR   OMA; FLLANHR; -.
DR   OrthoDB; EOG091G0IH0; -.
DR   PhylomeDB; Q8WW43; -.
DR   TreeFam; TF314362; -.
DR   Reactome; R-HSA-1251985; Nuclear signaling by ERBB4.
DR   Reactome; R-HSA-193692; Regulated proteolysis of p75NTR.
DR   Reactome; R-HSA-1980148; Signaling by NOTCH3.
DR   Reactome; R-HSA-1980150; Signaling by NOTCH4.
DR   Reactome; R-HSA-205043; NRIF signals cell death from the nucleus.
DR   Reactome; R-HSA-2122948; Activated NOTCH1 Transmits Signal to the Nucleus.
DR   Reactome; R-HSA-2644606; Constitutive Signaling by NOTCH1 PEST Domain Mutants.
DR   Reactome; R-HSA-2894862; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants.
DR   Reactome; R-HSA-2979096; NOTCH2 Activation and Transmission of Signal to the Nucleus.
DR   Reactome; R-HSA-3928665; EPH-ephrin mediated repulsion of cells.
DR   SignaLink; Q8WW43; -.
DR   SIGNOR; Q8WW43; -.
DR   ChiTaRS; APH1B; human.
DR   GenomeRNAi; 83464; -.
DR   PRO; PR:Q8WW43; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000138613; -.
DR   CleanEx; HS_APH1B; -.
DR   ExpressionAtlas; Q8WW43; baseline and differential.
DR   Genevisible; Q8WW43; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IBA:GO_Central.
DR   GO; GO:0070765; C:gamma-secretase complex; IBA:GO_Central.
DR   GO; GO:0016021; C:integral component of membrane; IDA:MGI.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0030133; C:transport vesicle; IDA:LIFEdb.
DR   GO; GO:0004175; F:endopeptidase activity; IBA:GO_Central.
DR   GO; GO:0008233; F:peptidase activity; IDA:MGI.
DR   GO; GO:0048013; P:ephrin receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0031293; P:membrane protein intracellular domain proteolysis; TAS:Reactome.
DR   GO; GO:0007220; P:Notch receptor processing; IBA:GO_Central.
DR   GO; GO:0007219; P:Notch signaling pathway; IBA:GO_Central.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome.
DR   GO; GO:0043085; P:positive regulation of catalytic activity; IEA:InterPro.
DR   GO; GO:0016485; P:protein processing; IDA:MGI.
DR   InterPro; IPR009294; Aph-1.
DR   PANTHER; PTHR12889; PTHR12889; 1.
DR   Pfam; PF06105; Aph-1; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Membrane;
KW   Notch signaling pathway; Polymorphism; Reference proteome;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN         1    257       Gamma-secretase subunit APH-1B.
FT                                /FTId=PRO_0000221052.
FT   TRANSMEM      5     25       Helical; Name=1. {ECO:0000255}.
FT   TRANSMEM     32     52       Helical; Name=2. {ECO:0000255}.
FT   TRANSMEM     71     91       Helical; Name=3. {ECO:0000255}.
FT   TRANSMEM    115    135       Helical; Name=4. {ECO:0000255}.
FT   TRANSMEM    158    178       Helical; Name=5. {ECO:0000255}.
FT   TRANSMEM    186    206       Helical; Name=6. {ECO:0000255}.
FT   TRANSMEM    213    233       Helical; Name=7. {ECO:0000255}.
FT   VAR_SEQ     119    159       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15823552}.
FT                                /FTId=VSP_042945.
FT   VARIANT     217    217       F -> L (in dbSNP:rs1047552).
FT                                /FTId=VAR_048315.
FT   CONFLICT     27     27       T -> I (in Ref. 4; AAQ89061).
FT                                {ECO:0000305}.
FT   CONFLICT     83     83       Q -> R (in Ref. 1; AAN63817 and 3;
FT                                CAB66606). {ECO:0000305}.
SQ   SEQUENCE   257 AA;  28460 MW;  A7A0C0076E20990A CRC64;
     MTAAVFFGCA FIAFGPALAL YVFTIATEPL RIIFLIAGAF FWLVSLLISS LVWFMARVII
     DNKDGPTQKY LLIFGAFVSV YIQEMFRFAY YKLLKKASEG LKSINPGETA PSMRLLAYVS
     GLGFGIMSGV FSFVNTLSDS LGPGTVGIHG DSPQFFLYSA FMTLVIILLH VFWGIVFFDG
     CEKKKWGILL IVLLTHLLVS AQTFISSYYG INLASAFIIL VLMGTWAFLA AGGSCRSLKL
     CLLCQDKNFL LYNQRSR
//
ID   JAG1B_DANRE             Reviewed;        1213 AA.
AC   Q90Y54;
DT   02-MAY-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   22-NOV-2017, entry version 127.
DE   RecName: Full=Protein jagged-1b;
DE            Short=Jagged1b;
DE   AltName: Full=Jagged3;
DE   Flags: Precursor;
GN   Name=jag1b; Synonyms=jag3;
OS   Danio rerio (Zebrafish) (Brachydanio rerio).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Actinopterygii; Neopterygii; Teleostei; Ostariophysi; Cypriniformes;
OC   Cyprinidae; Danio.
OX   NCBI_TaxID=7955;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Oda T., Chandrasekharappa S.C.;
RT   "Isolation, characterization and expression analysis of zebrafish
RT   Jagged genes.";
RL   Submitted (JAN-2000) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Ligand for Notch receptors and involved in the mediation
CC       of Notch signaling (By similarity). Seems to be involved in cell-
CC       fate decisions. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I
CC       membrane protein {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF229451; AAL08216.1; -; mRNA.
DR   UniGene; Dr.12589; -.
DR   ProteinModelPortal; Q90Y54; -.
DR   SMR; Q90Y54; -.
DR   STRING; 7955.ENSDARP00000008197; -.
DR   PaxDb; Q90Y54; -.
DR   ZFIN; ZDB-GENE-011128-4; jag1b.
DR   eggNOG; KOG1217; Eukaryota.
DR   eggNOG; ENOG410XP6K; LUCA.
DR   HOGENOM; HOG000113124; -.
DR   HOVERGEN; HBG031645; -.
DR   InParanoid; Q90Y54; -.
DR   PhylomeDB; Q90Y54; -.
DR   PRO; PR:Q90Y54; -.
DR   Proteomes; UP000000437; Unplaced.
DR   GO; GO:0016021; C:integral component of membrane; NAS:ZFIN.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0005112; F:Notch binding; IEA:InterPro.
DR   GO; GO:0060117; P:auditory receptor cell development; IMP:ZFIN.
DR   GO; GO:0060351; P:cartilage development involved in endochondral bone morphogenesis; IMP:ZFIN.
DR   GO; GO:1904888; P:cranial skeletal system development; IMP:ZFIN.
DR   GO; GO:0009953; P:dorsal/ventral pattern formation; IMP:ZFIN.
DR   GO; GO:0060325; P:face morphogenesis; IMP:ZFIN.
DR   GO; GO:0031101; P:fin regeneration; IMP:ZFIN.
DR   GO; GO:0042472; P:inner ear morphogenesis; IMP:ZFIN.
DR   GO; GO:0001889; P:liver development; IGI:ZFIN.
DR   GO; GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0032474; P:otolith morphogenesis; IMP:ZFIN.
DR   GO; GO:0031016; P:pancreas development; IGI:ZFIN.
DR   GO; GO:0060872; P:semicircular canal development; IMP:ZFIN.
DR   GO; GO:0048752; P:semicircular canal morphogenesis; IMP:ZFIN.
DR   GO; GO:0030878; P:thyroid gland development; IMP:ZFIN.
DR   InterPro; IPR001774; DSL.
DR   InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR000152; EGF-type_Asp/Asn_hydroxyl_site.
DR   InterPro; IPR018097; EGF_Ca-bd_CS.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   InterPro; IPR026219; Jagged/Serrate.
DR   InterPro; IPR011651; Notch_ligand_N.
DR   InterPro; IPR001007; VWF_dom.
DR   Pfam; PF01414; DSL; 1.
DR   Pfam; PF00008; EGF; 10.
DR   Pfam; PF07645; EGF_CA; 1.
DR   Pfam; PF12661; hEGF; 2.
DR   Pfam; PF07657; MNNL; 1.
DR   PRINTS; PR02059; JAGGEDFAMILY.
DR   SMART; SM00051; DSL; 1.
DR   SMART; SM00181; EGF; 16.
DR   SMART; SM00179; EGF_CA; 14.
DR   SMART; SM00214; VWC; 1.
DR   SMART; SM00215; VWC_out; 1.
DR   SUPFAM; SSF57184; SSF57184; 2.
DR   PROSITE; PS00010; ASX_HYDROXYL; 10.
DR   PROSITE; PS51051; DSL; 1.
DR   PROSITE; PS00022; EGF_1; 16.
DR   PROSITE; PS01186; EGF_2; 12.
DR   PROSITE; PS50026; EGF_3; 15.
DR   PROSITE; PS01187; EGF_CA; 8.
PE   2: Evidence at transcript level;
KW   Calcium; Complete proteome; Developmental protein; Disulfide bond;
KW   EGF-like domain; Glycoprotein; Membrane; Notch signaling pathway;
KW   Reference proteome; Repeat; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     26       {ECO:0000255}.
FT   CHAIN        27   1213       Protein jagged-1b.
FT                                /FTId=PRO_0000007631.
FT   TOPO_DOM     27   1064       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1065   1087       Helical. {ECO:0000255}.
FT   TOPO_DOM   1088   1213       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      182    226       DSL. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00377}.
FT   DOMAIN      227    260       EGF-like 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      261    291       EGF-like 2; atypical.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      293    331       EGF-like 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      333    369       EGF-like 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      371    407       EGF-like 5; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      409    445       EGF-like 6; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      447    482       EGF-like 7; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      484    520       EGF-like 8; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      522    558       EGF-like 9. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      592    624       EGF-like 10. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      626    662       EGF-like 11; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      664    700       EGF-like 12; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      702    738       EGF-like 13. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      746    777       EGF-like 14. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      779    815       EGF-like 15; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      817    853       EGF-like 16; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      860    914       VWFC.
FT   DOMAIN      918    956       EGF-like 17. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   COMPBIAS    938    941       Poly-Pro.
FT   CARBOHYD    139    139       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    214    214       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    556    556       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    742    742       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    957    957       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    988    988       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1042   1042       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    184    193       {ECO:0000250}.
FT   DISULFID    197    209       {ECO:0000250}.
FT   DISULFID    217    226       {ECO:0000250}.
FT   DISULFID    231    242       {ECO:0000250}.
FT   DISULFID    235    248       {ECO:0000250}.
FT   DISULFID    250    259       {ECO:0000250}.
FT   DISULFID    262    273       {ECO:0000250}.
FT   DISULFID    268    279       {ECO:0000250}.
FT   DISULFID    281    290       {ECO:0000250}.
FT   DISULFID    297    309       {ECO:0000250}.
FT   DISULFID    303    319       {ECO:0000250}.
FT   DISULFID    321    330       {ECO:0000250}.
FT   DISULFID    337    348       {ECO:0000250}.
FT   DISULFID    342    357       {ECO:0000250}.
FT   DISULFID    359    368       {ECO:0000250}.
FT   DISULFID    375    386       {ECO:0000250}.
FT   DISULFID    380    395       {ECO:0000250}.
FT   DISULFID    397    406       {ECO:0000250}.
FT   DISULFID    413    424       {ECO:0000250}.
FT   DISULFID    418    433       {ECO:0000250}.
FT   DISULFID    435    444       {ECO:0000250}.
FT   DISULFID    451    461       {ECO:0000250}.
FT   DISULFID    455    470       {ECO:0000250}.
FT   DISULFID    472    481       {ECO:0000250}.
FT   DISULFID    488    499       {ECO:0000250}.
FT   DISULFID    493    508       {ECO:0000250}.
FT   DISULFID    510    519       {ECO:0000250}.
FT   DISULFID    526    537       {ECO:0000250}.
FT   DISULFID    531    546       {ECO:0000250}.
FT   DISULFID    548    557       {ECO:0000250}.
FT   DISULFID    596    612       {ECO:0000250}.
FT   DISULFID    614    623       {ECO:0000250}.
FT   DISULFID    630    641       {ECO:0000250}.
FT   DISULFID    635    650       {ECO:0000250}.
FT   DISULFID    652    661       {ECO:0000250}.
FT   DISULFID    668    679       {ECO:0000250}.
FT   DISULFID    673    688       {ECO:0000250}.
FT   DISULFID    690    699       {ECO:0000250}.
FT   DISULFID    706    717       {ECO:0000250}.
FT   DISULFID    711    726       {ECO:0000250}.
FT   DISULFID    728    737       {ECO:0000250}.
FT   DISULFID    745    756       {ECO:0000250}.
FT   DISULFID    750    765       {ECO:0000250}.
FT   DISULFID    767    776       {ECO:0000250}.
FT   DISULFID    783    794       {ECO:0000250}.
FT   DISULFID    788    803       {ECO:0000250}.
FT   DISULFID    805    814       {ECO:0000250}.
FT   DISULFID    821    832       {ECO:0000250}.
FT   DISULFID    826    841       {ECO:0000250}.
FT   DISULFID    843    852       {ECO:0000250}.
SQ   SEQUENCE   1213 AA;  133366 MW;  5C5F16A7E20D9534 CRC64;
     MILRRSSVFS AFYLHAFLLC LRTTVSDASG HFELEILSMQ NANGELQNGA CCDGARNPAD
     RKCTRDECDT YFKVCLKEYQ SRVSSAGACS FGTGSTPVLG GNKFSTKGTR SEKSRIVLPF
     SFAWPRSYTL IVEALDFNNE TASESGKLIE KAYHSGMINP NRQWQRLTHN GPVAQFEYQI
     RVTCLEHYYG FGCNKFCRPR DEFFGHYTCD QNGNKTCLEG WTGPDCNTAI CRQGCSTEHG
     SCKQPGGCKC LYGWQGPYCD KCIPHPGCVH GTCVEPWQCL CDTNWGGQLC DKDLNYCGTH
     QPCLNGGTCS NTGPDKYQCS CEDGYSGVNC ERAEHACLSN PCANGGTCKE TSQGYECHCA
     IGWSGTSCEI NVDDCTPNQC KHGGTCQDLV NGFKCACPPH WTGKTCQIDA NECEDKPCVN
     AKSCHNLIGA YFCECLPGWS GQNCDININD CKGQCLNGGT CKDLVNGYRC LCPPGYTGEQ
     CEKDVDECAS SPCLNGGRCQ DEVNGFQCLC PAGFSGQLCQ LDIDYCKPNP CQNGAQCFNL
     ASDYFCKCPD DYEGKNCSHL KDHCRTTSCQ VIDSCTVAVA SNSTPEGVRY ISSNVCGPHG
     RCRSQAGGQF TCECQEGFRG TYCHENINDC ESNPCRNGGT CIDKVNVYQC ICADGWEGVH
     CEINIDDCSL NPCLNKGACQ DLVNDFYCEC RNGWKGKTCH SRDSQCDEAT CNNGGTCHDE
     GDTFKCRCSP GWEGATCNIA KNSSCLPNPC ENGGTCVVNG DSFNCVCKEG WEGSTCTENT
     NDCNPHPCYN SGTCVDGENW YRCECAPGFA GPDCRININE CQSSPCAFGS TCVDEINGYR
     CLCPPGRIGP DCQEVVGRPC IANGQVTADG AKWEEDCNIC QCQNGRIHCT MMWCGPKSCR
     IGKARGGCPA SQSCVPIKEE QCFVKPCPSL GECWPSAPPP PSKCHASFSY QDDSCANITF
     TFNKENMPQG LSVEHVCNEL RHWYLLKNLS TEYAVSISCE PSSSASNEIH ISISTEEPRT
     DRSPIKDITV QIIDLVSKHN GNSTIIKAIT GVRVHQIPSP KTDYLVPLLS SIFIVLWIFA
     LASAFLWCIH RRRKQNTHSN TATSATEDNT TNNVREQLNQ IKNPIEKHAA HGVPIKDYEG
     KNSIIAKIRT HNSEVEEEDM DKHLQKARFT KQPAYTLVER EERAPNKNPN WTNKQDNRDL
     ETAQSLNRME YIV
//
ID   NICA_HUMAN              Reviewed;         709 AA.
AC   Q92542; Q5T207; Q5T208; Q86VV5;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2001, sequence version 2.
DT   22-NOV-2017, entry version 167.
DE   RecName: Full=Nicastrin;
DE   Flags: Precursor;
GN   Name=NCSTN; Synonyms=KIAA0253; ORFNames=UNQ1874/PRO4317;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), IDENTIFICATION BY MASS
RP   SPECTROMETRY, FUNCTION, IDENTIFICATION IN THE GAMMA-SECRETASE COMPLEX,
RP   INTERACTION WITH PSEN1 AND PSEN2, SUBCELLULAR LOCATION, GLYCOSYLATION,
RP   TISSUE SPECIFICITY, AND MUTAGENESIS OF 336-ASP-TYR-337.
RC   TISSUE=Embryonic kidney;
RX   PubMed=10993067; DOI=10.1038/35024009;
RA   Yu G., Nishimura M., Arawaka S., Levitan D., Zhang L., Tandon A.,
RA   Song Y.-Q., Rogaeva E., Chen F., Kawarai T., Supala A., Levesque L.,
RA   Yu H., Yang D.-S., Holmes E., Milman P., Liang Y., Zhang D.M.,
RA   Xu D.H., Sato C., Rogaev E., Smith M., Janus C., Zhang Y.,
RA   Aebersold R., Farrer L.S., Sorbi S., Bruni A., Fraser P.E.,
RA   St George-Hyslop P.H.;
RT   "Nicastrin modulates presenilin-mediated notch/glp-1 signal
RT   transduction and betaAPP processing.";
RL   Nature 407:48-54(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 2-709 (ISOFORM 1).
RC   TISSUE=Bone marrow;
RX   PubMed=9039502; DOI=10.1093/dnares/3.5.321;
RA   Nagase T., Seki N., Ishikawa K., Ohira M., Kawarabayasi Y., Ohara O.,
RA   Tanaka A., Kotani H., Miyajima N., Nomura N.;
RT   "Prediction of the coding sequences of unidentified human genes. VI.
RT   The coding sequences of 80 new genes (KIAA0201-KIAA0280) deduced by
RT   analysis of cDNA clones from cell line KG-1 and brain.";
RL   DNA Res. 3:321-329(1996).
RN   [8]
RP   TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=11396676; DOI=10.1046/j.1440-1789.2001.00378.x;
RA   Satoh J., Kuroda Y.;
RT   "Nicastrin, a key regulator of presenilin function, is expressed
RT   constitutively in human neural cell lines.";
RL   Neuropathology 21:115-122(2001).
RN   [9]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=12643545; DOI=10.1021/pr025562r;
RA   Basrur V., Yang F., Kushimoto T., Higashimoto Y., Yasumoto K.,
RA   Valencia J., Muller J., Vieira W.D., Watabe H., Shabanowitz J.,
RA   Hearing V.J., Hunt D.F., Appella E.;
RT   "Proteomic analysis of early melanosomes: identification of novel
RT   melanosomal proteins.";
RL   J. Proteome Res. 2:69-79(2003).
RN   [10]
RP   COMPONENT OF A GAMMA-SECRETASE COMPLEX WITH PEN2; PSEN1/PSEN2 AND
RP   APH1A.
RX   PubMed=12740439; DOI=10.1073/pnas.1037392100;
RA   Kimberly W.T., LaVoie M.J., Ostaszewski B.L., Ye W., Wolfe M.S.,
RA   Selkoe D.J.;
RT   "Gamma-secretase is a membrane protein complex comprised of
RT   presenilin, nicastrin, Aph-1, and Pen-2.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:6382-6387(2003).
RN   [11]
RP   ENZYME ACTIVITY OF A GAMMA-SECRETASE COMPLEX.
RX   PubMed=12679784; DOI=10.1038/ncb960;
RA   Edbauer D., Winkler E., Regula J.T., Pesold B., Steiner H., Haass C.;
RT   "Reconstitution of gamma-secretase activity.";
RL   Nat. Cell Biol. 5:486-488(2003).
RN   [12]
RP   GLYCOSYLATION AT ASN-387.
RX   PubMed=12754519; DOI=10.1038/nbt827;
RA   Zhang H., Li X.-J., Martin D.B., Aebersold R.;
RT   "Identification and quantification of N-linked glycoproteins using
RT   hydrazide chemistry, stable isotope labeling and mass spectrometry.";
RL   Nat. Biotechnol. 21:660-666(2003).
RN   [13]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H.,
RA   Mangini N.J., Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R.,
RA   Yamagishi S., Shabanowitz J., Hearing V.J., Wu C., Appella E.,
RA   Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [14]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-45; ASN-187 AND ASN-387.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [15]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-612.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19349973; DOI=10.1038/nbt.1532;
RA   Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,
RA   Schiess R., Aebersold R., Watts J.D.;
RT   "Mass-spectrometric identification and relative quantification of N-
RT   linked cell surface glycoproteins.";
RL   Nat. Biotechnol. 27:378-386(2009).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [18]
RP   STRUCTURE BY ELECTRON MICROSCOPY (5.40 ANGSTROMS), FUNCTION,
RP   SUBCELLULAR LOCATION, TOPOLOGY, SUBUNIT, DISULFIDE BONDS, AND
RP   GLYCOSYLATION.
RX   PubMed=25043039; DOI=10.1038/nature13567;
RA   Lu P., Bai X.C., Ma D., Xie T., Yan C., Sun L., Yang G., Zhao Y.,
RA   Zhou R., Scheres S.H., Shi Y.;
RT   "Three-dimensional structure of human gamma-secretase.";
RL   Nature 512:166-170(2014).
RN   [19]
RP   STRUCTURE BY ELECTRON MICROSCOPY (4.00 ANGSTROMS), DISULFIDE BONDS,
RP   SUBCELLULAR LOCATION, TOPOLOGY, AND SUBUNIT.
RX   PubMed=26623517; DOI=10.7554/eLife.11182;
RA   Bai X.C., Rajendra E., Yang G., Shi Y., Scheres S.H.;
RT   "Sampling the conformational space of the catalytic subunit of human
RT   gamma-secretase.";
RL   Elife 4:0-0(2015).
RN   [20]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.40 ANGSTROMS), FUNCTION,
RP   SUBCELLULAR LOCATION, TOPOLOGY, SUBUNIT, DISULFIDE BONDS, AND
RP   GLYCOSYLATION AT ASN-45; ASN-55; ASN-187; ASN-264; ASN-387; ASN-435;
RP   ASN-464; ASN-506; ASN-530; ASN-562 AND ASN-573.
RX   PubMed=26280335; DOI=10.1038/nature14892;
RA   Bai X.C., Yan C., Yang G., Lu P., Ma D., Sun L., Zhou R.,
RA   Scheres S.H., Shi Y.;
RT   "An atomic structure of human gamma-secretase.";
RL   Nature 525:212-217(2015).
RN   [21]
RP   STRUCTURE BY ELECTRON MICROSCOPY (4.40 ANGSTROMS) OF 42-665, DISULFIDE
RP   BONDS, SUBCELLULAR LOCATION, TOPOLOGY, AND SUBUNIT.
RX   PubMed=25918421; DOI=10.1073/pnas.1506242112;
RA   Sun L., Zhao L., Yang G., Yan C., Zhou R., Zhou X., Xie T., Zhao Y.,
RA   Wu S., Li X., Shi Y.;
RT   "Structural basis of human gamma-secretase assembly.";
RL   Proc. Natl. Acad. Sci. U.S.A. 112:6003-6008(2015).
RN   [22]
RP   STRUCTURE BY NMR OF 664-709, AND SUBCELLULAR LOCATION.
RX   PubMed=26776682; DOI=10.1038/srep19522;
RA   Li Y., Liew L.S., Li Q., Kang C.;
RT   "Structure of the transmembrane domain of human nicastrin-a component
RT   of gamma-secretase.";
RL   Sci. Rep. 6:19522-19522(2016).
RN   [23]
RP   INVOLVEMENT IN ACNINV1.
RX   PubMed=20929727; DOI=10.1126/science.1196284;
RA   Wang B., Yang W., Wen W., Sun J., Su B., Liu B., Ma D., Lv D., Wen Y.,
RA   Qu T., Chen M., Sun M., Shen Y., Zhang X.;
RT   "Gamma-secretase gene mutations in familial acne inversa.";
RL   Science 330:1065-1065(2010).
RN   [24]
RP   INVOLVEMENT IN ACNINV1.
RX   PubMed=21430701; DOI=10.1038/jid.2011.62;
RA   Liu Y., Gao M., Lv Y.M., Yang X., Ren Y.Q., Jiang T., Zhang X.,
RA   Guo B.R., Li M., Zhang Q., Zhang P., Zhou F.S., Chen G., Yin X.Y.,
RA   Zuo X.B., Sun L.D., Zheng X.D., Zhang S.M., Liu J.J., Zhou Y.,
RA   Li Y.R., Wang J., Wang J., Yang H.M., Yang S., Li R.Q., Zhang X.J.;
RT   "Confirmation by exome sequencing of the pathogenic role of NCSTN
RT   mutations in acne inversa (hidradenitis suppurativa).";
RL   J. Invest. Dermatol. 131:1570-1572(2011).
RN   [25]
RP   VARIANT ACNINV1 ARG-211.
RX   PubMed=21495993; DOI=10.1111/j.1365-2133.2011.10372.x;
RA   Li C.R., Jiang M.J., Shen D.B., Xu H.X., Wang H.S., Yao X., Zhang Y.,
RA   Zhou W.Q., Wang B.;
RT   "Two novel mutations of the nicastrin gene in Chinese patients with
RT   acne inversa.";
RL   Br. J. Dermatol. 165:415-418(2011).
CC   -!- FUNCTION: Essential subunit of the gamma-secretase complex, an
CC       endoprotease complex that catalyzes the intramembrane cleavage of
CC       integral membrane proteins such as Notch receptors and APP
CC       (amyloid-beta precursor protein) (PubMed:10993067,
CC       PubMed:12679784, PubMed:25043039, PubMed:26280335). The gamma-
CC       secretase complex plays a role in Notch and Wnt signaling cascades
CC       and regulation of downstream processes via its role in processing
CC       key regulatory proteins, and by regulating cytosolic CTNNB1
CC       levels. {ECO:0000269|PubMed:10993067, ECO:0000269|PubMed:12679784,
CC       ECO:0000269|PubMed:25043039, ECO:0000269|PubMed:26280335}.
CC   -!- SUBUNIT: Component of the gamma-secretase complex
CC       (PubMed:10993067). The functional gamma-secretase complex is
CC       composed of at least four polypeptides: a presenilin homodimer
CC       (PSEN1 or PSEN2), nicastrin (NCSTN), APH1 (APH1A or APH1B) and
CC       PEN2 (PubMed:12740439, PubMed:25043039, PubMed:26623517,
CC       PubMed:26280335, PubMed:25918421). Binds to proteolytic processed
CC       C-terminal fragments C83 and C99 of the amyloid precursor protein
CC       (APP) (PubMed:10993067). Interacts with PSEN1 and PSEN2
CC       (PubMed:10993067). {ECO:0000269|PubMed:10993067,
CC       ECO:0000269|PubMed:12740439, ECO:0000269|PubMed:25043039,
CC       ECO:0000269|PubMed:25918421, ECO:0000269|PubMed:26280335,
CC       ECO:0000269|PubMed:26623517}.
CC   -!- INTERACTION:
CC       Q96BI3:APH1A; NbExp=4; IntAct=EBI-998440, EBI-2606935;
CC       P49768:PSEN1; NbExp=3; IntAct=EBI-998440, EBI-297277;
CC       Q9NZ42:PSENEN; NbExp=3; IntAct=EBI-998440, EBI-998468;
CC       P49755:TMED10; NbExp=5; IntAct=EBI-998440, EBI-998422;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:10993067,
CC       ECO:0000269|PubMed:25043039, ECO:0000269|PubMed:25918421,
CC       ECO:0000269|PubMed:26280335, ECO:0000269|PubMed:26623517,
CC       ECO:0000269|PubMed:26776682}; Single-pass type I membrane protein
CC       {ECO:0000269|PubMed:25043039, ECO:0000269|PubMed:25918421,
CC       ECO:0000269|PubMed:26280335, ECO:0000269|PubMed:26623517}.
CC       Cytoplasmic vesicle membrane {ECO:0000269|PubMed:10993067};
CC       Single-pass type I membrane protein {ECO:0000269|PubMed:25043039,
CC       ECO:0000269|PubMed:25918421, ECO:0000269|PubMed:26280335,
CC       ECO:0000269|PubMed:26623517}. Melanosome
CC       {ECO:0000269|PubMed:12643545, ECO:0000269|PubMed:17081065}.
CC       Note=Identified by mass spectrometry in melanosome fractions from
CC       stage I to stage IV.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q92542-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q92542-2; Sequence=VSP_008385, VSP_008386;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Detected in brain (at protein level)
CC       (PubMed:10993067). Widely expressed (PubMed:11396676).
CC       {ECO:0000269|PubMed:10993067, ECO:0000269|PubMed:11396676}.
CC   -!- INDUCTION: Constitutively expressed in neural cells.
CC       {ECO:0000269|PubMed:11396676}.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:10993067,
CC       ECO:0000269|PubMed:25043039, ECO:0000269|PubMed:26280335}.
CC   -!- DISEASE: Acne inversa, familial, 1 (ACNINV1) [MIM:142690]: A
CC       chronic relapsing inflammatory disease of the hair follicles
CC       characterized by recurrent draining sinuses, painful skin
CC       abscesses, and disfiguring scars. Manifestations typically appear
CC       after puberty. {ECO:0000269|PubMed:20929727,
CC       ECO:0000269|PubMed:21430701, ECO:0000269|PubMed:21495993}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the nicastrin family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF240468; AAG11412.1; -; mRNA.
DR   EMBL; AY359120; AAQ89478.1; -; mRNA.
DR   EMBL; AK314764; BAG37302.1; -; mRNA.
DR   EMBL; AL445230; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471121; EAW52720.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW52721.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW52722.1; -; Genomic_DNA.
DR   EMBL; BC047621; AAH47621.1; -; mRNA.
DR   EMBL; D87442; BAA13383.1; -; mRNA.
DR   CCDS; CCDS1203.1; -. [Q92542-1]
DR   CCDS; CCDS76228.1; -. [Q92542-2]
DR   RefSeq; NP_001277113.1; NM_001290184.1. [Q92542-2]
DR   RefSeq; NP_001277115.1; NM_001290186.1.
DR   RefSeq; NP_056146.1; NM_015331.2. [Q92542-1]
DR   UniGene; Hs.517249; -.
DR   PDB; 2N7Q; NMR; -; A=664-709.
DR   PDB; 2N7R; NMR; -; A=664-709.
DR   PDB; 4UIS; EM; 4.40 A; A=42-665.
DR   PDB; 5A63; EM; 3.40 A; A=1-709.
DR   PDB; 5FN2; EM; 4.20 A; A=1-709.
DR   PDB; 5FN3; EM; 4.10 A; A=1-709.
DR   PDB; 5FN4; EM; 4.00 A; A=1-709.
DR   PDB; 5FN5; EM; 4.30 A; A=1-709.
DR   PDBsum; 2N7Q; -.
DR   PDBsum; 2N7R; -.
DR   PDBsum; 4UIS; -.
DR   PDBsum; 5A63; -.
DR   PDBsum; 5FN2; -.
DR   PDBsum; 5FN3; -.
DR   PDBsum; 5FN4; -.
DR   PDBsum; 5FN5; -.
DR   ProteinModelPortal; Q92542; -.
DR   SMR; Q92542; -.
DR   BioGrid; 116961; 135.
DR   CORUM; Q92542; -.
DR   DIP; DIP-36336N; -.
DR   IntAct; Q92542; 66.
DR   MINT; MINT-3048708; -.
DR   STRING; 9606.ENSP00000294785; -.
DR   BindingDB; Q92542; -.
DR   ChEMBL; CHEMBL3418; -.
DR   iPTMnet; Q92542; -.
DR   PhosphoSitePlus; Q92542; -.
DR   SwissPalm; Q92542; -.
DR   BioMuta; NCSTN; -.
DR   DMDM; 12231037; -.
DR   EPD; Q92542; -.
DR   MaxQB; Q92542; -.
DR   PaxDb; Q92542; -.
DR   PeptideAtlas; Q92542; -.
DR   PRIDE; Q92542; -.
DR   TopDownProteomics; Q92542-2; -. [Q92542-2]
DR   DNASU; 23385; -.
DR   Ensembl; ENST00000294785; ENSP00000294785; ENSG00000162736. [Q92542-1]
DR   Ensembl; ENST00000368063; ENSP00000357042; ENSG00000162736. [Q92542-2]
DR   GeneID; 23385; -.
DR   KEGG; hsa:23385; -.
DR   UCSC; uc001fvx.4; human. [Q92542-1]
DR   CTD; 23385; -.
DR   DisGeNET; 23385; -.
DR   EuPathDB; HostDB:ENSG00000162736.15; -.
DR   GeneCards; NCSTN; -.
DR   HGNC; HGNC:17091; NCSTN.
DR   HPA; CAB021982; -.
DR   HPA; HPA054846; -.
DR   HPA; HPA070642; -.
DR   MalaCards; NCSTN; -.
DR   MIM; 142690; phenotype.
DR   MIM; 605254; gene.
DR   neXtProt; NX_Q92542; -.
DR   OpenTargets; ENSG00000162736; -.
DR   Orphanet; 387; Hidradenitis suppurativa.
DR   PharmGKB; PA142671271; -.
DR   eggNOG; KOG2657; Eukaryota.
DR   eggNOG; ENOG410XT6X; LUCA.
DR   GeneTree; ENSGT00390000014633; -.
DR   HOGENOM; HOG000044212; -.
DR   HOVERGEN; HBG006497; -.
DR   InParanoid; Q92542; -.
DR   KO; K06171; -.
DR   OMA; TWTESTW; -.
DR   OrthoDB; EOG091G03DV; -.
DR   PhylomeDB; Q92542; -.
DR   TreeFam; TF317086; -.
DR   Reactome; R-HSA-1251985; Nuclear signaling by ERBB4.
DR   Reactome; R-HSA-1474228; Degradation of the extracellular matrix.
DR   Reactome; R-HSA-193692; Regulated proteolysis of p75NTR.
DR   Reactome; R-HSA-1980148; Signaling by NOTCH3.
DR   Reactome; R-HSA-1980150; Signaling by NOTCH4.
DR   Reactome; R-HSA-205043; NRIF signals cell death from the nucleus.
DR   Reactome; R-HSA-2122948; Activated NOTCH1 Transmits Signal to the Nucleus.
DR   Reactome; R-HSA-2644606; Constitutive Signaling by NOTCH1 PEST Domain Mutants.
DR   Reactome; R-HSA-2894862; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants.
DR   Reactome; R-HSA-2979096; NOTCH2 Activation and Transmission of Signal to the Nucleus.
DR   Reactome; R-HSA-3928665; EPH-ephrin mediated repulsion of cells.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   SignaLink; Q92542; -.
DR   SIGNOR; Q92542; -.
DR   ChiTaRS; NCSTN; human.
DR   GeneWiki; Nicastrin; -.
DR   GenomeRNAi; 23385; -.
DR   PRO; PR:Q92542; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000162736; -.
DR   CleanEx; HS_NCSTN; -.
DR   ExpressionAtlas; Q92542; baseline and differential.
DR   Genevisible; Q92542; HS.
DR   GO; GO:0035577; C:azurophil granule membrane; TAS:Reactome.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:HGNC.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; IDA:UniProtKB.
DR   GO; GO:0070765; C:gamma-secretase complex; IDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HGNC.
DR   GO; GO:0016021; C:integral component of membrane; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:HGNC.
DR   GO; GO:0005765; C:lysosomal membrane; IDA:UniProtKB.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0004175; F:endopeptidase activity; IBA:GO_Central.
DR   GO; GO:0042987; P:amyloid precursor protein catabolic process; TAS:HGNC.
DR   GO; GO:0042982; P:amyloid precursor protein metabolic process; IDA:UniProtKB.
DR   GO; GO:0034205; P:amyloid-beta formation; IMP:UniProtKB.
DR   GO; GO:0048013; P:ephrin receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0050673; P:epithelial cell proliferation; IEA:Ensembl.
DR   GO; GO:0006509; P:membrane protein ectodomain proteolysis; IDA:HGNC.
DR   GO; GO:0031293; P:membrane protein intracellular domain proteolysis; TAS:Reactome.
DR   GO; GO:0002262; P:myeloid cell homeostasis; IEA:Ensembl.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0007220; P:Notch receptor processing; TAS:HGNC.
DR   GO; GO:0007219; P:Notch signaling pathway; TAS:Reactome.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome.
DR   GO; GO:0043085; P:positive regulation of catalytic activity; IDA:HGNC.
DR   GO; GO:0016485; P:protein processing; IDA:HGNC.
DR   GO; GO:0006508; P:proteolysis; NAS:UniProtKB.
DR   GO; GO:0042098; P:T cell proliferation; IEA:Ensembl.
DR   InterPro; IPR008710; Nicastrin.
DR   PANTHER; PTHR21092; PTHR21092; 1.
DR   Pfam; PF05450; Nicastrin; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome;
KW   Cytoplasmic vesicle; Disease mutation; Disulfide bond; Glycoprotein;
KW   Membrane; Notch signaling pathway; Polymorphism; Reference proteome;
KW   Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL        1     33       {ECO:0000255}.
FT   CHAIN        34    709       Nicastrin.
FT                                /FTId=PRO_0000019681.
FT   TOPO_DOM     34    669       Extracellular.
FT                                {ECO:0000305|PubMed:26280335,
FT                                ECO:0000305|PubMed:26776682}.
FT   TRANSMEM    670    690       Helical. {ECO:0000305|PubMed:26280335,
FT                                ECO:0000305|PubMed:26776682}.
FT   TOPO_DOM    691    709       Cytoplasmic.
FT                                {ECO:0000305|PubMed:26280335,
FT                                ECO:0000305|PubMed:26776682}.
FT   CARBOHYD     45     45       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:5A63,
FT                                ECO:0000269|PubMed:19159218,
FT                                ECO:0000269|PubMed:26280335}.
FT   CARBOHYD     55     55       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:5A63, ECO:0000255,
FT                                ECO:0000269|PubMed:26280335}.
FT   CARBOHYD    187    187       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:5A63,
FT                                ECO:0000269|PubMed:19159218,
FT                                ECO:0000269|PubMed:26280335}.
FT   CARBOHYD    200    200       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    204    204       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    264    264       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:5A63, ECO:0000255,
FT                                ECO:0000269|PubMed:26280335}.
FT   CARBOHYD    387    387       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:5A63,
FT                                ECO:0000269|PubMed:12754519,
FT                                ECO:0000269|PubMed:19159218,
FT                                ECO:0000269|PubMed:26280335}.
FT   CARBOHYD    417    417       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    435    435       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:5A63, ECO:0000255,
FT                                ECO:0000269|PubMed:26280335}.
FT   CARBOHYD    464    464       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:5A63, ECO:0000255,
FT                                ECO:0000269|PubMed:26280335}.
FT   CARBOHYD    506    506       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:5A63, ECO:0000255,
FT                                ECO:0000269|PubMed:26280335}.
FT   CARBOHYD    530    530       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:5A63, ECO:0000255,
FT                                ECO:0000269|PubMed:26280335}.
FT   CARBOHYD    562    562       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:5A63, ECO:0000255,
FT                                ECO:0000269|PubMed:26280335}.
FT   CARBOHYD    573    573       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000244|PDB:5A63, ECO:0000255,
FT                                ECO:0000269|PubMed:26280335}.
FT   CARBOHYD    580    580       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    612    612       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19349973}.
FT   DISULFID     50     62       {ECO:0000244|PDB:4UIS,
FT                                ECO:0000244|PDB:5A63,
FT                                ECO:0000244|PDB:5FN2,
FT                                ECO:0000244|PDB:5FN3,
FT                                ECO:0000244|PDB:5FN4,
FT                                ECO:0000244|PDB:5FN5,
FT                                ECO:0000269|PubMed:26280335,
FT                                ECO:0000269|PubMed:26623517,
FT                                ECO:0000305|PubMed:25043039,
FT                                ECO:0000305|PubMed:25918421}.
FT   DISULFID    140    159       {ECO:0000244|PDB:5A63,
FT                                ECO:0000244|PDB:5FN2,
FT                                ECO:0000244|PDB:5FN3,
FT                                ECO:0000244|PDB:5FN4,
FT                                ECO:0000244|PDB:5FN5,
FT                                ECO:0000269|PubMed:26280335,
FT                                ECO:0000269|PubMed:26623517}.
FT   DISULFID    195    213       {ECO:0000244|PDB:4UIS,
FT                                ECO:0000244|PDB:5A63,
FT                                ECO:0000244|PDB:5FN2,
FT                                ECO:0000244|PDB:5FN3,
FT                                ECO:0000244|PDB:5FN4,
FT                                ECO:0000244|PDB:5FN5,
FT                                ECO:0000269|PubMed:26280335,
FT                                ECO:0000269|PubMed:26623517,
FT                                ECO:0000305|PubMed:25918421}.
FT   DISULFID    230    248       {ECO:0000244|PDB:4UIS,
FT                                ECO:0000244|PDB:5A63,
FT                                ECO:0000244|PDB:5FN2,
FT                                ECO:0000244|PDB:5FN3,
FT                                ECO:0000244|PDB:5FN4,
FT                                ECO:0000244|PDB:5FN5,
FT                                ECO:0000269|PubMed:26280335,
FT                                ECO:0000269|PubMed:26623517,
FT                                ECO:0000305|PubMed:25918421}.
FT   DISULFID    586    620       {ECO:0000244|PDB:5A63,
FT                                ECO:0000244|PDB:5FN2,
FT                                ECO:0000244|PDB:5FN3,
FT                                ECO:0000244|PDB:5FN4,
FT                                ECO:0000244|PDB:5FN5,
FT                                ECO:0000269|PubMed:26280335,
FT                                ECO:0000269|PubMed:26623517}.
FT   VAR_SEQ       1     20       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_008385.
FT   VAR_SEQ      21     29       LSFCVLLAG -> MDFNLILES (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_008386.
FT   VARIANT      75     75       V -> I (in dbSNP:rs12045198).
FT                                /FTId=VAR_050274.
FT   VARIANT      77     77       E -> D (in dbSNP:rs35603924).
FT                                /FTId=VAR_050275.
FT   VARIANT     211    211       P -> R (in ACNINV1).
FT                                {ECO:0000269|PubMed:21495993}.
FT                                /FTId=VAR_067756.
FT   MUTAGEN     336    337       DY->AA: Increases production of amyloid-
FT                                beta (beta-APP40 and beta-APP42) in APP
FT                                processing.
FT                                {ECO:0000269|PubMed:10993067}.
FT   CONFLICT    657    657       R -> H (in Ref. 6; AAH47621).
FT                                {ECO:0000305}.
FT   HELIX       665    697       {ECO:0000244|PDB:2N7Q}.
FT   STRAND      698    700       {ECO:0000244|PDB:2N7R}.
FT   HELIX       704    706       {ECO:0000244|PDB:2N7Q}.
SQ   SEQUENCE   709 AA;  78411 MW;  C8C0EAEAD89E976A CRC64;
     MATAGGGSGA DPGSRGLLRL LSFCVLLAGL CRGNSVERKI YIPLNKTAPC VRLLNATHQI
     GCQSSISGDT GVIHVVEKEE DLQWVLTDGP NPPYMVLLES KHFTRDLMEK LKGRTSRIAG
     LAVSLTKPSP ASGFSPSVQC PNDGFGVYSN SYGPEFAHCR EIQWNSLGNG LAYEDFSFPI
     FLLEDENETK VIKQCYQDHN LSQNGSAPTF PLCAMQLFSH MHAVISTATC MRRSSIQSTF
     SINPEIVCDP LSDYNVWSML KPINTTGTLK PDDRVVVAAT RLDSRSFFWN VAPGAESAVA
     SFVTQLAAAE ALQKAPDVTT LPRNVMFVFF QGETFDYIGS SRMVYDMEKG KFPVQLENVD
     SFVELGQVAL RTSLELWMHT DPVSQKNESV RNQVEDLLAT LEKSGAGVPA VILRRPNQSQ
     PLPPSSLQRF LRARNISGVV LADHSGAFHN KYYQSIYDTA ENINVSYPEW LSPEEDLNFV
     TDTAKALADV ATVLGRALYE LAGGTNFSDT VQADPQTVTR LLYGFLIKAN NSWFQSILRQ
     DLRSYLGDGP LQHYIAVSSP TNTTYVVQYA LANLTGTVVN LTREQCQDPS KVPSENKDLY
     EYSWVQGPLH SNETDRLPRC VRSTARLARA LSPAFELSQW SSTEYSTWTE SRWKDIRARI
     FLIASKELEL ITLTVGFGIL IFSLIVTYCI NAKADVLFIA PREPGAVSY
//
ID   APH1A_HUMAN             Reviewed;         265 AA.
AC   Q96BI3; B4DQK0; Q5TB22; Q5TB23; Q969R6; Q9BVG0; Q9Y386;
DT   26-SEP-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   25-OCT-2017, entry version 147.
DE   RecName: Full=Gamma-secretase subunit APH-1A;
DE            Short=APH-1a;
DE   AltName: Full=Aph-1alpha;
DE   AltName: Full=Presenilin-stabilization factor;
GN   Name=APH1A; Synonyms=PSF; ORFNames=CGI-78, UNQ579/PRO1141;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND INTERACTION WITH
RP   PSEN1; PSEN2 AND NCSTN.
RC   TISSUE=Glioblastoma;
RX   PubMed=12297508; DOI=10.1074/jbc.M208164200;
RA   Lee S.-F., Shah S., Li H., Yu C., Han W., Yu G.;
RT   "Mammalian APH-1 interacts with presenilin and nicastrin and is
RT   required for intramembrane proteolysis of amyloid-beta precursor
RT   protein and Notch.";
RL   J. Biol. Chem. 277:45013-45019(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RA   Lee H.-J., Kim T.-W.;
RT   "PSF is essential for gamma-secretase activity and stabilization of
RT   presenilin and nicastrin.";
RL   Submitted (MAY-2002) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=10810093; DOI=10.1101/gr.10.5.703;
RA   Lai C.-H., Chou C.-Y., Ch'ang L.-Y., Liu C.-S., Lin W.-C.;
RT   "Identification of novel human genes evolutionarily conserved in
RT   Caenorhabditis elegans by comparative proteomics.";
RL   Genome Res. 10:703-713(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Retinoblastoma, and Thyroid;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Adrenal gland, Brain, Cervix, Eye, Glial tumor, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   TISSUE SPECIFICITY.
RX   PubMed=12110170; DOI=10.1016/S1534-5807(02)00189-2;
RA   Francis R., McGrath G., Zhang J., Ruddy D.A., Sym M., Apfeld J.,
RA   Nicoll M., Maxwell M., Hai B., Ellis M.C., Parks A.L., Xu W., Li J.,
RA   Gurney M., Myers R.L., Himes C.S., Hiebsch R., Ruble C., Nye J.S.,
RA   Curtis D.;
RT   "aph-1 and pen-2 are required for Notch pathway signaling, gamma-
RT   secretase cleavage of betaAPP, and presenilin protein accumulation.";
RL   Dev. Cell 3:85-97(2002).
RN   [10]
RP   SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=12522139; DOI=10.1074/jbc.C200648200;
RA   Luo W.-J., Wang H., Li H., Kim B.S., Shah S., Lee H.-J.,
RA   Thinakaran G., Kim T.-W., Yu G., Xu H.;
RT   "PEN-2 and APH-1 coordinately regulate proteolytic processing of
RT   presenilin 1.";
RL   J. Biol. Chem. 278:7850-7854(2003).
RN   [11]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH PSEN1.
RX   PubMed=12471034; DOI=10.1074/jbc.M209499200;
RA   Gu Y., Chen F., Sanjo N., Kawarai T., Hasegawa H., Duthie M., Li W.,
RA   Ruan X., Luthra A., Mount H.T.J., Tandon A., Fraser P.E.,
RA   St George-Hyslop P.H.;
RT   "APH-1 interacts with mature and immature forms of presenilins and
RT   nicastrin and may play a role in maturation of presenilin.nicastrin
RT   complexes.";
RL   J. Biol. Chem. 278:7374-7380(2003).
RN   [12]
RP   FUNCTION IN THE GAMMA-SECRETASE COMPLEX.
RX   PubMed=12763021; DOI=10.1016/S0006-291X(03)00797-6;
RA   Marlow L., Canet R.M., Haugabook S.J., Hardy J.A., Lahiri D.K.,
RA   Sambamurti K.;
RT   "APH1, PEN2, and nicastrin increase Abeta levels and gamma-secretase
RT   activity.";
RL   Biochem. Biophys. Res. Commun. 305:502-509(2003).
RN   [13]
RP   COMPONENT OF A GAMMA-SECRETASE COMPLEX WITH PEN2; PSEN1/PSEN2 AND
RP   NCSTN, AND SUBUNIT.
RX   PubMed=12740439; DOI=10.1073/pnas.1037392100;
RA   Kimberly W.T., LaVoie M.J., Ostaszewski B.L., Ye W., Wolfe M.S.,
RA   Selkoe D.J.;
RT   "Gamma-secretase is a membrane protein complex comprised of
RT   presenilin, nicastrin, Aph-1, and Pen-2.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:6382-6387(2003).
RN   [14]
RP   ENZYME ACTIVITY OF A GAMMA-SECRETASE COMPLEX, AND FUNCTION.
RX   PubMed=12679784; DOI=10.1038/ncb960;
RA   Edbauer D., Winkler E., Regula J.T., Pesold B., Steiner H., Haass C.;
RT   "Reconstitution of gamma-secretase activity.";
RL   Nat. Cell Biol. 5:486-488(2003).
RN   [15]
RP   SUBCELLULAR LOCATION, AND MEMBRANE TOPOLOGY.
RX   PubMed=14593096; DOI=10.1074/jbc.M310505200;
RA   Fortna R.R., Crystal A.S., Morais V.A., Pijak D.S., Lee V.M.,
RA   Doms R.W.;
RT   "Membrane topology and nicastrin-enhanced endoproteolysis of APH-1, a
RT   component of the gamma-secretase complex.";
RL   J. Biol. Chem. 279:3685-3693(2004).
RN   [16]
RP   FUNCTION, SUBUNIT, SUBCELLULAR LOCATION, AND MUTAGENESIS OF HIS-171
RP   AND HIS-197.
RX   PubMed=19369254; DOI=10.1074/jbc.M109.000067;
RA   Pardossi-Piquard R., Yang S.P., Kanemoto S., Gu Y., Chen F., Boehm C.,
RA   Sevalle J., Li T., Wong P.C., Checler F., Schmitt-Ulms G.,
RA   St George-Hyslop P., Fraser P.E.;
RT   "APH1 polar transmembrane residues regulate the assembly and activity
RT   of presenilin complexes.";
RL   J. Biol. Chem. 284:16298-16307(2009).
RN   [17]
RP   STRUCTURE BY ELECTRON MICROSCOPY (4.5 ANGSTROMS), FUNCTION,
RP   SUBCELLULAR LOCATION, TOPOLOGY, AND SUBUNIT.
RX   PubMed=25043039; DOI=10.1038/nature13567;
RA   Lu P., Bai X.C., Ma D., Xie T., Yan C., Sun L., Yang G., Zhao Y.,
RA   Zhou R., Scheres S.H., Shi Y.;
RT   "Three-dimensional structure of human gamma-secretase.";
RL   Nature 512:166-170(2014).
RN   [18]
RP   STRUCTURE BY ELECTRON MICROSCOPY (4.00 ANGSTROMS), SUBCELLULAR
RP   LOCATION, TISSUE SPECIFICITY, AND SUBUNIT.
RX   PubMed=26623517; DOI=10.7554/eLife.11182;
RA   Bai X.C., Rajendra E., Yang G., Shi Y., Scheres S.H.;
RT   "Sampling the conformational space of the catalytic subunit of human
RT   gamma-secretase.";
RL   Elife 4:0-0(2015).
RN   [19]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.40 ANGSTROMS), FUNCTION,
RP   SUBCELLULAR LOCATION, TOPOLOGY, AND SUBUNIT.
RX   PubMed=26280335; DOI=10.1038/nature14892;
RA   Bai X.C., Yan C., Yang G., Lu P., Ma D., Sun L., Zhou R.,
RA   Scheres S.H., Shi Y.;
RT   "An atomic structure of human gamma-secretase.";
RL   Nature 525:212-217(2015).
CC   -!- FUNCTION: Non-catalytic subunit of the gamma-secretase complex, an
CC       endoprotease complex that catalyzes the intramembrane cleavage of
CC       integral membrane proteins such as Notch receptors and APP
CC       (amyloid-beta precursor protein) (PubMed:12297508,
CC       PubMed:12522139, PubMed:12763021, PubMed:12679784,
CC       PubMed:25043039, PubMed:26280335). Required for normal gamma-
CC       secretase assembly (PubMed:12522139, PubMed:12471034,
CC       PubMed:12763021, PubMed:19369254). The gamma-secretase complex
CC       plays a role in Notch and Wnt signaling cascades and regulation of
CC       downstream processes via its role in processing key regulatory
CC       proteins, and by regulating cytosolic CTNNB1 levels (Probable).
CC       {ECO:0000269|PubMed:12297508, ECO:0000269|PubMed:12471034,
CC       ECO:0000269|PubMed:12522139, ECO:0000269|PubMed:12679784,
CC       ECO:0000269|PubMed:12763021, ECO:0000269|PubMed:25043039,
CC       ECO:0000269|PubMed:26280335, ECO:0000305}.
CC   -!- SUBUNIT: The functional gamma-secretase complex is composed of at
CC       least four polypeptides: a presenilin homodimer (PSEN1 or PSEN2),
CC       nicastrin (NCSTN), APH1 (APH1A or APH1B) and PEN2
CC       (PubMed:12297508, PubMed:12740439, PubMed:19369254,
CC       PubMed:25043039, PubMed:26623517, PubMed:26280335).
CC       {ECO:0000269|PubMed:12297508, ECO:0000269|PubMed:12740439,
CC       ECO:0000269|PubMed:19369254, ECO:0000269|PubMed:25043039,
CC       ECO:0000269|PubMed:26280335, ECO:0000269|PubMed:26623517}.
CC   -!- INTERACTION:
CC       Q92542:NCSTN; NbExp=4; IntAct=EBI-2606935, EBI-998440;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:12522139}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:25043039, ECO:0000269|PubMed:26280335,
CC       ECO:0000269|PubMed:26623517}. Golgi apparatus, Golgi stack
CC       membrane {ECO:0000269|PubMed:12522139}; Multi-pass membrane
CC       protein {ECO:0000269|PubMed:25043039, ECO:0000269|PubMed:26280335,
CC       ECO:0000269|PubMed:26623517}. Note=Predominantly located in the
CC       endoplasmic reticulum and in the cis-Golgi.
CC       {ECO:0000269|PubMed:12522139}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=L, Aph-alpha1;
CC         IsoId=Q96BI3-1; Sequence=Displayed;
CC       Name=2; Synonyms=S, Aph-alpha2;
CC         IsoId=Q96BI3-2; Sequence=VSP_008355, VSP_008356;
CC       Name=3;
CC         IsoId=Q96BI3-3; Sequence=VSP_045424;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Expressed in leukocytes,
CC       lung, placenta, small intestine, liver, kidney, spleen thymus,
CC       skeletal muscle, heart and brain. Isoform 1 and isoform 2 are
CC       nearly expressed at the same level. {ECO:0000269|PubMed:12110170}.
CC   -!- SIMILARITY: Belongs to the APH-1 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD34072.1; Type=Frameshift; Positions=243; Evidence={ECO:0000305};
CC       Sequence=AAN63816.1; Type=Frameshift; Positions=243; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF508787; AAN63816.1; ALT_FRAME; mRNA.
DR   EMBL; AY113698; AAM61955.1; -; mRNA.
DR   EMBL; AY113699; AAM61956.1; -; mRNA.
DR   EMBL; AF151835; AAD34072.1; ALT_FRAME; mRNA.
DR   EMBL; AY358951; AAQ89310.1; -; mRNA.
DR   EMBL; AK027879; BAG51389.1; -; mRNA.
DR   EMBL; AK075295; BAC11529.1; -; mRNA.
DR   EMBL; AK298832; BAG60962.1; -; mRNA.
DR   EMBL; AL138795; CAI22811.1; -; Genomic_DNA.
DR   EMBL; AL138795; CAI22812.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW53565.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW53566.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW53567.1; -; Genomic_DNA.
DR   EMBL; BC001230; AAH01230.1; -; mRNA.
DR   EMBL; BC008732; AAH08732.1; -; mRNA.
DR   EMBL; BC009501; AAH09501.1; -; mRNA.
DR   EMBL; BC015568; AAH15568.1; -; mRNA.
DR   EMBL; BC017699; AAH17699.1; -; mRNA.
DR   EMBL; BC020590; AAH20590.1; -; mRNA.
DR   CCDS; CCDS41390.1; -. [Q96BI3-1]
DR   CCDS; CCDS41391.1; -. [Q96BI3-2]
DR   CCDS; CCDS58025.1; -. [Q96BI3-3]
DR   RefSeq; NP_001071096.1; NM_001077628.2. [Q96BI3-1]
DR   RefSeq; NP_001230700.1; NM_001243771.1.
DR   RefSeq; NP_001230701.1; NM_001243772.1. [Q96BI3-3]
DR   RefSeq; NP_057106.2; NM_016022.3. [Q96BI3-2]
DR   UniGene; Hs.108408; -.
DR   UniGene; Hs.735911; -.
DR   PDB; 5A63; EM; 3.40 A; C=1-265.
DR   PDB; 5FN2; EM; 4.20 A; C=1-265.
DR   PDB; 5FN3; EM; 4.10 A; C=1-265.
DR   PDB; 5FN4; EM; 4.00 A; C=1-265.
DR   PDB; 5FN5; EM; 4.30 A; C=1-265.
DR   PDBsum; 5A63; -.
DR   PDBsum; 5FN2; -.
DR   PDBsum; 5FN3; -.
DR   PDBsum; 5FN4; -.
DR   PDBsum; 5FN5; -.
DR   ProteinModelPortal; Q96BI3; -.
DR   SMR; Q96BI3; -.
DR   BioGrid; 119296; 22.
DR   CORUM; Q96BI3; -.
DR   DIP; DIP-44671N; -.
DR   IntAct; Q96BI3; 18.
DR   STRING; 9606.ENSP00000358105; -.
DR   BindingDB; Q96BI3; -.
DR   ChEMBL; CHEMBL2094135; -.
DR   DrugBank; DB05171; E2012.
DR   iPTMnet; Q96BI3; -.
DR   PhosphoSitePlus; Q96BI3; -.
DR   SwissPalm; Q96BI3; -.
DR   BioMuta; APH1A; -.
DR   DMDM; 37077707; -.
DR   MaxQB; Q96BI3; -.
DR   PaxDb; Q96BI3; -.
DR   PeptideAtlas; Q96BI3; -.
DR   PRIDE; Q96BI3; -.
DR   TopDownProteomics; Q96BI3-2; -. [Q96BI3-2]
DR   DNASU; 51107; -.
DR   Ensembl; ENST00000360244; ENSP00000353380; ENSG00000117362. [Q96BI3-2]
DR   Ensembl; ENST00000369109; ENSP00000358105; ENSG00000117362. [Q96BI3-1]
DR   Ensembl; ENST00000414276; ENSP00000397473; ENSG00000117362. [Q96BI3-3]
DR   GeneID; 51107; -.
DR   KEGG; hsa:51107; -.
DR   UCSC; uc001ety.3; human. [Q96BI3-1]
DR   CTD; 51107; -.
DR   DisGeNET; 51107; -.
DR   EuPathDB; HostDB:ENSG00000117362.12; -.
DR   GeneCards; APH1A; -.
DR   HGNC; HGNC:29509; APH1A.
DR   HPA; CAB037272; -.
DR   MIM; 607629; gene.
DR   neXtProt; NX_Q96BI3; -.
DR   OpenTargets; ENSG00000117362; -.
DR   PharmGKB; PA142672599; -.
DR   eggNOG; KOG3972; Eukaryota.
DR   eggNOG; ENOG4111FIJ; LUCA.
DR   GeneTree; ENSGT00390000002049; -.
DR   HOGENOM; HOG000007541; -.
DR   HOVERGEN; HBG050541; -.
DR   InParanoid; Q96BI3; -.
DR   KO; K06172; -.
DR   OMA; WSVIFFN; -.
DR   OrthoDB; EOG091G0IH0; -.
DR   PhylomeDB; Q96BI3; -.
DR   TreeFam; TF314362; -.
DR   Reactome; R-HSA-1251985; Nuclear signaling by ERBB4.
DR   Reactome; R-HSA-193692; Regulated proteolysis of p75NTR.
DR   Reactome; R-HSA-1980148; Signaling by NOTCH3.
DR   Reactome; R-HSA-1980150; Signaling by NOTCH4.
DR   Reactome; R-HSA-205043; NRIF signals cell death from the nucleus.
DR   Reactome; R-HSA-2122948; Activated NOTCH1 Transmits Signal to the Nucleus.
DR   Reactome; R-HSA-2644606; Constitutive Signaling by NOTCH1 PEST Domain Mutants.
DR   Reactome; R-HSA-2894862; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants.
DR   Reactome; R-HSA-2979096; NOTCH2 Activation and Transmission of Signal to the Nucleus.
DR   Reactome; R-HSA-3928665; EPH-ephrin mediated repulsion of cells.
DR   SignaLink; Q96BI3; -.
DR   SIGNOR; Q96BI3; -.
DR   ChiTaRS; APH1A; human.
DR   GenomeRNAi; 51107; -.
DR   PRO; PR:Q96BI3; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000117362; -.
DR   CleanEx; HS_APH1A; -.
DR   ExpressionAtlas; Q96BI3; baseline and differential.
DR   Genevisible; Q96BI3; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:HGNC.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0070765; C:gamma-secretase complex; IDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HGNC.
DR   GO; GO:0032580; C:Golgi cisterna membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:HGNC.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0004175; F:endopeptidase activity; IBA:GO_Central.
DR   GO; GO:0042987; P:amyloid precursor protein catabolic process; IMP:UniProtKB.
DR   GO; GO:0042982; P:amyloid precursor protein metabolic process; IDA:UniProtKB.
DR   GO; GO:0034205; P:amyloid-beta formation; IMP:UniProtKB.
DR   GO; GO:0048013; P:ephrin receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0006509; P:membrane protein ectodomain proteolysis; IDA:HGNC.
DR   GO; GO:0031293; P:membrane protein intracellular domain proteolysis; IMP:UniProtKB.
DR   GO; GO:0001656; P:metanephros development; IEA:Ensembl.
DR   GO; GO:0007220; P:Notch receptor processing; IMP:UniProtKB.
DR   GO; GO:0007219; P:Notch signaling pathway; IBA:GO_Central.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome.
DR   GO; GO:0043085; P:positive regulation of catalytic activity; IDA:HGNC.
DR   GO; GO:0016485; P:protein processing; IDA:HGNC.
DR   InterPro; IPR009294; Aph-1.
DR   PANTHER; PTHR12889; PTHR12889; 1.
DR   Pfam; PF06105; Aph-1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome;
KW   Endoplasmic reticulum; Golgi apparatus; Membrane;
KW   Notch signaling pathway; Reference proteome; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1    265       Gamma-secretase subunit APH-1A.
FT                                /FTId=PRO_0000221050.
FT   TOPO_DOM      1      2       Lumenal. {ECO:0000269|PubMed:26280335,
FT                                ECO:0000305|PubMed:14593096}.
FT   TRANSMEM      3     23       Helical; Name=1.
FT                                {ECO:0000269|PubMed:26280335}.
FT   TOPO_DOM     24     31       Cytoplasmic.
FT                                {ECO:0000269|PubMed:26280335,
FT                                ECO:0000305|PubMed:14593096}.
FT   TRANSMEM     32     52       Helical; Name=2.
FT                                {ECO:0000269|PubMed:26280335}.
FT   TOPO_DOM     53     68       Lumenal. {ECO:0000269|PubMed:26280335,
FT                                ECO:0000305|PubMed:14593096}.
FT   TRANSMEM     69     89       Helical; Name=3.
FT                                {ECO:0000269|PubMed:26280335}.
FT   TOPO_DOM     90    118       Cytoplasmic.
FT                                {ECO:0000269|PubMed:26280335,
FT                                ECO:0000305|PubMed:14593096}.
FT   TRANSMEM    119    139       Helical; Name=4.
FT                                {ECO:0000269|PubMed:26280335}.
FT   TOPO_DOM    140    158       Lumenal. {ECO:0000269|PubMed:26280335,
FT                                ECO:0000305|PubMed:14593096}.
FT   TRANSMEM    159    179       Helical; Name=5.
FT                                {ECO:0000269|PubMed:26280335}.
FT   TOPO_DOM    180    186       Cytoplasmic.
FT                                {ECO:0000269|PubMed:26280335,
FT                                ECO:0000305|PubMed:14593096}.
FT   TRANSMEM    187    207       Helical; Name=6.
FT                                {ECO:0000269|PubMed:26280335}.
FT   TOPO_DOM    208    213       Lumenal. {ECO:0000269|PubMed:26280335,
FT                                ECO:0000305|PubMed:14593096}.
FT   TRANSMEM    214    234       Helical; Name=7.
FT                                {ECO:0000269|PubMed:26280335}.
FT   TOPO_DOM    235    265       Cytoplasmic.
FT                                {ECO:0000269|PubMed:26280335,
FT                                ECO:0000305|PubMed:14593096}.
FT   VAR_SEQ      39    120       AFFWLVSLLLASVVWFILVHVTDRSDARLQYGLLIFGAAVS
FT                                VLLQEVFRFAYYKLLKKADEGLASLSEDGRSPISIRQMAYV
FT                                -> RCSALPTTSCLI (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045424.
FT   VAR_SEQ     246    247       RR -> KD (in isoform 2).
FT                                {ECO:0000303|PubMed:10810093,
FT                                ECO:0000303|PubMed:12975309,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.2}.
FT                                /FTId=VSP_008355.
FT   VAR_SEQ     248    265       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:10810093,
FT                                ECO:0000303|PubMed:12975309,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.2}.
FT                                /FTId=VSP_008356.
FT   MUTAGEN     171    171       H->A: Impaired gamma-secretease assembly
FT                                and reduced proteolytic activity of the
FT                                gamma-secretase complex.
FT                                {ECO:0000269|PubMed:19369254}.
FT   MUTAGEN     197    197       H->A: Impaired gamma-secretease assembly
FT                                and reduced proteolytic activity of the
FT                                gamma-secretase complex.
FT                                {ECO:0000269|PubMed:19369254}.
FT   CONFLICT    236    236       L -> I (in Ref. 8; AAH01230).
FT                                {ECO:0000305}.
FT   HELIX         3     23       {ECO:0000244|PDB:5A63}.
FT   HELIX        29     60       {ECO:0000244|PDB:5A63}.
FT   HELIX        65    102       {ECO:0000244|PDB:5A63}.
FT   TURN        103    106       {ECO:0000244|PDB:5A63}.
FT   STRAND      107    109       {ECO:0000244|PDB:5A63}.
FT   HELIX       114    141       {ECO:0000244|PDB:5A63}.
FT   HELIX       156    184       {ECO:0000244|PDB:5A63}.
FT   HELIX       187    205       {ECO:0000244|PDB:5A63}.
FT   TURN        206    208       {ECO:0000244|PDB:5A63}.
FT   HELIX       210    231       {ECO:0000244|PDB:5A63}.
FT   HELIX       236    242       {ECO:0000244|PDB:5A63}.
SQ   SEQUENCE   265 AA;  28996 MW;  8E37984A1DECC263 CRC64;
     MGAAVFFGCT FVAFGPAFAL FLITVAGDPL RVIILVAGAF FWLVSLLLAS VVWFILVHVT
     DRSDARLQYG LLIFGAAVSV LLQEVFRFAY YKLLKKADEG LASLSEDGRS PISIRQMAYV
     SGLSFGIISG VFSVINILAD ALGPGVVGIH GDSPYYFLTS AFLTAAIILL HTFWGVVFFD
     ACERRRYWAL GLVVGSHLLT SGLTFLNPWY EASLLPIYAV TVSMGLWAFI TAGGSLRSIQ
     RSLLCRRQED SRVMVYSALR IPPED
//
ID   APH1C_MOUSE             Reviewed;         258 AA.
AC   Q9DCZ9; Q3U2R3;
DT   26-SEP-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   20-DEC-2017, entry version 108.
DE   RecName: Full=Putative gamma-secretase subunit APH-1C;
GN   Name=Aph1c;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J, and NOD; TISSUE=Kidney;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Potential subunit of the gamma-secretase complex, an
CC       endoprotease complex that catalyzes the intramembrane cleavage of
CC       integral proteins such as Notch receptors and APP (amyloid-beta
CC       precursor protein). {ECO:0000250}.
CC   -!- SUBUNIT: Potential component of the gamma-secretase complex.
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the APH-1 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK002310; BAB22004.1; -; mRNA.
DR   EMBL; AK155147; BAE33077.1; -; mRNA.
DR   EMBL; BC050923; AAH50923.1; -; mRNA.
DR   EMBL; BC063254; AAH63254.1; -; mRNA.
DR   CCDS; CCDS23308.1; -.
DR   RefSeq; NP_080950.1; NM_026674.3.
DR   UniGene; Mm.284229; -.
DR   ProteinModelPortal; Q9DCZ9; -.
DR   SMR; Q9DCZ9; -.
DR   STRING; 10090.ENSMUSP00000130359; -.
DR   TCDB; 9.B.47.1.1; the Gama-secretase (Gama-secretase) family.
DR   iPTMnet; Q9DCZ9; -.
DR   PhosphoSitePlus; Q9DCZ9; -.
DR   PaxDb; Q9DCZ9; -.
DR   PRIDE; Q9DCZ9; -.
DR   Ensembl; ENSMUST00000169282; ENSMUSP00000130359; ENSMUSG00000053040.
DR   GeneID; 68318; -.
DR   KEGG; mmu:68318; -.
DR   UCSC; uc009qfi.1; mouse.
DR   CTD; 68318; -.
DR   MGI; MGI:1915568; Aph1c.
DR   eggNOG; KOG3972; Eukaryota.
DR   eggNOG; ENOG4111FIJ; LUCA.
DR   GeneTree; ENSGT00390000002049; -.
DR   HOGENOM; HOG000007541; -.
DR   HOVERGEN; HBG050541; -.
DR   InParanoid; Q9DCZ9; -.
DR   KO; K06172; -.
DR   OMA; TINPYEK; -.
DR   OrthoDB; EOG091G0IH0; -.
DR   TreeFam; TF314362; -.
DR   Reactome; R-MMU-1251985; Nuclear signaling by ERBB4.
DR   Reactome; R-MMU-193692; Regulated proteolysis of p75NTR.
DR   Reactome; R-MMU-1980148; Signaling by NOTCH3.
DR   Reactome; R-MMU-1980150; Signaling by NOTCH4.
DR   Reactome; R-MMU-205043; NRIF signals cell death from the nucleus.
DR   Reactome; R-MMU-3928665; EPH-ephrin mediated repulsion of cells.
DR   ChiTaRS; Aph1c; mouse.
DR   PRO; PR:Q9DCZ9; -.
DR   Proteomes; UP000000589; Chromosome 9.
DR   Bgee; ENSMUSG00000053040; -.
DR   ExpressionAtlas; Q9DCZ9; baseline and differential.
DR   Genevisible; Q9DCZ9; MM.
DR   GO; GO:0005783; C:endoplasmic reticulum; IBA:GO_Central.
DR   GO; GO:0070765; C:gamma-secretase complex; IBA:GO_Central.
DR   GO; GO:0016021; C:integral component of membrane; ISA:MGI.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0004175; F:endopeptidase activity; IGI:MGI.
DR   GO; GO:0008233; F:peptidase activity; ISA:MGI.
DR   GO; GO:0001656; P:metanephros development; IMP:MGI.
DR   GO; GO:0007220; P:Notch receptor processing; IBA:GO_Central.
DR   GO; GO:0007219; P:Notch signaling pathway; IBA:GO_Central.
DR   GO; GO:0043085; P:positive regulation of catalytic activity; IEA:InterPro.
DR   GO; GO:0016485; P:protein processing; IGI:MGI.
DR   InterPro; IPR009294; Aph-1.
DR   PANTHER; PTHR12889; PTHR12889; 1.
DR   Pfam; PF06105; Aph-1; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Membrane; Notch signaling pathway;
KW   Reference proteome; Transmembrane; Transmembrane helix.
FT   CHAIN         1    258       Putative gamma-secretase subunit APH-1C.
FT                                /FTId=PRO_0000221055.
FT   TRANSMEM      5     25       Helical; Name=1. {ECO:0000255}.
FT   TRANSMEM     32     52       Helical; Name=2. {ECO:0000255}.
FT   TRANSMEM     71     91       Helical; Name=3. {ECO:0000255}.
FT   TRANSMEM    116    136       Helical; Name=4. {ECO:0000255}.
FT   TRANSMEM    161    181       Helical; Name=5. {ECO:0000255}.
FT   TRANSMEM    187    207       Helical; Name=6. {ECO:0000255}.
FT   TRANSMEM    214    234       Helical; Name=7. {ECO:0000255}.
SQ   SEQUENCE   258 AA;  29045 MW;  2AC2C475735F8246 CRC64;
     MTLPVFFGCA FIAFGPAFAL YLFTIATDPL RVIFLIAGAF FWLVSLLLSS MFWFLVRVIT
     NNRDESVQNY LLIFGALLSV CIQELFRLAY YKLLKKASEG LKSINPEEDI APSMRLLAYV
     SGLGFGIMSG VFSFVNTLSN SLGPGTVGIH GDSPQFFLNS AFMTLVVIML HVFWGVVFFD
     GCEKNKWYTL LTVLLTHLVV STQTFLSPYY EVNLVTAYII MVLMGIWAFY VAGGSCRSLK
     FCLLCQDKDF LLYNQRSR
//
ID   PEN2_ARATH              Reviewed;         146 AA.
AC   Q9FY84;
DT   26-SEP-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   05-JUL-2017, entry version 93.
DE   RecName: Full=Probable gamma-secretase subunit PEN-2;
GN   OrderedLocusNames=At5g09310; ORFNames=T5E8.110;
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; eudicotyledons; Gunneridae;
OC   Pentapetalae; rosids; malvids; Brassicales; Brassicaceae; Camelineae;
OC   Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=11130714; DOI=10.1038/35048507;
RA   Tabata S., Kaneko T., Nakamura Y., Kotani H., Kato T., Asamizu E.,
RA   Miyajima N., Sasamoto S., Kimura T., Hosouchi T., Kawashima K.,
RA   Kohara M., Matsumoto M., Matsuno A., Muraki A., Nakayama S.,
RA   Nakazaki N., Naruo K., Okumura S., Shinpo S., Takeuchi C., Wada T.,
RA   Watanabe A., Yamada M., Yasuda M., Sato S., de la Bastide M.,
RA   Huang E., Spiegel L., Gnoj L., O'Shaughnessy A., Preston R.,
RA   Habermann K., Murray J., Johnson D., Rohlfing T., Nelson J.,
RA   Stoneking T., Pepin K., Spieth J., Sekhon M., Armstrong J., Becker M.,
RA   Belter E., Cordum H., Cordes M., Courtney L., Courtney W., Dante M.,
RA   Du H., Edwards J., Fryman J., Haakensen B., Lamar E., Latreille P.,
RA   Leonard S., Meyer R., Mulvaney E., Ozersky P., Riley A., Strowmatt C.,
RA   Wagner-McPherson C., Wollam A., Yoakum M., Bell M., Dedhia N.,
RA   Parnell L., Shah R., Rodriguez M., Hoon See L., Vil D., Baker J.,
RA   Kirchoff K., Toth K., King L., Bahret A., Miller B., Marra M.A.,
RA   Martienssen R., McCombie W.R., Wilson R.K., Murphy G., Bancroft I.,
RA   Volckaert G., Wambutt R., Duesterhoeft A., Stiekema W., Pohl T.,
RA   Entian K.-D., Terryn N., Hartley N., Bent E., Johnson S.,
RA   Langham S.-A., McCullagh B., Robben J., Grymonprez B., Zimmermann W.,
RA   Ramsperger U., Wedler H., Balke K., Wedler E., Peters S.,
RA   van Staveren M., Dirkse W., Mooijman P., Klein Lankhorst R.,
RA   Weitzenegger T., Bothe G., Rose M., Hauf J., Berneiser S., Hempel S.,
RA   Feldpausch M., Lamberth S., Villarroel R., Gielen J., Ardiles W.,
RA   Bents O., Lemcke K., Kolesov G., Mayer K.F.X., Rudd S., Schoof H.,
RA   Schueller C., Zaccaria P., Mewes H.-W., Bevan M., Fransz P.F.;
RT   "Sequence and analysis of chromosome 5 of the plant Arabidopsis
RT   thaliana.";
RL   Nature 408:823-826(2000).
RN   [2]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RG   The Arabidopsis Information Portal (Araport);
RL   Submitted (MAY-2016) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=11910074; DOI=10.1126/science.1071006;
RA   Seki M., Narusaka M., Kamiya A., Ishida J., Satou M., Sakurai T.,
RA   Nakajima M., Enju A., Akiyama K., Oono Y., Muramatsu M.,
RA   Hayashizaki Y., Kawai J., Carninci P., Itoh M., Ishii Y., Arakawa T.,
RA   Shibata K., Shinagawa A., Shinozaki K.;
RT   "Functional annotation of a full-length Arabidopsis cDNA collection.";
RL   Science 296:141-145(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=14593172; DOI=10.1126/science.1088305;
RA   Yamada K., Lim J., Dale J.M., Chen H., Shinn P., Palm C.J.,
RA   Southwick A.M., Wu H.C., Kim C.J., Nguyen M., Pham P.K., Cheuk R.F.,
RA   Karlin-Newmann G., Liu S.X., Lam B., Sakano H., Wu T., Yu G.,
RA   Miranda M., Quach H.L., Tripp M., Chang C.H., Lee J.M., Toriumi M.J.,
RA   Chan M.M., Tang C.C., Onodera C.S., Deng J.M., Akiyama K., Ansari Y.,
RA   Arakawa T., Banh J., Banno F., Bowser L., Brooks S.Y., Carninci P.,
RA   Chao Q., Choy N., Enju A., Goldsmith A.D., Gurjal M., Hansen N.F.,
RA   Hayashizaki Y., Johnson-Hopson C., Hsuan V.W., Iida K., Karnes M.,
RA   Khan S., Koesema E., Ishida J., Jiang P.X., Jones T., Kawai J.,
RA   Kamiya A., Meyers C., Nakajima M., Narusaka M., Seki M., Sakurai T.,
RA   Satou M., Tamse R., Vaysberg M., Wallender E.K., Wong C., Yamamura Y.,
RA   Yuan S., Shinozaki K., Davis R.W., Theologis A., Ecker J.R.;
RT   "Empirical analysis of transcriptional activity in the Arabidopsis
RT   genome.";
RL   Science 302:842-846(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Brover V.V., Troukhan M.E., Alexandrov N.A., Lu Y.-P., Flavell R.B.,
RA   Feldmann K.A.;
RT   "Full-length cDNA from Arabidopsis thaliana.";
RL   Submitted (MAR-2002) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Probable subunit of the gamma-secretase complex, an
CC       endoprotease complex that catalyzes the intramembrane cleavage of
CC       integral membrane proteins such as Notch receptors. {ECO:0000250}.
CC   -!- SUBUNIT: Probable component of the gamma-secretase complex, a
CC       complex composed of a presenilin homodimer, nicastrin, APH1 and
CC       PEN2. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the PEN-2 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL391712; CAC05457.1; -; Genomic_DNA.
DR   EMBL; CP002688; AED91373.1; -; Genomic_DNA.
DR   EMBL; AK118667; BAC43262.1; -; mRNA.
DR   EMBL; BT009650; AAP75800.1; -; mRNA.
DR   EMBL; AY088593; AAM66122.1; -; mRNA.
DR   RefSeq; NP_196493.1; NM_120967.5.
DR   UniGene; At.32532; -.
DR   UniGene; At.69559; -.
DR   ProteinModelPortal; Q9FY84; -.
DR   SMR; Q9FY84; -.
DR   BioGrid; 16068; 3.
DR   STRING; 3702.AT5G09310.1; -.
DR   PaxDb; Q9FY84; -.
DR   EnsemblPlants; AT5G09310.1; AT5G09310.1; AT5G09310.
DR   GeneID; 830790; -.
DR   Gramene; AT5G09310.1; AT5G09310.1; AT5G09310.
DR   KEGG; ath:AT5G09310; -.
DR   Araport; AT5G09310; -.
DR   TAIR; locus:2184712; AT5G09310.
DR   eggNOG; KOG3402; Eukaryota.
DR   eggNOG; ENOG4111W09; LUCA.
DR   HOGENOM; HOG000006264; -.
DR   InParanoid; Q9FY84; -.
DR   KO; K06170; -.
DR   OMA; NPIRNRN; -.
DR   OrthoDB; EOG09360SVN; -.
DR   PhylomeDB; Q9FY84; -.
DR   PRO; PR:Q9FY84; -.
DR   Proteomes; UP000006548; Chromosome 5.
DR   ExpressionAtlas; Q9FY84; baseline and differential.
DR   Genevisible; Q9FY84; AT.
DR   GO; GO:0070765; C:gamma-secretase complex; IBA:GO_Central.
DR   GO; GO:0005798; C:Golgi-associated vesicle; IDA:TAIR.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW.
DR   InterPro; IPR019379; Gamma_Secretase_Asp_P_PEN2.
DR   PANTHER; PTHR16318; PTHR16318; 1.
DR   Pfam; PF10251; PEN-2; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Membrane; Notch signaling pathway;
KW   Reference proteome; Transmembrane; Transmembrane helix.
FT   CHAIN         1    146       Probable gamma-secretase subunit PEN-2.
FT                                /FTId=PRO_0000190905.
FT   TOPO_DOM      1     61       Lumenal. {ECO:0000255}.
FT   TRANSMEM     62     82       Helical. {ECO:0000255}.
FT   TOPO_DOM     83     98       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     99    119       Helical. {ECO:0000255}.
FT   TOPO_DOM    120    146       Lumenal. {ECO:0000255}.
SQ   SEQUENCE   146 AA;  16489 MW;  9BEE1E7E686E58AF CRC64;
     MEATRSDDPS LNPIRNRNPN PNPNPNPLST IISSAQVWPT IDGPLGLTEE ASVDYARRFY
     KFGFALLPWL WFVNCFYFWP VLRHSRAFPQ IRNYVVRSAI GFSVFTALLS AWALTFSIGG
     EQLFGPLYDK LVMYNVADRL GLSGLA
//
ID   DLL4_MOUSE              Reviewed;         686 AA.
AC   Q9JI71; Q9DBU9; Q9JHZ7;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   27-JUL-2011, sequence version 2.
DT   22-NOV-2017, entry version 153.
DE   RecName: Full=Delta-like protein 4;
DE   AltName: Full=Drosophila Delta homolog 4;
DE            Short=Delta4;
DE   Flags: Precursor;
GN   Name=Dll4;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Adipose tissue;
RX   PubMed=10837024;
RA   Shutter J.R., Scully S., Fan W., Richards W.G., Kitajewski J.,
RA   Deblandre G.A., Kintner C.R., Stark K.L.;
RT   "Dll4, a novel Notch ligand expressed in arterial endothelium.";
RL   Genes Dev. 14:1313-1318(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND FUNCTION.
RX   PubMed=11134954; DOI=10.1093/oxfordjournals.jbchem.a002832;
RA   Yoneya T., Tahara T., Nagao K., Yamada Y., Yamamoto T., Miyatani S.,
RA   Nishikawa M.;
RT   "Molecular cloning of Delta-4, a new mouse and human Notch ligand.";
RL   J. Biochem. 129:27-34(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=129/Ola;
RA   Mailhos C., Lewis J., Ish-Horowicz D.;
RT   "A novel Notch ligand expressed in embryonic and tumour vasculation.";
RL   Submitted (MAY-2000) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Lung;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S.,
RA   She X., Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W.,
RA   Kapustin Y., Meric P., Maglott D., Birtle Z., Marques A.C., Graves T.,
RA   Zhou S., Teague B., Potamousis K., Churas C., Place M., Herschleb J.,
RA   Runnheim R., Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z.,
RA   Lindblad-Toh K., Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of
RT   the mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J, and Czech II; TISSUE=Brain, and Mammary tumor;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION IN RETINAL DEVELOPMENT, TISSUE SPECIFICITY, DEVELOPMENTAL
RP   STAGE, AND DISRUPTION PHENOTYPE.
RX   PubMed=22323600; DOI=10.1073/pnas.1115767109;
RA   Luo H., Jin K., Xie Z., Qiu F., Li S., Zou M., Cai L., Hozumi K.,
RA   Shima D.T., Xiang M.;
RT   "Forkhead box N4 (Foxn4) activates Dll4-Notch signaling to suppress
RT   photoreceptor cell fates of early retinal progenitors.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:E553-E562(2012).
CC   -!- FUNCTION: Involved in the Notch signaling pathway as Notch ligand
CC       (PubMed:11134954). Activates NOTCH1 and NOTCH4. Involved in
CC       angiogenesis; negatively regulates endothelial cell proliferation
CC       and migration and angiogenic sprouting (By similarity). Essential
CC       for retinal progenitor proliferation. Required for suppressing rod
CC       fates in late retinal progenitors as well as for proper generation
CC       of other retinal cell types (PubMed:22323600). During spinal cord
CC       neurogenesis, inhibits V2a interneuron fate (By similarity).
CC       {ECO:0000250|UniProtKB:Q9NR61, ECO:0000269|PubMed:11134954,
CC       ECO:0000269|PubMed:22323600}.
CC   -!- SUBUNIT: Interacts with NOTCH4. Interacts (via N-terminal DSL and
CC       MNNL domains) with NOTCH1 (via EGF-like domains).
CC       {ECO:0000250|UniProtKB:D3ZHH1}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Single-pass
CC       type I membrane protein {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Expressed in vascular endothelium. Expressed
CC       in retina at least during embryogenesis.
CC       {ECO:0000269|PubMed:22323600}.
CC   -!- DEVELOPMENTAL STAGE: At 14.5, expressed within the retina outer
CC       neuroblastic layer. {ECO:0000269|PubMed:22323600}.
CC   -!- DISRUPTION PHENOTYPE: Conditional knockdowns in retinal
CC       progenitors have thinner retinas with occasional regions
CC       abnormally organized into rosette-like structures in the outer
CC       nuclear layer and an optic nerve with a reduced diameter.
CC       {ECO:0000269|PubMed:22323600}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF253469; AAF76428.1; -; mRNA.
DR   EMBL; AF273454; AAF78785.1; -; mRNA.
DR   EMBL; AB043893; BAB18580.1; -; mRNA.
DR   EMBL; AK004739; BAB23520.1; -; mRNA.
DR   EMBL; AL929318; CAM25342.1; -; Genomic_DNA.
DR   EMBL; BC042497; AAH42497.1; -; mRNA.
DR   EMBL; BC049130; AAH49130.1; -; mRNA.
DR   CCDS; CCDS16600.1; -.
DR   PIR; JC7569; JC7569.
DR   RefSeq; NP_062327.2; NM_019454.3.
DR   UniGene; Mm.143719; -.
DR   ProteinModelPortal; Q9JI71; -.
DR   SMR; Q9JI71; -.
DR   BioGrid; 207669; 3.
DR   IntAct; Q9JI71; 4.
DR   STRING; 10090.ENSMUSP00000099575; -.
DR   iPTMnet; Q9JI71; -.
DR   PhosphoSitePlus; Q9JI71; -.
DR   PaxDb; Q9JI71; -.
DR   PRIDE; Q9JI71; -.
DR   Ensembl; ENSMUST00000102517; ENSMUSP00000099575; ENSMUSG00000027314.
DR   GeneID; 54485; -.
DR   KEGG; mmu:54485; -.
DR   UCSC; uc008ltr.2; mouse.
DR   CTD; 54567; -.
DR   MGI; MGI:1859388; Dll4.
DR   eggNOG; KOG1217; Eukaryota.
DR   eggNOG; ENOG410XP6K; LUCA.
DR   GeneTree; ENSGT00810000125346; -.
DR   HOGENOM; HOG000267024; -.
DR   HOVERGEN; HBG007139; -.
DR   InParanoid; Q9JI71; -.
DR   KO; K06051; -.
DR   OMA; FNGATCY; -.
DR   OrthoDB; EOG091G07YQ; -.
DR   TreeFam; TF351835; -.
DR   Reactome; R-MMU-1980148; Signaling by NOTCH3.
DR   Reactome; R-MMU-1980150; Signaling by NOTCH4.
DR   Reactome; R-MMU-2979096; NOTCH2 Activation and Transmission of Signal to the Nucleus.
DR   PRO; PR:Q9JI71; -.
DR   Proteomes; UP000000589; Chromosome 2.
DR   Bgee; ENSMUSG00000027314; -.
DR   CleanEx; MM_DLL4; -.
DR   Genevisible; Q9JI71; MM.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISS:MGI.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0005112; F:Notch binding; IDA:MGI.
DR   GO; GO:0001525; P:angiogenesis; IMP:MGI.
DR   GO; GO:0072554; P:blood vessel lumenization; IMP:BHF-UCL.
DR   GO; GO:0001974; P:blood vessel remodeling; IMP:BHF-UCL.
DR   GO; GO:0001569; P:branching involved in blood vessel morphogenesis; IMP:BHF-UCL.
DR   GO; GO:0003209; P:cardiac atrium morphogenesis; IMP:BHF-UCL.
DR   GO; GO:0003208; P:cardiac ventricle morphogenesis; IMP:BHF-UCL.
DR   GO; GO:0044344; P:cellular response to fibroblast growth factor stimulus; ISS:UniProtKB.
DR   GO; GO:0035924; P:cellular response to vascular endothelial growth factor stimulus; ISS:UniProtKB.
DR   GO; GO:0035912; P:dorsal aorta morphogenesis; IMP:BHF-UCL.
DR   GO; GO:0043537; P:negative regulation of blood vessel endothelial cell migration; IDA:MGI.
DR   GO; GO:1903588; P:negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis; ISO:MGI.
DR   GO; GO:0090051; P:negative regulation of cell migration involved in sprouting angiogenesis; ISS:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; ISS:UniProtKB.
DR   GO; GO:0010596; P:negative regulation of endothelial cell migration; ISS:UniProtKB.
DR   GO; GO:0010629; P:negative regulation of gene expression; ISO:MGI.
DR   GO; GO:0045746; P:negative regulation of Notch signaling pathway; IDA:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL.
DR   GO; GO:0061314; P:Notch signaling involved in heart development; IMP:BHF-UCL.
DR   GO; GO:0007219; P:Notch signaling pathway; IDA:MGI.
DR   GO; GO:0003344; P:pericardium morphogenesis; IMP:BHF-UCL.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISO:MGI.
DR   GO; GO:2000179; P:positive regulation of neural precursor cell proliferation; IMP:UniProtKB.
DR   GO; GO:0045747; P:positive regulation of Notch signaling pathway; IDA:UniProtKB.
DR   GO; GO:0061074; P:regulation of neural retina development; IMP:UniProtKB.
DR   GO; GO:0050767; P:regulation of neurogenesis; IMP:MGI.
DR   GO; GO:0030217; P:T cell differentiation; IDA:UniProtKB.
DR   GO; GO:0060579; P:ventral spinal cord interneuron fate commitment; ISS:UniProtKB.
DR   GO; GO:0003222; P:ventricular trabecula myocardium morphogenesis; IMP:BHF-UCL.
DR   GO; GO:0007601; P:visual perception; IEA:UniProtKB-KW.
DR   InterPro; IPR001774; DSL.
DR   InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR000152; EGF-type_Asp/Asn_hydroxyl_site.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   InterPro; IPR011651; Notch_ligand_N.
DR   Pfam; PF01414; DSL; 1.
DR   Pfam; PF00008; EGF; 4.
DR   Pfam; PF12661; hEGF; 1.
DR   Pfam; PF07657; MNNL; 1.
DR   SMART; SM00051; DSL; 1.
DR   SMART; SM00181; EGF; 9.
DR   SMART; SM00179; EGF_CA; 6.
DR   SUPFAM; SSF57184; SSF57184; 1.
DR   PROSITE; PS00010; ASX_HYDROXYL; 1.
DR   PROSITE; PS51051; DSL; 1.
DR   PROSITE; PS00022; EGF_1; 8.
DR   PROSITE; PS01186; EGF_2; 7.
DR   PROSITE; PS50026; EGF_3; 8.
PE   1: Evidence at protein level;
KW   Angiogenesis; Cell membrane; Complete proteome; Developmental protein;
KW   Differentiation; Disulfide bond; EGF-like domain; Glycoprotein;
KW   Membrane; Neurogenesis; Notch signaling pathway; Reference proteome;
KW   Repeat; Sensory transduction; Signal; Transmembrane;
KW   Transmembrane helix; Vision.
FT   SIGNAL        1     26       {ECO:0000255}.
FT   CHAIN        27    686       Delta-like protein 4.
FT                                /FTId=PRO_0000007513.
FT   TOPO_DOM     27    532       Extracellular. {ECO:0000255}.
FT   TRANSMEM    533    553       Helical. {ECO:0000255}.
FT   TOPO_DOM    554    686       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      174    218       DSL. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00377}.
FT   DOMAIN      219    252       EGF-like 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      253    283       EGF-like 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      285    323       EGF-like 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      325    361       EGF-like 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      364    401       EGF-like 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      403    439       EGF-like 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      441    477       EGF-like 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      481    519       EGF-like 8. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   REGION      186    188       Interaction with Notch1.
FT                                {ECO:0000250|UniProtKB:D3ZHH1}.
FT   REGION      192    196       Interaction with Notch1.
FT                                {ECO:0000250|UniProtKB:D3ZHH1}.
FT   SITE        111    111       Interaction with Notch1.
FT                                {ECO:0000250|UniProtKB:D3ZHH1}.
FT   SITE        217    217       Interaction with Notch1.
FT                                {ECO:0000250|UniProtKB:D3ZHH1}.
FT   CARBOHYD     79     79       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000250|UniProtKB:D3ZHH1}.
FT   CARBOHYD    109    109       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000250|UniProtKB:D3ZHH1}.
FT   CARBOHYD    162    162       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000250|UniProtKB:D3ZHH1}.
FT   CARBOHYD    297    297       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    394    394       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     51     55       {ECO:0000250|UniProtKB:D3ZHH1}.
FT   DISULFID     62     75       {ECO:0000250|UniProtKB:D3ZHH1}.
FT   DISULFID    176    185       {ECO:0000250|UniProtKB:D3ZHH1,
FT                                ECO:0000255|PROSITE-ProRule:PRU00377}.
FT   DISULFID    189    201       {ECO:0000250|UniProtKB:D3ZHH1,
FT                                ECO:0000255|PROSITE-ProRule:PRU00377}.
FT   DISULFID    209    218       {ECO:0000250|UniProtKB:D3ZHH1,
FT                                ECO:0000255|PROSITE-ProRule:PRU00377}.
FT   DISULFID    223    234       {ECO:0000250|UniProtKB:D3ZHH1,
FT                                ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    227    240       {ECO:0000250|UniProtKB:D3ZHH1,
FT                                ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    242    251       {ECO:0000250|UniProtKB:D3ZHH1,
FT                                ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    254    265       {ECO:0000250|UniProtKB:D3ZHH1}.
FT   DISULFID    260    271       {ECO:0000250|UniProtKB:D3ZHH1}.
FT   DISULFID    273    282       {ECO:0000250|UniProtKB:D3ZHH1,
FT                                ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    289    301       {ECO:0000250}.
FT   DISULFID    295    311       {ECO:0000250}.
FT   DISULFID    313    322       {ECO:0000250}.
FT   DISULFID    329    340       {ECO:0000250}.
FT   DISULFID    334    349       {ECO:0000250}.
FT   DISULFID    351    360       {ECO:0000250}.
FT   DISULFID    367    378       {ECO:0000250}.
FT   DISULFID    372    389       {ECO:0000250}.
FT   DISULFID    391    400       {ECO:0000250}.
FT   DISULFID    407    418       {ECO:0000250}.
FT   DISULFID    412    427       {ECO:0000250}.
FT   DISULFID    429    438       {ECO:0000250}.
FT   DISULFID    445    456       {ECO:0000250}.
FT   DISULFID    450    465       {ECO:0000250}.
FT   DISULFID    467    476       {ECO:0000250}.
FT   DISULFID    485    496       {ECO:0000250}.
FT   DISULFID    490    507       {ECO:0000250}.
FT   DISULFID    509    518       {ECO:0000250}.
FT   CONFLICT    419    419       Q -> L (in Ref. 1; AAF76428 and 3;
FT                                AAF78785). {ECO:0000305}.
FT   CONFLICT    527    528       SF -> CS (in Ref. 3; AAF78785).
FT                                {ECO:0000305}.
FT   CONFLICT    627    627       G -> S (in Ref. 1; AAF76428 and 3;
FT                                AAF78785). {ECO:0000305}.
FT   CONFLICT    639    649       LGEKVPLRLHS -> IGQGATSVTH (in Ref. 3;
FT                                AAF78785). {ECO:0000305}.
SQ   SEQUENCE   686 AA;  74991 MW;  E7DD4FC15C4AFFBA CRC64;
     MTPASRSACR WALLLLAVLW PQQRAAGSGI FQLRLQEFVN QRGMLANGQS CEPGCRTFFR
     ICLKHFQATF SEGPCTFGNV STPVLGTNSF VVRDKNSGSG RNPLQLPFNF TWPGTFSLNI
     QAWHTPGDDL RPETSPGNSL ISQIIIQGSL AVGKIWRTDE QNDTLTRLSY SYRVICSDNY
     YGESCSRLCK KRDDHFGHYE CQPDGSLSCL PGWTGKYCDQ PICLSGCHEQ NGYCSKPDEC
     ICRPGWQGRL CNECIPHNGC RHGTCSIPWQ CACDEGWGGL FCDQDLNYCT HHSPCKNGST
     CSNSGPKGYT CTCLPGYTGE HCELGLSKCA SNPCRNGGSC KDQENSYHCL CPPGYYGQHC
     EHSTLTCADS PCFNGGSCRE RNQGSSYACE CPPNFTGSNC EKKVDRCTSN PCANGGQCQN
     RGPSRTCRCR PGFTGTHCEL HISDCARSPC AHGGTCHDLE NGPVCTCPAG FSGRRCEVRI
     THDACASGPC FNGATCYTGL SPNNFVCNCP YGFVGSRCEF PVGLPPSFPW VAVSLGVGLV
     VLLVLLVMVV VAVRQLRLRR PDDESREAMN NLSDFQKDNL IPAAQLKNTN QKKELEVDCG
     LDKSNCGKLQ NHTLDYNLAP GLLGRGGMPG KYPHSDKSLG EKVPLRLHSE KPECRISAIC
     SPRDSMYQSV CLISEERNEC VIATEV
//
ID   DLL4_HUMAN              Reviewed;         685 AA.
AC   Q9NR61; Q3KP23; Q9NQT9;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   22-NOV-2017, entry version 162.
DE   RecName: Full=Delta-like protein 4;
DE   AltName: Full=Drosophila Delta homolog 4;
DE            Short=Delta4;
DE   Flags: Precursor;
GN   Name=DLL4; ORFNames=UNQ1895/PRO4341;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=10837024;
RA   Shutter J.R., Scully S., Fan W., Richards W.G., Kitajewski J.,
RA   Deblandre G.A., Kintner C.R., Stark K.L.;
RT   "Dll4, a novel Notch ligand expressed in arterial endothelium.";
RL   Genes Dev. 14:1313-1318(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Sakano S.;
RT   "Human Delta-2, Notch ligand gene.";
RL   Submitted (JAN-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND FUNCTION.
RX   PubMed=11134954; DOI=10.1093/oxfordjournals.jbchem.a002832;
RA   Yoneya T., Tahara T., Nagao K., Yamada Y., Yamamoto T., Miyatani S.,
RA   Nishikawa M.;
RT   "Molecular cloning of Delta-4, a new mouse and human Notch ligand.";
RL   J. Biochem. 129:27-34(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 27-41.
RX   PubMed=15340161; DOI=10.1110/ps.04682504;
RA   Zhang Z., Henzel W.J.;
RT   "Signal peptide prediction based on analysis of experimentally
RT   verified cleavage sites.";
RL   Protein Sci. 13:2819-2824(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 33-685.
RC   TISSUE=Placenta;
RA   Mailhos C., Modlich U., Lewis J., Harris A., Bicknell R.,
RA   Ish-Horowicz D.;
RT   "A novel Delta gene expressed in embryonic and tumour vasculature.";
RL   Submitted (JUN-2000) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   FUNCTION IN NEUROGENESIS.
RX   PubMed=17728344; DOI=10.1242/dev.005868;
RA   Del Barrio M.G., Taveira-Marques R., Muroyama Y., Yuk D.I., Li S.,
RA   Wines-Samuelson M., Shen J., Smith H.K., Xiang M., Rowitch D.,
RA   Richardson W.D.;
RT   "A regulatory network involving Foxn4, Mash1 and delta-like 4/Notch1
RT   generates V2a and V2b spinal interneurons from a common progenitor
RT   pool.";
RL   Development 134:3427-3436(2007).
RN   [9]
RP   FUNCTION IN ANGIOGENESIS.
RX   PubMed=20616313; DOI=10.1161/CIRCRESAHA.110.217257;
RA   Brutsch R., Liebler S.S., Wustehube J., Bartol A., Herberich S.E.,
RA   Adam M.G., Telzerow A., Augustin H.G., Fischer A.;
RT   "Integrin cytoplasmic domain-associated protein-1 attenuates sprouting
RT   angiogenesis.";
RL   Circ. Res. 107:592-601(2010).
RN   [10]
RP   INVOLVEMENT IN AOS6, AND VARIANTS AOS6 PRO-121; CYS-186; LEU-195;
RP   THR-267; ARG-390; TYR-390 AND TRP-455.
RX   PubMed=26299364; DOI=10.1016/j.ajhg.2015.07.015;
RA   Meester J.A., Southgate L., Stittrich A.B., Venselaar H.,
RA   Beekmans S.J., den Hollander N., Bijlsma E.K.,
RA   Helderman-van den Enden A., Verheij J.B., Glusman G., Roach J.C.,
RA   Lehman A., Patel M.S., de Vries B.B., Ruivenkamp C., Itin P.,
RA   Prescott K., Clarke S., Trembath R., Zenker M., Sukalo M.,
RA   Van Laer L., Loeys B., Wuyts W.;
RT   "Heterozygous loss-of-function mutations in DLL4 cause Adams-Oliver
RT   syndrome.";
RL   Am. J. Hum. Genet. 97:475-482(2015).
CC   -!- FUNCTION: Involved in the Notch signaling pathway as Notch ligand
CC       (PubMed:11134954). Activates NOTCH1 and NOTCH4. Involved in
CC       angiogenesis; negatively regulates endothelial cell proliferation
CC       and migration and angiogenic sprouting (PubMed:20616313).
CC       Essential for retinal progenitor proliferation. Required for
CC       suppressing rod fates in late retinal progenitors as well as for
CC       proper generation of other retinal cell types (By similarity).
CC       During spinal cord neurogenesis, inhibits V2a interneuron fate
CC       (PubMed:17728344). {ECO:0000250|UniProtKB:Q9JI71,
CC       ECO:0000269|PubMed:11134954, ECO:0000269|PubMed:17728344,
CC       ECO:0000269|PubMed:20616313}.
CC   -!- SUBUNIT: Interacts with NOTCH4. Interacts (via N-terminal DSL and
CC       MNNL domains) with NOTCH1 (via EGF-like domains).
CC       {ECO:0000250|UniProtKB:D3ZHH1}.
CC   -!- INTERACTION:
CC       P57105:SYNJ2BP; NbExp=3; IntAct=EBI-11700027, EBI-1049004;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Single-pass
CC       type I membrane protein {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Expressed in vascular endothelium.
CC   -!- DOMAIN: The Delta-Serrate-Lag2 (DSL) domain is required for
CC       binding to the Notch receptor.
CC   -!- DISEASE: Adams-Oliver syndrome 6 (AOS6) [MIM:616589]: A form of
CC       Adams-Oliver syndrome, a disorder characterized by the congenital
CC       absence of skin (aplasia cutis congenita) in combination with
CC       transverse limb defects. Aplasia cutis congenita can be located
CC       anywhere on the body, but in the vast majority of the cases, it is
CC       present on the posterior parietal region where it is often
CC       associated with an underlying defect of the parietal bones. Limb
CC       abnormalities are typically limb truncation defects affecting the
CC       distal phalanges or entire digits (true ectrodactyly). Only
CC       rarely, metatarsals/metacarpals or more proximal limb structures
CC       are also affected. Apart from transverse limb defects, syndactyly,
CC       most commonly of second and third toes, can also be observed. The
CC       clinical features are highly variable and can also include
CC       cardiovascular malformations, brain abnormalities and vascular
CC       defects such as cutis marmorata and dilated scalp veins.
CC       {ECO:0000269|PubMed:26299364}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF253468; AAF76427.1; -; mRNA.
DR   EMBL; AB036931; BAB16085.1; -; mRNA.
DR   EMBL; AB043894; BAB18581.1; -; mRNA.
DR   EMBL; AY358894; AAQ89253.1; -; mRNA.
DR   EMBL; BC106950; AAI06951.1; -; mRNA.
DR   EMBL; AF279305; AAF81912.1; -; mRNA.
DR   CCDS; CCDS45232.1; -.
DR   PIR; JC7570; JC7570.
DR   RefSeq; NP_061947.1; NM_019074.3.
DR   UniGene; Hs.511076; -.
DR   PDB; 5MVX; X-ray; 2.17 A; A=27-325.
DR   PDBsum; 5MVX; -.
DR   ProteinModelPortal; Q9NR61; -.
DR   SMR; Q9NR61; -.
DR   IntAct; Q9NR61; 1.
DR   STRING; 9606.ENSP00000249749; -.
DR   ChEMBL; CHEMBL3712916; -.
DR   iPTMnet; Q9NR61; -.
DR   PhosphoSitePlus; Q9NR61; -.
DR   BioMuta; DLL4; -.
DR   DMDM; 13431490; -.
DR   EPD; Q9NR61; -.
DR   PaxDb; Q9NR61; -.
DR   PeptideAtlas; Q9NR61; -.
DR   PRIDE; Q9NR61; -.
DR   Ensembl; ENST00000249749; ENSP00000249749; ENSG00000128917.
DR   GeneID; 54567; -.
DR   KEGG; hsa:54567; -.
DR   UCSC; uc001zng.3; human.
DR   CTD; 54567; -.
DR   DisGeNET; 54567; -.
DR   EuPathDB; HostDB:ENSG00000128917.6; -.
DR   GeneCards; DLL4; -.
DR   HGNC; HGNC:2910; DLL4.
DR   HPA; HPA023392; -.
DR   MalaCards; DLL4; -.
DR   MIM; 605185; gene.
DR   MIM; 616589; phenotype.
DR   neXtProt; NX_Q9NR61; -.
DR   OpenTargets; ENSG00000128917; -.
DR   PharmGKB; PA27366; -.
DR   eggNOG; KOG1217; Eukaryota.
DR   eggNOG; ENOG410XP6K; LUCA.
DR   GeneTree; ENSGT00810000125346; -.
DR   HOGENOM; HOG000267024; -.
DR   HOVERGEN; HBG007139; -.
DR   InParanoid; Q9NR61; -.
DR   KO; K06051; -.
DR   OMA; FNGATCY; -.
DR   OrthoDB; EOG091G07YQ; -.
DR   PhylomeDB; Q9NR61; -.
DR   TreeFam; TF351835; -.
DR   Reactome; R-HSA-1980148; Signaling by NOTCH3.
DR   Reactome; R-HSA-1980150; Signaling by NOTCH4.
DR   Reactome; R-HSA-2122948; Activated NOTCH1 Transmits Signal to the Nucleus.
DR   Reactome; R-HSA-2644606; Constitutive Signaling by NOTCH1 PEST Domain Mutants.
DR   Reactome; R-HSA-2660826; Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant.
DR   Reactome; R-HSA-2691232; Constitutive Signaling by NOTCH1 HD Domain Mutants.
DR   Reactome; R-HSA-2894862; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants.
DR   Reactome; R-HSA-2979096; NOTCH2 Activation and Transmission of Signal to the Nucleus.
DR   SignaLink; Q9NR61; -.
DR   SIGNOR; Q9NR61; -.
DR   GeneWiki; DLL4; -.
DR   GenomeRNAi; 54567; -.
DR   PRO; PR:Q9NR61; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000128917; -.
DR   CleanEx; HS_DLL4; -.
DR   Genevisible; Q9NR61; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0005112; F:Notch binding; TAS:ProtInc.
DR   GO; GO:0001525; P:angiogenesis; ISS:BHF-UCL.
DR   GO; GO:0008015; P:blood circulation; TAS:ProtInc.
DR   GO; GO:0072554; P:blood vessel lumenization; IEA:Ensembl.
DR   GO; GO:0001974; P:blood vessel remodeling; ISS:BHF-UCL.
DR   GO; GO:0001569; P:branching involved in blood vessel morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0003209; P:cardiac atrium morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0003208; P:cardiac ventricle morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0044344; P:cellular response to fibroblast growth factor stimulus; IDA:UniProtKB.
DR   GO; GO:0035924; P:cellular response to vascular endothelial growth factor stimulus; IMP:UniProtKB.
DR   GO; GO:0035912; P:dorsal aorta morphogenesis; ISS:BHF-UCL.
DR   GO; GO:1903588; P:negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis; IDA:UniProtKB.
DR   GO; GO:0090051; P:negative regulation of cell migration involved in sprouting angiogenesis; IDA:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IMP:UniProtKB.
DR   GO; GO:0010596; P:negative regulation of endothelial cell migration; IMP:UniProtKB.
DR   GO; GO:0010629; P:negative regulation of gene expression; IDA:UniProtKB.
DR   GO; GO:0045746; P:negative regulation of Notch signaling pathway; ISS:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL.
DR   GO; GO:0007220; P:Notch receptor processing; TAS:Reactome.
DR   GO; GO:0061314; P:Notch signaling involved in heart development; ISS:BHF-UCL.
DR   GO; GO:0007219; P:Notch signaling pathway; TAS:Reactome.
DR   GO; GO:0003344; P:pericardium morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0010628; P:positive regulation of gene expression; IDA:UniProtKB.
DR   GO; GO:2000179; P:positive regulation of neural precursor cell proliferation; ISS:UniProtKB.
DR   GO; GO:0045747; P:positive regulation of Notch signaling pathway; ISS:UniProtKB.
DR   GO; GO:0061074; P:regulation of neural retina development; ISS:UniProtKB.
DR   GO; GO:0050767; P:regulation of neurogenesis; IEA:Ensembl.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   GO; GO:0030217; P:T cell differentiation; ISS:UniProtKB.
DR   GO; GO:0060579; P:ventral spinal cord interneuron fate commitment; IMP:UniProtKB.
DR   GO; GO:0003222; P:ventricular trabecula myocardium morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0007601; P:visual perception; IEA:UniProtKB-KW.
DR   InterPro; IPR001774; DSL.
DR   InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR000152; EGF-type_Asp/Asn_hydroxyl_site.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   InterPro; IPR011651; Notch_ligand_N.
DR   Pfam; PF01414; DSL; 1.
DR   Pfam; PF00008; EGF; 5.
DR   Pfam; PF07657; MNNL; 1.
DR   SMART; SM00051; DSL; 1.
DR   SMART; SM00181; EGF; 9.
DR   SMART; SM00179; EGF_CA; 6.
DR   SUPFAM; SSF57184; SSF57184; 1.
DR   PROSITE; PS00010; ASX_HYDROXYL; 1.
DR   PROSITE; PS51051; DSL; 1.
DR   PROSITE; PS00022; EGF_1; 8.
DR   PROSITE; PS01186; EGF_2; 7.
DR   PROSITE; PS50026; EGF_3; 8.
PE   1: Evidence at protein level;
KW   3D-structure; Angiogenesis; Cell membrane; Complete proteome;
KW   Developmental protein; Differentiation; Direct protein sequencing;
KW   Disease mutation; Disulfide bond; EGF-like domain; Glycoprotein;
KW   Membrane; Neurogenesis; Notch signaling pathway; Reference proteome;
KW   Repeat; Sensory transduction; Signal; Transmembrane;
KW   Transmembrane helix; Vision.
FT   SIGNAL        1     26       {ECO:0000269|PubMed:15340161}.
FT   CHAIN        27    685       Delta-like protein 4.
FT                                /FTId=PRO_0000007512.
FT   TOPO_DOM     27    529       Extracellular. {ECO:0000255}.
FT   TRANSMEM    530    550       Helical. {ECO:0000255}.
FT   TOPO_DOM    551    685       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      173    217       DSL. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00377}.
FT   DOMAIN      218    251       EGF-like 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      252    282       EGF-like 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      284    322       EGF-like 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      324    360       EGF-like 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      362    400       EGF-like 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      402    438       EGF-like 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      440    476       EGF-like 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      480    518       EGF-like 8. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   REGION      185    187       Interaction with Notch1.
FT                                {ECO:0000250|UniProtKB:D3ZHH1}.
FT   REGION      191    195       Interaction with Notch1.
FT                                {ECO:0000250|UniProtKB:D3ZHH1}.
FT   SITE        110    110       Interaction with Notch1.
FT                                {ECO:0000250|UniProtKB:D3ZHH1}.
FT   SITE        216    216       Interaction with Notch1.
FT                                {ECO:0000250|UniProtKB:D3ZHH1}.
FT   CARBOHYD    108    108       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000250|UniProtKB:D3ZHH1}.
FT   CARBOHYD    183    183       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    205    205       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    393    393       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     50     54       {ECO:0000250|UniProtKB:D3ZHH1}.
FT   DISULFID     61     74       {ECO:0000250|UniProtKB:D3ZHH1}.
FT   DISULFID    175    184       {ECO:0000250|UniProtKB:D3ZHH1,
FT                                ECO:0000255|PROSITE-ProRule:PRU00377}.
FT   DISULFID    188    200       {ECO:0000250|UniProtKB:D3ZHH1,
FT                                ECO:0000255|PROSITE-ProRule:PRU00377}.
FT   DISULFID    208    217       {ECO:0000250|UniProtKB:D3ZHH1,
FT                                ECO:0000255|PROSITE-ProRule:PRU00377}.
FT   DISULFID    222    233       {ECO:0000250|UniProtKB:D3ZHH1,
FT                                ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    226    239       {ECO:0000250|UniProtKB:D3ZHH1,
FT                                ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    241    250       {ECO:0000250|UniProtKB:D3ZHH1,
FT                                ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    253    264       {ECO:0000250|UniProtKB:D3ZHH1}.
FT   DISULFID    259    270       {ECO:0000250|UniProtKB:D3ZHH1}.
FT   DISULFID    272    281       {ECO:0000250|UniProtKB:D3ZHH1,
FT                                ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    288    300       {ECO:0000250}.
FT   DISULFID    294    310       {ECO:0000250}.
FT   DISULFID    312    321       {ECO:0000250}.
FT   DISULFID    328    339       {ECO:0000250}.
FT   DISULFID    333    348       {ECO:0000250}.
FT   DISULFID    350    359       {ECO:0000250}.
FT   DISULFID    366    377       {ECO:0000250}.
FT   DISULFID    371    388       {ECO:0000250}.
FT   DISULFID    390    399       {ECO:0000250}.
FT   DISULFID    406    417       {ECO:0000250}.
FT   DISULFID    411    426       {ECO:0000250}.
FT   DISULFID    428    437       {ECO:0000250}.
FT   DISULFID    444    455       {ECO:0000250}.
FT   DISULFID    449    464       {ECO:0000250}.
FT   DISULFID    466    475       {ECO:0000250}.
FT   DISULFID    484    495       {ECO:0000250}.
FT   DISULFID    489    506       {ECO:0000250}.
FT   DISULFID    508    517       {ECO:0000250}.
FT   VARIANT     121    121       A -> P (in AOS6; dbSNP:rs796065350).
FT                                {ECO:0000269|PubMed:26299364}.
FT                                /FTId=VAR_075858.
FT   VARIANT     186    186       R -> C (in AOS6; dbSNP:rs796065348).
FT                                {ECO:0000269|PubMed:26299364}.
FT                                /FTId=VAR_075859.
FT   VARIANT     195    195       F -> L (in AOS6; dbSNP:rs796065351).
FT                                {ECO:0000269|PubMed:26299364}.
FT                                /FTId=VAR_075860.
FT   VARIANT     267    267       P -> T (in AOS6; dbSNP:rs796065349).
FT                                {ECO:0000269|PubMed:26299364}.
FT                                /FTId=VAR_075861.
FT   VARIANT     390    390       C -> R (in AOS6; dbSNP:rs796065347).
FT                                {ECO:0000269|PubMed:26299364}.
FT                                /FTId=VAR_075862.
FT   VARIANT     390    390       C -> Y (in AOS6; dbSNP:rs796065346).
FT                                {ECO:0000269|PubMed:26299364}.
FT                                /FTId=VAR_075863.
FT   VARIANT     455    455       C -> W (in AOS6; dbSNP:rs796065345).
FT                                {ECO:0000269|PubMed:26299364}.
FT                                /FTId=VAR_075864.
FT   STRAND       28     38       {ECO:0000244|PDB:5MVX}.
FT   STRAND       51     53       {ECO:0000244|PDB:5MVX}.
FT   STRAND       55     64       {ECO:0000244|PDB:5MVX}.
FT   STRAND       77     80       {ECO:0000244|PDB:5MVX}.
FT   STRAND       85     90       {ECO:0000244|PDB:5MVX}.
FT   STRAND      103    109       {ECO:0000244|PDB:5MVX}.
FT   STRAND      113    123       {ECO:0000244|PDB:5MVX}.
FT   STRAND      125    127       {ECO:0000244|PDB:5MVX}.
FT   TURN        131    133       {ECO:0000244|PDB:5MVX}.
FT   HELIX       136    138       {ECO:0000244|PDB:5MVX}.
FT   STRAND      139    148       {ECO:0000244|PDB:5MVX}.
FT   STRAND      151    153       {ECO:0000244|PDB:5MVX}.
FT   STRAND      156    161       {ECO:0000244|PDB:5MVX}.
FT   STRAND      166    174       {ECO:0000244|PDB:5MVX}.
FT   STRAND      179    181       {ECO:0000244|PDB:5MVX}.
FT   STRAND      191    193       {ECO:0000244|PDB:5MVX}.
FT   STRAND      196    200       {ECO:0000244|PDB:5MVX}.
FT   STRAND      206    208       {ECO:0000244|PDB:5MVX}.
FT   STRAND      212    214       {ECO:0000244|PDB:5MVX}.
FT   TURN        228    230       {ECO:0000244|PDB:5MVX}.
FT   STRAND      245    247       {ECO:0000244|PDB:5MVX}.
FT   STRAND      260    263       {ECO:0000244|PDB:5MVX}.
FT   TURN        278    281       {ECO:0000244|PDB:5MVX}.
FT   STRAND      283    285       {ECO:0000244|PDB:5MVX}.
FT   HELIX       287    291       {ECO:0000244|PDB:5MVX}.
FT   STRAND      299    303       {ECO:0000244|PDB:5MVX}.
FT   TURN        304    306       {ECO:0000244|PDB:5MVX}.
FT   STRAND      307    311       {ECO:0000244|PDB:5MVX}.
FT   STRAND      316    321       {ECO:0000244|PDB:5MVX}.
SQ   SEQUENCE   685 AA;  74605 MW;  6CF89D3C220ACC89 CRC64;
     MAAASRSASG WALLLLVALW QQRAAGSGVF QLQLQEFINE RGVLASGRPC EPGCRTFFRV
     CLKHFQAVVS PGPCTFGTVS TPVLGTNSFA VRDDSSGGGR NPLQLPFNFT WPGTFSLIIE
     AWHAPGDDLR PEALPPDALI SKIAIQGSLA VGQNWLLDEQ TSTLTRLRYS YRVICSDNYY
     GDNCSRLCKK RNDHFGHYVC QPDGNLSCLP GWTGEYCQQP ICLSGCHEQN GYCSKPAECL
     CRPGWQGRLC NECIPHNGCR HGTCSTPWQC TCDEGWGGLF CDQDLNYCTH HSPCKNGATC
     SNSGQRSYTC TCRPGYTGVD CELELSECDS NPCRNGGSCK DQEDGYHCLC PPGYYGLHCE
     HSTLSCADSP CFNGGSCRER NQGANYACEC PPNFTGSNCE KKVDRCTSNP CANGGQCLNR
     GPSRMCRCRP GFTGTYCELH VSDCARNPCA HGGTCHDLEN GLMCTCPAGF SGRRCEVRTS
     IDACASSPCF NRATCYTDLS TDTFVCNCPY GFVGSRCEFP VGLPPSFPWV AVSLGVGLAV
     LLVLLGMVAV AVRQLRLRRP DDGSREAMNN LSDFQKDNLI PAAQLKNTNQ KKELEVDCGL
     DKSNCGKQQN HTLDYNLAPG PLGRGTMPGK FPHSDKSLGE KAPLRLHSEK PECRISAICS
     PRDSMYQSVC LISEERNECV IATEV
//
ID   DLL3_HUMAN              Reviewed;         618 AA.
AC   Q9NYJ7; E9PFG2; Q8NBS4;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   22-NOV-2017, entry version 169.
DE   RecName: Full=Delta-like protein 3;
DE   AltName: Full=Drosophila Delta homolog 3;
DE            Short=Delta3;
DE   Flags: Precursor;
GN   Name=DLL3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1), AND VARIANT
RP   SCDO1 ASP-385.
RX   PubMed=10742114; DOI=10.1038/74307;
RA   Bulman M.P., Kusumi K., Frayling T.M., McKeown C., Garrett C.,
RA   Lander E.S., Krumlauf R., Hattersley A.T., Ellard S., Turnpenny P.D.;
RT   "Mutations in the human delta homologue, DLL3, cause axial skeletal
RT   defects in spondylocostal dysostosis.";
RL   Nat. Genet. 24:438-441(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANTS
RP   CYS-172 AND PRO-218.
RX   PubMed=16303743; DOI=10.1093/dnares/12.2.117;
RA   Otsuki T., Ota T., Nishikawa T., Hayashi K., Suzuki Y., Yamamoto J.,
RA   Wakamatsu A., Kimura K., Sakamoto K., Hatano N., Kawai Y., Ishii S.,
RA   Saito K., Kojima S., Sugiyama T., Ono T., Okano K., Yoshikawa Y.,
RA   Aotsuka S., Sasaki N., Hattori A., Okumura K., Nagai K., Sugano S.,
RA   Isogai T.;
RT   "Signal sequence and keyword trap in silico for selection of full-
RT   length human cDNAs encoding secretion or membrane proteins from oligo-
RT   capped cDNA libraries.";
RL   DNA Res. 12:117-126(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   VARIANTS THR-115; GLN-142; CYS-172 AND PRO-218.
RX   PubMed=18485326; DOI=10.1016/j.ajhg.2008.04.014;
RA   Cornier A.S., Staehling-Hampton K., Delventhal K.M., Saga Y.,
RA   Caubet J.-F., Sasaki N., Ellard S., Young E., Ramirez N., Carlo S.E.,
RA   Torres J., Emans J.B., Turnpenny P.D., Pourquie O.;
RT   "Mutations in the MESP2 gene cause spondylothoracic dysostosis/Jarcho-
RT   Levin syndrome.";
RL   Am. J. Hum. Genet. 82:1334-1341(2008).
CC   -!- FUNCTION: Inhibits primary neurogenesis. May be required to divert
CC       neurons along a specific differentiation pathway. Plays a role in
CC       the formation of somite boundaries during segmentation of the
CC       paraxial mesoderm (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Can bind and activate Notch-1 or another Notch receptor.
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I
CC       membrane protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9NYJ7-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NYJ7-2; Sequence=VSP_045249;
CC         Note=No experimental confirmation available.;
CC   -!- DOMAIN: The DSL domain is required for binding to the Notch
CC       receptor.
CC   -!- PTM: Ubiquitinated by MIB (MIB1 or MIB2), leading to its
CC       endocytosis and subsequent degradation. {ECO:0000250}.
CC   -!- DISEASE: Spondylocostal dysostosis 1, autosomal recessive (SCDO1)
CC       [MIM:277300]: A condition of variable severity associated with
CC       vertebral and rib segmentation defects. The main skeletal
CC       malformations include fusion of vertebrae, hemivertebrae, fusion
CC       of certain ribs, and other rib malformations. Deformity of the
CC       chest and spine (severe scoliosis, kyphoscoliosis and lordosis) is
CC       a natural consequence of the malformation and leads to a dwarf-
CC       like appearance. As the thorax is small, infants frequently have
CC       respiratory insufficiency and repeated respiratory infections
CC       resulting in life-threatening complications in the first year of
CC       life. {ECO:0000269|PubMed:10742114}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF241373; AAF62542.1; -; Genomic_DNA.
DR   EMBL; AF241367; AAF62542.1; JOINED; Genomic_DNA.
DR   EMBL; AF241368; AAF62542.1; JOINED; Genomic_DNA.
DR   EMBL; AF241369; AAF62542.1; JOINED; Genomic_DNA.
DR   EMBL; AF241370; AAF62542.1; JOINED; Genomic_DNA.
DR   EMBL; AF241371; AAF62542.1; JOINED; Genomic_DNA.
DR   EMBL; AF241372; AAF62542.1; JOINED; Genomic_DNA.
DR   EMBL; AK075302; BAC11535.1; -; mRNA.
DR   EMBL; AC011500; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC000218; AAH00218.1; -; mRNA.
DR   CCDS; CCDS12537.1; -. [Q9NYJ7-2]
DR   CCDS; CCDS12538.1; -. [Q9NYJ7-1]
DR   RefSeq; NP_058637.1; NM_016941.3. [Q9NYJ7-1]
DR   RefSeq; NP_982353.1; NM_203486.2. [Q9NYJ7-2]
DR   UniGene; Hs.127792; -.
DR   ProteinModelPortal; Q9NYJ7; -.
DR   SMR; Q9NYJ7; -.
DR   STRING; 9606.ENSP00000205143; -.
DR   iPTMnet; Q9NYJ7; -.
DR   PhosphoSitePlus; Q9NYJ7; -.
DR   BioMuta; DLL3; -.
DR   DMDM; 12229810; -.
DR   PaxDb; Q9NYJ7; -.
DR   PeptideAtlas; Q9NYJ7; -.
DR   PRIDE; Q9NYJ7; -.
DR   DNASU; 10683; -.
DR   Ensembl; ENST00000205143; ENSP00000205143; ENSG00000090932. [Q9NYJ7-1]
DR   Ensembl; ENST00000356433; ENSP00000348810; ENSG00000090932. [Q9NYJ7-2]
DR   GeneID; 10683; -.
DR   KEGG; hsa:10683; -.
DR   UCSC; uc002olw.3; human. [Q9NYJ7-1]
DR   CTD; 10683; -.
DR   DisGeNET; 10683; -.
DR   EuPathDB; HostDB:ENSG00000090932.10; -.
DR   GeneCards; DLL3; -.
DR   GeneReviews; DLL3; -.
DR   HGNC; HGNC:2909; DLL3.
DR   HPA; HPA056533; -.
DR   MalaCards; DLL3; -.
DR   MIM; 277300; phenotype.
DR   MIM; 602768; gene.
DR   neXtProt; NX_Q9NYJ7; -.
DR   OpenTargets; ENSG00000090932; -.
DR   Orphanet; 2311; Autosomal recessive spondylocostal dysostosis.
DR   PharmGKB; PA27365; -.
DR   eggNOG; KOG1217; Eukaryota.
DR   eggNOG; ENOG410XP6K; LUCA.
DR   GeneTree; ENSGT00890000139375; -.
DR   HOGENOM; HOG000267024; -.
DR   HOVERGEN; HBG007139; -.
DR   InParanoid; Q9NYJ7; -.
DR   KO; K06051; -.
DR   OMA; DECEAPP; -.
DR   OrthoDB; EOG091G058A; -.
DR   PhylomeDB; Q9NYJ7; -.
DR   TreeFam; TF351835; -.
DR   SignaLink; Q9NYJ7; -.
DR   SIGNOR; Q9NYJ7; -.
DR   ChiTaRS; DLL3; human.
DR   GeneWiki; DLL3; -.
DR   GenomeRNAi; 10683; -.
DR   PRO; PR:Q9NYJ7; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000090932; -.
DR   CleanEx; HS_DLL3; -.
DR   ExpressionAtlas; Q9NYJ7; baseline and differential.
DR   Genevisible; Q9NYJ7; HS.
DR   GO; GO:0016021; C:integral component of membrane; NAS:UniProtKB.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0005112; F:Notch binding; NAS:UniProtKB.
DR   GO; GO:0007386; P:compartment pattern specification; IEA:Ensembl.
DR   GO; GO:0050768; P:negative regulation of neurogenesis; IEA:Ensembl.
DR   GO; GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0048339; P:paraxial mesoderm development; IEA:Ensembl.
DR   GO; GO:0001501; P:skeletal system development; IMP:UniProtKB.
DR   GO; GO:0001756; P:somitogenesis; IEA:Ensembl.
DR   InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   Pfam; PF00008; EGF; 4.
DR   Pfam; PF12661; hEGF; 1.
DR   SMART; SM00181; EGF; 6.
DR   SMART; SM00179; EGF_CA; 5.
DR   SUPFAM; SSF57184; SSF57184; 1.
DR   PROSITE; PS00022; EGF_1; 6.
DR   PROSITE; PS01186; EGF_2; 6.
DR   PROSITE; PS50026; EGF_3; 6.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Developmental protein;
KW   Differentiation; Disease mutation; Disulfide bond; Dwarfism;
KW   EGF-like domain; Membrane; Notch signaling pathway; Polymorphism;
KW   Reference proteome; Repeat; Signal; Transmembrane;
KW   Transmembrane helix; Ubl conjugation.
FT   SIGNAL        1     26       {ECO:0000255}.
FT   CHAIN        27    618       Delta-like protein 3.
FT                                /FTId=PRO_0000007509.
FT   TOPO_DOM     27    492       Extracellular. {ECO:0000255}.
FT   TRANSMEM    493    513       Helical. {ECO:0000255}.
FT   TOPO_DOM    514    618       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      176    215       DSL.
FT   DOMAIN      216    249       EGF-like 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      274    310       EGF-like 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      312    351       EGF-like 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      353    389       EGF-like 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      391    427       EGF-like 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      429    465       EGF-like 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DISULFID    220    231       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    224    237       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    239    248       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    278    289       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    283    298       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    300    309       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    316    327       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    321    339       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    341    350       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    357    368       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    362    377       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    379    388       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    395    406       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    400    415       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    417    426       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    433    444       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    438    453       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    455    464       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   VAR_SEQ     587    618       VATPLFPPLHTGRAGQRQHLLFPYPSSILSVK -> A (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:16303743}.
FT                                /FTId=VSP_045249.
FT   VARIANT     115    115       A -> T (in dbSNP:rs71647811).
FT                                {ECO:0000269|PubMed:18485326}.
FT                                /FTId=VAR_046782.
FT   VARIANT     142    142       L -> Q (in dbSNP:rs55741253).
FT                                {ECO:0000269|PubMed:18485326}.
FT                                /FTId=VAR_046783.
FT   VARIANT     172    172       F -> C (in dbSNP:rs8107127).
FT                                {ECO:0000269|PubMed:16303743,
FT                                ECO:0000269|PubMed:18485326}.
FT                                /FTId=VAR_046784.
FT   VARIANT     218    218       L -> P (in dbSNP:rs1110627).
FT                                {ECO:0000269|PubMed:16303743,
FT                                ECO:0000269|PubMed:18485326}.
FT                                /FTId=VAR_016776.
FT   VARIANT     385    385       G -> D (in SCDO1; dbSNP:rs104894674).
FT                                {ECO:0000269|PubMed:10742114}.
FT                                /FTId=VAR_009952.
FT   CONFLICT    318    318       D -> N (in Ref. 2; BAC11535).
FT                                {ECO:0000305}.
FT   CONFLICT    435    435       A -> V (in Ref. 2; BAC11535).
FT                                {ECO:0000305}.
SQ   SEQUENCE   618 AA;  64618 MW;  58A9BC0A7DEAD1A0 CRC64;
     MVSPRMSGLL SQTVILALIF LPQTRPAGVF ELQIHSFGPG PGPGAPRSPC SARLPCRLFF
     RVCLKPGLSE EAAESPCALG AALSARGPVY TEQPGAPAPD LPLPDGLLQV PFRDAWPGTF
     SFIIETWREE LGDQIGGPAW SLLARVAGRR RLAAGGPWAR DIQRAGAWEL RFSYRARCEP
     PAVGTACTRL CRPRSAPSRC GPGLRPCAPL EDECEAPLVC RAGCSPEHGF CEQPGECRCL
     EGWTGPLCTV PVSTSSCLSP RGPSSATTGC LVPGPGPCDG NPCANGGSCS ETPRSFECTC
     PRGFYGLRCE VSGVTCADGP CFNGGLCVGG ADPDSAYICH CPPGFQGSNC EKRVDRCSLQ
     PCRNGGLCLD LGHALRCRCR AGFAGPRCEH DLDDCAGRAC ANGGTCVEGG GAHRCSCALG
     FGGRDCRERA DPCAARPCAH GGRCYAHFSG LVCACAPGYM GARCEFPVHP DGASALPAAP
     PGLRPGDPQR YLLPPALGLL VAAGVAGAAL LLVHVRRRGH SQDAGSRLLA GTPEPSVHAL
     PDALNNLRTQ EGSGDGPSSS VDWNRPEDVD PQGIYVISAP SIYAREVATP LFPPLHTGRA
     GQRQHLLFPY PSSILSVK
//
ID   PEN2_HUMAN              Reviewed;         101 AA.
AC   Q9NZ42; B2R5L9;
DT   26-SEP-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   27-SEP-2017, entry version 143.
DE   RecName: Full=Gamma-secretase subunit PEN-2;
DE   AltName: Full=Presenilin enhancer protein 2;
GN   Name=PSENEN; Synonyms=PEN2; ORFNames=MDS033;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Hematopoietic stem cell;
RA   Zhao M., Gu J., Li N., Peng Y., Han Z., Chen Z.;
RT   "Novel genes expressed in hematopoietic stem/progenitor cells from
RT   myelodysplastic syndrome patients.";
RL   Submitted (DEC-1999) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   INTERACTION WITH NCSTN; PSEN1 AND PSEN2, SUBUNIT, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=12198112; DOI=10.1074/jbc.C200469200;
RA   Steiner H., Winkler E., Edbauer D., Prokop S., Basset G., Yamasaki A.,
RA   Kostka M., Haass C.;
RT   "PEN-2 is an integral component of the gamma-secretase complex
RT   required for coordinated expression of presenilin and nicastrin.";
RL   J. Biol. Chem. 277:39062-39065(2002).
RN   [5]
RP   TISSUE SPECIFICITY.
RX   PubMed=12110170; DOI=10.1016/S1534-5807(02)00189-2;
RA   Francis R., McGrath G., Zhang J., Ruddy D.A., Sym M., Apfeld J.,
RA   Nicoll M., Maxwell M., Hai B., Ellis M.C., Parks A.L., Xu W., Li J.,
RA   Gurney M., Myers R.L., Himes C.S., Hiebsch R., Ruble C., Nye J.S.,
RA   Curtis D.;
RT   "aph-1 and pen-2 are required for Notch pathway signaling, gamma-
RT   secretase cleavage of betaAPP, and presenilin protein accumulation.";
RL   Dev. Cell 3:85-97(2002).
RN   [6]
RP   SUBCELLULAR LOCATION, FUNCTION, AND SUBUNIT.
RX   PubMed=12522139; DOI=10.1074/jbc.C200648200;
RA   Luo W.-J., Wang H., Li H., Kim B.S., Shah S., Lee H.-J.,
RA   Thinakaran G., Kim T.-W., Yu G., Xu H.;
RT   "PEN-2 and APH-1 coordinately regulate proteolytic processing of
RT   presenilin 1.";
RL   J. Biol. Chem. 278:7850-7854(2003).
RN   [7]
RP   MEMBRANE TOPOLOGY, SUBCELLULAR LOCATION, AND MUTAGENESIS OF GLU-10;
RP   ALA-46 AND SER-93.
RX   PubMed=12639958; DOI=10.1074/jbc.M213107200;
RA   Crystal A.S., Morais V.A., Pierson T.C., Pijak D.S., Carlin D.,
RA   Lee V.M., Doms R.W.;
RT   "Membrane topology of gamma-secretase component PEN-2.";
RL   J. Biol. Chem. 278:20117-20123(2003).
RN   [8]
RP   FUNCTION IN THE GAMMA-SECRETASE COMPLEX.
RX   PubMed=12763021; DOI=10.1016/S0006-291X(03)00797-6;
RA   Marlow L., Canet R.M., Haugabook S.J., Hardy J.A., Lahiri D.K.,
RA   Sambamurti K.;
RT   "APH1, PEN2, and nicastrin increase Abeta levels and gamma-secretase
RT   activity.";
RL   Biochem. Biophys. Res. Commun. 305:502-509(2003).
RN   [9]
RP   TISSUE SPECIFICITY, FUNCTION, COMPONENT OF A GAMMA-SECRETASE COMPLEX
RP   WITH APH1A; PSEN1/PSEN2 AND NCSTN, AND SUBUNIT.
RX   PubMed=12740439; DOI=10.1073/pnas.1037392100;
RA   Kimberly W.T., LaVoie M.J., Ostaszewski B.L., Ye W., Wolfe M.S.,
RA   Selkoe D.J.;
RT   "Gamma-secretase is a membrane protein complex comprised of
RT   presenilin, nicastrin, Aph-1, and Pen-2.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:6382-6387(2003).
RN   [10]
RP   ENZYME ACTIVITY OF A GAMMA-SECRETASE COMPLEX.
RX   PubMed=12679784; DOI=10.1038/ncb960;
RA   Edbauer D., Winkler E., Regula J.T., Pesold B., Steiner H., Haass C.;
RT   "Reconstitution of gamma-secretase activity.";
RL   Nat. Cell Biol. 5:486-488(2003).
RN   [11]
RP   INVOLVEMENT IN ACNINV2.
RX   PubMed=20929727; DOI=10.1126/science.1196284;
RA   Wang B., Yang W., Wen W., Sun J., Su B., Liu B., Ma D., Lv D., Wen Y.,
RA   Qu T., Chen M., Sun M., Shen Y., Zhang X.;
RT   "Gamma-secretase gene mutations in familial acne inversa.";
RL   Science 330:1065-1065(2010).
RN   [12]
RP   FUNCTION, SUBUNIT, SUBCELLULAR LOCATION, AND MUTAGENESIS OF CYS-15;
RP   PHE-25; LEU-26; TRP-30; ASN-33; TRP-36; LYS-54 AND PHE-94.
RX   PubMed=24941111; DOI=10.1021/bi500489j;
RA   Holmes O., Paturi S., Selkoe D.J., Wolfe M.S.;
RT   "Pen-2 is essential for gamma-secretase complex stability and
RT   trafficking but partially dispensable for endoproteolysis.";
RL   Biochemistry 53:4393-4406(2014).
RN   [13]
RP   STRUCTURE BY ELECTRON MICROSCOPY (4.5 ANGSTROMS), FUNCTION,
RP   SUBCELLULAR LOCATION, TOPOLOGY, AND SUBUNIT.
RX   PubMed=25043039; DOI=10.1038/nature13567;
RA   Lu P., Bai X.C., Ma D., Xie T., Yan C., Sun L., Yang G., Zhao Y.,
RA   Zhou R., Scheres S.H., Shi Y.;
RT   "Three-dimensional structure of human gamma-secretase.";
RL   Nature 512:166-170(2014).
RN   [14]
RP   STRUCTURE BY ELECTRON MICROSCOPY (4.00 ANGSTROMS), SUBUNIT,
RP   SUBCELLULAR LOCATION, AND TOPOLOGY.
RX   PubMed=26623517; DOI=10.7554/eLife.11182;
RA   Bai X.C., Rajendra E., Yang G., Shi Y., Scheres S.H.;
RT   "Sampling the conformational space of the catalytic subunit of human
RT   gamma-secretase.";
RL   Elife 4:0-0(2015).
RN   [15]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.40 ANGSTROMS), FUNCTION,
RP   SUBCELLULAR LOCATION, TOPOLOGY, AND SUBUNIT.
RX   PubMed=26280335; DOI=10.1038/nature14892;
RA   Bai X.C., Yan C., Yang G., Lu P., Ma D., Sun L., Zhou R.,
RA   Scheres S.H., Shi Y.;
RT   "An atomic structure of human gamma-secretase.";
RL   Nature 525:212-217(2015).
CC   -!- FUNCTION: Essential subunit of the gamma-secretase complex, an
CC       endoprotease complex that catalyzes the intramembrane cleavage of
CC       integral membrane proteins such as Notch receptors and APP
CC       (amyloid-beta precursor protein) (PubMed:12522139,
CC       PubMed:12763021, PubMed:12740439, PubMed:12679784,
CC       PubMed:24941111). The gamma-secretase complex plays a role in
CC       Notch and Wnt signaling cascades and regulation of downstream
CC       processes via its role in processing key regulatory proteins, and
CC       by regulating cytosolic CTNNB1 levels (Probable). PSENEN modulates
CC       both endoproteolysis of presenilin and gamma-secretase activity
CC       (PubMed:12522139, PubMed:12763021, PubMed:12740439,
CC       PubMed:12679784, PubMed:24941111). {ECO:0000269|PubMed:12522139,
CC       ECO:0000269|PubMed:12679784, ECO:0000269|PubMed:12740439,
CC       ECO:0000269|PubMed:12763021, ECO:0000269|PubMed:24941111,
CC       ECO:0000305}.
CC   -!- SUBUNIT: The functional gamma-secretase complex is composed of at
CC       least four polypeptides: a presenilin homodimer (PSEN1 or PSEN2),
CC       nicastrin (NCSTN), APH1 (APH1A or APH1B) and PEN2.
CC       {ECO:0000269|PubMed:12198112, ECO:0000269|PubMed:12522139,
CC       ECO:0000269|PubMed:12740439, ECO:0000269|PubMed:24941111,
CC       ECO:0000269|PubMed:25043039, ECO:0000269|PubMed:26280335,
CC       ECO:0000269|PubMed:26623517}.
CC   -!- INTERACTION:
CC       P02792:FTL; NbExp=4; IntAct=EBI-998468, EBI-713279;
CC       Q92542:NCSTN; NbExp=3; IntAct=EBI-998468, EBI-998440;
CC       P49755:TMED10; NbExp=3; IntAct=EBI-998468, EBI-998422;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:12522139, ECO:0000269|PubMed:12639958}; Multi-
CC       pass membrane protein {ECO:0000269|PubMed:12639958,
CC       ECO:0000269|PubMed:25043039, ECO:0000269|PubMed:26280335,
CC       ECO:0000269|PubMed:26623517}. Golgi apparatus, Golgi stack
CC       membrane {ECO:0000269|PubMed:12522139,
CC       ECO:0000269|PubMed:12639958}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:12639958, ECO:0000269|PubMed:25043039,
CC       ECO:0000269|PubMed:26280335, ECO:0000269|PubMed:26623517}. Cell
CC       membrane {ECO:0000269|PubMed:24941111}; Multi-pass membrane
CC       protein {ECO:0000269|PubMed:12639958, ECO:0000269|PubMed:25043039,
CC       ECO:0000269|PubMed:26280335, ECO:0000269|PubMed:26623517}.
CC       Membrane {ECO:0000269|PubMed:12198112}; Multi-pass membrane
CC       protein {ECO:0000269|PubMed:12639958, ECO:0000269|PubMed:25043039,
CC       ECO:0000269|PubMed:26280335, ECO:0000269|PubMed:26623517}.
CC       Note=Predominantly located in the endoplasmic reticulum and in the
CC       cis-Golgi. {ECO:0000269|PubMed:12639958}.
CC   -!- TISSUE SPECIFICITY: Widely expressed. Expressed in leukocytes,
CC       lung, placenta, small intestine, liver, kidney, spleen thymus,
CC       skeletal muscle, heart and brain. {ECO:0000269|PubMed:12110170,
CC       ECO:0000269|PubMed:12740439}.
CC   -!- DISEASE: Acne inversa, familial, 2 (ACNINV2) [MIM:613736]: A
CC       chronic relapsing inflammatory disease of the hair follicles
CC       characterized by recurrent draining sinuses, painful skin
CC       abscesses, and disfiguring scars. Manifestations typically appear
CC       after puberty. {ECO:0000269|PubMed:20929727}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the PEN-2 family. {ECO:0000305}.
CC   -!- CAUTION: The high-resolution electron microscopy structures
CC       indicate that the N-terminus is cytoplasmic, followed by two short
CC       helices that dip into the membrane, but do not cross it
CC       (PubMed:26280335). In contrast, results based on mutagenesis to
CC       create N-glycosylation sites indicate that the N-terminus is
CC       lumenal (PubMed:12639958). Both studies indicate that the C-
CC       terminus is lumenal (PubMed:12639958, PubMed:26280335).
CC       {ECO:0000269|PubMed:12639958, ECO:0000269|PubMed:26280335}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF220053; AAF67646.1; -; mRNA.
DR   EMBL; AK312233; BAG35166.1; -; mRNA.
DR   EMBL; BC009575; AAH09575.1; -; mRNA.
DR   CCDS; CCDS12474.1; -.
DR   RefSeq; NP_001268461.1; NM_001281532.2.
DR   RefSeq; NP_758844.1; NM_172341.3.
DR   UniGene; Hs.534465; -.
DR   UniGene; Hs.733080; -.
DR   PDB; 5A63; EM; 3.40 A; D=1-101.
DR   PDB; 5FN2; EM; 4.20 A; D=1-101.
DR   PDB; 5FN3; EM; 4.10 A; D=1-101.
DR   PDB; 5FN4; EM; 4.00 A; D=1-101.
DR   PDB; 5FN5; EM; 4.30 A; D=1-101.
DR   PDBsum; 5A63; -.
DR   PDBsum; 5FN2; -.
DR   PDBsum; 5FN3; -.
DR   PDBsum; 5FN4; -.
DR   PDBsum; 5FN5; -.
DR   ProteinModelPortal; Q9NZ42; -.
DR   SMR; Q9NZ42; -.
DR   BioGrid; 120953; 9.
DR   CORUM; Q9NZ42; -.
DR   DIP; DIP-36337N; -.
DR   IntAct; Q9NZ42; 7.
DR   MINT; MINT-5207259; -.
DR   STRING; 9606.ENSP00000222266; -.
DR   BindingDB; Q9NZ42; -.
DR   ChEMBL; CHEMBL2374; -.
DR   DrugBank; DB05171; E2012.
DR   iPTMnet; Q9NZ42; -.
DR   PhosphoSitePlus; Q9NZ42; -.
DR   DMDM; 37081820; -.
DR   EPD; Q9NZ42; -.
DR   MaxQB; Q9NZ42; -.
DR   PaxDb; Q9NZ42; -.
DR   PeptideAtlas; Q9NZ42; -.
DR   PRIDE; Q9NZ42; -.
DR   TopDownProteomics; Q9NZ42; -.
DR   DNASU; 55851; -.
DR   Ensembl; ENST00000222266; ENSP00000222266; ENSG00000205155.
DR   Ensembl; ENST00000587708; ENSP00000468411; ENSG00000205155.
DR   GeneID; 55851; -.
DR   KEGG; hsa:55851; -.
DR   UCSC; uc002obi.3; human.
DR   CTD; 55851; -.
DR   DisGeNET; 55851; -.
DR   EuPathDB; HostDB:ENSG00000205155.7; -.
DR   GeneCards; PSENEN; -.
DR   H-InvDB; HIX0080122; -.
DR   HGNC; HGNC:30100; PSENEN.
DR   HPA; HPA047435; -.
DR   MalaCards; PSENEN; -.
DR   MIM; 607632; gene.
DR   MIM; 613736; phenotype.
DR   neXtProt; NX_Q9NZ42; -.
DR   OpenTargets; ENSG00000205155; -.
DR   Orphanet; 387; Hidradenitis suppurativa.
DR   PharmGKB; PA142671122; -.
DR   eggNOG; KOG3402; Eukaryota.
DR   eggNOG; ENOG4111W09; LUCA.
DR   GeneTree; ENSGT00390000016319; -.
DR   HOGENOM; HOG000006914; -.
DR   HOVERGEN; HBG045628; -.
DR   InParanoid; Q9NZ42; -.
DR   KO; K06170; -.
DR   OMA; WFFQEAF; -.
DR   OrthoDB; EOG091G0X8A; -.
DR   PhylomeDB; Q9NZ42; -.
DR   Reactome; R-HSA-1251985; Nuclear signaling by ERBB4.
DR   Reactome; R-HSA-193692; Regulated proteolysis of p75NTR.
DR   Reactome; R-HSA-1980148; Signaling by NOTCH3.
DR   Reactome; R-HSA-1980150; Signaling by NOTCH4.
DR   Reactome; R-HSA-205043; NRIF signals cell death from the nucleus.
DR   Reactome; R-HSA-2122948; Activated NOTCH1 Transmits Signal to the Nucleus.
DR   Reactome; R-HSA-2644606; Constitutive Signaling by NOTCH1 PEST Domain Mutants.
DR   Reactome; R-HSA-2894862; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants.
DR   Reactome; R-HSA-2979096; NOTCH2 Activation and Transmission of Signal to the Nucleus.
DR   Reactome; R-HSA-3928665; EPH-ephrin mediated repulsion of cells.
DR   SignaLink; Q9NZ42; -.
DR   SIGNOR; Q9NZ42; -.
DR   ChiTaRS; PSENEN; human.
DR   GenomeRNAi; 55851; -.
DR   PRO; PR:Q9NZ42; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000205155; -.
DR   CleanEx; HS_PSENEN; -.
DR   ExpressionAtlas; Q9NZ42; baseline and differential.
DR   Genevisible; Q9NZ42; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:HGNC.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0070765; C:gamma-secretase complex; IDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HGNC.
DR   GO; GO:0032580; C:Golgi cisterna membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:HGNC.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0042987; P:amyloid precursor protein catabolic process; TAS:HGNC.
DR   GO; GO:0042982; P:amyloid precursor protein metabolic process; IDA:UniProtKB.
DR   GO; GO:0034205; P:amyloid-beta formation; IMP:UniProtKB.
DR   GO; GO:0048013; P:ephrin receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0006509; P:membrane protein ectodomain proteolysis; IDA:HGNC.
DR   GO; GO:0031293; P:membrane protein intracellular domain proteolysis; TAS:Reactome.
DR   GO; GO:0007220; P:Notch receptor processing; TAS:HGNC.
DR   GO; GO:0007219; P:Notch signaling pathway; TAS:Reactome.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome.
DR   GO; GO:0043085; P:positive regulation of catalytic activity; IDA:HGNC.
DR   GO; GO:0016485; P:protein processing; IDA:HGNC.
DR   InterPro; IPR019379; Gamma_Secretase_Asp_P_PEN2.
DR   PANTHER; PTHR16318; PTHR16318; 1.
DR   Pfam; PF10251; PEN-2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Complete proteome; Endoplasmic reticulum;
KW   Golgi apparatus; Membrane; Notch signaling pathway;
KW   Reference proteome; Transmembrane; Transmembrane helix.
FT   CHAIN         1    101       Gamma-secretase subunit PEN-2.
FT                                /FTId=PRO_0000190900.
FT   TOPO_DOM      1     17       Cytoplasmic.
FT                                {ECO:0000269|PubMed:26280335}.
FT   INTRAMEM     18     36       Helical. {ECO:0000269|PubMed:26280335}.
FT   TOPO_DOM     37     57       Cytoplasmic.
FT                                {ECO:0000269|PubMed:26280335}.
FT   TRANSMEM     58     78       Helical. {ECO:0000269|PubMed:26280335}.
FT   TOPO_DOM     79    101       Lumenal. {ECO:0000269|PubMed:26280335,
FT                                ECO:0000305|PubMed:12639958}.
FT   MUTAGEN      10     10       E->S: Induces a N-linked glycosylation on
FT                                N-8. {ECO:0000269|PubMed:12639958}.
FT   MUTAGEN      15     15       C->A: Decreased APP processing by the
FT                                gamma-secretase complex.
FT                                {ECO:0000269|PubMed:24941111}.
FT   MUTAGEN      15     15       C->S: No effect on APP processing by the
FT                                gamma-secretase complex.
FT                                {ECO:0000269|PubMed:24941111}.
FT   MUTAGEN      25     25       F->A: Decreased APP processing by the
FT                                gamma-secretase complex.
FT                                {ECO:0000269|PubMed:24941111}.
FT   MUTAGEN      26     26       L->A: Decreased APP processing by the
FT                                gamma-secretase complex.
FT                                {ECO:0000269|PubMed:24941111}.
FT   MUTAGEN      30     30       W->A: Decreased expression levels, and
FT                                decreased stimulation of presenilin
FT                                endoproteolysis.
FT                                {ECO:0000269|PubMed:24941111}.
FT   MUTAGEN      33     33       N->A: Increased expression at the cell
FT                                membrane. {ECO:0000269|PubMed:24941111}.
FT   MUTAGEN      36     36       W->A: Decreased APP processing by the
FT                                gamma-secretase complex.
FT                                {ECO:0000269|PubMed:24941111}.
FT   MUTAGEN      46     46       A->N: No effect.
FT                                {ECO:0000269|PubMed:12639958}.
FT   MUTAGEN      54     54       K->A: Decreased APP processing by the
FT                                gamma-secretase complex.
FT                                {ECO:0000269|PubMed:24941111}.
FT   MUTAGEN      93     93       S->N: Induces a N-linked glycosylation.
FT                                {ECO:0000269|PubMed:12639958}.
FT   MUTAGEN      94     94       F->A: Decreased APP processing by the
FT                                gamma-secretase complex.
FT                                {ECO:0000269|PubMed:24941111}.
FT   HELIX         3      5       {ECO:0000244|PDB:5A63}.
FT   HELIX         8     21       {ECO:0000244|PDB:5A63}.
FT   HELIX        27     35       {ECO:0000244|PDB:5A63}.
FT   HELIX        38     43       {ECO:0000244|PDB:5A63}.
FT   HELIX        50     84       {ECO:0000244|PDB:5A63}.
FT   HELIX        87     92       {ECO:0000244|PDB:5A63}.
FT   STRAND       93     95       {ECO:0000244|PDB:5A63}.
SQ   SEQUENCE   101 AA;  12029 MW;  FDBA4D299488EA02 CRC64;
     MNLERVSNEE KLNLCRKYYL GGFAFLPFLW LVNIFWFFRE AFLVPAYTEQ SQIKGYVWRS
     AVGFLFWVIV LTSWITIFQI YRPRWGALGD YLSFTIPLGT P
//
ID   JAG2_MOUSE              Reviewed;        1247 AA.
AC   Q9QYE5; F8VPV5; O55139; O70219;
DT   27-MAR-2002, integrated into UniProtKB/Swiss-Prot.
DT   03-OCT-2012, sequence version 2.
DT   20-DEC-2017, entry version 158.
DE   RecName: Full=Protein jagged-2;
DE            Short=Jagged2;
DE   Flags: Precursor;
GN   Name=Jag2;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Swiss Webster / NIH;
RA   Tsai S.;
RL   Submitted (DEC-1997) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S.,
RA   She X., Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W.,
RA   Kapustin Y., Meric P., Maglott D., Birtle Z., Marques A.C., Graves T.,
RA   Zhou S., Teague B., Potamousis K., Churas C., Place M., Herschleb J.,
RA   Runnheim R., Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z.,
RA   Lindblad-Toh K., Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of
RT   the mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 302-819.
RC   TISSUE=Brain;
RX   PubMed=9341252; DOI=10.1007/s003359900642;
RA   Lan Y., Jiang R., Shawber C., Weinmaster G., Gridley T.;
RT   "The Jagged2 gene maps to chromosome 12 and is a candidate for the lgl
RT   and sm mutations.";
RL   Mamm. Genome 8:875-876(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 325-759.
RC   TISSUE=Brain;
RX   PubMed=9486542; DOI=10.1016/S0925-4773(97)00146-9;
RA   Valsecchi C., Ghezzi C., Ballabio A., Rugarli E.I.;
RT   "JAGGED2: a putative Notch ligand expressed in the apical ectodermal
RT   ridge and in sites of epithelial-mesenchymal interactions.";
RL   Mech. Dev. 69:203-207(1997).
RN   [5]
RP   TISSUE SPECIFICITY.
RX   PubMed=9315665; DOI=10.1128/MCB.17.10.6057;
RA   Luo B., Aster J.C., Hasserjian R.P., Kuo F., Sklar J.;
RT   "Isolation and functional analysis of a cDNA for human Jagged2, a gene
RT   encoding a ligand for the Notch1 receptor.";
RL   Mol. Cell. Biol. 17:6057-6067(1997).
CC   -!- FUNCTION: Putative Notch ligand involved in the mediation of Notch
CC       signaling. Plays an essential role during limb, craniofacial and
CC       thymic development. May be involved in myogenesis and in the
CC       development of peripheral and central nervous systems.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- TISSUE SPECIFICITY: Found to be highest in fetal thymus,
CC       epidermis, foregut dorsal root ganglia and inner ear. In 2-weeK-
CC       old mice, abundant in heart, lung, thymus, skeletal muscle, brain
CC       and testis. Expression overlaps partially with Notch1 expression.
CC       {ECO:0000269|PubMed:9315665}.
CC   -!- DEVELOPMENTAL STAGE: At 13 dpc, found in paravertebral vessels and
CC       dorsal root ganglia. At 14 dpc, in oropharyngeal epithelium,
CC       developing thymus and in the muscles of the tongue. By 15 dpc, in
CC       many tissues.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF038572; AAF16411.1; -; mRNA.
DR   EMBL; AC160929; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AF010137; AAC14010.1; -; mRNA.
DR   EMBL; Y14495; CAA74835.1; -; mRNA.
DR   CCDS; CCDS26200.1; -.
DR   RefSeq; NP_034718.2; NM_010588.2.
DR   UniGene; Mm.186146; -.
DR   ProteinModelPortal; Q9QYE5; -.
DR   SMR; Q9QYE5; -.
DR   BioGrid; 200855; 1.
DR   STRING; 10090.ENSMUSP00000075224; -.
DR   iPTMnet; Q9QYE5; -.
DR   PhosphoSitePlus; Q9QYE5; -.
DR   MaxQB; Q9QYE5; -.
DR   PaxDb; Q9QYE5; -.
DR   PeptideAtlas; Q9QYE5; -.
DR   PRIDE; Q9QYE5; -.
DR   Ensembl; ENSMUST00000075827; ENSMUSP00000075224; ENSMUSG00000002799.
DR   GeneID; 16450; -.
DR   KEGG; mmu:16450; -.
DR   UCSC; uc007pfl.1; mouse.
DR   CTD; 3714; -.
DR   MGI; MGI:1098270; Jag2.
DR   eggNOG; KOG1217; Eukaryota.
DR   eggNOG; ENOG410XP6K; LUCA.
DR   GeneTree; ENSGT00810000125346; -.
DR   HOGENOM; HOG000113124; -.
DR   HOVERGEN; HBG031645; -.
DR   InParanoid; Q9QYE5; -.
DR   KO; K21635; -.
DR   OMA; HHPCTNG; -.
DR   OrthoDB; EOG091G0A88; -.
DR   TreeFam; TF351835; -.
DR   Reactome; R-MMU-1980148; Signaling by NOTCH3.
DR   Reactome; R-MMU-1980150; Signaling by NOTCH4.
DR   Reactome; R-MMU-2122948; Activated NOTCH1 Transmits Signal to the Nucleus.
DR   PRO; PR:Q9QYE5; -.
DR   Proteomes; UP000000589; Chromosome 12.
DR   Bgee; ENSMUSG00000002799; -.
DR   CleanEx; MM_JAG2; -.
DR   Genevisible; Q9QYE5; MM.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:MGI.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0008083; F:growth factor activity; ISS:UniProtKB.
DR   GO; GO:0005112; F:Notch binding; IPI:UniProtKB.
DR   GO; GO:0009912; P:auditory receptor cell fate commitment; IMP:UniProtKB.
DR   GO; GO:0030154; P:cell differentiation; ISO:MGI.
DR   GO; GO:0001709; P:cell fate determination; NAS:UniProtKB.
DR   GO; GO:1990134; P:epithelial cell apoptotic process involved in palatal shelf morphogenesis; IMP:MGI.
DR   GO; GO:0042492; P:gamma-delta T cell differentiation; IMP:UniProtKB.
DR   GO; GO:0001701; P:in utero embryonic development; IMP:MGI.
DR   GO; GO:0016331; P:morphogenesis of embryonic epithelium; IMP:MGI.
DR   GO; GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0042475; P:odontogenesis of dentin-containing tooth; IMP:MGI.
DR   GO; GO:0045747; P:positive regulation of Notch signaling pathway; IDA:UniProtKB.
DR   GO; GO:0030155; P:regulation of cell adhesion; IMP:MGI.
DR   GO; GO:0042127; P:regulation of cell proliferation; ISS:UniProtKB.
DR   GO; GO:0003016; P:respiratory system process; IMP:MGI.
DR   GO; GO:0007605; P:sensory perception of sound; NAS:UniProtKB.
DR   GO; GO:0001501; P:skeletal system development; IMP:MGI.
DR   GO; GO:0007283; P:spermatogenesis; IEA:Ensembl.
DR   GO; GO:0030217; P:T cell differentiation; ISO:MGI.
DR   GO; GO:0045061; P:thymic T cell selection; ISS:UniProtKB.
DR   InterPro; IPR001774; DSL.
DR   InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR000152; EGF-type_Asp/Asn_hydroxyl_site.
DR   InterPro; IPR018097; EGF_Ca-bd_CS.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   InterPro; IPR033108; Jag2.
DR   InterPro; IPR026219; Jagged/Serrate.
DR   InterPro; IPR011651; Notch_ligand_N.
DR   InterPro; IPR001007; VWF_dom.
DR   PANTHER; PTHR44097:SF1; PTHR44097:SF1; 1.
DR   Pfam; PF01414; DSL; 1.
DR   Pfam; PF00008; EGF; 9.
DR   Pfam; PF07645; EGF_CA; 1.
DR   Pfam; PF12661; hEGF; 3.
DR   Pfam; PF07657; MNNL; 1.
DR   PRINTS; PR02059; JAGGEDFAMILY.
DR   SMART; SM00051; DSL; 1.
DR   SMART; SM00181; EGF; 16.
DR   SMART; SM00179; EGF_CA; 14.
DR   SMART; SM00215; VWC_out; 1.
DR   SUPFAM; SSF57184; SSF57184; 2.
DR   PROSITE; PS00010; ASX_HYDROXYL; 10.
DR   PROSITE; PS51051; DSL; 1.
DR   PROSITE; PS00022; EGF_1; 16.
DR   PROSITE; PS01186; EGF_2; 11.
DR   PROSITE; PS50026; EGF_3; 15.
DR   PROSITE; PS01187; EGF_CA; 7.
PE   2: Evidence at transcript level;
KW   Calcium; Complete proteome; Developmental protein; Disulfide bond;
KW   EGF-like domain; Glycoprotein; Membrane; Notch signaling pathway;
KW   Phosphoprotein; Reference proteome; Repeat; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     23       {ECO:0000255}.
FT   CHAIN        24   1247       Protein jagged-2.
FT                                /FTId=PRO_0000007630.
FT   TOPO_DOM     24   1082       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1083   1103       Helical. {ECO:0000255}.
FT   TOPO_DOM   1104   1247       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      196    240       DSL. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00377}.
FT   DOMAIN      241    274       EGF-like 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      275    305       EGF-like 2; atypical.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      307    345       EGF-like 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      347    383       EGF-like 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      385    421       EGF-like 5; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      423    459       EGF-like 6; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      461    496       EGF-like 7; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      498    534       EGF-like 8. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      536    572       EGF-like 9. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      574    634       EGF-like 10; atypical.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      636    672       EGF-like 11; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      674    710       EGF-like 12; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      712    748       EGF-like 13. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      751    787       EGF-like 14. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      789    825       EGF-like 15; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      827    863       EGF-like 16; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   MOD_RES    1125   1125       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9Y219}.
FT   CARBOHYD    153    153       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    570    570       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    619    619       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    752    752       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1060   1060       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    198    207       {ECO:0000250}.
FT   DISULFID    211    223       {ECO:0000250}.
FT   DISULFID    231    240       {ECO:0000250}.
FT   DISULFID    245    256       {ECO:0000250}.
FT   DISULFID    249    262       {ECO:0000250}.
FT   DISULFID    264    273       {ECO:0000250}.
FT   DISULFID    276    287       {ECO:0000250}.
FT   DISULFID    282    293       {ECO:0000250}.
FT   DISULFID    295    304       {ECO:0000250}.
FT   DISULFID    311    323       {ECO:0000250}.
FT   DISULFID    317    333       {ECO:0000250}.
FT   DISULFID    335    344       {ECO:0000250}.
FT   DISULFID    351    362       {ECO:0000250}.
FT   DISULFID    356    371       {ECO:0000250}.
FT   DISULFID    373    382       {ECO:0000250}.
FT   DISULFID    389    400       {ECO:0000250}.
FT   DISULFID    394    409       {ECO:0000250}.
FT   DISULFID    411    420       {ECO:0000250}.
FT   DISULFID    427    438       {ECO:0000250}.
FT   DISULFID    432    447       {ECO:0000250}.
FT   DISULFID    449    458       {ECO:0000250}.
FT   DISULFID    465    475       {ECO:0000250}.
FT   DISULFID    469    484       {ECO:0000250}.
FT   DISULFID    486    495       {ECO:0000250}.
FT   DISULFID    502    513       {ECO:0000250}.
FT   DISULFID    507    522       {ECO:0000250}.
FT   DISULFID    524    533       {ECO:0000250}.
FT   DISULFID    540    551       {ECO:0000250}.
FT   DISULFID    545    560       {ECO:0000250}.
FT   DISULFID    562    571       {ECO:0000250}.
FT   DISULFID    589    612       {ECO:0000255}.
FT   DISULFID    606    622       {ECO:0000255}.
FT   DISULFID    624    633       {ECO:0000250}.
FT   DISULFID    640    651       {ECO:0000250}.
FT   DISULFID    645    660       {ECO:0000250}.
FT   DISULFID    662    671       {ECO:0000250}.
FT   DISULFID    678    689       {ECO:0000250}.
FT   DISULFID    683    698       {ECO:0000250}.
FT   DISULFID    700    709       {ECO:0000250}.
FT   DISULFID    716    727       {ECO:0000250}.
FT   DISULFID    721    736       {ECO:0000250}.
FT   DISULFID    738    747       {ECO:0000250}.
FT   DISULFID    755    766       {ECO:0000250}.
FT   DISULFID    760    775       {ECO:0000250}.
FT   DISULFID    777    786       {ECO:0000250}.
FT   DISULFID    793    804       {ECO:0000250}.
FT   DISULFID    798    813       {ECO:0000250}.
FT   DISULFID    815    824       {ECO:0000250}.
FT   DISULFID    831    842       {ECO:0000250}.
FT   DISULFID    836    851       {ECO:0000250}.
FT   DISULFID    853    862       {ECO:0000250}.
FT   CONFLICT    302    302       L -> M (in Ref. 3; AAC14010).
FT                                {ECO:0000305}.
FT   CONFLICT    378    378       N -> S (in Ref. 1; AAF16411, 3; AAC14010
FT                                and 4; CAA74835). {ECO:0000305}.
FT   CONFLICT    461    461       N -> T (in Ref. 3; AAC14010).
FT                                {ECO:0000305}.
FT   CONFLICT    469    478       CQHGGTCKDL -> VSAWGHLQGP (in Ref. 3;
FT                                AAC14010). {ECO:0000305}.
FT   CONFLICT    492    492       G -> V (in Ref. 3; AAC14010).
FT                                {ECO:0000305}.
FT   CONFLICT    546    546       L -> F (in Ref. 3; AAC14010).
FT                                {ECO:0000305}.
FT   CONFLICT    549    549       A -> V (in Ref. 3; AAC14010).
FT                                {ECO:0000305}.
FT   CONFLICT    735    738       RCAC -> PAR (in Ref. 4; CAA74835).
FT                                {ECO:0000305}.
FT   CONFLICT    809    809       N -> H (in Ref. 3; AAC14010).
FT                                {ECO:0000305}.
FT   CONFLICT    812    812       R -> A (in Ref. 3; AAC14010).
FT                                {ECO:0000305}.
FT   CONFLICT   1030   1030       V -> M (in Ref. 1; AAF16411).
FT                                {ECO:0000305}.
FT   CONFLICT   1126   1126       A -> T (in Ref. 1; AAF16411).
FT                                {ECO:0000305}.
FT   CONFLICT   1223   1223       R -> C (in Ref. 1; AAF16411).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1247 AA;  134745 MW;  E1352B1856946EA6 CRC64;
     MRARGWGRLP RRLLLLLVLC VQATRPMGYF ELQLSALRNV NGELLSGACC DGDGRTTRAG
     GCGRDECDTY VRVCLKEYQA KVTPTGPCSY GYGATPVLGG NSFYLPPAGA AGDRARARSR
     TGGHQDPGLV VIPFQFAWPR SFTLIVEAWD WDNDTTPDEE LLIERVSHAG MINPEDRWKS
     LHFSGHVAHL ELQIRVRCDE NYYSATCNKF CRPRNDFFGH YTCDQYGNKA CMDGWMGKEC
     KEAVCKQGCN LLHGGCTVPG ECRCSYGWQG KFCDECVPYP GCVHGSCVEP WHCDCETNWG
     GLLCDKDLNY CGSHHPCVNG GTCINAEPDQ YLCACPDGYL GKNCERAEHA CASNPCANGG
     SCHEVPSGFE CHCPSGWNGP TCALDIDECA SNPCAAGGTC VDQVDGFECI CPEQWVGATC
     QLDANECEGK PCLNAFSCKN LIGGYYCDCL PGWKGINCQI NINDCHGQCQ HGGTCKDLVN
     GYQCVCPRGF GGRHCELEYD KCASSPCRRG GICEDLVDGF RCHCPRGLSG LHCEVDMDLC
     EPSPCLNGAR CYNLEGDYYC ACPEDFGGKN CSVPRDTCPG GACRVIDGCG FEAGSRARGV
     APSGICGPHG HCVSLPGGNF SCICDSGFTG TYCHENIDDC MGQPCRNGGT CIDEVDSFRC
     FCPSGWEGEL CDINPNDCLP DPCHSRGRCY DLVNDFYCAC DDGWKGKTCH SREFQCDAYT
     CSNGGTCYDS GDTFRCACPP GWKGSTCTIA KNSSCVPNPC VNGGTCVGSG DSFSCICRDG
     WEGRTCTHNT NDCNPLPCYN GGICVDGVNW FRCECAPGFA GPDCRINIDE CQSSPCAYGA
     TCVDEINGYR CSCPPGRSGP RCQEVVIFTR PCWSRGMSFP HGSSWMEDCN SCRCLDGHRD
     CSKVWCGWKP CLLSGQPSDP SAQCPPGQQC QEKAVGQCLQ PPCENWGECT AEEPLPPSTP
     CQPRSSHLDN NCARLTLRFN RDQVPQGTTV GAICSGIRAL PATRAAAHDR LLLLLCDRAS
     SGASAVEVAV SFSPARDLPD SSLIQSTAHA IVAAITQRGN SSLLLAVTEV KVETVVMGGS
     STGLLVPVLC SVFSVLWLAC VVICVWWTRK RRKERERSRL PRDESANNQW APLNPIRNPI
     ERPGGSGLGT GGHKDILYQC KNFTPPPRRA GEALPGPAGH GAGGEDEEDE ELSRGDGDSP
     EAEKFISHKF TKDPSCSLGR PARWAPGPKV DNRAVRSTKD VRRAGRE
//
ID   PSNB_ARATH              Reviewed;         397 AA.
AC   Q9SIK7; Q0IGK6;
DT   26-SEP-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   25-OCT-2017, entry version 111.
DE   RecName: Full=Presenilin-like protein At2g29900;
GN   OrderedLocusNames=At2g29900; ORFNames=F6K5.3;
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliophyta; eudicotyledons; Gunneridae;
OC   Pentapetalae; rosids; malvids; Brassicales; Brassicaceae; Camelineae;
OC   Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=10617197; DOI=10.1038/45471;
RA   Lin X., Kaul S., Rounsley S.D., Shea T.P., Benito M.-I., Town C.D.,
RA   Fujii C.Y., Mason T.M., Bowman C.L., Barnstead M.E., Feldblyum T.V.,
RA   Buell C.R., Ketchum K.A., Lee J.J., Ronning C.M., Koo H.L.,
RA   Moffat K.S., Cronin L.A., Shen M., Pai G., Van Aken S., Umayam L.,
RA   Tallon L.J., Gill J.E., Adams M.D., Carrera A.J., Creasy T.H.,
RA   Goodman H.M., Somerville C.R., Copenhaver G.P., Preuss D.,
RA   Nierman W.C., White O., Eisen J.A., Salzberg S.L., Fraser C.M.,
RA   Venter J.C.;
RT   "Sequence and analysis of chromosome 2 of the plant Arabidopsis
RT   thaliana.";
RL   Nature 402:761-768(1999).
RN   [2]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RG   The Arabidopsis Information Portal (Araport);
RL   Submitted (MAY-2016) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=cv. Columbia;
RA   Bautista V.R., Kim C.J., Chen H., Quinitio C., Ecker J.R.;
RT   "Arabidopsis ORF clones.";
RL   Submitted (SEP-2006) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Probable subunit of the gamma-secretase complex, an
CC       endoprotease complex that catalyzes the intramembrane cleavage of
CC       integral membrane proteins such as Notch receptors. {ECO:0000250}.
CC   -!- SUBUNIT: Homodimer. Probable component of the gamma-secretase
CC       complex, a complex composed of a presenilin homodimer, nicastrin,
CC       APH1 and PEN2 (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}. Golgi
CC       apparatus membrane {ECO:0000250}; Multi-pass membrane protein
CC       {ECO:0000250}.
CC   -!- DOMAIN: The PAL motif is required for normal active site
CC       conformation. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the peptidase A22A family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC007113; AAD23630.1; -; Genomic_DNA.
DR   EMBL; CP002685; AEC08318.1; -; Genomic_DNA.
DR   EMBL; BT028914; ABI49461.1; -; mRNA.
DR   PIR; A84702; A84702.
DR   RefSeq; NP_180551.1; NM_128544.4.
DR   UniGene; At.66277; -.
DR   ProteinModelPortal; Q9SIK7; -.
DR   SMR; Q9SIK7; -.
DR   BioGrid; 2890; 2.
DR   STRING; 3702.AT2G29900.1; -.
DR   MEROPS; A22.A02; -.
DR   iPTMnet; Q9SIK7; -.
DR   PaxDb; Q9SIK7; -.
DR   EnsemblPlants; AT2G29900.1; AT2G29900.1; AT2G29900.
DR   GeneID; 817540; -.
DR   Gramene; AT2G29900.1; AT2G29900.1; AT2G29900.
DR   KEGG; ath:AT2G29900; -.
DR   Araport; AT2G29900; -.
DR   TAIR; locus:2052080; AT2G29900.
DR   eggNOG; KOG2736; Eukaryota.
DR   eggNOG; ENOG410XPZD; LUCA.
DR   HOGENOM; HOG000240228; -.
DR   InParanoid; Q9SIK7; -.
DR   KO; K04505; -.
DR   OMA; IAIHWKG; -.
DR   OrthoDB; EOG09360DOM; -.
DR   PhylomeDB; Q9SIK7; -.
DR   Reactome; R-ATH-6798695; Neutrophil degranulation.
DR   PRO; PR:Q9SIK7; -.
DR   Proteomes; UP000006548; Chromosome 2.
DR   ExpressionAtlas; Q9SIK7; baseline and differential.
DR   Genevisible; Q9SIK7; AT.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005798; C:Golgi-associated vesicle; IDA:TAIR.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:TAIR.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0004190; F:aspartic-type endopeptidase activity; IEA:InterPro.
DR   GO; GO:0004175; F:endopeptidase activity; IBA:GO_Central.
DR   GO; GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0016485; P:protein processing; IEA:InterPro.
DR   InterPro; IPR001108; Peptidase_A22A.
DR   InterPro; IPR006639; Preselin/SPP.
DR   PANTHER; PTHR10202; PTHR10202; 2.
DR   Pfam; PF01080; Presenilin; 1.
DR   PRINTS; PR01072; PRESENILIN.
DR   SMART; SM00730; PSN; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Endoplasmic reticulum; Golgi apparatus; Membrane;
KW   Notch signaling pathway; Reference proteome; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1    397       Presenilin-like protein At2g29900.
FT                                /FTId=PRO_0000073906.
FT   TOPO_DOM      1     17       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     18     38       Helical. {ECO:0000255}.
FT   TOPO_DOM     39     76       Lumenal. {ECO:0000255}.
FT   TRANSMEM     77     97       Helical. {ECO:0000255}.
FT   TOPO_DOM     98    106       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    107    127       Helical. {ECO:0000255}.
FT   TOPO_DOM    128    135       Lumenal. {ECO:0000255}.
FT   TRANSMEM    136    156       Helical. {ECO:0000255}.
FT   TOPO_DOM    157    158       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    159    179       Helical. {ECO:0000255}.
FT   TOPO_DOM    180    188       Lumenal. {ECO:0000255}.
FT   TRANSMEM    189    209       Helical. {ECO:0000255}.
FT   TOPO_DOM    210    305       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    306    326       Helical. {ECO:0000255}.
FT   TOPO_DOM    327    336       Lumenal. {ECO:0000255}.
FT   TRANSMEM    337    357       Helical. {ECO:0000255}.
FT   TOPO_DOM    358    366       Cytoplasmic. {ECO:0000255}.
FT   INTRAMEM    367    387       Helical. {ECO:0000255}.
FT   TOPO_DOM    388    397       Cytoplasmic. {ECO:0000255}.
FT   MOTIF       363    365       PAL.
FT   ACT_SITE    198    198       {ECO:0000250}.
FT   ACT_SITE    318    318       {ECO:0000250}.
SQ   SEQUENCE   397 AA;  44012 MW;  DE6804D6CA186783 CRC64;
     MDRNQRPRSI LDSLGEELIA ILTPVSICMF TVVLLVCILN SDPSSSSASF SSIATAAYSE
     SDSDSSWDKF VGALLNSVVF VAAITVATFV LVLLFYLRCV KFLKFYMGFS AFIVLGNLGG
     EILVLLIDRF RFPIDSITFL ILLFNFSVVG VFAVFMSKFS ILITQGYLVW IGVLVAYFFT
     LLPEWTTWVL LVALALYDIA AVLLPVGPLR LLVEMAISRD EDIPALVYEA RPVIRNDSRS
     VQRRVWREQR SSQNNANRNE VRVVESAEVE EEHVGSSERA EISVPLIDRR PEQAENSETF
     LEGIGLGSSG AIKLGLGDFI FYSVLVGRAA MYDLMTVYAC YLAIIAGLGI TLMLLSVYQK
     ALPALPVSIM LGVVFYFLAR LLLEVFVVQC SSNLVMF
//
ID   PEN2_CAEEL              Reviewed;         101 AA.
AC   Q9U357;
DT   26-SEP-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   22-NOV-2017, entry version 116.
DE   RecName: Full=Gamma-secretase subunit pen-2;
DE   AltName: Full=Presenilin enhancer protein 2;
GN   Name=pen-2; ORFNames=T28D6.9;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditoidea; Rhabditidae; Peloderinae; Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=12110170; DOI=10.1016/S1534-5807(02)00189-2;
RA   Francis R., McGrath G., Zhang J., Ruddy D.A., Sym M., Apfeld J.,
RA   Nicoll M., Maxwell M., Hai B., Ellis M.C., Parks A.L., Xu W., Li J.,
RA   Gurney M., Myers R.L., Himes C.S., Hiebsch R., Ruble C., Nye J.S.,
RA   Curtis D.;
RT   "aph-1 and pen-2 are required for Notch pathway signaling, gamma-
RT   secretase cleavage of betaAPP, and presenilin protein accumulation.";
RL   Dev. Cell 3:85-97(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for
RT   investigating biology.";
RL   Science 282:2012-2018(1998).
CC   -!- FUNCTION: Essential subunit of the gamma-secretase complex, an
CC       endoprotease complex that catalyzes the intramembrane cleavage of
CC       integral membrane proteins such as Notch (glp-1 or lin-12). It may
CC       represent a stabilizing cofactor for the presenilin homodimer that
CC       promotes the formation of a stable complex.
CC       {ECO:0000269|PubMed:12110170}.
CC   -!- SUBUNIT: Component of the gamma-secretase complex, a complex
CC       probably composed of the presenilin homodimer (sel-12, hop-1 or
CC       spe-4), nicastrin (aph-2), aph-1 and pen-2. {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:12110170}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:12110170}. Golgi apparatus membrane
CC       {ECO:0000269|PubMed:12110170}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:12110170}. Note=Predominantly located in the
CC       endoplasmic reticulum and Golgi region.
CC   -!- TISSUE SPECIFICITY: Expressed from 100-cell stage in most somatic
CC       tissues, including neurons, muscle, intestine and developing
CC       vulva. Little or not expressed in early embryos.
CC       {ECO:0000269|PubMed:12110170}.
CC   -!- SIMILARITY: Belongs to the PEN-2 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Z81134; CAB54316.1; -; Genomic_DNA.
DR   PIR; T25417; T25417.
DR   RefSeq; NP_499459.1; NM_067058.4.
DR   UniGene; Cel.9963; -.
DR   ProteinModelPortal; Q9U357; -.
DR   SMR; Q9U357; -.
DR   BioGrid; 41747; 1.
DR   DIP; DIP-26665N; -.
DR   MINT; MINT-1063487; -.
DR   STRING; 6239.T28D6.9; -.
DR   PaxDb; Q9U357; -.
DR   EnsemblMetazoa; T28D6.9; T28D6.9; WBGene00003975.
DR   GeneID; 176565; -.
DR   KEGG; cel:CELE_T28D6.9; -.
DR   UCSC; T28D6.9; c. elegans.
DR   CTD; 251430; -.
DR   WormBase; T28D6.9; CE24023; WBGene00003975; pen-2.
DR   eggNOG; KOG3402; Eukaryota.
DR   eggNOG; ENOG4111W09; LUCA.
DR   GeneTree; ENSGT00390000016319; -.
DR   HOGENOM; HOG000006914; -.
DR   InParanoid; Q9U357; -.
DR   KO; K06170; -.
DR   OMA; WFFQEAF; -.
DR   OrthoDB; EOG091G0X8A; -.
DR   PhylomeDB; Q9U357; -.
DR   Reactome; R-CEL-3928665; EPH-ephrin mediated repulsion of cells.
DR   SignaLink; Q9U357; -.
DR   PRO; PR:Q9U357; -.
DR   Proteomes; UP000001940; Chromosome III.
DR   Bgee; WBGene00003975; -.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0070765; C:gamma-secretase complex; ISS:WormBase.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; IDA:WormBase.
DR   GO; GO:0045165; P:cell fate commitment; IGI:WormBase.
DR   GO; GO:0009792; P:embryo development ending in birth or egg hatching; IMP:WormBase.
DR   GO; GO:0048598; P:embryonic morphogenesis; IMP:WormBase.
DR   GO; GO:0007281; P:germ cell development; IGI:WormBase.
DR   GO; GO:0007220; P:Notch receptor processing; IBA:GO_Central.
DR   GO; GO:0007219; P:Notch signaling pathway; IMP:WormBase.
DR   GO; GO:0060465; P:pharynx development; IMP:WormBase.
DR   InterPro; IPR019379; Gamma_Secretase_Asp_P_PEN2.
DR   PANTHER; PTHR16318; PTHR16318; 1.
DR   Pfam; PF10251; PEN-2; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Endoplasmic reticulum; Golgi apparatus; Membrane;
KW   Notch signaling pathway; Reference proteome; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1    101       Gamma-secretase subunit pen-2.
FT                                /FTId=PRO_0000190903.
FT   TOPO_DOM      1     17       Lumenal. {ECO:0000255}.
FT   TRANSMEM     18     38       Helical. {ECO:0000255}.
FT   TOPO_DOM     39     57       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     58     78       Helical. {ECO:0000255}.
FT   TOPO_DOM     79    101       Lumenal. {ECO:0000255}.
SQ   SEQUENCE   101 AA;  11943 MW;  4DE2725C569CDB4B CRC64;
     MDISKLTDVK KVDLCKKYFL IGACFLPLVW IVNTFWFFSD AFCKPINAHR RQIRKYVIAS
     IVGSIFWIIV LSAWEIFFQH YRAQGLVWTD FLTFVFPTGR V
//
ID   AMX_DROME               Reviewed;         284 AA.
AC   Q9U4H5; Q9W361;
DT   21-AUG-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   27-SEP-2017, entry version 100.
DE   RecName: Full=TM2 domain-containing protein almondex;
DE   Flags: Precursor;
GN   Name=amx; ORFNames=CG12127;
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha;
OC   Ephydroidea; Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Ovary;
RX   PubMed=14595834; DOI=10.1002/gene.10233;
RA   Michellod M.-A.E., Forquignon F., Santamaria P., Randsholt N.B.;
RT   "Differential requirements for the neurogenic gene almondex during
RT   Drosophila melanogaster development.";
RL   Genesis 37:113-122(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley;
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X.,
RA   Brandon R.C., Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D.,
RA   Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G.,
RA   Abril J.F., Agbayani A., An H.-J., Andrews-Pfannkoch C., Baldwin D.,
RA   Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M.,
RA   Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S.,
RA   Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P.,
RA   Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I.,
RA   Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P.,
RA   de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M.,
RA   Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P.,
RA   Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W.,
RA   Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K.,
RA   Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J.,
RA   Hostin D., Houston K.A., Howland T.J., Wei M.-H., Ibegwam C.,
RA   Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A.,
RA   Kimmel B.E., Kodira C.D., Kraft C.L., Kravitz S., Kulp D., Lai Z.,
RA   Lasko P., Lei Y., Levitsky A.A., Li J.H., Li Z., Liang Y., Lin X.,
RA   Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D.,
RA   Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A.,
RA   Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L.,
RA   Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M.,
RA   Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G.,
RA   Reinert K., Remington K., Saunders R.D.C., Scheeler F., Shen H.,
RA   Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E.,
RA   Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X.,
RA   Wang Z.-Y., Wassarman D.A., Weinstock G.M., Weissenbach J.,
RA   Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A.,
RA   Ye J., Yeh R.-F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L.,
RA   Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S.C., Zhu X.,
RA   Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q.,
RA   Stapleton M., Yamada C., Ashburner M., Gelbart W.M., Rubin G.M.,
RA   Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a
RT   systematic review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=Berkeley; TISSUE=Head;
RX   PubMed=10731138; DOI=10.1126/science.287.5461.2222;
RA   Rubin G.M., Hong L., Brokstein P., Evans-Holm M., Frise E.,
RA   Stapleton M., Harvey D.A.;
RT   "A Drosophila complementary DNA resource.";
RL   Science 287:2222-2224(2000).
CC   -!- FUNCTION: Involved in the control of cell fates in the
CC       neurectoderm. Acts as a positive regulator of Notch pathway and is
CC       required at different levels during development.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the TM2 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF217797; AAF36924.2; -; mRNA.
DR   EMBL; AE014298; AAF46474.2; -; Genomic_DNA.
DR   EMBL; AF181623; AAD55409.1; -; mRNA.
DR   RefSeq; NP_001245591.1; NM_001258662.2.
DR   RefSeq; NP_524644.1; NM_079905.3.
DR   UniGene; Dm.1883; -.
DR   BioGrid; 68680; 2.
DR   PaxDb; Q9U4H5; -.
DR   PRIDE; Q9U4H5; -.
DR   EnsemblMetazoa; FBtr0071331; FBpp0071266; FBgn0000077.
DR   EnsemblMetazoa; FBtr0307281; FBpp0298282; FBgn0000077.
DR   GeneID; 43869; -.
DR   KEGG; dme:Dmel_CG12127; -.
DR   UCSC; CG12127-RA; d. melanogaster.
DR   CTD; 43869; -.
DR   FlyBase; FBgn0000077; amx.
DR   eggNOG; ENOG410IU6Z; Eukaryota.
DR   eggNOG; ENOG4111HJK; LUCA.
DR   GeneTree; ENSGT00730000110935; -.
DR   InParanoid; Q9U4H5; -.
DR   OMA; LLISMHY; -.
DR   OrthoDB; EOG091G0MAM; -.
DR   PhylomeDB; Q9U4H5; -.
DR   GenomeRNAi; 43869; -.
DR   PRO; PR:Q9U4H5; -.
DR   Proteomes; UP000000803; Chromosome X.
DR   Bgee; FBgn0000077; -.
DR   Genevisible; Q9U4H5; DM.
DR   GO; GO:0044214; C:spanning component of plasma membrane; ISM:FlyBase.
DR   GO; GO:0007398; P:ectoderm development; TAS:FlyBase.
DR   GO; GO:0001713; P:ectodermal cell fate determination; IMP:UniProtKB.
DR   GO; GO:0046331; P:lateral inhibition; IMP:FlyBase.
DR   GO; GO:0007498; P:mesoderm development; IMP:FlyBase.
DR   GO; GO:0007220; P:Notch receptor processing; IGI:FlyBase.
DR   GO; GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0045747; P:positive regulation of Notch signaling pathway; IMP:UniProtKB.
DR   InterPro; IPR007829; TM2.
DR   Pfam; PF05154; TM2; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome; Developmental protein; Glycoprotein; Membrane;
KW   Notch signaling pathway; Reference proteome; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     32       {ECO:0000255}.
FT   CHAIN        33    284       TM2 domain-containing protein almondex.
FT                                /FTId=PRO_0000298999.
FT   TRANSMEM    226    246       Helical. {ECO:0000255}.
FT   TRANSMEM    250    270       Helical. {ECO:0000255}.
FT   CARBOHYD     53     53       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     89     89       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    141    141       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    194    194       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    206    206       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    216    216       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
SQ   SEQUENCE   284 AA;  31364 MW;  8FB8FFB5733AC851 CRC64;
     MRLQRQCIVV NMRSAIVLIM IFVLTGIRNS ETASGGNQMD LSDSKGDHKD NSNASNGNGN
     ANDNEVYVPP LVSSMVAKSG GGAGGLLDNI TAYSSSSSSS SSNGNNNMLC PYDKETPCDR
     LQFPCIRCNY NHGCIYGRDL NVTCEVINNV QCLGERSFQR QMNCRYCYQT EMWQQSCGQR
     SSCNSATDKL FRTNCTVHHD VLCLGNRSFT RNLRCNWTQG YRWSTALLIS LTLGGFGADR
     FYLGHWQEGI GKLFSFGGLG VWTIIDVLLI SMHYLGPADG SLYI
//
ID   SE1L1_HUMAN             Reviewed;         794 AA.
AC   Q9UBV2; Q6UWT6; Q9P1T9; Q9UHK7;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   12-APR-2005, sequence version 3.
DT   25-OCT-2017, entry version 154.
DE   RecName: Full=Protein sel-1 homolog 1;
DE   AltName: Full=Suppressor of lin-12-like protein 1;
DE            Short=Sel-1L;
DE   Flags: Precursor;
GN   Name=SEL1L; Synonyms=TSA305; ORFNames=UNQ128/PRO1063;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Pancreas;
RX   PubMed=10496078; DOI=10.1007/s100380050171;
RA   Harada Y., Ozaki K., Suzuki M., Fujiwara T., Takahashi E.,
RA   Nakamura Y., Tanigami A.;
RT   "Complete cDNA sequence and genomic organization of a human pancreas-
RT   specific gene homologous to Caenorhabditis elegans sel-1.";
RL   J. Hum. Genet. 44:330-336(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Pancreas;
RX   PubMed=10746565; DOI=10.1007/s004390051032;
RA   Biunno I., Bernard L., Dear P., Cattaneo M., Volorio S., Zannini L.,
RA   Bankier A., Zollo M.;
RT   "SEL1L, the human homolog of C. elegans sel-1: refined physical
RT   mapping, gene structure and identification of polymorphic markers.";
RL   Hum. Genet. 106:227-235(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [4]
RP   GLYCOSYLATION AT ASN-272.
RX   PubMed=12754519; DOI=10.1038/nbt827;
RA   Zhang H., Li X.-J., Martin D.B., Aebersold R.;
RT   "Identification and quantification of N-linked glycoproteins using
RT   hydrazide chemistry, stable isotope labeling and mass spectrometry.";
RL   Nat. Biotechnol. 21:660-666(2003).
RN   [5]
RP   FUNCTION, INTERACTION WITH SYVN1, IDENTIFICATION IN A COMPLEX WITH
RP   SYVN1 AND DERL2, AND SUBCELLULAR LOCATION.
RX   PubMed=16186509; DOI=10.1073/pnas.0505014102;
RA   Lilley B.N., Ploegh H.L.;
RT   "Multiprotein complexes that link dislocation, ubiquitination, and
RT   extraction of misfolded proteins from the endoplasmic reticulum
RT   membrane.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:14296-14301(2005).
RN   [6]
RP   GLYCOSYLATION, AND INTERACTION WITH ERLEC1; HSPA5; OS9 AND SYVN1.
RX   PubMed=18502753; DOI=10.1074/jbc.M709336200;
RA   Hosokawa N., Wada I., Nagasawa K., Moriyama T., Okawa K., Nagata K.;
RT   "Human XTP3-B forms an endoplasmic reticulum quality control scaffold
RT   with the HRD1-SEL1L ubiquitin ligase complex and BiP.";
RL   J. Biol. Chem. 283:20914-20924(2008).
RN   [7]
RP   INTERACTION WITH ERLEC1; OS9 AND SYVN1.
RX   PubMed=18264092; DOI=10.1038/ncb1689;
RA   Christianson J.C., Shaler T.A., Tyler R.E., Kopito R.R.;
RT   "OS-9 and GRP94 deliver mutant alpha1-antitrypsin to the Hrd1-SEL1L
RT   ubiquitin ligase complex for ERAD.";
RL   Nat. Cell Biol. 10:272-282(2008).
RN   [8]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-431 AND ASN-608.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [9]
RP   INTERACTION WITH EDEM1.
RX   PubMed=19524542; DOI=10.1016/j.molcel.2009.05.018;
RA   Cormier J.H., Tamura T., Sunryd J.C., Hebert D.N.;
RT   "EDEM1 recognition and delivery of misfolded proteins to the SEL1L-
RT   containing ERAD complex.";
RL   Mol. Cell 34:627-633(2009).
RN   [10]
RP   INTERACTION WITH FOXRED2.
RX   PubMed=19706418; DOI=10.1073/pnas.0900742106;
RA   Riemer J., Appenzeller-Herzog C., Johansson L., Bodenmiller B.,
RA   Hartmann-Petersen R., Ellgaard L.;
RT   "A luminal flavoprotein in endoplasmic reticulum-associated
RT   degradation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:14831-14836(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   INTERACTION WITH LPL.
RX   PubMed=25066055; DOI=10.1016/j.cmet.2014.06.015;
RA   Sha H., Sun S., Francisco A.B., Ehrhardt N., Xue Z., Liu L.,
RA   Lawrence P., Mattijssen F., Guber R.D., Panhwar M.S., Brenna J.T.,
RA   Shi H., Xue B., Kersten S., Bensadoun A., Peterfy M., Long Q., Qi L.;
RT   "The ER-associated degradation adaptor protein Sel1L regulates LPL
RT   secretion and lipid metabolism.";
RL   Cell Metab. 20:458-470(2014).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-63, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14]
RP   FUNCTION, AND INTERACTION WITH SYVN1.
RX   PubMed=26471130; DOI=10.1111/febs.13564;
RA   Hosokawa N., Wada I.;
RT   "Association of the SEL1L protein transmembrane domain with HRD1
RT   ubiquitin ligase regulates ERAD-L.";
RL   FEBS J. 283:157-172(2016).
CC   -!- FUNCTION: Plays a role in the endoplasmic reticulum quality
CC       control (ERQC) system also called ER-associated degradation (ERAD)
CC       involved in ubiquitin-dependent degradation of misfolded
CC       endoplasmic reticulum proteins (PubMed:16186509). Enhances SYVN1
CC       stability. Plays a role in LPL maturation and secretion. Required
CC       for normal differentiation of the pancreas epithelium, and for
CC       normal exocrine function and survival of pancreatic cells. May
CC       play a role in Notch signaling. {ECO:0000250|UniProtKB:Q9Z2G6,
CC       ECO:0000269|PubMed:16186509}.
CC   -!- SUBUNIT: Homodimer and homooligomer (By similarity). Interacts
CC       with SYVN1; the interaction is direct (PubMed:26471130). Part of a
CC       complex containing SEL1L, SYVN1 and DERL2 (PubMed:16186509). May
CC       form a complex with ERLEC1, HSPA5, OS9, and SYVN1
CC       (PubMed:18502753, PubMed:18264092). Interacts with FOXRED2 and
CC       EDEM1 (PubMed:19524542, PubMed:19706418). Interacts with LPL
CC       (PubMed:25066055). Interacts with LMF1; may stabilize the complex
CC       formed by LPL and LMF1 and thereby promote the export of LPL
CC       dimers (By similarity). {ECO:0000250|UniProtKB:Q9Z2G6,
CC       ECO:0000269|PubMed:16186509, ECO:0000269|PubMed:18264092,
CC       ECO:0000269|PubMed:18502753, ECO:0000269|PubMed:19524542,
CC       ECO:0000269|PubMed:19706418, ECO:0000269|PubMed:25066055,
CC       ECO:0000269|PubMed:26471130}.
CC   -!- INTERACTION:
CC       O75460-1:ERN1; NbExp=2; IntAct=EBI-358766, EBI-15600828;
CC       Q8IWF2:FOXRED2; NbExp=3; IntAct=EBI-358766, EBI-10763361;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:16186509}; Single-pass type I membrane protein
CC       {ECO:0000269|PubMed:16186509}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9UBV2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UBV2-2; Sequence=VSP_013322, VSP_013323;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Highly expressed in pancreas.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:12754519,
CC       ECO:0000269|PubMed:18502753, ECO:0000269|PubMed:19159218}.
CC   -!- SIMILARITY: Belongs to the sel-1 family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/SEL1LID42246ch14q24.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB024763; BAA89204.1; -; Genomic_DNA.
DR   EMBL; AB020335; BAA87904.1; -; mRNA.
DR   EMBL; AF052059; AAF29413.1; -; mRNA.
DR   EMBL; AF157516; AAF24176.1; -; Genomic_DNA.
DR   EMBL; AF198647; AAL40905.1; -; Genomic_DNA.
DR   EMBL; AF198631; AAL40905.1; JOINED; Genomic_DNA.
DR   EMBL; AF198632; AAL40905.1; JOINED; Genomic_DNA.
DR   EMBL; AF198633; AAL40905.1; JOINED; Genomic_DNA.
DR   EMBL; AF198634; AAL40905.1; JOINED; Genomic_DNA.
DR   EMBL; AF198635; AAL40905.1; JOINED; Genomic_DNA.
DR   EMBL; AF198636; AAL40905.1; JOINED; Genomic_DNA.
DR   EMBL; AF198637; AAL40905.1; JOINED; Genomic_DNA.
DR   EMBL; AF198638; AAL40905.1; JOINED; Genomic_DNA.
DR   EMBL; AF198639; AAL40905.1; JOINED; Genomic_DNA.
DR   EMBL; AF198640; AAL40905.1; JOINED; Genomic_DNA.
DR   EMBL; AF198641; AAL40905.1; JOINED; Genomic_DNA.
DR   EMBL; AF198642; AAL40905.1; JOINED; Genomic_DNA.
DR   EMBL; AF198643; AAL40905.1; JOINED; Genomic_DNA.
DR   EMBL; AF198644; AAL40905.1; JOINED; Genomic_DNA.
DR   EMBL; AF198645; AAL40905.1; JOINED; Genomic_DNA.
DR   EMBL; AF198646; AAL40905.1; JOINED; Genomic_DNA.
DR   EMBL; AY358651; AAQ89014.1; -; mRNA.
DR   CCDS; CCDS58333.1; -. [Q9UBV2-2]
DR   CCDS; CCDS9876.1; -. [Q9UBV2-1]
DR   RefSeq; NP_001231913.1; NM_001244984.1. [Q9UBV2-2]
DR   RefSeq; NP_005056.3; NM_005065.5. [Q9UBV2-1]
DR   UniGene; Hs.181300; -.
DR   ProteinModelPortal; Q9UBV2; -.
DR   SMR; Q9UBV2; -.
DR   BioGrid; 112300; 63.
DR   CORUM; Q9UBV2; -.
DR   DIP; DIP-46259N; -.
DR   IntAct; Q9UBV2; 17.
DR   MINT; MINT-1153834; -.
DR   STRING; 9606.ENSP00000337053; -.
DR   iPTMnet; Q9UBV2; -.
DR   PhosphoSitePlus; Q9UBV2; -.
DR   SwissPalm; Q9UBV2; -.
DR   BioMuta; SEL1L; -.
DR   DMDM; 62512184; -.
DR   EPD; Q9UBV2; -.
DR   PaxDb; Q9UBV2; -.
DR   PeptideAtlas; Q9UBV2; -.
DR   PRIDE; Q9UBV2; -.
DR   Ensembl; ENST00000336735; ENSP00000337053; ENSG00000071537. [Q9UBV2-1]
DR   Ensembl; ENST00000555824; ENSP00000450709; ENSG00000071537. [Q9UBV2-2]
DR   GeneID; 6400; -.
DR   KEGG; hsa:6400; -.
DR   UCSC; uc001xvo.5; human. [Q9UBV2-1]
DR   CTD; 6400; -.
DR   DisGeNET; 6400; -.
DR   EuPathDB; HostDB:ENSG00000071537.13; -.
DR   GeneCards; SEL1L; -.
DR   HGNC; HGNC:10717; SEL1L.
DR   HPA; HPA024267; -.
DR   MIM; 602329; gene.
DR   neXtProt; NX_Q9UBV2; -.
DR   OpenTargets; ENSG00000071537; -.
DR   PharmGKB; PA35639; -.
DR   eggNOG; KOG1550; Eukaryota.
DR   eggNOG; COG0790; LUCA.
DR   GeneTree; ENSGT00530000063170; -.
DR   HOGENOM; HOG000239927; -.
DR   HOVERGEN; HBG057766; -.
DR   InParanoid; Q9UBV2; -.
DR   KO; K14026; -.
DR   OMA; LAQMAMG; -.
DR   OrthoDB; EOG091G0315; -.
DR   PhylomeDB; Q9UBV2; -.
DR   TreeFam; TF315257; -.
DR   Reactome; R-HSA-1912420; Pre-NOTCH Processing in Golgi.
DR   Reactome; R-HSA-382556; ABC-family proteins mediated transport.
DR   Reactome; R-HSA-5358346; Hedgehog ligand biogenesis.
DR   Reactome; R-HSA-5362768; Hh mutants that don't undergo autocatalytic processing are degraded by ERAD.
DR   Reactome; R-HSA-5678895; Defective CFTR causes cystic fibrosis.
DR   Reactome; R-HSA-901032; ER Quality Control Compartment (ERQC).
DR   ChiTaRS; SEL1L; human.
DR   GeneWiki; SEL1L; -.
DR   GenomeRNAi; 6400; -.
DR   PRO; PR:Q9UBV2; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000071537; -.
DR   CleanEx; HS_SEL1L; -.
DR   ExpressionAtlas; Q9UBV2; baseline and differential.
DR   Genevisible; Q9UBV2; HS.
DR   GO; GO:0036513; C:Derlin-1 retrotranslocation complex; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0044322; C:endoplasmic reticulum quality control compartment; IEA:GOC.
DR   GO; GO:0000836; C:Hrd1p ubiquitin ligase complex; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0000839; C:Hrd1p ubiquitin ligase ERAD-L complex; IMP:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:1904380; P:endoplasmic reticulum mannose trimming; TAS:Reactome.
DR   GO; GO:0036503; P:ERAD pathway; IMP:UniProtKB.
DR   GO; GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0009306; P:protein secretion; ISS:UniProtKB.
DR   GO; GO:0050821; P:protein stabilization; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0030970; P:retrograde protein transport, ER to cytosol; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0055085; P:transmembrane transport; TAS:Reactome.
DR   GO; GO:0006641; P:triglyceride metabolic process; ISS:UniProtKB.
DR   GO; GO:0030433; P:ubiquitin-dependent ERAD pathway; TAS:ParkinsonsUK-UCL.
DR   CDD; cd00062; FN2; 1.
DR   Gene3D; 2.10.10.10; -; 1.
DR   InterPro; IPR000562; FN_type2_dom.
DR   InterPro; IPR036943; FN_type2_sf.
DR   InterPro; IPR013806; Kringle-like.
DR   InterPro; IPR006597; Sel1-like.
DR   Pfam; PF00040; fn2; 1.
DR   Pfam; PF08238; Sel1; 12.
DR   SMART; SM00059; FN2; 1.
DR   SMART; SM00671; SEL1; 11.
DR   SUPFAM; SSF57440; SSF57440; 1.
DR   PROSITE; PS00023; FN2_1; 1.
DR   PROSITE; PS51092; FN2_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Disulfide bond;
KW   Endoplasmic reticulum; Glycoprotein; Membrane;
KW   Notch signaling pathway; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repeat; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     21       {ECO:0000255}.
FT   CHAIN        22    794       Protein sel-1 homolog 1.
FT                                /FTId=PRO_0000022294.
FT   TOPO_DOM     22    738       Lumenal. {ECO:0000255}.
FT   TRANSMEM    739    759       Helical. {ECO:0000255}.
FT   TOPO_DOM    760    794       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      122    170       Fibronectin type-II.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00479}.
FT   REPEAT      183    218       Sel1-like 1.
FT   REPEAT      219    254       Sel1-like 2.
FT   REPEAT      255    290       Sel1-like 3.
FT   REPEAT      291    326       Sel1-like 4.
FT   REPEAT      373    409       Sel1-like 5.
FT   REPEAT      410    446       Sel1-like 6.
FT   REPEAT      447    482       Sel1-like 7.
FT   REPEAT      483    518       Sel1-like 8.
FT   REPEAT      519    554       Sel1-like 9.
FT   REPEAT      627    662       Sel1-like 10.
FT   REPEAT      664    699       Sel1-like 11.
FT   REGION       22    737       Interaction with ERLEC1, OS9 and SYVN1.
FT   REGION      352    537       Important for homodimerization and
FT                                oligomerization.
FT                                {ECO:0000250|UniProtKB:Q9Z2G6}.
FT   REGION      643    723       Interaction with SYVN1.
FT                                {ECO:0000250|UniProtKB:Q9Z2G6}.
FT   REGION      738    794       Mediates retention in the endoplasmic
FT                                reticulum.
FT   COMPBIAS    770    793       Pro-rich.
FT   MOD_RES      63     63       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   CARBOHYD    195    195       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    217    217       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    272    272       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:12754519}.
FT   CARBOHYD    431    431       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    608    608       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   DISULFID    127    153       {ECO:0000255|PROSITE-ProRule:PRU00479}.
FT   DISULFID    141    168       {ECO:0000255|PROSITE-ProRule:PRU00479}.
FT   VAR_SEQ     298    301       GYRY -> VSRL (in isoform 2).
FT                                {ECO:0000303|PubMed:12975309}.
FT                                /FTId=VSP_013322.
FT   VAR_SEQ     302    794       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:12975309}.
FT                                /FTId=VSP_013323.
FT   VARIANT     162    162       D -> G (in dbSNP:rs11499034).
FT                                /FTId=VAR_029303.
FT   VARIANT     714    714       V -> I (in dbSNP:rs1051193).
FT                                /FTId=VAR_053963.
FT   CONFLICT    186    186       M -> V (in Ref. 2; AAF29413/AAL40905).
FT                                {ECO:0000305}.
SQ   SEQUENCE   794 AA;  88755 MW;  323EB03DC7485459 CRC64;
     MRVRIGLTLL LCAVLLSLAS ASSDEEGSQD ESLDSKTTLT SDESVKDHTT AGRVVAGQIF
     LDSEESELES SIQEEEDSLK SQEGESVTED ISFLESPNPE NKDYEEPKKV RKPALTAIEG
     TAHGEPCHFP FLFLDKEYDE CTSDGREDGR LWCATTYDYK ADEKWGFCET EEEAAKRRQM
     QEAEMMYQTG MKILNGSNKK SQKREAYRYL QKAASMNHTK ALERVSYALL FGDYLPQNIQ
     AAREMFEKLT EEGSPKGQTA LGFLYASGLG VNSSQAKALV YYTFGALGGN LIAHMVLGYR
     YWAGIGVLQS CESALTHYRL VANHVASDIS LTGGSVVQRI RLPDEVENPG MNSGMLEEDL
     IQYYQFLAEK GDVQAQVGLG QLHLHGGRGV EQNHQRAFDY FNLAANAGNS HAMAFLGKMY
     SEGSDIVPQS NETALHYFKK AADMGNPVGQ SGLGMAYLYG RGVQVNYDLA LKYFQKAAEQ
     GWVDGQLQLG SMYYNGIGVK RDYKQALKYF NLASQGGHIL AFYNLAQMHA SGTGVMRSCH
     TAVELFKNVC ERGRWSERLM TAYNSYKDGD YNAAVIQYLL LAEQGYEVAQ SNAAFILDQR
     EASIVGENET YPRALLHWNR AASQGYTVAR IKLGDYHFYG FGTDVDYETA FIHYRLASEQ
     QHSAQAMFNL GYMHEKGLGI KQDIHLAKRF YDMAAEASPD AQVPVFLALC KLGVVYFLQY
     IRETNIRDMF TQLDMDQLLG PEWDLYLMTI IALLLGTVIA YRQRQHQDMP APRPPGPRPA
     PPQQEGPPEQ QPPQ
//
ID   NOTC3_HUMAN             Reviewed;        2321 AA.
AC   Q9UM47; Q9UEB3; Q9UPL3; Q9Y6L8;
DT   27-MAR-2002, integrated into UniProtKB/Swiss-Prot.
DT   08-FEB-2011, sequence version 2.
DT   20-DEC-2017, entry version 187.
DE   RecName: Full=Neurogenic locus notch homolog protein 3;
DE            Short=Notch 3;
DE   Contains:
DE     RecName: Full=Notch 3 extracellular truncation;
DE   Contains:
DE     RecName: Full=Notch 3 intracellular domain;
DE   Flags: Precursor;
GN   Name=NOTCH3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT VAL-2223.
RX   PubMed=8878478; DOI=10.1038/383707a0;
RA   Joutel A., Corpechot C., Ducros A., Vahedi K., Chabriat H., Mouton P.,
RA   Alamowitch S., Domenga V., Cecillion M., Marechal E., Maciazek J.,
RA   Vayssiere C., Cruaud C., Cabanis E.-A., Ruchoux M.M., Weissenbach J.,
RA   Bach J.-F., Bousser M.-G., Tournier-Lasserve E.;
RT   "Notch3 mutations in CADASIL, a hereditary adult-onset condition
RT   causing stroke and dementia.";
RL   Nature 383:707-710(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Gunel M., Artavanis-Tsakonas S.;
RL   Submitted (APR-1998) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [4]
RP   IDENTIFICATION OF LIGANDS.
RX   PubMed=10079256; DOI=10.1016/S0002-9440(10)65325-4;
RA   Gray G.E., Mann R.S., Mitsiadis E., Henrique D., Carcangiu M.-L.,
RA   Banks A., Leiman J., Ward D., Ish-Horowitz D., Artavanis-Tsakonas S.;
RT   "Human ligands of the Notch receptor.";
RL   Am. J. Pathol. 154:785-794(1999).
RN   [5]
RP   INTERACTION WITH MAML1.
RX   PubMed=11101851; DOI=10.1038/82644;
RA   Wu L., Aster J.C., Blacklow S.C., Lake R., Artavanis-Tsakonas S.,
RA   Griffin J.D.;
RT   "MAML1, a human homologue of Drosophila mastermind, is a
RT   transcriptional co-activator for NOTCH receptors.";
RL   Nat. Genet. 26:484-489(2000).
RN   [6]
RP   INTERACTION WITH MAML2 AND MAML3.
RX   PubMed=12370315; DOI=10.1128/MCB.22.21.7688-7700.2002;
RA   Wu L., Sun T., Kobayashi K., Gao P., Griffin J.D.;
RT   "Identification of a family of mastermind-like transcriptional
RT   coactivators for mammalian notch receptors.";
RL   Mol. Cell. Biol. 22:7688-7700(2002).
RN   [7]
RP   INTERACTION WITH PSMA1.
RX   PubMed=17292860; DOI=10.1016/j.bbrc.2007.01.151;
RA   Zhang Y., Jia L., Lee S.J., Wang M.M.;
RT   "Conserved signal peptide of Notch3 inhibits interaction with
RT   proteasome.";
RL   Biochem. Biophys. Res. Commun. 355:245-251(2007).
RN   [8]
RP   INTERACTION WITH HIF1AN.
RX   PubMed=17573339; DOI=10.1074/jbc.M704102200;
RA   Coleman M.L., McDonough M.A., Hewitson K.S., Coles C., Mecinovic J.,
RA   Edelmann M., Cook K.M., Cockman M.E., Lancaster D.E., Kessler B.M.,
RA   Oldham N.J., Ratcliffe P.J., Schofield C.J.;
RT   "Asparaginyl hydroxylation of the Notch ankyrin repeat domain by
RT   factor inhibiting hypoxia-inducible factor.";
RL   J. Biol. Chem. 282:24027-24038(2007).
RN   [9]
RP   HYDROXYLATION BY HIF1AN.
RX   PubMed=18299578; DOI=10.1073/pnas.0711591105;
RA   Zheng X., Linke S., Dias J.M., Zheng X., Gradin K., Wallis T.P.,
RA   Hamilton B.R., Gustafsson M., Ruas J.L., Wilkins S., Bilton R.L.,
RA   Brismar K., Whitelaw M.L., Pereira T., Gorman J.J., Ericson J.,
RA   Peet D.J., Lendahl U., Poellinger L.;
RT   "Interaction with factor inhibiting HIF-1 defines an additional mode
RT   of cross-coupling between the Notch and hypoxia signaling pathways.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:3368-3373(2008).
RN   [10]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-2174, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.O113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V.,
RA   Aguiar M., Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C.,
RA   Vemulapalli V., Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [11]
RP   INVOLVEMENT IN LMNS.
RX   PubMed=25394726; DOI=10.1002/ajmg.a.36863;
RA   Gripp K.W., Robbins K.M., Sobreira N.L., Witmer P.D., Bird L.M.,
RA   Avela K., Makitie O., Alves D., Hogue J.S., Zackai E.H., Doheny K.F.,
RA   Stabley D.L., Sol-Church K.;
RT   "Truncating mutations in the last exon of NOTCH3 cause lateral
RT   meningocele syndrome.";
RL   Am. J. Med. Genet. A 167A:271-281(2015).
RN   [12]
RP   VARIANTS CADASIL1 TYR-49; CYS-71; CYS-90; CYS-110; CYS-133; CYS-141;
RP   ARG-146; CYS-153; CYS-169; CYS-171; CYS-182; ARG-185; SER-212;
RP   GLY-222; TYR-224; CYS-258; TYR-542; CYS-558; CYS-578; CYS-728;
RP   CYS-985; CYS-1006; CYS-1031; CYS-1231 AND ARG-1261, AND VARIANTS
RP   ARG-170; LEU-496; GLN-1133; MET-1183 AND VAL-2223.
RX   PubMed=9388399; DOI=10.1016/S0140-6736(97)08083-5;
RA   Joutel A., Vahedi K., Corpechot C., Troesch A., Chabriat H.,
RA   Vayssiere C., Cruaud C., Maciazek J., Weissenbach J., Bousser M.-G.,
RA   Bach J.-F., Tournier-Lasserve E.;
RT   "Strong clustering and stereotyped nature of Notch3 mutations in
RT   CADASIL patients.";
RL   Lancet 350:1511-1515(1997).
RN   [13]
RP   VARIANTS CADASIL1 CYS-90; PHE-117; CYS-133; CYS-141; CYS-169; TYR-174;
RP   CYS-182 AND ARG-183.
RX   PubMed=10227618; DOI=10.1212/WNL.52.7.1361;
RA   Dichgans M., Filippi M., Bruening R., Iannucci G., Berchtenbreiter C.,
RA   Minicucci L., Uttner I., Crispin A., Ludwig H., Gasser T.,
RA   Yousry T.A.;
RT   "Quantitative MRI in CADASIL: correlation with disability and
RT   cognitive performance.";
RL   Neurology 52:1361-1367(1999).
RN   [14]
RP   VARIANTS CADASIL1 CYS-133; CYS-141; CYS-153; CYS-182; CYS-207; CYS-544
RP   AND ARG-1015.
RX   PubMed=10371548; DOI=10.1212/WNL.52.9.1913;
RG   Dutch CADASIL research group;
RA   Lesnik Oberstein S.A.J., Ferrari M.D., Bakker E., van Gestel J.,
RA   Kneppers A.L.J., Frants R.R., Breuning M.H., Haan J.;
RT   "Diagnostic Notch3 sequence analysis in CADASIL: three new mutations
RT   in Dutch patients. Dutch CADASIL Research Group.";
RL   Neurology 52:1913-1915(1999).
RN   [15]
RP   VARIANTS CADASIL1 80-ASP--SER-84 DEL; CYS-90; PHE-93; CYS-110;
RP   PHE-117; PHE-123; CYS-133; CYS-141; SER-144; TYR-144; CYS-150;
RP   153-ARG--CYS-155 DEL; CYS-153; CYS-169; TYR-174; CYS-182; ARG-183;
RP   SER-183; ARG-185 AND PHE-194.
RX   PubMed=10854111; DOI=10.1038/sj.ejhg.5200460;
RA   Dichgans M., Ludwig H., Mueller-Hoecker J., Messerschmidt A.,
RA   Gasser T.;
RT   "Small in-frame deletions and missense mutations in CADASIL: 3D models
RT   predict misfolding of Notch3 EGF-like repeat domains.";
RL   Eur. J. Hum. Genet. 8:280-285(2000).
RN   [16]
RP   VARIANT CADASIL1 PHE-144.
RX   PubMed=11058919;
RX   DOI=10.1002/1098-1004(200011)16:5<449::AID-HUMU26>3.3.CO;2-9;
RA   Grigg R., Lea R., Sullivan A.A., Curtain R., MacMillian J.,
RA   Griffiths L.;
RT   "Identification of a novel mutation C144F in the Notch3 gene in an
RT   Australian CADASIL pedigree.";
RL   Hum. Mutat. 16:449-450(2000).
RN   [17]
RP   VARIANTS CADASIL1 TYR-49; CYS-54; CYS-90; CYS-110; 114-GLY--PRO-120
RP   DEL; TYR-123; CYS-133; CYS-141; ARG-146; CYS-153; SER-162; CYS-169;
RP   TYR-174; CYS-180; CYS-182; ARG-185; TYR-194; TYR-206; CYS-207;
RP   SER-212; GLY-222; TYR-224; CYS-258; TYR-542; CYS-558; CYS-578;
RP   CYS-607; CYS-728; CYS-984; CYS-985; CYS-1006; CYS-1031; CYS-1231 AND
RP   ARG-1261.
RX   PubMed=11102981;
RX   DOI=10.1002/1098-1004(200012)16:6<518::AID-HUMU9>3.3.CO;2-H;
RA   Escary J.-L., Cecillon M., Maciazek J., Lathrop M.,
RA   Tournier-Lasserve E., Joutel A.;
RT   "Evaluation of DHPLC analysis in mutational scanning of Notch3, a gene
RT   with a high G-C content.";
RL   Hum. Mutat. 16:518-526(2000).
RN   [18]
RP   VARIANT CADASIL1 114-GLY--PRO-120 DEL.
RX   PubMed=10802807; DOI=10.1212/WNL.54.9.1874;
RA   Joutel A., Chabriat H., Vahedi K., Domenga V., Vayssiere C.,
RA   Ruchoux M.M., Lucas C., Leys D., Bousser M.-G., Tournier-Lasserve E.;
RT   "Splice site mutation causing a seven amino acid Notch3 in-frame
RT   deletion in CADASIL.";
RL   Neurology 54:1874-1875(2000).
RN   [19]
RP   VARIANT CADASIL1 CYS-332.
RX   PubMed=11559313; DOI=10.1001/archneur.58.9.1418;
RA   Oliveri R.L., Muglia M., De Stefano N., Mazzei R., Labate A.,
RA   Conforti F.L., Patitucci A., Gabriele A.L., Tagarelli G.,
RA   Magariello A., Zappia M., Gambardella A., Federico A., Quattrone A.;
RT   "A novel mutation in the Notch3 gene in an Italian family with
RT   cerebral autosomal dominant arteriopathy with subcortical infarcts and
RT   leukoencephalopathy: genetic and magnetic resonance spectroscopic
RT   findings.";
RL   Arch. Neurol. 58:1418-1422(2001).
RN   [20]
RP   VARIANTS CADASIL1 CYS-110; CYS-133; TRP-134; CYS-141; CYS-153;
RP   CYS-182; GLY-185; CYS-207; SER-212; GLY-222; SER-428; CYS-558; CYS-985
RP   AND CYS-1063.
RX   PubMed=11755616; DOI=10.1016/S0140-6736(01)07142-2;
RA   Joutel A., Favrole P., Labauge P., Chabriat H., Lescoat C.,
RA   Andreux F., Domenga V., Cecillon M., Vahedi K., Ducros A.,
RA   Cave-Riant F., Bousser M.G., Tournier-Lasserve E.;
RT   "Skin biopsy immunostaining with a Notch3 monoclonal antibody for
RT   CADASIL diagnosis.";
RL   Lancet 358:2049-2051(2001).
RN   [21]
RP   VARIANT CADASIL1 TRP-134.
RX   PubMed=11810186; DOI=10.1007/s004010100439;
RA   Feuerhake F., Volk B., Ostertag C.B., Jungling F.D., Kassubek J.,
RA   Orszagh M., Dichgans M.;
RT   "Reversible coma with raised intracranial pressure: an unusual
RT   clinical manifestation of CADASIL.";
RL   Acta Neuropathol. 103:188-192(2002).
RN   [22]
RP   VARIANTS CADASIL1 ARG-76; TYR-93; TYR-128; CYS-142; ARG-194; TYR-222;
RP   SER-233; ARG-251; CYS-420; GLY-440; CYS-449; CYS-953 AND CYS-1021.
RX   PubMed=12146805;
RA   Kalimo H., Ruchoux M.-M., Viitanen M., Kalaria R.N.;
RT   "CADASIL: a common form of hereditary arteriopathy causing brain
RT   infarcts and dementia.";
RL   Brain Pathol. 12:371-384(2002).
RN   [23]
RP   VARIANT CADASIL1 ARG-455.
RX   PubMed=12136071; DOI=10.1212/WNL.59.2.277;
RA   Arboleda-Velasquez J.F., Lopera F., Lopez E., Frosch M.P.,
RA   Sepulveda-Falla D., Gutierrez J.E., Vargas S., Medina M.,
RA   Martinez De Arrieta C., Lebo R.V., Slaugenhaupt S.A., Betensky R.A.,
RA   Villegas A., Arcos-Burgos M., Rivera D., Restrepo J.C., Kosik K.S.;
RT   "C455R notch3 mutation in a Colombian CADASIL kindred with early onset
RT   of stroke.";
RL   Neurology 59:277-279(2002).
RN   [24]
RP   VARIANT CADASIL1 TYR-67.
RX   PubMed=12589106;
RA   Moon S.-Y., Kim H.-Y., Seok J.-I., Kwon J.-C., Ki C.-S., Kim J.-W.,
RA   Suh Y.-L., Na D.L.;
RT   "A novel mutation (C67Y)in the NOTCH3 gene in a Korean CADASIL
RT   patient.";
RL   J. Korean Med. Sci. 18:141-144(2003).
RN   [25]
RP   VARIANTS CADASIL1 CYS-90; CYS-133; CYS-169; ARG-174; PHE-174 AND
RP   LYS-213.
RX   PubMed=12810003; DOI=10.1016/S0022-510X(03)00109-6;
RA   Santa Y., Uyama E., Chui D.H., Arima M., Kotorii S., Takahashi K.,
RA   Tabira T.;
RT   "Genetic, clinical and pathological studies of CADASIL in Japan: a
RT   partial contribution of Notch3 mutations and implications of smooth
RT   muscle cell degeneration for the pathogenesis.";
RL   J. Neurol. Sci. 212:79-84(2003).
RN   [26]
RP   VARIANTS CADASIL1 ARG-76; CYS-90; CYS-110; CYS-141; CYS-153; CYS-169;
RP   CYS-182; ARG-183; CYS-189; SER-194; CYS-207; ARG-251; CYS-332;
RP   GLY-440; CYS-607; CYS-953 AND CYS-1231.
RX   PubMed=15229130; DOI=10.1093/brain/awh223;
RA   Singhal S., Bevan S., Barrick T., Rich P., Markus H.S.;
RT   "The influence of genetic and cardiovascular risk factors on the
RT   CADASIL phenotype.";
RL   Brain 127:2031-2038(2004).
RN   [27]
RP   VARIANTS CADASIL1 GLY-43; PHE-49; CYS-60; SER-65; TRP-76;
RP   77-GLN--CYS-82 DEL; 80-ASP--SER-84 DEL; ARG-87; TYR-87; CYS-90;
RP   PHE-93; TRP-106; TYR-108; CYS-110; PHE-117; PHE-123; CYS-133; TRP-134;
RP   CYS-141; SER-144; TYR-144; CYS-145; CYS-149; CYS-150; 153-ARG--155-CYS
RP   DEL; CYS-153; SER-155; CYS-169; ARG-174; TYR-174; CYS-182; ARG-183;
RP   SER-183; PHE-183; ARG-185; PHE-194; TYR-201; CYS-207; TYR-233;
RP   239-ASP--ASP-253 DEL; SER-240; ARG-245; TYR-260; CYS-332; CYS-335;
RP   CYS-337; SER-379; ARG-395; CYS-421; TYR-428; ARG-440; SER-446;
RP   TYR-484; TYR-495; ARG-511; TYR-549; CYS-558; CYS-985 AND TYR-1261.
RX   PubMed=15364702; DOI=10.1093/brain/awh282;
RA   Opherk C., Peters N., Herzog J., Luedtke R., Dichgans M.;
RT   "Long-term prognosis and causes of death in CADASIL: a retrospective
RT   study in 411 patients.";
RL   Brain 127:2533-2539(2004).
RN   [28]
RP   VARIANT CADASIL1 CYS-133.
RX   PubMed=15378071; DOI=10.1038/sj.ejhg.5201221;
RA   Mykkaenen K., Savontaus M.L., Juvonen V., Sistonen P., Tuisku S.,
RA   Tuominen S., Penttinen M., Lundkvist J., Viitanen M., Kalimo H.,
RA   Peoyhoenen M.;
RT   "Detection of the founder effect in Finnish CADASIL families.";
RL   Eur. J. Hum. Genet. 12:813-819(2004).
RN   [29]
RP   VARIANT CADASIL1 TRP-108.
RX   PubMed=15300988;
RA   Rojas-Marcos I., Encarnacion M., Martinez-Yelamos S., Ferrer I.,
RA   Arbizu T., Gil-Peralta A., Garcia-Lozano J.R.;
RT   "Gene symbol: NOTCH3. Disease: CADASIL.";
RL   Hum. Genet. 115:175-175(2004).
RN   [30]
RP   VARIANTS CADASIL1 GLY-43; PHE-49; CYS-60; SER-65; TRP-76;
RP   80-ASP--SER-84 DEL; ARG-87; CYS-90; PHE-93; TYR-108; CYS-110; PHE-117;
RP   PHE-123; CYS-133; TRP-134; CYS-141; SER-144; TYR-144; CYS-149;
RP   CYS-150; CYS-153; 153-ARG--CYS-155 DEL; CYS-169; ARG-174; TYR-174;
RP   CYS-182; SER-183; PHE-183; ARG-185; PHE-194; CYS-207; TYR-233;
RP   SER-240; ARG-245; TYR-260; 239-ASP--ASP-253 DEL; CYS-319; CYS-332;
RP   CYS-335; CYS-337; SER-379; ARG-395; CYS-421; TYR-428; ARG-440;
RP   PHE-484; TYR-495; ARG-511; TYR-549; CYS-558; CYS-728; SER-775; CYS-985
RP   AND TYR-1261.
RX   PubMed=16009764; DOI=10.1001/archneur.62.7.1091;
RA   Peters N., Opherk C., Bergmann T., Castro M., Herzog J., Dichgans M.;
RT   "Spectrum of mutations in biopsy-proven CADASIL: implications for
RT   diagnostic strategies.";
RL   Arch. Neurol. 62:1091-1094(2005).
RN   [31]
RP   VARIANT CADASIL1 CYS-118.
RX   PubMed=15818833;
RA   Soong B.W., Lee Y.-C., Lu Y.-C.;
RT   "Gene symbol: NOTCH3. Disease: cerebral autosomal dominant
RT   arteriopathy with subcortical infarcts and leukoencephalopathy.";
RL   Hum. Genet. 116:242-242(2005).
RN   [32]
RP   VARIANT BRAIN SMALL-VESSEL-DISEASE PRO-1515.
RX   PubMed=18273901; DOI=10.1002/humu.9527;
RA   Fouillade C., Chabriat H., Riant F., Mine M., Arnoud M., Magy L.,
RA   Bousser M.G., Tournier-Lasserve E., Joutel A.;
RT   "Activating NOTCH3 mutation in a patient with small-vessel-disease of
RT   the brain.";
RL   Hum. Mutat. 29:452-452(2008).
RN   [33]
RP   VARIANT IMF2 PRO-1519.
RX   PubMed=23731542; DOI=10.1016/j.ajhg.2013.04.024;
RA   Martignetti J.A., Tian L., Li D., Ramirez M.C., Camacho-Vanegas O.,
RA   Camacho S.C., Guo Y., Zand D.J., Bernstein A.M., Masur S.K., Kim C.E.,
RA   Otieno F.G., Hou C., Abdel-Magid N., Tweddale B., Metry D.,
RA   Fournet J.C., Papp E., McPherson E.W., Zabel C., Vaksmann G.,
RA   Morisot C., Keating B., Sleiman P.M., Cleveland J.A., Everman D.B.,
RA   Zackai E., Hakonarson H.;
RT   "Mutations in PDGFRB cause autosomal-dominant infantile
RT   myofibromatosis.";
RL   Am. J. Hum. Genet. 92:1001-1007(2013).
RN   [34]
RP   VARIANT CADASIL1 CYS-710.
RX   PubMed=24000151; DOI=10.1002/humu.22432;
RA   Rutten J.W., Boon E.M., Liem M.K., Dauwerse J.G., Pont M.J.,
RA   Vollebregt E., Maat-Kievit A.J., Ginjaar H.B., Lakeman P.,
RA   van Duinen S.G., Terwindt G.M., Lesnik Oberstein S.A.;
RT   "Hypomorphic NOTCH3 alleles do not cause CADASIL in humans.";
RL   Hum. Mutat. 34:1486-1489(2013).
CC   -!- FUNCTION: Functions as a receptor for membrane-bound ligands
CC       Jagged1, Jagged2 and Delta1 to regulate cell-fate determination.
CC       Upon ligand activation through the released notch intracellular
CC       domain (NICD) it forms a transcriptional activator complex with
CC       RBPJ/RBPSUH and activates genes of the enhancer of split locus.
CC       Affects the implementation of differentiation, proliferation and
CC       apoptotic programs (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Heterodimer of a C-terminal fragment N(TM) and a N-
CC       terminal fragment N(EC) which are probably linked by disulfide
CC       bonds (By similarity). Interacts with MAML1, MAML2 and MAML3 which
CC       act as transcriptional coactivators for NOTCH3. Interacts with
CC       PSMA1. Interacts with HIF1AN. {ECO:0000250,
CC       ECO:0000269|PubMed:11101851, ECO:0000269|PubMed:12370315,
CC       ECO:0000269|PubMed:17292860, ECO:0000269|PubMed:17573339}.
CC   -!- INTERACTION:
CC       Self; NbExp=2; IntAct=EBI-1236377, EBI-1236377;
CC       Q9R1P4:Psma1 (xeno); NbExp=2; IntAct=EBI-1236377, EBI-991653;
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane
CC       protein.
CC   -!- SUBCELLULAR LOCATION: Notch 3 intracellular domain: Nucleus.
CC       Note=Following proteolytical processing NICD is translocated to
CC       the nucleus.
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed in fetal and adult
CC       tissues.
CC   -!- PTM: Synthesized in the endoplasmic reticulum as an inactive form
CC       which is proteolytically cleaved by a furin-like convertase in the
CC       trans-Golgi network before it reaches the plasma membrane to yield
CC       an active, ligand-accessible form. Cleavage results in a C-
CC       terminal fragment N(TM) and a N-terminal fragment N(EC). Following
CC       ligand binding, it is cleaved by TNF-alpha converting enzyme
CC       (TACE) to yield a membrane-associated intermediate fragment called
CC       notch extracellular truncation (NEXT). This fragment is then
CC       cleaved by presenilin dependent gamma-secretase to release a
CC       notch-derived peptide containing the intracellular domain (NICD)
CC       from the membrane (By similarity). {ECO:0000250}.
CC   -!- PTM: Phosphorylated. {ECO:0000250}.
CC   -!- PTM: Hydroxylated by HIF1AN. {ECO:0000269|PubMed:18299578}.
CC   -!- DISEASE: Cerebral arteriopathy, autosomal dominant, with
CC       subcortical infarcts and leukoencephalopathy, 1 (CADASIL1)
CC       [MIM:125310]: A cerebrovascular disease characterized by multiple
CC       subcortical infarcts, pseudobulbar palsy, dementia, and the
CC       presence of granular deposits in small cerebral arteries producing
CC       ischemic stroke. {ECO:0000269|PubMed:10227618,
CC       ECO:0000269|PubMed:10371548, ECO:0000269|PubMed:10802807,
CC       ECO:0000269|PubMed:10854111, ECO:0000269|PubMed:11058919,
CC       ECO:0000269|PubMed:11102981, ECO:0000269|PubMed:11559313,
CC       ECO:0000269|PubMed:11755616, ECO:0000269|PubMed:11810186,
CC       ECO:0000269|PubMed:12136071, ECO:0000269|PubMed:12146805,
CC       ECO:0000269|PubMed:12589106, ECO:0000269|PubMed:12810003,
CC       ECO:0000269|PubMed:15229130, ECO:0000269|PubMed:15300988,
CC       ECO:0000269|PubMed:15364702, ECO:0000269|PubMed:15378071,
CC       ECO:0000269|PubMed:15818833, ECO:0000269|PubMed:16009764,
CC       ECO:0000269|PubMed:24000151, ECO:0000269|PubMed:9388399}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- DISEASE: Myofibromatosis, infantile 2 (IMF2) [MIM:615293]: A rare
CC       mesenchymal disorder characterized by the development of benign
CC       tumors in the skin, striated muscles, bones, and, more rarely,
CC       visceral organs. Subcutaneous or soft tissue nodules commonly
CC       involve the skin of the head, neck, and trunk. Skeletal and
CC       muscular lesions occur in about half of the patients. Lesions may
CC       be solitary or multicentric, and they may be present at birth or
CC       become apparent in early infancy or occasionally in adult life.
CC       Visceral lesions are associated with high morbidity and mortality.
CC       {ECO:0000269|PubMed:23731542}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Lateral meningocele syndrome (LMNS) [MIM:130720]: A very
CC       rare skeletal disorder with facial anomalies, hypotonia and
CC       neurologic dysfunction due to meningocele, a protrusion of the
CC       meninges, unaccompanied by neural tissue, through a bony defect in
CC       the skull or vertebral column. LMNS facial features include
CC       hypertelorism and telecanthus, high arched eyebrows, ptosis, mid-
CC       facial hypoplasia, micrognathia, high and narrow palate, low-set
CC       ears and a hypotonic appearance. Additional variable features are
CC       connective tissue abnormalities, aortic dilation, a high-pitched
CC       nasal voice, wormian bones and osteolysis.
CC       {ECO:0000269|PubMed:25394726}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the NOTCH family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/NOTCH3ID41557ch19p13.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U97669; AAB91371.1; -; mRNA.
DR   EMBL; AF058900; AAC14346.1; -; Genomic_DNA.
DR   EMBL; AF058881; AAC14346.1; JOINED; Genomic_DNA.
DR   EMBL; AF058882; AAC14346.1; JOINED; Genomic_DNA.
DR   EMBL; AF058883; AAC14346.1; JOINED; Genomic_DNA.
DR   EMBL; AF058884; AAC14346.1; JOINED; Genomic_DNA.
DR   EMBL; AF058885; AAC14346.1; JOINED; Genomic_DNA.
DR   EMBL; AF058886; AAC14346.1; JOINED; Genomic_DNA.
DR   EMBL; AF058887; AAC14346.1; JOINED; Genomic_DNA.
DR   EMBL; AF058888; AAC14346.1; JOINED; Genomic_DNA.
DR   EMBL; AF058889; AAC14346.1; JOINED; Genomic_DNA.
DR   EMBL; AF058890; AAC14346.1; JOINED; Genomic_DNA.
DR   EMBL; AF058891; AAC14346.1; JOINED; Genomic_DNA.
DR   EMBL; AF058892; AAC14346.1; JOINED; Genomic_DNA.
DR   EMBL; AF058893; AAC14346.1; JOINED; Genomic_DNA.
DR   EMBL; AF058894; AAC14346.1; JOINED; Genomic_DNA.
DR   EMBL; AF058895; AAC14346.1; JOINED; Genomic_DNA.
DR   EMBL; AF058896; AAC14346.1; JOINED; Genomic_DNA.
DR   EMBL; AF058897; AAC14346.1; JOINED; Genomic_DNA.
DR   EMBL; AF058898; AAC14346.1; JOINED; Genomic_DNA.
DR   EMBL; AF058899; AAC14346.1; JOINED; Genomic_DNA.
DR   EMBL; AC004257; AAC04897.1; -; Genomic_DNA.
DR   EMBL; AC004663; AAC15789.1; -; Genomic_DNA.
DR   CCDS; CCDS12326.1; -.
DR   PIR; S78549; S78549.
DR   RefSeq; NP_000426.2; NM_000435.2.
DR   UniGene; Hs.8546; -.
DR   PDB; 4ZLP; X-ray; 2.48 A; A/B=1378-1640.
DR   PDB; 5CZV; X-ray; 3.19 A; A=1378-1640.
DR   PDB; 5CZX; X-ray; 2.10 A; A/B=1378-1640.
DR   PDBsum; 4ZLP; -.
DR   PDBsum; 5CZV; -.
DR   PDBsum; 5CZX; -.
DR   ProteinModelPortal; Q9UM47; -.
DR   SMR; Q9UM47; -.
DR   BioGrid; 110916; 65.
DR   DIP; DIP-39827N; -.
DR   ELM; Q9UM47; -.
DR   IntAct; Q9UM47; 19.
DR   MINT; MINT-2822317; -.
DR   STRING; 9606.ENSP00000263388; -.
DR   BindingDB; Q9UM47; -.
DR   ChEMBL; CHEMBL3407319; -.
DR   GuidetoPHARMACOLOGY; 2860; -.
DR   iPTMnet; Q9UM47; -.
DR   PhosphoSitePlus; Q9UM47; -.
DR   BioMuta; NOTCH3; -.
DR   DMDM; 322510053; -.
DR   EPD; Q9UM47; -.
DR   MaxQB; Q9UM47; -.
DR   PaxDb; Q9UM47; -.
DR   PeptideAtlas; Q9UM47; -.
DR   PRIDE; Q9UM47; -.
DR   Ensembl; ENST00000263388; ENSP00000263388; ENSG00000074181.
DR   GeneID; 4854; -.
DR   KEGG; hsa:4854; -.
DR   UCSC; uc002nan.4; human.
DR   CTD; 4854; -.
DR   DisGeNET; 4854; -.
DR   EuPathDB; HostDB:ENSG00000074181.8; -.
DR   GeneCards; NOTCH3; -.
DR   GeneReviews; NOTCH3; -.
DR   H-InvDB; HIX0040142; -.
DR   H-InvDB; HIX0174419; -.
DR   HGNC; HGNC:7883; NOTCH3.
DR   HPA; CAB005393; -.
DR   HPA; HPA044392; -.
DR   MalaCards; NOTCH3; -.
DR   MIM; 125310; phenotype.
DR   MIM; 130720; phenotype.
DR   MIM; 600276; gene.
DR   MIM; 615293; phenotype.
DR   neXtProt; NX_Q9UM47; -.
DR   OpenTargets; ENSG00000074181; -.
DR   Orphanet; 136; CADASIL.
DR   Orphanet; 2591; Infantile myofibromatosis.
DR   PharmGKB; PA31685; -.
DR   eggNOG; ENOG410IR7G; Eukaryota.
DR   eggNOG; COG0666; LUCA.
DR   GeneTree; ENSGT00810000125346; -.
DR   HOGENOM; HOG000234369; -.
DR   HOVERGEN; HBG052650; -.
DR   InParanoid; Q9UM47; -.
DR   KO; K20995; -.
DR   OMA; ADHFADG; -.
DR   OrthoDB; EOG091G01NU; -.
DR   PhylomeDB; Q9UM47; -.
DR   TreeFam; TF351641; -.
DR   Reactome; R-HSA-1912399; Pre-NOTCH Processing in the Endoplasmic Reticulum.
DR   Reactome; R-HSA-1912408; Pre-NOTCH Transcription and Translation.
DR   Reactome; R-HSA-1912420; Pre-NOTCH Processing in Golgi.
DR   Reactome; R-HSA-1980148; Signaling by NOTCH3.
DR   Reactome; R-HSA-350054; Notch-HLH transcription pathway.
DR   Reactome; R-HSA-5083630; Defective LFNG causes SCDO3.
DR   SignaLink; Q9UM47; -.
DR   SIGNOR; Q9UM47; -.
DR   ChiTaRS; NOTCH3; human.
DR   GeneWiki; Notch_3; -.
DR   GenomeRNAi; 4854; -.
DR   PRO; PR:Q9UM47; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000074181; -.
DR   CleanEx; HS_NOTCH3; -.
DR   ExpressionAtlas; Q9UM47; baseline and differential.
DR   Genevisible; Q9UM47; HS.
DR   GO; GO:0015629; C:actin cytoskeleton; IDA:HPA.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0043235; C:receptor complex; IDA:MGI.
DR   GO; GO:0045296; F:cadherin binding; IDA:BHF-UCL.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0019899; F:enzyme binding; IEA:Ensembl.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0004872; F:receptor activity; IEA:InterPro.
DR   GO; GO:0048844; P:artery morphogenesis; IEA:Ensembl.
DR   GO; GO:0030900; P:forebrain development; IEA:Ensembl.
DR   GO; GO:0072104; P:glomerular capillary formation; IEA:Ensembl.
DR   GO; GO:0045665; P:negative regulation of neuron differentiation; IEA:Ensembl.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   GO; GO:0048663; P:neuron fate commitment; IEA:Ensembl.
DR   GO; GO:0007220; P:Notch receptor processing; TAS:Reactome.
DR   GO; GO:0007219; P:Notch signaling pathway; TAS:Reactome.
DR   GO; GO:0048661; P:positive regulation of smooth muscle cell proliferation; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   GO; GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome.
DR   CDD; cd00204; ANK; 2.
DR   Gene3D; 1.25.40.20; -; 3.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR024600; DUF3454_notch.
DR   InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR000152; EGF-type_Asp/Asn_hydroxyl_site.
DR   InterPro; IPR018097; EGF_Ca-bd_CS.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   InterPro; IPR008297; Notch.
DR   InterPro; IPR035993; Notch-like_dom_sf.
DR   InterPro; IPR022331; Notch_3.
DR   InterPro; IPR000800; Notch_dom.
DR   InterPro; IPR010660; Notch_NOD_dom.
DR   InterPro; IPR011656; Notch_NODP_dom.
DR   Pfam; PF12796; Ank_2; 2.
DR   Pfam; PF11936; DUF3454; 1.
DR   Pfam; PF00008; EGF; 19.
DR   Pfam; PF07645; EGF_CA; 6.
DR   Pfam; PF12661; hEGF; 3.
DR   Pfam; PF06816; NOD; 1.
DR   Pfam; PF07684; NODP; 1.
DR   Pfam; PF00066; Notch; 3.
DR   PIRSF; PIRSF002279; Notch; 1.
DR   PRINTS; PR01452; LNOTCHREPEAT.
DR   PRINTS; PR01986; NOTCH3.
DR   SMART; SM00248; ANK; 6.
DR   SMART; SM01334; DUF3454; 1.
DR   SMART; SM00181; EGF; 34.
DR   SMART; SM00179; EGF_CA; 31.
DR   SMART; SM00004; NL; 3.
DR   SMART; SM01338; NOD; 1.
DR   SMART; SM01339; NODP; 1.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   SUPFAM; SSF57184; SSF57184; 4.
DR   SUPFAM; SSF90193; SSF90193; 3.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 4.
DR   PROSITE; PS00010; ASX_HYDROXYL; 18.
DR   PROSITE; PS00022; EGF_1; 33.
DR   PROSITE; PS01186; EGF_2; 25.
DR   PROSITE; PS50026; EGF_3; 34.
DR   PROSITE; PS01187; EGF_CA; 16.
DR   PROSITE; PS50258; LNR; 3.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; ANK repeat; Cell membrane; Complete proteome;
KW   Developmental protein; Differentiation; Disease mutation;
KW   Disulfide bond; EGF-like domain; Glycoprotein; Membrane; Methylation;
KW   Notch signaling pathway; Nucleus; Phosphoprotein; Polymorphism;
KW   Receptor; Reference proteome; Repeat; Signal; Transcription;
KW   Transcription regulation; Transmembrane; Transmembrane helix.
FT   SIGNAL        1     39       {ECO:0000255}.
FT   CHAIN        40   2321       Neurogenic locus notch homolog protein 3.
FT                                /FTId=PRO_0000007692.
FT   CHAIN      1629   2321       Notch 3 extracellular truncation.
FT                                {ECO:0000250}.
FT                                /FTId=PRO_0000007693.
FT   CHAIN      1662   2321       Notch 3 intracellular domain.
FT                                {ECO:0000250}.
FT                                /FTId=PRO_0000007694.
FT   TOPO_DOM     40   1643       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1644   1664       Helical. {ECO:0000255}.
FT   TOPO_DOM   1665   2321       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       40     77       EGF-like 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN       78    118       EGF-like 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      119    156       EGF-like 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      158    195       EGF-like 4; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      197    234       EGF-like 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      236    272       EGF-like 6; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      274    312       EGF-like 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      314    350       EGF-like 8; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      351    389       EGF-like 9. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      391    429       EGF-like 10; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      431    467       EGF-like 11; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      469    505       EGF-like 12; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      507    543       EGF-like 13; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      545    580       EGF-like 14; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      582    618       EGF-like 15; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      620    655       EGF-like 16; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      657    693       EGF-like 17; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      695    730       EGF-like 18. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      734    770       EGF-like 19. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      771    808       EGF-like 20. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      810    847       EGF-like 21; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      849    885       EGF-like 22; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      887    922       EGF-like 23; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      924    960       EGF-like 24. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      962    998       EGF-like 25. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN     1000   1034       EGF-like 26. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN     1047   1082       EGF-like 27. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN     1084   1120       EGF-like 28. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN     1122   1158       EGF-like 29; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN     1160   1203       EGF-like 30; calcium-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN     1205   1244       EGF-like 31. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN     1246   1287       EGF-like 32. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN     1289   1325       EGF-like 33. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN     1335   1373       EGF-like 34. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   REPEAT     1387   1427       LNR 1.
FT   REPEAT     1428   1458       LNR 2.
FT   REPEAT     1467   1505       LNR 3.
FT   REPEAT     1838   1867       ANK 1.
FT   REPEAT     1871   1901       ANK 2.
FT   REPEAT     1905   1934       ANK 3.
FT   REPEAT     1938   1967       ANK 4.
FT   REPEAT     1971   2000       ANK 5.
FT   SITE       1571   1572       Cleavage; by furin-like protease.
FT                                {ECO:0000250}.
FT   MOD_RES    2174   2174       Omega-N-methylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   CARBOHYD   1179   1179       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1336   1336       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1438   1438       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     43     55       {ECO:0000250}.
FT   DISULFID     49     65       {ECO:0000250}.
FT   DISULFID     67     76       {ECO:0000250}.
FT   DISULFID     82     93       {ECO:0000250}.
FT   DISULFID     87    106       {ECO:0000250}.
FT   DISULFID    108    117       {ECO:0000250}.
FT   DISULFID    123    134       {ECO:0000250}.
FT   DISULFID    128    144       {ECO:0000250}.
FT   DISULFID    146    155       {ECO:0000250}.
FT   DISULFID    162    174       {ECO:0000250}.
FT   DISULFID    168    183       {ECO:0000250}.
FT   DISULFID    185    194       {ECO:0000250}.
FT   DISULFID    201    212       {ECO:0000250}.
FT   DISULFID    206    222       {ECO:0000250}.
FT   DISULFID    224    233       {ECO:0000250}.
FT   DISULFID    240    251       {ECO:0000250}.
FT   DISULFID    245    260       {ECO:0000250}.
FT   DISULFID    262    271       {ECO:0000250}.
FT   DISULFID    278    291       {ECO:0000250}.
FT   DISULFID    285    300       {ECO:0000250}.
FT   DISULFID    302    311       {ECO:0000250}.
FT   DISULFID    318    329       {ECO:0000250}.
FT   DISULFID    323    338       {ECO:0000250}.
FT   DISULFID    340    349       {ECO:0000250}.
FT   DISULFID    355    366       {ECO:0000250}.
FT   DISULFID    360    377       {ECO:0000250}.
FT   DISULFID    379    388       {ECO:0000250}.
FT   DISULFID    395    408       {ECO:0000250}.
FT   DISULFID    402    417       {ECO:0000250}.
FT   DISULFID    419    428       {ECO:0000250}.
FT   DISULFID    435    446       {ECO:0000250}.
FT   DISULFID    440    455       {ECO:0000250}.
FT   DISULFID    457    466       {ECO:0000250}.
FT   DISULFID    473    484       {ECO:0000250}.
FT   DISULFID    478    493       {ECO:0000250}.
FT   DISULFID    495    504       {ECO:0000250}.
FT   DISULFID    511    522       {ECO:0000250}.
FT   DISULFID    516    531       {ECO:0000250}.
FT   DISULFID    533    542       {ECO:0000250}.
FT   DISULFID    549    559       {ECO:0000250}.
FT   DISULFID    554    568       {ECO:0000250}.
FT   DISULFID    570    579       {ECO:0000250}.
FT   DISULFID    586    597       {ECO:0000250}.
FT   DISULFID    591    606       {ECO:0000250}.
FT   DISULFID    608    617       {ECO:0000250}.
FT   DISULFID    624    634       {ECO:0000250}.
FT   DISULFID    629    643       {ECO:0000250}.
FT   DISULFID    645    654       {ECO:0000250}.
FT   DISULFID    661    672       {ECO:0000250}.
FT   DISULFID    666    681       {ECO:0000250}.
FT   DISULFID    683    692       {ECO:0000250}.
FT   DISULFID    699    709       {ECO:0000250}.
FT   DISULFID    704    718       {ECO:0000250}.
FT   DISULFID    720    729       {ECO:0000250}.
FT   DISULFID    738    749       {ECO:0000250}.
FT   DISULFID    743    758       {ECO:0000250}.
FT   DISULFID    760    769       {ECO:0000250}.
FT   DISULFID    775    786       {ECO:0000250}.
FT   DISULFID    780    796       {ECO:0000250}.
FT   DISULFID    798    807       {ECO:0000250}.
FT   DISULFID    814    826       {ECO:0000250}.
FT   DISULFID    820    835       {ECO:0000250}.
FT   DISULFID    837    846       {ECO:0000250}.
FT   DISULFID    853    864       {ECO:0000250}.
FT   DISULFID    858    873       {ECO:0000250}.
FT   DISULFID    875    884       {ECO:0000250}.
FT   DISULFID    891    901       {ECO:0000250}.
FT   DISULFID    896    910       {ECO:0000250}.
FT   DISULFID    912    921       {ECO:0000250}.
FT   DISULFID    928    939       {ECO:0000250}.
FT   DISULFID    933    948       {ECO:0000250}.
FT   DISULFID    950    959       {ECO:0000250}.
FT   DISULFID    966    977       {ECO:0000250}.
FT   DISULFID    971    986       {ECO:0000250}.
FT   DISULFID    988    997       {ECO:0000250}.
FT   DISULFID   1004   1015       {ECO:0000250}.
FT   DISULFID   1009   1022       {ECO:0000250}.
FT   DISULFID   1024   1033       {ECO:0000250}.
FT   DISULFID   1040   1061       {ECO:0000250}.
FT   DISULFID   1055   1070       {ECO:0000250}.
FT   DISULFID   1072   1081       {ECO:0000250}.
FT   DISULFID   1088   1099       {ECO:0000250}.
FT   DISULFID   1093   1108       {ECO:0000250}.
FT   DISULFID   1110   1119       {ECO:0000250}.
FT   DISULFID   1126   1137       {ECO:0000250}.
FT   DISULFID   1131   1146       {ECO:0000250}.
FT   DISULFID   1148   1157       {ECO:0000250}.
FT   DISULFID   1164   1182       {ECO:0000250}.
FT   DISULFID   1176   1191       {ECO:0000250}.
FT   DISULFID   1193   1202       {ECO:0000250}.
FT   DISULFID   1209   1222       {ECO:0000250}.
FT   DISULFID   1214   1232       {ECO:0000250}.
FT   DISULFID   1234   1243       {ECO:0000250}.
FT   DISULFID   1250   1261       {ECO:0000250}.
FT   DISULFID   1255   1275       {ECO:0000250}.
FT   DISULFID   1277   1286       {ECO:0000250}.
FT   DISULFID   1293   1304       {ECO:0000250}.
FT   DISULFID   1298   1313       {ECO:0000250}.
FT   DISULFID   1315   1324       {ECO:0000250}.
FT   DISULFID   1339   1350       {ECO:0000250}.
FT   DISULFID   1344   1361       {ECO:0000250}.
FT   DISULFID   1363   1372       {ECO:0000250}.
FT   DISULFID   1387   1410       {ECO:0000250}.
FT   DISULFID   1392   1405       {ECO:0000250}.
FT   DISULFID   1401   1417       {ECO:0000250}.
FT   DISULFID   1428   1451       {ECO:0000250}.
FT   DISULFID   1433   1446       {ECO:0000250}.
FT   DISULFID   1442   1458       {ECO:0000250}.
FT   DISULFID   1467   1493       {ECO:0000250}.
FT   DISULFID   1475   1488       {ECO:0000250}.
FT   DISULFID   1484   1500       {ECO:0000250}.
FT   VARIANT      43     43       C -> G (in CADASIL1).
FT                                {ECO:0000269|PubMed:15364702,
FT                                ECO:0000269|PubMed:16009764}.
FT                                /FTId=VAR_044230.
FT   VARIANT      49     49       C -> F (in CADASIL1; dbSNP:rs193921045).
FT                                {ECO:0000269|PubMed:15364702,
FT                                ECO:0000269|PubMed:16009764}.
FT                                /FTId=VAR_044231.
FT   VARIANT      49     49       C -> Y (in CADASIL1).
FT                                {ECO:0000269|PubMed:11102981,
FT                                ECO:0000269|PubMed:9388399}.
FT                                /FTId=VAR_012871.
FT   VARIANT      54     54       R -> C (in CADASIL1).
FT                                {ECO:0000269|PubMed:11102981}.
FT                                /FTId=VAR_044232.
FT   VARIANT      60     60       S -> C (in CADASIL1).
FT                                {ECO:0000269|PubMed:15364702,
FT                                ECO:0000269|PubMed:16009764}.
FT                                /FTId=VAR_044233.
FT   VARIANT      65     65       C -> S (in CADASIL1).
FT                                {ECO:0000269|PubMed:15364702,
FT                                ECO:0000269|PubMed:16009764}.
FT                                /FTId=VAR_044234.
FT   VARIANT      67     67       C -> Y (in CADASIL1).
FT                                {ECO:0000269|PubMed:12589106}.
FT                                /FTId=VAR_044235.
FT   VARIANT      71     71       W -> C (in CADASIL1; dbSNP:rs28937321).
FT                                {ECO:0000269|PubMed:9388399}.
FT                                /FTId=VAR_012872.
FT   VARIANT      76     76       C -> R (in CADASIL1).
FT                                {ECO:0000269|PubMed:12146805,
FT                                ECO:0000269|PubMed:15229130}.
FT                                /FTId=VAR_044236.
FT   VARIANT      76     76       C -> W (in CADASIL1).
FT                                {ECO:0000269|PubMed:15364702,
FT                                ECO:0000269|PubMed:16009764}.
FT                                /FTId=VAR_044237.
FT   VARIANT      77     82       Missing (in CADASIL1).
FT                                {ECO:0000269|PubMed:15364702}.
FT                                /FTId=VAR_044238.
FT   VARIANT      80     84       Missing (in CADASIL1).
FT                                {ECO:0000269|PubMed:10854111,
FT                                ECO:0000269|PubMed:15364702,
FT                                ECO:0000269|PubMed:16009764}.
FT                                /FTId=VAR_044239.
FT   VARIANT      87     87       C -> R (in CADASIL1).
FT                                {ECO:0000269|PubMed:15364702,
FT                                ECO:0000269|PubMed:16009764}.
FT                                /FTId=VAR_044240.
FT   VARIANT      87     87       C -> Y (in CADASIL1).
FT                                {ECO:0000269|PubMed:15364702}.
FT                                /FTId=VAR_044241.
FT   VARIANT      90     90       R -> C (in CADASIL1).
FT                                {ECO:0000269|PubMed:10227618,
FT                                ECO:0000269|PubMed:10854111,
FT                                ECO:0000269|PubMed:11102981,
FT                                ECO:0000269|PubMed:12810003,
FT                                ECO:0000269|PubMed:15229130,
FT                                ECO:0000269|PubMed:15364702,
FT                                ECO:0000269|PubMed:16009764,
FT                                ECO:0000269|PubMed:9388399}.
FT                                /FTId=VAR_012873.
FT   VARIANT      93     93       C -> F (in CADASIL1).
FT                                {ECO:0000269|PubMed:10854111,
FT                                ECO:0000269|PubMed:15364702,
FT                                ECO:0000269|PubMed:16009764}.
FT                                /FTId=VAR_044242.
FT   VARIANT      93     93       C -> Y (in CADASIL1).
FT                                {ECO:0000269|PubMed:12146805}.
FT                                /FTId=VAR_044243.
FT   VARIANT     106    106       C -> W (in CADASIL1).
FT                                {ECO:0000269|PubMed:15364702}.
FT                                /FTId=VAR_044244.
FT   VARIANT     108    108       C -> W (in CADASIL1).
FT                                {ECO:0000269|PubMed:15300988}.
FT                                /FTId=VAR_044245.
FT   VARIANT     108    108       C -> Y (in CADASIL1).
FT                                {ECO:0000269|PubMed:15364702,
FT                                ECO:0000269|PubMed:16009764}.
FT                                /FTId=VAR_044246.
FT   VARIANT     110    110       R -> C (in CADASIL1).
FT                                {ECO:0000269|PubMed:10854111,
FT                                ECO:0000269|PubMed:11102981,
FT                                ECO:0000269|PubMed:11755616,
FT                                ECO:0000269|PubMed:15229130,
FT                                ECO:0000269|PubMed:15364702,
FT                                ECO:0000269|PubMed:16009764,
FT                                ECO:0000269|PubMed:9388399}.
FT                                /FTId=VAR_012874.
FT   VARIANT     114    120       Missing (in CADASIL1).
FT                                {ECO:0000269|PubMed:10802807,
FT                                ECO:0000269|PubMed:11102981}.
FT                                /FTId=VAR_012875.
FT   VARIANT     117    117       C -> F (in CADASIL1; dbSNP:rs773539041).
FT                                {ECO:0000269|PubMed:10227618,
FT                                ECO:0000269|PubMed:10854111,
FT                                ECO:0000269|PubMed:15364702,
FT                                ECO:0000269|PubMed:16009764}.
FT                                /FTId=VAR_044247.
FT   VARIANT     118    118       S -> C (in CADASIL1).
FT                                {ECO:0000269|PubMed:15818833}.
FT                                /FTId=VAR_044248.
FT   VARIANT     123    123       C -> F (in CADASIL1).
FT                                {ECO:0000269|PubMed:10854111,
FT                                ECO:0000269|PubMed:15364702,
FT                                ECO:0000269|PubMed:16009764}.
FT                                /FTId=VAR_044249.
FT   VARIANT     123    123       C -> Y (in CADASIL1).
FT                                {ECO:0000269|PubMed:11102981}.
FT                                /FTId=VAR_044250.
FT   VARIANT     128    128       C -> Y (in CADASIL1).
FT                                {ECO:0000269|PubMed:12146805}.
FT                                /FTId=VAR_044251.
FT   VARIANT     133    133       R -> C (in CADASIL1; dbSNP:rs137852642).
FT                                {ECO:0000269|PubMed:10227618,
FT                                ECO:0000269|PubMed:10371548,
FT                                ECO:0000269|PubMed:10854111,
FT                                ECO:0000269|PubMed:11102981,
FT                                ECO:0000269|PubMed:11755616,
FT                                ECO:0000269|PubMed:12810003,
FT                                ECO:0000269|PubMed:15364702,
FT                                ECO:0000269|PubMed:15378071,
FT                                ECO:0000269|PubMed:16009764,
FT                                ECO:0000269|PubMed:9388399}.
FT                                /FTId=VAR_012876.
FT   VARIANT     134    134       C -> W (in CADASIL1).
FT                                {ECO:0000269|PubMed:11755616,
FT                                ECO:0000269|PubMed:11810186,
FT                                ECO:0000269|PubMed:15364702,
FT                                ECO:0000269|PubMed:16009764}.
FT                                /FTId=VAR_044252.
FT   VARIANT     141    141       R -> C (in CADASIL1).
FT                                {ECO:0000269|PubMed:10227618,
FT                                ECO:0000269|PubMed:10371548,
FT                                ECO:0000269|PubMed:10854111,
FT                                ECO:0000269|PubMed:11102981,
FT                                ECO:0000269|PubMed:11755616,
FT                                ECO:0000269|PubMed:15229130,
FT                                ECO:0000269|PubMed:15364702,
FT                                ECO:0000269|PubMed:16009764,
FT                                ECO:0000269|PubMed:9388399}.
FT                                /FTId=VAR_012877.
FT   VARIANT     142    142       F -> C (in CADASIL1).
FT                                {ECO:0000269|PubMed:12146805}.
FT                                /FTId=VAR_044253.
FT   VARIANT     144    144       C -> F (in CADASIL1).
FT                                {ECO:0000269|PubMed:11058919}.
FT                                /FTId=VAR_044254.
FT   VARIANT     144    144       C -> S (in CADASIL1).
FT                                {ECO:0000269|PubMed:10854111,
FT                                ECO:0000269|PubMed:15364702,
FT                                ECO:0000269|PubMed:16009764}.
FT                                /FTId=VAR_044255.
FT   VARIANT     144    144       C -> Y (in CADASIL1).
FT                                {ECO:0000269|PubMed:10854111,
FT                                ECO:0000269|PubMed:15364702,
FT                                ECO:0000269|PubMed:16009764}.
FT                                /FTId=VAR_044256.
FT   VARIANT     145    145       S -> C (in CADASIL1).
FT                                {ECO:0000269|PubMed:15364702}.
FT                                /FTId=VAR_044257.
FT   VARIANT     146    146       C -> R (in CADASIL1).
FT                                {ECO:0000269|PubMed:11102981,
FT                                ECO:0000269|PubMed:9388399}.
FT                                /FTId=VAR_012878.
FT   VARIANT     149    149       G -> C (in CADASIL1).
FT                                {ECO:0000269|PubMed:15364702,
FT                                ECO:0000269|PubMed:16009764}.
FT                                /FTId=VAR_044258.
FT   VARIANT     150    150       Y -> C (in CADASIL1).
FT                                {ECO:0000269|PubMed:10854111,
FT                                ECO:0000269|PubMed:15364702,
FT                                ECO:0000269|PubMed:16009764}.
FT                                /FTId=VAR_044259.
FT   VARIANT     153    155       Missing (in CADASIL1).
FT                                {ECO:0000269|PubMed:10854111,
FT                                ECO:0000269|PubMed:16009764}.
FT                                /FTId=VAR_044260.
FT   VARIANT     153    153       R -> C (in CADASIL1; dbSNP:rs797045014).
FT                                {ECO:0000269|PubMed:10371548,
FT                                ECO:0000269|PubMed:10854111,
FT                                ECO:0000269|PubMed:11102981,
FT                                ECO:0000269|PubMed:11755616,
FT                                ECO:0000269|PubMed:15229130,
FT                                ECO:0000269|PubMed:15364702,
FT                                ECO:0000269|PubMed:16009764,
FT                                ECO:0000269|PubMed:9388399}.
FT                                /FTId=VAR_012879.
FT   VARIANT     155    155       C -> S (in CADASIL1).
FT                                {ECO:0000269|PubMed:15364702}.
FT                                /FTId=VAR_044261.
FT   VARIANT     162    162       C -> S (in CADASIL1).
FT                                {ECO:0000269|PubMed:11102981}.
FT                                /FTId=VAR_044262.
FT   VARIANT     169    169       R -> C (in CADASIL1; dbSNP:rs28933696).
FT                                {ECO:0000269|PubMed:10227618,
FT                                ECO:0000269|PubMed:10854111,
FT                                ECO:0000269|PubMed:11102981,
FT                                ECO:0000269|PubMed:12810003,
FT                                ECO:0000269|PubMed:15229130,
FT                                ECO:0000269|PubMed:15364702,
FT                                ECO:0000269|PubMed:16009764,
FT                                ECO:0000269|PubMed:9388399}.
FT                                /FTId=VAR_012880.
FT   VARIANT     170    170       H -> R (in dbSNP:rs147373451).
FT                                {ECO:0000269|PubMed:9388399}.
FT                                /FTId=VAR_012881.
FT   VARIANT     171    171       G -> C (in CADASIL1).
FT                                {ECO:0000269|PubMed:9388399}.
FT                                /FTId=VAR_012882.
FT   VARIANT     174    174       C -> F (in CADASIL1).
FT                                {ECO:0000269|PubMed:12810003}.
FT                                /FTId=VAR_044263.
FT   VARIANT     174    174       C -> R (in CADASIL1).
FT                                {ECO:0000269|PubMed:12810003,
FT                                ECO:0000269|PubMed:15364702,
FT                                ECO:0000269|PubMed:16009764}.
FT                                /FTId=VAR_044264.
FT   VARIANT     174    174       C -> Y (in CADASIL1).
FT                                {ECO:0000269|PubMed:10227618,
FT                                ECO:0000269|PubMed:10854111,
FT                                ECO:0000269|PubMed:11102981,
FT                                ECO:0000269|PubMed:15364702,
FT                                ECO:0000269|PubMed:16009764}.
FT                                /FTId=VAR_044265.
FT   VARIANT     180    180       S -> C (in CADASIL1).
FT                                {ECO:0000269|PubMed:11102981}.
FT                                /FTId=VAR_044266.
FT   VARIANT     182    182       R -> C (in CADASIL1; dbSNP:rs28933697).
FT                                {ECO:0000269|PubMed:10227618,
FT                                ECO:0000269|PubMed:10371548,
FT                                ECO:0000269|PubMed:10854111,
FT                                ECO:0000269|PubMed:11102981,
FT                                ECO:0000269|PubMed:11755616,
FT                                ECO:0000269|PubMed:15229130,
FT                                ECO:0000269|PubMed:15364702,
FT                                ECO:0000269|PubMed:16009764,
FT                                ECO:0000269|PubMed:9388399}.
FT                                /FTId=VAR_012883.
FT   VARIANT     183    183       C -> F (in CADASIL1).
FT                                {ECO:0000269|PubMed:15364702,
FT                                ECO:0000269|PubMed:16009764}.
FT                                /FTId=VAR_044267.
FT   VARIANT     183    183       C -> R (in CADASIL1).
FT                                {ECO:0000269|PubMed:10227618,
FT                                ECO:0000269|PubMed:10854111,
FT                                ECO:0000269|PubMed:15229130,
FT                                ECO:0000269|PubMed:15364702}.
FT                                /FTId=VAR_044268.
FT   VARIANT     183    183       C -> S (in CADASIL1).
FT                                {ECO:0000269|PubMed:10854111,
FT                                ECO:0000269|PubMed:15364702,
FT                                ECO:0000269|PubMed:16009764}.
FT                                /FTId=VAR_044269.
FT   VARIANT     185    185       C -> G (in CADASIL1).
FT                                {ECO:0000269|PubMed:11755616}.
FT                                /FTId=VAR_044270.
FT   VARIANT     185    185       C -> R (in CADASIL1).
FT                                {ECO:0000269|PubMed:10854111,
FT                                ECO:0000269|PubMed:11102981,
FT                                ECO:0000269|PubMed:15364702,
FT                                ECO:0000269|PubMed:16009764,
FT                                ECO:0000269|PubMed:9388399}.
FT                                /FTId=VAR_012884.
FT   VARIANT     189    189       Y -> C (in CADASIL1).
FT                                {ECO:0000269|PubMed:15229130}.
FT                                /FTId=VAR_044271.
FT   VARIANT     194    194       C -> F (in CADASIL1).
FT                                {ECO:0000269|PubMed:10854111,
FT                                ECO:0000269|PubMed:15364702,
FT                                ECO:0000269|PubMed:16009764}.
FT                                /FTId=VAR_044272.
FT   VARIANT     194    194       C -> R (in CADASIL1).
FT                                {ECO:0000269|PubMed:12146805}.
FT                                /FTId=VAR_044273.
FT   VARIANT     194    194       C -> S (in CADASIL1).
FT                                {ECO:0000269|PubMed:15229130}.
FT                                /FTId=VAR_044274.
FT   VARIANT     194    194       C -> Y (in CADASIL1).
FT                                {ECO:0000269|PubMed:11102981}.
FT                                /FTId=VAR_044275.
FT   VARIANT     201    201       C -> Y (in CADASIL1).
FT                                {ECO:0000269|PubMed:15364702}.
FT                                /FTId=VAR_044276.
FT   VARIANT     206    206       C -> Y (in CADASIL1).
FT                                {ECO:0000269|PubMed:11102981}.
FT                                /FTId=VAR_044277.
FT   VARIANT     207    207       R -> C (in CADASIL1; dbSNP:rs775267348).
FT                                {ECO:0000269|PubMed:10371548,
FT                                ECO:0000269|PubMed:11102981,
FT                                ECO:0000269|PubMed:11755616,
FT                                ECO:0000269|PubMed:15229130,
FT                                ECO:0000269|PubMed:15364702,
FT                                ECO:0000269|PubMed:16009764}.
FT                                /FTId=VAR_044278.
FT   VARIANT     212    212       C -> S (in CADASIL1).
FT                                {ECO:0000269|PubMed:11102981,
FT                                ECO:0000269|PubMed:11755616,
FT                                ECO:0000269|PubMed:9388399}.
FT                                /FTId=VAR_012885.
FT   VARIANT     213    213       R -> K (in CADASIL1).
FT                                {ECO:0000269|PubMed:12810003}.
FT                                /FTId=VAR_044279.
FT   VARIANT     222    222       C -> G (in CADASIL1).
FT                                {ECO:0000269|PubMed:11102981,
FT                                ECO:0000269|PubMed:11755616,
FT                                ECO:0000269|PubMed:9388399}.
FT                                /FTId=VAR_012886.
FT   VARIANT     222    222       C -> Y (in CADASIL1).
FT                                {ECO:0000269|PubMed:12146805}.
FT                                /FTId=VAR_044280.
FT   VARIANT     224    224       C -> Y (in CADASIL1).
FT                                {ECO:0000269|PubMed:11102981,
FT                                ECO:0000269|PubMed:9388399}.
FT                                /FTId=VAR_012887.
FT   VARIANT     233    233       C -> S (in CADASIL1).
FT                                {ECO:0000269|PubMed:12146805}.
FT                                /FTId=VAR_044281.
FT   VARIANT     233    233       C -> Y (in CADASIL1).
FT                                {ECO:0000269|PubMed:15364702,
FT                                ECO:0000269|PubMed:16009764}.
FT                                /FTId=VAR_044282.
FT   VARIANT     239    253       Missing (in CADASIL1).
FT                                {ECO:0000269|PubMed:15364702,
FT                                ECO:0000269|PubMed:16009764}.
FT                                /FTId=VAR_044283.
FT   VARIANT     240    240       C -> S (in CADASIL1).
FT                                {ECO:0000269|PubMed:15364702,
FT                                ECO:0000269|PubMed:16009764}.
FT                                /FTId=VAR_044284.
FT   VARIANT     245    245       C -> R (in CADASIL1).
FT                                {ECO:0000269|PubMed:15364702,
FT                                ECO:0000269|PubMed:16009764}.
FT                                /FTId=VAR_044285.
FT   VARIANT     251    251       C -> R (in CADASIL1).
FT                                {ECO:0000269|PubMed:12146805,
FT                                ECO:0000269|PubMed:15229130}.
FT                                /FTId=VAR_044286.
FT   VARIANT     258    258       Y -> C (in CADASIL1).
FT                                {ECO:0000269|PubMed:11102981,
FT                                ECO:0000269|PubMed:9388399}.
FT                                /FTId=VAR_012888.
FT   VARIANT     260    260       C -> Y (in CADASIL1).
FT                                {ECO:0000269|PubMed:15364702,
FT                                ECO:0000269|PubMed:16009764}.
FT                                /FTId=VAR_044287.
FT   VARIANT     319    319       A -> C (in CADASIL1; requires 2
FT                                nucleotide substitutions).
FT                                {ECO:0000269|PubMed:16009764}.
FT                                /FTId=VAR_044288.
FT   VARIANT     332    332       R -> C (in CADASIL1; dbSNP:rs137852641).
FT                                {ECO:0000269|PubMed:11559313,
FT                                ECO:0000269|PubMed:15229130,
FT                                ECO:0000269|PubMed:15364702,
FT                                ECO:0000269|PubMed:16009764}.
FT                                /FTId=VAR_044289.
FT   VARIANT     335    335       S -> C (in CADASIL1).
FT                                {ECO:0000269|PubMed:15364702,
FT                                ECO:0000269|PubMed:16009764}.
FT                                /FTId=VAR_044290.
FT   VARIANT     337    337       Y -> C (in CADASIL1).
FT                                {ECO:0000269|PubMed:15364702,
FT                                ECO:0000269|PubMed:16009764}.
FT                                /FTId=VAR_044291.
FT   VARIANT     379    379       C -> S (in CADASIL1).
FT                                {ECO:0000269|PubMed:15364702,
FT                                ECO:0000269|PubMed:16009764}.
FT                                /FTId=VAR_044292.
FT   VARIANT     395    395       C -> R (in CADASIL1).
FT                                {ECO:0000269|PubMed:15364702,
FT                                ECO:0000269|PubMed:16009764}.
FT                                /FTId=VAR_044293.
FT   VARIANT     420    420       G -> C (in CADASIL1).
FT                                {ECO:0000269|PubMed:12146805}.
FT                                /FTId=VAR_044294.
FT   VARIANT     421    421       R -> C (in CADASIL1).
FT                                {ECO:0000269|PubMed:15364702,
FT                                ECO:0000269|PubMed:16009764}.
FT                                /FTId=VAR_044295.
FT   VARIANT     428    428       C -> S (in CADASIL1; dbSNP:rs267606915).
FT                                {ECO:0000269|PubMed:11755616}.
FT                                /FTId=VAR_044296.
FT   VARIANT     428    428       C -> Y (in CADASIL1).
FT                                {ECO:0000269|PubMed:15364702,
FT                                ECO:0000269|PubMed:16009764}.
FT                                /FTId=VAR_044297.
FT   VARIANT     440    440       C -> G (in CADASIL1).
FT                                {ECO:0000269|PubMed:12146805,
FT                                ECO:0000269|PubMed:15229130}.
FT                                /FTId=VAR_044298.
FT   VARIANT     440    440       C -> R (in CADASIL1).
FT                                {ECO:0000269|PubMed:15364702,
FT                                ECO:0000269|PubMed:16009764}.
FT                                /FTId=VAR_044299.
FT   VARIANT     446    446       C -> S (in CADASIL1).
FT                                {ECO:0000269|PubMed:15364702}.
FT                                /FTId=VAR_044300.
FT   VARIANT     449    449       R -> C (in CADASIL1).
FT                                {ECO:0000269|PubMed:12146805}.
FT                                /FTId=VAR_044301.
FT   VARIANT     455    455       C -> R (in CADASIL1; dbSNP:rs28933698).
FT                                {ECO:0000269|PubMed:12136071}.
FT                                /FTId=VAR_044302.
FT   VARIANT     484    484       C -> F (in CADASIL1).
FT                                {ECO:0000269|PubMed:16009764}.
FT                                /FTId=VAR_044303.
FT   VARIANT     484    484       C -> Y (in CADASIL1).
FT                                {ECO:0000269|PubMed:15364702}.
FT                                /FTId=VAR_044304.
FT   VARIANT     495    495       C -> Y (in CADASIL1).
FT                                {ECO:0000269|PubMed:15364702,
FT                                ECO:0000269|PubMed:16009764}.
FT                                /FTId=VAR_044305.
FT   VARIANT     496    496       P -> L (in dbSNP:rs11670799).
FT                                {ECO:0000269|PubMed:9388399}.
FT                                /FTId=VAR_012889.
FT   VARIANT     511    511       C -> R (in CADASIL1).
FT                                {ECO:0000269|PubMed:15364702,
FT                                ECO:0000269|PubMed:16009764}.
FT                                /FTId=VAR_044306.
FT   VARIANT     542    542       C -> Y (in CADASIL1).
FT                                {ECO:0000269|PubMed:11102981,
FT                                ECO:0000269|PubMed:9388399}.
FT                                /FTId=VAR_012890.
FT   VARIANT     544    544       R -> C (in CADASIL1; dbSNP:rs201118034).
FT                                {ECO:0000269|PubMed:10371548}.
FT                                /FTId=VAR_044307.
FT   VARIANT     549    549       C -> Y (in CADASIL1).
FT                                {ECO:0000269|PubMed:15364702,
FT                                ECO:0000269|PubMed:16009764}.
FT                                /FTId=VAR_044308.
FT   VARIANT     558    558       R -> C (in CADASIL1; dbSNP:rs75068032).
FT                                {ECO:0000269|PubMed:11102981,
FT                                ECO:0000269|PubMed:11755616,
FT                                ECO:0000269|PubMed:15364702,
FT                                ECO:0000269|PubMed:16009764,
FT                                ECO:0000269|PubMed:9388399}.
FT                                /FTId=VAR_012891.
FT   VARIANT     578    578       R -> C (in CADASIL1; dbSNP:rs769773673).
FT                                {ECO:0000269|PubMed:11102981,
FT                                ECO:0000269|PubMed:9388399}.
FT                                /FTId=VAR_012892.
FT   VARIANT     607    607       R -> C (in CADASIL1; dbSNP:rs777751303).
FT                                {ECO:0000269|PubMed:11102981,
FT                                ECO:0000269|PubMed:15229130}.
FT                                /FTId=VAR_044309.
FT   VARIANT     710    710       Y -> C (in CADASIL1; found in a compound
FT                                heterozygote also carrying an intragenic
FT                                frameshift deletion).
FT                                {ECO:0000269|PubMed:24000151}.
FT                                /FTId=VAR_072080.
FT   VARIANT     728    728       R -> C (in CADASIL1; dbSNP:rs1057519101).
FT                                {ECO:0000269|PubMed:11102981,
FT                                ECO:0000269|PubMed:16009764,
FT                                ECO:0000269|PubMed:9388399}.
FT                                /FTId=VAR_012893.
FT   VARIANT     775    775       C -> S (in CADASIL1).
FT                                {ECO:0000269|PubMed:16009764}.
FT                                /FTId=VAR_044310.
FT   VARIANT     953    953       G -> C (in CADASIL1).
FT                                {ECO:0000269|PubMed:12146805,
FT                                ECO:0000269|PubMed:15229130}.
FT                                /FTId=VAR_044311.
FT   VARIANT     984    984       F -> C (in CADASIL1).
FT                                {ECO:0000269|PubMed:11102981}.
FT                                /FTId=VAR_044312.
FT   VARIANT     985    985       R -> C (in CADASIL1).
FT                                {ECO:0000269|PubMed:11102981,
FT                                ECO:0000269|PubMed:11755616,
FT                                ECO:0000269|PubMed:15364702,
FT                                ECO:0000269|PubMed:16009764,
FT                                ECO:0000269|PubMed:9388399}.
FT                                /FTId=VAR_012894.
FT   VARIANT    1006   1006       R -> C (in CADASIL1).
FT                                {ECO:0000269|PubMed:11102981,
FT                                ECO:0000269|PubMed:9388399}.
FT                                /FTId=VAR_012895.
FT   VARIANT    1015   1015       C -> R (in CADASIL1).
FT                                {ECO:0000269|PubMed:10371548}.
FT                                /FTId=VAR_044313.
FT   VARIANT    1020   1020       A -> P (in dbSNP:rs35769976).
FT                                /FTId=VAR_044314.
FT   VARIANT    1021   1021       Y -> C (in CADASIL1).
FT                                {ECO:0000269|PubMed:12146805}.
FT                                /FTId=VAR_044315.
FT   VARIANT    1031   1031       R -> C (in CADASIL1).
FT                                {ECO:0000269|PubMed:11102981,
FT                                ECO:0000269|PubMed:9388399}.
FT                                /FTId=VAR_012896.
FT   VARIANT    1063   1063       D -> C (in CADASIL1; requires 2
FT                                nucleotide substitutions).
FT                                {ECO:0000269|PubMed:11755616}.
FT                                /FTId=VAR_044316.
FT   VARIANT    1133   1133       H -> Q (in dbSNP:rs112197217).
FT                                {ECO:0000269|PubMed:9388399}.
FT                                /FTId=VAR_012897.
FT   VARIANT    1183   1183       V -> M (in dbSNP:rs10408676).
FT                                {ECO:0000269|PubMed:9388399}.
FT                                /FTId=VAR_012898.
FT   VARIANT    1231   1231       R -> C (in CADASIL1; dbSNP:rs201680145).
FT                                {ECO:0000269|PubMed:11102981,
FT                                ECO:0000269|PubMed:15229130,
FT                                ECO:0000269|PubMed:9388399}.
FT                                /FTId=VAR_012899.
FT   VARIANT    1261   1261       C -> R (in CADASIL1).
FT                                {ECO:0000269|PubMed:11102981,
FT                                ECO:0000269|PubMed:9388399}.
FT                                /FTId=VAR_012900.
FT   VARIANT    1261   1261       C -> Y (in CADASIL1).
FT                                {ECO:0000269|PubMed:15364702,
FT                                ECO:0000269|PubMed:16009764}.
FT                                /FTId=VAR_044317.
FT   VARIANT    1515   1515       L -> P (in brain small-vessel-disease;
FT                                exhibits increased NOTCH3 signaling in a
FT                                ligand-independent fashion).
FT                                {ECO:0000269|PubMed:18273901}.
FT                                /FTId=VAR_044318.
FT   VARIANT    1519   1519       L -> P (in IMF2; dbSNP:rs367543285).
FT                                {ECO:0000269|PubMed:23731542}.
FT                                /FTId=VAR_069927.
FT   VARIANT    2223   2223       A -> V (in dbSNP:rs1044009).
FT                                {ECO:0000269|PubMed:8878478,
FT                                ECO:0000269|PubMed:9388399}.
FT                                /FTId=VAR_012901.
FT   STRAND     1389   1391       {ECO:0000244|PDB:5CZX}.
FT   HELIX      1393   1395       {ECO:0000244|PDB:5CZV}.
FT   STRAND     1398   1400       {ECO:0000244|PDB:5CZX}.
FT   HELIX      1403   1405       {ECO:0000244|PDB:4ZLP}.
FT   TURN       1408   1410       {ECO:0000244|PDB:5CZX}.
FT   HELIX      1411   1414       {ECO:0000244|PDB:5CZX}.
FT   TURN       1415   1420       {ECO:0000244|PDB:5CZX}.
FT   TURN       1424   1427       {ECO:0000244|PDB:5CZX}.
FT   TURN       1431   1433       {ECO:0000244|PDB:5CZX}.
FT   HELIX      1434   1437       {ECO:0000244|PDB:5CZX}.
FT   STRAND     1439   1441       {ECO:0000244|PDB:5CZX}.
FT   HELIX      1444   1446       {ECO:0000244|PDB:5CZX}.
FT   TURN       1449   1451       {ECO:0000244|PDB:5CZX}.
FT   HELIX      1452   1456       {ECO:0000244|PDB:5CZX}.
FT   TURN       1457   1459       {ECO:0000244|PDB:5CZX}.
FT   HELIX      1463   1465       {ECO:0000244|PDB:5CZX}.
FT   HELIX      1469   1471       {ECO:0000244|PDB:5CZX}.
FT   HELIX      1472   1478       {ECO:0000244|PDB:5CZX}.
FT   STRAND     1481   1483       {ECO:0000244|PDB:5CZX}.
FT   HELIX      1486   1488       {ECO:0000244|PDB:5CZX}.
FT   HELIX      1491   1493       {ECO:0000244|PDB:5CZX}.
FT   HELIX      1495   1498       {ECO:0000244|PDB:5CZX}.
FT   STRAND     1510   1519       {ECO:0000244|PDB:5CZX}.
FT   HELIX      1521   1526       {ECO:0000244|PDB:5CZX}.
FT   HELIX      1528   1539       {ECO:0000244|PDB:5CZX}.
FT   STRAND     1541   1545       {ECO:0000244|PDB:5CZX}.
FT   STRAND     1555   1558       {ECO:0000244|PDB:5CZX}.
FT   STRAND     1579   1587       {ECO:0000244|PDB:5CZX}.
FT   TURN       1589   1592       {ECO:0000244|PDB:5CZV}.
FT   TURN       1595   1597       {ECO:0000244|PDB:4ZLP}.
FT   STRAND     1598   1600       {ECO:0000244|PDB:5CZV}.
FT   HELIX      1604   1616       {ECO:0000244|PDB:5CZX}.
FT   STRAND     1626   1632       {ECO:0000244|PDB:5CZX}.
SQ   SEQUENCE   2321 AA;  243631 MW;  3E70EC12A59CD638 CRC64;
     MGPGARGRRR RRRPMSPPPP PPPVRALPLL LLLAGPGAAA PPCLDGSPCA NGGRCTQLPS
     REAACLCPPG WVGERCQLED PCHSGPCAGR GVCQSSVVAG TARFSCRCPR GFRGPDCSLP
     DPCLSSPCAH GARCSVGPDG RFLCSCPPGY QGRSCRSDVD ECRVGEPCRH GGTCLNTPGS
     FRCQCPAGYT GPLCENPAVP CAPSPCRNGG TCRQSGDLTY DCACLPGFEG QNCEVNVDDC
     PGHRCLNGGT CVDGVNTYNC QCPPEWTGQF CTEDVDECQL QPNACHNGGT CFNTLGGHSC
     VCVNGWTGES CSQNIDDCAT AVCFHGATCH DRVASFYCAC PMGKTGLLCH LDDACVSNPC
     HEDAICDTNP VNGRAICTCP PGFTGGACDQ DVDECSIGAN PCEHLGRCVN TQGSFLCQCG
     RGYTGPRCET DVNECLSGPC RNQATCLDRI GQFTCICMAG FTGTYCEVDI DECQSSPCVN
     GGVCKDRVNG FSCTCPSGFS GSTCQLDVDE CASTPCRNGA KCVDQPDGYE CRCAEGFEGT
     LCDRNVDDCS PDPCHHGRCV DGIASFSCAC APGYTGTRCE SQVDECRSQP CRHGGKCLDL
     VDKYLCRCPS GTTGVNCEVN IDDCASNPCT FGVCRDGINR YDCVCQPGFT GPLCNVEINE
     CASSPCGEGG SCVDGENGFR CLCPPGSLPP LCLPPSHPCA HEPCSHGICY DAPGGFRCVC
     EPGWSGPRCS QSLARDACES QPCRAGGTCS SDGMGFHCTC PPGVQGRQCE LLSPCTPNPC
     EHGGRCESAP GQLPVCSCPQ GWQGPRCQQD VDECAGPAPC GPHGICTNLA GSFSCTCHGG
     YTGPSCDQDI NDCDPNPCLN GGSCQDGVGS FSCSCLPGFA GPRCARDVDE CLSNPCGPGT
     CTDHVASFTC TCPPGYGGFH CEQDLPDCSP SSCFNGGTCV DGVNSFSCLC RPGYTGAHCQ
     HEADPCLSRP CLHGGVCSAA HPGFRCTCLE SFTGPQCQTL VDWCSRQPCQ NGGRCVQTGA
     YCLCPPGWSG RLCDIRSLPC REAAAQIGVR LEQLCQAGGQ CVDEDSSHYC VCPEGRTGSH
     CEQEVDPCLA QPCQHGGTCR GYMGGYMCEC LPGYNGDNCE DDVDECASQP CQHGGSCIDL
     VARYLCSCPP GTLGVLCEIN EDDCGPGPPL DSGPRCLHNG TCVDLVGGFR CTCPPGYTGL
     RCEADINECR SGACHAAHTR DCLQDPGGGF RCLCHAGFSG PRCQTVLSPC ESQPCQHGGQ
     CRPSPGPGGG LTFTCHCAQP FWGPRCERVA RSCRELQCPV GVPCQQTPRG PRCACPPGLS
     GPSCRSFPGS PPGASNASCA AAPCLHGGSC RPAPLAPFFR CACAQGWTGP RCEAPAAAPE
     VSEEPRCPRA ACQAKRGDQR CDRECNSPGC GWDGGDCSLS VGDPWRQCEA LQCWRLFNNS
     RCDPACSSPA CLYDNFDCHA GGRERTCNPV YEKYCADHFA DGRCDQGCNT EECGWDGLDC
     ASEVPALLAR GVLVLTVLLP PEELLRSSAD FLQRLSAILR TSLRFRLDAH GQAMVFPYHR
     PSPGSEPRAR RELAPEVIGS VVMLEIDNRL CLQSPENDHC FPDAQSAADY LGALSAVERL
     DFPYPLRDVR GEPLEPPEPS VPLLPLLVAG AVLLLVILVL GVMVARRKRE HSTLWFPEGF
     SLHKDVASGH KGRREPVGQD ALGMKNMAKG ESLMGEVATD WMDTECPEAK RLKVEEPGMG
     AEEAVDCRQW TQHHLVAADI RVAPAMALTP PQGDADADGM DVNVRGPDGF TPLMLASFCG
     GALEPMPTEE DEADDTSASI ISDLICQGAQ LGARTDRTGE TALHLAARYA RADAAKRLLD
     AGADTNAQDH SGRTPLHTAV TADAQGVFQI LIRNRSTDLD ARMADGSTAL ILAARLAVEG
     MVEELIASHA DVNAVDELGK SALHWAAAVN NVEATLALLK NGANKDMQDS KEETPLFLAA
     REGSYEAAKL LLDHFANREI TDHLDRLPRD VAQERLHQDI VRLLDQPSGP RSPPGPHGLG
     PLLCPPGAFL PGLKAAQSGS KKSRRPPGKA GLGPQGPRGR GKKLTLACPG PLADSSVTLS
     PVDSLDSPRP FGGPPASPGG FPLEGPYAAA TATAVSLAQL GGPGRAGLGR QPPGGCVLSL
     GLLNPVAVPL DWARLPPPAP PGPSFLLPLA PGPQLLNPGT PVSPQERPPP YLAVPGHGEE
     YPAAGAHSSP PKARFLRVPS EHPYLTPSPE SPEHWASPSP PSLSDWSEST PSPATATGAM
     ATTTGALPAQ PLPLSVPSSL AQAQTQLGPQ PEVTPKRQVL A
//
ID   APH1_DROME              Reviewed;         238 AA.
AC   Q9VQG2;
DT   26-SEP-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   25-OCT-2017, entry version 120.
DE   RecName: Full=Gamma-secretase subunit Aph-1;
DE   AltName: Full=Presenilin-stabilization factor;
GN   Name=aph-1; Synonyms=PSF; ORFNames=CG2855;
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta;
OC   Pterygota; Neoptera; Holometabola; Diptera; Brachycera; Muscomorpha;
OC   Ephydroidea; Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Lee H.-J., Kim T.-W.;
RT   "PSF is essential for gamma-secretase activity and stabilization of
RT   presenilin and nicastrin.";
RL   Submitted (MAY-2002) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley;
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X.,
RA   Brandon R.C., Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D.,
RA   Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G.,
RA   Abril J.F., Agbayani A., An H.-J., Andrews-Pfannkoch C., Baldwin D.,
RA   Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M.,
RA   Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S.,
RA   Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P.,
RA   Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I.,
RA   Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P.,
RA   de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M.,
RA   Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P.,
RA   Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W.,
RA   Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K.,
RA   Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J.,
RA   Hostin D., Houston K.A., Howland T.J., Wei M.-H., Ibegwam C.,
RA   Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A.,
RA   Kimmel B.E., Kodira C.D., Kraft C.L., Kravitz S., Kulp D., Lai Z.,
RA   Lasko P., Lei Y., Levitsky A.A., Li J.H., Li Z., Liang Y., Lin X.,
RA   Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D.,
RA   Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A.,
RA   Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L.,
RA   Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M.,
RA   Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G.,
RA   Reinert K., Remington K., Saunders R.D.C., Scheeler F., Shen H.,
RA   Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E.,
RA   Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X.,
RA   Wang Z.-Y., Wassarman D.A., Weinstock G.M., Weissenbach J.,
RA   Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A.,
RA   Ye J., Yeh R.-F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L.,
RA   Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S.C., Zhu X.,
RA   Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=Berkeley;
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q.,
RA   Stapleton M., Yamada C., Ashburner M., Gelbart W.M., Rubin G.M.,
RA   Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a
RT   systematic review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=Berkeley; TISSUE=Embryo;
RX   PubMed=12537569; DOI=10.1186/gb-2002-3-12-research0080;
RA   Stapleton M., Carlson J.W., Brokstein P., Yu C., Champe M.,
RA   George R.A., Guarin H., Kronmiller B., Pacleb J.M., Park S., Wan K.H.,
RA   Rubin G.M., Celniker S.E.;
RT   "A Drosophila full-length cDNA resource.";
RL   Genome Biol. 3:RESEARCH0080.1-RESEARCH0080.8(2002).
RN   [5]
RP   FUNCTION.
RX   PubMed=12110170; DOI=10.1016/S1534-5807(02)00189-2;
RA   Francis R., McGrath G., Zhang J., Ruddy D.A., Sym M., Apfeld J.,
RA   Nicoll M., Maxwell M., Hai B., Ellis M.C., Parks A.L., Xu W., Li J.,
RA   Gurney M., Myers R.L., Himes C.S., Hiebsch R., Ruble C., Nye J.S.,
RA   Curtis D.;
RT   "aph-1 and pen-2 are required for Notch pathway signaling, gamma-
RT   secretase cleavage of betaAPP, and presenilin protein accumulation.";
RL   Dev. Cell 3:85-97(2002).
RN   [6]
RP   FUNCTION IN THE GAMMA-SECRETASE COMPLEX, AND INTERACTION WITH PEN-2;
RP   PSN AND NCT.
RX   PubMed=12660785; DOI=10.1038/nature01506;
RA   Takasugi N., Tomita T., Hayashi I., Tsuruoka M., Niimura M.,
RA   Takahashi Y., Thinakaran G., Iwatsubo T.;
RT   "The role of presenilin cofactors in the gamma-secretase complex.";
RL   Nature 422:438-441(2003).
CC   -!- FUNCTION: Essential subunit of the gamma-secretase complex, an
CC       endoprotease complex that catalyzes the intramembrane cleavage of
CC       integral membrane proteins such as Notch. It probably represents a
CC       stabilizing cofactor for the presenilin homodimer that promotes
CC       the formation of a stable complex. {ECO:0000269|PubMed:12110170,
CC       ECO:0000269|PubMed:12660785}.
CC   -!- SUBUNIT: Component of the gamma-secretase complex, a complex
CC       composed of a presenilin (Psn) homodimer, nicastrin (Nct), Aph-1
CC       and Pen-2.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the APH-1 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF508786; AAN63815.1; -; mRNA.
DR   EMBL; AE014134; AAF51212.1; -; Genomic_DNA.
DR   EMBL; AY051658; AAK93082.1; -; mRNA.
DR   RefSeq; NP_001259963.1; NM_001273034.1.
DR   RefSeq; NP_608710.1; NM_134866.3.
DR   UniGene; Dm.19771; -.
DR   ProteinModelPortal; Q9VQG2; -.
DR   SMR; Q9VQG2; -.
DR   BioGrid; 59690; 10.
DR   MINT; MINT-827568; -.
DR   STRING; 7227.FBpp0077400; -.
DR   PaxDb; Q9VQG2; -.
DR   PRIDE; Q9VQG2; -.
DR   EnsemblMetazoa; FBtr0077716; FBpp0077400; FBgn0031458.
DR   EnsemblMetazoa; FBtr0335127; FBpp0307126; FBgn0031458.
DR   GeneID; 33467; -.
DR   KEGG; dme:Dmel_CG2855; -.
DR   CTD; 33467; -.
DR   FlyBase; FBgn0031458; aph-1.
DR   eggNOG; KOG3972; Eukaryota.
DR   eggNOG; ENOG4111FIJ; LUCA.
DR   GeneTree; ENSGT00390000002049; -.
DR   InParanoid; Q9VQG2; -.
DR   KO; K06172; -.
DR   OMA; WSVIFFN; -.
DR   OrthoDB; EOG091G0IH0; -.
DR   PhylomeDB; Q9VQG2; -.
DR   Reactome; R-DME-1251985; Nuclear signaling by ERBB4.
DR   Reactome; R-DME-1980148; Signaling by NOTCH3.
DR   Reactome; R-DME-1980150; Signaling by NOTCH4.
DR   Reactome; R-DME-3928665; EPH-ephrin mediated repulsion of cells.
DR   SignaLink; Q9VQG2; -.
DR   GenomeRNAi; 33467; -.
DR   PRO; PR:Q9VQG2; -.
DR   Proteomes; UP000000803; Chromosome 2L.
DR   Bgee; FBgn0031458; -.
DR   ExpressionAtlas; Q9VQG2; differential.
DR   Genevisible; Q9VQG2; DM.
DR   GO; GO:0005783; C:endoplasmic reticulum; IBA:GO_Central.
DR   GO; GO:0070765; C:gamma-secretase complex; IPI:FlyBase.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005770; C:late endosome; IDA:FlyBase.
DR   GO; GO:0055037; C:recycling endosome; IDA:FlyBase.
DR   GO; GO:0004175; F:endopeptidase activity; IMP:UniProtKB.
DR   GO; GO:0007220; P:Notch receptor processing; IBA:GO_Central.
DR   GO; GO:0007219; P:Notch signaling pathway; IMP:UniProtKB.
DR   GO; GO:0043085; P:positive regulation of catalytic activity; IEA:InterPro.
DR   GO; GO:0016485; P:protein processing; IBA:GO_Central.
DR   GO; GO:0008593; P:regulation of Notch signaling pathway; IGI:FlyBase.
DR   InterPro; IPR009294; Aph-1.
DR   PANTHER; PTHR12889; PTHR12889; 1.
DR   Pfam; PF06105; Aph-1; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Membrane; Notch signaling pathway;
KW   Reference proteome; Transmembrane; Transmembrane helix.
FT   CHAIN         1    238       Gamma-secretase subunit Aph-1.
FT                                /FTId=PRO_0000221058.
FT   TRANSMEM      6     26       Helical; Name=1. {ECO:0000255}.
FT   TRANSMEM     32     52       Helical; Name=2. {ECO:0000255}.
FT   TRANSMEM     53     73       Helical; Name=3. {ECO:0000255}.
FT   TRANSMEM    105    125       Helical; Name=4. {ECO:0000255}.
FT   TRANSMEM    152    172       Helical; Name=5. {ECO:0000255}.
FT   TRANSMEM    178    198       Helical; Name=6. {ECO:0000255}.
FT   TRANSMEM    201    221       Helical; Name=7. {ECO:0000255}.
SQ   SEQUENCE   238 AA;  26437 MW;  C61A24518DCA150F CRC64;
     MTLPEFFGCT FIAFGPPFAL FVFTIANDPV RIIILIAAAF FWLLSLLISS LWYALIPLKE
     FLAFGVVFSV CFQEAFRYII YRILRSTEQG LHAVAEDTRV TDNKHILAYV SGLGFGIISG
     MFALVNVLAD MSGPGTMGLK GGTELFFVTS AAQALSIILL HTFWSVIFFN AFDTNNYIHI
     GYVVFSHLFV SLITLLNANE LYTTTLLINY LVTILTGVLA FRVAGGTSRS FRKFITCQ
//
ID   PSN1_DANRE              Reviewed;         456 AA.
AC   Q9W6T7;
DT   26-SEP-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   25-OCT-2017, entry version 107.
DE   RecName: Full=Presenilin-1;
DE            Short=PS-1;
DE            Short=Zf-PS1;
DE            EC=3.4.23.- {ECO:0000269|PubMed:10521267};
GN   Name=psen1;
OS   Danio rerio (Zebrafish) (Brachydanio rerio).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Actinopterygii; Neopterygii; Teleostei; Ostariophysi; Cypriniformes;
OC   Cyprinidae; Danio.
OX   NCBI_TaxID=7955;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, CATALYTIC ACTIVITY, PROTEOLYTIC
RP   CLEAVAGE, MUTAGENESIS OF ASP-374, AND ACTIVE SITE.
RX   PubMed=10521267; DOI=10.1021/bi991453n;
RA   Leimer U., Lun K., Romig H., Walter J., Gruenberg J., Brand M.,
RA   Haass C.;
RT   "Zebrafish (Danio rerio) presenilin promotes aberrant amyloid beta-
RT   peptide production and requires a critical aspartate residue for its
RT   function in amyloidogenesis.";
RL   Biochemistry 38:13602-13609(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Embryo;
RG   NIH - Zebrafish Gene Collection (ZGC) project;
RL   Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Catalytic subunit of the gamma-secretase complex, an
CC       endoprotease complex that catalyzes the intramembrane cleavage of
CC       integral membrane proteins such as Notch receptors and APP
CC       (amyloid-beta precursor protein) (PubMed:10521267). Requires the
CC       presence of the other members of the gamma-secretase complex for
CC       protease activity. Plays a role in Notch and Wnt signaling
CC       cascades and regulation of downstream processes via its role in
CC       processing key regulatory proteins (By similarity).
CC       {ECO:0000250|UniProtKB:P49768, ECO:0000269|PubMed:10521267}.
CC   -!- SUBUNIT: Homodimer. The functional gamma-secretase complex is
CC       composed of at least four polypeptides: a presenilin homodimer
CC       (PSEN1 or PSEN2), nicastrin (NCSTN), APH1 (APH1A or APH1B) and
CC       PEN2. Such minimal complex is sufficient for secretase activity.
CC       {ECO:0000250|UniProtKB:P49768}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:P49768}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:P49768}. Golgi apparatus membrane
CC       {ECO:0000250|UniProtKB:P49768}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:P49768}. Cytoplasmic granule
CC       {ECO:0000250|UniProtKB:P49768}. Cell membrane
CC       {ECO:0000250|UniProtKB:P49768}. Cell projection, axon
CC       {ECO:0000250|UniProtKB:Q4JIM4}. Cell junction, synapse
CC       {ECO:0000250|UniProtKB:Q4JIM4}.
CC   -!- DEVELOPMENTAL STAGE: Expressed both maternally and zygotically.
CC       Ubiquitously expressed during embryogenesis.
CC   -!- DOMAIN: The PAL motif is required for normal active site
CC       conformation. {ECO:0000250|UniProtKB:P49768}.
CC   -!- PTM: Cleaved, probably through autocleavage.
CC       {ECO:0000269|PubMed:10521267}.
CC   -!- PTM: Heterogeneous proteolytic processing generates N-terminal
CC       (NTF) and C-terminal (CTF) fragments of approximately 35 and 20
CC       kDa, respectively. During apoptosis, the C-terminal fragment (CTF)
CC       is further cleaved by a caspase. {ECO:0000250|UniProtKB:P49768}.
CC   -!- SIMILARITY: Belongs to the peptidase A22A family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH54639.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ132931; CAB40386.1; -; mRNA.
DR   EMBL; BC054639; AAH54639.1; ALT_INIT; mRNA.
DR   RefSeq; NP_571099.1; NM_131024.1.
DR   UniGene; Dr.75852; -.
DR   STRING; 7955.ENSDARP00000030180; -.
DR   MEROPS; A22.001; -.
DR   PaxDb; Q9W6T7; -.
DR   PRIDE; Q9W6T7; -.
DR   GeneID; 30221; -.
DR   KEGG; dre:30221; -.
DR   CTD; 5663; -.
DR   ZFIN; ZDB-GENE-991119-4; psen1.
DR   eggNOG; KOG2736; Eukaryota.
DR   eggNOG; ENOG410XPZD; LUCA.
DR   HOGENOM; HOG000240228; -.
DR   HOVERGEN; HBG011375; -.
DR   InParanoid; Q9W6T7; -.
DR   KO; K04505; -.
DR   PhylomeDB; Q9W6T7; -.
DR   PRO; PR:Q9W6T7; -.
DR   Proteomes; UP000000437; Unplaced.
DR   GO; GO:0030424; C:axon; IBA:GO_Central.
DR   GO; GO:0005938; C:cell cortex; IBA:GO_Central.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0009986; C:cell surface; IBA:GO_Central.
DR   GO; GO:0035253; C:ciliary rootlet; IBA:GO_Central.
DR   GO; GO:0043198; C:dendritic shaft; IBA:GO_Central.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0070765; C:gamma-secretase complex; ISS:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; ISS:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0030426; C:growth cone; IBA:GO_Central.
DR   GO; GO:0016021; C:integral component of membrane; ISS:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISS:UniProtKB.
DR   GO; GO:0031224; C:intrinsic component of membrane; IDA:ZFIN.
DR   GO; GO:0005765; C:lysosomal membrane; IBA:GO_Central.
DR   GO; GO:0045121; C:membrane raft; IBA:GO_Central.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IBA:GO_Central.
DR   GO; GO:0005739; C:mitochondrion; ISS:UniProtKB.
DR   GO; GO:0031594; C:neuromuscular junction; IBA:GO_Central.
DR   GO; GO:0043025; C:neuronal cell body; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0005790; C:smooth endoplasmic reticulum; IEA:GOC.
DR   GO; GO:0030018; C:Z disc; IBA:GO_Central.
DR   GO; GO:0042500; F:aspartic endopeptidase activity, intramembrane cleaving; ISS:UniProtKB.
DR   GO; GO:0008013; F:beta-catenin binding; IBA:GO_Central.
DR   GO; GO:0045296; F:cadherin binding; IBA:GO_Central.
DR   GO; GO:0004175; F:endopeptidase activity; IBA:GO_Central.
DR   GO; GO:0034205; P:amyloid-beta formation; IDA:ZFIN.
DR   GO; GO:0007420; P:brain development; IMP:ZFIN.
DR   GO; GO:0006816; P:calcium ion transport; IBA:GO_Central.
DR   GO; GO:0060070; P:canonical Wnt signaling pathway; IMP:ZFIN.
DR   GO; GO:0001946; P:lymphangiogenesis; IMP:ZFIN.
DR   GO; GO:0030318; P:melanocyte differentiation; IMP:ZFIN.
DR   GO; GO:0006509; P:membrane protein ectodomain proteolysis; ISS:UniProtKB.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IBA:GO_Central.
DR   GO; GO:0007220; P:Notch receptor processing; IBA:GO_Central.
DR   GO; GO:0007219; P:Notch signaling pathway; IDA:ZFIN.
DR   GO; GO:0043085; P:positive regulation of catalytic activity; ISS:UniProtKB.
DR   GO; GO:0016485; P:protein processing; ISS:UniProtKB.
DR   GO; GO:0060828; P:regulation of canonical Wnt signaling pathway; ISS:UniProtKB.
DR   GO; GO:0052548; P:regulation of endopeptidase activity; IDA:ZFIN.
DR   GO; GO:0001666; P:response to hypoxia; IDA:ZFIN.
DR   GO; GO:0051563; P:smooth endoplasmic reticulum calcium ion homeostasis; IBA:GO_Central.
DR   GO; GO:0061053; P:somite development; IMP:ZFIN.
DR   GO; GO:0036269; P:swimming behavior; IMP:ZFIN.
DR   InterPro; IPR001108; Peptidase_A22A.
DR   InterPro; IPR006639; Preselin/SPP.
DR   PANTHER; PTHR10202; PTHR10202; 1.
DR   Pfam; PF01080; Presenilin; 1.
DR   PRINTS; PR01072; PRESENILIN.
DR   SMART; SM00730; PSN; 1.
PE   1: Evidence at protein level;
KW   Cell junction; Cell membrane; Cell projection; Complete proteome;
KW   Endoplasmic reticulum; Golgi apparatus; Hydrolase; Membrane;
KW   Notch signaling pathway; Protease; Reference proteome; Synapse;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN         1    456       Presenilin-1.
FT                                /FTId=PRO_0000073897.
FT   TOPO_DOM      1     70       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P49768}.
FT   TRANSMEM     71     91       Helical. {ECO:0000250|UniProtKB:P49768}.
FT   TOPO_DOM     92    121       Lumenal. {ECO:0000250|UniProtKB:P49768}.
FT   TRANSMEM    122    142       Helical. {ECO:0000250|UniProtKB:P49768}.
FT   TOPO_DOM    143    155       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P49768}.
FT   TRANSMEM    156    178       Helical. {ECO:0000250|UniProtKB:P49768}.
FT   TOPO_DOM    179    183       Lumenal. {ECO:0000250|UniProtKB:P49768}.
FT   TRANSMEM    184    205       Helical. {ECO:0000250|UniProtKB:P49768}.
FT   TOPO_DOM    206    209       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P49768}.
FT   TRANSMEM    210    230       Helical. {ECO:0000250|UniProtKB:P49768}.
FT   TOPO_DOM    231    237       Lumenal. {ECO:0000250|UniProtKB:P49768}.
FT   TRANSMEM    238    261       Helical. {ECO:0000250|UniProtKB:P49768}.
FT   TOPO_DOM    262    369       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P49768}.
FT   TRANSMEM    370    390       Helical. {ECO:0000250|UniProtKB:P49768}.
FT   TOPO_DOM    391    396       Lumenal. {ECO:0000250|UniProtKB:P49768}.
FT   TRANSMEM    397    417       Helical. {ECO:0000250|UniProtKB:P49768}.
FT   TOPO_DOM    418    421       Cytoplasmic.
FT                                {ECO:0000250|UniProtKB:P49768}.
FT   TRANSMEM    422    442       Helical. {ECO:0000250|UniProtKB:P49768}.
FT   TOPO_DOM    443    456       Lumenal. {ECO:0000250|UniProtKB:P49768}.
FT   MOTIF       422    424       PAL. {ECO:0000305}.
FT   ACT_SITE    246    246       {ECO:0000250|UniProtKB:P49768}.
FT   ACT_SITE    374    374       {ECO:0000305|PubMed:10521267}.
FT   SITE        280    281       Cleavage; alternate.
FT                                {ECO:0000250|UniProtKB:P49768}.
FT   SITE        281    282       Cleavage; alternate.
FT                                {ECO:0000250|UniProtKB:P49768}.
FT   SITE        287    288       Cleavage. {ECO:0000250|UniProtKB:P49768}.
FT   MUTAGEN     374    374       D->A: Abolishes its endoproteolysis.
FT                                Probably loss of function.
FT                                {ECO:0000269|PubMed:10521267}.
FT   CONFLICT    308    308       Missing (in Ref. 2; AAH54639).
FT                                {ECO:0000305}.
FT   CONFLICT    317    317       A -> P (in Ref. 2; AAH54639).
FT                                {ECO:0000305}.
SQ   SEQUENCE   456 AA;  50981 MW;  B90C42280C874F8D CRC64;
     MADLVQNAAN NVLNDGMDTS RHTSSTAAPP SRNEVELNGQ PPTAPPPQVV TDSEEDEDEE
     LTLKYGAKHV IMLFIPVTLC MVVVVATIKS VSFYTQKDGQ QLIYTPFRED TETVGQRALH
     SMLNAIIMIS VIVVMTLVLV VLYKYRCYKV IQAWLFFSNL LLLFFFSLIY LGEVFKTYNV
     AMDYFTLALI IWNFGVVGMI CIHWKGPLRL QQAYLIMISA LMALVFIKYL PEWTAWLILA
     AISVYDLLAV LCPKGPLRIL VETAQERNEA IFPALIYSST MVWLFNMADS AETRNNSSHP
     VPQQENQVVA MAPTAQAEDD GGFTPAWVDH QQHQLGPMQS TEESRRQIQE MPSARPPPPA
     DDDEERGVKL GLGDFIFYSM LVGKASATAS GDWNTTLACF VAILIGLCLT LLLLAIFKKA
     LPALPISITF GLVFYFATDN LVRPFMDQLA VHQFYI
//
